data_1emo_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1emo _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A 2129 ' ' ASP . . . . . 0.548 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 17.2 t0 . . . . . 0 N--CA 1.485 1.325 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2130 ' ' GLU . . . . . 0.561 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 2.0 mt-10 81.89 -44.91 0.18 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.864 -0.523 . . . . 0.0 110.511 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2131 ' ' CYS . . . . . 0.502 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 6.6 p -91.26 -31.92 15.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.038 -1.039 . . . . 0.0 110.041 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2132 ' ' LYS . . . . . 0.441 ' HB2' ' CG ' ' A' 2129 ' ' ASP . 0.1 OUTLIER -69.66 -7.47 39.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.088 -1.008 . . . . 0.0 109.622 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -70.32 151.87 95.68 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.378 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2134 ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -66.19 -7.46 17.36 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.374 2.049 . . . . 0.0 110.619 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2135 ' ' ASP . . . . . 0.518 ' O ' ' ND2' ' A' 2162 ' ' ASN . 0.5 OUTLIER -117.44 19.66 13.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.031 -1.043 . . . . 0.0 109.917 -179.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 2136 ' ' VAL . . . . . 0.57 HG12 ' CE2' ' A' 2149 ' ' TYR . 21.4 t -144.55 127.94 11.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2137 ' ' CYS . . . . . 0.511 ' O ' ' HB2' ' A' 2138 ' ' LYS . 85.9 m 55.99 -90.28 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2138 ' ' LYS . . . . . 0.53 ' O ' ' CB ' ' A' 2139 ' ' HIS . 0.0 OUTLIER 70.0 19.39 6.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.397 -0.814 . . . . 0.0 109.983 179.121 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 2139 ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.3 OUTLIER 163.26 42.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.99 -1.069 . . . . 0.0 110.222 179.388 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -157.39 172.58 34.8 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.523 -1.323 . . . . 0.0 110.345 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2141 ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' 2152 ' ' GLU . 13.4 tt0 -89.71 98.08 11.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -1.1 . . . . 0.0 109.146 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2142 ' ' CYS . . . . . . . . . . . . . 24.0 p -89.04 177.81 6.55 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.312 -0.868 . . . . 0.0 110.204 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 2.6 mp -134.97 99.84 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2144 ' ' ASN . . . . . 0.548 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 6.5 t-20 -56.66 112.69 1.36 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.303 -0.873 . . . . 0.0 110.77 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2145 ' ' THR . . . . . 0.446 HG22 ' HA ' ' A' 2149 ' ' TYR . 14.4 p -96.24 178.95 5.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.313 -0.867 . . . . 0.0 108.962 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -65.04 -48.8 72.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.225 -0.922 . . . . 0.0 109.703 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2147 ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' 2148 ' ' SER . . . -132.3 49.81 0.91 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2148 ' ' SER . . . . . 0.465 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER 171.56 -160.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -1.19 . . . . 0.0 109.54 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 2149 ' ' TYR . . . . . 0.57 ' CE2' HG12 ' A' 2136 ' ' VAL . 3.9 p90 -158.13 -177.82 6.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.424 -0.798 . . . . 0.0 109.468 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2150 ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -151.52 99.38 2.61 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.17 -0.956 . . . . 0.0 109.706 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.86 136.21 56.62 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.561 -0.712 . . . . 0.0 109.778 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2152 ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' 2141 ' ' GLN . 0.1 OUTLIER -141.95 90.39 2.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.887 . . . . 0.0 109.241 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 2153 ' ' CYS . . . . . 0.505 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -69.38 149.26 97.29 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 109.496 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 2154 ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.2 -167.03 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.507 2.138 . . . . 0.0 111.112 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.05 105.52 17.87 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.6 -17.29 5.01 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 107.762 -2.135 . . . . 0.0 107.762 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2157 ' ' TYR . . . . . 0.528 ' CD2' ' C ' ' A' 2165 ' ' VAL . 9.0 m-85 -108.08 -171.46 1.87 Allowed 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.559 -0.965 . . . . 0.0 110.087 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2158 ' ' ILE . . . . . 0.56 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.1 OUTLIER -156.17 -166.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 2159 ' ' LEU . . . . . . . . . . . . . 33.9 tp -138.33 118.7 13.73 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.634 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -97.02 49.14 1.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.431 -0.793 . . . . 0.0 109.439 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 94.57 -28.82 10.09 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2162 ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' 2135 ' ' ASP . 1.4 m-20 -172.5 -43.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -1.116 . . . . 0.0 109.435 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -73.19 125.82 28.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.333 -0.855 . . . . 0.0 109.282 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2164 ' ' CYS . . . . . 0.462 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -102.74 137.88 40.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 108.956 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 2165 ' ' VAL . . . . . 0.528 ' C ' ' CD2' ' A' 2157 ' ' TYR . 0.6 OUTLIER -160.63 -166.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.05 -1.031 . . . . 0.0 109.97 -179.595 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 2166 ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 0.5 OUTLIER -88.56 150.62 22.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.973 . . . . 0.0 110.358 -179.15 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 2167 ' ' THR . . . . . 0.56 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 13.2 t -92.39 -175.9 4.15 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2168 ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' 2171 ' ' SER . 54.0 t0 -94.31 94.44 8.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.943 -1.098 . . . . 0.0 108.89 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2169 ' ' GLU . . . . . 0.569 ' HB3' ' CD1' ' A' 2188 ' ' PHE . 0.8 OUTLIER -70.77 -30.59 67.12 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.289 -0.882 . . . . 0.0 109.644 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 2170 ' ' CYS . . . . . 0.467 ' O ' ' SG ' ' A' 2181 ' ' CYS . 1.6 t -65.14 -11.29 38.55 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.231 -0.918 . . . . 0.0 108.616 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2171 ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.1 OUTLIER -68.99 -6.11 25.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.126 -0.984 . . . . 0.0 109.354 179.426 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 23.8 t -76.17 -67.98 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.291 -0.881 . . . . 0.0 109.247 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2173 ' ' GLY . . . . . . . . . . . . . . . 156.51 66.98 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2174 ' ' ASN . . . . . 0.502 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 2.8 t-20 49.75 84.92 0.2 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.22 -1.165 . . . . 0.0 109.573 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2175 ' ' PRO . . . . . 0.582 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 5.0 Cg_endo -68.9 -14.25 38.36 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.07 1.846 . . . . 0.0 109.548 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2176 ' ' CYS . . . . . 0.461 ' HB2' ' ND2' ' A' 2174 ' ' ASN . 1.0 OUTLIER -57.91 -62.01 2.12 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.972 0.891 . . . . 0.0 109.316 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 154.55 -21.27 0.62 Allowed Glycine 0 N--CA 1.482 1.744 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2178 ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' 2179 ' ' GLY . 1.2 t30 -165.1 -38.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -1.172 . . . . 0.0 110.148 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2179 ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -58.06 -141.8 0.01 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 2.3 p -127.46 154.67 44.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -1.139 . . . . 0.0 109.015 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2181 ' ' CYS . . . . . 0.557 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 9.5 p -95.21 163.22 13.37 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.238 1.018 . . . . 0.0 111.327 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2182 ' ' LYS . . . . . 0.529 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.6 OUTLIER -143.0 157.82 44.18 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 2183 ' ' ASN . . . . . 0.434 ' CG ' ' HA ' ' A' 2168 ' ' ASP . 44.5 t30 -94.64 131.14 40.74 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.349 -1.47 . . . . 0.0 110.007 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2184 ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' A' 2185 ' ' ILE . 0.3 OUTLIER -135.97 -163.23 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.589 -0.695 . . . . 0.0 109.481 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 2185 ' ' ILE . . . . . 0.524 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 2.8 mp -107.85 142.48 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.147 -0.971 . . . . 0.0 110.39 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2186 ' ' GLY . . . . . 0.406 ' O ' ' SD ' ' A' 2201 ' ' MET . . . 67.33 8.67 51.94 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2187 ' ' GLY . . . . . 0.503 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 166.59 -115.31 0.62 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2188 ' ' PHE . . . . . 0.582 ' CD2' ' HG2' ' A' 2175 ' ' PRO . 1.7 p90 -167.34 -178.62 4.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -1.116 . . . . 0.0 109.676 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2189 ' ' GLU . . . . . 0.529 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.2 OUTLIER -125.53 175.18 7.71 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 2190 ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' 2191 ' ' THR . 0.1 OUTLIER -170.82 158.12 5.78 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 118.649 -1.22 . . . . 0.0 110.01 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 2191 ' ' THR . . . . . 0.506 ' N ' ' SG ' ' A' 2190 ' ' CYS . 18.8 m -129.51 78.98 1.88 Allowed 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2192 ' ' CYS . . . . . 0.618 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 1.2 m -47.84 177.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -0.915 . . . . 0.0 109.412 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2193 ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.2 OUTLIER -49.56 113.76 0.9 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 2194 ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.7 tp10 -32.23 129.36 0.19 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.535 0.683 . . . . 0.0 110.907 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.78 0.38 10.91 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2196 ' ' PHE . . . . . 0.675 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.8 OUTLIER -111.19 -162.85 0.81 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.257 -1.143 . . . . 0.0 110.367 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 2197 ' ' GLU . . . . . 0.58 ' N ' ' CG ' ' A' 2196 ' ' PHE . 2.0 mm-40 -147.52 98.04 3.97 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2198 ' ' PRO . . . . . 0.675 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.9 Cg_endo -68.71 -158.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.292 1.995 . . . . 0.0 111.292 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -138.57 -173.97 13.22 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.66 -57.83 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.14 1.893 . . . . 0.0 110.937 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A 2201 ' ' MET . . . . . 0.503 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -157.84 49.08 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 110.266 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A 2202 ' ' MET . . . . . 0.524 ' O ' ' CE2' ' A' 2188 ' ' PHE . 2.7 mmt -119.73 -89.58 0.6 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.043 -1.035 . . . . 0.0 109.979 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2203 ' ' THR . . . . . 0.438 HG21 ' N ' ' A' 2204 ' ' CYS . 6.1 t -157.88 -164.27 1.49 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.208 -0.933 . . . . 0.0 109.404 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2204 ' ' CYS . . . . . 0.532 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 3.9 t -74.08 139.63 44.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.134 -0.979 . . . . 0.0 109.04 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A 2205 ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' 2197 ' ' GLU . 3.2 pt-20 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.631 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2129 ' ' ASP . . . . . 0.519 ' O ' ' CB ' ' A' 2130 ' ' GLU . 18.1 t0 . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2130 ' ' GLU . . . . . 0.592 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 1.7 mt-10 82.14 -46.97 0.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.741 -0.599 . . . . 0.0 110.537 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2131 ' ' CYS . . . . . 0.466 ' SG ' ' OD1' ' A' 2129 ' ' ASP . 11.2 p -90.42 -28.51 18.59 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.947 -1.096 . . . . 0.0 109.472 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2132 ' ' LYS . . . . . 0.47 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.1 OUTLIER -81.46 7.4 11.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.323 -0.86 . . . . 0.0 109.357 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 2133 ' ' GLU . . . . . 0.471 ' HB2' HG22 ' A' 2136 ' ' VAL . 44.8 mt-10 -69.57 149.93 96.91 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 121.297 -0.877 . . . . 0.0 109.158 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2134 ' ' PRO . . . . . 0.401 ' O ' ' HD2' ' A' 2138 ' ' LYS . 1.7 Cg_endo -65.38 -2.47 6.07 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.631 2.221 . . . . 0.0 111.74 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2135 ' ' ASP . . . . . 0.424 ' C ' ' OD1' ' A' 2135 ' ' ASP . 17.6 p30 -134.3 6.26 3.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.682 -1.261 . . . . 0.0 110.633 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2136 ' ' VAL . . . . . 0.517 ' O ' ' CB ' ' A' 2162 ' ' ASN . 53.4 t -101.22 -94.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.924 -1.11 . . . . 0.0 109.851 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2137 ' ' CYS . . . . . 0.476 ' O ' ' HB2' ' A' 2138 ' ' LYS . 0.1 OUTLIER -81.02 -72.77 0.41 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.988 -1.07 . . . . 0.0 109.364 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 2138 ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' 2137 ' ' CYS . 0.1 OUTLIER 65.48 100.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 110.079 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 2139 ' ' HIS . . . . . 0.486 ' O ' ' HB3' ' A' 2164 ' ' CYS . 57.6 m-70 67.29 55.2 0.68 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 110.026 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -153.96 174.9 32.4 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -105.03 82.96 1.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -1.159 . . . . 0.0 108.963 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2142 ' ' CYS . . . . . 0.429 ' C ' HD13 ' A' 2143 ' ' ILE . 17.3 p -88.32 177.09 6.95 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.37 -0.831 . . . . 0.0 110.345 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2143 ' ' ILE . . . . . 0.429 HD13 ' C ' ' A' 2142 ' ' CYS . 4.0 mp -134.24 101.83 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2144 ' ' ASN . . . . . 0.461 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 6.6 t-20 -58.37 116.87 3.9 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.197 -0.939 . . . . 0.0 110.522 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2145 ' ' THR . . . . . 0.418 ' OG1' ' C ' ' A' 2148 ' ' SER . 0.2 OUTLIER -103.73 174.25 5.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.469 -0.769 . . . . 0.0 108.955 179.142 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.64 -71.15 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.367 -0.833 . . . . 0.0 109.599 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2147 ' ' GLY . . . . . 0.483 ' O ' ' CB ' ' A' 2148 ' ' SER . . . -121.29 62.06 0.52 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2148 ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' 2147 ' ' GLY . 0.3 OUTLIER 166.83 -162.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -1.113 . . . . 0.0 109.546 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 2149 ' ' TYR . . . . . 0.592 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 51.4 p90 -169.1 -170.27 1.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 0.0 109.568 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2150 ' ' ARG . . . . . 0.41 ' HG3' HD11 ' A' 2143 ' ' ILE . 5.2 ptp180 -160.86 112.07 1.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.38 -0.825 . . . . 0.0 109.18 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 1.5 m -75.42 90.21 2.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.9 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -105.58 99.56 9.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 108.878 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2153 ' ' CYS . . . . . 0.5 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -67.64 153.55 94.83 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.249 -0.907 . . . . 0.0 109.9 -179.472 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 2154 ' ' PRO . . . . . 0.457 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.7 Cg_endo -66.06 -167.23 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.593 2.195 . . . . 0.0 111.318 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 81.6 t80 -90.44 102.61 15.34 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.86 -13.88 5.52 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2157 ' ' TYR . . . . . 0.5 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 7.6 m-85 -108.78 -169.87 1.57 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.439 -1.036 . . . . 0.0 110.016 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2158 ' ' ILE . . . . . 0.583 ' N ' ' CD1' ' A' 2158 ' ' ILE . 0.1 OUTLIER -154.76 -163.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 2159 ' ' LEU . . . . . 0.45 HD11 ' SG ' ' A' 2164 ' ' CYS . 29.6 tp -141.74 122.12 14.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.199 -0.938 . . . . 0.0 109.718 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -99.58 53.34 0.94 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.307 -0.871 . . . . 0.0 109.265 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2161 ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 87.36 -12.31 63.14 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2162 ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' 2136 ' ' VAL . 1.3 m-20 168.95 -44.85 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.303 -1.116 . . . . 0.0 109.382 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -71.5 114.5 9.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 109.144 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2164 ' ' CYS . . . . . 0.486 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -92.26 139.07 30.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 109.539 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 2165 ' ' VAL . . . . . 0.511 HG21 ' CD1' ' A' 2158 ' ' ILE . 3.7 m -156.99 -168.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.953 . . . . 0.0 109.569 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2166 ' ' ASP . . . . . 0.47 ' OD2' ' O ' ' A' 2184 ' ' VAL . 13.8 t70 -90.16 155.78 18.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.019 -1.051 . . . . 0.0 109.909 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2167 ' ' THR . . . . . 0.56 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 10.0 t -98.41 174.96 6.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -0.842 . . . . 0.0 109.248 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2168 ' ' ASP . . . . . 0.448 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 44.4 t0 -93.46 95.17 9.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.077 -1.014 . . . . 0.0 108.935 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2169 ' ' GLU . . . . . 0.565 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.6 OUTLIER -69.05 -32.26 71.61 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.318 -0.864 . . . . 0.0 109.573 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 2170 ' ' CYS . . . . . 0.498 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.1 t -65.22 -12.23 49.23 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.61 4.64 10.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.184 -0.947 . . . . 0.0 109.696 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 55.0 t -105.38 -79.03 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.21 -0.931 . . . . 0.0 109.857 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2173 ' ' GLY . . . . . 0.484 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -153.95 135.0 4.57 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2174 ' ' ASN . . . . . 0.583 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 26.0 p-10 -41.68 101.61 0.25 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.41 -1.053 . . . . 0.0 110.092 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2175 ' ' PRO . . . . . 0.553 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 1.1 Cg_endo -65.99 -21.87 56.13 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.827 1.685 . . . . 0.0 109.719 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2176 ' ' CYS . . . . . 0.582 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.1 OUTLIER -52.77 -35.76 57.0 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.169 -0.957 . . . . 0.0 109.308 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 114.4 -14.0 20.8 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2178 ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' 2179 ' ' GLY . 5.0 p-10 -171.48 -47.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.456 -1.026 . . . . 0.0 109.557 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2179 ' ' GLY . . . . . 0.536 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -52.47 -114.64 0.01 OUTLIER Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2180 ' ' THR . . . . . 0.48 HG21 ' O ' ' A' 2179 ' ' GLY . 0.8 OUTLIER -150.48 158.54 44.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -1.186 . . . . 0.0 109.371 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 2181 ' ' CYS . . . . . 0.583 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 16.0 p -90.3 166.14 13.49 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 122.368 1.08 . . . . 0.0 111.23 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2182 ' ' LYS . . . . . 0.586 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 11.3 tptt -143.84 155.81 44.25 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2183 ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 60.7 t30 -98.78 132.44 44.14 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.483 -1.385 . . . . 0.0 109.734 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2184 ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -140.8 -171.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 2185 ' ' ILE . . . . . 0.423 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 4.5 mp -104.85 135.67 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.85 -1.156 . . . . 0.0 110.387 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 72.68 13.53 78.14 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2187 ' ' GLY . . . . . 0.477 ' C ' ' CD2' ' A' 2188 ' ' PHE . . . 166.21 -121.18 0.97 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2188 ' ' PHE . . . . . 0.565 ' HB3' ' HB2' ' A' 2169 ' ' GLU . 4.3 p90 -176.4 173.71 2.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.355 -1.085 . . . . 0.0 108.966 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2189 ' ' GLU . . . . . 0.586 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 3.1 tt0 -120.9 178.07 4.86 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2190 ' ' CYS . . . . . 0.434 ' HB2' ' O ' ' A' 2180 ' ' THR . 7.6 p -170.9 152.17 3.54 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.861 -1.149 . . . . 0.0 109.436 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2191 ' ' THR . . . . . . . . . . . . . 46.0 m -122.37 91.21 3.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 0.0 110.032 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2192 ' ' CYS . . . . . 0.609 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -54.49 177.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.033 -1.042 . . . . 0.0 108.383 179.173 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 2193 ' ' GLU . . . . . 0.469 ' O ' ' C ' ' A' 2194 ' ' GLU . 7.4 tt0 -54.66 119.34 5.17 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 178.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2194 ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' 2193 ' ' GLU . 2.1 tt0 -35.08 131.58 0.4 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.536 0.684 . . . . 0.0 110.857 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.49 3.76 10.17 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2196 ' ' PHE . . . . . 0.678 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.0 OUTLIER -116.87 -163.89 0.94 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.224 -1.162 . . . . 0.0 110.489 -179.573 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 2197 ' ' GLU . . . . . 0.567 ' N ' ' CG ' ' A' 2196 ' ' PHE . 20.8 mt-10 -145.31 96.67 4.85 Favored Pre-proline 0 C--N 1.305 -1.364 0 O-C-N 121.633 -0.667 . . . . 0.0 109.512 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2198 ' ' PRO . . . . . 0.678 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.0 Cg_endo -68.69 -164.17 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.149 1.9 . . . . 0.0 111.012 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -133.29 -171.0 12.57 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.39 -81.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.028 1.819 . . . . 0.0 110.431 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2201 ' ' MET . . . . . 0.475 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.0 OUTLIER -133.99 49.97 2.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.089 -1.007 . . . . 0.0 109.684 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 1.7 mmm -122.1 -75.84 0.59 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.336 -0.853 . . . . 0.0 109.601 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A 2203 ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' 2175 ' ' PRO . 14.9 t -173.21 -173.69 0.95 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 109.748 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A 2204 ' ' CYS . . . . . 0.582 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -108.73 151.63 25.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.371 -0.831 . . . . 0.0 109.149 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.049 -0.976 . . . . 0.0 109.544 -179.984 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A 2129 ' ' ASP . . . . . 0.524 ' O ' ' ND2' ' A' 2144 ' ' ASN . 19.1 t0 . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2130 ' ' GLU . . . . . 0.553 ' CB ' ' CD2' ' A' 2149 ' ' TYR . 0.7 OUTLIER 81.52 -41.25 0.15 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.491 -0.756 . . . . 0.0 111.503 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 2131 ' ' CYS . . . . . 0.477 ' SG ' ' OD1' ' A' 2129 ' ' ASP . 14.5 p -90.57 -36.66 14.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.629 -1.294 . . . . 0.0 110.263 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2132 ' ' LYS . . . . . 0.48 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -81.62 7.62 11.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.164 -0.96 . . . . 0.0 109.798 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 2133 ' ' GLU . . . . . 0.466 ' HB2' HG22 ' A' 2136 ' ' VAL . 10.0 mt-10 -72.7 153.48 91.44 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.208 -0.933 . . . . 0.0 109.29 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2134 ' ' PRO . . . . . 0.507 ' HA ' ' CG ' ' A' 2138 ' ' LYS . 1.3 Cg_endo -63.72 -8.24 14.97 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.274 1.983 . . . . 0.0 110.667 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2135 ' ' ASP . . . . . 0.511 ' O ' ' ND2' ' A' 2162 ' ' ASN . 1.0 OUTLIER -104.34 -20.87 13.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.05 -1.031 . . . . 0.0 110.071 -179.577 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 2136 ' ' VAL . . . . . 0.527 ' CG1' ' CE1' ' A' 2149 ' ' TYR . 2.0 t -109.86 -140.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.1 -1.0 . . . . 0.0 108.98 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2137 ' ' CYS . . . . . 0.421 ' C ' ' O ' ' A' 2136 ' ' VAL . 0.8 OUTLIER -45.7 96.38 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.897 -1.127 . . . . 0.0 108.984 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 2138 ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' 2136 ' ' VAL . 5.0 mtmt -102.12 26.85 7.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.253 -0.904 . . . . 0.0 110.118 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2139 ' ' HIS . . . . . 0.496 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.1 OUTLIER 165.4 48.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.023 -1.048 . . . . 0.0 110.027 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 2140 ' ' GLY . . . . . 0.427 ' HA2' ' HD3' ' A' 2154 ' ' PRO . . . -152.97 -179.65 28.67 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -100.89 72.03 1.47 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.409 -1.054 . . . . 0.0 109.289 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2142 ' ' CYS . . . . . . . . . . . . . 7.4 p -62.9 -169.22 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.355 -0.84 . . . . 0.0 110.05 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 4.0 mp -141.54 103.09 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2144 ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' 2129 ' ' ASP . 6.6 t-20 -62.25 116.99 5.48 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.216 -0.927 . . . . 0.0 110.468 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2145 ' ' THR . . . . . 0.431 ' OG1' ' C ' ' A' 2148 ' ' SER . 2.2 p -107.23 -170.6 1.73 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.429 -0.795 . . . . 0.0 108.949 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.79 85.25 4.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.286 -0.883 . . . . 0.0 109.735 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 96.89 -55.58 1.34 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2148 ' ' SER . . . . . 0.431 ' C ' ' OG1' ' A' 2145 ' ' THR . 0.4 OUTLIER -84.72 -158.99 0.39 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -1.097 . . . . 0.0 109.828 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 2149 ' ' TYR . . . . . 0.553 ' CD2' ' CB ' ' A' 2130 ' ' GLU . 41.2 p90 -178.82 -167.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.489 -0.757 . . . . 0.0 109.375 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2150 ' ' ARG . . . . . 0.49 ' CB ' ' CZ ' ' A' 2150 ' ' ARG . 0.0 OUTLIER -169.02 115.07 0.6 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 109.321 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 43.3 t -81.55 113.1 19.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.704 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.48 84.29 2.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.011 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2153 ' ' CYS . . . . . 0.495 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -47.4 155.57 0.71 Allowed Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.259 -0.901 . . . . 0.0 109.798 -179.52 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 2154 ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' 2157 ' ' TYR . 1.1 Cg_endo -64.23 -168.8 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.73 2.286 . . . . 0.0 111.703 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 43.9 t80 -88.48 102.81 15.27 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.66 -14.76 5.51 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2157 ' ' TYR . . . . . 0.495 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 7.5 m-85 -109.05 -170.03 1.59 Allowed 'General case' 0 N--CA 1.483 1.222 0 O-C-N 121.574 -0.957 . . . . 0.0 109.74 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2158 ' ' ILE . . . . . 0.558 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.2 OUTLIER -156.95 -160.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.579 -0.701 . . . . 0.0 109.563 179.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 2159 ' ' LEU . . . . . 0.476 ' N ' HG12 ' A' 2158 ' ' ILE . 29.4 tp -145.57 124.17 12.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.414 -0.804 . . . . 0.0 109.377 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -99.02 51.54 0.96 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.353 -0.842 . . . . 0.0 109.486 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 90.26 -22.76 24.93 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2162 ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' 2135 ' ' ASP . 1.4 m-20 -176.03 -45.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.125 -1.22 . . . . 0.0 109.953 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -75.52 127.14 32.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.048 -1.033 . . . . 0.0 109.614 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2164 ' ' CYS . . . . . 0.476 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -99.74 140.38 34.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.69 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 2165 ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' 2164 ' ' CYS . 0.9 OUTLIER -161.82 -166.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.374 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 2166 ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 23.1 t70 -90.13 159.27 16.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.068 -1.02 . . . . 0.0 109.863 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2167 ' ' THR . . . . . 0.558 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 5.5 t -99.88 -167.42 1.46 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.185 -0.947 . . . . 0.0 109.362 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2168 ' ' ASP . . . . . 0.47 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 57.6 t0 -108.92 99.79 9.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.183 -0.948 . . . . 0.0 109.325 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2169 ' ' GLU . . . . . 0.558 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.6 OUTLIER -74.38 -30.68 62.08 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.21 -0.931 . . . . 0.0 109.446 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 2170 ' ' CYS . . . . . 0.467 ' O ' ' SG ' ' A' 2181 ' ' CYS . 3.1 t -66.85 -8.32 28.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.282 -0.886 . . . . 0.0 109.023 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2171 ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -70.33 -3.8 19.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.066 -1.021 . . . . 0.0 109.541 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 2172 ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' 2169 ' ' GLU . 17.7 t -86.27 -72.51 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 109.569 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2173 ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' 2174 ' ' ASN . . . 166.2 77.94 0.04 OUTLIER Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.641 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2174 ' ' ASN . . . . . 0.597 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 11.0 p-10 36.56 89.12 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.537 -0.978 . . . . 0.0 110.993 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2175 ' ' PRO . . . . . 0.578 ' HG2' ' CE2' ' A' 2188 ' ' PHE . 5.8 Cg_endo -67.5 -12.71 36.67 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.153 1.902 . . . . 0.0 109.227 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2176 ' ' CYS . . . . . 0.475 ' HB3' ' SG ' ' A' 2192 ' ' CYS . 0.9 OUTLIER -55.92 -58.02 9.63 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.834 0.826 . . . . 0.0 109.543 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 146.84 -26.22 1.62 Allowed Glycine 0 N--CA 1.484 1.854 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2178 ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.4 OUTLIER -157.05 -39.39 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.306 -1.114 . . . . 0.0 109.845 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 2179 ' ' GLY . . . . . 0.623 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -59.43 -140.02 0.01 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.5 p -133.19 148.0 52.04 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.53 -0.982 . . . . 0.0 109.4 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2181 ' ' CYS . . . . . 0.597 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 11.8 p -82.1 167.37 18.83 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.372 1.082 . . . . 0.0 111.439 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2182 ' ' LYS . . . . . 0.545 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 6.9 tttm -142.39 161.61 37.6 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2183 ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 46.6 t30 -101.12 128.78 47.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.412 -1.43 . . . . 0.0 110.108 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2184 ' ' VAL . . . . . 0.52 ' CG1' ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -137.41 -175.57 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 2185 ' ' ILE . . . . . 0.436 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 3.7 mp -100.05 140.85 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.114 -0.991 . . . . 0.0 110.053 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 70.62 8.4 63.2 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2187 ' ' GLY . . . . . 0.503 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 167.72 -121.4 0.96 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2188 ' ' PHE . . . . . 0.578 ' CE2' ' HG2' ' A' 2175 ' ' PRO . 2.3 p90 -169.04 178.61 4.39 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.272 -1.134 . . . . 0.0 109.295 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2189 ' ' GLU . . . . . 0.545 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.4 tt0 -124.19 -179.67 4.53 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2190 ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' 2191 ' ' THR . 0.5 OUTLIER -171.05 157.74 5.33 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 118.959 -1.096 . . . . 0.0 110.17 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 2191 ' ' THR . . . . . 0.514 ' N ' ' SG ' ' A' 2190 ' ' CYS . 80.3 m -128.75 80.27 1.96 Allowed 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2192 ' ' CYS . . . . . 0.623 ' HA ' ' HA3' ' A' 2179 ' ' GLY . 1.2 m -54.16 175.64 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.224 -0.922 . . . . 0.0 110.149 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2193 ' ' GLU . . . . . 0.508 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.5 tt0 -47.11 108.8 0.16 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2194 ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.4 OUTLIER -28.5 125.72 0.1 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.45 0.643 . . . . 0.0 111.237 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.78 4.22 9.7 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2196 ' ' PHE . . . . . 0.675 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.8 OUTLIER -112.71 -164.26 0.91 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.252 -1.146 . . . . 0.0 110.498 -179.628 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 2197 ' ' GLU . . . . . 0.556 ' N ' ' CG ' ' A' 2196 ' ' PHE . 16.6 mt-10 -145.39 97.29 4.74 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2198 ' ' PRO . . . . . 0.675 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.0 Cg_endo -68.47 -159.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.026 1.818 . . . . 0.0 110.999 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -136.05 -174.88 13.54 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.534 -1.827 . . . . 0.0 108.534 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.63 -52.79 1.64 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.114 1.876 . . . . 0.0 110.622 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A 2201 ' ' MET . . . . . 0.503 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -163.93 57.69 0.16 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.399 -0.813 . . . . 0.0 109.462 -179.52 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -127.99 -84.09 0.59 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 110.002 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2203 ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' 2175 ' ' PRO . 13.3 t -163.36 -164.15 0.91 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.346 -0.846 . . . . 0.0 108.827 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2204 ' ' CYS . . . . . 0.565 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 3.3 t -74.26 140.86 45.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.953 -1.092 . . . . 0.0 109.329 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A 2205 ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' 2197 ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.514 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2129 ' ' ASP . . . . . 0.522 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 53.5 t0 . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2130 ' ' GLU . . . . . 0.531 ' O ' ' CG1' ' A' 2136 ' ' VAL . 22.7 mp0 -49.11 -26.93 3.04 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.289 -0.882 . . . . 0.0 110.547 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2131 ' ' CYS . . . . . 0.491 ' O ' ' HB2' ' A' 2137 ' ' CYS . 0.8 OUTLIER -78.47 -36.1 45.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.701 -1.25 . . . . 0.0 109.678 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 2132 ' ' LYS . . . . . 0.434 ' HB2' ' CG ' ' A' 2129 ' ' ASP . 0.0 OUTLIER -85.53 44.8 1.13 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.003 -1.061 . . . . 0.0 108.623 178.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 2133 ' ' GLU . . . . . 0.54 ' CB ' ' HD2' ' A' 2134 ' ' PRO . 1.4 mt-10 -104.59 173.56 3.26 Favored Pre-proline 0 N--CA 1.486 1.349 0 O-C-N 121.466 -0.771 . . . . 0.0 109.765 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2134 ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' 2133 ' ' GLU . 3.1 Cg_exo -60.41 -11.62 17.32 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.584 2.189 . . . . 0.0 112.542 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2135 ' ' ASP . . . . . 0.581 ' O ' ' C ' ' A' 2136 ' ' VAL . 26.8 m-20 -145.95 -77.41 0.19 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.274 -1.516 . . . . 0.0 111.502 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2136 ' ' VAL . . . . . 0.626 ' CG2' ' CE1' ' A' 2149 ' ' TYR . 0.1 OUTLIER -12.77 -78.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 120.89 0.376 . . . . 0.0 111.057 -178.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 2137 ' ' CYS . . . . . 0.523 ' SG ' ' CG2' ' A' 2136 ' ' VAL . 13.0 m -121.11 146.07 47.13 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.689 -1.257 . . . . 0.0 108.949 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2138 ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' 2139 ' ' HIS . 2.4 mtpt -161.08 115.99 2.11 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.092 -1.005 . . . . 0.0 109.807 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2139 ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' 2138 ' ' LYS . 20.6 m80 71.42 46.63 0.41 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.212 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -154.17 174.9 32.56 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -89.81 86.14 6.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -1.159 . . . . 0.0 108.513 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2142 ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' 2150 ' ' ARG . 13.4 p -85.26 178.84 7.35 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.285 -0.884 . . . . 0.0 110.811 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 4.0 mp -140.02 88.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2144 ' ' ASN . . . . . 0.522 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 8.0 t-20 -53.94 116.08 2.36 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.515 0.674 . . . . 0.0 110.515 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2145 ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' 2146 ' ' ASP . 56.4 p -107.75 -171.31 1.85 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2146 ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' 2145 ' ' THR . 0.4 OUTLIER -45.4 -79.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 109.284 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -115.45 -33.61 1.57 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2148 ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.77 -162.13 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -1.138 . . . . 0.0 109.44 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2149 ' ' TYR . . . . . 0.626 ' CE1' ' CG2' ' A' 2136 ' ' VAL . 12.9 p90 -172.58 -172.72 0.93 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.373 -0.83 . . . . 0.0 109.312 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2150 ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' A' 2149 ' ' TYR . 11.6 mtt180 -159.6 113.79 2.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.392 -0.818 . . . . 0.0 109.24 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2151 ' ' CYS . . . . . 0.474 ' HB2' HD11 ' A' 2159 ' ' LEU . 4.1 m -84.03 68.21 9.96 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.492 -0.755 . . . . 0.0 109.275 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -79.49 134.74 36.52 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.314 -0.866 . . . . 0.0 108.983 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2153 ' ' CYS . . . . . 0.5 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -101.53 154.23 37.38 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.245 -0.909 . . . . 0.0 109.772 -179.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 2154 ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' 2157 ' ' TYR . 1.5 Cg_endo -64.4 -166.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.505 2.137 . . . . 0.0 110.906 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 65.8 t80 -90.34 102.53 15.26 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.26 -13.9 5.42 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.169 -1.973 . . . . 0.0 108.169 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2157 ' ' TYR . . . . . 0.528 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 7.4 m-85 -108.21 -167.92 1.3 Allowed 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.533 -0.981 . . . . 0.0 109.901 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2158 ' ' ILE . . . . . 0.553 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.2 OUTLIER -156.21 -166.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.6 -0.687 . . . . 0.0 109.193 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 2159 ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' 2151 ' ' CYS . 9.5 tp -143.17 130.4 20.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.313 -0.867 . . . . 0.0 109.332 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -101.4 46.6 0.93 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.261 -0.899 . . . . 0.0 108.921 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2161 ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' 2162 ' ' ASN . . . 86.36 -9.28 70.95 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2162 ' ' ASN . . . . . 0.509 ' CA ' ' O ' ' A' 2136 ' ' VAL . 12.7 p-10 178.05 -47.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.248 . . . . 0.0 109.882 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2163 ' ' GLU . . . . . 0.423 ' N ' ' CG ' ' A' 2162 ' ' ASN . 11.5 tt0 -77.82 116.54 18.41 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.7 -0.625 . . . . 0.0 109.867 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2164 ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' 2158 ' ' ILE . 0.0 OUTLIER -93.21 140.72 29.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.93 . . . . 0.0 109.457 179.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 2165 ' ' VAL . . . . . 0.459 ' O ' ' HB3' ' A' 2157 ' ' TYR . 1.4 m -157.12 -165.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.105 -0.997 . . . . 0.0 109.562 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2166 ' ' ASP . . . . . . . . . . . . . 35.0 t70 -89.13 165.75 14.29 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.936 -1.102 . . . . 0.0 110.226 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2167 ' ' THR . . . . . 0.553 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 1.6 t -113.56 -169.94 1.6 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.408 -0.808 . . . . 0.0 109.407 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2168 ' ' ASP . . . . . 0.516 ' N ' HG21 ' A' 2167 ' ' THR . 55.7 t0 -109.3 98.85 8.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.249 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2169 ' ' GLU . . . . . 0.549 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.6 OUTLIER -73.47 -31.61 63.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.366 -0.834 . . . . 0.0 109.33 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 2170 ' ' CYS . . . . . 0.444 ' O ' ' SG ' ' A' 2170 ' ' CYS . 1.7 t -66.27 -9.47 32.91 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.342 -0.849 . . . . 0.0 108.735 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.52 7.92 8.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.363 -0.836 . . . . 0.0 110.234 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 57.4 t -112.42 -80.23 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.0 -1.062 . . . . 0.0 109.772 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2173 ' ' GLY . . . . . 0.479 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -147.63 131.73 3.99 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2174 ' ' ASN . . . . . 0.585 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 26.9 p-10 -43.78 102.66 0.29 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.301 -1.117 . . . . 0.0 109.577 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2175 ' ' PRO . . . . . 0.57 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 2.7 Cg_endo -70.65 -20.24 30.9 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.807 1.671 . . . . 0.0 110.015 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2176 ' ' CYS . . . . . 0.565 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.1 OUTLIER -50.88 -31.12 16.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -0.989 . . . . 0.0 109.3 -179.463 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 112.63 -23.72 14.69 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.67 -34.57 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.577 -0.955 . . . . 0.0 110.028 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2179 ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -63.65 -127.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 2.8 p -135.71 157.79 46.0 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.527 -0.984 . . . . 0.0 109.133 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2181 ' ' CYS . . . . . 0.585 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 12.9 p -95.46 162.31 13.7 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.053 -1.03 . . . . 0.0 111.186 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2182 ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 5.3 tptm -142.23 165.28 27.87 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2183 ' ' ASN . . . . . 0.474 ' N ' ' HG3' ' A' 2182 ' ' LYS . 63.1 t30 -100.74 138.15 38.18 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.505 -1.372 . . . . 0.0 110.09 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2184 ' ' VAL . . . . . 0.574 ' CG1' ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -147.33 165.88 6.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 2185 ' ' ILE . . . . . 0.528 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 3.2 mp -86.85 131.47 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.071 -1.018 . . . . 0.0 110.224 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 86.43 6.34 81.0 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2187 ' ' GLY . . . . . 0.5 ' C ' ' CD1' ' A' 2188 ' ' PHE . . . 162.73 -113.63 0.57 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2188 ' ' PHE . . . . . 0.574 ' N ' ' CG1' ' A' 2184 ' ' VAL . 2.9 p90 -173.3 179.48 2.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.171 -1.194 . . . . 0.0 109.352 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2189 ' ' GLU . . . . . 0.539 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.6 tt0 -125.71 173.24 9.16 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 3.5 p -170.87 148.01 2.8 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.653 -1.279 . . . . 0.0 110.016 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2191 ' ' THR . . . . . . . . . . . . . 60.6 m -118.67 87.87 2.81 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.376 -0.828 . . . . 0.0 109.291 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2192 ' ' CYS . . . . . 0.6 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.0 OUTLIER -51.81 178.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.299 -0.876 . . . . 0.0 108.92 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 2193 ' ' GLU . . . . . 0.46 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.0 OUTLIER -53.33 118.22 3.65 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.494 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 2194 ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.4 mt-10 -34.2 128.94 0.38 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.444 0.64 . . . . 0.0 110.991 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.77 4.04 9.79 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2196 ' ' PHE . . . . . 0.672 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.1 p90 -115.06 -164.01 0.91 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.306 -1.114 . . . . 0.0 110.487 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2197 ' ' GLU . . . . . 0.555 ' N ' ' CG ' ' A' 2196 ' ' PHE . 14.5 mt-10 -145.58 96.64 4.76 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.652 -0.655 . . . . 0.0 109.444 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2198 ' ' PRO . . . . . 0.672 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.1 Cg_endo -68.42 -166.3 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.249 1.966 . . . . 0.0 111.44 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -133.25 -173.82 13.39 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.75 -78.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.005 1.803 . . . . 0.0 110.751 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2201 ' ' MET . . . . . 0.478 ' SD ' ' O ' ' A' 2185 ' ' ILE . 0.0 OUTLIER -138.73 40.76 2.18 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.224 -0.922 . . . . 0.0 109.634 -179.271 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 1.6 mmm -112.41 -69.25 0.88 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.131 -0.98 . . . . 0.0 109.721 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2203 ' ' THR . . . . . . . . . . . . . 7.0 t -175.48 -168.27 0.3 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.854 . . . . 0.0 109.504 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A 2204 ' ' CYS . . . . . 0.579 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.0 OUTLIER -114.81 153.93 29.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 108.936 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.563 -179.892 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A 2129 ' ' ASP . . . . . 0.52 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 25.3 t0 . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2130 ' ' GLU . . . . . 0.538 ' O ' ' CG2' ' A' 2136 ' ' VAL . 1.7 mt-10 81.26 -38.67 0.13 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.754 -0.592 . . . . 0.0 110.452 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2131 ' ' CYS . . . . . 0.492 ' O ' ' HB2' ' A' 2137 ' ' CYS . 5.2 p -90.71 -40.36 11.9 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.752 -1.217 . . . . 0.0 110.02 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2132 ' ' LYS . . . . . 0.483 ' N ' ' SG ' ' A' 2131 ' ' CYS . 0.0 OUTLIER -75.6 7.11 3.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.099 -1.001 . . . . 0.0 110.465 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 2133 ' ' GLU . . . . . 0.463 ' HB2' HG22 ' A' 2136 ' ' VAL . 7.3 mm-40 -69.22 151.5 96.99 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.989 -1.069 . . . . 0.0 109.448 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2134 ' ' PRO . . . . . 0.474 ' O ' ' CE ' ' A' 2138 ' ' LYS . 1.4 Cg_endo -64.47 -6.45 11.98 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.392 2.061 . . . . 0.0 110.889 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2135 ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' 2162 ' ' ASN . 10.6 m-20 -118.15 -25.85 6.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.929 -1.107 . . . . 0.0 110.407 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2136 ' ' VAL . . . . . 0.538 ' CG2' ' O ' ' A' 2130 ' ' GLU . 16.4 t -83.48 -119.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.076 -1.015 . . . . 0.0 108.813 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2137 ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' 2131 ' ' CYS . 59.3 m -67.4 145.89 54.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.554 -1.341 . . . . 0.0 108.392 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2138 ' ' LYS . . . . . 0.491 ' O ' ' CB ' ' A' 2139 ' ' HIS . 4.1 mttm -149.99 28.43 0.76 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.045 -1.035 . . . . 0.0 110.139 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2139 ' ' HIS . . . . . 0.491 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.1 OUTLIER 162.72 36.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.221 -0.925 . . . . 0.0 109.804 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -150.88 -176.09 23.45 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.62 111.72 24.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -1.066 . . . . 0.0 109.541 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2142 ' ' CYS . . . . . 0.424 ' C ' HD13 ' A' 2143 ' ' ILE . 11.0 p -99.39 -167.81 1.53 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.301 -0.874 . . . . 0.0 109.594 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2143 ' ' ILE . . . . . 0.509 HD11 ' CB ' ' A' 2150 ' ' ARG . 3.4 mp -149.89 101.09 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 109.259 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2144 ' ' ASN . . . . . 0.52 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 11.2 t-20 -52.65 113.99 1.25 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.3 -0.875 . . . . 0.0 110.189 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2145 ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' 2149 ' ' TYR . 5.0 p -117.41 -179.81 3.83 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.372 -0.83 . . . . 0.0 109.083 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.56 117.9 31.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.309 -0.869 . . . . 0.0 109.558 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 73.61 18.75 79.56 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2148 ' ' SER . . . . . 0.424 ' C ' ' OG1' ' A' 2145 ' ' THR . 0.0 OUTLIER -174.81 -171.1 0.52 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -1.147 . . . . 0.0 109.566 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 2149 ' ' TYR . . . . . 0.514 ' CE2' HG12 ' A' 2136 ' ' VAL . 7.0 p90 -164.11 -168.43 1.57 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.86 . . . . 0.0 109.408 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2150 ' ' ARG . . . . . 0.509 ' CB ' HD11 ' A' 2143 ' ' ILE . 0.0 OUTLIER -130.65 -165.0 1.49 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.869 . . . . 0.0 109.562 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 2151 ' ' CYS . . . . . 0.452 ' SG ' HD12 ' A' 2159 ' ' LEU . 0.1 OUTLIER 176.79 38.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.417 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.83 147.19 30.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.356 -0.84 . . . . 0.0 109.364 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2153 ' ' CYS . . . . . 0.482 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -110.16 160.77 27.06 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.335 -0.853 . . . . 0.0 109.536 -179.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 2154 ' ' PRO . . . . . 0.466 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 2.3 Cg_endo -61.72 -174.46 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.664 2.243 . . . . 0.0 111.669 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 4.4 t80 -81.44 103.19 11.01 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.92 -19.74 4.9 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 107.182 -2.367 . . . . 0.0 107.182 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2157 ' ' TYR . . . . . 0.485 ' O ' ' CG2' ' A' 2158 ' ' ILE . 20.1 m-85 -108.35 178.71 4.41 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.806 -0.82 . . . . 0.0 109.794 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2158 ' ' ILE . . . . . 0.594 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.2 OUTLIER -157.61 -166.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 2159 ' ' LEU . . . . . 0.452 HD12 ' SG ' ' A' 2151 ' ' CYS . 11.4 tp -131.31 144.98 51.67 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.245 -0.91 . . . . 0.0 109.835 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2160 ' ' ALA . . . . . 0.408 ' N ' ' HG ' ' A' 2159 ' ' LEU . . . -121.11 53.82 1.13 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.389 -0.819 . . . . 0.0 109.013 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 93.59 -21.39 41.29 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2162 ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' A' 2135 ' ' ASP . 4.0 m-20 173.04 -40.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.357 -1.084 . . . . 0.0 109.502 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -77.87 122.27 25.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 0.0 109.295 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2164 ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.1 OUTLIER -92.41 143.38 26.43 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 0.0 109.397 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 2165 ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' 2164 ' ' CYS . 1.5 m -160.89 -168.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.12 -0.987 . . . . 0.0 109.485 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2166 ' ' ASP . . . . . 0.42 ' OD2' ' O ' ' A' 2184 ' ' VAL . 1.1 t0 -90.61 144.85 25.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.001 -1.062 . . . . 0.0 109.747 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2167 ' ' THR . . . . . 0.594 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 9.1 t -91.96 179.64 5.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.886 . . . . 0.0 109.528 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2168 ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' 2171 ' ' SER . 33.2 t0 -86.74 95.6 9.88 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2169 ' ' GLU . . . . . 0.547 ' HB3' ' CD2' ' A' 2188 ' ' PHE . 0.4 OUTLIER -66.22 -27.89 68.32 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.135 -0.978 . . . . 0.0 110.418 -179.006 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 2170 ' ' CYS . . . . . 0.444 ' HB3' ' OD1' ' A' 2168 ' ' ASP . 0.7 OUTLIER -58.13 -13.18 4.37 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.901 -1.125 . . . . 0.0 108.891 178.493 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 2171 ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -61.24 -10.66 7.19 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.137 -0.977 . . . . 0.0 110.159 -179.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 2172 ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' 2169 ' ' GLU . 17.4 t -77.06 -69.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.173 -0.954 . . . . 0.0 109.406 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2173 ' ' GLY . . . . . . . . . . . . . . . 156.36 92.96 0.09 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2174 ' ' ASN . . . . . . . . . . . . . 1.3 t-20 45.68 87.79 0.11 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.199 -1.177 . . . . 0.0 110.027 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2175 ' ' PRO . . . . . 0.661 ' CB ' ' CD1' ' A' 2188 ' ' PHE . 1.6 Cg_endo -63.02 -23.45 73.91 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.896 1.731 . . . . 0.0 110.212 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2176 ' ' CYS . . . . . 0.475 ' HB3' ' SG ' ' A' 2192 ' ' CYS . 0.4 OUTLIER -76.83 -68.11 0.64 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 109.288 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 159.81 -20.89 0.26 Allowed Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 1.3 t30 -166.55 -30.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.156 -1.202 . . . . 0.0 110.853 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2179 ' ' GLY . . . . . 0.562 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -61.72 -103.91 0.01 OUTLIER Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.6 -1.286 . . . . 0.0 109.937 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.1 p -153.75 162.33 41.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.467 -1.019 . . . . 0.0 109.027 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2181 ' ' CYS . . . . . 0.52 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 27.3 p -97.05 161.63 13.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.11 -0.994 . . . . 0.0 110.41 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2182 ' ' LYS . . . . . 0.575 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.2 OUTLIER -146.65 155.12 42.2 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.338 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 64.0 t30 -101.12 127.85 47.48 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.685 -1.259 . . . . 0.0 109.106 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2184 ' ' VAL . . . . . 0.42 ' O ' ' OD2' ' A' 2166 ' ' ASP . 0.6 OUTLIER -134.33 -166.76 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.419 -0.801 . . . . 0.0 109.367 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 2185 ' ' ILE . . . . . 0.415 ' HA ' ' OD2' ' A' 2166 ' ' ASP . 3.9 mp -105.89 134.57 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.0 110.032 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2186 ' ' GLY . . . . . 0.426 ' O ' ' SD ' ' A' 2201 ' ' MET . . . 78.8 4.16 87.99 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2187 ' ' GLY . . . . . 0.459 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 170.54 -116.96 0.67 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.457 -1.354 . . . . 0.0 109.985 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2188 ' ' PHE . . . . . 0.661 ' CD1' ' CB ' ' A' 2175 ' ' PRO . 5.0 p90 -168.25 173.13 8.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.39 -1.065 . . . . 0.0 109.184 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2189 ' ' GLU . . . . . 0.575 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.2 tp10 -127.02 155.69 42.83 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2190 ' ' CYS . . . . . 0.407 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 25.4 p -151.25 145.79 25.61 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.711 -1.243 . . . . 0.0 110.035 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2191 ' ' THR . . . . . 0.477 ' O ' ' HA3' ' A' 2179 ' ' GLY . 23.3 m -112.24 84.67 2.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.379 -0.826 . . . . 0.0 109.847 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2192 ' ' CYS . . . . . 0.613 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.1 m -48.79 -179.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.293 -0.879 . . . . 0.0 109.608 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2193 ' ' GLU . . . . . 0.476 ' O ' ' C ' ' A' 2194 ' ' GLU . 19.1 tt0 -50.65 116.49 1.96 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2194 ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.3 OUTLIER -34.85 125.69 0.54 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.71 -0.619 . . . . 0.0 110.723 -179.256 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.16 1.24 10.41 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2196 ' ' PHE . . . . . 0.675 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.3 p90 -108.89 -163.28 0.86 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.199 -1.177 . . . . 0.0 109.987 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2197 ' ' GLU . . . . . 0.529 ' N ' ' CG ' ' A' 2196 ' ' PHE . 16.8 mt-10 -145.62 95.58 4.92 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 121.496 -0.753 . . . . 0.0 109.556 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2198 ' ' PRO . . . . . 0.675 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.8 Cg_endo -68.71 -165.23 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.213 1.942 . . . . 0.0 111.259 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -133.13 -169.09 12.09 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.71 -81.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.998 1.799 . . . . 0.0 110.563 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A 2201 ' ' MET . . . . . 0.491 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.0 OUTLIER -137.08 56.38 1.79 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.974 . . . . 0.0 109.952 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A 2202 ' ' MET . . . . . 0.428 ' O ' ' HB ' ' A' 2203 ' ' THR . 2.4 mmt -123.81 -72.25 0.69 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.271 -0.893 . . . . 0.0 109.615 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2203 ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' 2175 ' ' PRO . 11.3 t -180.0 -170.84 0.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.844 . . . . 0.0 109.432 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2204 ' ' CYS . . . . . 0.478 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.4 t -70.27 146.83 50.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 109.565 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.385 179.977 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A 2129 ' ' ASP . . . . . 0.541 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 20.1 t0 . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2130 ' ' GLU . . . . . 0.543 ' HB3' ' CD2' ' A' 2149 ' ' TYR . 1.5 mt-10 80.85 -41.15 0.17 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.651 -0.656 . . . . 0.0 110.943 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2131 ' ' CYS . . . . . 0.482 ' HB2' ' SG ' ' A' 2137 ' ' CYS . 9.8 p -90.23 -33.07 16.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.664 -1.273 . . . . 0.0 110.005 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2132 ' ' LYS . . . . . 0.459 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -81.53 6.86 13.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.135 -0.978 . . . . 0.0 109.225 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 2133 ' ' GLU . . . . . 0.489 ' HB2' HG22 ' A' 2136 ' ' VAL . 2.0 mt-10 -69.71 154.04 95.09 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.254 -0.904 . . . . 0.0 109.343 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2134 ' ' PRO . . . . . 0.472 ' O ' ' HD2' ' A' 2138 ' ' LYS . 3.7 Cg_endo -68.5 1.49 3.61 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.504 2.136 . . . . 0.0 111.536 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -134.36 0.05 3.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.602 -1.311 . . . . 0.0 110.733 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2136 ' ' VAL . . . . . 0.589 HG12 ' CZ ' ' A' 2149 ' ' TYR . 21.7 t -106.3 -119.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.818 -1.176 . . . . 0.0 109.594 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2137 ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' 2131 ' ' CYS . 3.8 m -76.74 111.45 12.27 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.754 -1.216 . . . . 0.0 108.799 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2138 ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' 2134 ' ' PRO . 6.2 mtpp -116.37 112.58 21.71 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.242 -0.911 . . . . 0.0 110.096 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2139 ' ' HIS . . . . . 0.474 ' O ' ' HB3' ' A' 2164 ' ' CYS . 2.1 m-70 74.14 56.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.884 . . . . 0.0 109.944 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -159.7 -176.98 32.37 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -103.6 91.14 3.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -1.122 . . . . 0.0 109.043 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2142 ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' 2150 ' ' ARG . 26.7 p -86.48 -178.94 6.54 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.228 -0.92 . . . . 0.0 110.2 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2143 ' ' ILE . . . . . 0.469 ' O ' HG21 ' A' 2145 ' ' THR . 3.6 mp -141.45 94.24 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.441 -0.787 . . . . 0.0 108.886 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2144 ' ' ASN . . . . . 0.541 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 11.1 t-20 -47.95 117.83 2.07 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.36 -0.837 . . . . 0.0 110.054 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2145 ' ' THR . . . . . 0.469 HG21 ' O ' ' A' 2143 ' ' ILE . 70.9 p -116.49 -174.66 2.6 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.431 -0.793 . . . . 0.0 109.046 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.31 118.44 25.75 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.341 -0.849 . . . . 0.0 109.602 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2147 ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' 2148 ' ' SER . . . 53.62 42.3 66.73 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2148 ' ' SER . . . . . 0.466 ' O ' ' OE1' ' A' 2130 ' ' GLU . 1.8 t 178.16 -162.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -1.109 . . . . 0.0 109.66 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2149 ' ' TYR . . . . . 0.589 ' CZ ' HG12 ' A' 2136 ' ' VAL . 45.2 p90 179.66 -169.5 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.806 . . . . 0.0 109.336 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2150 ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' 2149 ' ' TYR . 12.4 mtt180 -160.46 119.67 2.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.493 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2151 ' ' CYS . . . . . 0.412 ' CB ' HD12 ' A' 2159 ' ' LEU . 82.3 m -83.18 69.76 9.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.328 -0.857 . . . . 0.0 109.234 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -80.47 109.18 14.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.522 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2153 ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -82.38 152.66 67.76 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 121.148 -0.97 . . . . 0.0 109.356 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 2154 ' ' PRO . . . . . 0.406 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.2 Cg_endo -64.58 -168.54 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.493 2.128 . . . . 0.0 111.207 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 9.1 t80 -90.19 103.25 15.94 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.93 -14.17 5.49 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2157 ' ' TYR . . . . . 0.527 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 7.7 m-85 -107.86 -169.37 1.51 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.516 -0.99 . . . . 0.0 109.945 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2158 ' ' ILE . . . . . 0.516 HG22 ' HB ' ' A' 2167 ' ' THR . 0.1 OUTLIER -155.78 -165.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.452 -0.78 . . . . 0.0 109.458 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 2159 ' ' LEU . . . . . 0.46 ' N ' HG12 ' A' 2158 ' ' ILE . 28.7 tp -141.35 125.76 17.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.365 -0.834 . . . . 0.0 109.574 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -101.92 52.67 0.82 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.899 . . . . 0.0 109.261 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2161 ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 88.28 -9.66 74.32 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2162 ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' 2136 ' ' VAL . 1.7 m-20 167.04 -47.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -1.195 . . . . 0.0 109.444 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -70.28 115.94 10.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.304 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2164 ' ' CYS . . . . . 0.474 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -92.33 144.55 25.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.52 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 2165 ' ' VAL . . . . . 0.52 ' O ' ' CD2' ' A' 2157 ' ' TYR . 0.4 OUTLIER -159.17 -167.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.426 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 2166 ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' 2184 ' ' VAL . 35.6 t70 -85.95 166.59 15.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.956 -1.09 . . . . 0.0 109.796 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2167 ' ' THR . . . . . 0.549 ' CG2' ' OE1' ' A' 2169 ' ' GLU . 5.6 t -113.73 -168.82 1.4 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.391 -0.818 . . . . 0.0 109.46 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2168 ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' 2168 ' ' ASP . 61.0 t0 -110.39 103.58 12.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.0 109.602 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2169 ' ' GLU . . . . . 0.556 ' CB ' ' CD1' ' A' 2188 ' ' PHE . 0.5 OUTLIER -79.99 -30.58 39.72 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.323 -0.86 . . . . 0.0 109.157 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 2170 ' ' CYS . . . . . 0.506 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 0.5 OUTLIER -64.74 -11.24 34.24 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.371 -0.831 . . . . 0.0 109.008 179.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -6.48 26.19 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.195 -0.94 . . . . 0.0 109.445 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2172 ' ' VAL . . . . . 0.469 HG21 ' O ' ' A' 2169 ' ' GLU . 19.0 t -78.58 -70.5 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.196 -0.94 . . . . 0.0 109.051 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2173 ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' 2174 ' ' ASN . . . 161.78 77.04 0.03 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2174 ' ' ASN . . . . . 0.476 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 9.4 t-20 43.85 82.36 0.23 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.257 -1.143 . . . . 0.0 109.835 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2175 ' ' PRO . . . . . 0.591 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 0.9 OUTLIER -64.6 -20.86 65.79 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.289 1.993 . . . . 0.0 110.141 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 2176 ' ' CYS . . . . . 0.48 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.1 OUTLIER -55.63 -58.01 9.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.051 -1.031 . . . . 0.0 108.758 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 143.77 -19.59 2.19 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 1.1 t30 -160.6 -34.95 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -1.172 . . . . 0.0 110.539 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2179 ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -66.15 -125.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.034 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 2.5 p -140.92 162.22 35.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.491 -1.005 . . . . 0.0 109.252 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2181 ' ' CYS . . . . . 0.565 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 24.5 p -99.7 151.16 21.53 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.09 0.948 . . . . 0.0 111.341 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2182 ' ' LYS . . . . . 0.5 ' HB3' ' O ' ' A' 2189 ' ' GLU . 4.9 tptt -134.36 157.0 47.51 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 58.5 t30 -95.9 139.71 31.71 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.361 -1.462 . . . . 0.0 109.862 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2184 ' ' VAL . . . . . 0.436 HG13 ' CA ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -147.78 176.7 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.528 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 2185 ' ' ILE . . . . . 0.527 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 1.2 mp -93.77 139.06 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.01 -1.056 . . . . 0.0 110.118 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2186 ' ' GLY . . . . . 0.434 ' N ' HG21 ' A' 2185 ' ' ILE . . . 74.75 8.63 82.15 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2187 ' ' GLY . . . . . 0.468 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 161.94 -128.76 1.95 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2188 ' ' PHE . . . . . 0.591 ' CD2' ' HG2' ' A' 2175 ' ' PRO . 1.2 p90 -158.7 -178.78 7.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -1.15 . . . . 0.0 109.532 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2189 ' ' GLU . . . . . 0.5 ' O ' ' HB3' ' A' 2182 ' ' LYS . 0.6 OUTLIER -131.85 111.14 11.34 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 31.2 p -110.65 137.48 48.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.785 -1.197 . . . . 0.0 109.774 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2191 ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' 2192 ' ' CYS . 59.5 m -111.1 87.39 2.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.283 -0.886 . . . . 0.0 109.175 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2192 ' ' CYS . . . . . 0.601 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.0 OUTLIER -48.33 -179.01 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.671 0.748 . . . . 0.0 109.703 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 2193 ' ' GLU . . . . . 0.475 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.6 OUTLIER -59.15 123.83 17.94 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 2194 ' ' GLU . . . . . 0.475 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.6 OUTLIER -34.74 129.5 0.43 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.43 0.633 . . . . 0.0 110.878 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.47 1.51 10.04 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2196 ' ' PHE . . . . . 0.673 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.8 OUTLIER -116.33 -164.54 0.98 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.184 -1.186 . . . . 0.0 110.192 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 2197 ' ' GLU . . . . . 0.564 ' N ' ' CG ' ' A' 2196 ' ' PHE . 0.3 OUTLIER -146.14 98.15 4.39 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 2198 ' ' PRO . . . . . 0.673 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.9 Cg_endo -68.68 -164.44 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.242 1.962 . . . . 0.0 111.174 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -132.49 -173.71 13.4 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.4 -54.63 0.75 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.919 1.746 . . . . 0.0 110.629 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2201 ' ' MET . . . . . 0.468 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -159.8 49.57 0.3 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 0.0 109.566 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 2.1 mmm -118.63 -79.3 0.59 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.253 -0.904 . . . . 0.0 109.674 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A 2203 ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' 2175 ' ' PRO . 6.7 t -173.51 -166.36 0.32 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.306 -0.871 . . . . 0.0 109.228 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2204 ' ' CYS . . . . . 0.548 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.2 t -70.31 141.63 52.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.073 -1.017 . . . . 0.0 109.541 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A 2205 ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' 2197 ' ' GLU . 23.0 pt-20 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.35 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2129 ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' 2130 ' ' GLU . 1.3 t0 . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2130 ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' 2129 ' ' ASP . 0.1 OUTLIER 81.29 -67.59 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.792 -0.568 . . . . 0.0 110.46 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 2131 ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' 2137 ' ' CYS . 1.7 t -81.28 -9.82 59.69 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.133 -0.979 . . . . 0.0 109.828 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2132 ' ' LYS . . . . . 0.498 ' CB ' ' HB3' ' A' 2129 ' ' ASP . 0.0 OUTLIER -72.42 -15.02 61.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.787 -1.196 . . . . 0.0 109.785 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 2133 ' ' GLU . . . . . 0.444 ' HB2' HG21 ' A' 2136 ' ' VAL . 3.7 mt-10 -74.3 146.5 84.32 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.152 -0.968 . . . . 0.0 109.631 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2134 ' ' PRO . . . . . 0.469 ' O ' ' HG3' ' A' 2138 ' ' LYS . 1.2 Cg_endo -65.22 -11.98 32.65 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.273 1.982 . . . . 0.0 110.133 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2135 ' ' ASP . . . . . 0.511 ' O ' ' ND2' ' A' 2162 ' ' ASN . 0.4 OUTLIER -110.35 21.57 16.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.95 . . . . 0.0 109.483 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 2136 ' ' VAL . . . . . 0.481 HG12 ' CZ ' ' A' 2149 ' ' TYR . 18.5 t -136.86 109.75 7.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2137 ' ' CYS . . . . . 0.543 ' CA ' ' O ' ' A' 2162 ' ' ASN . 56.4 m 64.92 -89.65 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2138 ' ' LYS . . . . . 0.514 ' O ' ' CB ' ' A' 2139 ' ' HIS . 0.0 OUTLIER 68.11 28.29 6.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.963 -1.086 . . . . 0.0 111.268 178.089 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 2139 ' ' HIS . . . . . 0.524 ' CB ' ' HB3' ' A' 2164 ' ' CYS . 0.2 OUTLIER 164.36 41.09 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.842 -1.161 . . . . 0.0 110.287 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 2140 ' ' GLY . . . . . 0.464 ' HA2' ' HD3' ' A' 2154 ' ' PRO . . . -166.41 175.73 41.77 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2141 ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' 2152 ' ' GLU . 0.2 OUTLIER -89.38 96.66 10.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.184 -1.186 . . . . 0.0 108.259 179.29 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 2142 ' ' CYS . . . . . 0.493 ' SG ' ' CB ' ' A' 2137 ' ' CYS . 0.0 OUTLIER -96.32 174.07 7.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -0.86 . . . . 0.0 110.223 -178.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 2143 ' ' ILE . . . . . 0.453 ' O ' HG21 ' A' 2145 ' ' THR . 4.0 mp -137.2 111.91 10.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2144 ' ' ASN . . . . . 0.428 ' OD1' ' C ' ' A' 2129 ' ' ASP . 0.6 OUTLIER -60.17 118.09 5.93 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.207 -0.933 . . . . 0.0 109.756 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 2145 ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' 2148 ' ' SER . 3.1 p -103.97 -179.5 3.97 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.157 -0.965 . . . . 0.0 109.011 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.13 -74.12 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.356 -0.84 . . . . 0.0 109.771 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -117.27 41.49 2.07 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2148 ' ' SER . . . . . 0.509 ' O ' ' HG2' ' A' 2130 ' ' GLU . 0.6 OUTLIER -174.13 -171.85 0.65 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -1.18 . . . . 0.0 109.831 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 2149 ' ' TYR . . . . . 0.481 ' CZ ' HG12 ' A' 2136 ' ' VAL . 42.0 p90 -153.05 -171.84 4.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 109.474 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2150 ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' 2149 ' ' TYR . 28.5 mtm180 -155.86 98.41 1.9 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.374 -0.829 . . . . 0.0 110.041 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2151 ' ' CYS . . . . . 0.464 ' CB ' HD12 ' A' 2159 ' ' LEU . 70.7 m -63.02 87.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.527 -0.733 . . . . 0.0 109.069 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2152 ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' 2141 ' ' GLN . 0.0 OUTLIER -87.09 70.32 10.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.503 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 2153 ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' 2158 ' ' ILE . 93.1 m -48.33 147.88 3.65 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 121.379 -0.826 . . . . 0.0 109.177 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2154 ' ' PRO . . . . . 0.464 ' HD3' ' HA2' ' A' 2140 ' ' GLY . 1.4 Cg_endo -63.48 -169.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.541 2.161 . . . . 0.0 111.25 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 75.2 t80 -89.22 102.01 14.67 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.28 -11.63 5.54 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2157 ' ' TYR . . . . . 0.476 ' CD2' ' O ' ' A' 2165 ' ' VAL . 5.7 m-85 -108.17 -170.69 1.72 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.399 -1.059 . . . . 0.0 109.801 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2158 ' ' ILE . . . . . 0.551 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.2 OUTLIER -156.38 -173.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.061 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 2159 ' ' LEU . . . . . 0.464 HD12 ' CB ' ' A' 2151 ' ' CYS . 21.6 tp -130.89 143.52 50.79 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.276 -0.89 . . . . 0.0 109.85 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -120.52 47.71 1.73 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 0.0 109.175 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2161 ' ' GLY . . . . . 0.427 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 94.35 -16.8 60.26 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2162 ' ' ASN . . . . . 0.543 ' O ' ' CA ' ' A' 2137 ' ' CYS . 1.3 m-20 169.47 -30.34 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.342 -1.093 . . . . 0.0 109.171 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -88.21 119.63 28.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 108.749 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2164 ' ' CYS . . . . . 0.528 ' O ' ' CG1' ' A' 2165 ' ' VAL . 38.2 t -95.78 159.47 14.97 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.173 -0.955 . . . . 0.0 109.239 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2165 ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' 2164 ' ' CYS . 0.6 OUTLIER -169.15 -167.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 2166 ' ' ASP . . . . . 0.461 ' OD2' ' O ' ' A' 2184 ' ' VAL . 34.7 t70 -88.88 165.12 14.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.049 -1.032 . . . . 0.0 109.454 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2167 ' ' THR . . . . . 0.551 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 6.3 t -111.35 -172.92 2.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.39 -0.818 . . . . 0.0 109.371 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2168 ' ' ASP . . . . . 0.463 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 51.8 t0 -107.48 100.96 10.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.409 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2169 ' ' GLU . . . . . 0.583 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.6 OUTLIER -76.33 -31.92 58.39 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.496 -0.752 . . . . 0.0 109.288 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 2170 ' ' CYS . . . . . 0.469 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 2.0 t -66.77 -9.68 39.37 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.314 -0.866 . . . . 0.0 108.877 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2171 ' ' SER . . . . . 0.421 ' HB2' ' CG ' ' A' 2168 ' ' ASP . 0.2 OUTLIER -81.23 7.83 10.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.855 . . . . 0.0 109.894 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 49.5 t -108.22 -72.34 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.07 -1.019 . . . . 0.0 109.536 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2173 ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -163.08 133.81 3.2 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2174 ' ' ASN . . . . . 0.597 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 18.9 p-10 -40.25 99.86 0.21 Allowed Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.461 -1.023 . . . . 0.0 109.959 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2175 ' ' PRO . . . . . 0.563 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 1.4 Cg_endo -68.66 -22.01 38.33 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.798 1.665 . . . . 0.0 109.85 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2176 ' ' CYS . . . . . 0.564 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -48.61 -40.36 27.28 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.305 -0.872 . . . . 0.0 109.206 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 123.0 -16.5 8.2 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -175.44 -34.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.481 -1.011 . . . . 0.0 109.71 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2179 ' ' GLY . . . . . 0.583 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -63.15 -122.24 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.51 154.63 44.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.39 -1.065 . . . . 0.0 109.708 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2181 ' ' CYS . . . . . 0.597 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 21.4 p -92.52 161.39 14.63 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.352 1.072 . . . . 0.0 111.286 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2182 ' ' LYS . . . . . 0.542 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 43.3 tptt -141.48 163.33 33.22 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2183 ' ' ASN . . . . . 0.488 ' N ' ' HG3' ' A' 2182 ' ' LYS . 62.9 t30 -101.13 140.07 35.94 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.618 -1.301 . . . . 0.0 110.006 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2184 ' ' VAL . . . . . 0.534 HG13 ' CA ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -148.91 -177.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.566 -0.709 . . . . 0.0 109.308 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 2185 ' ' ILE . . . . . . . . . . . . . 2.4 mp -97.83 135.7 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.02 -1.05 . . . . 0.0 110.196 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 75.15 10.62 84.26 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2187 ' ' GLY . . . . . 0.485 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 163.42 -121.04 0.98 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2188 ' ' PHE . . . . . 0.583 ' HB3' ' HB2' ' A' 2169 ' ' GLU . 2.3 p90 -169.17 -179.67 3.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -1.168 . . . . 0.0 109.526 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2189 ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 4.5 tt0 -124.67 170.21 11.19 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 6.0 p -170.58 145.56 2.57 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.461 -1.399 . . . . 0.0 109.949 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2191 ' ' THR . . . . . . . . . . . . . 17.9 m -117.98 92.98 3.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.422 -0.799 . . . . 0.0 109.728 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2192 ' ' CYS . . . . . 0.594 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -54.82 179.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 0.0 108.795 179.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 2193 ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' 2194 ' ' GLU . 4.2 tt0 -56.64 121.22 9.24 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2194 ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' 2193 ' ' GLU . 2.2 mt-10 -34.65 127.52 0.48 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.672 -0.643 . . . . 0.0 110.877 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.11 8.58 7.16 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2196 ' ' PHE . . . . . 0.664 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.4 p90 -119.91 -161.54 0.88 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.251 -1.146 . . . . 0.0 110.301 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2197 ' ' GLU . . . . . 0.582 ' N ' ' CG ' ' A' 2196 ' ' PHE . 1.8 mm-40 -146.13 96.03 4.67 Favored Pre-proline 0 C--N 1.305 -1.339 0 O-C-N 121.64 -0.663 . . . . 0.0 109.763 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2198 ' ' PRO . . . . . 0.664 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.0 Cg_endo -68.1 -159.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.389 2.059 . . . . 0.0 111.4 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -143.99 -169.87 13.15 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -65.31 -81.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.993 1.796 . . . . 0.0 110.844 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2201 ' ' MET . . . . . 0.485 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -135.29 41.73 2.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 110.024 -179.308 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 5.0 mtm -112.33 -78.59 0.58 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.182 -0.948 . . . . 0.0 109.582 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2203 ' ' THR . . . . . . . . . . . . . 6.0 t -168.24 -164.43 0.53 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.477 -0.764 . . . . 0.0 109.175 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A 2204 ' ' CYS . . . . . 0.577 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.0 OUTLIER -115.91 144.97 43.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 108.943 -179.696 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.581 -179.724 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A 2129 ' ' ASP . . . . . 0.536 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 48.5 t0 . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2130 ' ' GLU . . . . . 0.567 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 2.0 mt-10 82.4 -44.57 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.85 -0.531 . . . . 0.0 110.027 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2131 ' ' CYS . . . . . 0.525 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 14.4 p -90.71 -24.72 20.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.007 -1.058 . . . . 0.0 109.288 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2132 ' ' LYS . . . . . 0.413 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -68.92 -8.98 49.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 109.851 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 2133 ' ' GLU . . . . . 0.486 ' HB2' HG22 ' A' 2136 ' ' VAL . 6.3 mt-10 -72.12 144.47 87.44 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.082 -1.011 . . . . 0.0 109.171 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2134 ' ' PRO . . . . . 0.53 ' HA ' ' CG ' ' A' 2138 ' ' LYS . 1.9 Cg_endo -67.53 -4.12 11.41 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.239 1.959 . . . . 0.0 110.882 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2135 ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' 2135 ' ' ASP . 2.6 m-20 -116.29 4.96 13.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.011 -1.056 . . . . 0.0 110.03 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2136 ' ' VAL . . . . . 0.525 ' CG1' ' HA ' ' A' 2131 ' ' CYS . 75.4 t -110.32 -91.92 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.988 -1.07 . . . . 0.0 109.695 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2137 ' ' CYS . . . . . 0.519 ' N ' HG13 ' A' 2136 ' ' VAL . 0.5 OUTLIER -79.98 -74.43 0.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.115 -0.991 . . . . 0.0 109.572 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 2138 ' ' LYS . . . . . 0.53 ' CG ' ' HA ' ' A' 2134 ' ' PRO . 0.0 OUTLIER 65.46 89.42 0.1 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.377 -0.827 . . . . 0.0 109.963 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 2139 ' ' HIS . . . . . 0.501 ' O ' ' HB3' ' A' 2164 ' ' CYS . 3.5 m170 75.56 51.1 0.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.349 -0.844 . . . . 0.0 110.125 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -151.68 173.38 30.99 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -104.11 89.58 3.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -1.139 . . . . 0.0 108.966 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2142 ' ' CYS . . . . . 0.476 ' HB3' ' SG ' ' A' 2137 ' ' CYS . 9.0 p -88.86 -177.0 5.39 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.347 -0.846 . . . . 0.0 110.345 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.29 93.04 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2144 ' ' ASN . . . . . 0.536 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 21.2 t-20 -46.11 115.61 1.04 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.516 -0.74 . . . . 0.0 110.963 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2145 ' ' THR . . . . . 0.485 ' OG1' ' HA ' ' A' 2149 ' ' TYR . 0.4 OUTLIER -113.37 -178.7 3.44 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.282 -0.886 . . . . 0.0 108.936 178.743 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.59 110.15 17.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.379 -0.826 . . . . 0.0 109.769 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 65.85 25.77 71.97 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2148 ' ' SER . . . . . 0.443 ' O ' ' OG1' ' A' 2145 ' ' THR . 0.0 OUTLIER -173.66 -178.72 1.66 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.123 -1.222 . . . . 0.0 109.738 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 2149 ' ' TYR . . . . . 0.567 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 17.8 p90 -160.31 -172.37 3.55 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.443 -0.786 . . . . 0.0 109.446 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2150 ' ' ARG . . . . . 0.461 ' CG ' ' O ' ' A' 2149 ' ' TYR . 1.8 mtt-85 -156.52 107.16 2.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.414 -0.804 . . . . 0.0 109.142 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2151 ' ' CYS . . . . . 0.458 ' HB3' HD12 ' A' 2159 ' ' LEU . 1.6 m -74.33 107.17 6.33 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.489 -0.757 . . . . 0.0 110.431 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.63 -178.63 3.49 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2153 ' ' CYS . . . . . 0.508 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -148.24 152.37 39.16 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 120.952 -1.093 . . . . 0.0 109.672 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 2154 ' ' PRO . . . . . 0.456 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.4 Cg_endo -64.22 -166.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.604 2.203 . . . . 0.0 111.478 -178.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 13.4 t80 -89.8 101.96 14.66 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2156 ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' 2166 ' ' ASP . . . 130.81 -14.08 5.52 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.169 -1.973 . . . . 0.0 108.169 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2157 ' ' TYR . . . . . 0.531 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 8.4 m-85 -108.3 -174.28 2.48 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.532 -0.981 . . . . 0.0 110.288 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2158 ' ' ILE . . . . . 0.566 ' N ' ' CD1' ' A' 2158 ' ' ILE . 0.1 OUTLIER -157.65 -165.89 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 2159 ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' 2151 ' ' CYS . 27.7 tp -131.92 127.74 37.05 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.408 -0.807 . . . . 0.0 109.574 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -107.06 49.23 0.81 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 0.0 109.327 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 95.67 -20.25 50.55 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2162 ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' 2136 ' ' VAL . 1.3 t-20 172.8 -38.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -1.172 . . . . 0.0 109.447 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2163 ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' 2137 ' ' CYS . 2.1 tt0 -79.09 111.02 14.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.416 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2164 ' ' CYS . . . . . 0.501 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.1 OUTLIER -85.93 137.55 32.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.895 . . . . 0.0 109.089 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 2165 ' ' VAL . . . . . 0.492 ' CG1' ' O ' ' A' 2164 ' ' CYS . 6.7 m -160.53 -166.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.145 -0.972 . . . . 0.0 109.539 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2166 ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' 2156 ' ' GLY . 1.3 t0 -90.23 144.8 25.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.875 -1.141 . . . . 0.0 109.773 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2167 ' ' THR . . . . . 0.554 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 12.7 t -85.09 169.62 13.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.257 -0.902 . . . . 0.0 109.017 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2168 ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' 2171 ' ' SER . 60.2 t0 -82.11 96.78 7.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.865 -1.147 . . . . 0.0 109.175 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2169 ' ' GLU . . . . . 0.648 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 40.2 mp0 -70.09 -37.07 75.33 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.474 -0.766 . . . . 0.0 109.186 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2170 ' ' CYS . . . . . 0.46 ' O ' ' SG ' ' A' 2181 ' ' CYS . 0.6 OUTLIER -68.19 -7.86 33.87 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.249 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 2171 ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.2 OUTLIER -74.09 -1.5 20.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.357 -0.839 . . . . 0.0 109.452 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 12.2 t -99.04 -72.55 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.17 -0.956 . . . . 0.0 109.671 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2173 ' ' GLY . . . . . 0.504 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -169.46 138.48 5.09 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2174 ' ' ASN . . . . . 0.553 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 22.7 p-10 -36.97 97.67 0.14 Allowed Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.721 -0.87 . . . . 0.0 110.335 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2175 ' ' PRO . . . . . 0.536 ' HG2' ' CD1' ' A' 2188 ' ' PHE . 1.5 Cg_endo -63.2 -22.23 72.56 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.821 1.681 . . . . 0.0 109.998 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2176 ' ' CYS . . . . . 0.53 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -52.12 -54.99 23.83 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 141.96 -21.95 2.47 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -162.93 -34.84 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.336 -1.097 . . . . 0.0 110.176 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2179 ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -62.48 -119.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.96 153.65 41.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.466 -1.02 . . . . 0.0 109.14 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2181 ' ' CYS . . . . . 0.553 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 11.5 p -82.06 164.95 21.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.086 -1.009 . . . . 0.0 110.813 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2182 ' ' LYS . . . . . 0.573 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.4 OUTLIER -144.63 155.05 43.42 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 64.1 t30 -100.16 138.59 37.03 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.543 -1.348 . . . . 0.0 109.544 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2184 ' ' VAL . . . . . 0.436 ' CG1' ' N ' ' A' 2185 ' ' ILE . 0.6 OUTLIER -145.94 -162.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.329 -179.401 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A 2185 ' ' ILE . . . . . 0.531 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 3.0 mp -108.28 134.23 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.036 -1.04 . . . . 0.0 110.356 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 68.56 8.7 56.93 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2187 ' ' GLY . . . . . 0.468 ' O ' ' OE1' ' A' 2169 ' ' GLU . . . 174.12 -137.59 4.07 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2188 ' ' PHE . . . . . 0.648 ' HB3' ' HB2' ' A' 2169 ' ' GLU . 5.5 p90 -161.02 169.5 22.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -1.151 . . . . 0.0 109.271 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2189 ' ' GLU . . . . . 0.573 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 2.8 tt0 -118.2 178.63 4.37 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 30.3 p -169.39 143.26 2.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.702 -1.249 . . . . 0.0 109.584 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2191 ' ' THR . . . . . . . . . . . . . 20.1 m -109.91 85.81 2.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.316 -0.865 . . . . 0.0 109.696 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2192 ' ' CYS . . . . . 0.589 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.1 m -51.23 177.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.205 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2193 ' ' GLU . . . . . 0.474 ' O ' ' C ' ' A' 2194 ' ' GLU . 7.4 tt0 -50.97 116.48 2.01 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2194 ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.8 mt-10 -33.93 127.77 0.39 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.484 0.659 . . . . 0.0 111.043 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.08 5.22 8.97 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2196 ' ' PHE . . . . . 0.674 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.3 p90 -114.82 -163.22 0.86 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.234 -1.156 . . . . 0.0 110.268 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2197 ' ' GLU . . . . . 0.519 ' N ' ' CG ' ' A' 2196 ' ' PHE . 1.8 mm-40 -144.58 95.98 5.28 Favored Pre-proline 0 C--N 1.304 -1.37 0 O-C-N 121.526 -0.733 . . . . 0.0 109.597 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2198 ' ' PRO . . . . . 0.674 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 8.1 Cg_endo -66.94 -162.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.279 1.986 . . . . 0.0 111.075 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -137.0 -175.08 13.59 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.63 -72.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.991 1.794 . . . . 0.0 110.675 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A 2201 ' ' MET . . . . . 0.481 ' HA ' ' O ' ' A' 2188 ' ' PHE . 7.3 ptp -141.07 48.62 1.68 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.186 -0.947 . . . . 0.0 110.107 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2202 ' ' MET . . . . . 0.412 ' O ' ' CE1' ' A' 2188 ' ' PHE . 2.1 mmt -120.19 -85.03 0.66 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.081 -1.012 . . . . 0.0 109.845 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2203 ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' 2175 ' ' PRO . 7.3 t -168.66 -168.32 0.88 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.249 -0.907 . . . . 0.0 109.568 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2204 ' ' CYS . . . . . 0.575 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.7 t -71.59 144.81 49.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.934 . . . . 0.0 109.484 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.457 179.956 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A 2129 ' ' ASP . . . . . 0.544 ' O ' ' ND2' ' A' 2144 ' ' ASN . 27.5 t0 . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2130 ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' 2129 ' ' ASP . 1.5 mt-10 81.21 -48.74 0.26 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.668 -0.645 . . . . 0.0 110.427 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2131 ' ' CYS . . . . . 0.486 ' O ' ' O ' ' A' 2136 ' ' VAL . 13.7 p -90.97 -26.58 19.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.882 -1.136 . . . . 0.0 109.715 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2132 ' ' LYS . . . . . 0.511 ' HB2' ' CB ' ' A' 2129 ' ' ASP . 0.0 OUTLIER -65.34 -11.45 42.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.839 -1.163 . . . . 0.0 109.137 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -70.28 148.75 95.82 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.399 -0.813 . . . . 0.0 109.413 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2134 ' ' PRO . . . . . 0.504 ' HA ' ' CD ' ' A' 2138 ' ' LYS . 1.2 Cg_endo -64.67 -7.8 15.69 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.232 1.954 . . . . 0.0 110.726 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.91 16.94 15.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.044 -1.035 . . . . 0.0 109.841 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2136 ' ' VAL . . . . . 0.64 ' CG1' ' CE1' ' A' 2149 ' ' TYR . 22.1 t -143.09 118.84 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.134 -0.979 . . . . 0.0 109.314 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2137 ' ' CYS . . . . . 0.459 ' SG ' HG13 ' A' 2136 ' ' VAL . 1.9 m 41.64 71.05 0.22 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.331 -0.856 . . . . 0.0 109.252 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2138 ' ' LYS . . . . . 0.504 ' CD ' ' HA ' ' A' 2134 ' ' PRO . 0.0 OUTLIER -98.35 129.24 45.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 0.0 109.928 -179.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 2139 ' ' HIS . . . . . 0.463 ' O ' ' HB3' ' A' 2164 ' ' CYS . 0.7 OUTLIER 67.95 52.2 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.499 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -161.52 -160.77 11.11 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2141 ' ' GLN . . . . . 0.426 ' HB3' ' O ' ' A' 2152 ' ' GLU . 1.6 tt0 -119.03 94.49 4.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.321 -1.105 . . . . 0.0 109.405 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2142 ' ' CYS . . . . . . . . . . . . . 10.9 p -90.47 177.7 6.31 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.294 -0.879 . . . . 0.0 110.011 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 3.6 mp -132.16 117.22 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2144 ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' 2129 ' ' ASP . 5.2 t-20 -75.32 113.61 12.9 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.096 -1.002 . . . . 0.0 111.367 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2145 ' ' THR . . . . . 0.441 ' OG1' ' C ' ' A' 2148 ' ' SER . 16.2 p -99.87 179.53 4.49 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -59.14 -47.94 83.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 109.849 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -142.58 57.71 0.56 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2148 ' ' SER . . . . . 0.467 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER 174.92 -160.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -1.116 . . . . 0.0 109.287 -179.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 2149 ' ' TYR . . . . . 0.64 ' CE1' ' CG1' ' A' 2136 ' ' VAL . 43.2 p90 -174.11 -170.9 0.58 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.35 -0.844 . . . . 0.0 109.336 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2150 ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' 2149 ' ' TYR . 26.8 mtt180 -160.04 107.61 1.66 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.339 -0.851 . . . . 0.0 109.435 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2151 ' ' CYS . . . . . 0.449 ' HB3' HD12 ' A' 2159 ' ' LEU . 36.2 m -64.82 89.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.464 -0.772 . . . . 0.0 109.746 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2152 ' ' GLU . . . . . 0.426 ' O ' ' HB3' ' A' 2141 ' ' GLN . 2.0 mt-10 -102.16 86.18 2.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.034 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2153 ' ' CYS . . . . . 0.487 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -59.24 153.38 47.61 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.297 -0.877 . . . . 0.0 109.973 -179.407 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 2154 ' ' PRO . . . . . 0.416 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.1 Cg_endo -65.16 -167.56 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.624 2.216 . . . . 0.0 111.205 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 17.9 t80 -90.15 104.89 17.42 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.03 -17.91 5.1 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2157 ' ' TYR . . . . . 0.487 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 12.0 m-85 -107.98 -175.38 2.77 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.673 -0.898 . . . . 0.0 109.574 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2158 ' ' ILE . . . . . 0.588 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.1 OUTLIER -153.6 -163.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.661 -0.65 . . . . 0.0 109.319 179.429 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 2159 ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' 2151 ' ' CYS . 24.4 tp -135.41 136.36 41.33 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.195 -0.941 . . . . 0.0 110.073 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -113.99 44.14 1.71 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.411 -0.806 . . . . 0.0 109.255 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 100.42 -28.31 16.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2162 ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -179.46 -35.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -1.109 . . . . 0.0 109.47 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -81.66 113.62 19.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 0.0 109.254 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2164 ' ' CYS . . . . . 0.463 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -87.37 135.59 33.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.919 . . . . 0.0 109.854 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 2165 ' ' VAL . . . . . 0.475 ' O ' HD12 ' A' 2158 ' ' ILE . 0.3 OUTLIER -158.42 -168.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.416 -0.802 . . . . 0.0 108.848 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 2166 ' ' ASP . . . . . 0.473 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 0.6 OUTLIER -90.46 140.04 30.1 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.895 -1.128 . . . . 0.0 109.405 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 2167 ' ' THR . . . . . 0.588 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 7.6 t -93.13 161.33 14.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.252 -0.905 . . . . 0.0 109.373 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2168 ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' 2171 ' ' SER . 59.7 t0 -69.92 95.38 0.92 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.831 -1.168 . . . . 0.0 109.517 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2169 ' ' GLU . . . . . 0.554 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 41.2 mp0 -69.35 -35.85 76.29 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.489 -0.757 . . . . 0.0 109.399 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2170 ' ' CYS . . . . . 0.475 ' O ' ' SG ' ' A' 2181 ' ' CYS . 0.2 OUTLIER -65.01 -8.7 17.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.451 -0.781 . . . . 0.0 109.057 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 2171 ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -72.18 -0.6 12.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.962 -1.087 . . . . 0.0 109.781 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 9.9 t -98.82 -74.04 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.092 -1.005 . . . . 0.0 109.914 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2173 ' ' GLY . . . . . 0.483 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -166.61 138.92 5.46 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2174 ' ' ASN . . . . . 0.554 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 18.5 p-10 -38.64 99.31 0.19 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.694 -0.886 . . . . 0.0 110.245 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2175 ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' 2181 ' ' CYS . 1.8 Cg_endo -61.87 -27.94 80.73 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.053 1.835 . . . . 0.0 110.182 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2176 ' ' CYS . . . . . 0.531 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -46.14 -50.48 15.47 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 133.14 -16.92 4.62 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2178 ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.4 OUTLIER -162.86 -40.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -1.111 . . . . 0.0 109.911 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 2179 ' ' GLY . . . . . 0.579 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -60.85 -119.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.3 p -143.11 160.42 40.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.432 -1.04 . . . . 0.0 109.469 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2181 ' ' CYS . . . . . 0.554 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 16.7 p -88.1 166.42 14.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.137 -0.977 . . . . 0.0 110.794 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2182 ' ' LYS . . . . . 0.575 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.2 OUTLIER -145.62 156.01 43.39 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.604 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 61.3 t30 -100.59 131.33 46.55 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.698 -1.251 . . . . 0.0 109.506 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2184 ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' 2188 ' ' PHE . 0.6 OUTLIER -140.89 -166.8 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.515 -0.741 . . . . 0.0 109.368 -179.566 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 2185 ' ' ILE . . . . . 0.473 ' HA ' ' OD2' ' A' 2166 ' ' ASP . 4.0 mp -107.36 136.41 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.029 -1.045 . . . . 0.0 109.909 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 72.92 6.93 68.96 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2187 ' ' GLY . . . . . 0.48 ' O ' ' OE1' ' A' 2169 ' ' GLU . . . 169.81 -129.76 1.9 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2188 ' ' PHE . . . . . 0.554 ' HB3' ' HB2' ' A' 2169 ' ' GLU . 3.2 p90 -164.38 173.16 12.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -1.157 . . . . 0.0 108.997 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2189 ' ' GLU . . . . . 0.575 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 2.6 tt0 -120.54 159.33 25.42 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 22.4 p -149.18 145.34 27.11 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.738 -1.226 . . . . 0.0 109.917 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2191 ' ' THR . . . . . . . . . . . . . 25.2 m -113.9 85.96 2.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.299 -0.875 . . . . 0.0 109.564 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2192 ' ' CYS . . . . . 0.602 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.9 OUTLIER -51.01 178.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 109.273 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 2193 ' ' GLU . . . . . 0.49 ' O ' ' C ' ' A' 2194 ' ' GLU . 2.0 tm-20 -52.71 117.79 3.17 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2194 ' ' GLU . . . . . 0.49 ' C ' ' O ' ' A' 2193 ' ' GLU . 5.7 mt-10 -34.15 127.73 0.42 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.494 0.664 . . . . 0.0 110.833 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.59 4.61 8.82 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2196 ' ' PHE . . . . . 0.669 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.1 p90 -114.99 -162.77 0.84 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.193 -1.181 . . . . 0.0 110.1 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2197 ' ' GLU . . . . . 0.542 ' N ' ' CG ' ' A' 2196 ' ' PHE . 25.3 mt-10 -145.42 95.55 5.0 Favored Pre-proline 0 C--N 1.304 -1.386 0 O-C-N 121.46 -0.775 . . . . 0.0 109.481 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2198 ' ' PRO . . . . . 0.669 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 8.3 Cg_endo -67.38 -159.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.27 1.98 . . . . 0.0 111.098 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -140.62 -170.49 12.1 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.47 -81.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 121.919 1.746 . . . . 0.0 110.531 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2201 ' ' MET . . . . . 0.483 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.4 OUTLIER -135.02 56.52 1.84 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.819 -179.475 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -124.53 -78.63 0.6 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.22 -0.925 . . . . 0.0 109.654 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2203 ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' 2175 ' ' PRO . 6.7 t -178.5 -165.56 0.09 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.382 -0.824 . . . . 0.0 109.196 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2204 ' ' CYS . . . . . 0.564 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.4 t -75.08 144.79 42.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 0.0 109.462 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.563 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2129 ' ' ASP . . . . . 0.532 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 17.5 t0 . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2130 ' ' GLU . . . . . 0.581 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 42.4 mp0 -56.11 -24.76 42.58 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.43 -0.794 . . . . 0.0 110.529 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2131 ' ' CYS . . . . . 0.493 ' HA ' HG13 ' A' 2136 ' ' VAL . 1.8 t -84.49 -26.72 27.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.653 -1.279 . . . . 0.0 109.094 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2132 ' ' LYS . . . . . 0.46 ' HB2' ' HB3' ' A' 2129 ' ' ASP . 0.0 OUTLIER -84.75 13.05 6.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.07 -1.019 . . . . 0.0 109.089 179.445 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 2133 ' ' GLU . . . . . 0.522 ' HB2' ' CG2' ' A' 2136 ' ' VAL . 7.7 mt-10 -70.66 165.04 49.81 Favored Pre-proline 0 N--CA 1.486 1.365 0 O-C-N 121.346 -0.847 . . . . 0.0 109.498 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2134 ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' 2133 ' ' GLU . 2.6 Cg_endo -65.85 -27.76 51.3 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.57 2.18 . . . . 0.0 112.342 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -138.91 39.36 2.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.53 -1.356 . . . . 0.0 111.487 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2136 ' ' VAL . . . . . 0.538 HG12 ' CE2' ' A' 2149 ' ' TYR . 46.5 t -102.84 -100.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.834 -1.167 . . . . 0.0 109.248 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2137 ' ' CYS . . . . . 0.528 ' N ' ' CG1' ' A' 2136 ' ' VAL . 16.2 m -89.46 -65.48 1.01 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.767 -1.208 . . . . 0.0 108.696 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2138 ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' 2137 ' ' CYS . 0.3 OUTLIER 61.17 124.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.373 -0.829 . . . . 0.0 110.383 178.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 2139 ' ' HIS . . . . . 0.464 ' O ' ' HB3' ' A' 2164 ' ' CYS . 0.7 OUTLIER 63.18 40.83 8.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.335 -0.853 . . . . 0.0 110.366 179.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -154.79 162.15 30.65 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.04 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -94.44 87.9 5.32 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.493 -1.004 . . . . 0.0 108.727 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2142 ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' 2150 ' ' ARG . 0.8 OUTLIER -88.22 -166.83 1.69 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.3 -0.875 . . . . 0.0 109.769 -179.136 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 2143 ' ' ILE . . . . . 0.407 ' CD1' ' C ' ' A' 2142 ' ' CYS . 4.1 mp -144.72 103.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2144 ' ' ASN . . . . . 0.532 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 5.7 t-20 -57.63 116.02 3.14 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.302 -0.874 . . . . 0.0 110.3 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2145 ' ' THR . . . . . 0.427 ' OG1' ' C ' ' A' 2148 ' ' SER . 1.3 p -104.48 -177.46 3.37 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.381 -0.825 . . . . 0.0 109.196 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.86 -72.96 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.331 -0.856 . . . . 0.0 109.675 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -128.21 38.28 2.11 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2148 ' ' SER . . . . . 0.468 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER -155.0 -160.06 1.02 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.245 -1.15 . . . . 0.0 109.513 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 2149 ' ' TYR . . . . . 0.581 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 8.5 p90 -163.38 -169.72 2.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.658 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2150 ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' 2142 ' ' CYS . 32.4 mtt180 -157.81 99.51 1.7 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.388 -0.82 . . . . 0.0 109.374 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 30.6 m -70.09 111.97 6.13 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.252 -0.905 . . . . 0.0 109.17 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.03 84.8 2.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.239 -0.913 . . . . 0.0 109.416 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2153 ' ' CYS . . . . . 0.486 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -54.88 148.1 29.29 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.341 -0.849 . . . . 0.0 109.207 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 2154 ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.93 -167.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.405 2.07 . . . . 0.0 111.018 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 6.5 t80 -90.08 104.72 17.27 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.23 -16.14 5.24 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2157 ' ' TYR . . . . . 0.538 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 6.4 m-85 -105.52 -169.24 1.56 Allowed 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.564 -0.963 . . . . 0.0 110.155 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2158 ' ' ILE . . . . . 0.571 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.1 OUTLIER -153.46 -167.35 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.617 -0.677 . . . . 0.0 109.206 179.481 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 2159 ' ' LEU . . . . . 0.435 HD11 ' SG ' ' A' 2164 ' ' CYS . 37.9 tp -139.52 127.42 22.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.372 -0.83 . . . . 0.0 109.463 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -103.93 44.17 1.04 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.366 -0.834 . . . . 0.0 109.605 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2161 ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' 2162 ' ' ASN . . . 93.87 -17.79 57.96 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2162 ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' 2136 ' ' VAL . 4.0 p-10 179.72 -49.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -1.142 . . . . 0.0 109.469 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2163 ' ' GLU . . . . . 0.456 ' N ' ' CG ' ' A' 2162 ' ' ASN . 0.6 OUTLIER -73.45 120.07 18.55 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.56 -0.712 . . . . 0.0 109.255 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 2164 ' ' CYS . . . . . 0.464 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -97.08 139.4 33.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 109.456 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 2165 ' ' VAL . . . . . 0.466 ' O ' ' CD1' ' A' 2158 ' ' ILE . 1.6 m -158.39 -172.27 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.064 -1.023 . . . . 0.0 109.475 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2166 ' ' ASP . . . . . . . . . . . . . 7.6 t70 -88.11 152.65 21.86 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.952 -1.092 . . . . 0.0 109.562 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2167 ' ' THR . . . . . 0.571 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 5.5 t -92.19 -168.16 1.93 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 109.13 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2168 ' ' ASP . . . . . 0.417 ' C ' ' OD1' ' A' 2168 ' ' ASP . 58.5 t0 -111.36 100.0 8.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.085 -1.009 . . . . 0.0 109.213 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2169 ' ' GLU . . . . . 0.568 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.7 OUTLIER -74.0 -33.28 63.75 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.448 -0.783 . . . . 0.0 109.22 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 2170 ' ' CYS . . . . . 0.458 ' HB2' ' N ' ' A' 2182 ' ' LYS . 1.8 t -69.59 -9.62 54.81 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2171 ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -72.72 -12.86 61.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 0.0 109.549 -179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 21.7 t -84.76 -71.99 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.146 -0.971 . . . . 0.0 109.288 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2173 ' ' GLY . . . . . 0.465 ' O ' ' SG ' ' A' 2181 ' ' CYS . . . -154.09 -127.58 1.16 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2174 ' ' ASN . . . . . 0.552 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 26.5 p-10 -130.28 97.79 21.93 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.075 -1.25 . . . . 0.0 109.213 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2175 ' ' PRO . . . . . 0.473 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.6 Cg_endo -66.58 -18.97 54.6 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 121.918 1.745 . . . . 0.0 109.967 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2176 ' ' CYS . . . . . 0.53 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.1 OUTLIER -51.39 -49.12 62.19 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.06 0.933 . . . . 0.0 108.926 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 128.64 -21.05 5.41 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 108.326 -1.909 . . . . 0.0 108.326 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -166.52 -34.09 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.498 -1.001 . . . . 0.0 110.045 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2179 ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -69.26 -130.51 0.05 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.6 p -131.97 157.0 45.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.605 -0.938 . . . . 0.0 109.193 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2181 ' ' CYS . . . . . 0.552 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 24.7 p -89.17 167.09 13.39 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.336 1.065 . . . . 0.0 110.899 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2182 ' ' LYS . . . . . 0.527 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 3.9 tttp -146.4 160.79 41.6 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2183 ' ' ASN . . . . . 0.416 ' N ' ' CG ' ' A' 2182 ' ' LYS . 56.3 t30 -100.59 126.32 47.05 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.602 -1.311 . . . . 0.0 110.014 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2184 ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -132.46 -176.32 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 2185 ' ' ILE . . . . . 0.538 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 4.0 mp -100.29 140.29 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.019 -1.051 . . . . 0.0 110.008 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 70.64 12.19 69.92 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2187 ' ' GLY . . . . . 0.479 ' C ' ' CD1' ' A' 2188 ' ' PHE . . . 164.39 -117.92 0.78 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2188 ' ' PHE . . . . . 0.576 ' N ' ' CG1' ' A' 2184 ' ' VAL . 2.2 p90 -170.57 -179.27 2.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -1.19 . . . . 0.0 109.902 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2189 ' ' GLU . . . . . 0.527 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.3 OUTLIER -127.63 169.53 13.66 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.187 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 11.7 p -170.56 146.69 2.78 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.498 -1.376 . . . . 0.0 110.229 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2191 ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' 2192 ' ' CYS . 89.2 m -114.84 86.61 2.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.533 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2192 ' ' CYS . . . . . 0.605 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -50.27 -179.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.044 -1.035 . . . . 0.0 108.865 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 2193 ' ' GLU . . . . . 0.489 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.5 tt0 -55.15 113.92 1.56 Allowed 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2194 ' ' GLU . . . . . 0.489 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.2 tt0 -31.1 129.18 0.14 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.589 0.709 . . . . 0.0 111.029 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.61 4.27 9.81 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2196 ' ' PHE . . . . . 0.67 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.3 p90 -114.93 -163.63 0.89 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.229 -1.159 . . . . 0.0 110.385 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2197 ' ' GLU . . . . . 0.55 ' N ' ' CG ' ' A' 2196 ' ' PHE . 7.1 mt-10 -145.32 95.54 5.04 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 121.615 -0.678 . . . . 0.0 109.596 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2198 ' ' PRO . . . . . 0.67 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.2 Cg_endo -67.63 -162.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.349 2.033 . . . . 0.0 111.42 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -138.27 -174.82 13.58 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.54 -71.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.055 1.837 . . . . 0.0 110.726 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2201 ' ' MET . . . . . 0.466 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.1 OUTLIER -144.4 42.35 1.38 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.756 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.35 -77.11 0.58 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.217 -0.927 . . . . 0.0 109.532 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A 2203 ' ' THR . . . . . . . . . . . . . 12.2 t -168.32 -168.69 0.96 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.409 -0.807 . . . . 0.0 109.094 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A 2204 ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.0 OUTLIER -115.04 149.7 37.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.895 . . . . 0.0 108.989 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.077 -0.964 . . . . 0.0 109.564 179.919 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A 2129 ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' 2130 ' ' GLU . 16.3 t0 . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2130 ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' 2129 ' ' ASP . 2.5 mt-10 82.86 -51.15 0.17 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.857 -0.527 . . . . 0.0 110.265 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2131 ' ' CYS . . . . . 0.544 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 12.0 p -89.51 -25.05 21.63 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.094 -1.004 . . . . 0.0 109.614 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2132 ' ' LYS . . . . . 0.468 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -85.2 41.11 0.86 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.177 -0.952 . . . . 0.0 109.539 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -112.65 155.93 43.18 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.295 -0.878 . . . . 0.0 109.2 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2134 ' ' PRO . . . . . 0.465 ' O ' ' HD2' ' A' 2138 ' ' LYS . 1.5 Cg_endo -64.67 -5.46 10.34 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.361 2.041 . . . . 0.0 111.262 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2135 ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' A' 2162 ' ' ASN . 2.9 t0 -124.18 -29.5 3.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.802 -1.186 . . . . 0.0 110.216 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2136 ' ' VAL . . . . . 0.555 ' CG1' ' CE2' ' A' 2149 ' ' TYR . 61.7 t -77.82 -106.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.041 -1.037 . . . . 0.0 109.146 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2137 ' ' CYS . . . . . 0.483 ' N ' HG13 ' A' 2136 ' ' VAL . 0.1 OUTLIER -84.2 138.66 32.86 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.771 -1.206 . . . . 0.0 108.813 179.526 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 2138 ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' 2139 ' ' HIS . 0.5 OUTLIER -139.6 23.86 2.47 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.1 -1.0 . . . . 0.0 110.017 -179.269 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 2139 ' ' HIS . . . . . 0.541 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.1 OUTLIER 162.27 42.36 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.314 -0.867 . . . . 0.0 110.036 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -144.76 170.99 26.15 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.256 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2141 ' ' GLN . . . . . 0.431 ' O ' ' HG3' ' A' 2141 ' ' GLN . 5.7 pt20 -92.09 65.78 4.81 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.441 -1.035 . . . . 0.0 109.166 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2142 ' ' CYS . . . . . 0.469 ' O ' HG13 ' A' 2143 ' ' ILE . 21.5 p -62.44 -174.13 0.06 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.368 -0.833 . . . . 0.0 110.274 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2143 ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' 2142 ' ' CYS . 1.7 mp -148.71 83.09 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2144 ' ' ASN . . . . . 0.515 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 2.9 t30 -59.08 113.28 2.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.253 -0.904 . . . . 0.0 109.584 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2145 ' ' THR . . . . . . . . . . . . . 27.7 p -97.26 -151.79 0.37 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.371 -0.83 . . . . 0.0 109.415 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.76 -79.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 110.123 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -120.64 22.26 8.27 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2148 ' ' SER . . . . . 0.494 ' N ' ' OE2' ' A' 2130 ' ' GLU . 0.1 OUTLIER -144.85 -161.8 1.37 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -1.16 . . . . 0.0 109.214 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 2149 ' ' TYR . . . . . 0.555 ' CE2' ' CG1' ' A' 2136 ' ' VAL . 24.3 p90 179.6 -164.21 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.695 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2150 ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' 2149 ' ' TYR . 0.1 OUTLIER -166.58 119.45 1.03 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 109.358 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 13.2 m -89.03 106.67 18.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.885 . . . . 0.0 109.81 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -119.49 97.7 5.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 108.909 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2153 ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -58.22 152.95 39.09 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.21 -0.931 . . . . 0.0 109.817 -179.481 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 2154 ' ' PRO . . . . . 0.462 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 2.0 Cg_endo -66.11 -167.12 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.525 2.15 . . . . 0.0 111.023 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 22.1 t80 -90.59 104.72 17.27 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2156 ' ' GLY . . . . . 0.429 ' O ' HG21 ' A' 2167 ' ' THR . . . 131.05 -16.37 5.27 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.045 -2.022 . . . . 0.0 108.045 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2157 ' ' TYR . . . . . 0.52 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 8.2 m-85 -107.39 -169.69 1.58 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.599 -0.942 . . . . 0.0 110.005 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2158 ' ' ILE . . . . . 0.532 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.1 OUTLIER -151.24 -163.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.594 -0.691 . . . . 0.0 109.398 179.42 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 2159 ' ' LEU . . . . . 0.498 ' N ' HG12 ' A' 2158 ' ' ILE . 25.0 tp -145.51 113.26 6.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.413 -0.804 . . . . 0.0 109.297 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -95.55 60.66 2.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.323 -0.861 . . . . 0.0 109.715 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2161 ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 88.59 -19.49 36.37 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2162 ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' 2135 ' ' ASP . 0.1 OUTLIER 167.98 -34.08 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.361 -1.082 . . . . 0.0 109.357 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -76.49 111.62 12.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 109.15 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2164 ' ' CYS . . . . . 0.481 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.1 OUTLIER -87.83 144.74 26.43 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.301 -0.874 . . . . 0.0 109.69 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 2165 ' ' VAL . . . . . 0.521 HG21 ' CD1' ' A' 2158 ' ' ILE . 1.4 m -161.96 -169.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.292 -0.88 . . . . 0.0 109.54 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2166 ' ' ASP . . . . . 0.43 ' OD1' ' HA ' ' A' 2185 ' ' ILE . 34.7 t70 -78.54 164.35 24.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 110.179 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2167 ' ' THR . . . . . 0.532 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 6.0 t -117.25 -173.57 2.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.643 -0.661 . . . . 0.0 109.295 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2168 ' ' ASP . . . . . . . . . . . . . 42.0 t0 -101.6 102.47 13.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.197 -0.94 . . . . 0.0 108.976 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2169 ' ' GLU . . . . . 0.544 ' HB3' ' CD1' ' A' 2188 ' ' PHE . 0.3 OUTLIER -75.54 -23.89 56.67 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.276 -0.89 . . . . 0.0 110.359 -179.122 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 2170 ' ' CYS . . . . . 0.449 ' O ' ' SG ' ' A' 2170 ' ' CYS . 2.8 t -59.49 -12.34 6.1 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.784 -1.197 . . . . 0.0 108.805 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.48 -10.74 12.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.258 -0.901 . . . . 0.0 110.091 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2172 ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' 2169 ' ' GLU . 25.3 t -74.9 -68.21 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.232 -0.918 . . . . 0.0 109.422 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2173 ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' 2174 ' ' ASN . . . 162.54 78.28 0.03 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2174 ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' 2173 ' ' GLY . 1.0 OUTLIER 44.22 91.9 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.275 -1.132 . . . . 0.0 109.557 -179.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 2175 ' ' PRO . . . . . 0.611 ' CB ' ' CE2' ' A' 2188 ' ' PHE . 1.3 Cg_endo -66.68 -21.12 52.29 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.104 1.869 . . . . 0.0 110.238 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2176 ' ' CYS . . . . . 0.543 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -65.44 -60.0 3.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 109.521 -179.682 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 141.62 -18.09 2.62 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.74 -31.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.662 -0.905 . . . . 0.0 109.731 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2179 ' ' GLY . . . . . 0.542 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -60.68 -114.02 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.1 p -145.65 154.73 42.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.397 -1.061 . . . . 0.0 109.096 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2181 ' ' CYS . . . . . 0.467 ' HB3' ' HD2' ' A' 2175 ' ' PRO . 26.1 p -96.08 160.07 14.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.072 -1.018 . . . . 0.0 110.621 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2182 ' ' LYS . . . . . 0.527 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 3.6 tptm -146.06 156.65 43.61 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2183 ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' 2167 ' ' THR . 59.7 t30 -100.68 140.14 35.38 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.6 -1.313 . . . . 0.0 109.443 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2184 ' ' VAL . . . . . 0.451 HG11 ' C ' ' A' 2187 ' ' GLY . 0.5 OUTLIER -146.95 168.21 5.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.456 -0.777 . . . . 0.0 109.124 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 2185 ' ' ILE . . . . . 0.52 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 2.3 mp -80.64 140.32 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 110.755 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2186 ' ' GLY . . . . . 0.436 ' O ' ' SD ' ' A' 2201 ' ' MET . . . 69.81 9.26 62.26 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2187 ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 165.51 -136.66 4.29 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2188 ' ' PHE . . . . . 0.611 ' CE2' ' CB ' ' A' 2175 ' ' PRO . 1.2 p90 -153.06 179.26 8.86 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.199 -1.177 . . . . 0.0 109.055 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2189 ' ' GLU . . . . . 0.527 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.2 tp10 -131.49 171.27 13.61 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 7.8 p -170.79 148.8 2.98 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.78 -1.2 . . . . 0.0 109.876 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2191 ' ' THR . . . . . . . . . . . . . 10.1 m -118.39 88.94 3.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.908 . . . . 0.0 109.965 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2192 ' ' CYS . . . . . 0.604 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.7 OUTLIER -51.58 -179.48 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.171 -0.956 . . . . 0.0 109.219 179.586 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 2193 ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' 2194 ' ' GLU . 4.7 tt0 -57.2 118.17 4.8 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2194 ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.5 OUTLIER -32.21 128.49 0.22 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.409 0.623 . . . . 0.0 111.006 -178.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.41 4.69 8.94 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2196 ' ' PHE . . . . . 0.672 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.9 OUTLIER -117.37 -165.98 1.14 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.259 -1.142 . . . . 0.0 110.313 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 2197 ' ' GLU . . . . . 0.535 ' N ' ' CG ' ' A' 2196 ' ' PHE . 4.9 mm-40 -143.86 95.98 5.63 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.635 -0.666 . . . . 0.0 109.388 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2198 ' ' PRO . . . . . 0.672 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 6.8 Cg_endo -65.95 -167.17 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.187 1.925 . . . . 0.0 111.273 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -134.65 -171.33 12.47 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.1 -76.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.111 1.874 . . . . 0.0 110.822 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2201 ' ' MET . . . . . 0.502 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -140.26 52.2 1.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.485 -0.759 . . . . 0.0 109.997 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 8.8 mmm -126.37 -73.84 0.61 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.002 -1.062 . . . . 0.0 110.062 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A 2203 ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' 2175 ' ' PRO . 7.0 t -170.78 -169.12 0.74 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.218 -0.926 . . . . 0.0 109.746 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A 2204 ' ' CYS . . . . . 0.571 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.0 OUTLIER -112.46 148.03 35.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.47 -0.769 . . . . 0.0 108.974 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.43 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2129 ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' 2130 ' ' GLU . 5.2 t0 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2130 ' ' GLU . . . . . 0.534 ' CB ' ' O ' ' A' 2129 ' ' ASP . 2.1 mt-10 83.03 -61.29 0.13 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.757 -0.589 . . . . 0.0 110.831 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2131 ' ' CYS . . . . . 0.528 ' HB3' ' CD2' ' A' 2149 ' ' TYR . 29.5 p -85.45 -5.78 59.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.961 -1.087 . . . . 0.0 110.047 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2132 ' ' LYS . . . . . 0.537 ' CG ' ' O ' ' A' 2132 ' ' LYS . 13.7 tttt -94.89 3.18 55.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -0.976 . . . . 0.0 109.34 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2133 ' ' GLU . . . . . 0.409 ' HB2' HG22 ' A' 2136 ' ' VAL . 5.3 mt-10 -69.61 147.24 96.52 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 120.99 -1.069 . . . . 0.0 109.188 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2134 ' ' PRO . . . . . 0.466 ' HA ' ' CG ' ' A' 2138 ' ' LYS . 1.4 Cg_endo -63.9 -6.13 10.44 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.278 1.985 . . . . 0.0 110.935 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.16 -3.73 12.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.983 -1.073 . . . . 0.0 110.078 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2136 ' ' VAL . . . . . 0.475 ' CG1' ' HA ' ' A' 2131 ' ' CYS . 76.9 t -96.86 -101.03 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.037 -1.04 . . . . 0.0 109.788 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2137 ' ' CYS . . . . . 0.48 ' HB2' ' O ' ' A' 2131 ' ' CYS . 0.5 OUTLIER -73.27 -72.58 0.25 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.868 -1.145 . . . . 0.0 109.523 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 2138 ' ' LYS . . . . . 0.509 ' O ' ' CB ' ' A' 2139 ' ' HIS . 1.1 mtmt 63.53 100.57 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.296 -0.878 . . . . 0.0 109.805 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2139 ' ' HIS . . . . . 0.509 ' CB ' ' O ' ' A' 2138 ' ' LYS . 7.7 m-70 76.54 26.68 0.85 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -0.893 . . . . 0.0 109.579 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -132.34 166.82 23.23 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2141 ' ' GLN . . . . . 0.521 ' O ' ' CG ' ' A' 2152 ' ' GLU . 0.9 OUTLIER -103.86 71.51 1.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -1.17 . . . . 0.0 109.022 179.803 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 2142 ' ' CYS . . . . . 0.46 ' O ' HG13 ' A' 2143 ' ' ILE . 25.4 p -70.17 -164.33 0.08 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.865 0.841 . . . . 0.0 110.449 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2143 ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' 2142 ' ' CYS . 2.5 mp -151.68 84.58 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2144 ' ' ASN . . . . . 0.506 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 3.2 t30 -61.74 113.64 2.86 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.54 -0.725 . . . . 0.0 110.362 -178.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2145 ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' 2146 ' ' ASP . 16.5 p -101.1 -157.2 0.59 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.531 -0.731 . . . . 0.0 109.324 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2146 ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' 2146 ' ' ASP . 0.6 OUTLIER -48.37 -94.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.625 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -108.04 16.99 35.57 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2148 ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.69 -166.37 1.77 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.202 -1.175 . . . . 0.0 109.165 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2149 ' ' TYR . . . . . 0.528 ' CD2' ' HB3' ' A' 2131 ' ' CYS . 40.5 p90 -176.4 -176.86 0.8 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.655 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2150 ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.09 134.9 23.58 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -102.25 119.67 39.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.086 -1.009 . . . . 0.0 109.937 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2152 ' ' GLU . . . . . 0.521 ' CG ' ' O ' ' A' 2141 ' ' GLN . 0.8 OUTLIER -134.68 178.64 6.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 109.389 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 2153 ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -142.09 158.34 61.84 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.302 -179.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 2154 ' ' PRO . . . . . 0.471 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.8 Cg_endo -62.93 -171.08 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.457 2.104 . . . . 0.0 111.52 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.18 102.47 14.49 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.39 -16.7 5.4 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2157 ' ' TYR . . . . . 0.537 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 5.2 m-85 -105.25 -170.44 1.75 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.682 -0.893 . . . . 0.0 109.898 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2158 ' ' ILE . . . . . 0.529 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.2 OUTLIER -158.91 -161.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.624 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 2159 ' ' LEU . . . . . 0.51 ' N ' HG12 ' A' 2158 ' ' ILE . 26.3 tp -136.55 123.34 21.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.831 . . . . 0.0 109.499 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -96.39 51.78 1.21 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.359 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 90.36 -29.62 6.53 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2162 ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' 2136 ' ' VAL . 2.8 p-10 -171.13 -48.84 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.153 -1.204 . . . . 0.0 109.331 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2163 ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' 2137 ' ' CYS . 53.8 tt0 -72.57 121.78 20.27 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.543 -0.723 . . . . 0.0 109.273 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2164 ' ' CYS . . . . . 0.471 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.1 OUTLIER -90.94 138.88 31.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 109.593 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 2165 ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -159.84 -167.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.941 . . . . 0.0 109.297 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2166 ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 8.7 t70 -89.97 155.73 18.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.975 -1.078 . . . . 0.0 109.786 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2167 ' ' THR . . . . . 0.529 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 7.2 t -90.99 -169.49 2.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 109.449 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2168 ' ' ASP . . . . . 0.465 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 64.9 t0 -109.15 102.44 11.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.218 -0.926 . . . . 0.0 109.836 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2169 ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.5 OUTLIER -74.95 -32.65 61.79 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.361 -0.837 . . . . 0.0 109.066 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 2170 ' ' CYS . . . . . 0.526 ' HB2' ' N ' ' A' 2182 ' ' LYS . 0.6 OUTLIER -64.6 -11.55 36.1 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.776 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.35 5.22 13.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.845 . . . . 0.0 109.383 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 40.5 t -103.61 -65.88 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.355 -0.84 . . . . 0.0 109.402 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2173 ' ' GLY . . . . . . . . . . . . . . . -153.53 -135.18 2.1 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2174 ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -122.85 102.69 37.85 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.316 -1.109 . . . . 0.0 109.07 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2175 ' ' PRO . . . . . 0.645 ' CB ' ' CE2' ' A' 2188 ' ' PHE . 3.4 Cg_endo -69.07 -18.58 40.19 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.695 1.597 . . . . 0.0 109.839 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2176 ' ' CYS . . . . . 0.569 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -69.77 -50.36 44.05 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.127 -0.983 . . . . 0.0 109.653 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 124.75 -17.94 7.2 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -166.37 -37.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -1.079 . . . . 0.0 110.12 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2179 ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -63.95 -120.55 0.01 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.4 p -141.55 161.29 38.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.54 -0.976 . . . . 0.0 109.198 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2181 ' ' CYS . . . . . 0.517 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 26.7 p -97.81 160.76 14.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.043 -1.036 . . . . 0.0 110.593 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2182 ' ' LYS . . . . . 0.542 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 2.5 tppt? -145.46 155.67 43.26 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2183 ' ' ASN . . . . . 0.465 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 32.4 t30 -92.71 137.34 32.45 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.52 -1.363 . . . . 0.0 110.203 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2184 ' ' VAL . . . . . 0.588 ' CG1' ' CA ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -140.92 -167.63 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 2185 ' ' ILE . . . . . 0.537 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 1.5 mp -107.17 141.42 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.106 -0.996 . . . . 0.0 110.461 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 64.7 13.48 56.11 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2187 ' ' GLY . . . . . 0.492 ' C ' ' CD1' ' A' 2188 ' ' PHE . . . 167.24 -118.85 0.81 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2188 ' ' PHE . . . . . 0.645 ' CE2' ' CB ' ' A' 2175 ' ' PRO . 1.5 p90 -171.84 -179.19 2.38 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.367 -1.078 . . . . 0.0 109.497 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2189 ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.5 OUTLIER -128.87 169.19 14.9 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.387 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 8.9 p -170.53 147.66 2.96 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.789 -1.194 . . . . 0.0 109.749 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2191 ' ' THR . . . . . . . . . . . . . 25.2 m -118.18 90.97 3.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.644 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2192 ' ' CYS . . . . . 0.614 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.8 OUTLIER -52.99 -179.88 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.031 -1.043 . . . . 0.0 108.783 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 2193 ' ' GLU . . . . . 0.499 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.6 tt0 -52.45 112.76 0.87 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2194 ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -31.34 125.73 0.21 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.439 0.637 . . . . 0.0 111.136 -178.601 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.53 11.18 6.17 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2196 ' ' PHE . . . . . 0.686 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.8 p90 -118.33 -162.34 0.88 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.135 -1.215 . . . . 0.0 110.489 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2197 ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' 2196 ' ' PHE . 18.4 mt-10 -142.28 92.54 7.45 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 121.434 -0.792 . . . . 0.0 110.058 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2198 ' ' PRO . . . . . 0.686 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.0 Cg_endo -67.05 -160.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.303 2.002 . . . . 0.0 111.273 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -140.21 -175.74 14.63 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A 2200 ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' 2189 ' ' GLU . 2.0 Cg_endo -62.14 -74.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 121.702 1.601 . . . . 0.0 110.61 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2201 ' ' MET . . . . . 0.446 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -143.44 46.47 1.5 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.213 -0.929 . . . . 0.0 109.458 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 2202 ' ' MET . . . . . 0.427 ' O ' ' HB ' ' A' 2203 ' ' THR . 0.1 OUTLIER -116.95 -65.59 1.17 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.303 -0.873 . . . . 0.0 109.779 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 2203 ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' 2202 ' ' MET . 13.3 t -179.9 -171.45 0.18 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A 2204 ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.0 OUTLIER -112.44 143.51 43.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.086 -1.009 . . . . 0.0 109.269 -179.552 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.495 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2129 ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' 2130 ' ' GLU . 4.5 t0 . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2130 ' ' GLU . . . . . 0.614 ' HB2' ' O ' ' A' 2129 ' ' ASP . 1.8 mp0 75.81 -57.52 0.57 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 120.92 0.391 . . . . 0.0 111.45 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2131 ' ' CYS . . . . . 0.56 ' HB2' ' CB ' ' A' 2137 ' ' CYS . 0.5 OUTLIER -84.43 -19.31 33.67 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.765 -1.209 . . . . 0.0 109.974 -178.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 2132 ' ' LYS . . . . . 0.481 ' HB3' ' HB3' ' A' 2129 ' ' ASP . 4.4 tttt -68.4 -9.92 51.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.13 -0.981 . . . . 0.0 109.838 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2133 ' ' GLU . . . . . 0.533 ' HB2' ' CG2' ' A' 2136 ' ' VAL . 6.7 mt-10 -69.13 147.62 97.54 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.329 -0.857 . . . . 0.0 109.921 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2134 ' ' PRO . . . . . 0.479 ' O ' ' HD2' ' A' 2138 ' ' LYS . 3.8 Cg_endo -69.27 3.25 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.499 2.132 . . . . 0.0 111.17 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2135 ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' 2162 ' ' ASN . 0.6 OUTLIER -127.08 -6.08 6.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.638 -1.289 . . . . 0.0 110.3 -179.551 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 2136 ' ' VAL . . . . . 0.533 ' CG2' ' HB2' ' A' 2133 ' ' GLU . 2.4 t -102.31 -143.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.866 -1.146 . . . . 0.0 108.117 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2137 ' ' CYS . . . . . 0.56 ' CB ' ' HB2' ' A' 2131 ' ' CYS . 2.6 t -49.97 128.94 19.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.548 -1.345 . . . . 0.0 108.336 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2138 ' ' LYS . . . . . 0.516 ' O ' ' CB ' ' A' 2139 ' ' HIS . 2.9 mtpt -135.4 28.8 3.34 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.119 -0.988 . . . . 0.0 110.353 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2139 ' ' HIS . . . . . 0.516 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.1 OUTLIER 162.21 45.43 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.311 -0.868 . . . . 0.0 109.698 179.582 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -153.92 179.76 29.91 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -88.8 82.62 6.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -1.135 . . . . 0.0 109.171 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2142 ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' 2150 ' ' ARG . 21.4 p -78.67 147.63 33.46 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.366 -0.834 . . . . 0.0 110.032 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 5.0 mm -113.37 129.03 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2144 ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' 2129 ' ' ASP . 4.0 t-20 -84.16 103.47 13.4 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 110.545 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2145 ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' 2146 ' ' ASP . 4.1 p -94.45 -167.19 1.61 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2146 ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' 2145 ' ' THR . 0.4 OUTLIER -45.78 -93.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 109.342 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -108.12 -7.6 30.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2148 ' ' SER . . . . . 0.438 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.2 OUTLIER -100.24 -162.61 0.96 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -1.129 . . . . 0.0 109.471 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 2149 ' ' TYR . . . . . 0.594 ' CD2' ' HB3' ' A' 2130 ' ' GLU . 29.6 p90 -164.85 -171.12 2.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.193 -0.942 . . . . 0.0 109.577 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2150 ' ' ARG . . . . . 0.531 ' CG ' ' O ' ' A' 2149 ' ' TYR . 18.0 mtt180 -160.55 104.5 1.41 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.465 -0.772 . . . . 0.0 109.412 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2151 ' ' CYS . . . . . 0.462 ' SG ' HD12 ' A' 2159 ' ' LEU . 41.9 t -86.68 78.82 9.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.351 -0.843 . . . . 0.0 109.482 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.86 98.12 11.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.921 . . . . 0.0 109.209 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2153 ' ' CYS . . . . . 0.51 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -58.08 157.46 16.29 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.335 -0.853 . . . . 0.0 109.748 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 2154 ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' 2157 ' ' TYR . 1.2 Cg_endo -65.22 -166.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.703 2.269 . . . . 0.0 111.278 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 8.4 t80 -90.43 102.34 15.08 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.82 -15.4 5.42 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 107.742 -2.143 . . . . 0.0 107.742 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2157 ' ' TYR . . . . . 0.533 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 9.0 m-85 -109.3 -171.19 1.79 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.647 -0.913 . . . . 0.0 109.724 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2158 ' ' ILE . . . . . 0.588 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.1 OUTLIER -157.34 -161.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.641 -0.662 . . . . 0.0 109.597 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 2159 ' ' LEU . . . . . 0.462 HD12 ' SG ' ' A' 2151 ' ' CYS . 15.5 tp -134.35 120.72 20.23 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.326 -0.859 . . . . 0.0 109.67 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -97.1 57.47 1.47 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.2 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2161 ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 86.94 -14.0 57.96 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2162 ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' 2161 ' ' GLY . 1.6 m-20 165.44 -41.81 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.253 -1.145 . . . . 0.0 109.683 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -73.63 118.38 16.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.372 -0.83 . . . . 0.0 109.223 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2164 ' ' CYS . . . . . 0.491 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -85.24 138.78 32.12 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.26 -0.9 . . . . 0.0 109.642 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 2165 ' ' VAL . . . . . 0.488 ' CG1' ' O ' ' A' 2164 ' ' CYS . 1.6 m -164.63 -170.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 0.0 109.07 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2166 ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' 2184 ' ' VAL . 3.0 t70 -89.74 147.66 23.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.991 -1.068 . . . . 0.0 109.465 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2167 ' ' THR . . . . . 0.588 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 6.8 t -89.72 -173.72 4.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.363 -0.836 . . . . 0.0 109.111 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2168 ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' 2171 ' ' SER . 44.5 t0 -98.94 97.02 8.24 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.266 -0.896 . . . . 0.0 108.649 178.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2169 ' ' GLU . . . . . 0.542 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.6 OUTLIER -72.58 -31.18 65.03 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.185 -0.947 . . . . 0.0 109.443 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 2170 ' ' CYS . . . . . 0.498 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 3.3 t -70.59 -4.7 24.49 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.301 -0.874 . . . . 0.0 108.894 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2171 ' ' SER . . . . . 0.487 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.1 OUTLIER -65.62 -8.52 20.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.831 -1.168 . . . . 0.0 109.413 179.572 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 24.9 t -83.11 -71.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.156 -0.965 . . . . 0.0 109.571 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2173 ' ' GLY . . . . . 0.459 ' O ' ' SG ' ' A' 2181 ' ' CYS . . . -172.72 -70.21 0.05 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2174 ' ' ASN . . . . . 0.544 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 27.5 p-10 -171.47 95.58 0.41 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.221 -1.164 . . . . 0.0 109.021 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2175 ' ' PRO . . . . . 0.582 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.5 Cg_endo -63.98 -19.75 66.96 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.915 1.743 . . . . 0.0 110.253 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2176 ' ' CYS . . . . . 0.501 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -56.04 -58.69 6.86 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.052 -1.03 . . . . 0.0 108.239 179.697 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 148.1 -18.21 1.37 Allowed Glycine 0 N--CA 1.483 1.826 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2178 ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.2 OUTLIER -169.48 -32.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -1.131 . . . . 0.0 110.297 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 2179 ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -61.18 -115.6 0.01 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2180 ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' 2190 ' ' CYS . 1.1 p -151.3 152.51 33.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -1.07 . . . . 0.0 109.486 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2181 ' ' CYS . . . . . 0.566 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 20.7 p -87.83 164.29 15.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.974 -1.079 . . . . 0.0 110.896 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2182 ' ' LYS . . . . . 0.549 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.0 OUTLIER -145.16 158.97 43.68 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.467 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 2183 ' ' ASN . . . . . 0.467 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 57.2 t30 -99.72 129.9 45.88 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.446 -1.408 . . . . 0.0 109.735 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2184 ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -140.08 -170.3 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 2185 ' ' ILE . . . . . 0.533 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 4.6 mp -101.6 136.78 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.96 -1.087 . . . . 0.0 110.448 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 76.33 -2.23 57.97 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2187 ' ' GLY . . . . . 0.533 ' C ' ' CD1' ' A' 2188 ' ' PHE . . . 178.27 -113.67 0.42 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2188 ' ' PHE . . . . . 0.582 ' CD2' ' HG2' ' A' 2175 ' ' PRO . 3.0 p90 -176.19 176.42 1.71 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.384 -1.068 . . . . 0.0 108.876 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2189 ' ' GLU . . . . . 0.549 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 8.1 tt0 -124.26 133.67 53.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.125 -0.984 . . . . 0.0 108.685 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2190 ' ' CYS . . . . . 0.448 ' HA ' ' O ' ' A' 2180 ' ' THR . 20.7 p -128.16 136.99 51.88 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.906 -1.121 . . . . 0.0 109.869 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2191 ' ' THR . . . . . 0.472 ' O ' ' HA3' ' A' 2179 ' ' GLY . 17.9 m -109.86 87.95 2.63 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.38 -0.825 . . . . 0.0 109.243 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2192 ' ' CYS . . . . . 0.602 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 1.2 m -48.91 -179.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.414 -0.804 . . . . 0.0 109.167 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2193 ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' 2194 ' ' GLU . 20.5 tt0 -56.26 122.35 11.6 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2194 ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -36.7 130.17 0.76 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.616 -0.678 . . . . 0.0 110.585 -178.886 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.31 0.02 10.44 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2196 ' ' PHE . . . . . 0.683 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.2 p90 -112.1 -162.47 0.8 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.277 -1.131 . . . . 0.0 110.015 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2197 ' ' GLU . . . . . 0.551 ' N ' ' CG ' ' A' 2196 ' ' PHE . 9.3 mt-10 -145.96 94.33 5.01 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.429 -0.795 . . . . 0.0 109.872 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2198 ' ' PRO . . . . . 0.683 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 7.9 Cg_endo -67.65 -158.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.444 2.096 . . . . 0.0 111.355 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -146.44 -167.4 12.78 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.13 -79.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.874 1.716 . . . . 0.0 110.634 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A 2201 ' ' MET . . . . . 0.493 ' HA ' ' O ' ' A' 2188 ' ' PHE . 5.0 ptp -136.93 62.31 1.6 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.823 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -127.69 -86.1 0.58 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.236 -0.915 . . . . 0.0 109.933 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2203 ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' 2175 ' ' PRO . 15.1 t -175.7 -170.42 0.4 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.387 -0.821 . . . . 0.0 108.961 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A 2204 ' ' CYS . . . . . 0.54 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.7 OUTLIER -61.66 135.98 57.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.011 -1.055 . . . . 0.0 108.972 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A 2205 ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' 2197 ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.579 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2129 ' ' ASP . . . . . 0.524 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 19.3 t0 . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2130 ' ' GLU . . . . . 0.633 ' CB ' ' CD1' ' A' 2149 ' ' TYR . 1.3 mt-10 80.3 -43.96 0.25 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.925 -0.484 . . . . 0.0 111.066 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2131 ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' 2132 ' ' LYS . 10.4 p -91.0 -42.19 10.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.66 -1.275 . . . . 0.0 110.111 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2132 ' ' LYS . . . . . 0.507 ' N ' ' SG ' ' A' 2131 ' ' CYS . 0.0 OUTLIER -67.27 -2.4 5.91 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.993 -1.067 . . . . 0.0 110.52 -179.571 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -68.75 153.56 95.76 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 120.963 -1.086 . . . . 0.0 109.459 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2134 ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -65.52 -3.81 8.43 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.533 2.155 . . . . 0.0 111.101 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -119.26 3.13 11.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.861 -1.15 . . . . 0.0 110.346 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2136 ' ' VAL . . . . . 0.603 HG13 ' CE2' ' A' 2149 ' ' TYR . 19.1 t -121.82 -119.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.827 -1.171 . . . . 0.0 109.785 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2137 ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' 2131 ' ' CYS . 0.1 OUTLIER -50.78 -56.19 13.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.624 -1.298 . . . . 0.0 109.488 -179.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 2138 ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' 2137 ' ' CYS . 3.8 mttt 72.64 -81.91 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.4 -0.813 . . . . 0.0 109.866 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2139 ' ' HIS . . . . . 0.493 ' O ' ' HB3' ' A' 2164 ' ' CYS . 21.2 m80 -115.27 58.87 0.71 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.052 -1.03 . . . . 0.0 110.186 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -141.7 -166.74 10.97 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.04 93.75 3.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -1.153 . . . . 0.0 109.037 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2142 ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' 2143 ' ' ILE . 12.8 p -91.52 -152.25 0.29 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.235 -0.916 . . . . 0.0 110.491 -179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2143 ' ' ILE . . . . . 0.495 ' N ' ' SG ' ' A' 2142 ' ' CYS . 2.9 mp -148.46 90.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2144 ' ' ASN . . . . . 0.524 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 30.2 t-20 -39.33 108.5 0.09 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.404 0.621 . . . . 0.0 110.826 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2145 ' ' THR . . . . . 0.416 ' OG1' ' C ' ' A' 2148 ' ' SER . 0.1 OUTLIER -98.67 170.35 8.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.401 -0.812 . . . . 0.0 108.994 179.302 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.92 -84.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.797 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -107.08 50.83 0.77 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2148 ' ' SER . . . . . 0.466 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER -178.06 -162.68 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -1.153 . . . . 0.0 109.714 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 2149 ' ' TYR . . . . . 0.633 ' CD1' ' CB ' ' A' 2130 ' ' GLU . 42.0 p90 -169.77 -169.49 0.9 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.454 -0.779 . . . . 0.0 109.737 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2150 ' ' ARG . . . . . 0.454 ' O ' ' SG ' ' A' 2151 ' ' CYS . 0.4 OUTLIER -144.18 -160.78 1.17 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 2151 ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' 2150 ' ' ARG . 1.2 m -169.77 69.9 0.06 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.072 -1.017 . . . . 0.0 109.66 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -89.89 137.71 32.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.408 -0.807 . . . . 0.0 109.151 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2153 ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -112.07 158.54 36.61 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.192 -0.943 . . . . 0.0 109.501 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 2154 ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' 2157 ' ' TYR . 2.7 Cg_endo -61.61 -176.03 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.68 2.253 . . . . 0.0 111.817 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 12.7 t80 -82.29 103.15 11.67 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.54 -19.03 5.11 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 107.119 -2.393 . . . . 0.0 107.119 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2157 ' ' TYR . . . . . 0.506 ' O ' ' CG2' ' A' 2158 ' ' ILE . 18.2 m-85 -108.2 176.42 5.13 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.824 -0.81 . . . . 0.0 109.601 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2158 ' ' ILE . . . . . 0.612 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.1 OUTLIER -158.08 -163.74 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.658 -0.651 . . . . 0.0 109.403 -179.764 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 2159 ' ' LEU . . . . . 0.401 HD23 ' HB3' ' A' 2151 ' ' CYS . 19.4 tp -131.34 122.78 26.97 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.435 -0.79 . . . . 0.0 109.481 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -93.47 43.01 1.11 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.299 -0.875 . . . . 0.0 109.129 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2161 ' ' GLY . . . . . 0.451 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 97.42 -8.94 64.63 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2162 ' ' ASN . . . . . 0.521 ' ND2' ' HA ' ' A' 2136 ' ' VAL . 1.3 m-20 167.93 -43.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -1.167 . . . . 0.0 109.635 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -79.42 118.83 21.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 109.376 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2164 ' ' CYS . . . . . 0.528 ' O ' ' CG1' ' A' 2165 ' ' VAL . 0.1 OUTLIER -88.53 137.77 32.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.418 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 2165 ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' 2164 ' ' CYS . 1.8 m -166.43 -166.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.374 -0.829 . . . . 0.0 108.92 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2166 ' ' ASP . . . . . 0.411 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 0.7 OUTLIER -83.82 139.18 32.84 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.733 -1.23 . . . . 0.0 109.453 179.83 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 2167 ' ' THR . . . . . 0.612 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 9.9 t -97.44 178.31 5.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.354 -0.841 . . . . 0.0 109.362 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2168 ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' 2171 ' ' SER . 51.3 t0 -88.55 96.04 10.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.164 -0.96 . . . . 0.0 109.024 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2169 ' ' GLU . . . . . 0.553 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.4 OUTLIER -66.67 -34.14 77.21 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.296 -0.877 . . . . 0.0 109.228 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 2170 ' ' CYS . . . . . 0.459 ' O ' ' SG ' ' A' 2170 ' ' CYS . 1.7 t -68.67 -9.08 48.0 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.327 -0.858 . . . . 0.0 108.753 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2171 ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -78.32 5.84 9.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.372 -0.83 . . . . 0.0 110.574 -179.176 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 5.6 t -112.3 -76.93 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.903 -1.123 . . . . 0.0 109.87 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2173 ' ' GLY . . . . . 0.485 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -150.7 137.53 6.15 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2174 ' ' ASN . . . . . 0.603 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 23.2 p-10 -47.03 104.51 0.41 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.312 -1.111 . . . . 0.0 109.969 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2175 ' ' PRO . . . . . 0.556 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 1.7 Cg_endo -70.42 -23.55 27.66 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.879 1.719 . . . . 0.0 109.763 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2176 ' ' CYS . . . . . 0.543 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -47.33 -30.97 3.52 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.395 -0.815 . . . . 0.0 109.492 -179.585 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 114.49 -23.47 12.21 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.3 -34.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.606 -0.937 . . . . 0.0 109.791 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2179 ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -62.47 -127.81 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.3 p -134.64 156.76 48.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.601 -0.941 . . . . 0.0 109.549 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2181 ' ' CYS . . . . . 0.603 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 14.6 p -94.12 163.06 13.62 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.199 1.0 . . . . 0.0 111.258 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2182 ' ' LYS . . . . . 0.555 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 5.9 tttp -143.06 156.9 44.92 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 60.9 t30 -99.31 133.09 44.12 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.3 -1.5 . . . . 0.0 109.967 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2184 ' ' VAL . . . . . 0.497 HG13 ' CA ' ' A' 2188 ' ' PHE . 0.4 OUTLIER -140.37 -176.77 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.635 -0.666 . . . . 0.0 109.227 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 2185 ' ' ILE . . . . . 0.411 ' HA ' ' OD2' ' A' 2166 ' ' ASP . 1.9 mp -95.8 143.51 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.117 -0.989 . . . . 0.0 110.131 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 65.07 12.33 54.59 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2187 ' ' GLY . . . . . 0.472 ' O ' ' OE2' ' A' 2169 ' ' GLU . . . 165.12 -129.25 1.92 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2188 ' ' PHE . . . . . 0.553 ' HB3' ' HB2' ' A' 2169 ' ' GLU . 1.4 p90 -164.11 -179.32 6.1 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.3 -1.118 . . . . 0.0 108.81 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2189 ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.2 OUTLIER -125.48 174.2 8.38 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.39 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 1.8 p -171.61 147.71 2.36 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.769 -1.207 . . . . 0.0 109.81 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2191 ' ' THR . . . . . 0.474 ' O ' ' O ' ' A' 2192 ' ' CYS . 13.6 m -123.06 89.9 3.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.0 109.898 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2192 ' ' CYS . . . . . 0.592 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.8 OUTLIER -48.91 -179.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.341 -0.85 . . . . 0.0 109.32 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 2193 ' ' GLU . . . . . 0.462 ' O ' ' C ' ' A' 2194 ' ' GLU . 3.3 tt0 -61.12 125.43 23.7 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2194 ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -34.86 129.76 0.43 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.344 0.592 . . . . 0.0 110.842 -179.244 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.21 5.39 8.77 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2196 ' ' PHE . . . . . 0.672 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.9 OUTLIER -121.5 -163.5 1.05 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.289 -1.124 . . . . 0.0 110.195 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 2197 ' ' GLU . . . . . 0.584 ' N ' ' CG ' ' A' 2196 ' ' PHE . 24.4 mt-10 -148.15 98.07 3.8 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.619 -0.675 . . . . 0.0 109.428 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2198 ' ' PRO . . . . . 0.672 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.8 Cg_endo -69.01 -166.31 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.339 2.026 . . . . 0.0 111.597 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -135.84 -170.35 12.04 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.17 -83.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.21 1.94 . . . . 0.0 110.994 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A 2201 ' ' MET . . . . . 0.492 ' HA ' ' O ' ' A' 2188 ' ' PHE . 8.4 mtt -132.77 52.22 2.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.991 -1.068 . . . . 0.0 109.975 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2202 ' ' MET . . . . . 0.441 ' O ' ' HB ' ' A' 2203 ' ' THR . 1.0 OUTLIER -122.98 -71.23 0.73 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.21 -0.931 . . . . 0.0 109.791 -179.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 2203 ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' 2202 ' ' MET . 11.7 t 179.33 -167.82 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.458 -0.776 . . . . 0.0 109.048 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A 2204 ' ' CYS . . . . . 0.543 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -111.52 150.17 30.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.095 -1.003 . . . . 0.0 109.215 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 117.896 -1.049 . . . . 0.0 109.572 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2129 ' ' ASP . . . . . 0.555 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 1.3 p30 . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2130 ' ' GLU . . . . . 0.636 ' CB ' ' CD2' ' A' 2149 ' ' TYR . 1.4 mt-10 80.44 -42.86 0.22 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 122.015 -0.428 . . . . 0.0 111.292 177.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2131 ' ' CYS . . . . . 0.507 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 17.5 p -90.82 27.16 1.86 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.922 -1.111 . . . . 0.0 110.204 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2132 ' ' LYS . . . . . 0.525 ' N ' ' OD1' ' A' 2129 ' ' ASP . 0.6 OUTLIER -131.94 -6.25 3.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.91 . . . . 0.0 109.728 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 2133 ' ' GLU . . . . . 0.454 ' HB3' ' HD2' ' A' 2134 ' ' PRO . 5.8 mt-10 -70.03 158.74 86.62 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.141 -0.974 . . . . 0.0 109.323 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2134 ' ' PRO . . . . . 0.491 ' O ' ' HD2' ' A' 2138 ' ' LYS . 2.8 Cg_endo -67.27 -1.53 6.54 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.379 2.053 . . . . 0.0 110.804 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.07 4.65 9.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.8 -1.188 . . . . 0.0 110.088 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2136 ' ' VAL . . . . . 0.507 ' CG1' ' HA ' ' A' 2131 ' ' CYS . 55.0 t -107.46 -107.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.869 -1.145 . . . . 0.0 110.116 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2137 ' ' CYS . . . . . 0.491 ' O ' ' HB2' ' A' 2138 ' ' LYS . 1.3 m -56.21 -77.39 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.796 -1.19 . . . . 0.0 109.599 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2138 ' ' LYS . . . . . 0.58 ' O ' ' CG ' ' A' 2139 ' ' HIS . 0.1 OUTLIER 68.7 3.05 3.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.584 -0.698 . . . . 0.0 111.12 179.188 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 2139 ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' 2138 ' ' LYS . 0.8 OUTLIER 168.64 40.43 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.701 -1.249 . . . . 0.0 110.835 178.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -158.21 160.65 31.03 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.116 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -89.51 124.22 34.32 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2142 ' ' CYS . . . . . 0.483 ' HA ' ' O ' ' A' 2150 ' ' ARG . 22.8 p -111.86 -166.85 1.11 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.131 -0.98 . . . . 0.0 111.237 -178.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2143 ' ' ILE . . . . . 0.477 ' CD1' ' C ' ' A' 2142 ' ' CYS . 4.2 mp -150.24 98.1 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2144 ' ' ASN . . . . . 0.555 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 26.6 t-20 -46.86 114.54 0.86 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.452 -0.78 . . . . 0.0 111.254 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2145 ' ' THR . . . . . 0.475 ' OG1' ' HA ' ' A' 2149 ' ' TYR . 0.1 OUTLIER -108.54 175.55 5.43 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.236 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.25 105.64 9.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.349 -0.844 . . . . 0.0 110.055 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 73.01 8.77 74.69 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2148 ' ' SER . . . . . 0.488 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.5 OUTLIER -152.68 -173.6 4.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.977 -1.308 . . . . 0.0 109.951 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 2149 ' ' TYR . . . . . 0.636 ' CD2' ' CB ' ' A' 2130 ' ' GLU . 50.7 p90 -165.66 -168.4 1.31 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.522 -0.736 . . . . 0.0 109.168 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2150 ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' 2142 ' ' CYS . 0.4 OUTLIER -168.93 124.98 0.92 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.324 -0.86 . . . . 0.0 108.914 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 2.1 t -105.49 107.2 18.07 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.149 -0.969 . . . . 0.0 110.278 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.77 134.15 42.08 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2153 ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -97.54 161.07 27.15 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.071 -1.018 . . . . 0.0 109.955 -179.149 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 2154 ' ' PRO . . . . . 0.473 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.8 Cg_endo -61.43 -169.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 122.812 2.342 . . . . 0.0 111.812 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 3.4 t80 -86.12 99.86 11.79 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.09 -13.17 5.77 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2157 ' ' TYR . . . . . 0.536 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 5.1 m-85 -107.16 -173.5 2.31 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.503 -0.998 . . . . 0.0 110.205 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2158 ' ' ILE . . . . . 0.557 ' N ' ' CD1' ' A' 2158 ' ' ILE . 0.1 OUTLIER -159.36 -166.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 2159 ' ' LEU . . . . . . . . . . . . . 31.4 tp -133.67 119.64 19.62 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.333 -0.854 . . . . 0.0 109.236 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -89.89 55.83 3.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 109.664 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2161 ' ' GLY . . . . . 0.505 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 80.08 -2.31 76.23 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2162 ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' 2161 ' ' GLY . 0.3 OUTLIER 166.51 -58.48 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.1 -1.236 . . . . 0.0 109.69 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -69.66 115.5 8.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.873 . . . . 0.0 109.49 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2164 ' ' CYS . . . . . 0.523 ' O ' ' CG1' ' A' 2165 ' ' VAL . 0.1 OUTLIER -86.2 140.32 30.26 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.307 -0.871 . . . . 0.0 109.273 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 2165 ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' 2164 ' ' CYS . 1.0 OUTLIER -166.35 -166.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.483 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 2166 ' ' ASP . . . . . 0.49 ' OD1' ' CE1' ' A' 2157 ' ' TYR . 0.7 OUTLIER -89.93 142.04 28.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.949 -1.095 . . . . 0.0 109.606 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 2167 ' ' THR . . . . . 0.548 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 12.8 t -81.67 175.75 10.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 0.0 108.972 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2168 ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' 2168 ' ' ASP . 56.6 t0 -95.38 94.59 7.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.102 -0.999 . . . . 0.0 109.248 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2169 ' ' GLU . . . . . 0.571 ' CB ' ' CD1' ' A' 2188 ' ' PHE . 0.8 OUTLIER -69.28 -33.82 73.79 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.407 -0.808 . . . . 0.0 109.363 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 2170 ' ' CYS . . . . . 0.502 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 2.3 t -69.62 -6.01 28.46 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.373 -0.83 . . . . 0.0 109.044 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2171 ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -79.59 7.59 8.03 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.992 -1.067 . . . . 0.0 109.941 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 24.1 t -112.87 -79.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.031 -1.043 . . . . 0.0 110.008 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2173 ' ' GLY . . . . . 0.489 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -152.45 139.74 7.22 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2174 ' ' ASN . . . . . 0.571 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 29.9 p-10 -45.9 104.19 0.39 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.51 -0.994 . . . . 0.0 110.249 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2175 ' ' PRO . . . . . 0.549 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 3.1 Cg_endo -67.29 -18.37 50.23 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.977 1.785 . . . . 0.0 110.324 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2176 ' ' CYS . . . . . 0.54 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -61.1 -10.52 6.36 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.111 -0.993 . . . . 0.0 110.185 -179.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 96.35 -31.47 7.4 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.272 -1.442 . . . . 0.0 109.58 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2178 ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.1 OUTLIER -158.26 -37.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -1.098 . . . . 0.0 109.962 -179.647 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 2179 ' ' GLY . . . . . 0.579 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -57.41 -113.25 0.01 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.4 p -154.23 168.71 25.65 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.411 -1.052 . . . . 0.0 109.305 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2181 ' ' CYS . . . . . 0.571 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 24.6 p -101.66 163.5 12.23 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.066 0.936 . . . . 0.0 111.414 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2182 ' ' LYS . . . . . 0.534 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.2 OUTLIER -144.68 158.34 43.82 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 178.542 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 58.2 t30 -100.35 128.67 46.36 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.555 -1.341 . . . . 0.0 108.957 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2184 ' ' VAL . . . . . 0.521 HG11 ' N ' ' A' 2188 ' ' PHE . 0.9 OUTLIER -137.24 -166.53 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.632 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 2185 ' ' ILE . . . . . 0.536 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 4.7 mp -101.08 140.53 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 110.176 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 71.02 4.16 54.47 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2187 ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 167.23 -116.13 0.66 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2188 ' ' PHE . . . . . 0.571 ' CD1' ' CB ' ' A' 2169 ' ' GLU . 2.4 p90 -166.85 -177.76 3.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.052 -1.263 . . . . 0.0 110.083 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2189 ' ' GLU . . . . . 0.534 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 7.5 tt0 -129.84 139.45 51.2 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2190 ' ' CYS . . . . . 0.448 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 13.7 p -128.48 144.06 51.08 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.606 -1.309 . . . . 0.0 110.179 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2191 ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' 2192 ' ' CYS . 73.3 m -111.17 84.23 1.9 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.86 . . . . 0.0 109.701 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2192 ' ' CYS . . . . . 0.598 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.8 OUTLIER -49.93 179.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 109.047 179.763 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 2193 ' ' GLU . . . . . 0.493 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.3 OUTLIER -54.83 115.76 2.36 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.788 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 2194 ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.3 OUTLIER -30.17 126.8 0.14 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.375 0.607 . . . . 0.0 111.072 -179.033 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.37 5.58 8.55 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2196 ' ' PHE . . . . . 0.671 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.8 OUTLIER -117.51 -164.17 0.98 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.212 -1.169 . . . . 0.0 110.283 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A 2197 ' ' GLU . . . . . 0.557 ' N ' ' CG ' ' A' 2196 ' ' PHE . 2.1 mm-40 -145.48 98.21 4.61 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2198 ' ' PRO . . . . . 0.671 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.1 Cg_endo -68.08 -160.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.066 1.844 . . . . 0.0 110.726 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -135.52 -170.33 12.07 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.63 -74.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 121.96 1.773 . . . . 0.0 110.711 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A 2201 ' ' MET . . . . . 0.482 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 4.5 ptt? -146.22 60.51 1.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.15 -0.969 . . . . 0.0 110.118 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2202 ' ' MET . . . . . 0.443 ' O ' ' HB ' ' A' 2203 ' ' THR . 1.9 mmt -129.55 -68.97 0.7 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.102 -0.999 . . . . 0.0 109.75 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2203 ' ' THR . . . . . 0.443 ' HB ' ' O ' ' A' 2202 ' ' MET . 10.7 t 179.02 -168.74 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.414 -0.804 . . . . 0.0 109.138 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2204 ' ' CYS . . . . . 0.564 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.4 t -74.25 143.79 44.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.002 -1.061 . . . . 0.0 109.685 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.352 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2129 ' ' ASP . . . . . 0.639 ' O ' ' HB2' ' A' 2130 ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2130 ' ' GLU . . . . . 0.639 ' HB2' ' O ' ' A' 2129 ' ' ASP . 1.9 mt-10 76.57 -69.48 0.16 Allowed 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.032 0.444 . . . . 0.0 110.457 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2131 ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' 2131 ' ' CYS . 47.5 t -78.69 8.22 5.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.998 -1.064 . . . . 0.0 110.199 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2132 ' ' LYS . . . . . 0.471 ' HB3' ' HB3' ' A' 2129 ' ' ASP . 0.0 OUTLIER -109.89 40.37 1.93 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.952 -1.093 . . . . 0.0 110.096 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 2133 ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' 2130 ' ' GLU . 2.0 mt-10 -129.69 140.62 39.17 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.09 -1.006 . . . . 0.0 109.509 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2134 ' ' PRO . . . . . 0.521 ' O ' ' CD ' ' A' 2138 ' ' LYS . 3.3 Cg_endo -68.83 -3.96 12.39 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.065 1.843 . . . . 0.0 109.964 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2135 ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' 2162 ' ' ASN . 5.7 p-10 -107.23 0.12 23.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.11 -0.993 . . . . 0.0 110.03 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2136 ' ' VAL . . . . . 0.5 ' HA ' ' ND2' ' A' 2162 ' ' ASN . 11.1 t -97.63 -121.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.062 -1.024 . . . . 0.0 108.641 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2137 ' ' CYS . . . . . 0.499 ' N ' ' SG ' ' A' 2151 ' ' CYS . 8.7 m -56.61 -68.6 0.2 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.579 -1.326 . . . . 0.0 109.297 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2138 ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' 2134 ' ' PRO . 1.9 mtmt 70.32 21.13 5.88 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.04 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2139 ' ' HIS . . . . . 0.478 ' CB ' ' O ' ' A' 2164 ' ' CYS . 0.0 OUTLIER 169.8 -42.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.485 -0.759 . . . . 0.0 109.323 179.591 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -86.31 175.06 47.62 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -93.52 123.54 36.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.148 -1.207 . . . . 0.0 109.539 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2142 ' ' CYS . . . . . 0.46 ' SG ' ' SG ' ' A' 2137 ' ' CYS . 0.1 OUTLIER -112.72 178.82 4.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.558 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 2143 ' ' ILE . . . . . 0.441 HD11 ' N ' ' A' 2143 ' ' ILE . 4.6 mp -142.51 129.27 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2144 ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' 2129 ' ' ASP . 0.7 OUTLIER -71.88 118.23 14.46 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.097 -1.002 . . . . 0.0 110.037 -179.142 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 2145 ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' 2148 ' ' SER . 40.4 p -117.69 -161.04 0.8 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.225 -0.922 . . . . 0.0 108.682 178.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.23 102.86 12.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.082 -1.011 . . . . 0.0 110.279 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 59.31 27.84 63.62 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2148 ' ' SER . . . . . 0.48 ' O ' ' HG2' ' A' 2130 ' ' GLU . 0.4 OUTLIER -166.45 179.14 5.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.059 -1.259 . . . . 0.0 109.773 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 2149 ' ' TYR . . . . . 0.515 ' HB3' ' HB3' ' A' 2130 ' ' GLU . 0.6 OUTLIER -139.85 -169.8 2.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.321 -0.862 . . . . 0.0 109.577 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 2150 ' ' ARG . . . . . 0.506 ' O ' ' C ' ' A' 2151 ' ' CYS . 9.1 mmt180 -139.07 27.74 2.35 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.3 -0.875 . . . . 0.0 109.34 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2151 ' ' CYS . . . . . 0.506 ' C ' ' O ' ' A' 2150 ' ' ARG . 0.8 OUTLIER -28.99 109.42 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.875 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -130.34 125.92 35.85 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2153 ' ' CYS . . . . . 0.5 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -84.14 155.93 63.59 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 121.167 -0.958 . . . . 0.0 110.339 -178.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 2154 ' ' PRO . . . . . 0.457 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.2 Cg_endo -63.44 -168.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.801 2.334 . . . . 0.0 111.794 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -88.01 102.31 14.63 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.54 -15.85 5.45 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 107.75 -2.14 . . . . 0.0 107.75 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2157 ' ' TYR . . . . . 0.5 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 6.5 m-85 -107.13 -174.81 2.62 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 121.655 -0.909 . . . . 0.0 109.828 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2158 ' ' ILE . . . . . 0.558 ' N ' ' CD1' ' A' 2158 ' ' ILE . 0.2 OUTLIER -146.03 -155.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.447 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 2159 ' ' LEU . . . . . 0.477 ' N ' HG12 ' A' 2158 ' ' ILE . 25.9 tp -148.84 127.0 12.07 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.376 -0.828 . . . . 0.0 109.281 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -102.27 62.05 0.86 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.376 -0.828 . . . . 0.0 109.293 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 86.96 -43.96 3.28 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2162 ' ' ASN . . . . . 0.5 ' ND2' ' HA ' ' A' 2136 ' ' VAL . 0.1 OUTLIER -158.33 -45.82 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.43 -1.041 . . . . 0.0 109.149 179.753 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 2163 ' ' GLU . . . . . 0.429 ' O ' HD13 ' A' 2159 ' ' LEU . 65.5 tt0 -62.64 159.85 15.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.344 -0.848 . . . . 0.0 109.229 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2164 ' ' CYS . . . . . 0.478 ' O ' ' CB ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -131.64 137.05 48.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.13 -0.981 . . . . 0.0 109.638 -179.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 2165 ' ' VAL . . . . . 0.49 ' C ' ' CD2' ' A' 2157 ' ' TYR . 1.2 m -156.1 -170.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.87 . . . . 0.0 109.282 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2166 ' ' ASP . . . . . 0.458 ' OD2' ' O ' ' A' 2184 ' ' VAL . 39.2 t70 -85.8 166.13 16.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.938 -1.101 . . . . 0.0 109.627 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2167 ' ' THR . . . . . 0.537 ' CG2' ' OE1' ' A' 2169 ' ' GLU . 11.6 t -106.8 167.86 9.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 0.0 109.423 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2168 ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' 2171 ' ' SER . 56.4 t0 -92.99 98.75 11.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.115 -0.991 . . . . 0.0 109.348 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2169 ' ' GLU . . . . . 0.584 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.8 OUTLIER -73.64 -32.11 63.86 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.426 -0.796 . . . . 0.0 109.415 -179.782 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 2170 ' ' CYS . . . . . 0.499 ' HB2' ' N ' ' A' 2182 ' ' LYS . 1.2 t -67.58 -8.1 31.56 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.319 -0.863 . . . . 0.0 108.981 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2171 ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -69.95 -4.59 21.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.168 -0.957 . . . . 0.0 109.537 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 9.3 t -100.55 -74.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.197 -0.939 . . . . 0.0 110.006 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2173 ' ' GLY . . . . . 0.508 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -168.82 141.48 6.78 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2174 ' ' ASN . . . . . 0.591 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 24.6 p-10 -36.61 97.31 0.13 Allowed Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.733 -0.863 . . . . 0.0 110.534 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2175 ' ' PRO . . . . . 0.581 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.8 Cg_endo -66.25 -20.31 55.82 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.982 1.788 . . . . 0.0 110.54 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2176 ' ' CYS . . . . . 0.52 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -51.54 -58.96 4.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.069 -1.019 . . . . 0.0 108.322 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 146.33 -20.82 1.72 Allowed Glycine 0 C--N 1.294 -1.781 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 4.1 t30 -160.53 -35.44 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -1.093 . . . . 0.0 110.127 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2179 ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -63.97 -119.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2180 ' ' THR . . . . . 0.464 ' HA ' ' HB3' ' A' 2174 ' ' ASN . 2.9 p -148.11 161.81 40.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.439 -1.036 . . . . 0.0 109.595 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2181 ' ' CYS . . . . . 0.591 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 27.0 p -93.64 160.8 14.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 110.906 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2182 ' ' LYS . . . . . 0.52 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 10.4 tttt -146.89 157.28 43.6 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2183 ' ' ASN . . . . . 0.466 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 59.0 t30 -93.4 129.09 39.67 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.453 -1.405 . . . . 0.0 110.13 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2184 ' ' VAL . . . . . 0.585 ' CG1' ' CA ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -132.81 -168.73 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 2185 ' ' ILE . . . . . 0.449 ' N ' ' CG1' ' A' 2184 ' ' VAL . 3.9 mp -105.56 140.53 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.956 -1.09 . . . . 0.0 110.282 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 64.48 14.36 57.17 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2187 ' ' GLY . . . . . 0.518 ' C ' ' CD1' ' A' 2188 ' ' PHE . . . 167.94 -117.98 0.76 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2188 ' ' PHE . . . . . 0.585 ' CA ' ' CG1' ' A' 2184 ' ' VAL . 2.0 p90 -172.92 177.1 2.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.173 -1.193 . . . . 0.0 109.609 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2189 ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.5 OUTLIER -123.28 139.57 53.9 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 2190 ' ' CYS . . . . . 0.444 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 22.9 p -135.73 137.33 41.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.765 -1.209 . . . . 0.0 109.721 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2191 ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' 2192 ' ' CYS . 25.3 m -108.79 83.45 1.76 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.412 -0.805 . . . . 0.0 109.478 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2192 ' ' CYS . . . . . 0.605 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -47.42 -179.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.934 0.873 . . . . 0.0 109.672 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 2193 ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' 2194 ' ' GLU . 11.3 tp10 -55.89 119.44 5.82 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2194 ' ' GLU . . . . . 0.494 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.5 OUTLIER -33.75 130.91 0.27 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.496 0.665 . . . . 0.0 110.675 -178.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.34 -0.67 10.48 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2196 ' ' PHE . . . . . 0.661 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.7 OUTLIER -114.37 -166.7 1.13 Allowed 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.264 -1.139 . . . . 0.0 110.109 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 2197 ' ' GLU . . . . . 0.554 ' N ' ' CG ' ' A' 2196 ' ' PHE . 1.7 mm-40 -145.31 98.02 4.68 Favored Pre-proline 0 C--N 1.299 -1.629 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2198 ' ' PRO . . . . . 0.661 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 7.9 Cg_endo -67.77 -161.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.118 1.879 . . . . 0.0 110.876 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -138.1 -170.4 11.86 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.75 -71.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.033 1.822 . . . . 0.0 110.547 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2201 ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.1 OUTLIER -139.18 53.53 1.74 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 110.192 -179.436 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 2.5 mmm -122.3 -93.68 0.51 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.048 -1.033 . . . . 0.0 109.995 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A 2203 ' ' THR . . . . . 0.487 ' OG1' ' O ' ' A' 2175 ' ' PRO . 6.0 t -169.42 -163.3 0.39 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.23 -0.919 . . . . 0.0 109.176 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2204 ' ' CYS . . . . . 0.52 ' HB2' ' O ' ' A' 2176 ' ' CYS . 1.9 t -67.82 138.35 56.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.09 -1.006 . . . . 0.0 109.306 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A 2205 ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' 2205 ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.515 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2129 ' ' ASP . . . . . 0.518 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 22.9 t0 . . . . . 0 N--CA 1.488 1.433 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2130 ' ' GLU . . . . . 0.456 ' O ' HG23 ' A' 2136 ' ' VAL . 30.5 mp0 -63.39 -21.6 66.38 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.407 -0.808 . . . . 0.0 110.398 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2131 ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' 2132 ' ' LYS . 5.8 p -88.07 -40.86 13.47 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 120.758 -1.214 . . . . 0.0 109.699 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2132 ' ' LYS . . . . . 0.502 ' N ' ' SG ' ' A' 2131 ' ' CYS . 0.0 OUTLIER -85.51 43.58 1.04 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.206 -0.934 . . . . 0.0 108.921 179.323 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 2133 ' ' GLU . . . . . 0.507 ' CB ' HG22 ' A' 2136 ' ' VAL . 4.8 mt-10 -94.39 171.91 6.26 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.331 -0.855 . . . . 0.0 109.537 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2134 ' ' PRO . . . . . 0.5 ' HD2' ' CB ' ' A' 2133 ' ' GLU . 1.3 Cg_endo -63.81 -17.93 61.89 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.51 2.14 . . . . 0.0 112.029 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 4.0 t70 -144.72 32.28 1.16 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.568 -1.332 . . . . 0.0 111.283 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2136 ' ' VAL . . . . . 0.507 HG22 ' CB ' ' A' 2133 ' ' GLU . 46.9 t -112.75 -110.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.777 -1.202 . . . . 0.0 109.901 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2137 ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' 2131 ' ' CYS . 64.5 m -74.11 -65.07 0.89 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.766 -1.209 . . . . 0.0 109.486 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2138 ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' 2137 ' ' CYS . 21.6 mttt 62.53 124.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.806 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2139 ' ' HIS . . . . . 0.45 ' O ' ' HB3' ' A' 2164 ' ' CYS . 2.6 m170 44.26 48.58 7.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.83 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -140.11 168.8 24.97 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.46 56.0 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -1.197 . . . . 0.0 108.842 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2142 ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' 2150 ' ' ARG . 26.3 p -65.82 174.76 2.22 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.349 -0.845 . . . . 0.0 110.56 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 3.3 mp -135.01 87.56 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2144 ' ' ASN . . . . . 0.518 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 8.4 t-20 -48.28 113.5 0.76 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.642 -0.661 . . . . 0.0 110.864 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2145 ' ' THR . . . . . . . . . . . . . 13.6 p -95.16 -174.65 3.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.405 -0.809 . . . . 0.0 109.021 179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2146 ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' 2146 ' ' ASP . 2.9 p30 -91.13 41.41 1.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.181 -0.949 . . . . 0.0 109.531 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2147 ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' A' 2148 ' ' SER . . . 145.55 41.01 0.05 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2148 ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' 2147 ' ' GLY . 0.3 OUTLIER 168.34 -163.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -1.191 . . . . 0.0 109.362 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 2149 ' ' TYR . . . . . 0.473 ' HB2' ' HB3' ' A' 2131 ' ' CYS . 43.9 p90 -169.03 -173.25 1.74 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 110.132 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2150 ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' 2142 ' ' CYS . 0.0 OUTLIER -159.43 110.31 2.0 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 58.8 m -86.78 61.99 7.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 109.947 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2152 ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' 2153 ' ' CYS . 0.3 OUTLIER -87.27 80.61 8.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.114 -0.991 . . . . 0.0 108.837 179.396 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 2153 ' ' CYS . . . . . 0.491 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -43.16 153.12 0.36 Allowed Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.355 -0.841 . . . . 0.0 109.993 -179.352 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 2154 ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' 2157 ' ' TYR . 1.7 Cg_endo -65.91 -166.67 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.589 2.192 . . . . 0.0 111.258 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 8.1 t80 -90.39 104.41 16.99 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.69 -16.66 5.33 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 107.897 -2.081 . . . . 0.0 107.897 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2157 ' ' TYR . . . . . 0.506 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 7.6 m-85 -106.12 -166.79 1.23 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.551 -0.97 . . . . 0.0 109.783 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2158 ' ' ILE . . . . . 0.523 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.2 OUTLIER -155.27 -163.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.534 -0.729 . . . . 0.0 109.468 179.723 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 2159 ' ' LEU . . . . . 0.495 ' N ' HG12 ' A' 2158 ' ' ILE . 30.5 tp -146.86 117.27 7.43 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.408 -0.807 . . . . 0.0 109.685 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -94.95 57.48 2.1 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.577 -0.702 . . . . 0.0 109.461 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2161 ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 87.18 -14.98 56.21 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2162 ' ' ASN . . . . . 0.448 ' O ' ' O ' ' A' 2136 ' ' VAL . 0.0 OUTLIER 168.81 -46.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.405 -1.056 . . . . 0.0 109.092 179.71 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -63.77 126.02 26.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 108.685 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2164 ' ' CYS . . . . . 0.45 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -104.32 139.78 38.82 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.912 -1.117 . . . . 0.0 109.953 -179.608 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 2165 ' ' VAL . . . . . 0.463 ' C ' ' CD2' ' A' 2157 ' ' TYR . 3.7 m -158.56 -177.8 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 109.441 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2166 ' ' ASP . . . . . 0.457 ' OD2' ' O ' ' A' 2184 ' ' VAL . 29.1 t70 -74.85 167.27 22.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.642 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2167 ' ' THR . . . . . 0.533 ' CG2' ' OE1' ' A' 2169 ' ' GLU . 4.9 t -114.26 -177.71 3.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.4 -0.812 . . . . 0.0 109.109 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2168 ' ' ASP . . . . . 0.478 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 51.9 t0 -103.29 100.64 10.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.087 -1.008 . . . . 0.0 109.74 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2169 ' ' GLU . . . . . 0.566 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.7 OUTLIER -77.01 -32.63 57.29 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.385 -0.822 . . . . 0.0 109.143 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 2170 ' ' CYS . . . . . 0.501 ' HB2' ' N ' ' A' 2182 ' ' LYS . 1.7 t -67.23 -10.07 46.85 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2171 ' ' SER . . . . . 0.404 ' HB2' ' CG ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -74.94 -10.62 59.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.34 -0.85 . . . . 0.0 109.72 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 21.9 t -86.35 -71.58 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.544 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2173 ' ' GLY . . . . . . . . . . . . . . . -149.29 -114.95 0.75 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2174 ' ' ASN . . . . . 0.474 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 16.1 t-20 -146.67 97.3 4.29 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.39 -1.065 . . . . 0.0 109.49 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2175 ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' 2181 ' ' CYS . 1.3 Cg_endo -68.38 -24.63 36.77 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.93 1.754 . . . . 0.0 110.58 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2176 ' ' CYS . . . . . 0.575 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.1 OUTLIER -48.6 -43.86 36.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.122 -0.986 . . . . 0.0 109.391 -179.352 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 120.45 -19.24 9.23 Favored Glycine 0 C--N 1.292 -1.861 0 N-CA-C 108.221 -1.952 . . . . 0.0 108.221 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -171.97 -32.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.462 -1.022 . . . . 0.0 110.259 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2179 ' ' GLY . . . . . 0.628 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -69.75 -128.06 0.05 OUTLIER Glycine 0 N--CA 1.491 2.335 0 O-C-N 120.932 -1.105 . . . . 0.0 110.358 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 2.0 p -132.58 153.85 50.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.549 -0.971 . . . . 0.0 109.631 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2181 ' ' CYS . . . . . 0.495 ' HB3' ' HD2' ' A' 2175 ' ' PRO . 25.0 p -92.48 161.85 14.46 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.125 0.964 . . . . 0.0 110.976 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2182 ' ' LYS . . . . . 0.522 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 44.0 tptt -144.2 166.77 24.1 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2183 ' ' ASN . . . . . 0.513 ' N ' ' HG3' ' A' 2182 ' ' LYS . 62.6 t30 -100.94 138.74 37.59 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.616 -1.302 . . . . 0.0 109.676 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2184 ' ' VAL . . . . . 0.583 ' CG1' ' CA ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -144.42 -168.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.484 -0.76 . . . . 0.0 109.246 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 2185 ' ' ILE . . . . . 0.506 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 2.7 mp -104.64 137.28 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.111 -0.993 . . . . 0.0 110.24 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 69.85 10.36 64.38 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2187 ' ' GLY . . . . . 0.551 ' C ' ' CD1' ' A' 2188 ' ' PHE . . . 168.99 -116.7 0.68 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2188 ' ' PHE . . . . . 0.583 ' CA ' ' CG1' ' A' 2184 ' ' VAL . 1.0 OUTLIER -171.87 -178.51 2.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.204 -1.174 . . . . 0.0 109.461 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 2189 ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 2.5 tt0 -128.33 174.13 9.57 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 2.6 p -171.08 149.7 2.93 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.621 -1.232 . . . . 0.0 110.41 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2191 ' ' THR . . . . . 0.415 ' O ' ' O ' ' A' 2192 ' ' CYS . 50.8 m -117.41 83.81 2.05 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.568 -0.708 . . . . 0.0 109.355 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2192 ' ' CYS . . . . . 0.628 ' HA ' ' HA3' ' A' 2179 ' ' GLY . 0.8 OUTLIER -50.54 178.27 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.09 -1.006 . . . . 0.0 109.189 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 2193 ' ' GLU . . . . . 0.486 ' O ' ' C ' ' A' 2194 ' ' GLU . 31.8 tt0 -53.97 116.38 2.53 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2194 ' ' GLU . . . . . 0.486 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -32.61 129.37 0.21 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.526 0.679 . . . . 0.0 110.917 -178.674 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.95 4.5 9.42 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2196 ' ' PHE . . . . . 0.681 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.9 OUTLIER -116.65 -164.51 0.98 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.197 -1.178 . . . . 0.0 110.169 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 2197 ' ' GLU . . . . . 0.556 ' N ' ' CG ' ' A' 2196 ' ' PHE . 14.0 mt-10 -145.81 96.95 4.63 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.596 -0.69 . . . . 0.0 109.373 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2198 ' ' PRO . . . . . 0.681 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.2 Cg_endo -68.68 -169.78 0.29 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.272 1.981 . . . . 0.0 111.084 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -124.89 178.06 16.65 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.93 -72.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 121.844 1.696 . . . . 0.0 110.306 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A 2201 ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.1 OUTLIER -132.78 33.27 3.74 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.14 -0.975 . . . . 0.0 109.791 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 2202 ' ' MET . . . . . 0.46 ' O ' ' CE2' ' A' 2188 ' ' PHE . 0.2 OUTLIER -105.6 -92.51 0.38 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.165 -0.959 . . . . 0.0 109.706 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 2203 ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' 2175 ' ' PRO . 6.0 t -159.68 -162.93 1.08 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.142 -0.974 . . . . 0.0 109.182 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A 2204 ' ' CYS . . . . . 0.583 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.0 OUTLIER -115.71 155.82 27.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.126 -0.984 . . . . 0.0 109.145 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.41 179.98 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A 2129 ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' 2130 ' ' GLU . 24.4 t0 . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2130 ' ' GLU . . . . . 0.539 ' O ' ' CG2' ' A' 2136 ' ' VAL . 1.9 mt-10 82.73 -50.77 0.18 Allowed 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.133 0.492 . . . . 0.0 110.065 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2131 ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' 2137 ' ' CYS . 7.7 t -80.47 -41.91 23.53 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.025 -1.047 . . . . 0.0 109.461 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2132 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.28 -26.59 3.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.436 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2133 ' ' GLU . . . . . 0.503 ' HB2' HG22 ' A' 2136 ' ' VAL . 1.3 mt-10 -73.28 137.53 78.44 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.162 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2134 ' ' PRO . . . . . 0.543 ' CA ' ' HD3' ' A' 2138 ' ' LYS . 5.5 Cg_endo -69.96 -2.39 10.23 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.177 1.918 . . . . 0.0 110.821 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -99.19 -11.7 21.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.001 -1.062 . . . . 0.0 110.395 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2136 ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' 2130 ' ' GLU . 2.2 t -107.39 -136.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.061 -1.024 . . . . 0.0 109.005 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2137 ' ' CYS . . . . . 0.544 ' CB ' ' HB3' ' A' 2142 ' ' CYS . 8.7 m -50.35 104.83 0.08 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.964 -1.085 . . . . 0.0 108.638 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2138 ' ' LYS . . . . . 0.543 ' HD3' ' CA ' ' A' 2134 ' ' PRO . 3.6 mtmt -124.07 140.54 52.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.912 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2139 ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' 2164 ' ' CYS . 10.6 m80 56.3 39.16 30.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.986 -1.071 . . . . 0.0 109.548 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -165.07 176.16 40.85 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -90.28 143.81 26.42 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.071 -1.253 . . . . 0.0 108.525 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2142 ' ' CYS . . . . . 0.544 ' HB3' ' CB ' ' A' 2137 ' ' CYS . 0.6 OUTLIER -126.54 153.95 44.5 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.072 -1.017 . . . . 0.0 110.535 -178.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 2143 ' ' ILE . . . . . 0.455 ' O ' HG22 ' A' 2145 ' ' THR . 4.3 mp -116.5 89.76 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2144 ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' 2129 ' ' ASP . 9.4 t-20 -47.21 114.94 0.96 Allowed 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.455 0.645 . . . . 0.0 110.66 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2145 ' ' THR . . . . . 0.455 HG22 ' O ' ' A' 2143 ' ' ILE . 23.0 p -107.68 -171.67 1.92 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.472 -0.767 . . . . 0.0 108.933 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.4 97.45 10.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.411 -0.806 . . . . 0.0 109.46 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 72.54 33.5 60.93 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2148 ' ' SER . . . . . 0.426 ' HB3' ' OG1' ' A' 2145 ' ' THR . 0.4 OUTLIER -173.11 -160.73 0.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -1.117 . . . . 0.0 109.792 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 2149 ' ' TYR . . . . . 0.435 ' CZ ' HG12 ' A' 2136 ' ' VAL . 7.8 p90 -168.43 -170.33 1.23 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.542 -0.724 . . . . 0.0 109.429 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2150 ' ' ARG . . . . . 0.547 ' O ' ' C ' ' A' 2151 ' ' CYS . 0.0 OUTLIER -153.1 33.38 0.47 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 109.0 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 2151 ' ' CYS . . . . . 0.547 ' C ' ' O ' ' A' 2150 ' ' ARG . 35.9 m -12.83 89.94 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.231 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -97.57 169.84 9.44 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2153 ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -131.77 159.14 73.24 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 120.934 -1.104 . . . . 0.0 109.831 -179.499 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 2154 ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' 2157 ' ' TYR . 1.5 Cg_endo -62.65 -168.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 122.63 2.22 . . . . 0.0 111.568 -178.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 39.4 t80 -88.17 101.19 13.58 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 129.92 -13.61 5.78 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 107.927 -2.069 . . . . 0.0 107.927 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2157 ' ' TYR . . . . . 0.488 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 5.8 m-85 -108.62 -172.5 2.07 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.661 -0.905 . . . . 0.0 109.961 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2158 ' ' ILE . . . . . 0.575 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.2 OUTLIER -156.29 -158.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.453 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 2159 ' ' LEU . . . . . 0.502 ' HG ' ' N ' ' A' 2160 ' ' ALA . 13.7 tp -142.19 146.8 35.64 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 109.768 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2160 ' ' ALA . . . . . 0.502 ' N ' ' HG ' ' A' 2159 ' ' LEU . . . -122.02 48.53 1.71 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.237 -0.914 . . . . 0.0 109.443 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 95.55 -35.76 4.15 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2162 ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -168.44 -34.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.242 . . . . 0.0 109.911 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2163 ' ' GLU . . . . . 0.455 ' OE1' ' HE2' ' A' 2138 ' ' LYS . 1.2 tp10 -88.59 111.26 21.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 0.0 109.837 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2164 ' ' CYS . . . . . 0.547 ' O ' ' CG1' ' A' 2165 ' ' VAL . 0.1 OUTLIER -82.13 147.83 28.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.442 -0.786 . . . . 0.0 109.362 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 2165 ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' A' 2164 ' ' CYS . 0.3 OUTLIER -170.86 -168.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 2166 ' ' ASP . . . . . . . . . . . . . 1.6 t70 -90.4 143.63 26.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.901 -1.124 . . . . 0.0 109.179 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2167 ' ' THR . . . . . 0.575 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 9.7 t -95.05 171.65 8.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.402 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2168 ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' 2171 ' ' SER . 62.5 t0 -85.73 96.29 9.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.948 -1.095 . . . . 0.0 109.352 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2169 ' ' GLU . . . . . 0.523 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.5 OUTLIER -67.3 -33.93 76.32 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.414 -0.804 . . . . 0.0 109.598 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 2170 ' ' CYS . . . . . 0.479 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.6 t -69.24 -7.49 37.21 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.172 -0.955 . . . . 0.0 108.915 179.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2171 ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.2 OUTLIER -77.09 3.13 13.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.086 -1.009 . . . . 0.0 109.663 179.847 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 48.5 t -105.6 -70.55 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.101 -1.0 . . . . 0.0 109.826 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2173 ' ' GLY . . . . . 0.496 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -168.97 138.17 4.95 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2174 ' ' ASN . . . . . 0.57 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 18.6 p-10 -39.38 99.31 0.19 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.517 -0.99 . . . . 0.0 110.22 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2175 ' ' PRO . . . . . 0.588 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.5 Cg_endo -65.47 -25.17 55.92 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.046 1.831 . . . . 0.0 110.487 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2176 ' ' CYS . . . . . 0.551 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -47.13 -50.89 19.41 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.069 -1.019 . . . . 0.0 108.588 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 138.25 -22.29 3.07 Favored Glycine 0 C--N 1.292 -1.9 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2178 ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.0 OUTLIER -162.53 -35.97 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.447 -1.031 . . . . 0.0 109.993 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 2179 ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -61.59 -119.21 0.01 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.34 160.36 42.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.378 -1.072 . . . . 0.0 109.637 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2181 ' ' CYS . . . . . 0.57 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 22.5 p -92.08 163.95 13.77 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.198 0.999 . . . . 0.0 111.306 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2182 ' ' LYS . . . . . 0.557 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.0 OUTLIER -142.56 155.88 45.05 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 57.7 t30 -100.55 140.56 34.65 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.39 -1.444 . . . . 0.0 109.883 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2184 ' ' VAL . . . . . 0.429 HG11 ' C ' ' A' 2187 ' ' GLY . 0.8 OUTLIER -154.52 174.48 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A 2185 ' ' ILE . . . . . . . . . . . . . 4.3 mp -91.77 136.73 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.051 -1.031 . . . . 0.0 109.882 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 80.39 5.45 89.78 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2187 ' ' GLY . . . . . 0.429 ' C ' HG11 ' A' 2184 ' ' VAL . . . 163.06 -131.32 2.45 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2188 ' ' PHE . . . . . 0.588 ' CD2' ' HG2' ' A' 2175 ' ' PRO . 5.6 p90 -160.94 173.31 15.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.353 -1.087 . . . . 0.0 109.165 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2189 ' ' GLU . . . . . 0.557 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.7 tt0 -121.61 138.98 54.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.3 -0.875 . . . . 0.0 108.826 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2190 ' ' CYS . . . . . 0.412 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 15.4 p -130.64 143.53 50.81 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.66 -1.275 . . . . 0.0 109.997 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2191 ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' 2192 ' ' CYS . 61.3 m -117.51 85.31 2.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.348 -0.845 . . . . 0.0 109.505 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2192 ' ' CYS . . . . . 0.591 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.1 m -49.09 179.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 109.242 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2193 ' ' GLU . . . . . 0.45 ' O ' ' C ' ' A' 2194 ' ' GLU . 18.5 tt0 -56.98 126.9 29.25 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2194 ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.2 tt0 -38.81 130.16 1.46 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.487 -0.758 . . . . 0.0 110.591 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.24 3.04 9.82 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2196 ' ' PHE . . . . . 0.683 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.2 p90 -116.56 -161.43 0.8 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.144 -1.209 . . . . 0.0 110.16 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2197 ' ' GLU . . . . . 0.561 ' N ' ' CG ' ' A' 2196 ' ' PHE . 34.8 mm-40 -146.09 95.14 4.82 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 121.53 -0.731 . . . . 0.0 109.82 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2198 ' ' PRO . . . . . 0.683 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 6.5 Cg_endo -66.91 -163.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.119 1.88 . . . . 0.0 111.021 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -138.22 -171.65 12.26 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.88 -80.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.004 1.802 . . . . 0.0 110.727 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A 2201 ' ' MET . . . . . 0.482 ' HA ' ' O ' ' A' 2188 ' ' PHE . 6.6 mtt -132.0 47.17 2.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.166 -0.959 . . . . 0.0 110.033 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2202 ' ' MET . . . . . 0.515 ' O ' ' CE2' ' A' 2188 ' ' PHE . 1.9 mmt -117.13 -88.42 0.6 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.238 -0.914 . . . . 0.0 109.849 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2203 ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' 2175 ' ' PRO . 5.8 t -169.33 -162.59 0.36 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.278 -0.889 . . . . 0.0 109.49 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2204 ' ' CYS . . . . . 0.569 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 5.2 t -76.28 145.06 39.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 109.39 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A 2205 ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' 2197 ' ' GLU . 8.6 pt-20 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.951 -1.024 . . . . 0.0 109.409 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2129 ' ' ASP . . . . . 0.567 ' O ' ' HB2' ' A' 2130 ' ' GLU . 11.5 t0 . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2130 ' ' GLU . . . . . 0.574 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 1.5 mt-10 80.58 -55.47 0.34 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.915 -0.491 . . . . 0.0 111.158 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2131 ' ' CYS . . . . . 0.557 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 8.0 p -91.34 -14.59 30.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.761 -1.212 . . . . 0.0 110.503 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2132 ' ' LYS . . . . . 0.485 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -88.93 6.57 38.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.996 -1.065 . . . . 0.0 109.218 179.534 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 2133 ' ' GLU . . . . . 0.467 ' HB3' ' HD2' ' A' 2134 ' ' PRO . 36.3 mt-10 -81.11 159.41 68.16 Favored Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.242 -0.911 . . . . 0.0 109.337 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2134 ' ' PRO . . . . . 0.493 ' O ' ' HD2' ' A' 2138 ' ' LYS . 4.7 Cg_endo -68.54 -1.88 8.24 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.341 2.027 . . . . 0.0 110.451 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2135 ' ' ASP . . . . . 0.506 ' O ' ' ND2' ' A' 2162 ' ' ASN . 0.4 OUTLIER -123.11 14.16 9.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.934 -1.104 . . . . 0.0 109.887 -179.57 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 2136 ' ' VAL . . . . . 0.637 ' CG1' ' CE2' ' A' 2149 ' ' TYR . 43.3 t -146.99 126.01 4.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.04 -1.038 . . . . 0.0 108.867 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2137 ' ' CYS . . . . . 0.542 ' CA ' ' O ' ' A' 2162 ' ' ASN . 0.5 OUTLIER 69.67 -84.78 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.428 -0.795 . . . . 0.0 109.969 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 2138 ' ' LYS . . . . . 0.493 ' HD2' ' O ' ' A' 2134 ' ' PRO . 0.8 OUTLIER 63.62 109.67 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.571 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 2139 ' ' HIS . . . . . 0.482 ' O ' ' HB3' ' A' 2164 ' ' CYS . 11.6 m170 62.03 50.39 4.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.866 . . . . 0.0 109.892 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -148.85 168.39 29.35 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -106.43 78.68 1.3 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -1.137 . . . . 0.0 109.13 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2142 ' ' CYS . . . . . 0.49 ' C ' ' CD1' ' A' 2143 ' ' ILE . 25.3 p -82.96 -177.65 6.84 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.306 -0.871 . . . . 0.0 110.634 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2143 ' ' ILE . . . . . 0.49 ' CD1' ' C ' ' A' 2142 ' ' CYS . 3.0 mm -127.63 122.6 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2144 ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' 2129 ' ' ASP . 4.3 t-20 -78.04 113.49 16.02 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.34 -0.85 . . . . 0.0 110.912 -178.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2145 ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' 2148 ' ' SER . 2.7 p -92.68 -162.79 0.97 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 1.3 p30 -86.7 -32.52 20.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.98 . . . . 0.0 110.449 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -129.77 -34.39 0.48 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.161 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2148 ' ' SER . . . . . 0.464 ' O ' ' OG1' ' A' 2145 ' ' THR . 0.5 OUTLIER -111.79 -164.44 0.92 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.144 -1.21 . . . . 0.0 110.035 -179.479 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 2149 ' ' TYR . . . . . 0.637 ' CE2' ' CG1' ' A' 2136 ' ' VAL . 13.5 p90 -148.67 -176.55 5.37 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2150 ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' 2149 ' ' TYR . 0.1 OUTLIER -148.32 116.48 6.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.476 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 6.2 m -87.32 118.62 26.87 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.338 -0.851 . . . . 0.0 109.545 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.01 81.05 1.94 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.869 . . . . 0.0 109.139 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2153 ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -54.25 156.24 5.92 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.276 -0.89 . . . . 0.0 109.257 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 2154 ' ' PRO . . . . . 0.455 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.3 Cg_endo -63.06 -171.76 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.417 2.078 . . . . 0.0 111.306 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -88.0 102.84 15.13 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.37 -14.79 5.59 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 107.885 -2.086 . . . . 0.0 107.885 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2157 ' ' TYR . . . . . 0.547 ' CD2' ' C ' ' A' 2165 ' ' VAL . 5.6 m-85 -106.01 -168.23 1.41 Allowed 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.635 -0.921 . . . . 0.0 109.549 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2158 ' ' ILE . . . . . 0.525 HG22 ' HB ' ' A' 2167 ' ' THR . 0.2 OUTLIER -156.93 -164.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.859 . . . . 0.0 109.923 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 2159 ' ' LEU . . . . . 0.512 ' N ' HG12 ' A' 2158 ' ' ILE . 39.5 tp -142.38 114.16 8.03 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -90.57 56.87 3.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.883 . . . . 0.0 109.589 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 89.11 -29.2 6.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2162 ' ' ASN . . . . . 0.542 ' O ' ' CA ' ' A' 2137 ' ' CYS . 1.5 m-20 -171.47 -46.69 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.241 -1.152 . . . . 0.0 109.332 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2163 ' ' GLU . . . . . 0.46 ' O ' HD11 ' A' 2159 ' ' LEU . 14.5 tt0 -66.17 147.78 52.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.118 -0.989 . . . . 0.0 109.248 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2164 ' ' CYS . . . . . 0.513 ' N ' ' O ' ' A' 2137 ' ' CYS . 0.1 OUTLIER -122.82 137.58 54.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.049 -1.032 . . . . 0.0 109.394 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 2165 ' ' VAL . . . . . 0.547 ' C ' ' CD2' ' A' 2157 ' ' TYR . 0.7 OUTLIER -161.1 -169.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.121 -0.987 . . . . 0.0 109.779 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 2166 ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' 2184 ' ' VAL . 36.8 t70 -77.02 166.94 22.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.167 -0.958 . . . . 0.0 110.035 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2167 ' ' THR . . . . . 0.528 ' CG2' ' OE1' ' A' 2169 ' ' GLU . 1.2 t -115.99 -170.6 1.82 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.355 -0.84 . . . . 0.0 109.414 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2168 ' ' ASP . . . . . 0.526 ' N ' HG22 ' A' 2167 ' ' THR . 64.6 t0 -109.4 101.26 10.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.945 . . . . 0.0 109.511 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2169 ' ' GLU . . . . . 0.578 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.5 OUTLIER -76.22 -30.93 58.14 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.347 -0.845 . . . . 0.0 109.337 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 2170 ' ' CYS . . . . . 0.49 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 0.1 OUTLIER -64.87 -12.32 47.47 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.578 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.76 -22.54 29.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 0.0 109.623 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 31.3 t -75.9 -68.56 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.33 -0.856 . . . . 0.0 109.448 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2173 ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -159.87 140.37 6.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2174 ' ' ASN . . . . . 0.471 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 1.6 t-20 -45.0 104.49 0.39 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.411 -1.052 . . . . 0.0 109.616 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2175 ' ' PRO . . . . . 0.648 ' CB ' ' CE2' ' A' 2188 ' ' PHE . 2.1 Cg_endo -68.92 -19.94 39.59 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.837 1.692 . . . . 0.0 110.03 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2176 ' ' CYS . . . . . 0.585 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -71.43 -24.08 61.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.152 -0.967 . . . . 0.0 109.902 -179.516 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 105.84 -25.79 22.99 Favored Glycine 0 N--CA 1.483 1.779 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2178 ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.1 OUTLIER -170.59 -31.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.295 -1.121 . . . . 0.0 110.611 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 2179 ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -59.77 -120.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.3 p -136.03 151.18 49.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.44 -1.035 . . . . 0.0 109.336 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2181 ' ' CYS . . . . . 0.492 ' HB3' ' HD2' ' A' 2175 ' ' PRO . 26.1 p -99.35 155.63 17.42 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.12 -0.987 . . . . 0.0 110.716 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2182 ' ' LYS . . . . . 0.518 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 8.5 tttp -140.67 159.07 43.01 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2183 ' ' ASN . . . . . 0.425 ' CG ' ' HA ' ' A' 2168 ' ' ASP . 53.5 t30 -100.26 129.64 46.28 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.562 -1.336 . . . . 0.0 110.175 -179.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2184 ' ' VAL . . . . . 0.583 ' CG1' ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -134.41 -179.42 3.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 2185 ' ' ILE . . . . . 0.428 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 4.1 mp -95.01 141.13 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.764 -1.21 . . . . 0.0 110.424 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2186 ' ' GLY . . . . . 0.408 ' N ' HG21 ' A' 2185 ' ' ILE . . . 67.94 10.92 59.89 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2187 ' ' GLY . . . . . 0.544 ' C ' ' CD1' ' A' 2188 ' ' PHE . . . 168.14 -118.77 0.8 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2188 ' ' PHE . . . . . 0.648 ' CE2' ' CB ' ' A' 2175 ' ' PRO . 2.6 p90 -175.23 178.58 1.68 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -1.109 . . . . 0.0 109.72 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2189 ' ' GLU . . . . . 0.518 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 5.6 tp10 -124.54 168.1 13.56 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 3.1 p -170.51 145.89 2.67 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.547 -1.345 . . . . 0.0 110.453 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2191 ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' 2192 ' ' CYS . 88.6 m -117.88 88.34 2.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.504 -0.748 . . . . 0.0 109.614 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2192 ' ' CYS . . . . . 0.611 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.5 OUTLIER -49.6 -178.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.167 -0.958 . . . . 0.0 109.049 179.786 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 2193 ' ' GLU . . . . . 0.548 ' O ' ' C ' ' A' 2194 ' ' GLU . 7.2 tt0 -55.24 102.27 0.06 Allowed 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2194 ' ' GLU . . . . . 0.548 ' C ' ' O ' ' A' 2193 ' ' GLU . 2.3 mt-10 -20.14 124.89 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.365 0.602 . . . . 0.0 111.716 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.71 11.35 6.0 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2196 ' ' PHE . . . . . 0.686 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.5 p90 -120.06 -161.93 0.9 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.357 -1.084 . . . . 0.0 110.165 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2197 ' ' GLU . . . . . 0.52 ' N ' ' CG ' ' A' 2196 ' ' PHE . 12.9 mt-10 -144.47 94.87 5.54 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 121.475 -0.766 . . . . 0.0 109.659 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2198 ' ' PRO . . . . . 0.686 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.2 Cg_endo -69.36 -162.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.353 2.035 . . . . 0.0 111.192 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -133.66 -177.02 14.66 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -62.36 -65.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.006 1.804 . . . . 0.0 110.618 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2201 ' ' MET . . . . . 0.474 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -147.29 41.11 1.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 109.58 -179.674 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 2202 ' ' MET . . . . . 0.431 ' O ' ' CE2' ' A' 2188 ' ' PHE . 0.0 OUTLIER -112.88 -84.4 0.59 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.208 -0.932 . . . . 0.0 109.613 -179.807 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 2203 ' ' THR . . . . . . . . . . . . . 11.5 t -162.6 -172.62 3.2 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.23 -0.918 . . . . 0.0 109.406 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A 2204 ' ' CYS . . . . . 0.585 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -110.42 144.94 38.44 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.285 -0.885 . . . . 0.0 108.933 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A 2205 ' ' GLU . . . . . 0.402 ' OXT' ' HG3' ' A' 2205 ' ' GLU . 9.3 pt-20 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.548 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2129 ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' 2130 ' ' GLU . 11.3 t70 . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2130 ' ' GLU . . . . . 0.527 ' CB ' ' O ' ' A' 2129 ' ' ASP . 6.4 mt-10 82.56 -43.16 0.13 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.856 -0.528 . . . . 0.0 109.798 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2131 ' ' CYS . . . . . 0.462 ' HA ' HG13 ' A' 2136 ' ' VAL . 0.1 OUTLIER -90.11 -23.02 21.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.176 -0.952 . . . . 0.0 109.086 179.603 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 2132 ' ' LYS . . . . . 0.425 ' HB2' ' CG ' ' A' 2129 ' ' ASP . 0.3 OUTLIER -87.6 40.25 0.92 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 109.144 179.561 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 2133 ' ' GLU . . . . . 0.506 ' HB3' ' HD2' ' A' 2134 ' ' PRO . 80.3 mt-10 -108.09 160.17 27.92 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.33 -0.856 . . . . 0.0 109.66 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2134 ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' 2133 ' ' GLU . 1.2 Cg_endo -66.02 0.51 3.12 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.539 2.159 . . . . 0.0 111.771 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2135 ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' 2162 ' ' ASN . 67.1 m-20 -130.03 -10.65 4.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.478 -1.389 . . . . 0.0 110.564 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2136 ' ' VAL . . . . . 0.462 HG13 ' HA ' ' A' 2131 ' ' CYS . 3.4 t -100.13 -131.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.927 -1.108 . . . . 0.0 108.492 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2137 ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' 2142 ' ' CYS . 5.0 t -58.45 131.46 50.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.521 -1.362 . . . . 0.0 108.65 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2138 ' ' LYS . . . . . 0.515 ' O ' ' CB ' ' A' 2139 ' ' HIS . 32.0 mtpt -139.64 43.03 1.99 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.185 -0.947 . . . . 0.0 110.061 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2139 ' ' HIS . . . . . 0.515 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.0 OUTLIER 163.73 -34.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.052 -1.03 . . . . 0.0 110.099 179.473 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -83.67 173.65 51.21 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -91.91 94.68 9.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.265 -1.138 . . . . 0.0 109.163 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2142 ' ' CYS . . . . . 0.465 ' HB2' ' SG ' ' A' 2137 ' ' CYS . 10.4 t -91.0 161.47 15.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.292 -0.88 . . . . 0.0 109.725 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 2.6 mp -122.72 98.59 5.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2144 ' ' ASN . . . . . 0.464 ' HB2' ' OD1' ' A' 2129 ' ' ASP . 3.2 t30 -60.02 112.85 2.03 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.273 -0.892 . . . . 0.0 109.712 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2145 ' ' THR . . . . . . . . . . . . . 30.5 p -90.73 -166.28 1.54 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.378 -0.826 . . . . 0.0 109.376 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 5.6 t0 -62.63 -72.48 0.13 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.817 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -118.12 37.0 3.41 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2148 ' ' SER . . . . . 0.468 ' O ' ' HB3' ' A' 2149 ' ' TYR . 0.8 OUTLIER -165.13 -160.89 0.51 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -1.157 . . . . 0.0 109.629 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 2149 ' ' TYR . . . . . 0.468 ' HB3' ' O ' ' A' 2148 ' ' SER . 27.2 p90 170.8 -175.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.49 -0.756 . . . . 0.0 109.217 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2150 ' ' ARG . . . . . 0.433 ' C ' ' SG ' ' A' 2142 ' ' CYS . 11.6 ptt180 -167.93 95.05 0.41 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.951 . . . . 0.0 109.831 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2151 ' ' CYS . . . . . 0.461 ' HA ' ' SG ' ' A' 2142 ' ' CYS . 42.5 t -57.64 102.56 0.1 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.615 -0.678 . . . . 0.0 109.447 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -104.47 108.02 19.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.314 -0.866 . . . . 0.0 109.256 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2153 ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -70.06 158.78 86.55 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.168 -0.957 . . . . 0.0 109.664 -179.657 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 2154 ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' 2157 ' ' TYR . 1.1 Cg_endo -63.85 -168.97 0.1 OUTLIER 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.858 2.372 . . . . 0.0 112.03 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -86.48 101.79 13.5 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 129.95 -15.49 5.63 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 107.821 -2.112 . . . . 0.0 107.821 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2157 ' ' TYR . . . . . 0.497 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 5.4 m-85 -106.34 -170.79 1.78 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.682 -0.893 . . . . 0.0 110.053 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2158 ' ' ILE . . . . . 0.572 ' N ' ' CD1' ' A' 2158 ' ' ILE . 0.2 OUTLIER -156.93 -160.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.522 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 2159 ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' 2162 ' ' ASN . 33.2 tp -147.55 122.81 10.24 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.187 -0.945 . . . . 0.0 109.942 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2160 ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' 2162 ' ' ASN . . . -90.22 -152.12 0.26 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2161 ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' 2160 ' ' ALA . . . -42.13 -25.95 0.29 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2162 ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' 2135 ' ' ASP . 1.5 t-20 178.75 -29.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.133 -1.216 . . . . 0.0 110.179 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -76.23 152.58 36.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.084 -1.01 . . . . 0.0 109.514 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2164 ' ' CYS . . . . . 0.51 ' O ' ' CG1' ' A' 2165 ' ' VAL . 0.1 OUTLIER -111.82 145.08 40.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.122 -0.986 . . . . 0.0 109.374 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 2165 ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' 2164 ' ' CYS . 1.6 m -164.81 -170.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 109.425 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2166 ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 3.3 t70 -90.41 149.69 22.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.002 -1.061 . . . . 0.0 109.706 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2167 ' ' THR . . . . . 0.568 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 8.7 t -87.84 175.38 7.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 109.511 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2168 ' ' ASP . . . . . 0.462 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 57.9 t0 -95.77 92.67 6.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.296 -0.877 . . . . 0.0 108.752 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2169 ' ' GLU . . . . . 0.517 ' OE1' ' CG2' ' A' 2167 ' ' THR . 0.7 OUTLIER -65.68 -32.15 73.55 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.331 -0.856 . . . . 0.0 109.883 -179.409 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 2170 ' ' CYS . . . . . 0.521 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.3 t -66.34 -12.04 54.44 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.165 -0.959 . . . . 0.0 108.891 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.68 -2.28 22.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.243 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 34.4 t -84.23 -69.71 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.21 -0.931 . . . . 0.0 109.549 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2173 ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' 2174 ' ' ASN . . . 164.26 76.46 0.03 OUTLIER Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.069 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2174 ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' 2178 ' ' ASN . 3.5 t-20 43.2 83.78 0.2 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.253 -1.145 . . . . 0.0 109.613 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2175 ' ' PRO . . . . . 0.615 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.4 Cg_endo -66.76 -20.03 52.7 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.257 1.971 . . . . 0.0 110.537 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2176 ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' 2204 ' ' CYS . 1.4 m -64.79 -55.41 19.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.926 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 160.2 -28.94 0.35 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2178 ' ' ASN . . . . . 0.503 ' N ' ' OD1' ' A' 2174 ' ' ASN . 1.5 t-20 -171.05 -26.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -1.185 . . . . 0.0 110.966 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2179 ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -59.66 -124.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.787 -1.196 . . . . 0.0 110.309 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2180 ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' 2190 ' ' CYS . 1.1 p -136.64 151.07 48.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.394 -1.062 . . . . 0.0 109.227 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2181 ' ' CYS . . . . . 0.539 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 23.0 p -99.54 150.19 22.48 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.089 -1.007 . . . . 0.0 111.468 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2182 ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' 2189 ' ' GLU . 0.5 OUTLIER -132.4 160.79 35.35 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.381 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 2183 ' ' ASN . . . . . 0.462 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 57.0 t30 -100.28 123.7 44.83 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.579 -1.326 . . . . 0.0 109.21 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2184 ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -130.89 -174.96 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.371 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 2185 ' ' ILE . . . . . 0.496 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 3.3 mp -94.62 139.26 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.028 -1.045 . . . . 0.0 110.287 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2186 ' ' GLY . . . . . 0.453 ' N ' HG21 ' A' 2185 ' ' ILE . . . 69.78 10.06 63.59 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2187 ' ' GLY . . . . . 0.515 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 166.2 -118.11 0.78 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.514 -1.326 . . . . 0.0 110.078 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2188 ' ' PHE . . . . . 0.615 ' CD2' ' HG2' ' A' 2175 ' ' PRO . 1.8 p90 -166.46 -179.45 4.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -1.139 . . . . 0.0 109.889 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2189 ' ' GLU . . . . . 0.534 ' O ' ' CB ' ' A' 2182 ' ' LYS . 0.1 OUTLIER -132.09 94.04 3.39 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.406 -0.808 . . . . 0.0 109.286 178.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 2190 ' ' CYS . . . . . 0.51 ' HB3' ' HA ' ' A' 2181 ' ' CYS . 9.1 p -114.26 139.26 49.56 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.92 -1.112 . . . . 0.0 109.802 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2191 ' ' THR . . . . . 0.549 HG21 ' CZ ' ' A' 2196 ' ' PHE . 1.8 m -113.85 106.58 14.62 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2192 ' ' CYS . . . . . 0.651 ' HB2' ' CD2' ' A' 2196 ' ' PHE . 0.5 OUTLIER -53.54 -172.36 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.057 -1.027 . . . . 0.0 110.157 -178.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 2193 ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.2 tp10 -68.03 136.43 53.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.656 -0.652 . . . . 0.0 110.1 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2194 ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -40.37 131.5 2.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.523 -0.736 . . . . 0.0 110.203 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 116.75 12.76 8.37 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2196 ' ' PHE . . . . . 0.678 ' CD2' ' HB2' ' A' 2204 ' ' CYS . 8.0 p90 -128.99 -158.71 0.9 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.575 -0.956 . . . . 0.0 110.22 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2197 ' ' GLU . . . . . 0.555 ' N ' ' CD2' ' A' 2196 ' ' PHE . 25.7 mt-10 -147.16 96.7 4.21 Favored Pre-proline 0 C--N 1.306 -1.319 0 O-C-N 121.565 -0.709 . . . . 0.0 109.496 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2198 ' ' PRO . . . . . 0.633 ' CD ' ' CE2' ' A' 2196 ' ' PHE . 2.2 Cg_endo -62.41 -170.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.356 2.037 . . . . 0.0 111.148 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -147.58 -168.02 13.74 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.04 -80.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.259 1.973 . . . . 0.0 110.929 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2201 ' ' MET . . . . . 0.515 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -142.54 42.11 1.6 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 110.115 -179.237 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 2.0 mmm -114.23 -72.28 0.71 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.411 -0.806 . . . . 0.0 109.502 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A 2203 ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' 2176 ' ' CYS . 11.8 t -166.84 -165.91 0.78 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2204 ' ' CYS . . . . . 0.678 ' HB2' ' CD2' ' A' 2196 ' ' PHE . 31.3 p -104.1 114.14 28.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.853 -1.155 . . . . 0.0 110.232 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A 2205 ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' 2205 ' ' GLU . 9.1 pt-20 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.513 179.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 2129 ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' 2130 ' ' GLU . 16.6 t0 . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 2130 ' ' GLU . . . . . 0.57 ' HB3' ' CD2' ' A' 2149 ' ' TYR . 2.0 mt-10 82.87 -47.11 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.845 -0.534 . . . . 0.0 109.942 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2131 ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' 2137 ' ' CYS . 0.0 OUTLIER -80.9 -46.14 15.67 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.963 -1.086 . . . . 0.0 109.152 179.968 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 2132 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -16.31 4.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.14 -0.975 . . . . 0.0 109.79 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2133 ' ' GLU . . . . . 0.429 ' HG3' ' C ' ' A' 2130 ' ' GLU . 7.5 mt-10 -69.95 146.06 94.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 110.204 -179.569 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2134 ' ' PRO . . . . . 0.528 ' O ' ' CE ' ' A' 2138 ' ' LYS . 6.4 Cg_endo -72.55 2.27 5.37 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.597 2.198 . . . . 0.0 110.309 179.113 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2135 ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' A' 2162 ' ' ASN . 36.3 t70 -108.43 -14.29 14.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.96 -1.087 . . . . 0.0 109.693 -179.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2136 ' ' VAL . . . . . 0.576 ' CG1' ' CE1' ' A' 2149 ' ' TYR . 2.3 t -112.21 -136.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.093 -1.005 . . . . 0.0 109.074 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2137 ' ' CYS . . . . . 0.471 ' HB3' ' SG ' ' A' 2131 ' ' CYS . 1.9 t -44.54 105.72 0.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.018 -1.051 . . . . 0.0 108.68 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2138 ' ' LYS . . . . . 0.528 ' CE ' ' O ' ' A' 2134 ' ' PRO . 3.7 mttm -114.22 18.35 17.09 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.336 -0.852 . . . . 0.0 110.332 -178.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2139 ' ' HIS . . . . . 0.478 ' O ' ' HB3' ' A' 2164 ' ' CYS . 0.9 OUTLIER 171.77 50.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.892 -1.13 . . . . 0.0 110.461 179.773 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -169.83 -175.22 38.7 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -89.78 142.8 27.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.348 -1.09 . . . . 0.0 108.611 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 2142 ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' 2150 ' ' ARG . 0.8 OUTLIER -128.78 175.93 8.22 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.092 -1.005 . . . . 0.0 110.492 -178.972 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 2143 ' ' ILE . . . . . 0.426 HD13 ' C ' ' A' 2142 ' ' CYS . 4.9 mp -139.51 107.92 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2144 ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' 2129 ' ' ASP . 5.2 t-20 -64.18 119.08 9.54 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.346 -0.846 . . . . 0.0 110.886 -178.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2145 ' ' THR . . . . . 0.423 ' OG1' ' C ' ' A' 2148 ' ' SER . 72.4 p -116.07 -179.08 3.56 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.35 109.75 21.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.957 . . . . 0.0 109.59 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 89.81 13.94 60.21 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 2148 ' ' SER . . . . . 0.423 ' C ' ' OG1' ' A' 2145 ' ' THR . 0.1 OUTLIER -178.72 -160.62 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.239 -1.153 . . . . 0.0 109.688 -179.866 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 2149 ' ' TYR . . . . . 0.576 ' CE1' ' CG1' ' A' 2136 ' ' VAL . 22.2 p90 -171.31 -174.43 1.45 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.397 -0.814 . . . . 0.0 108.979 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2150 ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' 2142 ' ' CYS . 0.0 OUTLIER -157.4 112.62 2.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.119 -0.988 . . . . 0.0 109.636 179.604 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 40.1 t -98.5 87.06 3.73 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.582 -0.699 . . . . 0.0 109.505 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -86.57 105.98 17.23 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.198 -0.938 . . . . 0.0 109.322 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 2153 ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -66.64 159.9 71.17 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 109.649 -179.624 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 2154 ' ' PRO . . . . . 0.474 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 0.9 OUTLIER -64.46 -166.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.61 2.207 . . . . 0.0 111.276 -179.024 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 21.0 t80 -90.21 103.42 16.1 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.81 -17.19 5.24 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 107.909 -2.076 . . . . 0.0 107.909 -178.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 2157 ' ' TYR . . . . . 0.522 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 9.7 m-85 -107.81 -172.34 2.05 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.625 -0.927 . . . . 0.0 109.799 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2158 ' ' ILE . . . . . 0.59 ' N ' ' CD1' ' A' 2158 ' ' ILE . 0.1 OUTLIER -155.5 -165.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.555 -0.716 . . . . 0.0 109.796 179.418 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 2159 ' ' LEU . . . . . 0.474 HD11 ' O ' ' A' 2163 ' ' GLU . 27.9 tp -141.9 121.8 13.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.387 -0.821 . . . . 0.0 109.508 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -94.63 50.94 1.37 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.357 -0.84 . . . . 0.0 109.83 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 91.32 -18.43 51.97 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 2162 ' ' ASN . . . . . 0.466 ' O ' HD13 ' A' 2159 ' ' LEU . 1.6 m-20 -178.03 -47.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.023 -1.281 . . . . 0.0 109.851 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2163 ' ' GLU . . . . . 0.474 ' O ' HD11 ' A' 2159 ' ' LEU . 78.7 tt0 -75.31 146.05 41.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.898 . . . . 0.0 109.035 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2164 ' ' CYS . . . . . 0.524 ' O ' ' CG1' ' A' 2165 ' ' VAL . 0.0 OUTLIER -115.35 140.9 48.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.031 -1.043 . . . . 0.0 109.395 -179.958 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 2165 ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' 2164 ' ' CYS . 4.7 m -162.42 -170.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 0.0 109.767 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2166 ' ' ASP . . . . . 0.461 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 1.3 t0 -89.78 144.77 25.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 109.415 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2167 ' ' THR . . . . . 0.558 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 8.9 t -85.39 170.74 12.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.306 -0.871 . . . . 0.0 109.682 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2168 ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' 2171 ' ' SER . 66.9 t0 -81.67 94.5 6.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.196 -0.94 . . . . 0.0 108.592 179.115 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2169 ' ' GLU . . . . . 0.55 ' CB ' ' HB3' ' A' 2188 ' ' PHE . 0.4 OUTLIER -65.56 -26.42 67.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 110.532 -179.012 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 2170 ' ' CYS . . . . . 0.439 ' HB2' ' HB2' ' A' 2181 ' ' CYS . 1.3 t -57.92 -12.82 3.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.912 -1.117 . . . . 0.0 108.77 178.461 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2171 ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.1 OUTLIER -59.44 -13.12 7.47 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.195 -0.94 . . . . 0.0 109.881 -179.553 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 2172 ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' 2169 ' ' GLU . 22.1 t -73.14 -67.95 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.312 -0.867 . . . . 0.0 109.242 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2173 ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' 2174 ' ' ASN . . . 154.95 85.55 0.05 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2174 ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' 2173 ' ' GLY . 1.1 t-20 47.31 91.55 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.26 -1.141 . . . . 0.0 109.421 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2175 ' ' PRO . . . . . 0.64 ' CB ' ' CD1' ' A' 2188 ' ' PHE . 1.0 OUTLIER -62.95 -21.95 73.5 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.078 1.852 . . . . 0.0 110.222 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 2176 ' ' CYS . . . . . 0.514 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.1 OUTLIER -75.97 -64.67 1.04 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -0.996 . . . . 0.0 108.926 179.68 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 147.93 -14.84 1.35 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -166.93 -34.76 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.205 -1.173 . . . . 0.0 110.106 -179.689 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2179 ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -61.48 -108.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.451 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2180 ' ' THR . . . . . 0.475 HG21 ' O ' ' A' 2179 ' ' GLY . 0.7 OUTLIER -151.18 157.19 42.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.393 -1.063 . . . . 0.0 109.307 -179.782 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 2181 ' ' CYS . . . . . 0.528 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 26.7 p -93.65 159.93 15.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.026 -1.046 . . . . 0.0 110.237 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2182 ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.0 OUTLIER -146.5 154.24 41.33 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.365 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 2183 ' ' ASN . . . . . 0.45 ' N ' ' HG3' ' A' 2182 ' ' LYS . 56.0 t30 -98.48 121.46 40.45 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.685 -1.259 . . . . 0.0 109.413 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2184 ' ' VAL . . . . . 0.489 ' CG1' ' N ' ' A' 2185 ' ' ILE . 0.3 OUTLIER -123.45 -162.78 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.524 -0.735 . . . . 0.0 109.558 -179.28 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 2185 ' ' ILE . . . . . 0.522 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 2.7 mp -108.52 138.36 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.186 -0.946 . . . . 0.0 110.213 -179.248 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 64.83 16.31 61.34 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.34 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 2187 ' ' GLY . . . . . 0.481 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 167.56 -128.08 1.67 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2188 ' ' PHE . . . . . 0.64 ' CD1' ' CB ' ' A' 2175 ' ' PRO . 5.7 p90 -162.6 170.4 18.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.218 -1.166 . . . . 0.0 109.374 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2189 ' ' GLU . . . . . 0.531 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.6 OUTLIER -120.57 151.28 39.63 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.314 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 17.8 p -149.96 141.03 22.98 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.756 -1.215 . . . . 0.0 109.794 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 2191 ' ' THR . . . . . 0.476 ' O ' ' HA3' ' A' 2179 ' ' GLY . 22.2 m -114.92 88.03 2.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.915 . . . . 0.0 109.773 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2192 ' ' CYS . . . . . 0.61 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -51.5 -178.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -0.873 . . . . 0.0 109.119 179.654 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 2193 ' ' GLU . . . . . 0.464 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.6 OUTLIER -58.15 123.59 16.51 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.374 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 2194 ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.8 OUTLIER -37.76 131.81 0.97 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.436 -0.79 . . . . 0.0 110.506 -178.796 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.03 -0.18 10.73 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 2196 ' ' PHE . . . . . 0.68 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.9 OUTLIER -113.69 -164.43 0.93 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.272 -1.134 . . . . 0.0 110.227 -179.904 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 2197 ' ' GLU . . . . . 0.532 ' N ' ' CG ' ' A' 2196 ' ' PHE . 2.5 mm-40 -145.33 96.31 4.9 Favored Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.541 -0.724 . . . . 0.0 109.665 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2198 ' ' PRO . . . . . 0.68 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 7.8 Cg_endo -67.79 -160.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.162 1.908 . . . . 0.0 111.138 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -140.29 -177.24 15.75 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.02 -57.44 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.051 1.834 . . . . 0.0 110.399 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A 2201 ' ' MET . . . . . 0.486 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.4 OUTLIER -158.41 60.74 0.44 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.615 -179.858 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 2202 ' ' MET . . . . . 0.464 ' O ' ' CE1' ' A' 2188 ' ' PHE . 0.8 OUTLIER -129.21 -77.16 0.55 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.192 -0.943 . . . . 0.0 109.542 -179.589 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A 2203 ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' 2175 ' ' PRO . 12.7 t -177.15 -173.91 0.48 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.398 -0.814 . . . . 0.0 109.485 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2204 ' ' CYS . . . . . 0.514 ' HB2' ' CA ' ' A' 2176 ' ' CYS . 7.7 t -71.99 148.82 45.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.459 -0.776 . . . . 0.0 109.467 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A 2205 ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' 2197 ' ' GLU . 14.7 pt-20 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.539 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 2129 ' ' ASP . . . . . 0.534 ' HB3' ' CG ' ' A' 2132 ' ' LYS . 10.7 t70 . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 2130 ' ' GLU . . . . . 0.615 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 1.7 mt-10 80.43 -41.55 0.2 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.021 0.438 . . . . 0.0 110.197 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2131 ' ' CYS . . . . . 0.477 ' HA ' HG13 ' A' 2136 ' ' VAL . 0.7 OUTLIER -90.93 -27.18 18.89 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.263 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A 2132 ' ' LYS . . . . . 0.534 ' CG ' ' HB3' ' A' 2129 ' ' ASP . 0.0 OUTLIER -56.7 -19.94 19.19 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.304 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A 2133 ' ' GLU . . . . . 0.469 ' HB2' HG22 ' A' 2136 ' ' VAL . 0.8 OUTLIER -70.06 137.86 87.25 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.519 -0.738 . . . . 0.0 109.443 -179.819 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A 2134 ' ' PRO . . . . . 0.473 ' O ' ' HD2' ' A' 2138 ' ' LYS . 4.3 Cg_endo -69.38 0.08 5.86 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.346 2.03 . . . . 0.0 111.181 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 22.7 t70 -124.14 1.07 8.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.766 -1.209 . . . . 0.0 110.344 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 2136 ' ' VAL . . . . . 0.518 ' CG1' ' N ' ' A' 2137 ' ' CYS . 40.5 t -91.73 -95.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.895 -1.128 . . . . 0.0 109.537 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2137 ' ' CYS . . . . . 0.518 ' N ' ' CG1' ' A' 2136 ' ' VAL . 48.3 t -84.3 -73.24 0.43 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.995 -1.065 . . . . 0.0 109.23 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2138 ' ' LYS . . . . . 0.473 ' HD2' ' O ' ' A' 2134 ' ' PRO . 0.0 OUTLIER 64.98 127.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 110.34 179.344 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A 2139 ' ' HIS . . . . . 0.489 ' O ' ' HB3' ' A' 2164 ' ' CYS . 9.6 m-70 51.03 26.4 2.74 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.371 -0.831 . . . . 0.0 110.934 178.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2140 ' ' GLY . . . . . 0.445 ' HA3' ' SG ' ' A' 2137 ' ' CYS . . . -128.98 166.89 21.28 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.399 -1.381 . . . . 0.0 110.197 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2141 ' ' GLN . . . . . 0.404 ' O ' HD12 ' A' 2143 ' ' ILE . 23.6 tt0 -89.45 47.87 1.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -1.142 . . . . 0.0 109.003 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2142 ' ' CYS . . . . . . . . . . . . . 1.6 p -49.23 160.58 0.22 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.625 -0.672 . . . . 0.0 110.184 -179.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 2143 ' ' ILE . . . . . 0.42 ' HA ' HD11 ' A' 2143 ' ' ILE . 38.1 mm -133.35 121.3 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2144 ' ' ASN . . . . . 0.487 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 13.3 t-20 -64.33 116.51 6.12 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.343 -0.848 . . . . 0.0 110.864 -179.088 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2145 ' ' THR . . . . . 0.507 ' OG1' ' HA ' ' A' 2149 ' ' TYR . 0.0 OUTLIER -108.89 175.4 5.48 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.455 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A 2146 ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' 2146 ' ' ASP . 4.2 p30 -70.08 103.06 2.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 110.042 -179.608 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 65.79 10.89 52.39 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 2148 ' ' SER . . . . . 0.459 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.0 OUTLIER -145.84 -174.7 4.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.112 -1.228 . . . . 0.0 109.607 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A 2149 ' ' TYR . . . . . 0.615 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 38.7 p90 -161.78 -170.02 2.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 109.519 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2150 ' ' ARG . . . . . 0.449 ' CB ' ' CZ ' ' A' 2150 ' ' ARG . 0.0 OUTLIER -170.75 104.18 0.25 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.485 -0.759 . . . . 0.0 109.51 179.531 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 36.5 t -72.14 84.09 1.01 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.37 -0.831 . . . . 0.0 109.151 179.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -93.47 87.48 5.58 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.364 -0.835 . . . . 0.0 109.208 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 2153 ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -49.79 152.87 2.37 Favored Pre-proline 0 C--N 1.302 -1.49 0 O-C-N 121.397 -0.815 . . . . 0.0 109.723 -179.625 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A 2154 ' ' PRO . . . . . 0.432 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 2.8 Cg_endo -65.4 -165.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.585 2.19 . . . . 0.0 111.018 -179.254 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 77.7 t80 -91.19 101.94 14.67 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.14 -11.88 5.56 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 -178.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 2157 ' ' TYR . . . . . 0.522 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 7.5 m-85 -110.16 -166.84 1.12 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.41 -1.053 . . . . 0.0 109.873 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2158 ' ' ILE . . . . . 0.539 ' CD1' HG21 ' A' 2165 ' ' VAL . 0.1 OUTLIER -156.5 -165.23 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.507 -0.745 . . . . 0.0 109.395 179.243 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A 2159 ' ' LEU . . . . . 0.445 ' N ' HG12 ' A' 2158 ' ' ILE . 28.5 tp -142.75 117.2 9.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.259 -0.9 . . . . 0.0 109.639 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -89.89 49.71 1.76 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.387 -0.821 . . . . 0.0 109.417 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 2161 ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' 2162 ' ' ASN . . . 90.62 -17.79 52.94 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2162 ' ' ASN . . . . . 0.489 ' CG ' ' N ' ' A' 2163 ' ' GLU . 3.1 p-10 -178.89 -49.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.105 -1.233 . . . . 0.0 109.793 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2163 ' ' GLU . . . . . 0.489 ' N ' ' CG ' ' A' 2162 ' ' ASN . 5.5 tt0 -70.87 133.41 46.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.505 -0.747 . . . . 0.0 109.236 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2164 ' ' CYS . . . . . 0.489 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -106.97 137.23 45.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.024 -1.047 . . . . 0.0 109.73 -179.628 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A 2165 ' ' VAL . . . . . 0.539 HG21 ' CD1' ' A' 2158 ' ' ILE . 1.9 m -152.07 -170.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.165 -0.959 . . . . 0.0 109.723 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2166 ' ' ASP . . . . . . . . . . . . . 27.0 t70 -76.75 166.94 22.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.366 -0.834 . . . . 0.0 110.164 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 2167 ' ' THR . . . . . 0.536 ' CG2' ' OE1' ' A' 2169 ' ' GLU . 1.4 t -116.83 -169.21 1.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.435 -0.791 . . . . 0.0 109.138 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2168 ' ' ASP . . . . . 0.505 ' N ' HG22 ' A' 2167 ' ' THR . 56.1 t0 -108.94 101.26 10.37 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.15 -0.969 . . . . 0.0 109.492 179.513 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2169 ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.9 OUTLIER -81.8 -29.75 32.56 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.413 -0.804 . . . . 0.0 109.396 179.916 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A 2170 ' ' CYS . . . . . 0.509 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 2.0 t -71.71 -4.82 29.64 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.456 -0.777 . . . . 0.0 109.07 179.458 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.65 -9.3 34.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.516 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 20.6 t -82.22 -70.33 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.941 . . . . 0.0 109.554 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 2173 ' ' GLY . . . . . 0.419 ' O ' ' SG ' ' A' 2181 ' ' CYS . . . -173.48 -73.84 0.05 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2174 ' ' ASN . . . . . 0.492 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 0.1 OUTLIER -167.09 96.18 0.67 Allowed Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.21 -1.17 . . . . 0.0 109.089 -179.465 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A 2175 ' ' PRO . . . . . 0.56 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 2.2 Cg_endo -63.22 -27.94 72.72 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.952 1.768 . . . . 0.0 110.615 -179.654 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2176 ' ' CYS . . . . . 0.535 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -51.46 -54.96 21.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.037 -1.039 . . . . 0.0 108.596 -179.974 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 138.6 -17.43 3.28 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 2178 ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' 2179 ' ' GLY . 1.6 t-20 -164.49 -37.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -1.091 . . . . 0.0 109.98 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2179 ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -60.17 -116.07 0.01 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 3.0 p -149.59 162.7 39.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.402 -1.057 . . . . 0.0 109.423 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 2181 ' ' CYS . . . . . 0.56 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 21.6 p -97.83 156.41 16.6 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.045 -1.034 . . . . 0.0 111.074 -179.382 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2182 ' ' LYS . . . . . 0.559 ' CB ' ' O ' ' A' 2189 ' ' GLU . 2.4 tppt? -137.97 159.58 41.63 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 178.556 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 60.1 t30 -100.66 126.64 47.19 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.46 -1.4 . . . . 0.0 109.471 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 2184 ' ' VAL . . . . . 0.539 HG11 ' N ' ' A' 2188 ' ' PHE . 0.7 OUTLIER -137.61 162.38 32.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.521 -0.737 . . . . 0.0 109.242 -179.656 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A 2185 ' ' ILE . . . . . 0.522 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 3.2 mp -76.64 130.51 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 110.258 -179.255 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 89.86 -8.51 79.69 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 2187 ' ' GLY . . . . . 0.471 ' C ' ' CD1' ' A' 2188 ' ' PHE . . . 174.2 -109.41 0.3 Allowed Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.588 -1.292 . . . . 0.0 109.925 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2188 ' ' PHE . . . . . 0.552 ' HB3' ' HB2' ' A' 2169 ' ' GLU . 3.4 p90 -171.16 178.58 3.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -1.132 . . . . 0.0 109.488 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2189 ' ' GLU . . . . . 0.559 ' O ' ' CB ' ' A' 2182 ' ' LYS . 3.1 tt0 -128.13 131.98 48.96 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.243 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2190 ' ' CYS . . . . . 0.449 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 18.3 p -124.07 137.5 54.57 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.576 -1.328 . . . . 0.0 110.039 -179.144 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2191 ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' 2192 ' ' CYS . 25.6 m -108.8 85.28 2.07 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.334 -0.854 . . . . 0.0 109.552 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2192 ' ' CYS . . . . . 0.598 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.9 OUTLIER -49.23 179.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.515 -0.741 . . . . 0.0 109.19 179.893 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A 2193 ' ' GLU . . . . . 0.509 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.3 tt0 -55.22 112.87 1.18 Allowed 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2194 ' ' GLU . . . . . 0.509 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.8 OUTLIER -28.26 127.43 0.08 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.446 0.641 . . . . 0.0 111.263 -178.775 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.18 6.65 8.16 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 2196 ' ' PHE . . . . . 0.67 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.2 p90 -117.89 -163.26 0.93 Allowed 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.288 -1.125 . . . . 0.0 110.231 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2197 ' ' GLU . . . . . 0.549 ' N ' ' CG ' ' A' 2196 ' ' PHE . 11.8 mt-10 -144.57 95.82 5.32 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 121.507 -0.746 . . . . 0.0 109.527 -179.699 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2198 ' ' PRO . . . . . 0.67 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 8.3 Cg_endo -67.52 -165.13 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.274 1.983 . . . . 0.0 111.199 -179.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -129.37 -171.59 12.98 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.79 -58.41 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.154 1.902 . . . . 0.0 111.169 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A 2201 ' ' MET . . . . . 0.514 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.0 OUTLIER -157.18 43.1 0.34 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.091 -1.006 . . . . 0.0 110.52 -179.119 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A 2202 ' ' MET . . . . . 0.451 ' O ' ' CE2' ' A' 2188 ' ' PHE . 17.2 mmm -115.82 -82.9 0.62 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.12 -0.987 . . . . 0.0 109.888 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2203 ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' 2175 ' ' PRO . 9.7 t -165.11 -169.97 1.8 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.182 -0.949 . . . . 0.0 109.604 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2204 ' ' CYS . . . . . 0.576 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.6 t -71.69 146.35 48.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.616 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.334 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -151.63 125.95 9.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.889 . . . . 0.0 109.447 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 5.7 p -108.6 146.89 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.205 -0.935 . . . . 0.0 109.394 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2127 ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.14 149.48 47.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.16 -0.962 . . . . 0.0 109.585 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.37 134.58 50.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.271 -0.893 . . . . 0.0 109.391 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2129 ' ' ASP . . . . . 0.548 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 17.2 t0 -66.88 -46.39 75.09 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.229 -0.919 . . . . 0.0 108.607 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2130 ' ' GLU . . . . . 0.561 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 2.0 mt-10 81.89 -44.91 0.18 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.864 -0.523 . . . . 0.0 110.511 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2131 ' ' CYS . . . . . 0.502 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 6.6 p -91.26 -31.92 15.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.038 -1.039 . . . . 0.0 110.041 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2132 ' ' LYS . . . . . 0.441 ' HB2' ' CG ' ' A' 2129 ' ' ASP . 0.1 OUTLIER -69.66 -7.47 39.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.088 -1.008 . . . . 0.0 109.622 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -70.32 151.87 95.68 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.378 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2134 ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -66.19 -7.46 17.36 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.374 2.049 . . . . 0.0 110.619 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2135 ' ' ASP . . . . . 0.518 ' O ' ' ND2' ' A' 2162 ' ' ASN . 0.5 OUTLIER -117.44 19.66 13.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.031 -1.043 . . . . 0.0 109.917 -179.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2136 ' ' VAL . . . . . 0.57 HG12 ' CE2' ' A' 2149 ' ' TYR . 21.4 t -144.55 127.94 11.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2137 ' ' CYS . . . . . 0.511 ' O ' ' HB2' ' A' 2138 ' ' LYS . 85.9 m 55.99 -90.28 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2138 ' ' LYS . . . . . 0.53 ' O ' ' CB ' ' A' 2139 ' ' HIS . 0.0 OUTLIER 70.0 19.39 6.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.397 -0.814 . . . . 0.0 109.983 179.121 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2139 ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.3 OUTLIER 163.26 42.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.99 -1.069 . . . . 0.0 110.222 179.388 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -157.39 172.58 34.8 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.523 -1.323 . . . . 0.0 110.345 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2141 ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' 2152 ' ' GLU . 13.4 tt0 -89.71 98.08 11.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -1.1 . . . . 0.0 109.146 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2142 ' ' CYS . . . . . . . . . . . . . 24.0 p -89.04 177.81 6.55 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.312 -0.868 . . . . 0.0 110.204 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 2.6 mp -134.97 99.84 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2144 ' ' ASN . . . . . 0.548 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 6.5 t-20 -56.66 112.69 1.36 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.303 -0.873 . . . . 0.0 110.77 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2145 ' ' THR . . . . . 0.446 HG22 ' HA ' ' A' 2149 ' ' TYR . 14.4 p -96.24 178.95 5.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.313 -0.867 . . . . 0.0 108.962 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -65.04 -48.8 72.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.225 -0.922 . . . . 0.0 109.703 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2147 ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' 2148 ' ' SER . . . -132.3 49.81 0.91 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2148 ' ' SER . . . . . 0.465 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER 171.56 -160.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -1.19 . . . . 0.0 109.54 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2149 ' ' TYR . . . . . 0.57 ' CE2' HG12 ' A' 2136 ' ' VAL . 3.9 p90 -158.13 -177.82 6.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.424 -0.798 . . . . 0.0 109.468 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2150 ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -151.52 99.38 2.61 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.17 -0.956 . . . . 0.0 109.706 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.86 136.21 56.62 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.561 -0.712 . . . . 0.0 109.778 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2152 ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' 2141 ' ' GLN . 0.1 OUTLIER -141.95 90.39 2.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.887 . . . . 0.0 109.241 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2153 ' ' CYS . . . . . 0.505 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -69.38 149.26 97.29 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 109.496 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2154 ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.2 -167.03 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.507 2.138 . . . . 0.0 111.112 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.05 105.52 17.87 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.6 -17.29 5.01 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 107.762 -2.135 . . . . 0.0 107.762 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2157 ' ' TYR . . . . . 0.528 ' CD2' ' C ' ' A' 2165 ' ' VAL . 9.0 m-85 -108.08 -171.46 1.87 Allowed 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.559 -0.965 . . . . 0.0 110.087 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2158 ' ' ILE . . . . . 0.56 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.1 OUTLIER -156.17 -166.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2159 ' ' LEU . . . . . . . . . . . . . 33.9 tp -138.33 118.7 13.73 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.634 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -97.02 49.14 1.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.431 -0.793 . . . . 0.0 109.439 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 94.57 -28.82 10.09 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2162 ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' 2135 ' ' ASP . 1.4 m-20 -172.5 -43.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -1.116 . . . . 0.0 109.435 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -73.19 125.82 28.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.333 -0.855 . . . . 0.0 109.282 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2164 ' ' CYS . . . . . 0.462 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -102.74 137.88 40.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 108.956 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2165 ' ' VAL . . . . . 0.528 ' C ' ' CD2' ' A' 2157 ' ' TYR . 0.6 OUTLIER -160.63 -166.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.05 -1.031 . . . . 0.0 109.97 -179.595 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2166 ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 0.5 OUTLIER -88.56 150.62 22.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.973 . . . . 0.0 110.358 -179.15 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2167 ' ' THR . . . . . 0.56 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 13.2 t -92.39 -175.9 4.15 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2168 ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' 2171 ' ' SER . 54.0 t0 -94.31 94.44 8.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.943 -1.098 . . . . 0.0 108.89 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2169 ' ' GLU . . . . . 0.569 ' HB3' ' CD1' ' A' 2188 ' ' PHE . 0.8 OUTLIER -70.77 -30.59 67.12 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.289 -0.882 . . . . 0.0 109.644 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2170 ' ' CYS . . . . . 0.467 ' O ' ' SG ' ' A' 2181 ' ' CYS . 1.6 t -65.14 -11.29 38.55 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.231 -0.918 . . . . 0.0 108.616 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2171 ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.1 OUTLIER -68.99 -6.11 25.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.126 -0.984 . . . . 0.0 109.354 179.426 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 23.8 t -76.17 -67.98 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.291 -0.881 . . . . 0.0 109.247 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2173 ' ' GLY . . . . . . . . . . . . . . . 156.51 66.98 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2174 ' ' ASN . . . . . 0.502 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 2.8 t-20 49.75 84.92 0.2 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.22 -1.165 . . . . 0.0 109.573 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2175 ' ' PRO . . . . . 0.582 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 5.0 Cg_endo -68.9 -14.25 38.36 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.07 1.846 . . . . 0.0 109.548 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2176 ' ' CYS . . . . . 0.461 ' HB2' ' ND2' ' A' 2174 ' ' ASN . 1.0 OUTLIER -57.91 -62.01 2.12 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.972 0.891 . . . . 0.0 109.316 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 154.55 -21.27 0.62 Allowed Glycine 0 N--CA 1.482 1.744 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2178 ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' 2179 ' ' GLY . 1.2 t30 -165.1 -38.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -1.172 . . . . 0.0 110.148 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2179 ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -58.06 -141.8 0.01 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 2.3 p -127.46 154.67 44.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -1.139 . . . . 0.0 109.015 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2181 ' ' CYS . . . . . 0.557 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 9.5 p -95.21 163.22 13.37 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.238 1.018 . . . . 0.0 111.327 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2182 ' ' LYS . . . . . 0.529 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.6 OUTLIER -143.0 157.82 44.18 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.664 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2183 ' ' ASN . . . . . 0.434 ' CG ' ' HA ' ' A' 2168 ' ' ASP . 44.5 t30 -94.64 131.14 40.74 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.349 -1.47 . . . . 0.0 110.007 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2184 ' ' VAL . . . . . 0.524 ' CG1' ' N ' ' A' 2185 ' ' ILE . 0.3 OUTLIER -135.97 -163.23 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.589 -0.695 . . . . 0.0 109.481 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2185 ' ' ILE . . . . . 0.524 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 2.8 mp -107.85 142.48 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.147 -0.971 . . . . 0.0 110.39 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2186 ' ' GLY . . . . . 0.406 ' O ' ' SD ' ' A' 2201 ' ' MET . . . 67.33 8.67 51.94 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2187 ' ' GLY . . . . . 0.503 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 166.59 -115.31 0.62 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2188 ' ' PHE . . . . . 0.582 ' CD2' ' HG2' ' A' 2175 ' ' PRO . 1.7 p90 -167.34 -178.62 4.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -1.116 . . . . 0.0 109.676 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2189 ' ' GLU . . . . . 0.529 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.2 OUTLIER -125.53 175.18 7.71 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2190 ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' 2191 ' ' THR . 0.1 OUTLIER -170.82 158.12 5.78 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 118.649 -1.22 . . . . 0.0 110.01 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2191 ' ' THR . . . . . 0.506 ' N ' ' SG ' ' A' 2190 ' ' CYS . 18.8 m -129.51 78.98 1.88 Allowed 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2192 ' ' CYS . . . . . 0.618 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 1.2 m -47.84 177.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -0.915 . . . . 0.0 109.412 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2193 ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.2 OUTLIER -49.56 113.76 0.9 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2194 ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.7 tp10 -32.23 129.36 0.19 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.535 0.683 . . . . 0.0 110.907 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.78 0.38 10.91 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2196 ' ' PHE . . . . . 0.675 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.8 OUTLIER -111.19 -162.85 0.81 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.257 -1.143 . . . . 0.0 110.367 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2197 ' ' GLU . . . . . 0.58 ' N ' ' CG ' ' A' 2196 ' ' PHE . 2.0 mm-40 -147.52 98.04 3.97 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2198 ' ' PRO . . . . . 0.675 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.9 Cg_endo -68.71 -158.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.292 1.995 . . . . 0.0 111.292 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -138.57 -173.97 13.22 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.66 -57.83 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.14 1.893 . . . . 0.0 110.937 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2201 ' ' MET . . . . . 0.503 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -157.84 49.08 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 110.266 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A 2202 ' ' MET . . . . . 0.524 ' O ' ' CE2' ' A' 2188 ' ' PHE . 2.7 mmt -119.73 -89.58 0.6 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.043 -1.035 . . . . 0.0 109.979 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2203 ' ' THR . . . . . 0.438 HG21 ' N ' ' A' 2204 ' ' CYS . 6.1 t -157.88 -164.27 1.49 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.208 -0.933 . . . . 0.0 109.404 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2204 ' ' CYS . . . . . 0.532 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 3.9 t -74.08 139.63 44.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.134 -0.979 . . . . 0.0 109.04 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A 2205 ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' 2197 ' ' GLU . 3.2 pt-20 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.631 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -59.83 107.34 0.6 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 109.495 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2126 ' ' VAL . . . . . 0.415 ' CG1' ' N ' ' A' 2127 ' ' ASP . 60.2 t -75.25 165.86 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.571 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2127 ' ' ASP . . . . . 0.415 ' N ' ' CG1' ' A' 2126 ' ' VAL . 7.3 t70 -80.65 135.65 36.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -0.85 . . . . 0.0 109.443 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 7.8 mmm -45.14 136.8 4.77 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.237 -0.915 . . . . 0.0 109.778 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2129 ' ' ASP . . . . . 0.519 ' O ' ' CB ' ' A' 2130 ' ' GLU . 18.1 t0 -70.06 -49.55 50.05 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2130 ' ' GLU . . . . . 0.592 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 1.7 mt-10 82.14 -46.97 0.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.741 -0.599 . . . . 0.0 110.537 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2131 ' ' CYS . . . . . 0.466 ' SG ' ' OD1' ' A' 2129 ' ' ASP . 11.2 p -90.42 -28.51 18.59 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.947 -1.096 . . . . 0.0 109.472 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2132 ' ' LYS . . . . . 0.47 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.1 OUTLIER -81.46 7.4 11.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.323 -0.86 . . . . 0.0 109.357 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 2133 ' ' GLU . . . . . 0.471 ' HB2' HG22 ' A' 2136 ' ' VAL . 44.8 mt-10 -69.57 149.93 96.91 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 121.297 -0.877 . . . . 0.0 109.158 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2134 ' ' PRO . . . . . 0.401 ' O ' ' HD2' ' A' 2138 ' ' LYS . 1.7 Cg_endo -65.38 -2.47 6.07 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.631 2.221 . . . . 0.0 111.74 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2135 ' ' ASP . . . . . 0.424 ' C ' ' OD1' ' A' 2135 ' ' ASP . 17.6 p30 -134.3 6.26 3.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.682 -1.261 . . . . 0.0 110.633 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2136 ' ' VAL . . . . . 0.517 ' O ' ' CB ' ' A' 2162 ' ' ASN . 53.4 t -101.22 -94.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.924 -1.11 . . . . 0.0 109.851 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2137 ' ' CYS . . . . . 0.476 ' O ' ' HB2' ' A' 2138 ' ' LYS . 0.1 OUTLIER -81.02 -72.77 0.41 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.988 -1.07 . . . . 0.0 109.364 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 2138 ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' 2137 ' ' CYS . 0.1 OUTLIER 65.48 100.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 110.079 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 2139 ' ' HIS . . . . . 0.486 ' O ' ' HB3' ' A' 2164 ' ' CYS . 57.6 m-70 67.29 55.2 0.68 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 110.026 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -153.96 174.9 32.4 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -105.03 82.96 1.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -1.159 . . . . 0.0 108.963 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2142 ' ' CYS . . . . . 0.429 ' C ' HD13 ' A' 2143 ' ' ILE . 17.3 p -88.32 177.09 6.95 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.37 -0.831 . . . . 0.0 110.345 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2143 ' ' ILE . . . . . 0.429 HD13 ' C ' ' A' 2142 ' ' CYS . 4.0 mp -134.24 101.83 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2144 ' ' ASN . . . . . 0.461 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 6.6 t-20 -58.37 116.87 3.9 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.197 -0.939 . . . . 0.0 110.522 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2145 ' ' THR . . . . . 0.418 ' OG1' ' C ' ' A' 2148 ' ' SER . 0.2 OUTLIER -103.73 174.25 5.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.469 -0.769 . . . . 0.0 108.955 179.142 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.64 -71.15 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.367 -0.833 . . . . 0.0 109.599 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2147 ' ' GLY . . . . . 0.483 ' O ' ' CB ' ' A' 2148 ' ' SER . . . -121.29 62.06 0.52 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2148 ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' 2147 ' ' GLY . 0.3 OUTLIER 166.83 -162.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -1.113 . . . . 0.0 109.546 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 2149 ' ' TYR . . . . . 0.592 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 51.4 p90 -169.1 -170.27 1.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 0.0 109.568 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2150 ' ' ARG . . . . . 0.41 ' HG3' HD11 ' A' 2143 ' ' ILE . 5.2 ptp180 -160.86 112.07 1.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.38 -0.825 . . . . 0.0 109.18 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 1.5 m -75.42 90.21 2.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.9 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -105.58 99.56 9.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 108.878 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2153 ' ' CYS . . . . . 0.5 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -67.64 153.55 94.83 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.249 -0.907 . . . . 0.0 109.9 -179.472 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 2154 ' ' PRO . . . . . 0.457 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.7 Cg_endo -66.06 -167.23 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.593 2.195 . . . . 0.0 111.318 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 81.6 t80 -90.44 102.61 15.34 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.86 -13.88 5.52 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2157 ' ' TYR . . . . . 0.5 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 7.6 m-85 -108.78 -169.87 1.57 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.439 -1.036 . . . . 0.0 110.016 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2158 ' ' ILE . . . . . 0.583 ' N ' ' CD1' ' A' 2158 ' ' ILE . 0.1 OUTLIER -154.76 -163.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 2159 ' ' LEU . . . . . 0.45 HD11 ' SG ' ' A' 2164 ' ' CYS . 29.6 tp -141.74 122.12 14.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.199 -0.938 . . . . 0.0 109.718 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -99.58 53.34 0.94 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.307 -0.871 . . . . 0.0 109.265 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2161 ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 87.36 -12.31 63.14 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2162 ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' 2136 ' ' VAL . 1.3 m-20 168.95 -44.85 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.303 -1.116 . . . . 0.0 109.382 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -71.5 114.5 9.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 109.144 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2164 ' ' CYS . . . . . 0.486 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -92.26 139.07 30.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 109.539 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 2165 ' ' VAL . . . . . 0.511 HG21 ' CD1' ' A' 2158 ' ' ILE . 3.7 m -156.99 -168.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.953 . . . . 0.0 109.569 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2166 ' ' ASP . . . . . 0.452 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 13.8 t70 -90.16 155.78 18.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.019 -1.051 . . . . 0.0 109.909 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2167 ' ' THR . . . . . 0.56 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 10.0 t -98.41 174.96 6.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -0.842 . . . . 0.0 109.248 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2168 ' ' ASP . . . . . 0.448 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 44.4 t0 -93.46 95.17 9.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.077 -1.014 . . . . 0.0 108.935 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2169 ' ' GLU . . . . . 0.565 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.6 OUTLIER -69.05 -32.26 71.61 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.318 -0.864 . . . . 0.0 109.573 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 2170 ' ' CYS . . . . . 0.498 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.1 t -65.22 -12.23 49.23 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.61 4.64 10.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.184 -0.947 . . . . 0.0 109.696 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 55.0 t -105.38 -79.03 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.21 -0.931 . . . . 0.0 109.857 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2173 ' ' GLY . . . . . 0.484 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -153.95 135.0 4.57 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2174 ' ' ASN . . . . . 0.583 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 26.0 p-10 -41.68 101.61 0.25 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.41 -1.053 . . . . 0.0 110.092 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2175 ' ' PRO . . . . . 0.553 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 1.1 Cg_endo -65.99 -21.87 56.13 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.827 1.685 . . . . 0.0 109.719 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2176 ' ' CYS . . . . . 0.582 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.1 OUTLIER -52.77 -35.76 57.0 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.169 -0.957 . . . . 0.0 109.308 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 114.4 -14.0 20.8 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2178 ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' 2179 ' ' GLY . 5.0 p-10 -171.48 -47.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.456 -1.026 . . . . 0.0 109.557 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2179 ' ' GLY . . . . . 0.536 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -52.47 -114.64 0.01 OUTLIER Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2180 ' ' THR . . . . . 0.48 HG21 ' O ' ' A' 2179 ' ' GLY . 0.8 OUTLIER -150.48 158.54 44.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -1.186 . . . . 0.0 109.371 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 2181 ' ' CYS . . . . . 0.583 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 16.0 p -90.3 166.14 13.49 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 122.368 1.08 . . . . 0.0 111.23 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2182 ' ' LYS . . . . . 0.586 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 11.3 tptt -143.84 155.81 44.25 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2183 ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 60.7 t30 -98.78 132.44 44.14 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.483 -1.385 . . . . 0.0 109.734 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2184 ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -140.8 -171.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 2185 ' ' ILE . . . . . 0.423 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 4.5 mp -104.85 135.67 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.85 -1.156 . . . . 0.0 110.387 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 72.68 13.53 78.14 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2187 ' ' GLY . . . . . 0.477 ' C ' ' CD2' ' A' 2188 ' ' PHE . . . 166.21 -121.18 0.97 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2188 ' ' PHE . . . . . 0.565 ' HB3' ' HB2' ' A' 2169 ' ' GLU . 4.3 p90 -176.4 173.71 2.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.355 -1.085 . . . . 0.0 108.966 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2189 ' ' GLU . . . . . 0.586 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 3.1 tt0 -120.9 178.07 4.86 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2190 ' ' CYS . . . . . 0.434 ' HB2' ' O ' ' A' 2180 ' ' THR . 7.6 p -170.9 152.17 3.54 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.861 -1.149 . . . . 0.0 109.436 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2191 ' ' THR . . . . . . . . . . . . . 46.0 m -122.37 91.21 3.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 0.0 110.032 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2192 ' ' CYS . . . . . 0.609 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -54.49 177.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.033 -1.042 . . . . 0.0 108.383 179.173 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 2193 ' ' GLU . . . . . 0.469 ' O ' ' C ' ' A' 2194 ' ' GLU . 7.4 tt0 -54.66 119.34 5.17 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 178.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2194 ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' 2193 ' ' GLU . 2.1 tt0 -35.08 131.58 0.4 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.536 0.684 . . . . 0.0 110.857 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.49 3.76 10.17 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2196 ' ' PHE . . . . . 0.678 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.0 OUTLIER -116.87 -163.89 0.94 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.224 -1.162 . . . . 0.0 110.489 -179.573 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 2197 ' ' GLU . . . . . 0.567 ' N ' ' CG ' ' A' 2196 ' ' PHE . 20.8 mt-10 -145.31 96.67 4.85 Favored Pre-proline 0 C--N 1.305 -1.364 0 O-C-N 121.633 -0.667 . . . . 0.0 109.512 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2198 ' ' PRO . . . . . 0.678 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.0 Cg_endo -68.69 -164.17 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.149 1.9 . . . . 0.0 111.012 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -133.29 -171.0 12.57 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.39 -81.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.028 1.819 . . . . 0.0 110.431 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2201 ' ' MET . . . . . 0.475 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.0 OUTLIER -133.99 49.97 2.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.089 -1.007 . . . . 0.0 109.684 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 1.7 mmm -122.1 -75.84 0.59 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.336 -0.853 . . . . 0.0 109.601 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 2203 ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' 2175 ' ' PRO . 14.9 t -173.21 -173.69 0.95 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 109.748 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A 2204 ' ' CYS . . . . . 0.582 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -108.73 151.63 25.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.371 -0.831 . . . . 0.0 109.149 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.049 -0.976 . . . . 0.0 109.544 -179.984 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 93.3 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . 58.0 43.75 20.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.474 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2126 ' ' VAL . . . . . 0.474 HG21 ' N ' ' A' 2127 ' ' ASP . 8.6 p -170.17 143.99 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.853 . . . . 0.0 109.389 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2127 ' ' ASP . . . . . 0.474 ' N ' HG21 ' A' 2126 ' ' VAL . 12.0 t70 -80.36 143.77 33.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 109.47 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 1.3 ttt -48.25 113.53 0.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 109.459 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2129 ' ' ASP . . . . . 0.524 ' O ' ' ND2' ' A' 2144 ' ' ASN . 19.1 t0 -66.1 -58.76 4.73 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.25 -0.907 . . . . 0.0 109.011 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2130 ' ' GLU . . . . . 0.553 ' CB ' ' CD2' ' A' 2149 ' ' TYR . 0.7 OUTLIER 81.52 -41.25 0.15 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.491 -0.756 . . . . 0.0 111.503 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 2131 ' ' CYS . . . . . 0.477 ' SG ' ' OD1' ' A' 2129 ' ' ASP . 14.5 p -90.57 -36.66 14.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.629 -1.294 . . . . 0.0 110.263 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2132 ' ' LYS . . . . . 0.48 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -81.62 7.62 11.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.164 -0.96 . . . . 0.0 109.798 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 2133 ' ' GLU . . . . . 0.466 ' HB2' HG22 ' A' 2136 ' ' VAL . 10.0 mt-10 -72.7 153.48 91.44 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.208 -0.933 . . . . 0.0 109.29 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2134 ' ' PRO . . . . . 0.507 ' HA ' ' CG ' ' A' 2138 ' ' LYS . 1.3 Cg_endo -63.72 -8.24 14.97 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.274 1.983 . . . . 0.0 110.667 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2135 ' ' ASP . . . . . 0.511 ' O ' ' ND2' ' A' 2162 ' ' ASN . 1.0 OUTLIER -104.34 -20.87 13.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.05 -1.031 . . . . 0.0 110.071 -179.577 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 2136 ' ' VAL . . . . . 0.527 ' CG1' ' CE1' ' A' 2149 ' ' TYR . 2.0 t -109.86 -140.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.1 -1.0 . . . . 0.0 108.98 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2137 ' ' CYS . . . . . 0.421 ' C ' ' O ' ' A' 2136 ' ' VAL . 0.8 OUTLIER -45.7 96.38 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.897 -1.127 . . . . 0.0 108.984 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 2138 ' ' LYS . . . . . 0.516 ' N ' ' O ' ' A' 2136 ' ' VAL . 5.0 mtmt -102.12 26.85 7.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.253 -0.904 . . . . 0.0 110.118 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2139 ' ' HIS . . . . . 0.496 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.1 OUTLIER 165.4 48.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.023 -1.048 . . . . 0.0 110.027 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 2140 ' ' GLY . . . . . 0.427 ' HA2' ' HD3' ' A' 2154 ' ' PRO . . . -152.97 -179.65 28.67 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -100.89 72.03 1.47 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.409 -1.054 . . . . 0.0 109.289 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2142 ' ' CYS . . . . . . . . . . . . . 7.4 p -62.9 -169.22 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.355 -0.84 . . . . 0.0 110.05 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 4.0 mp -141.54 103.09 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2144 ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' 2129 ' ' ASP . 6.6 t-20 -62.25 116.99 5.48 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.216 -0.927 . . . . 0.0 110.468 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2145 ' ' THR . . . . . 0.431 ' OG1' ' C ' ' A' 2148 ' ' SER . 2.2 p -107.23 -170.6 1.73 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.429 -0.795 . . . . 0.0 108.949 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.79 85.25 4.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.286 -0.883 . . . . 0.0 109.735 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 96.89 -55.58 1.34 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2148 ' ' SER . . . . . 0.431 ' C ' ' OG1' ' A' 2145 ' ' THR . 0.4 OUTLIER -84.72 -158.99 0.39 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -1.097 . . . . 0.0 109.828 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 2149 ' ' TYR . . . . . 0.553 ' CD2' ' CB ' ' A' 2130 ' ' GLU . 41.2 p90 -178.82 -167.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.489 -0.757 . . . . 0.0 109.375 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2150 ' ' ARG . . . . . 0.49 ' CB ' ' CZ ' ' A' 2150 ' ' ARG . 0.0 OUTLIER -169.02 115.07 0.6 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 109.321 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 43.3 t -81.55 113.1 19.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.704 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.48 84.29 2.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.011 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2153 ' ' CYS . . . . . 0.495 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -47.4 155.57 0.71 Allowed Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.259 -0.901 . . . . 0.0 109.798 -179.52 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 2154 ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' 2157 ' ' TYR . 1.1 Cg_endo -64.23 -168.8 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.73 2.286 . . . . 0.0 111.703 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 43.9 t80 -88.48 102.81 15.27 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.66 -14.76 5.51 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2157 ' ' TYR . . . . . 0.495 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 7.5 m-85 -109.05 -170.03 1.59 Allowed 'General case' 0 N--CA 1.483 1.222 0 O-C-N 121.574 -0.957 . . . . 0.0 109.74 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2158 ' ' ILE . . . . . 0.558 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.2 OUTLIER -156.95 -160.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.579 -0.701 . . . . 0.0 109.563 179.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 2159 ' ' LEU . . . . . 0.476 ' N ' HG12 ' A' 2158 ' ' ILE . 29.4 tp -145.57 124.17 12.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.414 -0.804 . . . . 0.0 109.377 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -99.02 51.54 0.96 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.353 -0.842 . . . . 0.0 109.486 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 90.26 -22.76 24.93 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2162 ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' 2135 ' ' ASP . 1.4 m-20 -176.03 -45.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.125 -1.22 . . . . 0.0 109.953 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -75.52 127.14 32.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.048 -1.033 . . . . 0.0 109.614 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2164 ' ' CYS . . . . . 0.476 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -99.74 140.38 34.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.69 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 2165 ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' 2164 ' ' CYS . 0.9 OUTLIER -161.82 -166.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.374 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 2166 ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 23.1 t70 -90.13 159.27 16.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.068 -1.02 . . . . 0.0 109.863 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2167 ' ' THR . . . . . 0.558 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 5.5 t -99.88 -167.42 1.46 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.185 -0.947 . . . . 0.0 109.362 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2168 ' ' ASP . . . . . 0.47 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 57.6 t0 -108.92 99.79 9.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.183 -0.948 . . . . 0.0 109.325 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2169 ' ' GLU . . . . . 0.558 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.6 OUTLIER -74.38 -30.68 62.08 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.21 -0.931 . . . . 0.0 109.446 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 2170 ' ' CYS . . . . . 0.467 ' O ' ' SG ' ' A' 2181 ' ' CYS . 3.1 t -66.85 -8.32 28.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.282 -0.886 . . . . 0.0 109.023 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2171 ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -70.33 -3.8 19.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.066 -1.021 . . . . 0.0 109.541 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 2172 ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' 2169 ' ' GLU . 17.7 t -86.27 -72.51 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 109.569 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2173 ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' 2174 ' ' ASN . . . 166.2 77.94 0.04 OUTLIER Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.641 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2174 ' ' ASN . . . . . 0.597 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 11.0 p-10 36.56 89.12 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.537 -0.978 . . . . 0.0 110.993 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2175 ' ' PRO . . . . . 0.578 ' HG2' ' CE2' ' A' 2188 ' ' PHE . 5.8 Cg_endo -67.5 -12.71 36.67 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.153 1.902 . . . . 0.0 109.227 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2176 ' ' CYS . . . . . 0.475 ' HB3' ' SG ' ' A' 2192 ' ' CYS . 0.9 OUTLIER -55.92 -58.02 9.63 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.834 0.826 . . . . 0.0 109.543 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 146.84 -26.22 1.62 Allowed Glycine 0 N--CA 1.484 1.854 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2178 ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.4 OUTLIER -157.05 -39.39 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.306 -1.114 . . . . 0.0 109.845 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 2179 ' ' GLY . . . . . 0.623 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -59.43 -140.02 0.01 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.5 p -133.19 148.0 52.04 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.53 -0.982 . . . . 0.0 109.4 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2181 ' ' CYS . . . . . 0.597 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 11.8 p -82.1 167.37 18.83 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.372 1.082 . . . . 0.0 111.439 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2182 ' ' LYS . . . . . 0.545 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 6.9 tttm -142.39 161.61 37.6 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2183 ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 46.6 t30 -101.12 128.78 47.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.412 -1.43 . . . . 0.0 110.108 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2184 ' ' VAL . . . . . 0.52 ' CG1' ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -137.41 -175.57 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 2185 ' ' ILE . . . . . 0.436 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 3.7 mp -100.05 140.85 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.114 -0.991 . . . . 0.0 110.053 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 70.62 8.4 63.2 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2187 ' ' GLY . . . . . 0.503 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 167.72 -121.4 0.96 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2188 ' ' PHE . . . . . 0.578 ' CE2' ' HG2' ' A' 2175 ' ' PRO . 2.3 p90 -169.04 178.61 4.39 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.272 -1.134 . . . . 0.0 109.295 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2189 ' ' GLU . . . . . 0.545 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.4 tt0 -124.19 -179.67 4.53 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2190 ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' 2191 ' ' THR . 0.5 OUTLIER -171.05 157.74 5.33 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 118.959 -1.096 . . . . 0.0 110.17 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 2191 ' ' THR . . . . . 0.514 ' N ' ' SG ' ' A' 2190 ' ' CYS . 80.3 m -128.75 80.27 1.96 Allowed 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2192 ' ' CYS . . . . . 0.623 ' HA ' ' HA3' ' A' 2179 ' ' GLY . 1.2 m -54.16 175.64 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.224 -0.922 . . . . 0.0 110.149 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2193 ' ' GLU . . . . . 0.508 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.5 tt0 -47.11 108.8 0.16 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2194 ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.4 OUTLIER -28.5 125.72 0.1 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.45 0.643 . . . . 0.0 111.237 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.78 4.22 9.7 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2196 ' ' PHE . . . . . 0.675 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.8 OUTLIER -112.71 -164.26 0.91 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.252 -1.146 . . . . 0.0 110.498 -179.628 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 2197 ' ' GLU . . . . . 0.556 ' N ' ' CG ' ' A' 2196 ' ' PHE . 16.6 mt-10 -145.39 97.29 4.74 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2198 ' ' PRO . . . . . 0.675 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.0 Cg_endo -68.47 -159.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.026 1.818 . . . . 0.0 110.999 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -136.05 -174.88 13.54 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.534 -1.827 . . . . 0.0 108.534 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.63 -52.79 1.64 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.114 1.876 . . . . 0.0 110.622 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 2201 ' ' MET . . . . . 0.503 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -163.93 57.69 0.16 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.399 -0.813 . . . . 0.0 109.462 -179.52 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -127.99 -84.09 0.59 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 110.002 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2203 ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' 2175 ' ' PRO . 13.3 t -163.36 -164.15 0.91 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.346 -0.846 . . . . 0.0 108.827 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2204 ' ' CYS . . . . . 0.565 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 3.3 t -74.26 140.86 45.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.953 -1.092 . . . . 0.0 109.329 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2205 ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' 2197 ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.514 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -99.07 107.04 19.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.718 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2126 ' ' VAL . . . . . 0.519 ' O ' ' CG1' ' A' 2126 ' ' VAL . 13.3 p -110.49 95.33 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.902 . . . . 0.0 109.444 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2127 ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' 2128 ' ' MET . 11.4 t0 -47.12 -39.3 13.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.53 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2128 ' ' MET . . . . . 0.507 ' CB ' ' O ' ' A' 2127 ' ' ASP . 1.5 ttm 76.28 109.85 0.07 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 109.724 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2129 ' ' ASP . . . . . 0.522 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 53.5 t0 -85.39 80.74 9.02 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2130 ' ' GLU . . . . . 0.531 ' O ' ' CG1' ' A' 2136 ' ' VAL . 22.7 mp0 -49.11 -26.93 3.04 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.289 -0.882 . . . . 0.0 110.547 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2131 ' ' CYS . . . . . 0.491 ' O ' ' HB2' ' A' 2137 ' ' CYS . 0.8 OUTLIER -78.47 -36.1 45.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.701 -1.25 . . . . 0.0 109.678 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 2132 ' ' LYS . . . . . 0.434 ' HB2' ' CG ' ' A' 2129 ' ' ASP . 0.0 OUTLIER -85.53 44.8 1.13 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.003 -1.061 . . . . 0.0 108.623 178.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 2133 ' ' GLU . . . . . 0.54 ' CB ' ' HD2' ' A' 2134 ' ' PRO . 1.4 mt-10 -104.59 173.56 3.26 Favored Pre-proline 0 N--CA 1.486 1.349 0 O-C-N 121.466 -0.771 . . . . 0.0 109.765 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2134 ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' 2133 ' ' GLU . 3.1 Cg_exo -60.41 -11.62 17.32 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.584 2.189 . . . . 0.0 112.542 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2135 ' ' ASP . . . . . 0.581 ' O ' ' C ' ' A' 2136 ' ' VAL . 26.8 m-20 -145.95 -77.41 0.19 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.274 -1.516 . . . . 0.0 111.502 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2136 ' ' VAL . . . . . 0.626 ' CG2' ' CE1' ' A' 2149 ' ' TYR . 0.1 OUTLIER -12.77 -78.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 120.89 0.376 . . . . 0.0 111.057 -178.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 2137 ' ' CYS . . . . . 0.523 ' SG ' ' CG2' ' A' 2136 ' ' VAL . 13.0 m -121.11 146.07 47.13 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.689 -1.257 . . . . 0.0 108.949 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2138 ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' 2139 ' ' HIS . 2.4 mtpt -161.08 115.99 2.11 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.092 -1.005 . . . . 0.0 109.807 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2139 ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' 2138 ' ' LYS . 20.6 m80 71.42 46.63 0.41 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.212 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -154.17 174.9 32.56 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -89.81 86.14 6.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -1.159 . . . . 0.0 108.513 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2142 ' ' CYS . . . . . 0.43 ' HA ' ' O ' ' A' 2150 ' ' ARG . 13.4 p -85.26 178.84 7.35 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.285 -0.884 . . . . 0.0 110.811 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 4.0 mp -140.02 88.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2144 ' ' ASN . . . . . 0.522 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 8.0 t-20 -53.94 116.08 2.36 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.515 0.674 . . . . 0.0 110.515 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2145 ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' 2146 ' ' ASP . 56.4 p -107.75 -171.31 1.85 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2146 ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' 2145 ' ' THR . 0.4 OUTLIER -45.4 -79.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 109.284 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -115.45 -33.61 1.57 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2148 ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.77 -162.13 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -1.138 . . . . 0.0 109.44 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2149 ' ' TYR . . . . . 0.626 ' CE1' ' CG2' ' A' 2136 ' ' VAL . 12.9 p90 -172.58 -172.72 0.93 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.373 -0.83 . . . . 0.0 109.312 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2150 ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' A' 2149 ' ' TYR . 11.6 mtt180 -159.6 113.79 2.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.392 -0.818 . . . . 0.0 109.24 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2151 ' ' CYS . . . . . 0.474 ' HB2' HD11 ' A' 2159 ' ' LEU . 4.1 m -84.03 68.21 9.96 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.492 -0.755 . . . . 0.0 109.275 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -79.49 134.74 36.52 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.314 -0.866 . . . . 0.0 108.983 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2153 ' ' CYS . . . . . 0.5 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -101.53 154.23 37.38 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.245 -0.909 . . . . 0.0 109.772 -179.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 2154 ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' 2157 ' ' TYR . 1.5 Cg_endo -64.4 -166.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.505 2.137 . . . . 0.0 110.906 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 65.8 t80 -90.34 102.53 15.26 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.26 -13.9 5.42 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.169 -1.973 . . . . 0.0 108.169 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2157 ' ' TYR . . . . . 0.528 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 7.4 m-85 -108.21 -167.92 1.3 Allowed 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.533 -0.981 . . . . 0.0 109.901 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2158 ' ' ILE . . . . . 0.553 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.2 OUTLIER -156.21 -166.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.6 -0.687 . . . . 0.0 109.193 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 2159 ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' 2151 ' ' CYS . 9.5 tp -143.17 130.4 20.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.313 -0.867 . . . . 0.0 109.332 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -101.4 46.6 0.93 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.261 -0.899 . . . . 0.0 108.921 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2161 ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' 2162 ' ' ASN . . . 86.36 -9.28 70.95 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2162 ' ' ASN . . . . . 0.509 ' CA ' ' O ' ' A' 2136 ' ' VAL . 12.7 p-10 178.05 -47.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.248 . . . . 0.0 109.882 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2163 ' ' GLU . . . . . 0.423 ' N ' ' CG ' ' A' 2162 ' ' ASN . 11.5 tt0 -77.82 116.54 18.41 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.7 -0.625 . . . . 0.0 109.867 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2164 ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' 2158 ' ' ILE . 0.0 OUTLIER -93.21 140.72 29.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.93 . . . . 0.0 109.457 179.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 2165 ' ' VAL . . . . . 0.459 ' O ' ' HB3' ' A' 2157 ' ' TYR . 1.4 m -157.12 -165.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.105 -0.997 . . . . 0.0 109.562 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2166 ' ' ASP . . . . . . . . . . . . . 35.0 t70 -89.13 165.75 14.29 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.936 -1.102 . . . . 0.0 110.226 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2167 ' ' THR . . . . . 0.553 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 1.6 t -113.56 -169.94 1.6 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.408 -0.808 . . . . 0.0 109.407 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2168 ' ' ASP . . . . . 0.516 ' N ' HG21 ' A' 2167 ' ' THR . 55.7 t0 -109.3 98.85 8.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.249 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2169 ' ' GLU . . . . . 0.549 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.6 OUTLIER -73.47 -31.61 63.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.366 -0.834 . . . . 0.0 109.33 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 2170 ' ' CYS . . . . . 0.444 ' O ' ' SG ' ' A' 2170 ' ' CYS . 1.7 t -66.27 -9.47 32.91 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.342 -0.849 . . . . 0.0 108.735 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.52 7.92 8.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.363 -0.836 . . . . 0.0 110.234 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 57.4 t -112.42 -80.23 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.0 -1.062 . . . . 0.0 109.772 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2173 ' ' GLY . . . . . 0.479 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -147.63 131.73 3.99 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2174 ' ' ASN . . . . . 0.585 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 26.9 p-10 -43.78 102.66 0.29 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.301 -1.117 . . . . 0.0 109.577 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2175 ' ' PRO . . . . . 0.57 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 2.7 Cg_endo -70.65 -20.24 30.9 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.807 1.671 . . . . 0.0 110.015 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2176 ' ' CYS . . . . . 0.565 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.1 OUTLIER -50.88 -31.12 16.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -0.989 . . . . 0.0 109.3 -179.463 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 112.63 -23.72 14.69 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.67 -34.57 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.577 -0.955 . . . . 0.0 110.028 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2179 ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -63.65 -127.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 2.8 p -135.71 157.79 46.0 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.527 -0.984 . . . . 0.0 109.133 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2181 ' ' CYS . . . . . 0.585 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 12.9 p -95.46 162.31 13.7 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.053 -1.03 . . . . 0.0 111.186 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2182 ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 5.3 tptm -142.23 165.28 27.87 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2183 ' ' ASN . . . . . 0.474 ' N ' ' HG3' ' A' 2182 ' ' LYS . 63.1 t30 -100.74 138.15 38.18 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.505 -1.372 . . . . 0.0 110.09 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2184 ' ' VAL . . . . . 0.574 ' CG1' ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -147.33 165.88 6.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 2185 ' ' ILE . . . . . 0.528 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 3.2 mp -86.85 131.47 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.071 -1.018 . . . . 0.0 110.224 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 86.43 6.34 81.0 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2187 ' ' GLY . . . . . 0.5 ' C ' ' CD1' ' A' 2188 ' ' PHE . . . 162.73 -113.63 0.57 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2188 ' ' PHE . . . . . 0.574 ' N ' ' CG1' ' A' 2184 ' ' VAL . 2.9 p90 -173.3 179.48 2.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.171 -1.194 . . . . 0.0 109.352 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2189 ' ' GLU . . . . . 0.539 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.6 tt0 -125.71 173.24 9.16 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 3.5 p -170.87 148.01 2.8 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.653 -1.279 . . . . 0.0 110.016 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2191 ' ' THR . . . . . . . . . . . . . 60.6 m -118.67 87.87 2.81 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.376 -0.828 . . . . 0.0 109.291 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2192 ' ' CYS . . . . . 0.6 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.0 OUTLIER -51.81 178.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.299 -0.876 . . . . 0.0 108.92 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 2193 ' ' GLU . . . . . 0.46 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.0 OUTLIER -53.33 118.22 3.65 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.494 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 2194 ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.4 mt-10 -34.2 128.94 0.38 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.444 0.64 . . . . 0.0 110.991 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.77 4.04 9.79 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2196 ' ' PHE . . . . . 0.672 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.1 p90 -115.06 -164.01 0.91 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.306 -1.114 . . . . 0.0 110.487 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2197 ' ' GLU . . . . . 0.555 ' N ' ' CG ' ' A' 2196 ' ' PHE . 14.5 mt-10 -145.58 96.64 4.76 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.652 -0.655 . . . . 0.0 109.444 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2198 ' ' PRO . . . . . 0.672 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.1 Cg_endo -68.42 -166.3 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.249 1.966 . . . . 0.0 111.44 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -133.25 -173.82 13.39 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.75 -78.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.005 1.803 . . . . 0.0 110.751 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2201 ' ' MET . . . . . 0.478 ' SD ' ' O ' ' A' 2185 ' ' ILE . 0.0 OUTLIER -138.73 40.76 2.18 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.224 -0.922 . . . . 0.0 109.634 -179.271 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 1.6 mmm -112.41 -69.25 0.88 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.131 -0.98 . . . . 0.0 109.721 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2203 ' ' THR . . . . . . . . . . . . . 7.0 t -175.48 -168.27 0.3 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.854 . . . . 0.0 109.504 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 2204 ' ' CYS . . . . . 0.579 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.0 OUTLIER -114.81 153.93 29.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 108.936 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.563 -179.892 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -150.58 -60.97 0.19 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.393 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 11.4 p -68.53 162.6 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.5 -0.75 . . . . 0.0 109.365 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2127 ' ' ASP . . . . . . . . . . . . . 63.9 t0 -68.66 -60.68 2.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.245 -0.909 . . . . 0.0 109.719 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 3.6 ttm 63.31 117.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.212 -0.93 . . . . 0.0 109.317 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2129 ' ' ASP . . . . . 0.52 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 25.3 t0 -58.85 -53.19 61.15 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2130 ' ' GLU . . . . . 0.538 ' O ' ' CG2' ' A' 2136 ' ' VAL . 1.7 mt-10 81.26 -38.67 0.13 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.754 -0.592 . . . . 0.0 110.452 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2131 ' ' CYS . . . . . 0.492 ' O ' ' HB2' ' A' 2137 ' ' CYS . 5.2 p -90.71 -40.36 11.9 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.752 -1.217 . . . . 0.0 110.02 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2132 ' ' LYS . . . . . 0.483 ' N ' ' SG ' ' A' 2131 ' ' CYS . 0.0 OUTLIER -75.6 7.11 3.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.099 -1.001 . . . . 0.0 110.465 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 2133 ' ' GLU . . . . . 0.463 ' HB2' HG22 ' A' 2136 ' ' VAL . 7.3 mm-40 -69.22 151.5 96.99 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.989 -1.069 . . . . 0.0 109.448 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2134 ' ' PRO . . . . . 0.474 ' O ' ' CE ' ' A' 2138 ' ' LYS . 1.4 Cg_endo -64.47 -6.45 11.98 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.392 2.061 . . . . 0.0 110.889 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2135 ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' 2162 ' ' ASN . 10.6 m-20 -118.15 -25.85 6.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.929 -1.107 . . . . 0.0 110.407 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2136 ' ' VAL . . . . . 0.538 ' CG2' ' O ' ' A' 2130 ' ' GLU . 16.4 t -83.48 -119.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.076 -1.015 . . . . 0.0 108.813 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2137 ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' 2131 ' ' CYS . 59.3 m -67.4 145.89 54.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.554 -1.341 . . . . 0.0 108.392 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2138 ' ' LYS . . . . . 0.491 ' O ' ' CB ' ' A' 2139 ' ' HIS . 4.1 mttm -149.99 28.43 0.76 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.045 -1.035 . . . . 0.0 110.139 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2139 ' ' HIS . . . . . 0.491 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.1 OUTLIER 162.72 36.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.221 -0.925 . . . . 0.0 109.804 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -150.88 -176.09 23.45 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.62 111.72 24.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -1.066 . . . . 0.0 109.541 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2142 ' ' CYS . . . . . 0.424 ' C ' HD13 ' A' 2143 ' ' ILE . 11.0 p -99.39 -167.81 1.53 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.301 -0.874 . . . . 0.0 109.594 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2143 ' ' ILE . . . . . 0.509 HD11 ' CB ' ' A' 2150 ' ' ARG . 3.4 mp -149.89 101.09 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 109.259 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2144 ' ' ASN . . . . . 0.52 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 11.2 t-20 -52.65 113.99 1.25 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.3 -0.875 . . . . 0.0 110.189 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2145 ' ' THR . . . . . 0.45 HG22 ' HA ' ' A' 2149 ' ' TYR . 5.0 p -117.41 -179.81 3.83 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.372 -0.83 . . . . 0.0 109.083 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.56 117.9 31.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.309 -0.869 . . . . 0.0 109.558 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 73.61 18.75 79.56 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2148 ' ' SER . . . . . 0.424 ' C ' ' OG1' ' A' 2145 ' ' THR . 0.0 OUTLIER -174.81 -171.1 0.52 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -1.147 . . . . 0.0 109.566 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 2149 ' ' TYR . . . . . 0.514 ' CE2' HG12 ' A' 2136 ' ' VAL . 7.0 p90 -164.11 -168.43 1.57 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.86 . . . . 0.0 109.408 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2150 ' ' ARG . . . . . 0.509 ' CB ' HD11 ' A' 2143 ' ' ILE . 0.0 OUTLIER -130.65 -165.0 1.49 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.869 . . . . 0.0 109.562 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 2151 ' ' CYS . . . . . 0.452 ' SG ' HD12 ' A' 2159 ' ' LEU . 0.1 OUTLIER 176.79 38.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.417 179.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.83 147.19 30.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.356 -0.84 . . . . 0.0 109.364 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2153 ' ' CYS . . . . . 0.482 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -110.16 160.77 27.06 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.335 -0.853 . . . . 0.0 109.536 -179.69 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 2154 ' ' PRO . . . . . 0.466 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 2.3 Cg_endo -61.72 -174.46 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.664 2.243 . . . . 0.0 111.669 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 4.4 t80 -81.44 103.19 11.01 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.92 -19.74 4.9 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 107.182 -2.367 . . . . 0.0 107.182 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2157 ' ' TYR . . . . . 0.485 ' O ' ' CG2' ' A' 2158 ' ' ILE . 20.1 m-85 -108.35 178.71 4.41 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.806 -0.82 . . . . 0.0 109.794 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2158 ' ' ILE . . . . . 0.594 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.2 OUTLIER -157.61 -166.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 2159 ' ' LEU . . . . . 0.452 HD12 ' SG ' ' A' 2151 ' ' CYS . 11.4 tp -131.31 144.98 51.67 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.245 -0.91 . . . . 0.0 109.835 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2160 ' ' ALA . . . . . 0.408 ' N ' ' HG ' ' A' 2159 ' ' LEU . . . -121.11 53.82 1.13 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.389 -0.819 . . . . 0.0 109.013 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 93.59 -21.39 41.29 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2162 ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' A' 2135 ' ' ASP . 4.0 m-20 173.04 -40.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.357 -1.084 . . . . 0.0 109.502 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -77.87 122.27 25.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 0.0 109.295 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2164 ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.1 OUTLIER -92.41 143.38 26.43 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 0.0 109.397 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 2165 ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' 2164 ' ' CYS . 1.5 m -160.89 -168.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.12 -0.987 . . . . 0.0 109.485 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2166 ' ' ASP . . . . . 0.415 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 1.1 t0 -90.61 144.85 25.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.001 -1.062 . . . . 0.0 109.747 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2167 ' ' THR . . . . . 0.594 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 9.1 t -91.96 179.64 5.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.886 . . . . 0.0 109.528 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2168 ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' 2171 ' ' SER . 33.2 t0 -86.74 95.6 9.88 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2169 ' ' GLU . . . . . 0.547 ' HB3' ' CD2' ' A' 2188 ' ' PHE . 0.4 OUTLIER -66.22 -27.89 68.32 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.135 -0.978 . . . . 0.0 110.418 -179.006 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 2170 ' ' CYS . . . . . 0.444 ' HB3' ' OD1' ' A' 2168 ' ' ASP . 0.7 OUTLIER -58.13 -13.18 4.37 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.901 -1.125 . . . . 0.0 108.891 178.493 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 2171 ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -61.24 -10.66 7.19 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.137 -0.977 . . . . 0.0 110.159 -179.335 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 2172 ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' 2169 ' ' GLU . 17.4 t -77.06 -69.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.173 -0.954 . . . . 0.0 109.406 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2173 ' ' GLY . . . . . . . . . . . . . . . 156.36 92.96 0.09 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2174 ' ' ASN . . . . . . . . . . . . . 1.3 t-20 45.68 87.79 0.11 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.199 -1.177 . . . . 0.0 110.027 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2175 ' ' PRO . . . . . 0.661 ' CB ' ' CD1' ' A' 2188 ' ' PHE . 1.6 Cg_endo -63.02 -23.45 73.91 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.896 1.731 . . . . 0.0 110.212 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2176 ' ' CYS . . . . . 0.475 ' HB3' ' SG ' ' A' 2192 ' ' CYS . 0.4 OUTLIER -76.83 -68.11 0.64 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 109.288 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 159.81 -20.89 0.26 Allowed Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 1.3 t30 -166.55 -30.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.156 -1.202 . . . . 0.0 110.853 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2179 ' ' GLY . . . . . 0.562 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -61.72 -103.91 0.01 OUTLIER Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.6 -1.286 . . . . 0.0 109.937 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.1 p -153.75 162.33 41.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.467 -1.019 . . . . 0.0 109.027 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2181 ' ' CYS . . . . . 0.52 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 27.3 p -97.05 161.63 13.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.11 -0.994 . . . . 0.0 110.41 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2182 ' ' LYS . . . . . 0.575 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.2 OUTLIER -146.65 155.12 42.2 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.338 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 64.0 t30 -101.12 127.85 47.48 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.685 -1.259 . . . . 0.0 109.106 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2184 ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -134.33 -166.76 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.419 -0.801 . . . . 0.0 109.367 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2185 ' ' ILE . . . . . 0.415 ' HA ' ' OD2' ' A' 2166 ' ' ASP . 3.9 mp -105.89 134.57 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.0 110.032 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2186 ' ' GLY . . . . . 0.426 ' O ' ' SD ' ' A' 2201 ' ' MET . . . 78.8 4.16 87.99 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2187 ' ' GLY . . . . . 0.459 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 170.54 -116.96 0.67 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.457 -1.354 . . . . 0.0 109.985 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2188 ' ' PHE . . . . . 0.661 ' CD1' ' CB ' ' A' 2175 ' ' PRO . 5.0 p90 -168.25 173.13 8.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.39 -1.065 . . . . 0.0 109.184 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2189 ' ' GLU . . . . . 0.575 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.2 tp10 -127.02 155.69 42.83 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2190 ' ' CYS . . . . . 0.407 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 25.4 p -151.25 145.79 25.61 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.711 -1.243 . . . . 0.0 110.035 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2191 ' ' THR . . . . . 0.477 ' O ' ' HA3' ' A' 2179 ' ' GLY . 23.3 m -112.24 84.67 2.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.379 -0.826 . . . . 0.0 109.847 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2192 ' ' CYS . . . . . 0.613 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.1 m -48.79 -179.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.293 -0.879 . . . . 0.0 109.608 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2193 ' ' GLU . . . . . 0.476 ' O ' ' C ' ' A' 2194 ' ' GLU . 19.1 tt0 -50.65 116.49 1.96 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2194 ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.3 OUTLIER -34.85 125.69 0.54 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.71 -0.619 . . . . 0.0 110.723 -179.256 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.16 1.24 10.41 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2196 ' ' PHE . . . . . 0.675 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.3 p90 -108.89 -163.28 0.86 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.199 -1.177 . . . . 0.0 109.987 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2197 ' ' GLU . . . . . 0.529 ' N ' ' CG ' ' A' 2196 ' ' PHE . 16.8 mt-10 -145.62 95.58 4.92 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 121.496 -0.753 . . . . 0.0 109.556 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2198 ' ' PRO . . . . . 0.675 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.8 Cg_endo -68.71 -165.23 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.213 1.942 . . . . 0.0 111.259 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -133.13 -169.09 12.09 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.71 -81.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.998 1.799 . . . . 0.0 110.563 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 2201 ' ' MET . . . . . 0.491 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.0 OUTLIER -137.08 56.38 1.79 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.974 . . . . 0.0 109.952 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A 2202 ' ' MET . . . . . 0.428 ' O ' ' HB ' ' A' 2203 ' ' THR . 2.4 mmt -123.81 -72.25 0.69 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.271 -0.893 . . . . 0.0 109.615 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2203 ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' 2175 ' ' PRO . 11.3 t -180.0 -170.84 0.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.844 . . . . 0.0 109.432 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2204 ' ' CYS . . . . . 0.478 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.4 t -70.27 146.83 50.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 109.565 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.385 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 2124 ' ' SER . . . . . 0.45 ' O ' ' HB1' ' A' 2125 ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2125 ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' 2124 ' ' SER . . . 61.96 76.46 0.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.463 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 12.4 p -124.16 130.41 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -0.902 . . . . 0.0 109.383 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2127 ' ' ASP . . . . . 0.418 ' OD1' ' C ' ' A' 2127 ' ' ASP . 2.9 p30 -58.34 -177.28 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.326 -0.859 . . . . 0.0 109.563 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 1.5 ttt -44.32 125.47 4.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.384 -0.823 . . . . 0.0 109.661 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2129 ' ' ASP . . . . . 0.541 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 20.1 t0 -66.14 -54.87 20.16 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.386 -0.821 . . . . 0.0 108.902 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2130 ' ' GLU . . . . . 0.543 ' HB3' ' CD2' ' A' 2149 ' ' TYR . 1.5 mt-10 80.85 -41.15 0.17 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.651 -0.656 . . . . 0.0 110.943 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2131 ' ' CYS . . . . . 0.482 ' HB2' ' SG ' ' A' 2137 ' ' CYS . 9.8 p -90.23 -33.07 16.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.664 -1.273 . . . . 0.0 110.005 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2132 ' ' LYS . . . . . 0.459 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -81.53 6.86 13.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.135 -0.978 . . . . 0.0 109.225 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 2133 ' ' GLU . . . . . 0.489 ' HB2' HG22 ' A' 2136 ' ' VAL . 2.0 mt-10 -69.71 154.04 95.09 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.254 -0.904 . . . . 0.0 109.343 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2134 ' ' PRO . . . . . 0.472 ' O ' ' HD2' ' A' 2138 ' ' LYS . 3.7 Cg_endo -68.5 1.49 3.61 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.504 2.136 . . . . 0.0 111.536 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -134.36 0.05 3.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.602 -1.311 . . . . 0.0 110.733 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2136 ' ' VAL . . . . . 0.589 HG12 ' CZ ' ' A' 2149 ' ' TYR . 21.7 t -106.3 -119.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.818 -1.176 . . . . 0.0 109.594 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2137 ' ' CYS . . . . . 0.482 ' SG ' ' HB2' ' A' 2131 ' ' CYS . 3.8 m -76.74 111.45 12.27 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.754 -1.216 . . . . 0.0 108.799 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2138 ' ' LYS . . . . . 0.472 ' HD2' ' O ' ' A' 2134 ' ' PRO . 6.2 mtpp -116.37 112.58 21.71 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.242 -0.911 . . . . 0.0 110.096 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2139 ' ' HIS . . . . . 0.474 ' O ' ' HB3' ' A' 2164 ' ' CYS . 2.1 m-70 74.14 56.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.884 . . . . 0.0 109.944 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -159.7 -176.98 32.37 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -103.6 91.14 3.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -1.122 . . . . 0.0 109.043 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2142 ' ' CYS . . . . . 0.457 ' HA ' ' O ' ' A' 2150 ' ' ARG . 26.7 p -86.48 -178.94 6.54 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.228 -0.92 . . . . 0.0 110.2 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2143 ' ' ILE . . . . . 0.469 ' O ' HG21 ' A' 2145 ' ' THR . 3.6 mp -141.45 94.24 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.441 -0.787 . . . . 0.0 108.886 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2144 ' ' ASN . . . . . 0.541 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 11.1 t-20 -47.95 117.83 2.07 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.36 -0.837 . . . . 0.0 110.054 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2145 ' ' THR . . . . . 0.469 HG21 ' O ' ' A' 2143 ' ' ILE . 70.9 p -116.49 -174.66 2.6 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.431 -0.793 . . . . 0.0 109.046 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.31 118.44 25.75 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.341 -0.849 . . . . 0.0 109.602 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2147 ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' 2148 ' ' SER . . . 53.62 42.3 66.73 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2148 ' ' SER . . . . . 0.466 ' O ' ' OE1' ' A' 2130 ' ' GLU . 1.8 t 178.16 -162.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -1.109 . . . . 0.0 109.66 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2149 ' ' TYR . . . . . 0.589 ' CZ ' HG12 ' A' 2136 ' ' VAL . 45.2 p90 179.66 -169.5 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.806 . . . . 0.0 109.336 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2150 ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' 2149 ' ' TYR . 12.4 mtt180 -160.46 119.67 2.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.493 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2151 ' ' CYS . . . . . 0.412 ' CB ' HD12 ' A' 2159 ' ' LEU . 82.3 m -83.18 69.76 9.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.328 -0.857 . . . . 0.0 109.234 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -80.47 109.18 14.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.522 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2153 ' ' CYS . . . . . 0.478 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -82.38 152.66 67.76 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 121.148 -0.97 . . . . 0.0 109.356 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 2154 ' ' PRO . . . . . 0.406 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.2 Cg_endo -64.58 -168.54 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.493 2.128 . . . . 0.0 111.207 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 9.1 t80 -90.19 103.25 15.94 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.93 -14.17 5.49 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2157 ' ' TYR . . . . . 0.527 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 7.7 m-85 -107.86 -169.37 1.51 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.516 -0.99 . . . . 0.0 109.945 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2158 ' ' ILE . . . . . 0.516 HG22 ' HB ' ' A' 2167 ' ' THR . 0.1 OUTLIER -155.78 -165.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.452 -0.78 . . . . 0.0 109.458 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 2159 ' ' LEU . . . . . 0.46 ' N ' HG12 ' A' 2158 ' ' ILE . 28.7 tp -141.35 125.76 17.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.365 -0.834 . . . . 0.0 109.574 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -101.92 52.67 0.82 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.899 . . . . 0.0 109.261 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2161 ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 88.28 -9.66 74.32 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2162 ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' 2136 ' ' VAL . 1.7 m-20 167.04 -47.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -1.195 . . . . 0.0 109.444 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 25.5 tt0 -70.28 115.94 10.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.304 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2164 ' ' CYS . . . . . 0.474 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -92.33 144.55 25.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.52 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 2165 ' ' VAL . . . . . 0.52 ' O ' ' CD2' ' A' 2157 ' ' TYR . 0.4 OUTLIER -159.17 -167.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.426 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 2166 ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' 2184 ' ' VAL . 35.6 t70 -85.95 166.59 15.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.956 -1.09 . . . . 0.0 109.796 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2167 ' ' THR . . . . . 0.549 ' CG2' ' OE1' ' A' 2169 ' ' GLU . 5.6 t -113.73 -168.82 1.4 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.391 -0.818 . . . . 0.0 109.46 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2168 ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' 2168 ' ' ASP . 61.0 t0 -110.39 103.58 12.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.0 109.602 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2169 ' ' GLU . . . . . 0.556 ' CB ' ' CD1' ' A' 2188 ' ' PHE . 0.5 OUTLIER -79.99 -30.58 39.72 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.323 -0.86 . . . . 0.0 109.157 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 2170 ' ' CYS . . . . . 0.506 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 0.5 OUTLIER -64.74 -11.24 34.24 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.371 -0.831 . . . . 0.0 109.008 179.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -6.48 26.19 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.195 -0.94 . . . . 0.0 109.445 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2172 ' ' VAL . . . . . 0.469 HG21 ' O ' ' A' 2169 ' ' GLU . 19.0 t -78.58 -70.5 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.196 -0.94 . . . . 0.0 109.051 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2173 ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' 2174 ' ' ASN . . . 161.78 77.04 0.03 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2174 ' ' ASN . . . . . 0.476 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 9.4 t-20 43.85 82.36 0.23 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.257 -1.143 . . . . 0.0 109.835 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2175 ' ' PRO . . . . . 0.591 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 0.9 OUTLIER -64.6 -20.86 65.79 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.289 1.993 . . . . 0.0 110.141 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 2176 ' ' CYS . . . . . 0.48 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.1 OUTLIER -55.63 -58.01 9.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.051 -1.031 . . . . 0.0 108.758 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 143.77 -19.59 2.19 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 1.1 t30 -160.6 -34.95 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -1.172 . . . . 0.0 110.539 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2179 ' ' GLY . . . . . 0.582 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -66.15 -125.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.034 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 2.5 p -140.92 162.22 35.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.491 -1.005 . . . . 0.0 109.252 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2181 ' ' CYS . . . . . 0.565 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 24.5 p -99.7 151.16 21.53 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.09 0.948 . . . . 0.0 111.341 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2182 ' ' LYS . . . . . 0.5 ' HB3' ' O ' ' A' 2189 ' ' GLU . 4.9 tptt -134.36 157.0 47.51 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 58.5 t30 -95.9 139.71 31.71 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.361 -1.462 . . . . 0.0 109.862 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2184 ' ' VAL . . . . . 0.436 HG13 ' CA ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -147.78 176.7 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.528 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 2185 ' ' ILE . . . . . 0.527 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 1.2 mp -93.77 139.06 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.01 -1.056 . . . . 0.0 110.118 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2186 ' ' GLY . . . . . 0.434 ' N ' HG21 ' A' 2185 ' ' ILE . . . 74.75 8.63 82.15 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2187 ' ' GLY . . . . . 0.468 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 161.94 -128.76 1.95 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2188 ' ' PHE . . . . . 0.591 ' CD2' ' HG2' ' A' 2175 ' ' PRO . 1.2 p90 -158.7 -178.78 7.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -1.15 . . . . 0.0 109.532 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2189 ' ' GLU . . . . . 0.5 ' O ' ' HB3' ' A' 2182 ' ' LYS . 0.6 OUTLIER -131.85 111.14 11.34 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 31.2 p -110.65 137.48 48.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.785 -1.197 . . . . 0.0 109.774 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2191 ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' 2192 ' ' CYS . 59.5 m -111.1 87.39 2.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.283 -0.886 . . . . 0.0 109.175 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2192 ' ' CYS . . . . . 0.601 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.0 OUTLIER -48.33 -179.01 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.671 0.748 . . . . 0.0 109.703 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 2193 ' ' GLU . . . . . 0.475 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.6 OUTLIER -59.15 123.83 17.94 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.712 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 2194 ' ' GLU . . . . . 0.475 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.6 OUTLIER -34.74 129.5 0.43 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.43 0.633 . . . . 0.0 110.878 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.47 1.51 10.04 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2196 ' ' PHE . . . . . 0.673 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.8 OUTLIER -116.33 -164.54 0.98 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.184 -1.186 . . . . 0.0 110.192 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 2197 ' ' GLU . . . . . 0.564 ' N ' ' CG ' ' A' 2196 ' ' PHE . 0.3 OUTLIER -146.14 98.15 4.39 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 2198 ' ' PRO . . . . . 0.673 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.9 Cg_endo -68.68 -164.44 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.242 1.962 . . . . 0.0 111.174 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -132.49 -173.71 13.4 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -64.4 -54.63 0.75 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.919 1.746 . . . . 0.0 110.629 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2201 ' ' MET . . . . . 0.468 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -159.8 49.57 0.3 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 0.0 109.566 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 2.1 mmm -118.63 -79.3 0.59 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.253 -0.904 . . . . 0.0 109.674 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2203 ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' 2175 ' ' PRO . 6.7 t -173.51 -166.36 0.32 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.306 -0.871 . . . . 0.0 109.228 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2204 ' ' CYS . . . . . 0.548 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.2 t -70.31 141.63 52.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.073 -1.017 . . . . 0.0 109.541 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A 2205 ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' 2197 ' ' GLU . 23.0 pt-20 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.35 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 59.5 p . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -120.22 174.4 6.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.418 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 21.6 t -47.04 117.83 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 109.49 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2127 ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' 2128 ' ' MET . 0.5 OUTLIER -89.05 17.69 5.6 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.111 -0.993 . . . . 0.0 109.573 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 2128 ' ' MET . . . . . 0.493 ' O ' ' OD1' ' A' 2144 ' ' ASN . 0.1 OUTLIER 70.06 133.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 109.706 179.78 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 2129 ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' 2130 ' ' GLU . 1.3 t0 -51.72 -22.58 3.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.501 -0.749 . . . . 0.0 109.201 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2130 ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' 2129 ' ' ASP . 0.1 OUTLIER 81.29 -67.59 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.792 -0.568 . . . . 0.0 110.46 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 2131 ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' 2137 ' ' CYS . 1.7 t -81.28 -9.82 59.69 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.133 -0.979 . . . . 0.0 109.828 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2132 ' ' LYS . . . . . 0.498 ' CB ' ' HB3' ' A' 2129 ' ' ASP . 0.0 OUTLIER -72.42 -15.02 61.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.787 -1.196 . . . . 0.0 109.785 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 2133 ' ' GLU . . . . . 0.444 ' HB2' HG21 ' A' 2136 ' ' VAL . 3.7 mt-10 -74.3 146.5 84.32 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.152 -0.968 . . . . 0.0 109.631 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2134 ' ' PRO . . . . . 0.469 ' O ' ' HG3' ' A' 2138 ' ' LYS . 1.2 Cg_endo -65.22 -11.98 32.65 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.273 1.982 . . . . 0.0 110.133 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2135 ' ' ASP . . . . . 0.511 ' O ' ' ND2' ' A' 2162 ' ' ASN . 0.4 OUTLIER -110.35 21.57 16.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.95 . . . . 0.0 109.483 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 2136 ' ' VAL . . . . . 0.481 HG12 ' CZ ' ' A' 2149 ' ' TYR . 18.5 t -136.86 109.75 7.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2137 ' ' CYS . . . . . 0.543 ' CA ' ' O ' ' A' 2162 ' ' ASN . 56.4 m 64.92 -89.65 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2138 ' ' LYS . . . . . 0.514 ' O ' ' CB ' ' A' 2139 ' ' HIS . 0.0 OUTLIER 68.11 28.29 6.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.963 -1.086 . . . . 0.0 111.268 178.089 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 2139 ' ' HIS . . . . . 0.524 ' CB ' ' HB3' ' A' 2164 ' ' CYS . 0.2 OUTLIER 164.36 41.09 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.842 -1.161 . . . . 0.0 110.287 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 2140 ' ' GLY . . . . . 0.464 ' HA2' ' HD3' ' A' 2154 ' ' PRO . . . -166.41 175.73 41.77 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2141 ' ' GLN . . . . . 0.477 ' O ' ' HB2' ' A' 2152 ' ' GLU . 0.2 OUTLIER -89.38 96.66 10.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.184 -1.186 . . . . 0.0 108.259 179.29 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 2142 ' ' CYS . . . . . 0.493 ' SG ' ' CB ' ' A' 2137 ' ' CYS . 0.0 OUTLIER -96.32 174.07 7.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -0.86 . . . . 0.0 110.223 -178.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 2143 ' ' ILE . . . . . 0.453 ' O ' HG21 ' A' 2145 ' ' THR . 4.0 mp -137.2 111.91 10.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2144 ' ' ASN . . . . . 0.493 ' OD1' ' O ' ' A' 2128 ' ' MET . 0.6 OUTLIER -60.17 118.09 5.93 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.207 -0.933 . . . . 0.0 109.756 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 2145 ' ' THR . . . . . 0.475 ' OG1' ' O ' ' A' 2148 ' ' SER . 3.1 p -103.97 -179.5 3.97 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.157 -0.965 . . . . 0.0 109.011 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.13 -74.12 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.356 -0.84 . . . . 0.0 109.771 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -117.27 41.49 2.07 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2148 ' ' SER . . . . . 0.509 ' O ' ' HG2' ' A' 2130 ' ' GLU . 0.6 OUTLIER -174.13 -171.85 0.65 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -1.18 . . . . 0.0 109.831 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 2149 ' ' TYR . . . . . 0.481 ' CZ ' HG12 ' A' 2136 ' ' VAL . 42.0 p90 -153.05 -171.84 4.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 109.474 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2150 ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' 2149 ' ' TYR . 28.5 mtm180 -155.86 98.41 1.9 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.374 -0.829 . . . . 0.0 110.041 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2151 ' ' CYS . . . . . 0.464 ' CB ' HD12 ' A' 2159 ' ' LEU . 70.7 m -63.02 87.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.527 -0.733 . . . . 0.0 109.069 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2152 ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' 2141 ' ' GLN . 0.0 OUTLIER -87.09 70.32 10.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.503 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 2153 ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' 2158 ' ' ILE . 93.1 m -48.33 147.88 3.65 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 121.379 -0.826 . . . . 0.0 109.177 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2154 ' ' PRO . . . . . 0.464 ' HD3' ' HA2' ' A' 2140 ' ' GLY . 1.4 Cg_endo -63.48 -169.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.541 2.161 . . . . 0.0 111.25 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 75.2 t80 -89.22 102.01 14.67 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.28 -11.63 5.54 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2157 ' ' TYR . . . . . 0.476 ' CD2' ' O ' ' A' 2165 ' ' VAL . 5.7 m-85 -108.17 -170.69 1.72 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.399 -1.059 . . . . 0.0 109.801 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2158 ' ' ILE . . . . . 0.551 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.2 OUTLIER -156.38 -173.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.061 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 2159 ' ' LEU . . . . . 0.464 HD12 ' CB ' ' A' 2151 ' ' CYS . 21.6 tp -130.89 143.52 50.79 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.276 -0.89 . . . . 0.0 109.85 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -120.52 47.71 1.73 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 0.0 109.175 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2161 ' ' GLY . . . . . 0.427 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 94.35 -16.8 60.26 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2162 ' ' ASN . . . . . 0.543 ' O ' ' CA ' ' A' 2137 ' ' CYS . 1.3 m-20 169.47 -30.34 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.342 -1.093 . . . . 0.0 109.171 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -88.21 119.63 28.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 108.749 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2164 ' ' CYS . . . . . 0.528 ' O ' ' CG1' ' A' 2165 ' ' VAL . 38.2 t -95.78 159.47 14.97 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.173 -0.955 . . . . 0.0 109.239 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2165 ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' 2164 ' ' CYS . 0.6 OUTLIER -169.15 -167.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 2166 ' ' ASP . . . . . 0.461 ' OD2' ' O ' ' A' 2184 ' ' VAL . 34.7 t70 -88.88 165.12 14.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.049 -1.032 . . . . 0.0 109.454 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2167 ' ' THR . . . . . 0.551 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 6.3 t -111.35 -172.92 2.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.39 -0.818 . . . . 0.0 109.371 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2168 ' ' ASP . . . . . 0.463 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 51.8 t0 -107.48 100.96 10.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.409 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2169 ' ' GLU . . . . . 0.583 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.6 OUTLIER -76.33 -31.92 58.39 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.496 -0.752 . . . . 0.0 109.288 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 2170 ' ' CYS . . . . . 0.469 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 2.0 t -66.77 -9.68 39.37 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.314 -0.866 . . . . 0.0 108.877 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2171 ' ' SER . . . . . 0.421 ' HB2' ' CG ' ' A' 2168 ' ' ASP . 0.2 OUTLIER -81.23 7.83 10.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.855 . . . . 0.0 109.894 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 49.5 t -108.22 -72.34 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.07 -1.019 . . . . 0.0 109.536 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2173 ' ' GLY . . . . . 0.492 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -163.08 133.81 3.2 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2174 ' ' ASN . . . . . 0.597 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 18.9 p-10 -40.25 99.86 0.21 Allowed Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.461 -1.023 . . . . 0.0 109.959 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2175 ' ' PRO . . . . . 0.563 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 1.4 Cg_endo -68.66 -22.01 38.33 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.798 1.665 . . . . 0.0 109.85 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2176 ' ' CYS . . . . . 0.564 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -48.61 -40.36 27.28 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.305 -0.872 . . . . 0.0 109.206 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 123.0 -16.5 8.2 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -175.44 -34.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.481 -1.011 . . . . 0.0 109.71 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2179 ' ' GLY . . . . . 0.583 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -63.15 -122.24 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.51 154.63 44.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.39 -1.065 . . . . 0.0 109.708 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2181 ' ' CYS . . . . . 0.597 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 21.4 p -92.52 161.39 14.63 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.352 1.072 . . . . 0.0 111.286 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2182 ' ' LYS . . . . . 0.542 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 43.3 tptt -141.48 163.33 33.22 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2183 ' ' ASN . . . . . 0.488 ' N ' ' HG3' ' A' 2182 ' ' LYS . 62.9 t30 -101.13 140.07 35.94 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.618 -1.301 . . . . 0.0 110.006 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2184 ' ' VAL . . . . . 0.534 HG13 ' CA ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -148.91 -177.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.566 -0.709 . . . . 0.0 109.308 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 2185 ' ' ILE . . . . . . . . . . . . . 2.4 mp -97.83 135.7 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.02 -1.05 . . . . 0.0 110.196 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 75.15 10.62 84.26 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2187 ' ' GLY . . . . . 0.485 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 163.42 -121.04 0.98 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2188 ' ' PHE . . . . . 0.583 ' HB3' ' HB2' ' A' 2169 ' ' GLU . 2.3 p90 -169.17 -179.67 3.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -1.168 . . . . 0.0 109.526 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2189 ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 4.5 tt0 -124.67 170.21 11.19 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 6.0 p -170.58 145.56 2.57 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.461 -1.399 . . . . 0.0 109.949 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2191 ' ' THR . . . . . . . . . . . . . 17.9 m -117.98 92.98 3.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.422 -0.799 . . . . 0.0 109.728 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2192 ' ' CYS . . . . . 0.594 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -54.82 179.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 0.0 108.795 179.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 2193 ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' 2194 ' ' GLU . 4.2 tt0 -56.64 121.22 9.24 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2194 ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' 2193 ' ' GLU . 2.2 mt-10 -34.65 127.52 0.48 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.672 -0.643 . . . . 0.0 110.877 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.11 8.58 7.16 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2196 ' ' PHE . . . . . 0.664 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.4 p90 -119.91 -161.54 0.88 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.251 -1.146 . . . . 0.0 110.301 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2197 ' ' GLU . . . . . 0.582 ' N ' ' CG ' ' A' 2196 ' ' PHE . 1.8 mm-40 -146.13 96.03 4.67 Favored Pre-proline 0 C--N 1.305 -1.339 0 O-C-N 121.64 -0.663 . . . . 0.0 109.763 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2198 ' ' PRO . . . . . 0.664 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.0 Cg_endo -68.1 -159.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.389 2.059 . . . . 0.0 111.4 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -143.99 -169.87 13.15 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -65.31 -81.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.993 1.796 . . . . 0.0 110.844 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2201 ' ' MET . . . . . 0.485 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -135.29 41.73 2.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 110.024 -179.308 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 5.0 mtm -112.33 -78.59 0.58 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.182 -0.948 . . . . 0.0 109.582 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2203 ' ' THR . . . . . . . . . . . . . 6.0 t -168.24 -164.43 0.53 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.477 -0.764 . . . . 0.0 109.175 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 2204 ' ' CYS . . . . . 0.577 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.0 OUTLIER -115.91 144.97 43.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 108.943 -179.696 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.581 -179.724 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 2124 ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' 2126 ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . 47.48 -92.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.588 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2126 ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' 2124 ' ' SER . 24.7 t -70.36 137.24 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 109.246 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2127 ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' 2128 ' ' MET . 12.8 t70 -87.84 120.3 29.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 109.775 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2128 ' ' MET . . . . . 0.422 ' C ' ' O ' ' A' 2127 ' ' ASP . 1.2 mtt -43.69 125.36 4.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 109.538 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2129 ' ' ASP . . . . . 0.536 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 48.5 t0 -66.2 -38.98 89.3 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2130 ' ' GLU . . . . . 0.567 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 2.0 mt-10 82.4 -44.57 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.85 -0.531 . . . . 0.0 110.027 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2131 ' ' CYS . . . . . 0.525 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 14.4 p -90.71 -24.72 20.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.007 -1.058 . . . . 0.0 109.288 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2132 ' ' LYS . . . . . 0.413 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -68.92 -8.98 49.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 109.851 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 2133 ' ' GLU . . . . . 0.486 ' HB2' HG22 ' A' 2136 ' ' VAL . 6.3 mt-10 -72.12 144.47 87.44 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.082 -1.011 . . . . 0.0 109.171 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2134 ' ' PRO . . . . . 0.53 ' HA ' ' CG ' ' A' 2138 ' ' LYS . 1.9 Cg_endo -67.53 -4.12 11.41 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.239 1.959 . . . . 0.0 110.882 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2135 ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' 2135 ' ' ASP . 2.6 m-20 -116.29 4.96 13.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.011 -1.056 . . . . 0.0 110.03 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2136 ' ' VAL . . . . . 0.525 ' CG1' ' HA ' ' A' 2131 ' ' CYS . 75.4 t -110.32 -91.92 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.988 -1.07 . . . . 0.0 109.695 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2137 ' ' CYS . . . . . 0.519 ' N ' HG13 ' A' 2136 ' ' VAL . 0.5 OUTLIER -79.98 -74.43 0.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.115 -0.991 . . . . 0.0 109.572 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 2138 ' ' LYS . . . . . 0.53 ' CG ' ' HA ' ' A' 2134 ' ' PRO . 0.0 OUTLIER 65.46 89.42 0.1 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.377 -0.827 . . . . 0.0 109.963 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 2139 ' ' HIS . . . . . 0.501 ' O ' ' HB3' ' A' 2164 ' ' CYS . 3.5 m170 75.56 51.1 0.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.349 -0.844 . . . . 0.0 110.125 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -151.68 173.38 30.99 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -104.11 89.58 3.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -1.139 . . . . 0.0 108.966 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2142 ' ' CYS . . . . . 0.476 ' HB3' ' SG ' ' A' 2137 ' ' CYS . 9.0 p -88.86 -177.0 5.39 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.347 -0.846 . . . . 0.0 110.345 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.29 93.04 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2144 ' ' ASN . . . . . 0.536 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 21.2 t-20 -46.11 115.61 1.04 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.516 -0.74 . . . . 0.0 110.963 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2145 ' ' THR . . . . . 0.485 ' OG1' ' HA ' ' A' 2149 ' ' TYR . 0.4 OUTLIER -113.37 -178.7 3.44 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.282 -0.886 . . . . 0.0 108.936 178.743 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.59 110.15 17.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.379 -0.826 . . . . 0.0 109.769 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 65.85 25.77 71.97 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2148 ' ' SER . . . . . 0.443 ' O ' ' OG1' ' A' 2145 ' ' THR . 0.0 OUTLIER -173.66 -178.72 1.66 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.123 -1.222 . . . . 0.0 109.738 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 2149 ' ' TYR . . . . . 0.567 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 17.8 p90 -160.31 -172.37 3.55 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.443 -0.786 . . . . 0.0 109.446 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2150 ' ' ARG . . . . . 0.461 ' CG ' ' O ' ' A' 2149 ' ' TYR . 1.8 mtt-85 -156.52 107.16 2.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.414 -0.804 . . . . 0.0 109.142 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2151 ' ' CYS . . . . . 0.458 ' HB3' HD12 ' A' 2159 ' ' LEU . 1.6 m -74.33 107.17 6.33 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.489 -0.757 . . . . 0.0 110.431 -179.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.63 -178.63 3.49 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2153 ' ' CYS . . . . . 0.508 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -148.24 152.37 39.16 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 120.952 -1.093 . . . . 0.0 109.672 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 2154 ' ' PRO . . . . . 0.456 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.4 Cg_endo -64.22 -166.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.604 2.203 . . . . 0.0 111.478 -178.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 13.4 t80 -89.8 101.96 14.66 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2156 ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' 2166 ' ' ASP . . . 130.81 -14.08 5.52 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.169 -1.973 . . . . 0.0 108.169 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2157 ' ' TYR . . . . . 0.531 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 8.4 m-85 -108.3 -174.28 2.48 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.532 -0.981 . . . . 0.0 110.288 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2158 ' ' ILE . . . . . 0.566 ' N ' ' CD1' ' A' 2158 ' ' ILE . 0.1 OUTLIER -157.65 -165.89 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 2159 ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' 2151 ' ' CYS . 27.7 tp -131.92 127.74 37.05 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.408 -0.807 . . . . 0.0 109.574 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -107.06 49.23 0.81 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 0.0 109.327 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 95.67 -20.25 50.55 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2162 ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' 2136 ' ' VAL . 1.3 t-20 172.8 -38.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -1.172 . . . . 0.0 109.447 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2163 ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' 2137 ' ' CYS . 2.1 tt0 -79.09 111.02 14.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.416 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2164 ' ' CYS . . . . . 0.501 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.1 OUTLIER -85.93 137.55 32.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.895 . . . . 0.0 109.089 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 2165 ' ' VAL . . . . . 0.492 ' CG1' ' O ' ' A' 2164 ' ' CYS . 6.7 m -160.53 -166.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.145 -0.972 . . . . 0.0 109.539 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2166 ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' 2156 ' ' GLY . 1.3 t0 -90.23 144.8 25.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.875 -1.141 . . . . 0.0 109.773 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2167 ' ' THR . . . . . 0.554 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 12.7 t -85.09 169.62 13.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.257 -0.902 . . . . 0.0 109.017 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2168 ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' 2171 ' ' SER . 60.2 t0 -82.11 96.78 7.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.865 -1.147 . . . . 0.0 109.175 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2169 ' ' GLU . . . . . 0.648 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 40.2 mp0 -70.09 -37.07 75.33 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.474 -0.766 . . . . 0.0 109.186 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2170 ' ' CYS . . . . . 0.46 ' O ' ' SG ' ' A' 2181 ' ' CYS . 0.6 OUTLIER -68.19 -7.86 33.87 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.249 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 2171 ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.2 OUTLIER -74.09 -1.5 20.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.357 -0.839 . . . . 0.0 109.452 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 12.2 t -99.04 -72.55 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.17 -0.956 . . . . 0.0 109.671 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2173 ' ' GLY . . . . . 0.504 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -169.46 138.48 5.09 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2174 ' ' ASN . . . . . 0.553 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 22.7 p-10 -36.97 97.67 0.14 Allowed Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.721 -0.87 . . . . 0.0 110.335 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2175 ' ' PRO . . . . . 0.536 ' HG2' ' CD1' ' A' 2188 ' ' PHE . 1.5 Cg_endo -63.2 -22.23 72.56 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.821 1.681 . . . . 0.0 109.998 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2176 ' ' CYS . . . . . 0.53 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -52.12 -54.99 23.83 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 141.96 -21.95 2.47 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -162.93 -34.84 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.336 -1.097 . . . . 0.0 110.176 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2179 ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -62.48 -119.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.96 153.65 41.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.466 -1.02 . . . . 0.0 109.14 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2181 ' ' CYS . . . . . 0.553 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 11.5 p -82.06 164.95 21.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.086 -1.009 . . . . 0.0 110.813 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2182 ' ' LYS . . . . . 0.573 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.4 OUTLIER -144.63 155.05 43.42 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 64.1 t30 -100.16 138.59 37.03 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.543 -1.348 . . . . 0.0 109.544 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2184 ' ' VAL . . . . . 0.436 ' CG1' ' N ' ' A' 2185 ' ' ILE . 0.6 OUTLIER -145.94 -162.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.329 -179.401 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A 2185 ' ' ILE . . . . . 0.531 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 3.0 mp -108.28 134.23 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.036 -1.04 . . . . 0.0 110.356 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 68.56 8.7 56.93 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2187 ' ' GLY . . . . . 0.468 ' O ' ' OE1' ' A' 2169 ' ' GLU . . . 174.12 -137.59 4.07 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2188 ' ' PHE . . . . . 0.648 ' HB3' ' HB2' ' A' 2169 ' ' GLU . 5.5 p90 -161.02 169.5 22.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -1.151 . . . . 0.0 109.271 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2189 ' ' GLU . . . . . 0.573 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 2.8 tt0 -118.2 178.63 4.37 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 30.3 p -169.39 143.26 2.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.702 -1.249 . . . . 0.0 109.584 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2191 ' ' THR . . . . . . . . . . . . . 20.1 m -109.91 85.81 2.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.316 -0.865 . . . . 0.0 109.696 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2192 ' ' CYS . . . . . 0.589 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.1 m -51.23 177.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.205 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2193 ' ' GLU . . . . . 0.474 ' O ' ' C ' ' A' 2194 ' ' GLU . 7.4 tt0 -50.97 116.48 2.01 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2194 ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.8 mt-10 -33.93 127.77 0.39 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.484 0.659 . . . . 0.0 111.043 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.08 5.22 8.97 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2196 ' ' PHE . . . . . 0.674 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.3 p90 -114.82 -163.22 0.86 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.234 -1.156 . . . . 0.0 110.268 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2197 ' ' GLU . . . . . 0.519 ' N ' ' CG ' ' A' 2196 ' ' PHE . 1.8 mm-40 -144.58 95.98 5.28 Favored Pre-proline 0 C--N 1.304 -1.37 0 O-C-N 121.526 -0.733 . . . . 0.0 109.597 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2198 ' ' PRO . . . . . 0.674 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 8.1 Cg_endo -66.94 -162.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.279 1.986 . . . . 0.0 111.075 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -137.0 -175.08 13.59 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.63 -72.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.991 1.794 . . . . 0.0 110.675 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 2201 ' ' MET . . . . . 0.481 ' HA ' ' O ' ' A' 2188 ' ' PHE . 7.3 ptp -141.07 48.62 1.68 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.186 -0.947 . . . . 0.0 110.107 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2202 ' ' MET . . . . . 0.412 ' O ' ' CE1' ' A' 2188 ' ' PHE . 2.1 mmt -120.19 -85.03 0.66 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.081 -1.012 . . . . 0.0 109.845 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2203 ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' 2175 ' ' PRO . 7.3 t -168.66 -168.32 0.88 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.249 -0.907 . . . . 0.0 109.568 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2204 ' ' CYS . . . . . 0.575 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.7 t -71.59 144.81 49.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.934 . . . . 0.0 109.484 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.457 179.956 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 58.6 m . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -113.37 114.48 26.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.423 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2126 ' ' VAL . . . . . 0.405 HG11 ' N ' ' A' 2127 ' ' ASP . 24.6 t -101.81 145.84 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.506 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2127 ' ' ASP . . . . . 0.405 ' N ' HG11 ' A' 2126 ' ' VAL . 15.6 t70 -97.26 109.29 22.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.49 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.76 130.57 47.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.878 . . . . 0.0 109.717 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2129 ' ' ASP . . . . . 0.544 ' O ' ' ND2' ' A' 2144 ' ' ASN . 27.5 t0 -67.35 -38.98 85.69 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2130 ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' 2129 ' ' ASP . 1.5 mt-10 81.21 -48.74 0.26 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.668 -0.645 . . . . 0.0 110.427 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2131 ' ' CYS . . . . . 0.486 ' O ' ' O ' ' A' 2136 ' ' VAL . 13.7 p -90.97 -26.58 19.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.882 -1.136 . . . . 0.0 109.715 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2132 ' ' LYS . . . . . 0.511 ' HB2' ' CB ' ' A' 2129 ' ' ASP . 0.0 OUTLIER -65.34 -11.45 42.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.839 -1.163 . . . . 0.0 109.137 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -70.28 148.75 95.82 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.399 -0.813 . . . . 0.0 109.413 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2134 ' ' PRO . . . . . 0.504 ' HA ' ' CD ' ' A' 2138 ' ' LYS . 1.2 Cg_endo -64.67 -7.8 15.69 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.232 1.954 . . . . 0.0 110.726 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.91 16.94 15.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.044 -1.035 . . . . 0.0 109.841 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2136 ' ' VAL . . . . . 0.64 ' CG1' ' CE1' ' A' 2149 ' ' TYR . 22.1 t -143.09 118.84 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.134 -0.979 . . . . 0.0 109.314 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2137 ' ' CYS . . . . . 0.459 ' SG ' HG13 ' A' 2136 ' ' VAL . 1.9 m 41.64 71.05 0.22 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.331 -0.856 . . . . 0.0 109.252 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2138 ' ' LYS . . . . . 0.504 ' CD ' ' HA ' ' A' 2134 ' ' PRO . 0.0 OUTLIER -98.35 129.24 45.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 0.0 109.928 -179.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 2139 ' ' HIS . . . . . 0.463 ' O ' ' HB3' ' A' 2164 ' ' CYS . 0.7 OUTLIER 67.95 52.2 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.499 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -161.52 -160.77 11.11 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2141 ' ' GLN . . . . . 0.426 ' HB3' ' O ' ' A' 2152 ' ' GLU . 1.6 tt0 -119.03 94.49 4.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.321 -1.105 . . . . 0.0 109.405 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2142 ' ' CYS . . . . . . . . . . . . . 10.9 p -90.47 177.7 6.31 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.294 -0.879 . . . . 0.0 110.011 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 3.6 mp -132.16 117.22 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2144 ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' 2129 ' ' ASP . 5.2 t-20 -75.32 113.61 12.9 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.096 -1.002 . . . . 0.0 111.367 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2145 ' ' THR . . . . . 0.441 ' OG1' ' C ' ' A' 2148 ' ' SER . 16.2 p -99.87 179.53 4.49 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -59.14 -47.94 83.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 109.849 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -142.58 57.71 0.56 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2148 ' ' SER . . . . . 0.467 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER 174.92 -160.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -1.116 . . . . 0.0 109.287 -179.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 2149 ' ' TYR . . . . . 0.64 ' CE1' ' CG1' ' A' 2136 ' ' VAL . 43.2 p90 -174.11 -170.9 0.58 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.35 -0.844 . . . . 0.0 109.336 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2150 ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' 2149 ' ' TYR . 26.8 mtt180 -160.04 107.61 1.66 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.339 -0.851 . . . . 0.0 109.435 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2151 ' ' CYS . . . . . 0.449 ' HB3' HD12 ' A' 2159 ' ' LEU . 36.2 m -64.82 89.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.464 -0.772 . . . . 0.0 109.746 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2152 ' ' GLU . . . . . 0.426 ' O ' ' HB3' ' A' 2141 ' ' GLN . 2.0 mt-10 -102.16 86.18 2.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.034 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2153 ' ' CYS . . . . . 0.487 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -59.24 153.38 47.61 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.297 -0.877 . . . . 0.0 109.973 -179.407 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 2154 ' ' PRO . . . . . 0.416 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.1 Cg_endo -65.16 -167.56 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.624 2.216 . . . . 0.0 111.205 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 17.9 t80 -90.15 104.89 17.42 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.03 -17.91 5.1 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2157 ' ' TYR . . . . . 0.487 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 12.0 m-85 -107.98 -175.38 2.77 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.673 -0.898 . . . . 0.0 109.574 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2158 ' ' ILE . . . . . 0.588 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.1 OUTLIER -153.6 -163.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.661 -0.65 . . . . 0.0 109.319 179.429 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 2159 ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' 2151 ' ' CYS . 24.4 tp -135.41 136.36 41.33 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.195 -0.941 . . . . 0.0 110.073 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -113.99 44.14 1.71 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.411 -0.806 . . . . 0.0 109.255 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 100.42 -28.31 16.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2162 ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -179.46 -35.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -1.109 . . . . 0.0 109.47 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -81.66 113.62 19.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 0.0 109.254 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2164 ' ' CYS . . . . . 0.463 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -87.37 135.59 33.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.919 . . . . 0.0 109.854 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 2165 ' ' VAL . . . . . 0.475 ' O ' HD12 ' A' 2158 ' ' ILE . 0.3 OUTLIER -158.42 -168.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.416 -0.802 . . . . 0.0 108.848 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 2166 ' ' ASP . . . . . 0.473 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 0.6 OUTLIER -90.46 140.04 30.1 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.895 -1.128 . . . . 0.0 109.405 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 2167 ' ' THR . . . . . 0.588 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 7.6 t -93.13 161.33 14.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.252 -0.905 . . . . 0.0 109.373 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2168 ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' 2171 ' ' SER . 59.7 t0 -69.92 95.38 0.92 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.831 -1.168 . . . . 0.0 109.517 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2169 ' ' GLU . . . . . 0.554 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 41.2 mp0 -69.35 -35.85 76.29 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.489 -0.757 . . . . 0.0 109.399 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2170 ' ' CYS . . . . . 0.475 ' O ' ' SG ' ' A' 2181 ' ' CYS . 0.2 OUTLIER -65.01 -8.7 17.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.451 -0.781 . . . . 0.0 109.057 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 2171 ' ' SER . . . . . 0.483 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -72.18 -0.6 12.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.962 -1.087 . . . . 0.0 109.781 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 9.9 t -98.82 -74.04 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.092 -1.005 . . . . 0.0 109.914 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2173 ' ' GLY . . . . . 0.483 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -166.61 138.92 5.46 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2174 ' ' ASN . . . . . 0.554 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 18.5 p-10 -38.64 99.31 0.19 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.694 -0.886 . . . . 0.0 110.245 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2175 ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' 2181 ' ' CYS . 1.8 Cg_endo -61.87 -27.94 80.73 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.053 1.835 . . . . 0.0 110.182 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2176 ' ' CYS . . . . . 0.531 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -46.14 -50.48 15.47 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 133.14 -16.92 4.62 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2178 ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.4 OUTLIER -162.86 -40.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -1.111 . . . . 0.0 109.911 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 2179 ' ' GLY . . . . . 0.579 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -60.85 -119.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.3 p -143.11 160.42 40.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.432 -1.04 . . . . 0.0 109.469 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2181 ' ' CYS . . . . . 0.554 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 16.7 p -88.1 166.42 14.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.137 -0.977 . . . . 0.0 110.794 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2182 ' ' LYS . . . . . 0.575 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.2 OUTLIER -145.62 156.01 43.39 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.604 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 61.3 t30 -100.59 131.33 46.55 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.698 -1.251 . . . . 0.0 109.506 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2184 ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' 2188 ' ' PHE . 0.6 OUTLIER -140.89 -166.8 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.515 -0.741 . . . . 0.0 109.368 -179.566 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 2185 ' ' ILE . . . . . 0.473 ' HA ' ' OD2' ' A' 2166 ' ' ASP . 4.0 mp -107.36 136.41 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.029 -1.045 . . . . 0.0 109.909 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 72.92 6.93 68.96 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2187 ' ' GLY . . . . . 0.48 ' O ' ' OE1' ' A' 2169 ' ' GLU . . . 169.81 -129.76 1.9 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2188 ' ' PHE . . . . . 0.554 ' HB3' ' HB2' ' A' 2169 ' ' GLU . 3.2 p90 -164.38 173.16 12.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -1.157 . . . . 0.0 108.997 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2189 ' ' GLU . . . . . 0.575 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 2.6 tt0 -120.54 159.33 25.42 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 22.4 p -149.18 145.34 27.11 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.738 -1.226 . . . . 0.0 109.917 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2191 ' ' THR . . . . . . . . . . . . . 25.2 m -113.9 85.96 2.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.299 -0.875 . . . . 0.0 109.564 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2192 ' ' CYS . . . . . 0.602 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.9 OUTLIER -51.01 178.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 109.273 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 2193 ' ' GLU . . . . . 0.49 ' O ' ' C ' ' A' 2194 ' ' GLU . 2.0 tm-20 -52.71 117.79 3.17 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2194 ' ' GLU . . . . . 0.49 ' C ' ' O ' ' A' 2193 ' ' GLU . 5.7 mt-10 -34.15 127.73 0.42 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.494 0.664 . . . . 0.0 110.833 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.59 4.61 8.82 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2196 ' ' PHE . . . . . 0.669 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.1 p90 -114.99 -162.77 0.84 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.193 -1.181 . . . . 0.0 110.1 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2197 ' ' GLU . . . . . 0.542 ' N ' ' CG ' ' A' 2196 ' ' PHE . 25.3 mt-10 -145.42 95.55 5.0 Favored Pre-proline 0 C--N 1.304 -1.386 0 O-C-N 121.46 -0.775 . . . . 0.0 109.481 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2198 ' ' PRO . . . . . 0.669 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 8.3 Cg_endo -67.38 -159.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.27 1.98 . . . . 0.0 111.098 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -140.62 -170.49 12.1 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.47 -81.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 121.919 1.746 . . . . 0.0 110.531 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2201 ' ' MET . . . . . 0.483 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.4 OUTLIER -135.02 56.52 1.84 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.819 -179.475 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -124.53 -78.63 0.6 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.22 -0.925 . . . . 0.0 109.654 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2203 ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' 2175 ' ' PRO . 6.7 t -178.5 -165.56 0.09 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.382 -0.824 . . . . 0.0 109.196 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2204 ' ' CYS . . . . . 0.564 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.4 t -75.08 144.79 42.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 0.0 109.462 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.563 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.276 0.56 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 2125 ' ' ALA . . . . . 0.408 ' O ' ' HB ' ' A' 2126 ' ' VAL . . . -141.58 26.6 1.93 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.536 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2126 ' ' VAL . . . . . 0.413 ' O ' ' C ' ' A' 2127 ' ' ASP . 44.4 t 58.85 100.9 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 0.0 109.551 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2127 ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' 2128 ' ' MET . 25.9 t70 -44.32 147.19 0.58 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.94 . . . . 0.0 109.556 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2128 ' ' MET . . . . . 0.422 ' C ' ' O ' ' A' 2127 ' ' ASP . 1.8 ttt -43.13 103.1 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.347 -0.846 . . . . 0.0 109.688 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2129 ' ' ASP . . . . . 0.532 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 17.5 t0 -82.69 89.04 6.7 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2130 ' ' GLU . . . . . 0.581 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 42.4 mp0 -56.11 -24.76 42.58 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.43 -0.794 . . . . 0.0 110.529 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2131 ' ' CYS . . . . . 0.493 ' HA ' HG13 ' A' 2136 ' ' VAL . 1.8 t -84.49 -26.72 27.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.653 -1.279 . . . . 0.0 109.094 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2132 ' ' LYS . . . . . 0.46 ' HB2' ' HB3' ' A' 2129 ' ' ASP . 0.0 OUTLIER -84.75 13.05 6.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.07 -1.019 . . . . 0.0 109.089 179.445 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 2133 ' ' GLU . . . . . 0.522 ' HB2' ' CG2' ' A' 2136 ' ' VAL . 7.7 mt-10 -70.66 165.04 49.81 Favored Pre-proline 0 N--CA 1.486 1.365 0 O-C-N 121.346 -0.847 . . . . 0.0 109.498 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2134 ' ' PRO . . . . . 0.482 ' HD2' ' HB3' ' A' 2133 ' ' GLU . 2.6 Cg_endo -65.85 -27.76 51.3 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.57 2.18 . . . . 0.0 112.342 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -138.91 39.36 2.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.53 -1.356 . . . . 0.0 111.487 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2136 ' ' VAL . . . . . 0.538 HG12 ' CE2' ' A' 2149 ' ' TYR . 46.5 t -102.84 -100.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.834 -1.167 . . . . 0.0 109.248 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2137 ' ' CYS . . . . . 0.528 ' N ' ' CG1' ' A' 2136 ' ' VAL . 16.2 m -89.46 -65.48 1.01 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.767 -1.208 . . . . 0.0 108.696 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2138 ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' 2137 ' ' CYS . 0.3 OUTLIER 61.17 124.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.373 -0.829 . . . . 0.0 110.383 178.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 2139 ' ' HIS . . . . . 0.464 ' O ' ' HB3' ' A' 2164 ' ' CYS . 0.7 OUTLIER 63.18 40.83 8.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.335 -0.853 . . . . 0.0 110.366 179.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -154.79 162.15 30.65 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.04 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -94.44 87.9 5.32 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.493 -1.004 . . . . 0.0 108.727 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2142 ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' 2150 ' ' ARG . 0.8 OUTLIER -88.22 -166.83 1.69 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.3 -0.875 . . . . 0.0 109.769 -179.136 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 2143 ' ' ILE . . . . . 0.407 ' CD1' ' C ' ' A' 2142 ' ' CYS . 4.1 mp -144.72 103.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2144 ' ' ASN . . . . . 0.532 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 5.7 t-20 -57.63 116.02 3.14 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.302 -0.874 . . . . 0.0 110.3 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2145 ' ' THR . . . . . 0.427 ' OG1' ' C ' ' A' 2148 ' ' SER . 1.3 p -104.48 -177.46 3.37 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.381 -0.825 . . . . 0.0 109.196 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.86 -72.96 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.331 -0.856 . . . . 0.0 109.675 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -128.21 38.28 2.11 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2148 ' ' SER . . . . . 0.468 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER -155.0 -160.06 1.02 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.245 -1.15 . . . . 0.0 109.513 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 2149 ' ' TYR . . . . . 0.581 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 8.5 p90 -163.38 -169.72 2.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.658 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2150 ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' 2142 ' ' CYS . 32.4 mtt180 -157.81 99.51 1.7 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.388 -0.82 . . . . 0.0 109.374 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 30.6 m -70.09 111.97 6.13 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.252 -0.905 . . . . 0.0 109.17 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.03 84.8 2.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.239 -0.913 . . . . 0.0 109.416 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2153 ' ' CYS . . . . . 0.486 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -54.88 148.1 29.29 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.341 -0.849 . . . . 0.0 109.207 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 2154 ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.93 -167.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.405 2.07 . . . . 0.0 111.018 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 6.5 t80 -90.08 104.72 17.27 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.23 -16.14 5.24 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2157 ' ' TYR . . . . . 0.538 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 6.4 m-85 -105.52 -169.24 1.56 Allowed 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.564 -0.963 . . . . 0.0 110.155 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2158 ' ' ILE . . . . . 0.571 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.1 OUTLIER -153.46 -167.35 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.617 -0.677 . . . . 0.0 109.206 179.481 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 2159 ' ' LEU . . . . . 0.435 HD11 ' SG ' ' A' 2164 ' ' CYS . 37.9 tp -139.52 127.42 22.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.372 -0.83 . . . . 0.0 109.463 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -103.93 44.17 1.04 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.366 -0.834 . . . . 0.0 109.605 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2161 ' ' GLY . . . . . 0.451 ' O ' ' HB3' ' A' 2162 ' ' ASN . . . 93.87 -17.79 57.96 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2162 ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' 2136 ' ' VAL . 4.0 p-10 179.72 -49.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -1.142 . . . . 0.0 109.469 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2163 ' ' GLU . . . . . 0.456 ' N ' ' CG ' ' A' 2162 ' ' ASN . 0.6 OUTLIER -73.45 120.07 18.55 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.56 -0.712 . . . . 0.0 109.255 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 2164 ' ' CYS . . . . . 0.464 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -97.08 139.4 33.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 109.456 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 2165 ' ' VAL . . . . . 0.466 ' O ' ' CD1' ' A' 2158 ' ' ILE . 1.6 m -158.39 -172.27 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.064 -1.023 . . . . 0.0 109.475 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2166 ' ' ASP . . . . . . . . . . . . . 7.6 t70 -88.11 152.65 21.86 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.952 -1.092 . . . . 0.0 109.562 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2167 ' ' THR . . . . . 0.571 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 5.5 t -92.19 -168.16 1.93 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 109.13 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2168 ' ' ASP . . . . . 0.417 ' C ' ' OD1' ' A' 2168 ' ' ASP . 58.5 t0 -111.36 100.0 8.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.085 -1.009 . . . . 0.0 109.213 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2169 ' ' GLU . . . . . 0.568 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.7 OUTLIER -74.0 -33.28 63.75 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.448 -0.783 . . . . 0.0 109.22 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 2170 ' ' CYS . . . . . 0.458 ' HB2' ' N ' ' A' 2182 ' ' LYS . 1.8 t -69.59 -9.62 54.81 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2171 ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -72.72 -12.86 61.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 0.0 109.549 -179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 21.7 t -84.76 -71.99 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.146 -0.971 . . . . 0.0 109.288 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2173 ' ' GLY . . . . . 0.465 ' O ' ' SG ' ' A' 2181 ' ' CYS . . . -154.09 -127.58 1.16 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2174 ' ' ASN . . . . . 0.552 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 26.5 p-10 -130.28 97.79 21.93 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.075 -1.25 . . . . 0.0 109.213 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2175 ' ' PRO . . . . . 0.473 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.6 Cg_endo -66.58 -18.97 54.6 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 121.918 1.745 . . . . 0.0 109.967 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2176 ' ' CYS . . . . . 0.53 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.1 OUTLIER -51.39 -49.12 62.19 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.06 0.933 . . . . 0.0 108.926 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 128.64 -21.05 5.41 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 108.326 -1.909 . . . . 0.0 108.326 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -166.52 -34.09 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.498 -1.001 . . . . 0.0 110.045 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2179 ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -69.26 -130.51 0.05 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.6 p -131.97 157.0 45.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.605 -0.938 . . . . 0.0 109.193 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2181 ' ' CYS . . . . . 0.552 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 24.7 p -89.17 167.09 13.39 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.336 1.065 . . . . 0.0 110.899 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2182 ' ' LYS . . . . . 0.527 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 3.9 tttp -146.4 160.79 41.6 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2183 ' ' ASN . . . . . 0.416 ' N ' ' CG ' ' A' 2182 ' ' LYS . 56.3 t30 -100.59 126.32 47.05 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.602 -1.311 . . . . 0.0 110.014 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2184 ' ' VAL . . . . . 0.576 ' CG1' ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -132.46 -176.32 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 2185 ' ' ILE . . . . . 0.538 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 4.0 mp -100.29 140.29 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.019 -1.051 . . . . 0.0 110.008 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 70.64 12.19 69.92 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2187 ' ' GLY . . . . . 0.479 ' C ' ' CD1' ' A' 2188 ' ' PHE . . . 164.39 -117.92 0.78 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2188 ' ' PHE . . . . . 0.576 ' N ' ' CG1' ' A' 2184 ' ' VAL . 2.2 p90 -170.57 -179.27 2.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -1.19 . . . . 0.0 109.902 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2189 ' ' GLU . . . . . 0.527 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.3 OUTLIER -127.63 169.53 13.66 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.187 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 11.7 p -170.56 146.69 2.78 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.498 -1.376 . . . . 0.0 110.229 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2191 ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' 2192 ' ' CYS . 89.2 m -114.84 86.61 2.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.533 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2192 ' ' CYS . . . . . 0.605 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -50.27 -179.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.044 -1.035 . . . . 0.0 108.865 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 2193 ' ' GLU . . . . . 0.489 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.5 tt0 -55.15 113.92 1.56 Allowed 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2194 ' ' GLU . . . . . 0.489 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.2 tt0 -31.1 129.18 0.14 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.589 0.709 . . . . 0.0 111.029 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.61 4.27 9.81 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2196 ' ' PHE . . . . . 0.67 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.3 p90 -114.93 -163.63 0.89 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.229 -1.159 . . . . 0.0 110.385 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2197 ' ' GLU . . . . . 0.55 ' N ' ' CG ' ' A' 2196 ' ' PHE . 7.1 mt-10 -145.32 95.54 5.04 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 121.615 -0.678 . . . . 0.0 109.596 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2198 ' ' PRO . . . . . 0.67 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.2 Cg_endo -67.63 -162.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.349 2.033 . . . . 0.0 111.42 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -138.27 -174.82 13.58 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.54 -71.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.055 1.837 . . . . 0.0 110.726 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2201 ' ' MET . . . . . 0.466 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.1 OUTLIER -144.4 42.35 1.38 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.756 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.35 -77.11 0.58 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.217 -0.927 . . . . 0.0 109.532 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A 2203 ' ' THR . . . . . . . . . . . . . 12.2 t -168.32 -168.69 0.96 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.409 -0.807 . . . . 0.0 109.094 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 2204 ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.0 OUTLIER -115.04 149.7 37.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.895 . . . . 0.0 108.989 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.077 -0.964 . . . . 0.0 109.564 179.919 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.265 0.555 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -154.79 -52.5 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.867 . . . . 0.0 109.433 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 12.5 m -66.15 162.56 2.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.321 -0.862 . . . . 0.0 109.584 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2127 ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' 2128 ' ' MET . 15.5 t70 -60.08 152.17 24.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.622 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2128 ' ' MET . . . . . 0.462 ' O ' ' HG3' ' A' 2130 ' ' GLU . 0.3 OUTLIER -43.88 132.43 5.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 109.569 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 2129 ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' 2130 ' ' GLU . 16.3 t0 -62.17 -41.84 98.7 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.413 -0.804 . . . . 0.0 108.856 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2130 ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' 2129 ' ' ASP . 2.5 mt-10 82.86 -51.15 0.17 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.857 -0.527 . . . . 0.0 110.265 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2131 ' ' CYS . . . . . 0.544 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 12.0 p -89.51 -25.05 21.63 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.094 -1.004 . . . . 0.0 109.614 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2132 ' ' LYS . . . . . 0.468 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -85.2 41.11 0.86 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.177 -0.952 . . . . 0.0 109.539 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -112.65 155.93 43.18 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.295 -0.878 . . . . 0.0 109.2 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2134 ' ' PRO . . . . . 0.465 ' O ' ' HD2' ' A' 2138 ' ' LYS . 1.5 Cg_endo -64.67 -5.46 10.34 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.361 2.041 . . . . 0.0 111.262 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2135 ' ' ASP . . . . . 0.459 ' O ' ' HB3' ' A' 2162 ' ' ASN . 2.9 t0 -124.18 -29.5 3.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.802 -1.186 . . . . 0.0 110.216 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2136 ' ' VAL . . . . . 0.555 ' CG1' ' CE2' ' A' 2149 ' ' TYR . 61.7 t -77.82 -106.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.041 -1.037 . . . . 0.0 109.146 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2137 ' ' CYS . . . . . 0.483 ' N ' HG13 ' A' 2136 ' ' VAL . 0.1 OUTLIER -84.2 138.66 32.86 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.771 -1.206 . . . . 0.0 108.813 179.526 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 2138 ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' 2139 ' ' HIS . 0.5 OUTLIER -139.6 23.86 2.47 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.1 -1.0 . . . . 0.0 110.017 -179.269 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 2139 ' ' HIS . . . . . 0.541 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.1 OUTLIER 162.27 42.36 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.314 -0.867 . . . . 0.0 110.036 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -144.76 170.99 26.15 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.256 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2141 ' ' GLN . . . . . 0.431 ' O ' ' HG3' ' A' 2141 ' ' GLN . 5.7 pt20 -92.09 65.78 4.81 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.441 -1.035 . . . . 0.0 109.166 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2142 ' ' CYS . . . . . 0.469 ' O ' HG13 ' A' 2143 ' ' ILE . 21.5 p -62.44 -174.13 0.06 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.368 -0.833 . . . . 0.0 110.274 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2143 ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' 2142 ' ' CYS . 1.7 mp -148.71 83.09 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2144 ' ' ASN . . . . . 0.515 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 2.9 t30 -59.08 113.28 2.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.253 -0.904 . . . . 0.0 109.584 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2145 ' ' THR . . . . . . . . . . . . . 27.7 p -97.26 -151.79 0.37 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.371 -0.83 . . . . 0.0 109.415 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.76 -79.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 110.123 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -120.64 22.26 8.27 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2148 ' ' SER . . . . . 0.494 ' N ' ' OE2' ' A' 2130 ' ' GLU . 0.1 OUTLIER -144.85 -161.8 1.37 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -1.16 . . . . 0.0 109.214 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 2149 ' ' TYR . . . . . 0.555 ' CE2' ' CG1' ' A' 2136 ' ' VAL . 24.3 p90 179.6 -164.21 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.695 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2150 ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' 2149 ' ' TYR . 0.1 OUTLIER -166.58 119.45 1.03 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 109.358 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 13.2 m -89.03 106.67 18.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.885 . . . . 0.0 109.81 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -119.49 97.7 5.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 108.909 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2153 ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -58.22 152.95 39.09 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.21 -0.931 . . . . 0.0 109.817 -179.481 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 2154 ' ' PRO . . . . . 0.462 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 2.0 Cg_endo -66.11 -167.12 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.525 2.15 . . . . 0.0 111.023 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 22.1 t80 -90.59 104.72 17.27 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2156 ' ' GLY . . . . . 0.429 ' O ' HG21 ' A' 2167 ' ' THR . . . 131.05 -16.37 5.27 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.045 -2.022 . . . . 0.0 108.045 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2157 ' ' TYR . . . . . 0.52 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 8.2 m-85 -107.39 -169.69 1.58 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.599 -0.942 . . . . 0.0 110.005 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2158 ' ' ILE . . . . . 0.532 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.1 OUTLIER -151.24 -163.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.594 -0.691 . . . . 0.0 109.398 179.42 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 2159 ' ' LEU . . . . . 0.498 ' N ' HG12 ' A' 2158 ' ' ILE . 25.0 tp -145.51 113.26 6.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.413 -0.804 . . . . 0.0 109.297 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -95.55 60.66 2.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.323 -0.861 . . . . 0.0 109.715 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2161 ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 88.59 -19.49 36.37 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2162 ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' 2135 ' ' ASP . 0.1 OUTLIER 167.98 -34.08 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.361 -1.082 . . . . 0.0 109.357 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -76.49 111.62 12.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 109.15 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2164 ' ' CYS . . . . . 0.481 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.1 OUTLIER -87.83 144.74 26.43 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.301 -0.874 . . . . 0.0 109.69 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 2165 ' ' VAL . . . . . 0.521 HG21 ' CD1' ' A' 2158 ' ' ILE . 1.4 m -161.96 -169.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.292 -0.88 . . . . 0.0 109.54 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2166 ' ' ASP . . . . . 0.43 ' OD1' ' HA ' ' A' 2185 ' ' ILE . 34.7 t70 -78.54 164.35 24.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 110.179 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2167 ' ' THR . . . . . 0.532 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 6.0 t -117.25 -173.57 2.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.643 -0.661 . . . . 0.0 109.295 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2168 ' ' ASP . . . . . . . . . . . . . 42.0 t0 -101.6 102.47 13.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.197 -0.94 . . . . 0.0 108.976 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2169 ' ' GLU . . . . . 0.544 ' HB3' ' CD1' ' A' 2188 ' ' PHE . 0.3 OUTLIER -75.54 -23.89 56.67 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.276 -0.89 . . . . 0.0 110.359 -179.122 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 2170 ' ' CYS . . . . . 0.449 ' O ' ' SG ' ' A' 2170 ' ' CYS . 2.8 t -59.49 -12.34 6.1 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.784 -1.197 . . . . 0.0 108.805 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.48 -10.74 12.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.258 -0.901 . . . . 0.0 110.091 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2172 ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' 2169 ' ' GLU . 25.3 t -74.9 -68.21 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.232 -0.918 . . . . 0.0 109.422 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2173 ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' 2174 ' ' ASN . . . 162.54 78.28 0.03 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2174 ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' 2173 ' ' GLY . 1.0 OUTLIER 44.22 91.9 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.275 -1.132 . . . . 0.0 109.557 -179.78 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 2175 ' ' PRO . . . . . 0.611 ' CB ' ' CE2' ' A' 2188 ' ' PHE . 1.3 Cg_endo -66.68 -21.12 52.29 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.104 1.869 . . . . 0.0 110.238 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2176 ' ' CYS . . . . . 0.543 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -65.44 -60.0 3.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 109.521 -179.682 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 141.62 -18.09 2.62 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.74 -31.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.662 -0.905 . . . . 0.0 109.731 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2179 ' ' GLY . . . . . 0.542 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -60.68 -114.02 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.1 p -145.65 154.73 42.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.397 -1.061 . . . . 0.0 109.096 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2181 ' ' CYS . . . . . 0.467 ' HB3' ' HD2' ' A' 2175 ' ' PRO . 26.1 p -96.08 160.07 14.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.072 -1.018 . . . . 0.0 110.621 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2182 ' ' LYS . . . . . 0.527 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 3.6 tptm -146.06 156.65 43.61 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2183 ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' 2167 ' ' THR . 59.7 t30 -100.68 140.14 35.38 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.6 -1.313 . . . . 0.0 109.443 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2184 ' ' VAL . . . . . 0.451 HG11 ' C ' ' A' 2187 ' ' GLY . 0.5 OUTLIER -146.95 168.21 5.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.456 -0.777 . . . . 0.0 109.124 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 2185 ' ' ILE . . . . . 0.52 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 2.3 mp -80.64 140.32 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 110.755 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2186 ' ' GLY . . . . . 0.436 ' O ' ' SD ' ' A' 2201 ' ' MET . . . 69.81 9.26 62.26 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2187 ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 165.51 -136.66 4.29 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2188 ' ' PHE . . . . . 0.611 ' CE2' ' CB ' ' A' 2175 ' ' PRO . 1.2 p90 -153.06 179.26 8.86 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.199 -1.177 . . . . 0.0 109.055 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2189 ' ' GLU . . . . . 0.527 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.2 tp10 -131.49 171.27 13.61 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 7.8 p -170.79 148.8 2.98 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.78 -1.2 . . . . 0.0 109.876 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2191 ' ' THR . . . . . . . . . . . . . 10.1 m -118.39 88.94 3.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.908 . . . . 0.0 109.965 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2192 ' ' CYS . . . . . 0.604 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.7 OUTLIER -51.58 -179.48 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.171 -0.956 . . . . 0.0 109.219 179.586 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 2193 ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' 2194 ' ' GLU . 4.7 tt0 -57.2 118.17 4.8 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2194 ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.5 OUTLIER -32.21 128.49 0.22 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.409 0.623 . . . . 0.0 111.006 -178.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.41 4.69 8.94 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2196 ' ' PHE . . . . . 0.672 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.9 OUTLIER -117.37 -165.98 1.14 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.259 -1.142 . . . . 0.0 110.313 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 2197 ' ' GLU . . . . . 0.535 ' N ' ' CG ' ' A' 2196 ' ' PHE . 4.9 mm-40 -143.86 95.98 5.63 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.635 -0.666 . . . . 0.0 109.388 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2198 ' ' PRO . . . . . 0.672 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 6.8 Cg_endo -65.95 -167.17 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.187 1.925 . . . . 0.0 111.273 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -134.65 -171.33 12.47 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.1 -76.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.111 1.874 . . . . 0.0 110.822 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2201 ' ' MET . . . . . 0.502 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -140.26 52.2 1.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.485 -0.759 . . . . 0.0 109.997 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 8.8 mmm -126.37 -73.84 0.61 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.002 -1.062 . . . . 0.0 110.062 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2203 ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' 2175 ' ' PRO . 7.0 t -170.78 -169.12 0.74 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.218 -0.926 . . . . 0.0 109.746 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A 2204 ' ' CYS . . . . . 0.571 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.0 OUTLIER -112.46 148.03 35.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.47 -0.769 . . . . 0.0 108.974 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.43 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -176.37 -34.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.908 . . . . 0.0 109.374 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 2.7 t -109.25 78.94 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.911 . . . . 0.0 109.315 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2127 ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' 2127 ' ' ASP . 9.5 t0 -76.81 -28.16 55.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.364 -0.835 . . . . 0.0 109.661 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 3.2 mtt 66.31 117.83 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 109.629 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2129 ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' 2130 ' ' GLU . 5.2 t0 -68.28 -40.3 81.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.43 -0.794 . . . . 0.0 109.229 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2130 ' ' GLU . . . . . 0.534 ' CB ' ' O ' ' A' 2129 ' ' ASP . 2.1 mt-10 83.03 -61.29 0.13 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.757 -0.589 . . . . 0.0 110.831 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2131 ' ' CYS . . . . . 0.528 ' HB3' ' CD2' ' A' 2149 ' ' TYR . 29.5 p -85.45 -5.78 59.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.961 -1.087 . . . . 0.0 110.047 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2132 ' ' LYS . . . . . 0.537 ' CG ' ' O ' ' A' 2132 ' ' LYS . 13.7 tttt -94.89 3.18 55.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -0.976 . . . . 0.0 109.34 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2133 ' ' GLU . . . . . 0.409 ' HB2' HG22 ' A' 2136 ' ' VAL . 5.3 mt-10 -69.61 147.24 96.52 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 120.99 -1.069 . . . . 0.0 109.188 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2134 ' ' PRO . . . . . 0.466 ' HA ' ' CG ' ' A' 2138 ' ' LYS . 1.4 Cg_endo -63.9 -6.13 10.44 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.278 1.985 . . . . 0.0 110.935 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.16 -3.73 12.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.983 -1.073 . . . . 0.0 110.078 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2136 ' ' VAL . . . . . 0.475 ' CG1' ' HA ' ' A' 2131 ' ' CYS . 76.9 t -96.86 -101.03 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.037 -1.04 . . . . 0.0 109.788 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2137 ' ' CYS . . . . . 0.48 ' HB2' ' O ' ' A' 2131 ' ' CYS . 0.5 OUTLIER -73.27 -72.58 0.25 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.868 -1.145 . . . . 0.0 109.523 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 2138 ' ' LYS . . . . . 0.509 ' O ' ' CB ' ' A' 2139 ' ' HIS . 1.1 mtmt 63.53 100.57 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.296 -0.878 . . . . 0.0 109.805 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2139 ' ' HIS . . . . . 0.509 ' CB ' ' O ' ' A' 2138 ' ' LYS . 7.7 m-70 76.54 26.68 0.85 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -0.893 . . . . 0.0 109.579 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -132.34 166.82 23.23 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2141 ' ' GLN . . . . . 0.521 ' O ' ' CG ' ' A' 2152 ' ' GLU . 0.9 OUTLIER -103.86 71.51 1.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -1.17 . . . . 0.0 109.022 179.803 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 2142 ' ' CYS . . . . . 0.46 ' O ' HG13 ' A' 2143 ' ' ILE . 25.4 p -70.17 -164.33 0.08 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.865 0.841 . . . . 0.0 110.449 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2143 ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' 2142 ' ' CYS . 2.5 mp -151.68 84.58 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2144 ' ' ASN . . . . . 0.506 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 3.2 t30 -61.74 113.64 2.86 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.54 -0.725 . . . . 0.0 110.362 -178.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2145 ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' 2146 ' ' ASP . 16.5 p -101.1 -157.2 0.59 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.531 -0.731 . . . . 0.0 109.324 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2146 ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' 2146 ' ' ASP . 0.6 OUTLIER -48.37 -94.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.625 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -108.04 16.99 35.57 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2148 ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.69 -166.37 1.77 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.202 -1.175 . . . . 0.0 109.165 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2149 ' ' TYR . . . . . 0.528 ' CD2' ' HB3' ' A' 2131 ' ' CYS . 40.5 p90 -176.4 -176.86 0.8 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.655 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2150 ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.09 134.9 23.58 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -102.25 119.67 39.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.086 -1.009 . . . . 0.0 109.937 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2152 ' ' GLU . . . . . 0.521 ' CG ' ' O ' ' A' 2141 ' ' GLN . 0.8 OUTLIER -134.68 178.64 6.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 109.389 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 2153 ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -142.09 158.34 61.84 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.302 -179.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 2154 ' ' PRO . . . . . 0.471 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.8 Cg_endo -62.93 -171.08 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.457 2.104 . . . . 0.0 111.52 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.18 102.47 14.49 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.39 -16.7 5.4 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2157 ' ' TYR . . . . . 0.537 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 5.2 m-85 -105.25 -170.44 1.75 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.682 -0.893 . . . . 0.0 109.898 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2158 ' ' ILE . . . . . 0.529 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.2 OUTLIER -158.91 -161.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.624 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 2159 ' ' LEU . . . . . 0.51 ' N ' HG12 ' A' 2158 ' ' ILE . 26.3 tp -136.55 123.34 21.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.831 . . . . 0.0 109.499 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -96.39 51.78 1.21 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.359 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 90.36 -29.62 6.53 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2162 ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' 2136 ' ' VAL . 2.8 p-10 -171.13 -48.84 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.153 -1.204 . . . . 0.0 109.331 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2163 ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' 2137 ' ' CYS . 53.8 tt0 -72.57 121.78 20.27 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.543 -0.723 . . . . 0.0 109.273 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2164 ' ' CYS . . . . . 0.471 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.1 OUTLIER -90.94 138.88 31.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 109.593 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 2165 ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -159.84 -167.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.941 . . . . 0.0 109.297 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2166 ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 8.7 t70 -89.97 155.73 18.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.975 -1.078 . . . . 0.0 109.786 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2167 ' ' THR . . . . . 0.529 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 7.2 t -90.99 -169.49 2.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 109.449 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2168 ' ' ASP . . . . . 0.465 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 64.9 t0 -109.15 102.44 11.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.218 -0.926 . . . . 0.0 109.836 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2169 ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.5 OUTLIER -74.95 -32.65 61.79 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.361 -0.837 . . . . 0.0 109.066 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 2170 ' ' CYS . . . . . 0.526 ' HB2' ' N ' ' A' 2182 ' ' LYS . 0.6 OUTLIER -64.6 -11.55 36.1 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.776 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.35 5.22 13.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.845 . . . . 0.0 109.383 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 40.5 t -103.61 -65.88 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.355 -0.84 . . . . 0.0 109.402 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2173 ' ' GLY . . . . . . . . . . . . . . . -153.53 -135.18 2.1 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2174 ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -122.85 102.69 37.85 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.316 -1.109 . . . . 0.0 109.07 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2175 ' ' PRO . . . . . 0.645 ' CB ' ' CE2' ' A' 2188 ' ' PHE . 3.4 Cg_endo -69.07 -18.58 40.19 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.695 1.597 . . . . 0.0 109.839 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2176 ' ' CYS . . . . . 0.569 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -69.77 -50.36 44.05 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.127 -0.983 . . . . 0.0 109.653 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 124.75 -17.94 7.2 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -166.37 -37.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -1.079 . . . . 0.0 110.12 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2179 ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -63.95 -120.55 0.01 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.4 p -141.55 161.29 38.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.54 -0.976 . . . . 0.0 109.198 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2181 ' ' CYS . . . . . 0.517 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 26.7 p -97.81 160.76 14.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.043 -1.036 . . . . 0.0 110.593 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2182 ' ' LYS . . . . . 0.542 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 2.5 tppt? -145.46 155.67 43.26 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2183 ' ' ASN . . . . . 0.465 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 32.4 t30 -92.71 137.34 32.45 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.52 -1.363 . . . . 0.0 110.203 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2184 ' ' VAL . . . . . 0.588 ' CG1' ' CA ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -140.92 -167.63 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 2185 ' ' ILE . . . . . 0.537 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 1.5 mp -107.17 141.42 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.106 -0.996 . . . . 0.0 110.461 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 64.7 13.48 56.11 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2187 ' ' GLY . . . . . 0.492 ' C ' ' CD1' ' A' 2188 ' ' PHE . . . 167.24 -118.85 0.81 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2188 ' ' PHE . . . . . 0.645 ' CE2' ' CB ' ' A' 2175 ' ' PRO . 1.5 p90 -171.84 -179.19 2.38 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.367 -1.078 . . . . 0.0 109.497 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2189 ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.5 OUTLIER -128.87 169.19 14.9 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.387 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 8.9 p -170.53 147.66 2.96 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.789 -1.194 . . . . 0.0 109.749 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2191 ' ' THR . . . . . . . . . . . . . 25.2 m -118.18 90.97 3.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.644 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2192 ' ' CYS . . . . . 0.614 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.8 OUTLIER -52.99 -179.88 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.031 -1.043 . . . . 0.0 108.783 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 2193 ' ' GLU . . . . . 0.499 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.6 tt0 -52.45 112.76 0.87 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2194 ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -31.34 125.73 0.21 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.439 0.637 . . . . 0.0 111.136 -178.601 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.53 11.18 6.17 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2196 ' ' PHE . . . . . 0.686 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.8 p90 -118.33 -162.34 0.88 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.135 -1.215 . . . . 0.0 110.489 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2197 ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' 2196 ' ' PHE . 18.4 mt-10 -142.28 92.54 7.45 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 121.434 -0.792 . . . . 0.0 110.058 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2198 ' ' PRO . . . . . 0.686 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.0 Cg_endo -67.05 -160.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.303 2.002 . . . . 0.0 111.273 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -140.21 -175.74 14.63 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2200 ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' 2189 ' ' GLU . 2.0 Cg_endo -62.14 -74.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 121.702 1.601 . . . . 0.0 110.61 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2201 ' ' MET . . . . . 0.446 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -143.44 46.47 1.5 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.213 -0.929 . . . . 0.0 109.458 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 2202 ' ' MET . . . . . 0.427 ' O ' ' HB ' ' A' 2203 ' ' THR . 0.1 OUTLIER -116.95 -65.59 1.17 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.303 -0.873 . . . . 0.0 109.779 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 2203 ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' 2202 ' ' MET . 13.3 t -179.9 -171.45 0.18 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A 2204 ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.0 OUTLIER -112.44 143.51 43.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.086 -1.009 . . . . 0.0 109.269 -179.552 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.495 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2125 ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' 2126 ' ' VAL . . . -125.36 29.48 6.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.895 . . . . 0.0 109.562 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2126 ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' 2125 ' ' ALA . 45.3 t 57.25 106.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.268 -0.895 . . . . 0.0 109.457 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2127 ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' 2128 ' ' MET . 2.8 p30 -83.66 -161.25 0.5 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.324 -0.86 . . . . 0.0 109.272 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2128 ' ' MET . . . . . 0.422 ' C ' ' O ' ' A' 2127 ' ' ASP . 0.0 OUTLIER -45.15 116.96 1.22 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.136 -0.978 . . . . 0.0 109.254 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 2129 ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' 2130 ' ' GLU . 4.5 t0 -65.62 -27.48 68.42 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.349 -0.844 . . . . 0.0 108.8 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2130 ' ' GLU . . . . . 0.614 ' HB2' ' O ' ' A' 2129 ' ' ASP . 1.8 mp0 75.81 -57.52 0.57 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 120.92 0.391 . . . . 0.0 111.45 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2131 ' ' CYS . . . . . 0.56 ' HB2' ' CB ' ' A' 2137 ' ' CYS . 0.5 OUTLIER -84.43 -19.31 33.67 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.765 -1.209 . . . . 0.0 109.974 -178.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 2132 ' ' LYS . . . . . 0.481 ' HB3' ' HB3' ' A' 2129 ' ' ASP . 4.4 tttt -68.4 -9.92 51.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.13 -0.981 . . . . 0.0 109.838 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2133 ' ' GLU . . . . . 0.533 ' HB2' ' CG2' ' A' 2136 ' ' VAL . 6.7 mt-10 -69.13 147.62 97.54 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.329 -0.857 . . . . 0.0 109.921 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2134 ' ' PRO . . . . . 0.479 ' O ' ' HD2' ' A' 2138 ' ' LYS . 3.8 Cg_endo -69.27 3.25 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.499 2.132 . . . . 0.0 111.17 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2135 ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' 2162 ' ' ASN . 0.6 OUTLIER -127.08 -6.08 6.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.638 -1.289 . . . . 0.0 110.3 -179.551 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 2136 ' ' VAL . . . . . 0.533 ' CG2' ' HB2' ' A' 2133 ' ' GLU . 2.4 t -102.31 -143.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.866 -1.146 . . . . 0.0 108.117 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2137 ' ' CYS . . . . . 0.56 ' CB ' ' HB2' ' A' 2131 ' ' CYS . 2.6 t -49.97 128.94 19.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.548 -1.345 . . . . 0.0 108.336 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2138 ' ' LYS . . . . . 0.516 ' O ' ' CB ' ' A' 2139 ' ' HIS . 2.9 mtpt -135.4 28.8 3.34 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.119 -0.988 . . . . 0.0 110.353 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2139 ' ' HIS . . . . . 0.516 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.1 OUTLIER 162.21 45.43 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.311 -0.868 . . . . 0.0 109.698 179.582 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -153.92 179.76 29.91 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -88.8 82.62 6.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -1.135 . . . . 0.0 109.171 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2142 ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' 2150 ' ' ARG . 21.4 p -78.67 147.63 33.46 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.366 -0.834 . . . . 0.0 110.032 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 5.0 mm -113.37 129.03 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2144 ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' 2129 ' ' ASP . 4.0 t-20 -84.16 103.47 13.4 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 110.545 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2145 ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' 2146 ' ' ASP . 4.1 p -94.45 -167.19 1.61 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2146 ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' 2145 ' ' THR . 0.4 OUTLIER -45.78 -93.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 109.342 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -108.12 -7.6 30.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2148 ' ' SER . . . . . 0.438 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.2 OUTLIER -100.24 -162.61 0.96 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -1.129 . . . . 0.0 109.471 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 2149 ' ' TYR . . . . . 0.594 ' CD2' ' HB3' ' A' 2130 ' ' GLU . 29.6 p90 -164.85 -171.12 2.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.193 -0.942 . . . . 0.0 109.577 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2150 ' ' ARG . . . . . 0.531 ' CG ' ' O ' ' A' 2149 ' ' TYR . 18.0 mtt180 -160.55 104.5 1.41 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.465 -0.772 . . . . 0.0 109.412 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2151 ' ' CYS . . . . . 0.462 ' SG ' HD12 ' A' 2159 ' ' LEU . 41.9 t -86.68 78.82 9.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.351 -0.843 . . . . 0.0 109.482 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.86 98.12 11.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.921 . . . . 0.0 109.209 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2153 ' ' CYS . . . . . 0.51 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -58.08 157.46 16.29 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.335 -0.853 . . . . 0.0 109.748 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 2154 ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' 2157 ' ' TYR . 1.2 Cg_endo -65.22 -166.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.703 2.269 . . . . 0.0 111.278 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 8.4 t80 -90.43 102.34 15.08 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.82 -15.4 5.42 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 107.742 -2.143 . . . . 0.0 107.742 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2157 ' ' TYR . . . . . 0.533 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 9.0 m-85 -109.3 -171.19 1.79 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.647 -0.913 . . . . 0.0 109.724 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2158 ' ' ILE . . . . . 0.588 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.1 OUTLIER -157.34 -161.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.641 -0.662 . . . . 0.0 109.597 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 2159 ' ' LEU . . . . . 0.462 HD12 ' SG ' ' A' 2151 ' ' CYS . 15.5 tp -134.35 120.72 20.23 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.326 -0.859 . . . . 0.0 109.67 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -97.1 57.47 1.47 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.2 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2161 ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 86.94 -14.0 57.96 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2162 ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' 2161 ' ' GLY . 1.6 m-20 165.44 -41.81 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.253 -1.145 . . . . 0.0 109.683 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -73.63 118.38 16.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.372 -0.83 . . . . 0.0 109.223 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2164 ' ' CYS . . . . . 0.491 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -85.24 138.78 32.12 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.26 -0.9 . . . . 0.0 109.642 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 2165 ' ' VAL . . . . . 0.488 ' CG1' ' O ' ' A' 2164 ' ' CYS . 1.6 m -164.63 -170.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 0.0 109.07 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2166 ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' 2184 ' ' VAL . 3.0 t70 -89.74 147.66 23.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.991 -1.068 . . . . 0.0 109.465 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2167 ' ' THR . . . . . 0.588 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 6.8 t -89.72 -173.72 4.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.363 -0.836 . . . . 0.0 109.111 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2168 ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' 2171 ' ' SER . 44.5 t0 -98.94 97.02 8.24 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.266 -0.896 . . . . 0.0 108.649 178.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2169 ' ' GLU . . . . . 0.542 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.6 OUTLIER -72.58 -31.18 65.03 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.185 -0.947 . . . . 0.0 109.443 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 2170 ' ' CYS . . . . . 0.498 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 3.3 t -70.59 -4.7 24.49 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.301 -0.874 . . . . 0.0 108.894 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2171 ' ' SER . . . . . 0.487 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.1 OUTLIER -65.62 -8.52 20.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.831 -1.168 . . . . 0.0 109.413 179.572 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 24.9 t -83.11 -71.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.156 -0.965 . . . . 0.0 109.571 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2173 ' ' GLY . . . . . 0.459 ' O ' ' SG ' ' A' 2181 ' ' CYS . . . -172.72 -70.21 0.05 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2174 ' ' ASN . . . . . 0.544 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 27.5 p-10 -171.47 95.58 0.41 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.221 -1.164 . . . . 0.0 109.021 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2175 ' ' PRO . . . . . 0.582 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.5 Cg_endo -63.98 -19.75 66.96 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.915 1.743 . . . . 0.0 110.253 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2176 ' ' CYS . . . . . 0.501 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -56.04 -58.69 6.86 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.052 -1.03 . . . . 0.0 108.239 179.697 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 148.1 -18.21 1.37 Allowed Glycine 0 N--CA 1.483 1.826 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2178 ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.2 OUTLIER -169.48 -32.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -1.131 . . . . 0.0 110.297 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 2179 ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -61.18 -115.6 0.01 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2180 ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' 2190 ' ' CYS . 1.1 p -151.3 152.51 33.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -1.07 . . . . 0.0 109.486 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2181 ' ' CYS . . . . . 0.566 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 20.7 p -87.83 164.29 15.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.974 -1.079 . . . . 0.0 110.896 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2182 ' ' LYS . . . . . 0.549 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.0 OUTLIER -145.16 158.97 43.68 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.467 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 2183 ' ' ASN . . . . . 0.467 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 57.2 t30 -99.72 129.9 45.88 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.446 -1.408 . . . . 0.0 109.735 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2184 ' ' VAL . . . . . 0.463 ' CG1' ' N ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -140.08 -170.3 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 2185 ' ' ILE . . . . . 0.533 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 4.6 mp -101.6 136.78 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.96 -1.087 . . . . 0.0 110.448 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 76.33 -2.23 57.97 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2187 ' ' GLY . . . . . 0.533 ' C ' ' CD1' ' A' 2188 ' ' PHE . . . 178.27 -113.67 0.42 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2188 ' ' PHE . . . . . 0.582 ' CD2' ' HG2' ' A' 2175 ' ' PRO . 3.0 p90 -176.19 176.42 1.71 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.384 -1.068 . . . . 0.0 108.876 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2189 ' ' GLU . . . . . 0.549 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 8.1 tt0 -124.26 133.67 53.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.125 -0.984 . . . . 0.0 108.685 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2190 ' ' CYS . . . . . 0.448 ' HA ' ' O ' ' A' 2180 ' ' THR . 20.7 p -128.16 136.99 51.88 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.906 -1.121 . . . . 0.0 109.869 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2191 ' ' THR . . . . . 0.472 ' O ' ' HA3' ' A' 2179 ' ' GLY . 17.9 m -109.86 87.95 2.63 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.38 -0.825 . . . . 0.0 109.243 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2192 ' ' CYS . . . . . 0.602 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 1.2 m -48.91 -179.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.414 -0.804 . . . . 0.0 109.167 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2193 ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' 2194 ' ' GLU . 20.5 tt0 -56.26 122.35 11.6 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2194 ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -36.7 130.17 0.76 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.616 -0.678 . . . . 0.0 110.585 -178.886 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.31 0.02 10.44 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2196 ' ' PHE . . . . . 0.683 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.2 p90 -112.1 -162.47 0.8 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.277 -1.131 . . . . 0.0 110.015 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2197 ' ' GLU . . . . . 0.551 ' N ' ' CG ' ' A' 2196 ' ' PHE . 9.3 mt-10 -145.96 94.33 5.01 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.429 -0.795 . . . . 0.0 109.872 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2198 ' ' PRO . . . . . 0.683 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 7.9 Cg_endo -67.65 -158.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.444 2.096 . . . . 0.0 111.355 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -146.44 -167.4 12.78 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.13 -79.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.874 1.716 . . . . 0.0 110.634 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 2201 ' ' MET . . . . . 0.493 ' HA ' ' O ' ' A' 2188 ' ' PHE . 5.0 ptp -136.93 62.31 1.6 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.823 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -127.69 -86.1 0.58 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.236 -0.915 . . . . 0.0 109.933 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2203 ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' 2175 ' ' PRO . 15.1 t -175.7 -170.42 0.4 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.387 -0.821 . . . . 0.0 108.961 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2204 ' ' CYS . . . . . 0.54 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.7 OUTLIER -61.66 135.98 57.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.011 -1.055 . . . . 0.0 108.972 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A 2205 ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' 2197 ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.579 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -160.64 -86.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.933 . . . . 0.0 109.409 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 1.1 t -77.63 155.65 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.391 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2127 ' ' ASP . . . . . . . . . . . . . 39.8 t0 -87.84 54.55 3.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 109.516 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2128 ' ' MET . . . . . 0.422 ' O ' ' HG3' ' A' 2130 ' ' GLU . 2.9 mtt -53.54 147.21 11.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.559 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2129 ' ' ASP . . . . . 0.524 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 19.3 t0 -61.64 -44.41 97.02 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2130 ' ' GLU . . . . . 0.633 ' CB ' ' CD1' ' A' 2149 ' ' TYR . 1.3 mt-10 80.3 -43.96 0.25 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.925 -0.484 . . . . 0.0 111.066 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2131 ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' 2132 ' ' LYS . 10.4 p -91.0 -42.19 10.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.66 -1.275 . . . . 0.0 110.111 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2132 ' ' LYS . . . . . 0.507 ' N ' ' SG ' ' A' 2131 ' ' CYS . 0.0 OUTLIER -67.27 -2.4 5.91 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.993 -1.067 . . . . 0.0 110.52 -179.571 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -68.75 153.56 95.76 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 120.963 -1.086 . . . . 0.0 109.459 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2134 ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -65.52 -3.81 8.43 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.533 2.155 . . . . 0.0 111.101 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -119.26 3.13 11.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.861 -1.15 . . . . 0.0 110.346 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2136 ' ' VAL . . . . . 0.603 HG13 ' CE2' ' A' 2149 ' ' TYR . 19.1 t -121.82 -119.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.827 -1.171 . . . . 0.0 109.785 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2137 ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' 2131 ' ' CYS . 0.1 OUTLIER -50.78 -56.19 13.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.624 -1.298 . . . . 0.0 109.488 -179.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 2138 ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' 2137 ' ' CYS . 3.8 mttt 72.64 -81.91 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.4 -0.813 . . . . 0.0 109.866 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2139 ' ' HIS . . . . . 0.493 ' O ' ' HB3' ' A' 2164 ' ' CYS . 21.2 m80 -115.27 58.87 0.71 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.052 -1.03 . . . . 0.0 110.186 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -141.7 -166.74 10.97 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.04 93.75 3.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -1.153 . . . . 0.0 109.037 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2142 ' ' CYS . . . . . 0.495 ' SG ' ' N ' ' A' 2143 ' ' ILE . 12.8 p -91.52 -152.25 0.29 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.235 -0.916 . . . . 0.0 110.491 -179.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2143 ' ' ILE . . . . . 0.495 ' N ' ' SG ' ' A' 2142 ' ' CYS . 2.9 mp -148.46 90.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2144 ' ' ASN . . . . . 0.524 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 30.2 t-20 -39.33 108.5 0.09 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.404 0.621 . . . . 0.0 110.826 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2145 ' ' THR . . . . . 0.416 ' OG1' ' C ' ' A' 2148 ' ' SER . 0.1 OUTLIER -98.67 170.35 8.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.401 -0.812 . . . . 0.0 108.994 179.302 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.92 -84.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.797 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -107.08 50.83 0.77 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2148 ' ' SER . . . . . 0.466 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER -178.06 -162.68 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -1.153 . . . . 0.0 109.714 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 2149 ' ' TYR . . . . . 0.633 ' CD1' ' CB ' ' A' 2130 ' ' GLU . 42.0 p90 -169.77 -169.49 0.9 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.454 -0.779 . . . . 0.0 109.737 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2150 ' ' ARG . . . . . 0.454 ' O ' ' SG ' ' A' 2151 ' ' CYS . 0.4 OUTLIER -144.18 -160.78 1.17 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 2151 ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' 2150 ' ' ARG . 1.2 m -169.77 69.9 0.06 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.072 -1.017 . . . . 0.0 109.66 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -89.89 137.71 32.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.408 -0.807 . . . . 0.0 109.151 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2153 ' ' CYS . . . . . 0.465 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -112.07 158.54 36.61 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.192 -0.943 . . . . 0.0 109.501 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 2154 ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' 2157 ' ' TYR . 2.7 Cg_endo -61.61 -176.03 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.68 2.253 . . . . 0.0 111.817 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 12.7 t80 -82.29 103.15 11.67 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.54 -19.03 5.11 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 107.119 -2.393 . . . . 0.0 107.119 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2157 ' ' TYR . . . . . 0.506 ' O ' ' CG2' ' A' 2158 ' ' ILE . 18.2 m-85 -108.2 176.42 5.13 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.824 -0.81 . . . . 0.0 109.601 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2158 ' ' ILE . . . . . 0.612 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.1 OUTLIER -158.08 -163.74 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.658 -0.651 . . . . 0.0 109.403 -179.764 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 2159 ' ' LEU . . . . . 0.401 HD23 ' HB3' ' A' 2151 ' ' CYS . 19.4 tp -131.34 122.78 26.97 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.435 -0.79 . . . . 0.0 109.481 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -93.47 43.01 1.11 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.299 -0.875 . . . . 0.0 109.129 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2161 ' ' GLY . . . . . 0.451 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 97.42 -8.94 64.63 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2162 ' ' ASN . . . . . 0.521 ' ND2' ' HA ' ' A' 2136 ' ' VAL . 1.3 m-20 167.93 -43.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -1.167 . . . . 0.0 109.635 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -79.42 118.83 21.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 109.376 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2164 ' ' CYS . . . . . 0.528 ' O ' ' CG1' ' A' 2165 ' ' VAL . 0.1 OUTLIER -88.53 137.77 32.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.418 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 2165 ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' 2164 ' ' CYS . 1.8 m -166.43 -166.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.374 -0.829 . . . . 0.0 108.92 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2166 ' ' ASP . . . . . 0.411 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 0.7 OUTLIER -83.82 139.18 32.84 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.733 -1.23 . . . . 0.0 109.453 179.83 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 2167 ' ' THR . . . . . 0.612 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 9.9 t -97.44 178.31 5.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.354 -0.841 . . . . 0.0 109.362 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2168 ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' 2171 ' ' SER . 51.3 t0 -88.55 96.04 10.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.164 -0.96 . . . . 0.0 109.024 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2169 ' ' GLU . . . . . 0.553 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.4 OUTLIER -66.67 -34.14 77.21 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.296 -0.877 . . . . 0.0 109.228 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 2170 ' ' CYS . . . . . 0.459 ' O ' ' SG ' ' A' 2170 ' ' CYS . 1.7 t -68.67 -9.08 48.0 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.327 -0.858 . . . . 0.0 108.753 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2171 ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -78.32 5.84 9.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.372 -0.83 . . . . 0.0 110.574 -179.176 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 5.6 t -112.3 -76.93 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.903 -1.123 . . . . 0.0 109.87 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2173 ' ' GLY . . . . . 0.485 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -150.7 137.53 6.15 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2174 ' ' ASN . . . . . 0.603 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 23.2 p-10 -47.03 104.51 0.41 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.312 -1.111 . . . . 0.0 109.969 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2175 ' ' PRO . . . . . 0.556 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 1.7 Cg_endo -70.42 -23.55 27.66 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.879 1.719 . . . . 0.0 109.763 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2176 ' ' CYS . . . . . 0.543 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -47.33 -30.97 3.52 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.395 -0.815 . . . . 0.0 109.492 -179.585 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 114.49 -23.47 12.21 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.3 -34.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.606 -0.937 . . . . 0.0 109.791 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2179 ' ' GLY . . . . . 0.578 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -62.47 -127.81 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.3 p -134.64 156.76 48.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.601 -0.941 . . . . 0.0 109.549 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2181 ' ' CYS . . . . . 0.603 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 14.6 p -94.12 163.06 13.62 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.199 1.0 . . . . 0.0 111.258 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2182 ' ' LYS . . . . . 0.555 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 5.9 tttp -143.06 156.9 44.92 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 60.9 t30 -99.31 133.09 44.12 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.3 -1.5 . . . . 0.0 109.967 -179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2184 ' ' VAL . . . . . 0.497 HG13 ' CA ' ' A' 2188 ' ' PHE . 0.4 OUTLIER -140.37 -176.77 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.635 -0.666 . . . . 0.0 109.227 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 2185 ' ' ILE . . . . . 0.411 ' HA ' ' OD2' ' A' 2166 ' ' ASP . 1.9 mp -95.8 143.51 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.117 -0.989 . . . . 0.0 110.131 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 65.07 12.33 54.59 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2187 ' ' GLY . . . . . 0.472 ' O ' ' OE2' ' A' 2169 ' ' GLU . . . 165.12 -129.25 1.92 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2188 ' ' PHE . . . . . 0.553 ' HB3' ' HB2' ' A' 2169 ' ' GLU . 1.4 p90 -164.11 -179.32 6.1 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.3 -1.118 . . . . 0.0 108.81 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2189 ' ' GLU . . . . . 0.555 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.2 OUTLIER -125.48 174.2 8.38 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.39 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 1.8 p -171.61 147.71 2.36 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.769 -1.207 . . . . 0.0 109.81 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2191 ' ' THR . . . . . 0.474 ' O ' ' O ' ' A' 2192 ' ' CYS . 13.6 m -123.06 89.9 3.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.0 109.898 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2192 ' ' CYS . . . . . 0.592 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.8 OUTLIER -48.91 -179.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.341 -0.85 . . . . 0.0 109.32 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 2193 ' ' GLU . . . . . 0.462 ' O ' ' C ' ' A' 2194 ' ' GLU . 3.3 tt0 -61.12 125.43 23.7 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2194 ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -34.86 129.76 0.43 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.344 0.592 . . . . 0.0 110.842 -179.244 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.21 5.39 8.77 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2196 ' ' PHE . . . . . 0.672 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.9 OUTLIER -121.5 -163.5 1.05 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.289 -1.124 . . . . 0.0 110.195 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 2197 ' ' GLU . . . . . 0.584 ' N ' ' CG ' ' A' 2196 ' ' PHE . 24.4 mt-10 -148.15 98.07 3.8 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.619 -0.675 . . . . 0.0 109.428 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2198 ' ' PRO . . . . . 0.672 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.8 Cg_endo -69.01 -166.31 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.339 2.026 . . . . 0.0 111.597 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -135.84 -170.35 12.04 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.17 -83.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.21 1.94 . . . . 0.0 110.994 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2201 ' ' MET . . . . . 0.492 ' HA ' ' O ' ' A' 2188 ' ' PHE . 8.4 mtt -132.77 52.22 2.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.991 -1.068 . . . . 0.0 109.975 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2202 ' ' MET . . . . . 0.441 ' O ' ' HB ' ' A' 2203 ' ' THR . 1.0 OUTLIER -122.98 -71.23 0.73 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.21 -0.931 . . . . 0.0 109.791 -179.775 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 2203 ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' 2202 ' ' MET . 11.7 t 179.33 -167.82 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.458 -0.776 . . . . 0.0 109.048 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A 2204 ' ' CYS . . . . . 0.543 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -111.52 150.17 30.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.095 -1.003 . . . . 0.0 109.215 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 117.896 -1.049 . . . . 0.0 109.572 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -176.08 50.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 109.401 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.43 159.88 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.38 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2127 ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' 2128 ' ' MET . 9.6 t70 -85.51 97.51 10.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.281 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2128 ' ' MET . . . . . 0.467 ' O ' ' HG3' ' A' 2130 ' ' GLU . 0.3 OUTLIER -41.37 120.07 1.34 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.458 -0.776 . . . . 0.0 109.587 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2129 ' ' ASP . . . . . 0.555 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 1.3 p30 -65.78 -39.08 90.62 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2130 ' ' GLU . . . . . 0.636 ' CB ' ' CD2' ' A' 2149 ' ' TYR . 1.4 mt-10 80.44 -42.86 0.22 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 122.015 -0.428 . . . . 0.0 111.292 177.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2131 ' ' CYS . . . . . 0.507 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 17.5 p -90.82 27.16 1.86 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.922 -1.111 . . . . 0.0 110.204 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2132 ' ' LYS . . . . . 0.525 ' N ' ' OD1' ' A' 2129 ' ' ASP . 0.6 OUTLIER -131.94 -6.25 3.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.91 . . . . 0.0 109.728 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2133 ' ' GLU . . . . . 0.454 ' HB3' ' HD2' ' A' 2134 ' ' PRO . 5.8 mt-10 -70.03 158.74 86.62 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.141 -0.974 . . . . 0.0 109.323 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2134 ' ' PRO . . . . . 0.491 ' O ' ' HD2' ' A' 2138 ' ' LYS . 2.8 Cg_endo -67.27 -1.53 6.54 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.379 2.053 . . . . 0.0 110.804 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.07 4.65 9.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.8 -1.188 . . . . 0.0 110.088 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2136 ' ' VAL . . . . . 0.507 ' CG1' ' HA ' ' A' 2131 ' ' CYS . 55.0 t -107.46 -107.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.869 -1.145 . . . . 0.0 110.116 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2137 ' ' CYS . . . . . 0.491 ' O ' ' HB2' ' A' 2138 ' ' LYS . 1.3 m -56.21 -77.39 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.796 -1.19 . . . . 0.0 109.599 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2138 ' ' LYS . . . . . 0.58 ' O ' ' CG ' ' A' 2139 ' ' HIS . 0.1 OUTLIER 68.7 3.05 3.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.584 -0.698 . . . . 0.0 111.12 179.188 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2139 ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' 2138 ' ' LYS . 0.8 OUTLIER 168.64 40.43 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.701 -1.249 . . . . 0.0 110.835 178.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -158.21 160.65 31.03 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.116 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -89.51 124.22 34.32 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2142 ' ' CYS . . . . . 0.483 ' HA ' ' O ' ' A' 2150 ' ' ARG . 22.8 p -111.86 -166.85 1.11 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.131 -0.98 . . . . 0.0 111.237 -178.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2143 ' ' ILE . . . . . 0.477 ' CD1' ' C ' ' A' 2142 ' ' CYS . 4.2 mp -150.24 98.1 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2144 ' ' ASN . . . . . 0.555 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 26.6 t-20 -46.86 114.54 0.86 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.452 -0.78 . . . . 0.0 111.254 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2145 ' ' THR . . . . . 0.475 ' OG1' ' HA ' ' A' 2149 ' ' TYR . 0.1 OUTLIER -108.54 175.55 5.43 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.236 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.25 105.64 9.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.349 -0.844 . . . . 0.0 110.055 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 73.01 8.77 74.69 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2148 ' ' SER . . . . . 0.488 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.5 OUTLIER -152.68 -173.6 4.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.977 -1.308 . . . . 0.0 109.951 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2149 ' ' TYR . . . . . 0.636 ' CD2' ' CB ' ' A' 2130 ' ' GLU . 50.7 p90 -165.66 -168.4 1.31 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.522 -0.736 . . . . 0.0 109.168 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2150 ' ' ARG . . . . . 0.483 ' O ' ' HA ' ' A' 2142 ' ' CYS . 0.4 OUTLIER -168.93 124.98 0.92 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.324 -0.86 . . . . 0.0 108.914 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 2.1 t -105.49 107.2 18.07 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.149 -0.969 . . . . 0.0 110.278 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.77 134.15 42.08 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2153 ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -97.54 161.07 27.15 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.071 -1.018 . . . . 0.0 109.955 -179.149 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2154 ' ' PRO . . . . . 0.473 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.8 Cg_endo -61.43 -169.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 122.812 2.342 . . . . 0.0 111.812 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 3.4 t80 -86.12 99.86 11.79 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.09 -13.17 5.77 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2157 ' ' TYR . . . . . 0.536 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 5.1 m-85 -107.16 -173.5 2.31 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.503 -0.998 . . . . 0.0 110.205 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2158 ' ' ILE . . . . . 0.557 ' N ' ' CD1' ' A' 2158 ' ' ILE . 0.1 OUTLIER -159.36 -166.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2159 ' ' LEU . . . . . . . . . . . . . 31.4 tp -133.67 119.64 19.62 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.333 -0.854 . . . . 0.0 109.236 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -89.89 55.83 3.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 109.664 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2161 ' ' GLY . . . . . 0.505 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 80.08 -2.31 76.23 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2162 ' ' ASN . . . . . 0.505 ' CB ' ' O ' ' A' 2161 ' ' GLY . 0.3 OUTLIER 166.51 -58.48 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.1 -1.236 . . . . 0.0 109.69 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -69.66 115.5 8.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.873 . . . . 0.0 109.49 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2164 ' ' CYS . . . . . 0.523 ' O ' ' CG1' ' A' 2165 ' ' VAL . 0.1 OUTLIER -86.2 140.32 30.26 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.307 -0.871 . . . . 0.0 109.273 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2165 ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' 2164 ' ' CYS . 1.0 OUTLIER -166.35 -166.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.483 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2166 ' ' ASP . . . . . 0.49 ' OD1' ' CE1' ' A' 2157 ' ' TYR . 0.7 OUTLIER -89.93 142.04 28.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.949 -1.095 . . . . 0.0 109.606 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2167 ' ' THR . . . . . 0.548 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 12.8 t -81.67 175.75 10.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 0.0 108.972 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2168 ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' 2168 ' ' ASP . 56.6 t0 -95.38 94.59 7.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.102 -0.999 . . . . 0.0 109.248 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2169 ' ' GLU . . . . . 0.571 ' CB ' ' CD1' ' A' 2188 ' ' PHE . 0.8 OUTLIER -69.28 -33.82 73.79 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.407 -0.808 . . . . 0.0 109.363 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2170 ' ' CYS . . . . . 0.502 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 2.3 t -69.62 -6.01 28.46 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.373 -0.83 . . . . 0.0 109.044 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2171 ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -79.59 7.59 8.03 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.992 -1.067 . . . . 0.0 109.941 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 24.1 t -112.87 -79.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.031 -1.043 . . . . 0.0 110.008 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2173 ' ' GLY . . . . . 0.489 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -152.45 139.74 7.22 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2174 ' ' ASN . . . . . 0.571 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 29.9 p-10 -45.9 104.19 0.39 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.51 -0.994 . . . . 0.0 110.249 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2175 ' ' PRO . . . . . 0.549 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 3.1 Cg_endo -67.29 -18.37 50.23 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.977 1.785 . . . . 0.0 110.324 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2176 ' ' CYS . . . . . 0.54 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -61.1 -10.52 6.36 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.111 -0.993 . . . . 0.0 110.185 -179.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 96.35 -31.47 7.4 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.272 -1.442 . . . . 0.0 109.58 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2178 ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.1 OUTLIER -158.26 -37.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -1.098 . . . . 0.0 109.962 -179.647 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2179 ' ' GLY . . . . . 0.579 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -57.41 -113.25 0.01 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.4 p -154.23 168.71 25.65 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.411 -1.052 . . . . 0.0 109.305 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2181 ' ' CYS . . . . . 0.571 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 24.6 p -101.66 163.5 12.23 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.066 0.936 . . . . 0.0 111.414 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2182 ' ' LYS . . . . . 0.534 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.2 OUTLIER -144.68 158.34 43.82 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 178.542 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 58.2 t30 -100.35 128.67 46.36 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.555 -1.341 . . . . 0.0 108.957 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2184 ' ' VAL . . . . . 0.521 HG11 ' N ' ' A' 2188 ' ' PHE . 0.9 OUTLIER -137.24 -166.53 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.632 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2185 ' ' ILE . . . . . 0.536 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 4.7 mp -101.08 140.53 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 110.176 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 71.02 4.16 54.47 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2187 ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 167.23 -116.13 0.66 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2188 ' ' PHE . . . . . 0.571 ' CD1' ' CB ' ' A' 2169 ' ' GLU . 2.4 p90 -166.85 -177.76 3.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.052 -1.263 . . . . 0.0 110.083 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2189 ' ' GLU . . . . . 0.534 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 7.5 tt0 -129.84 139.45 51.2 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2190 ' ' CYS . . . . . 0.448 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 13.7 p -128.48 144.06 51.08 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.606 -1.309 . . . . 0.0 110.179 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2191 ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' 2192 ' ' CYS . 73.3 m -111.17 84.23 1.9 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.86 . . . . 0.0 109.701 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2192 ' ' CYS . . . . . 0.598 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.8 OUTLIER -49.93 179.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 109.047 179.763 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2193 ' ' GLU . . . . . 0.493 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.3 OUTLIER -54.83 115.76 2.36 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.788 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2194 ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.3 OUTLIER -30.17 126.8 0.14 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.375 0.607 . . . . 0.0 111.072 -179.033 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.37 5.58 8.55 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2196 ' ' PHE . . . . . 0.671 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.8 OUTLIER -117.51 -164.17 0.98 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.212 -1.169 . . . . 0.0 110.283 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A 2197 ' ' GLU . . . . . 0.557 ' N ' ' CG ' ' A' 2196 ' ' PHE . 2.1 mm-40 -145.48 98.21 4.61 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2198 ' ' PRO . . . . . 0.671 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.1 Cg_endo -68.08 -160.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.066 1.844 . . . . 0.0 110.726 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -135.52 -170.33 12.07 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.63 -74.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 121.96 1.773 . . . . 0.0 110.711 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2201 ' ' MET . . . . . 0.482 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 4.5 ptt? -146.22 60.51 1.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.15 -0.969 . . . . 0.0 110.118 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2202 ' ' MET . . . . . 0.443 ' O ' ' HB ' ' A' 2203 ' ' THR . 1.9 mmt -129.55 -68.97 0.7 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.102 -0.999 . . . . 0.0 109.75 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2203 ' ' THR . . . . . 0.443 ' HB ' ' O ' ' A' 2202 ' ' MET . 10.7 t 179.02 -168.74 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.414 -0.804 . . . . 0.0 109.138 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2204 ' ' CYS . . . . . 0.564 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.4 t -74.25 143.79 44.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.002 -1.061 . . . . 0.0 109.685 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.352 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 2124 ' ' SER . . . . . 0.452 ' O ' ' CB ' ' A' 2125 ' ' ALA . 18.6 m . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.298 0.57 . . . . 0.0 109.559 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2125 ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' 2124 ' ' SER . . . 71.11 89.35 0.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.394 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 49.7 t -97.42 84.87 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.527 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2127 ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' 2128 ' ' MET . 0.9 OUTLIER -95.67 88.62 5.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.276 -0.89 . . . . 0.0 109.75 -179.864 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 2128 ' ' MET . . . . . 0.43 ' O ' ' O ' ' A' 2127 ' ' ASP . 0.1 OUTLIER 62.34 130.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.635 179.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 2129 ' ' ASP . . . . . 0.639 ' O ' ' HB2' ' A' 2130 ' ' GLU . 0.7 OUTLIER -68.16 -20.15 64.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 109.444 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 2130 ' ' GLU . . . . . 0.639 ' HB2' ' O ' ' A' 2129 ' ' ASP . 1.9 mt-10 76.57 -69.48 0.16 Allowed 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.032 0.444 . . . . 0.0 110.457 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2131 ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' 2131 ' ' CYS . 47.5 t -78.69 8.22 5.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.998 -1.064 . . . . 0.0 110.199 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2132 ' ' LYS . . . . . 0.471 ' HB3' ' HB3' ' A' 2129 ' ' ASP . 0.0 OUTLIER -109.89 40.37 1.93 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.952 -1.093 . . . . 0.0 110.096 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 2133 ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' 2130 ' ' GLU . 2.0 mt-10 -129.69 140.62 39.17 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.09 -1.006 . . . . 0.0 109.509 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2134 ' ' PRO . . . . . 0.521 ' O ' ' CD ' ' A' 2138 ' ' LYS . 3.3 Cg_endo -68.83 -3.96 12.39 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.065 1.843 . . . . 0.0 109.964 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2135 ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' 2162 ' ' ASN . 5.7 p-10 -107.23 0.12 23.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.11 -0.993 . . . . 0.0 110.03 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2136 ' ' VAL . . . . . 0.5 ' HA ' ' ND2' ' A' 2162 ' ' ASN . 11.1 t -97.63 -121.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.062 -1.024 . . . . 0.0 108.641 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2137 ' ' CYS . . . . . 0.499 ' N ' ' SG ' ' A' 2151 ' ' CYS . 8.7 m -56.61 -68.6 0.2 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.579 -1.326 . . . . 0.0 109.297 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2138 ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' 2134 ' ' PRO . 1.9 mtmt 70.32 21.13 5.88 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.04 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2139 ' ' HIS . . . . . 0.478 ' CB ' ' O ' ' A' 2164 ' ' CYS . 0.0 OUTLIER 169.8 -42.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.485 -0.759 . . . . 0.0 109.323 179.591 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -86.31 175.06 47.62 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -93.52 123.54 36.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.148 -1.207 . . . . 0.0 109.539 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2142 ' ' CYS . . . . . 0.46 ' SG ' ' SG ' ' A' 2137 ' ' CYS . 0.1 OUTLIER -112.72 178.82 4.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.558 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 2143 ' ' ILE . . . . . 0.441 HD11 ' N ' ' A' 2143 ' ' ILE . 4.6 mp -142.51 129.27 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2144 ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' 2129 ' ' ASP . 0.7 OUTLIER -71.88 118.23 14.46 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.097 -1.002 . . . . 0.0 110.037 -179.142 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 2145 ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' 2148 ' ' SER . 40.4 p -117.69 -161.04 0.8 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.225 -0.922 . . . . 0.0 108.682 178.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.23 102.86 12.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.082 -1.011 . . . . 0.0 110.279 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 59.31 27.84 63.62 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2148 ' ' SER . . . . . 0.48 ' O ' ' HG2' ' A' 2130 ' ' GLU . 0.4 OUTLIER -166.45 179.14 5.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.059 -1.259 . . . . 0.0 109.773 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 2149 ' ' TYR . . . . . 0.515 ' HB3' ' HB3' ' A' 2130 ' ' GLU . 0.6 OUTLIER -139.85 -169.8 2.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.321 -0.862 . . . . 0.0 109.577 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 2150 ' ' ARG . . . . . 0.506 ' O ' ' C ' ' A' 2151 ' ' CYS . 9.1 mmt180 -139.07 27.74 2.35 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.3 -0.875 . . . . 0.0 109.34 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2151 ' ' CYS . . . . . 0.506 ' C ' ' O ' ' A' 2150 ' ' ARG . 0.8 OUTLIER -28.99 109.42 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.875 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -130.34 125.92 35.85 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2153 ' ' CYS . . . . . 0.5 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -84.14 155.93 63.59 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 121.167 -0.958 . . . . 0.0 110.339 -178.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 2154 ' ' PRO . . . . . 0.457 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.2 Cg_endo -63.44 -168.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.801 2.334 . . . . 0.0 111.794 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -88.01 102.31 14.63 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.54 -15.85 5.45 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 107.75 -2.14 . . . . 0.0 107.75 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2157 ' ' TYR . . . . . 0.5 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 6.5 m-85 -107.13 -174.81 2.62 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 121.655 -0.909 . . . . 0.0 109.828 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2158 ' ' ILE . . . . . 0.558 ' N ' ' CD1' ' A' 2158 ' ' ILE . 0.2 OUTLIER -146.03 -155.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.447 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 2159 ' ' LEU . . . . . 0.477 ' N ' HG12 ' A' 2158 ' ' ILE . 25.9 tp -148.84 127.0 12.07 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.376 -0.828 . . . . 0.0 109.281 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -102.27 62.05 0.86 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.376 -0.828 . . . . 0.0 109.293 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 86.96 -43.96 3.28 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2162 ' ' ASN . . . . . 0.5 ' ND2' ' HA ' ' A' 2136 ' ' VAL . 0.1 OUTLIER -158.33 -45.82 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.43 -1.041 . . . . 0.0 109.149 179.753 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 2163 ' ' GLU . . . . . 0.429 ' O ' HD13 ' A' 2159 ' ' LEU . 65.5 tt0 -62.64 159.85 15.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.344 -0.848 . . . . 0.0 109.229 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2164 ' ' CYS . . . . . 0.478 ' O ' ' CB ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -131.64 137.05 48.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.13 -0.981 . . . . 0.0 109.638 -179.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 2165 ' ' VAL . . . . . 0.49 ' C ' ' CD2' ' A' 2157 ' ' TYR . 1.2 m -156.1 -170.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.87 . . . . 0.0 109.282 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2166 ' ' ASP . . . . . 0.458 ' OD2' ' O ' ' A' 2184 ' ' VAL . 39.2 t70 -85.8 166.13 16.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.938 -1.101 . . . . 0.0 109.627 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2167 ' ' THR . . . . . 0.537 ' CG2' ' OE1' ' A' 2169 ' ' GLU . 11.6 t -106.8 167.86 9.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 0.0 109.423 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2168 ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' 2171 ' ' SER . 56.4 t0 -92.99 98.75 11.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.115 -0.991 . . . . 0.0 109.348 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2169 ' ' GLU . . . . . 0.584 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.8 OUTLIER -73.64 -32.11 63.86 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.426 -0.796 . . . . 0.0 109.415 -179.782 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 2170 ' ' CYS . . . . . 0.499 ' HB2' ' N ' ' A' 2182 ' ' LYS . 1.2 t -67.58 -8.1 31.56 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.319 -0.863 . . . . 0.0 108.981 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2171 ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -69.95 -4.59 21.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.168 -0.957 . . . . 0.0 109.537 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 9.3 t -100.55 -74.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.197 -0.939 . . . . 0.0 110.006 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2173 ' ' GLY . . . . . 0.508 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -168.82 141.48 6.78 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2174 ' ' ASN . . . . . 0.591 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 24.6 p-10 -36.61 97.31 0.13 Allowed Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.733 -0.863 . . . . 0.0 110.534 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2175 ' ' PRO . . . . . 0.581 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.8 Cg_endo -66.25 -20.31 55.82 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.982 1.788 . . . . 0.0 110.54 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2176 ' ' CYS . . . . . 0.52 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -51.54 -58.96 4.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.069 -1.019 . . . . 0.0 108.322 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 146.33 -20.82 1.72 Allowed Glycine 0 C--N 1.294 -1.781 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 4.1 t30 -160.53 -35.44 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -1.093 . . . . 0.0 110.127 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2179 ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -63.97 -119.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2180 ' ' THR . . . . . 0.464 ' HA ' ' HB3' ' A' 2174 ' ' ASN . 2.9 p -148.11 161.81 40.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.439 -1.036 . . . . 0.0 109.595 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2181 ' ' CYS . . . . . 0.591 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 27.0 p -93.64 160.8 14.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 110.906 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2182 ' ' LYS . . . . . 0.52 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 10.4 tttt -146.89 157.28 43.6 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2183 ' ' ASN . . . . . 0.466 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 59.0 t30 -93.4 129.09 39.67 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.453 -1.405 . . . . 0.0 110.13 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2184 ' ' VAL . . . . . 0.585 ' CG1' ' CA ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -132.81 -168.73 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 2185 ' ' ILE . . . . . 0.449 ' N ' ' CG1' ' A' 2184 ' ' VAL . 3.9 mp -105.56 140.53 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.956 -1.09 . . . . 0.0 110.282 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 64.48 14.36 57.17 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2187 ' ' GLY . . . . . 0.518 ' C ' ' CD1' ' A' 2188 ' ' PHE . . . 167.94 -117.98 0.76 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2188 ' ' PHE . . . . . 0.585 ' CA ' ' CG1' ' A' 2184 ' ' VAL . 2.0 p90 -172.92 177.1 2.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.173 -1.193 . . . . 0.0 109.609 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2189 ' ' GLU . . . . . 0.52 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.5 OUTLIER -123.28 139.57 53.9 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 2190 ' ' CYS . . . . . 0.444 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 22.9 p -135.73 137.33 41.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.765 -1.209 . . . . 0.0 109.721 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2191 ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' 2192 ' ' CYS . 25.3 m -108.79 83.45 1.76 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.412 -0.805 . . . . 0.0 109.478 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2192 ' ' CYS . . . . . 0.605 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -47.42 -179.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.934 0.873 . . . . 0.0 109.672 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 2193 ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' 2194 ' ' GLU . 11.3 tp10 -55.89 119.44 5.82 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2194 ' ' GLU . . . . . 0.494 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.5 OUTLIER -33.75 130.91 0.27 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.496 0.665 . . . . 0.0 110.675 -178.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.34 -0.67 10.48 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2196 ' ' PHE . . . . . 0.661 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.7 OUTLIER -114.37 -166.7 1.13 Allowed 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.264 -1.139 . . . . 0.0 110.109 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 2197 ' ' GLU . . . . . 0.554 ' N ' ' CG ' ' A' 2196 ' ' PHE . 1.7 mm-40 -145.31 98.02 4.68 Favored Pre-proline 0 C--N 1.299 -1.629 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2198 ' ' PRO . . . . . 0.661 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 7.9 Cg_endo -67.77 -161.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.118 1.879 . . . . 0.0 110.876 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -138.1 -170.4 11.86 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.75 -71.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.033 1.822 . . . . 0.0 110.547 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2201 ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.1 OUTLIER -139.18 53.53 1.74 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 110.192 -179.436 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 2.5 mmm -122.3 -93.68 0.51 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.048 -1.033 . . . . 0.0 109.995 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 2203 ' ' THR . . . . . 0.487 ' OG1' ' O ' ' A' 2175 ' ' PRO . 6.0 t -169.42 -163.3 0.39 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.23 -0.919 . . . . 0.0 109.176 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2204 ' ' CYS . . . . . 0.52 ' HB2' ' O ' ' A' 2176 ' ' CYS . 1.9 t -67.82 138.35 56.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.09 -1.006 . . . . 0.0 109.306 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2205 ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' 2205 ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.515 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.245 0.545 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -134.72 156.66 48.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.49 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2126 ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' 2127 ' ' ASP . 7.3 p -143.31 133.07 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.253 -0.905 . . . . 0.0 109.48 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2127 ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' 2126 ' ' VAL . 2.7 p30 -52.87 -173.68 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.374 -0.829 . . . . 0.0 109.587 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.54 117.2 3.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 0.0 109.855 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2129 ' ' ASP . . . . . 0.518 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 22.9 t0 -86.49 92.48 8.88 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.282 -0.886 . . . . 0.0 108.906 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2130 ' ' GLU . . . . . 0.456 ' O ' HG23 ' A' 2136 ' ' VAL . 30.5 mp0 -63.39 -21.6 66.38 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.407 -0.808 . . . . 0.0 110.398 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2131 ' ' CYS . . . . . 0.502 ' SG ' ' N ' ' A' 2132 ' ' LYS . 5.8 p -88.07 -40.86 13.47 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 120.758 -1.214 . . . . 0.0 109.699 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2132 ' ' LYS . . . . . 0.502 ' N ' ' SG ' ' A' 2131 ' ' CYS . 0.0 OUTLIER -85.51 43.58 1.04 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.206 -0.934 . . . . 0.0 108.921 179.323 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 2133 ' ' GLU . . . . . 0.507 ' CB ' HG22 ' A' 2136 ' ' VAL . 4.8 mt-10 -94.39 171.91 6.26 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.331 -0.855 . . . . 0.0 109.537 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2134 ' ' PRO . . . . . 0.5 ' HD2' ' CB ' ' A' 2133 ' ' GLU . 1.3 Cg_endo -63.81 -17.93 61.89 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.51 2.14 . . . . 0.0 112.029 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 4.0 t70 -144.72 32.28 1.16 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.568 -1.332 . . . . 0.0 111.283 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2136 ' ' VAL . . . . . 0.507 HG22 ' CB ' ' A' 2133 ' ' GLU . 46.9 t -112.75 -110.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.777 -1.202 . . . . 0.0 109.901 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2137 ' ' CYS . . . . . 0.48 ' SG ' ' HB2' ' A' 2131 ' ' CYS . 64.5 m -74.11 -65.07 0.89 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.766 -1.209 . . . . 0.0 109.486 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2138 ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' 2137 ' ' CYS . 21.6 mttt 62.53 124.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.806 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2139 ' ' HIS . . . . . 0.45 ' O ' ' HB3' ' A' 2164 ' ' CYS . 2.6 m170 44.26 48.58 7.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.83 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -140.11 168.8 24.97 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.46 56.0 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -1.197 . . . . 0.0 108.842 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2142 ' ' CYS . . . . . 0.461 ' HA ' ' O ' ' A' 2150 ' ' ARG . 26.3 p -65.82 174.76 2.22 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.349 -0.845 . . . . 0.0 110.56 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 3.3 mp -135.01 87.56 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2144 ' ' ASN . . . . . 0.518 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 8.4 t-20 -48.28 113.5 0.76 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.642 -0.661 . . . . 0.0 110.864 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2145 ' ' THR . . . . . . . . . . . . . 13.6 p -95.16 -174.65 3.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.405 -0.809 . . . . 0.0 109.021 179.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2146 ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' A' 2146 ' ' ASP . 2.9 p30 -91.13 41.41 1.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.181 -0.949 . . . . 0.0 109.531 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2147 ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' A' 2148 ' ' SER . . . 145.55 41.01 0.05 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2148 ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' 2147 ' ' GLY . 0.3 OUTLIER 168.34 -163.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -1.191 . . . . 0.0 109.362 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 2149 ' ' TYR . . . . . 0.473 ' HB2' ' HB3' ' A' 2131 ' ' CYS . 43.9 p90 -169.03 -173.25 1.74 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 110.132 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2150 ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' 2142 ' ' CYS . 0.0 OUTLIER -159.43 110.31 2.0 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 58.8 m -86.78 61.99 7.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 109.947 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2152 ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' 2153 ' ' CYS . 0.3 OUTLIER -87.27 80.61 8.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.114 -0.991 . . . . 0.0 108.837 179.396 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 2153 ' ' CYS . . . . . 0.491 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -43.16 153.12 0.36 Allowed Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.355 -0.841 . . . . 0.0 109.993 -179.352 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 2154 ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' 2157 ' ' TYR . 1.7 Cg_endo -65.91 -166.67 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.589 2.192 . . . . 0.0 111.258 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 8.1 t80 -90.39 104.41 16.99 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.69 -16.66 5.33 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 107.897 -2.081 . . . . 0.0 107.897 -178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2157 ' ' TYR . . . . . 0.506 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 7.6 m-85 -106.12 -166.79 1.23 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.551 -0.97 . . . . 0.0 109.783 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2158 ' ' ILE . . . . . 0.523 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.2 OUTLIER -155.27 -163.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.534 -0.729 . . . . 0.0 109.468 179.723 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 2159 ' ' LEU . . . . . 0.495 ' N ' HG12 ' A' 2158 ' ' ILE . 30.5 tp -146.86 117.27 7.43 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.408 -0.807 . . . . 0.0 109.685 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -94.95 57.48 2.1 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.577 -0.702 . . . . 0.0 109.461 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2161 ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 87.18 -14.98 56.21 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2162 ' ' ASN . . . . . 0.448 ' O ' ' O ' ' A' 2136 ' ' VAL . 0.0 OUTLIER 168.81 -46.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.405 -1.056 . . . . 0.0 109.092 179.71 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -63.77 126.02 26.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 108.685 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2164 ' ' CYS . . . . . 0.45 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -104.32 139.78 38.82 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.912 -1.117 . . . . 0.0 109.953 -179.608 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 2165 ' ' VAL . . . . . 0.463 ' C ' ' CD2' ' A' 2157 ' ' TYR . 3.7 m -158.56 -177.8 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 109.441 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2166 ' ' ASP . . . . . 0.457 ' OD2' ' O ' ' A' 2184 ' ' VAL . 29.1 t70 -74.85 167.27 22.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.642 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2167 ' ' THR . . . . . 0.533 ' CG2' ' OE1' ' A' 2169 ' ' GLU . 4.9 t -114.26 -177.71 3.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.4 -0.812 . . . . 0.0 109.109 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2168 ' ' ASP . . . . . 0.478 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 51.9 t0 -103.29 100.64 10.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.087 -1.008 . . . . 0.0 109.74 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2169 ' ' GLU . . . . . 0.566 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.7 OUTLIER -77.01 -32.63 57.29 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.385 -0.822 . . . . 0.0 109.143 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 2170 ' ' CYS . . . . . 0.501 ' HB2' ' N ' ' A' 2182 ' ' LYS . 1.7 t -67.23 -10.07 46.85 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2171 ' ' SER . . . . . 0.404 ' HB2' ' CG ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -74.94 -10.62 59.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.34 -0.85 . . . . 0.0 109.72 -179.754 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 21.9 t -86.35 -71.58 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.544 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2173 ' ' GLY . . . . . . . . . . . . . . . -149.29 -114.95 0.75 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2174 ' ' ASN . . . . . 0.474 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 16.1 t-20 -146.67 97.3 4.29 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.39 -1.065 . . . . 0.0 109.49 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2175 ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' 2181 ' ' CYS . 1.3 Cg_endo -68.38 -24.63 36.77 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.93 1.754 . . . . 0.0 110.58 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2176 ' ' CYS . . . . . 0.575 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.1 OUTLIER -48.6 -43.86 36.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.122 -0.986 . . . . 0.0 109.391 -179.352 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 120.45 -19.24 9.23 Favored Glycine 0 C--N 1.292 -1.861 0 N-CA-C 108.221 -1.952 . . . . 0.0 108.221 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -171.97 -32.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.462 -1.022 . . . . 0.0 110.259 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2179 ' ' GLY . . . . . 0.628 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -69.75 -128.06 0.05 OUTLIER Glycine 0 N--CA 1.491 2.335 0 O-C-N 120.932 -1.105 . . . . 0.0 110.358 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 2.0 p -132.58 153.85 50.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.549 -0.971 . . . . 0.0 109.631 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2181 ' ' CYS . . . . . 0.495 ' HB3' ' HD2' ' A' 2175 ' ' PRO . 25.0 p -92.48 161.85 14.46 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.125 0.964 . . . . 0.0 110.976 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2182 ' ' LYS . . . . . 0.522 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 44.0 tptt -144.2 166.77 24.1 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2183 ' ' ASN . . . . . 0.513 ' N ' ' HG3' ' A' 2182 ' ' LYS . 62.6 t30 -100.94 138.74 37.59 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.616 -1.302 . . . . 0.0 109.676 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2184 ' ' VAL . . . . . 0.583 ' CG1' ' CA ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -144.42 -168.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.484 -0.76 . . . . 0.0 109.246 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 2185 ' ' ILE . . . . . 0.506 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 2.7 mp -104.64 137.28 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.111 -0.993 . . . . 0.0 110.24 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 69.85 10.36 64.38 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2187 ' ' GLY . . . . . 0.551 ' C ' ' CD1' ' A' 2188 ' ' PHE . . . 168.99 -116.7 0.68 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2188 ' ' PHE . . . . . 0.583 ' CA ' ' CG1' ' A' 2184 ' ' VAL . 1.0 OUTLIER -171.87 -178.51 2.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.204 -1.174 . . . . 0.0 109.461 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 2189 ' ' GLU . . . . . 0.522 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 2.5 tt0 -128.33 174.13 9.57 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 2.6 p -171.08 149.7 2.93 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.621 -1.232 . . . . 0.0 110.41 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2191 ' ' THR . . . . . 0.415 ' O ' ' O ' ' A' 2192 ' ' CYS . 50.8 m -117.41 83.81 2.05 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.568 -0.708 . . . . 0.0 109.355 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2192 ' ' CYS . . . . . 0.628 ' HA ' ' HA3' ' A' 2179 ' ' GLY . 0.8 OUTLIER -50.54 178.27 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.09 -1.006 . . . . 0.0 109.189 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 2193 ' ' GLU . . . . . 0.486 ' O ' ' C ' ' A' 2194 ' ' GLU . 31.8 tt0 -53.97 116.38 2.53 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2194 ' ' GLU . . . . . 0.486 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -32.61 129.37 0.21 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.526 0.679 . . . . 0.0 110.917 -178.674 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.95 4.5 9.42 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2196 ' ' PHE . . . . . 0.681 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.9 OUTLIER -116.65 -164.51 0.98 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.197 -1.178 . . . . 0.0 110.169 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 2197 ' ' GLU . . . . . 0.556 ' N ' ' CG ' ' A' 2196 ' ' PHE . 14.0 mt-10 -145.81 96.95 4.63 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.596 -0.69 . . . . 0.0 109.373 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2198 ' ' PRO . . . . . 0.681 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.2 Cg_endo -68.68 -169.78 0.29 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.272 1.981 . . . . 0.0 111.084 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -124.89 178.06 16.65 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.93 -72.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 121.844 1.696 . . . . 0.0 110.306 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 2201 ' ' MET . . . . . 0.484 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.1 OUTLIER -132.78 33.27 3.74 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.14 -0.975 . . . . 0.0 109.791 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 2202 ' ' MET . . . . . 0.46 ' O ' ' CE2' ' A' 2188 ' ' PHE . 0.2 OUTLIER -105.6 -92.51 0.38 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.165 -0.959 . . . . 0.0 109.706 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 2203 ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' 2175 ' ' PRO . 6.0 t -159.68 -162.93 1.08 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.142 -0.974 . . . . 0.0 109.182 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A 2204 ' ' CYS . . . . . 0.583 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.0 OUTLIER -115.71 155.82 27.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.126 -0.984 . . . . 0.0 109.145 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.41 179.98 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 2124 ' ' SER . . . . . 0.457 ' O ' ' HB1' ' A' 2125 ' ' ALA . 8.4 t . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2125 ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' 2124 ' ' SER . . . 60.78 -90.71 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.423 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2126 ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' 2126 ' ' VAL . 58.1 t 51.0 76.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.331 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2127 ' ' ASP . . . . . . . . . . . . . 27.1 t70 -90.65 120.59 31.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 109.791 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -47.7 127.91 12.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.338 -0.851 . . . . 0.0 109.893 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2129 ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' 2130 ' ' GLU . 24.4 t0 -66.56 -44.15 83.08 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2130 ' ' GLU . . . . . 0.539 ' O ' ' CG2' ' A' 2136 ' ' VAL . 1.9 mt-10 82.73 -50.77 0.18 Allowed 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.133 0.492 . . . . 0.0 110.065 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2131 ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' 2137 ' ' CYS . 7.7 t -80.47 -41.91 23.53 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.025 -1.047 . . . . 0.0 109.461 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2132 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.28 -26.59 3.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.436 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2133 ' ' GLU . . . . . 0.503 ' HB2' HG22 ' A' 2136 ' ' VAL . 1.3 mt-10 -73.28 137.53 78.44 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.162 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2134 ' ' PRO . . . . . 0.543 ' CA ' ' HD3' ' A' 2138 ' ' LYS . 5.5 Cg_endo -69.96 -2.39 10.23 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.177 1.918 . . . . 0.0 110.821 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -99.19 -11.7 21.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.001 -1.062 . . . . 0.0 110.395 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2136 ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' 2130 ' ' GLU . 2.2 t -107.39 -136.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.061 -1.024 . . . . 0.0 109.005 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2137 ' ' CYS . . . . . 0.544 ' CB ' ' HB3' ' A' 2142 ' ' CYS . 8.7 m -50.35 104.83 0.08 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.964 -1.085 . . . . 0.0 108.638 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2138 ' ' LYS . . . . . 0.543 ' HD3' ' CA ' ' A' 2134 ' ' PRO . 3.6 mtmt -124.07 140.54 52.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.912 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2139 ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' 2164 ' ' CYS . 10.6 m80 56.3 39.16 30.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.986 -1.071 . . . . 0.0 109.548 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -165.07 176.16 40.85 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -90.28 143.81 26.42 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.071 -1.253 . . . . 0.0 108.525 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2142 ' ' CYS . . . . . 0.544 ' HB3' ' CB ' ' A' 2137 ' ' CYS . 0.6 OUTLIER -126.54 153.95 44.5 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.072 -1.017 . . . . 0.0 110.535 -178.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 2143 ' ' ILE . . . . . 0.455 ' O ' HG22 ' A' 2145 ' ' THR . 4.3 mp -116.5 89.76 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2144 ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' 2129 ' ' ASP . 9.4 t-20 -47.21 114.94 0.96 Allowed 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.455 0.645 . . . . 0.0 110.66 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2145 ' ' THR . . . . . 0.455 HG22 ' O ' ' A' 2143 ' ' ILE . 23.0 p -107.68 -171.67 1.92 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.472 -0.767 . . . . 0.0 108.933 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.4 97.45 10.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.411 -0.806 . . . . 0.0 109.46 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 72.54 33.5 60.93 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2148 ' ' SER . . . . . 0.426 ' HB3' ' OG1' ' A' 2145 ' ' THR . 0.4 OUTLIER -173.11 -160.73 0.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -1.117 . . . . 0.0 109.792 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 2149 ' ' TYR . . . . . 0.435 ' CZ ' HG12 ' A' 2136 ' ' VAL . 7.8 p90 -168.43 -170.33 1.23 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.542 -0.724 . . . . 0.0 109.429 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2150 ' ' ARG . . . . . 0.547 ' O ' ' C ' ' A' 2151 ' ' CYS . 0.0 OUTLIER -153.1 33.38 0.47 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 109.0 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 2151 ' ' CYS . . . . . 0.547 ' C ' ' O ' ' A' 2150 ' ' ARG . 35.9 m -12.83 89.94 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.231 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -97.57 169.84 9.44 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2153 ' ' CYS . . . . . 0.488 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -131.77 159.14 73.24 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 120.934 -1.104 . . . . 0.0 109.831 -179.499 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 2154 ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' 2157 ' ' TYR . 1.5 Cg_endo -62.65 -168.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 122.63 2.22 . . . . 0.0 111.568 -178.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 39.4 t80 -88.17 101.19 13.58 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 129.92 -13.61 5.78 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 107.927 -2.069 . . . . 0.0 107.927 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2157 ' ' TYR . . . . . 0.488 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 5.8 m-85 -108.62 -172.5 2.07 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.661 -0.905 . . . . 0.0 109.961 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2158 ' ' ILE . . . . . 0.575 ' CG2' ' HB ' ' A' 2167 ' ' THR . 0.2 OUTLIER -156.29 -158.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.453 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 2159 ' ' LEU . . . . . 0.502 ' HG ' ' N ' ' A' 2160 ' ' ALA . 13.7 tp -142.19 146.8 35.64 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 109.768 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2160 ' ' ALA . . . . . 0.502 ' N ' ' HG ' ' A' 2159 ' ' LEU . . . -122.02 48.53 1.71 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.237 -0.914 . . . . 0.0 109.443 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 95.55 -35.76 4.15 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2162 ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -168.44 -34.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.242 . . . . 0.0 109.911 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2163 ' ' GLU . . . . . 0.455 ' OE1' ' HE2' ' A' 2138 ' ' LYS . 1.2 tp10 -88.59 111.26 21.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 0.0 109.837 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2164 ' ' CYS . . . . . 0.547 ' O ' ' CG1' ' A' 2165 ' ' VAL . 0.1 OUTLIER -82.13 147.83 28.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.442 -0.786 . . . . 0.0 109.362 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 2165 ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' A' 2164 ' ' CYS . 0.3 OUTLIER -170.86 -168.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 2166 ' ' ASP . . . . . . . . . . . . . 1.6 t70 -90.4 143.63 26.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.901 -1.124 . . . . 0.0 109.179 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2167 ' ' THR . . . . . 0.575 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 9.7 t -95.05 171.65 8.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.402 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2168 ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' 2171 ' ' SER . 62.5 t0 -85.73 96.29 9.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.948 -1.095 . . . . 0.0 109.352 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2169 ' ' GLU . . . . . 0.523 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.5 OUTLIER -67.3 -33.93 76.32 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.414 -0.804 . . . . 0.0 109.598 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 2170 ' ' CYS . . . . . 0.479 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.6 t -69.24 -7.49 37.21 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.172 -0.955 . . . . 0.0 108.915 179.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2171 ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.2 OUTLIER -77.09 3.13 13.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.086 -1.009 . . . . 0.0 109.663 179.847 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 48.5 t -105.6 -70.55 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.101 -1.0 . . . . 0.0 109.826 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2173 ' ' GLY . . . . . 0.496 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -168.97 138.17 4.95 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2174 ' ' ASN . . . . . 0.57 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 18.6 p-10 -39.38 99.31 0.19 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.517 -0.99 . . . . 0.0 110.22 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2175 ' ' PRO . . . . . 0.588 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.5 Cg_endo -65.47 -25.17 55.92 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.046 1.831 . . . . 0.0 110.487 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2176 ' ' CYS . . . . . 0.551 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -47.13 -50.89 19.41 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.069 -1.019 . . . . 0.0 108.588 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 138.25 -22.29 3.07 Favored Glycine 0 C--N 1.292 -1.9 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2178 ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.0 OUTLIER -162.53 -35.97 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.447 -1.031 . . . . 0.0 109.993 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 2179 ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -61.59 -119.21 0.01 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.34 160.36 42.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.378 -1.072 . . . . 0.0 109.637 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2181 ' ' CYS . . . . . 0.57 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 22.5 p -92.08 163.95 13.77 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.198 0.999 . . . . 0.0 111.306 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2182 ' ' LYS . . . . . 0.557 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.0 OUTLIER -142.56 155.88 45.05 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 57.7 t30 -100.55 140.56 34.65 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.39 -1.444 . . . . 0.0 109.883 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2184 ' ' VAL . . . . . 0.429 HG11 ' C ' ' A' 2187 ' ' GLY . 0.8 OUTLIER -154.52 174.48 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A 2185 ' ' ILE . . . . . . . . . . . . . 4.3 mp -91.77 136.73 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.051 -1.031 . . . . 0.0 109.882 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 80.39 5.45 89.78 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2187 ' ' GLY . . . . . 0.429 ' C ' HG11 ' A' 2184 ' ' VAL . . . 163.06 -131.32 2.45 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2188 ' ' PHE . . . . . 0.588 ' CD2' ' HG2' ' A' 2175 ' ' PRO . 5.6 p90 -160.94 173.31 15.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.353 -1.087 . . . . 0.0 109.165 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2189 ' ' GLU . . . . . 0.557 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.7 tt0 -121.61 138.98 54.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.3 -0.875 . . . . 0.0 108.826 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2190 ' ' CYS . . . . . 0.412 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 15.4 p -130.64 143.53 50.81 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.66 -1.275 . . . . 0.0 109.997 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2191 ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' 2192 ' ' CYS . 61.3 m -117.51 85.31 2.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.348 -0.845 . . . . 0.0 109.505 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2192 ' ' CYS . . . . . 0.591 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.1 m -49.09 179.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 109.242 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2193 ' ' GLU . . . . . 0.45 ' O ' ' C ' ' A' 2194 ' ' GLU . 18.5 tt0 -56.98 126.9 29.25 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2194 ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.2 tt0 -38.81 130.16 1.46 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.487 -0.758 . . . . 0.0 110.591 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.24 3.04 9.82 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2196 ' ' PHE . . . . . 0.683 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.2 p90 -116.56 -161.43 0.8 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.144 -1.209 . . . . 0.0 110.16 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2197 ' ' GLU . . . . . 0.561 ' N ' ' CG ' ' A' 2196 ' ' PHE . 34.8 mm-40 -146.09 95.14 4.82 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 121.53 -0.731 . . . . 0.0 109.82 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2198 ' ' PRO . . . . . 0.683 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 6.5 Cg_endo -66.91 -163.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.119 1.88 . . . . 0.0 111.021 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -138.22 -171.65 12.26 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.88 -80.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.004 1.802 . . . . 0.0 110.727 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2201 ' ' MET . . . . . 0.482 ' HA ' ' O ' ' A' 2188 ' ' PHE . 6.6 mtt -132.0 47.17 2.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.166 -0.959 . . . . 0.0 110.033 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2202 ' ' MET . . . . . 0.515 ' O ' ' CE2' ' A' 2188 ' ' PHE . 1.9 mmt -117.13 -88.42 0.6 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.238 -0.914 . . . . 0.0 109.849 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2203 ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' 2175 ' ' PRO . 5.8 t -169.33 -162.59 0.36 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.278 -0.889 . . . . 0.0 109.49 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2204 ' ' CYS . . . . . 0.569 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 5.2 t -76.28 145.06 39.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 109.39 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A 2205 ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' 2197 ' ' GLU . 8.6 pt-20 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.951 -1.024 . . . . 0.0 109.409 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 2124 ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' 2125 ' ' ALA . 79.6 p . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2125 ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' 2124 ' ' SER . . . 61.25 131.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.341 -0.849 . . . . 0.0 109.6 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 91.9 t -109.43 125.34 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 109.439 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2127 ' ' ASP . . . . . . . . . . . . . 23.5 t0 -55.97 93.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 109.589 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 8.3 mtp -64.42 147.6 52.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 109.503 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2129 ' ' ASP . . . . . 0.567 ' O ' ' HB2' ' A' 2130 ' ' GLU . 11.5 t0 -70.31 -42.04 72.49 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.339 -0.851 . . . . 0.0 108.86 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2130 ' ' GLU . . . . . 0.574 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 1.5 mt-10 80.58 -55.47 0.34 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.915 -0.491 . . . . 0.0 111.158 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2131 ' ' CYS . . . . . 0.557 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 8.0 p -91.34 -14.59 30.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.761 -1.212 . . . . 0.0 110.503 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2132 ' ' LYS . . . . . 0.485 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -88.93 6.57 38.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.996 -1.065 . . . . 0.0 109.218 179.534 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 2133 ' ' GLU . . . . . 0.467 ' HB3' ' HD2' ' A' 2134 ' ' PRO . 36.3 mt-10 -81.11 159.41 68.16 Favored Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.242 -0.911 . . . . 0.0 109.337 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2134 ' ' PRO . . . . . 0.493 ' O ' ' HD2' ' A' 2138 ' ' LYS . 4.7 Cg_endo -68.54 -1.88 8.24 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.341 2.027 . . . . 0.0 110.451 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2135 ' ' ASP . . . . . 0.506 ' O ' ' ND2' ' A' 2162 ' ' ASN . 0.4 OUTLIER -123.11 14.16 9.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.934 -1.104 . . . . 0.0 109.887 -179.57 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 2136 ' ' VAL . . . . . 0.637 ' CG1' ' CE2' ' A' 2149 ' ' TYR . 43.3 t -146.99 126.01 4.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.04 -1.038 . . . . 0.0 108.867 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2137 ' ' CYS . . . . . 0.542 ' CA ' ' O ' ' A' 2162 ' ' ASN . 0.5 OUTLIER 69.67 -84.78 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.428 -0.795 . . . . 0.0 109.969 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 2138 ' ' LYS . . . . . 0.493 ' HD2' ' O ' ' A' 2134 ' ' PRO . 0.8 OUTLIER 63.62 109.67 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.571 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 2139 ' ' HIS . . . . . 0.482 ' O ' ' HB3' ' A' 2164 ' ' CYS . 11.6 m170 62.03 50.39 4.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.866 . . . . 0.0 109.892 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -148.85 168.39 29.35 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -106.43 78.68 1.3 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -1.137 . . . . 0.0 109.13 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2142 ' ' CYS . . . . . 0.49 ' C ' ' CD1' ' A' 2143 ' ' ILE . 25.3 p -82.96 -177.65 6.84 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.306 -0.871 . . . . 0.0 110.634 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2143 ' ' ILE . . . . . 0.49 ' CD1' ' C ' ' A' 2142 ' ' CYS . 3.0 mm -127.63 122.6 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2144 ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' 2129 ' ' ASP . 4.3 t-20 -78.04 113.49 16.02 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.34 -0.85 . . . . 0.0 110.912 -178.356 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2145 ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' 2148 ' ' SER . 2.7 p -92.68 -162.79 0.97 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 1.3 p30 -86.7 -32.52 20.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.98 . . . . 0.0 110.449 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -129.77 -34.39 0.48 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.161 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2148 ' ' SER . . . . . 0.464 ' O ' ' OG1' ' A' 2145 ' ' THR . 0.5 OUTLIER -111.79 -164.44 0.92 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.144 -1.21 . . . . 0.0 110.035 -179.479 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 2149 ' ' TYR . . . . . 0.637 ' CE2' ' CG1' ' A' 2136 ' ' VAL . 13.5 p90 -148.67 -176.55 5.37 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2150 ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' 2149 ' ' TYR . 0.1 OUTLIER -148.32 116.48 6.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.476 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 6.2 m -87.32 118.62 26.87 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.338 -0.851 . . . . 0.0 109.545 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.01 81.05 1.94 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.869 . . . . 0.0 109.139 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2153 ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -54.25 156.24 5.92 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.276 -0.89 . . . . 0.0 109.257 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 2154 ' ' PRO . . . . . 0.455 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.3 Cg_endo -63.06 -171.76 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.417 2.078 . . . . 0.0 111.306 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -88.0 102.84 15.13 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.37 -14.79 5.59 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 107.885 -2.086 . . . . 0.0 107.885 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2157 ' ' TYR . . . . . 0.547 ' CD2' ' C ' ' A' 2165 ' ' VAL . 5.6 m-85 -106.01 -168.23 1.41 Allowed 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.635 -0.921 . . . . 0.0 109.549 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2158 ' ' ILE . . . . . 0.525 HG22 ' HB ' ' A' 2167 ' ' THR . 0.2 OUTLIER -156.93 -164.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.859 . . . . 0.0 109.923 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 2159 ' ' LEU . . . . . 0.512 ' N ' HG12 ' A' 2158 ' ' ILE . 39.5 tp -142.38 114.16 8.03 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -90.57 56.87 3.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.883 . . . . 0.0 109.589 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 89.11 -29.2 6.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2162 ' ' ASN . . . . . 0.542 ' O ' ' CA ' ' A' 2137 ' ' CYS . 1.5 m-20 -171.47 -46.69 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.241 -1.152 . . . . 0.0 109.332 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2163 ' ' GLU . . . . . 0.46 ' O ' HD11 ' A' 2159 ' ' LEU . 14.5 tt0 -66.17 147.78 52.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.118 -0.989 . . . . 0.0 109.248 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2164 ' ' CYS . . . . . 0.513 ' N ' ' O ' ' A' 2137 ' ' CYS . 0.1 OUTLIER -122.82 137.58 54.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.049 -1.032 . . . . 0.0 109.394 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 2165 ' ' VAL . . . . . 0.547 ' C ' ' CD2' ' A' 2157 ' ' TYR . 0.7 OUTLIER -161.1 -169.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.121 -0.987 . . . . 0.0 109.779 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 2166 ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' 2184 ' ' VAL . 36.8 t70 -77.02 166.94 22.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.167 -0.958 . . . . 0.0 110.035 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2167 ' ' THR . . . . . 0.528 ' CG2' ' OE1' ' A' 2169 ' ' GLU . 1.2 t -115.99 -170.6 1.82 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.355 -0.84 . . . . 0.0 109.414 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2168 ' ' ASP . . . . . 0.526 ' N ' HG22 ' A' 2167 ' ' THR . 64.6 t0 -109.4 101.26 10.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.945 . . . . 0.0 109.511 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2169 ' ' GLU . . . . . 0.578 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.5 OUTLIER -76.22 -30.93 58.14 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.347 -0.845 . . . . 0.0 109.337 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 2170 ' ' CYS . . . . . 0.49 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 0.1 OUTLIER -64.87 -12.32 47.47 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.578 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.76 -22.54 29.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 0.0 109.623 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 31.3 t -75.9 -68.56 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.33 -0.856 . . . . 0.0 109.448 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2173 ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -159.87 140.37 6.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2174 ' ' ASN . . . . . 0.471 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 1.6 t-20 -45.0 104.49 0.39 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.411 -1.052 . . . . 0.0 109.616 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2175 ' ' PRO . . . . . 0.648 ' CB ' ' CE2' ' A' 2188 ' ' PHE . 2.1 Cg_endo -68.92 -19.94 39.59 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.837 1.692 . . . . 0.0 110.03 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2176 ' ' CYS . . . . . 0.585 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -71.43 -24.08 61.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.152 -0.967 . . . . 0.0 109.902 -179.516 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 105.84 -25.79 22.99 Favored Glycine 0 N--CA 1.483 1.779 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2178 ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.1 OUTLIER -170.59 -31.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.295 -1.121 . . . . 0.0 110.611 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 2179 ' ' GLY . . . . . 0.571 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -59.77 -120.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.3 p -136.03 151.18 49.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.44 -1.035 . . . . 0.0 109.336 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2181 ' ' CYS . . . . . 0.492 ' HB3' ' HD2' ' A' 2175 ' ' PRO . 26.1 p -99.35 155.63 17.42 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.12 -0.987 . . . . 0.0 110.716 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2182 ' ' LYS . . . . . 0.518 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 8.5 tttp -140.67 159.07 43.01 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2183 ' ' ASN . . . . . 0.425 ' CG ' ' HA ' ' A' 2168 ' ' ASP . 53.5 t30 -100.26 129.64 46.28 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.562 -1.336 . . . . 0.0 110.175 -179.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2184 ' ' VAL . . . . . 0.583 ' CG1' ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -134.41 -179.42 3.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 2185 ' ' ILE . . . . . 0.428 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 4.1 mp -95.01 141.13 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.764 -1.21 . . . . 0.0 110.424 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2186 ' ' GLY . . . . . 0.408 ' N ' HG21 ' A' 2185 ' ' ILE . . . 67.94 10.92 59.89 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2187 ' ' GLY . . . . . 0.544 ' C ' ' CD1' ' A' 2188 ' ' PHE . . . 168.14 -118.77 0.8 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2188 ' ' PHE . . . . . 0.648 ' CE2' ' CB ' ' A' 2175 ' ' PRO . 2.6 p90 -175.23 178.58 1.68 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -1.109 . . . . 0.0 109.72 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2189 ' ' GLU . . . . . 0.518 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 5.6 tp10 -124.54 168.1 13.56 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 3.1 p -170.51 145.89 2.67 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.547 -1.345 . . . . 0.0 110.453 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2191 ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' 2192 ' ' CYS . 88.6 m -117.88 88.34 2.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.504 -0.748 . . . . 0.0 109.614 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2192 ' ' CYS . . . . . 0.611 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.5 OUTLIER -49.6 -178.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.167 -0.958 . . . . 0.0 109.049 179.786 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 2193 ' ' GLU . . . . . 0.548 ' O ' ' C ' ' A' 2194 ' ' GLU . 7.2 tt0 -55.24 102.27 0.06 Allowed 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2194 ' ' GLU . . . . . 0.548 ' C ' ' O ' ' A' 2193 ' ' GLU . 2.3 mt-10 -20.14 124.89 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.365 0.602 . . . . 0.0 111.716 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.71 11.35 6.0 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2196 ' ' PHE . . . . . 0.686 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.5 p90 -120.06 -161.93 0.9 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.357 -1.084 . . . . 0.0 110.165 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2197 ' ' GLU . . . . . 0.52 ' N ' ' CG ' ' A' 2196 ' ' PHE . 12.9 mt-10 -144.47 94.87 5.54 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 121.475 -0.766 . . . . 0.0 109.659 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2198 ' ' PRO . . . . . 0.686 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.2 Cg_endo -69.36 -162.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.353 2.035 . . . . 0.0 111.192 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -133.66 -177.02 14.66 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -62.36 -65.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.006 1.804 . . . . 0.0 110.618 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2201 ' ' MET . . . . . 0.474 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -147.29 41.11 1.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 109.58 -179.674 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 2202 ' ' MET . . . . . 0.431 ' O ' ' CE2' ' A' 2188 ' ' PHE . 0.0 OUTLIER -112.88 -84.4 0.59 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.208 -0.932 . . . . 0.0 109.613 -179.807 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 2203 ' ' THR . . . . . . . . . . . . . 11.5 t -162.6 -172.62 3.2 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.23 -0.918 . . . . 0.0 109.406 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2204 ' ' CYS . . . . . 0.585 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -110.42 144.94 38.44 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.285 -0.885 . . . . 0.0 108.933 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A 2205 ' ' GLU . . . . . 0.402 ' OXT' ' HG3' ' A' 2205 ' ' GLU . 9.3 pt-20 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.548 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -167.58 103.19 0.5 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 109.316 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 10.0 p -139.2 148.92 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 109.489 -179.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2127 ' ' ASP . . . . . 0.438 ' O ' ' CG ' ' A' 2127 ' ' ASP . 24.0 t70 -91.39 30.4 1.3 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.187 -0.946 . . . . 0.0 109.403 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2128 ' ' MET . . . . . 0.473 ' O ' ' HG3' ' A' 2130 ' ' GLU . 1.8 mtp 59.9 106.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.199 -0.938 . . . . 0.0 109.2 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2129 ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' 2130 ' ' GLU . 11.3 t70 -60.65 -46.24 91.08 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2130 ' ' GLU . . . . . 0.527 ' CB ' ' O ' ' A' 2129 ' ' ASP . 6.4 mt-10 82.56 -43.16 0.13 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.856 -0.528 . . . . 0.0 109.798 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2131 ' ' CYS . . . . . 0.462 ' HA ' HG13 ' A' 2136 ' ' VAL . 0.1 OUTLIER -90.11 -23.02 21.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.176 -0.952 . . . . 0.0 109.086 179.603 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 2132 ' ' LYS . . . . . 0.425 ' HB2' ' CG ' ' A' 2129 ' ' ASP . 0.3 OUTLIER -87.6 40.25 0.92 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 109.144 179.561 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 2133 ' ' GLU . . . . . 0.506 ' HB3' ' HD2' ' A' 2134 ' ' PRO . 80.3 mt-10 -108.09 160.17 27.92 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.33 -0.856 . . . . 0.0 109.66 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2134 ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' 2133 ' ' GLU . 1.2 Cg_endo -66.02 0.51 3.12 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.539 2.159 . . . . 0.0 111.771 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2135 ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' 2162 ' ' ASN . 67.1 m-20 -130.03 -10.65 4.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.478 -1.389 . . . . 0.0 110.564 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2136 ' ' VAL . . . . . 0.462 HG13 ' HA ' ' A' 2131 ' ' CYS . 3.4 t -100.13 -131.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.927 -1.108 . . . . 0.0 108.492 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2137 ' ' CYS . . . . . 0.465 ' SG ' ' HB2' ' A' 2142 ' ' CYS . 5.0 t -58.45 131.46 50.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.521 -1.362 . . . . 0.0 108.65 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2138 ' ' LYS . . . . . 0.515 ' O ' ' CB ' ' A' 2139 ' ' HIS . 32.0 mtpt -139.64 43.03 1.99 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.185 -0.947 . . . . 0.0 110.061 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2139 ' ' HIS . . . . . 0.515 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.0 OUTLIER 163.73 -34.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.052 -1.03 . . . . 0.0 110.099 179.473 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -83.67 173.65 51.21 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -91.91 94.68 9.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.265 -1.138 . . . . 0.0 109.163 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2142 ' ' CYS . . . . . 0.465 ' HB2' ' SG ' ' A' 2137 ' ' CYS . 10.4 t -91.0 161.47 15.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.292 -0.88 . . . . 0.0 109.725 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 2.6 mp -122.72 98.59 5.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2144 ' ' ASN . . . . . 0.464 ' HB2' ' OD1' ' A' 2129 ' ' ASP . 3.2 t30 -60.02 112.85 2.03 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.273 -0.892 . . . . 0.0 109.712 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2145 ' ' THR . . . . . . . . . . . . . 30.5 p -90.73 -166.28 1.54 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.378 -0.826 . . . . 0.0 109.376 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 5.6 t0 -62.63 -72.48 0.13 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.817 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -118.12 37.0 3.41 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2148 ' ' SER . . . . . 0.468 ' O ' ' HB3' ' A' 2149 ' ' TYR . 0.8 OUTLIER -165.13 -160.89 0.51 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -1.157 . . . . 0.0 109.629 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 2149 ' ' TYR . . . . . 0.468 ' HB3' ' O ' ' A' 2148 ' ' SER . 27.2 p90 170.8 -175.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.49 -0.756 . . . . 0.0 109.217 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2150 ' ' ARG . . . . . 0.433 ' C ' ' SG ' ' A' 2142 ' ' CYS . 11.6 ptt180 -167.93 95.05 0.41 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.951 . . . . 0.0 109.831 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2151 ' ' CYS . . . . . 0.461 ' HA ' ' SG ' ' A' 2142 ' ' CYS . 42.5 t -57.64 102.56 0.1 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.615 -0.678 . . . . 0.0 109.447 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -104.47 108.02 19.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.314 -0.866 . . . . 0.0 109.256 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2153 ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -70.06 158.78 86.55 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.168 -0.957 . . . . 0.0 109.664 -179.657 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 2154 ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' 2157 ' ' TYR . 1.1 Cg_endo -63.85 -168.97 0.1 OUTLIER 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.858 2.372 . . . . 0.0 112.03 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -86.48 101.79 13.5 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 129.95 -15.49 5.63 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 107.821 -2.112 . . . . 0.0 107.821 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2157 ' ' TYR . . . . . 0.497 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 5.4 m-85 -106.34 -170.79 1.78 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.682 -0.893 . . . . 0.0 110.053 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2158 ' ' ILE . . . . . 0.572 ' N ' ' CD1' ' A' 2158 ' ' ILE . 0.2 OUTLIER -156.93 -160.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.522 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 2159 ' ' LEU . . . . . 0.463 HD13 ' O ' ' A' 2162 ' ' ASN . 33.2 tp -147.55 122.81 10.24 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.187 -0.945 . . . . 0.0 109.942 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2160 ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' 2162 ' ' ASN . . . -90.22 -152.12 0.26 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2161 ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' 2160 ' ' ALA . . . -42.13 -25.95 0.29 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2162 ' ' ASN . . . . . 0.476 ' HB3' ' O ' ' A' 2135 ' ' ASP . 1.5 t-20 178.75 -29.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.133 -1.216 . . . . 0.0 110.179 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -76.23 152.58 36.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.084 -1.01 . . . . 0.0 109.514 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2164 ' ' CYS . . . . . 0.51 ' O ' ' CG1' ' A' 2165 ' ' VAL . 0.1 OUTLIER -111.82 145.08 40.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.122 -0.986 . . . . 0.0 109.374 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 2165 ' ' VAL . . . . . 0.51 ' CG1' ' O ' ' A' 2164 ' ' CYS . 1.6 m -164.81 -170.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 109.425 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2166 ' ' ASP . . . . . 0.474 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 3.3 t70 -90.41 149.69 22.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.002 -1.061 . . . . 0.0 109.706 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2167 ' ' THR . . . . . 0.568 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 8.7 t -87.84 175.38 7.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 109.511 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2168 ' ' ASP . . . . . 0.462 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 57.9 t0 -95.77 92.67 6.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.296 -0.877 . . . . 0.0 108.752 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2169 ' ' GLU . . . . . 0.517 ' OE1' ' CG2' ' A' 2167 ' ' THR . 0.7 OUTLIER -65.68 -32.15 73.55 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.331 -0.856 . . . . 0.0 109.883 -179.409 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 2170 ' ' CYS . . . . . 0.521 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.3 t -66.34 -12.04 54.44 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.165 -0.959 . . . . 0.0 108.891 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.68 -2.28 22.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.243 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 34.4 t -84.23 -69.71 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.21 -0.931 . . . . 0.0 109.549 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2173 ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' 2174 ' ' ASN . . . 164.26 76.46 0.03 OUTLIER Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.069 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2174 ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' 2178 ' ' ASN . 3.5 t-20 43.2 83.78 0.2 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.253 -1.145 . . . . 0.0 109.613 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2175 ' ' PRO . . . . . 0.615 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.4 Cg_endo -66.76 -20.03 52.7 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.257 1.971 . . . . 0.0 110.537 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2176 ' ' CYS . . . . . 0.523 ' SG ' ' HB3' ' A' 2204 ' ' CYS . 1.4 m -64.79 -55.41 19.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.926 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 160.2 -28.94 0.35 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2178 ' ' ASN . . . . . 0.503 ' N ' ' OD1' ' A' 2174 ' ' ASN . 1.5 t-20 -171.05 -26.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -1.185 . . . . 0.0 110.966 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2179 ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -59.66 -124.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.787 -1.196 . . . . 0.0 110.309 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2180 ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' 2190 ' ' CYS . 1.1 p -136.64 151.07 48.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.394 -1.062 . . . . 0.0 109.227 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2181 ' ' CYS . . . . . 0.539 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 23.0 p -99.54 150.19 22.48 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.089 -1.007 . . . . 0.0 111.468 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2182 ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' 2189 ' ' GLU . 0.5 OUTLIER -132.4 160.79 35.35 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.381 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 2183 ' ' ASN . . . . . 0.462 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 57.0 t30 -100.28 123.7 44.83 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.579 -1.326 . . . . 0.0 109.21 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2184 ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -130.89 -174.96 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.371 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 2185 ' ' ILE . . . . . 0.496 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 3.3 mp -94.62 139.26 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.028 -1.045 . . . . 0.0 110.287 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2186 ' ' GLY . . . . . 0.453 ' N ' HG21 ' A' 2185 ' ' ILE . . . 69.78 10.06 63.59 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2187 ' ' GLY . . . . . 0.515 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 166.2 -118.11 0.78 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.514 -1.326 . . . . 0.0 110.078 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2188 ' ' PHE . . . . . 0.615 ' CD2' ' HG2' ' A' 2175 ' ' PRO . 1.8 p90 -166.46 -179.45 4.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -1.139 . . . . 0.0 109.889 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2189 ' ' GLU . . . . . 0.534 ' O ' ' CB ' ' A' 2182 ' ' LYS . 0.1 OUTLIER -132.09 94.04 3.39 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.406 -0.808 . . . . 0.0 109.286 178.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 2190 ' ' CYS . . . . . 0.51 ' HB3' ' HA ' ' A' 2181 ' ' CYS . 9.1 p -114.26 139.26 49.56 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.92 -1.112 . . . . 0.0 109.802 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2191 ' ' THR . . . . . 0.549 HG21 ' CZ ' ' A' 2196 ' ' PHE . 1.8 m -113.85 106.58 14.62 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2192 ' ' CYS . . . . . 0.651 ' HB2' ' CD2' ' A' 2196 ' ' PHE . 0.5 OUTLIER -53.54 -172.36 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.057 -1.027 . . . . 0.0 110.157 -178.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 2193 ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.2 tp10 -68.03 136.43 53.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.656 -0.652 . . . . 0.0 110.1 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2194 ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -40.37 131.5 2.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.523 -0.736 . . . . 0.0 110.203 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 116.75 12.76 8.37 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2196 ' ' PHE . . . . . 0.678 ' CD2' ' HB2' ' A' 2204 ' ' CYS . 8.0 p90 -128.99 -158.71 0.9 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.575 -0.956 . . . . 0.0 110.22 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2197 ' ' GLU . . . . . 0.555 ' N ' ' CD2' ' A' 2196 ' ' PHE . 25.7 mt-10 -147.16 96.7 4.21 Favored Pre-proline 0 C--N 1.306 -1.319 0 O-C-N 121.565 -0.709 . . . . 0.0 109.496 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2198 ' ' PRO . . . . . 0.633 ' CD ' ' CE2' ' A' 2196 ' ' PHE . 2.2 Cg_endo -62.41 -170.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.356 2.037 . . . . 0.0 111.148 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -147.58 -168.02 13.74 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.04 -80.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.259 1.973 . . . . 0.0 110.929 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2201 ' ' MET . . . . . 0.515 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -142.54 42.11 1.6 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 110.115 -179.237 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 2.0 mmm -114.23 -72.28 0.71 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.411 -0.806 . . . . 0.0 109.502 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2203 ' ' THR . . . . . 0.477 ' OG1' ' HA ' ' A' 2176 ' ' CYS . 11.8 t -166.84 -165.91 0.78 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2204 ' ' CYS . . . . . 0.678 ' HB2' ' CD2' ' A' 2196 ' ' PHE . 31.3 p -104.1 114.14 28.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.853 -1.155 . . . . 0.0 110.232 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A 2205 ' ' GLU . . . . . 0.423 ' O ' ' CG ' ' A' 2205 ' ' GLU . 9.1 pt-20 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.513 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A 2124 ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' 2125 ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2125 ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' 2124 ' ' SER . . . 164.84 -87.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 109.475 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 38.7 t -119.39 156.32 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.278 -0.889 . . . . 0.0 109.521 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 2127 ' ' ASP . . . . . . . . . . . . . 2.8 p30 -75.39 -161.72 0.16 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.268 -0.895 . . . . 0.0 109.713 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 9.4 mtt -53.9 141.7 26.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.37 -0.831 . . . . 0.0 109.855 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 2129 ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' 2130 ' ' GLU . 16.6 t0 -69.6 -44.98 69.65 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.413 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2130 ' ' GLU . . . . . 0.57 ' HB3' ' CD2' ' A' 2149 ' ' TYR . 2.0 mt-10 82.87 -47.11 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.845 -0.534 . . . . 0.0 109.942 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2131 ' ' CYS . . . . . 0.471 ' SG ' ' HB3' ' A' 2137 ' ' CYS . 0.0 OUTLIER -80.9 -46.14 15.67 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.963 -1.086 . . . . 0.0 109.152 179.968 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 2132 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -16.31 4.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.14 -0.975 . . . . 0.0 109.79 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2133 ' ' GLU . . . . . 0.429 ' HG3' ' C ' ' A' 2130 ' ' GLU . 7.5 mt-10 -69.95 146.06 94.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 110.204 -179.569 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2134 ' ' PRO . . . . . 0.528 ' O ' ' CE ' ' A' 2138 ' ' LYS . 6.4 Cg_endo -72.55 2.27 5.37 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.597 2.198 . . . . 0.0 110.309 179.113 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2135 ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' A' 2162 ' ' ASN . 36.3 t70 -108.43 -14.29 14.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.96 -1.087 . . . . 0.0 109.693 -179.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2136 ' ' VAL . . . . . 0.576 ' CG1' ' CE1' ' A' 2149 ' ' TYR . 2.3 t -112.21 -136.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.093 -1.005 . . . . 0.0 109.074 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2137 ' ' CYS . . . . . 0.471 ' HB3' ' SG ' ' A' 2131 ' ' CYS . 1.9 t -44.54 105.72 0.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.018 -1.051 . . . . 0.0 108.68 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2138 ' ' LYS . . . . . 0.528 ' CE ' ' O ' ' A' 2134 ' ' PRO . 3.7 mttm -114.22 18.35 17.09 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.336 -0.852 . . . . 0.0 110.332 -178.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2139 ' ' HIS . . . . . 0.478 ' O ' ' HB3' ' A' 2164 ' ' CYS . 0.9 OUTLIER 171.77 50.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.892 -1.13 . . . . 0.0 110.461 179.773 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -169.83 -175.22 38.7 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -89.78 142.8 27.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.348 -1.09 . . . . 0.0 108.611 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 2142 ' ' CYS . . . . . 0.512 ' HA ' ' O ' ' A' 2150 ' ' ARG . 0.8 OUTLIER -128.78 175.93 8.22 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.092 -1.005 . . . . 0.0 110.492 -178.972 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 2143 ' ' ILE . . . . . 0.426 HD13 ' C ' ' A' 2142 ' ' CYS . 4.9 mp -139.51 107.92 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2144 ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' 2129 ' ' ASP . 5.2 t-20 -64.18 119.08 9.54 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.346 -0.846 . . . . 0.0 110.886 -178.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2145 ' ' THR . . . . . 0.423 ' OG1' ' C ' ' A' 2148 ' ' SER . 72.4 p -116.07 -179.08 3.56 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.823 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.35 109.75 21.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.957 . . . . 0.0 109.59 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 89.81 13.94 60.21 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 2148 ' ' SER . . . . . 0.423 ' C ' ' OG1' ' A' 2145 ' ' THR . 0.1 OUTLIER -178.72 -160.62 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.239 -1.153 . . . . 0.0 109.688 -179.866 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 2149 ' ' TYR . . . . . 0.576 ' CE1' ' CG1' ' A' 2136 ' ' VAL . 22.2 p90 -171.31 -174.43 1.45 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.397 -0.814 . . . . 0.0 108.979 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2150 ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' 2142 ' ' CYS . 0.0 OUTLIER -157.4 112.62 2.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.119 -0.988 . . . . 0.0 109.636 179.604 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 40.1 t -98.5 87.06 3.73 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.582 -0.699 . . . . 0.0 109.505 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -86.57 105.98 17.23 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.198 -0.938 . . . . 0.0 109.322 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 2153 ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -66.64 159.9 71.17 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 109.649 -179.624 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 2154 ' ' PRO . . . . . 0.474 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 0.9 OUTLIER -64.46 -166.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.61 2.207 . . . . 0.0 111.276 -179.024 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 21.0 t80 -90.21 103.42 16.1 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.81 -17.19 5.24 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 107.909 -2.076 . . . . 0.0 107.909 -178.393 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 2157 ' ' TYR . . . . . 0.522 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 9.7 m-85 -107.81 -172.34 2.05 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.625 -0.927 . . . . 0.0 109.799 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2158 ' ' ILE . . . . . 0.59 ' N ' ' CD1' ' A' 2158 ' ' ILE . 0.1 OUTLIER -155.5 -165.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.555 -0.716 . . . . 0.0 109.796 179.418 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 2159 ' ' LEU . . . . . 0.474 HD11 ' O ' ' A' 2163 ' ' GLU . 27.9 tp -141.9 121.8 13.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.387 -0.821 . . . . 0.0 109.508 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -94.63 50.94 1.37 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.357 -0.84 . . . . 0.0 109.83 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 91.32 -18.43 51.97 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 2162 ' ' ASN . . . . . 0.466 ' O ' HD13 ' A' 2159 ' ' LEU . 1.6 m-20 -178.03 -47.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.023 -1.281 . . . . 0.0 109.851 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2163 ' ' GLU . . . . . 0.474 ' O ' HD11 ' A' 2159 ' ' LEU . 78.7 tt0 -75.31 146.05 41.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.898 . . . . 0.0 109.035 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2164 ' ' CYS . . . . . 0.524 ' O ' ' CG1' ' A' 2165 ' ' VAL . 0.0 OUTLIER -115.35 140.9 48.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.031 -1.043 . . . . 0.0 109.395 -179.958 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 2165 ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' 2164 ' ' CYS . 4.7 m -162.42 -170.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 0.0 109.767 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2166 ' ' ASP . . . . . 0.461 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 1.3 t0 -89.78 144.77 25.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 109.415 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2167 ' ' THR . . . . . 0.558 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 8.9 t -85.39 170.74 12.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.306 -0.871 . . . . 0.0 109.682 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2168 ' ' ASP . . . . . 0.471 ' O ' ' HB2' ' A' 2171 ' ' SER . 66.9 t0 -81.67 94.5 6.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.196 -0.94 . . . . 0.0 108.592 179.115 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2169 ' ' GLU . . . . . 0.55 ' CB ' ' HB3' ' A' 2188 ' ' PHE . 0.4 OUTLIER -65.56 -26.42 67.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 110.532 -179.012 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 2170 ' ' CYS . . . . . 0.439 ' HB2' ' HB2' ' A' 2181 ' ' CYS . 1.3 t -57.92 -12.82 3.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.912 -1.117 . . . . 0.0 108.77 178.461 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2171 ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.1 OUTLIER -59.44 -13.12 7.47 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.195 -0.94 . . . . 0.0 109.881 -179.553 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 2172 ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' 2169 ' ' GLU . 22.1 t -73.14 -67.95 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.312 -0.867 . . . . 0.0 109.242 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2173 ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' 2174 ' ' ASN . . . 154.95 85.55 0.05 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2174 ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' 2173 ' ' GLY . 1.1 t-20 47.31 91.55 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.26 -1.141 . . . . 0.0 109.421 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2175 ' ' PRO . . . . . 0.64 ' CB ' ' CD1' ' A' 2188 ' ' PHE . 1.0 OUTLIER -62.95 -21.95 73.5 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.078 1.852 . . . . 0.0 110.222 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 2176 ' ' CYS . . . . . 0.514 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.1 OUTLIER -75.97 -64.67 1.04 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -0.996 . . . . 0.0 108.926 179.68 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 147.93 -14.84 1.35 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -166.93 -34.76 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.205 -1.173 . . . . 0.0 110.106 -179.689 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2179 ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -61.48 -108.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.451 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2180 ' ' THR . . . . . 0.475 HG21 ' O ' ' A' 2179 ' ' GLY . 0.7 OUTLIER -151.18 157.19 42.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.393 -1.063 . . . . 0.0 109.307 -179.782 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 2181 ' ' CYS . . . . . 0.528 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 26.7 p -93.65 159.93 15.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.026 -1.046 . . . . 0.0 110.237 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2182 ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.0 OUTLIER -146.5 154.24 41.33 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.365 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 2183 ' ' ASN . . . . . 0.45 ' N ' ' HG3' ' A' 2182 ' ' LYS . 56.0 t30 -98.48 121.46 40.45 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.685 -1.259 . . . . 0.0 109.413 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2184 ' ' VAL . . . . . 0.489 ' CG1' ' N ' ' A' 2185 ' ' ILE . 0.3 OUTLIER -123.45 -162.78 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.524 -0.735 . . . . 0.0 109.558 -179.28 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 2185 ' ' ILE . . . . . 0.522 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 2.7 mp -108.52 138.36 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.186 -0.946 . . . . 0.0 110.213 -179.248 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 64.83 16.31 61.34 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.34 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 2187 ' ' GLY . . . . . 0.481 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 167.56 -128.08 1.67 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2188 ' ' PHE . . . . . 0.64 ' CD1' ' CB ' ' A' 2175 ' ' PRO . 5.7 p90 -162.6 170.4 18.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.218 -1.166 . . . . 0.0 109.374 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2189 ' ' GLU . . . . . 0.531 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.6 OUTLIER -120.57 151.28 39.63 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.314 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 17.8 p -149.96 141.03 22.98 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.756 -1.215 . . . . 0.0 109.794 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 2191 ' ' THR . . . . . 0.476 ' O ' ' HA3' ' A' 2179 ' ' GLY . 22.2 m -114.92 88.03 2.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.915 . . . . 0.0 109.773 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2192 ' ' CYS . . . . . 0.61 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -51.5 -178.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -0.873 . . . . 0.0 109.119 179.654 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 2193 ' ' GLU . . . . . 0.464 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.6 OUTLIER -58.15 123.59 16.51 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.374 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 2194 ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.8 OUTLIER -37.76 131.81 0.97 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.436 -0.79 . . . . 0.0 110.506 -178.796 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.03 -0.18 10.73 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 2196 ' ' PHE . . . . . 0.68 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.9 OUTLIER -113.69 -164.43 0.93 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.272 -1.134 . . . . 0.0 110.227 -179.904 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 2197 ' ' GLU . . . . . 0.532 ' N ' ' CG ' ' A' 2196 ' ' PHE . 2.5 mm-40 -145.33 96.31 4.9 Favored Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.541 -0.724 . . . . 0.0 109.665 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2198 ' ' PRO . . . . . 0.68 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 7.8 Cg_endo -67.79 -160.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.162 1.908 . . . . 0.0 111.138 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -140.29 -177.24 15.75 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.02 -57.44 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.051 1.834 . . . . 0.0 110.399 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 2201 ' ' MET . . . . . 0.486 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.4 OUTLIER -158.41 60.74 0.44 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.615 -179.858 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 2202 ' ' MET . . . . . 0.464 ' O ' ' CE1' ' A' 2188 ' ' PHE . 0.8 OUTLIER -129.21 -77.16 0.55 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.192 -0.943 . . . . 0.0 109.542 -179.589 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A 2203 ' ' THR . . . . . 0.471 ' OG1' ' O ' ' A' 2175 ' ' PRO . 12.7 t -177.15 -173.91 0.48 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.398 -0.814 . . . . 0.0 109.485 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2204 ' ' CYS . . . . . 0.514 ' HB2' ' CA ' ' A' 2176 ' ' CYS . 7.7 t -71.99 148.82 45.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.459 -0.776 . . . . 0.0 109.467 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A 2205 ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' 2197 ' ' GLU . 14.7 pt-20 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.539 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A 2125 ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' 2126 ' ' VAL . . . -78.59 145.82 34.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.38 -0.825 . . . . 0.0 109.483 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2126 ' ' VAL . . . . . 0.56 ' CG2' ' N ' ' A' 2127 ' ' ASP . 0.8 OUTLIER 37.69 -160.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 O-C-N 121.63 -0.669 . . . . 0.0 110.389 179.283 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A 2127 ' ' ASP . . . . . 0.56 ' N ' ' CG2' ' A' 2126 ' ' VAL . 12.6 t0 -80.91 -47.27 13.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2128 ' ' MET . . . . . 0.462 ' CB ' ' O ' ' A' 2127 ' ' ASP . 0.0 OUTLIER 73.57 99.77 0.07 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.944 . . . . 0.0 109.117 -179.68 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A 2129 ' ' ASP . . . . . 0.534 ' HB3' ' CG ' ' A' 2132 ' ' LYS . 10.7 t70 -56.0 -42.65 76.7 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.398 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2130 ' ' GLU . . . . . 0.615 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 1.7 mt-10 80.43 -41.55 0.2 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.021 0.438 . . . . 0.0 110.197 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2131 ' ' CYS . . . . . 0.477 ' HA ' HG13 ' A' 2136 ' ' VAL . 0.7 OUTLIER -90.93 -27.18 18.89 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.263 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A 2132 ' ' LYS . . . . . 0.534 ' CG ' ' HB3' ' A' 2129 ' ' ASP . 0.0 OUTLIER -56.7 -19.94 19.19 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.304 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A 2133 ' ' GLU . . . . . 0.469 ' HB2' HG22 ' A' 2136 ' ' VAL . 0.8 OUTLIER -70.06 137.86 87.25 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.519 -0.738 . . . . 0.0 109.443 -179.819 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A 2134 ' ' PRO . . . . . 0.473 ' O ' ' HD2' ' A' 2138 ' ' LYS . 4.3 Cg_endo -69.38 0.08 5.86 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.346 2.03 . . . . 0.0 111.181 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 22.7 t70 -124.14 1.07 8.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.766 -1.209 . . . . 0.0 110.344 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 2136 ' ' VAL . . . . . 0.518 ' CG1' ' N ' ' A' 2137 ' ' CYS . 40.5 t -91.73 -95.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.895 -1.128 . . . . 0.0 109.537 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2137 ' ' CYS . . . . . 0.518 ' N ' ' CG1' ' A' 2136 ' ' VAL . 48.3 t -84.3 -73.24 0.43 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.995 -1.065 . . . . 0.0 109.23 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2138 ' ' LYS . . . . . 0.473 ' HD2' ' O ' ' A' 2134 ' ' PRO . 0.0 OUTLIER 64.98 127.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 110.34 179.344 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A 2139 ' ' HIS . . . . . 0.489 ' O ' ' HB3' ' A' 2164 ' ' CYS . 9.6 m-70 51.03 26.4 2.74 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.371 -0.831 . . . . 0.0 110.934 178.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2140 ' ' GLY . . . . . 0.445 ' HA3' ' SG ' ' A' 2137 ' ' CYS . . . -128.98 166.89 21.28 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.399 -1.381 . . . . 0.0 110.197 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2141 ' ' GLN . . . . . 0.404 ' O ' HD12 ' A' 2143 ' ' ILE . 23.6 tt0 -89.45 47.87 1.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -1.142 . . . . 0.0 109.003 179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2142 ' ' CYS . . . . . . . . . . . . . 1.6 p -49.23 160.58 0.22 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.625 -0.672 . . . . 0.0 110.184 -179.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 2143 ' ' ILE . . . . . 0.42 ' HA ' HD11 ' A' 2143 ' ' ILE . 38.1 mm -133.35 121.3 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2144 ' ' ASN . . . . . 0.487 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 13.3 t-20 -64.33 116.51 6.12 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.343 -0.848 . . . . 0.0 110.864 -179.088 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2145 ' ' THR . . . . . 0.507 ' OG1' ' HA ' ' A' 2149 ' ' TYR . 0.0 OUTLIER -108.89 175.4 5.48 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.455 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A 2146 ' ' ASP . . . . . 0.447 ' O ' ' OD1' ' A' 2146 ' ' ASP . 4.2 p30 -70.08 103.06 2.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 110.042 -179.608 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 65.79 10.89 52.39 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 2148 ' ' SER . . . . . 0.459 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.0 OUTLIER -145.84 -174.7 4.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.112 -1.228 . . . . 0.0 109.607 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A 2149 ' ' TYR . . . . . 0.615 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 38.7 p90 -161.78 -170.02 2.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 109.519 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2150 ' ' ARG . . . . . 0.449 ' CB ' ' CZ ' ' A' 2150 ' ' ARG . 0.0 OUTLIER -170.75 104.18 0.25 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.485 -0.759 . . . . 0.0 109.51 179.531 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 36.5 t -72.14 84.09 1.01 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.37 -0.831 . . . . 0.0 109.151 179.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -93.47 87.48 5.58 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.364 -0.835 . . . . 0.0 109.208 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 2153 ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -49.79 152.87 2.37 Favored Pre-proline 0 C--N 1.302 -1.49 0 O-C-N 121.397 -0.815 . . . . 0.0 109.723 -179.625 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A 2154 ' ' PRO . . . . . 0.432 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 2.8 Cg_endo -65.4 -165.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.585 2.19 . . . . 0.0 111.018 -179.254 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 77.7 t80 -91.19 101.94 14.67 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.14 -11.88 5.56 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 -178.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 2157 ' ' TYR . . . . . 0.522 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 7.5 m-85 -110.16 -166.84 1.12 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.41 -1.053 . . . . 0.0 109.873 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2158 ' ' ILE . . . . . 0.539 ' CD1' HG21 ' A' 2165 ' ' VAL . 0.1 OUTLIER -156.5 -165.23 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.507 -0.745 . . . . 0.0 109.395 179.243 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A 2159 ' ' LEU . . . . . 0.445 ' N ' HG12 ' A' 2158 ' ' ILE . 28.5 tp -142.75 117.2 9.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.259 -0.9 . . . . 0.0 109.639 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -89.89 49.71 1.76 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.387 -0.821 . . . . 0.0 109.417 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 2161 ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' 2162 ' ' ASN . . . 90.62 -17.79 52.94 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2162 ' ' ASN . . . . . 0.489 ' CG ' ' N ' ' A' 2163 ' ' GLU . 3.1 p-10 -178.89 -49.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.105 -1.233 . . . . 0.0 109.793 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2163 ' ' GLU . . . . . 0.489 ' N ' ' CG ' ' A' 2162 ' ' ASN . 5.5 tt0 -70.87 133.41 46.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.505 -0.747 . . . . 0.0 109.236 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2164 ' ' CYS . . . . . 0.489 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -106.97 137.23 45.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.024 -1.047 . . . . 0.0 109.73 -179.628 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A 2165 ' ' VAL . . . . . 0.539 HG21 ' CD1' ' A' 2158 ' ' ILE . 1.9 m -152.07 -170.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.165 -0.959 . . . . 0.0 109.723 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2166 ' ' ASP . . . . . . . . . . . . . 27.0 t70 -76.75 166.94 22.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.366 -0.834 . . . . 0.0 110.164 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 2167 ' ' THR . . . . . 0.536 ' CG2' ' OE1' ' A' 2169 ' ' GLU . 1.4 t -116.83 -169.21 1.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.435 -0.791 . . . . 0.0 109.138 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2168 ' ' ASP . . . . . 0.505 ' N ' HG22 ' A' 2167 ' ' THR . 56.1 t0 -108.94 101.26 10.37 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.15 -0.969 . . . . 0.0 109.492 179.513 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2169 ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.9 OUTLIER -81.8 -29.75 32.56 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.413 -0.804 . . . . 0.0 109.396 179.916 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A 2170 ' ' CYS . . . . . 0.509 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 2.0 t -71.71 -4.82 29.64 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.456 -0.777 . . . . 0.0 109.07 179.458 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.65 -9.3 34.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.516 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 20.6 t -82.22 -70.33 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.941 . . . . 0.0 109.554 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 2173 ' ' GLY . . . . . 0.419 ' O ' ' SG ' ' A' 2181 ' ' CYS . . . -173.48 -73.84 0.05 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2174 ' ' ASN . . . . . 0.492 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 0.1 OUTLIER -167.09 96.18 0.67 Allowed Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.21 -1.17 . . . . 0.0 109.089 -179.465 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A 2175 ' ' PRO . . . . . 0.56 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 2.2 Cg_endo -63.22 -27.94 72.72 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.952 1.768 . . . . 0.0 110.615 -179.654 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2176 ' ' CYS . . . . . 0.535 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -51.46 -54.96 21.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.037 -1.039 . . . . 0.0 108.596 -179.974 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 138.6 -17.43 3.28 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 2178 ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' 2179 ' ' GLY . 1.6 t-20 -164.49 -37.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -1.091 . . . . 0.0 109.98 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2179 ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -60.17 -116.07 0.01 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 3.0 p -149.59 162.7 39.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.402 -1.057 . . . . 0.0 109.423 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 2181 ' ' CYS . . . . . 0.56 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 21.6 p -97.83 156.41 16.6 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.045 -1.034 . . . . 0.0 111.074 -179.382 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2182 ' ' LYS . . . . . 0.559 ' CB ' ' O ' ' A' 2189 ' ' GLU . 2.4 tppt? -137.97 159.58 41.63 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 178.556 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 60.1 t30 -100.66 126.64 47.19 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.46 -1.4 . . . . 0.0 109.471 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 2184 ' ' VAL . . . . . 0.539 HG11 ' N ' ' A' 2188 ' ' PHE . 0.7 OUTLIER -137.61 162.38 32.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.521 -0.737 . . . . 0.0 109.242 -179.656 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A 2185 ' ' ILE . . . . . 0.522 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 3.2 mp -76.64 130.51 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 110.258 -179.255 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 89.86 -8.51 79.69 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 2187 ' ' GLY . . . . . 0.471 ' C ' ' CD1' ' A' 2188 ' ' PHE . . . 174.2 -109.41 0.3 Allowed Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.588 -1.292 . . . . 0.0 109.925 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2188 ' ' PHE . . . . . 0.552 ' HB3' ' HB2' ' A' 2169 ' ' GLU . 3.4 p90 -171.16 178.58 3.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -1.132 . . . . 0.0 109.488 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2189 ' ' GLU . . . . . 0.559 ' O ' ' CB ' ' A' 2182 ' ' LYS . 3.1 tt0 -128.13 131.98 48.96 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.243 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2190 ' ' CYS . . . . . 0.449 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 18.3 p -124.07 137.5 54.57 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.576 -1.328 . . . . 0.0 110.039 -179.144 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2191 ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' 2192 ' ' CYS . 25.6 m -108.8 85.28 2.07 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.334 -0.854 . . . . 0.0 109.552 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2192 ' ' CYS . . . . . 0.598 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.9 OUTLIER -49.23 179.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.515 -0.741 . . . . 0.0 109.19 179.893 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A 2193 ' ' GLU . . . . . 0.509 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.3 tt0 -55.22 112.87 1.18 Allowed 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2194 ' ' GLU . . . . . 0.509 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.8 OUTLIER -28.26 127.43 0.08 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.446 0.641 . . . . 0.0 111.263 -178.775 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.18 6.65 8.16 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 2196 ' ' PHE . . . . . 0.67 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.2 p90 -117.89 -163.26 0.93 Allowed 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.288 -1.125 . . . . 0.0 110.231 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2197 ' ' GLU . . . . . 0.549 ' N ' ' CG ' ' A' 2196 ' ' PHE . 11.8 mt-10 -144.57 95.82 5.32 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 121.507 -0.746 . . . . 0.0 109.527 -179.699 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2198 ' ' PRO . . . . . 0.67 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 8.3 Cg_endo -67.52 -165.13 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.274 1.983 . . . . 0.0 111.199 -179.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -129.37 -171.59 12.98 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.79 -58.41 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.154 1.902 . . . . 0.0 111.169 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 2201 ' ' MET . . . . . 0.514 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.0 OUTLIER -157.18 43.1 0.34 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.091 -1.006 . . . . 0.0 110.52 -179.119 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A 2202 ' ' MET . . . . . 0.451 ' O ' ' CE2' ' A' 2188 ' ' PHE . 17.2 mmm -115.82 -82.9 0.62 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.12 -0.987 . . . . 0.0 109.888 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2203 ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' 2175 ' ' PRO . 9.7 t -165.11 -169.97 1.8 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.182 -0.949 . . . . 0.0 109.604 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2204 ' ' CYS . . . . . 0.576 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.6 t -71.69 146.35 48.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.616 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.334 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A 2129 ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' 2130 ' ' GLU . 17.2 t0 . . . . . 0 N--CA 1.485 1.325 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2130 ' ' GLU . . . . . 0.591 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 2.0 mt-10 81.89 -44.91 0.18 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.864 -0.523 . . . . 0.0 110.511 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2131 ' ' CYS . . . . . 0.509 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 6.6 p -91.26 -31.92 15.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.038 -1.039 . . . . 0.0 110.041 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2132 ' ' LYS . . . . . 0.458 ' HB2' ' CG ' ' A' 2129 ' ' ASP . 0.1 OUTLIER -69.66 -7.47 39.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.088 -1.008 . . . . 0.0 109.622 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -70.32 151.87 95.68 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.378 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2134 ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -66.19 -7.46 17.36 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.374 2.049 . . . . 0.0 110.619 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2135 ' ' ASP . . . . . 0.518 ' O ' ' ND2' ' A' 2162 ' ' ASN . 0.5 OUTLIER -117.44 19.66 13.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.031 -1.043 . . . . 0.0 109.917 -179.551 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 2136 ' ' VAL . . . . . 0.533 ' CB ' ' O ' ' A' 2130 ' ' GLU . 21.4 t -144.55 127.94 11.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2137 ' ' CYS . . . . . 0.523 ' O ' ' HB2' ' A' 2138 ' ' LYS . 85.9 m 55.99 -90.28 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2138 ' ' LYS . . . . . 0.53 ' O ' ' CB ' ' A' 2139 ' ' HIS . 0.0 OUTLIER 70.0 19.39 6.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.397 -0.814 . . . . 0.0 109.983 179.121 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 2139 ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.3 OUTLIER 163.26 42.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.99 -1.069 . . . . 0.0 110.222 179.388 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -157.39 172.58 34.8 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.523 -1.323 . . . . 0.0 110.345 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2141 ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' 2152 ' ' GLU . 13.4 tt0 -89.71 98.08 11.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -1.1 . . . . 0.0 109.146 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2142 ' ' CYS . . . . . 0.54 ' C ' HD12 ' A' 2143 ' ' ILE . 24.0 p -89.04 177.81 6.55 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.312 -0.868 . . . . 0.0 110.204 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2143 ' ' ILE . . . . . 0.54 HD12 ' C ' ' A' 2142 ' ' CYS . 2.6 mp -134.97 99.84 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2144 ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' A' 2129 ' ' ASP . 14.8 t30 -56.66 112.69 1.36 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.303 -0.873 . . . . 0.0 110.77 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2145 ' ' THR . . . . . 0.519 HG23 ' HA ' ' A' 2149 ' ' TYR . 14.4 p -96.24 178.95 5.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.313 -0.867 . . . . 0.0 108.962 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -65.04 -48.8 72.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.225 -0.922 . . . . 0.0 109.703 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2147 ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' 2148 ' ' SER . . . -132.3 49.81 0.91 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2148 ' ' SER . . . . . 0.465 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER 171.56 -160.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -1.19 . . . . 0.0 109.54 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 2149 ' ' TYR . . . . . 0.591 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 3.9 p90 -158.13 -177.82 6.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.424 -0.798 . . . . 0.0 109.468 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2150 ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -151.52 99.38 2.61 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.17 -0.956 . . . . 0.0 109.706 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.86 136.21 56.62 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.561 -0.712 . . . . 0.0 109.778 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2152 ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' 2141 ' ' GLN . 0.1 OUTLIER -141.95 90.39 2.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.887 . . . . 0.0 109.241 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 2153 ' ' CYS . . . . . 0.543 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -69.38 149.26 97.29 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 109.496 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 2154 ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.2 -167.03 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.507 2.138 . . . . 0.0 111.112 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.05 105.52 17.87 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.6 -17.29 5.01 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 107.762 -2.135 . . . . 0.0 107.762 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2157 ' ' TYR . . . . . 0.543 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 9.0 m-85 -108.08 -171.46 1.87 Allowed 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.559 -0.965 . . . . 0.0 110.087 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2158 ' ' ILE . . . . . 0.716 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -156.17 -166.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 2159 ' ' LEU . . . . . 0.43 ' HA ' HD12 ' A' 2159 ' ' LEU . 33.9 tp -138.33 118.7 13.73 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.634 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -97.02 49.14 1.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.431 -0.793 . . . . 0.0 109.439 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 94.57 -28.82 10.09 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2162 ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' 2135 ' ' ASP . 1.4 m-20 -172.5 -43.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -1.116 . . . . 0.0 109.435 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -73.19 125.82 28.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.333 -0.855 . . . . 0.0 109.282 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2164 ' ' CYS . . . . . 0.687 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -102.74 137.88 40.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 108.956 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 2165 ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' 2164 ' ' CYS . 0.6 OUTLIER -160.63 -166.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.05 -1.031 . . . . 0.0 109.97 -179.595 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 2166 ' ' ASP . . . . . 0.496 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 0.5 OUTLIER -88.56 150.62 22.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.973 . . . . 0.0 110.358 -179.15 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 2167 ' ' THR . . . . . 0.64 HG23 ' OE1' ' A' 2169 ' ' GLU . 13.2 t -92.39 -175.9 4.15 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2168 ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' 2171 ' ' SER . 54.0 t0 -94.31 94.44 8.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.943 -1.098 . . . . 0.0 108.89 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2169 ' ' GLU . . . . . 0.691 ' O ' HG23 ' A' 2172 ' ' VAL . 0.8 OUTLIER -70.77 -30.59 67.12 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.289 -0.882 . . . . 0.0 109.644 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 2170 ' ' CYS . . . . . 0.469 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.6 t -65.14 -11.29 38.55 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.231 -0.918 . . . . 0.0 108.616 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2171 ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.1 OUTLIER -68.99 -6.11 25.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.126 -0.984 . . . . 0.0 109.354 179.426 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 2172 ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' 2169 ' ' GLU . 23.8 t -76.17 -67.98 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.291 -0.881 . . . . 0.0 109.247 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2173 ' ' GLY . . . . . . . . . . . . . . . 156.51 66.98 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2174 ' ' ASN . . . . . 0.502 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 2.8 t-20 49.75 84.92 0.2 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.22 -1.165 . . . . 0.0 109.573 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2175 ' ' PRO . . . . . 0.608 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 5.0 Cg_endo -68.9 -14.25 38.36 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.07 1.846 . . . . 0.0 109.548 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2176 ' ' CYS . . . . . 0.481 ' HB2' ' ND2' ' A' 2174 ' ' ASN . 1.0 OUTLIER -57.91 -62.01 2.12 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.972 0.891 . . . . 0.0 109.316 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 154.55 -21.27 0.62 Allowed Glycine 0 N--CA 1.482 1.744 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2178 ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' 2179 ' ' GLY . 1.2 t30 -165.1 -38.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -1.172 . . . . 0.0 110.148 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2179 ' ' GLY . . . . . 0.615 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -58.06 -141.8 0.01 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 2.3 p -127.46 154.67 44.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -1.139 . . . . 0.0 109.015 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2181 ' ' CYS . . . . . 0.588 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 9.5 p -95.21 163.22 13.37 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.238 1.018 . . . . 0.0 111.327 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2182 ' ' LYS . . . . . 0.547 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.6 OUTLIER -143.0 157.82 44.18 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.664 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 2183 ' ' ASN . . . . . 0.447 ' CG ' ' HA ' ' A' 2168 ' ' ASP . 44.5 t30 -94.64 131.14 40.74 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.349 -1.47 . . . . 0.0 110.007 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2184 ' ' VAL . . . . . 0.76 HG13 ' N ' ' A' 2185 ' ' ILE . 0.3 OUTLIER -135.97 -163.23 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.589 -0.695 . . . . 0.0 109.481 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 2185 ' ' ILE . . . . . 0.76 ' N ' HG13 ' A' 2184 ' ' VAL . 2.8 mp -107.85 142.48 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.147 -0.971 . . . . 0.0 110.39 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2186 ' ' GLY . . . . . 0.406 ' O ' ' SD ' ' A' 2201 ' ' MET . . . 67.33 8.67 51.94 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2187 ' ' GLY . . . . . 0.515 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 166.59 -115.31 0.62 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2188 ' ' PHE . . . . . 0.749 ' N ' HG12 ' A' 2184 ' ' VAL . 1.7 p90 -167.34 -178.62 4.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -1.116 . . . . 0.0 109.676 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2189 ' ' GLU . . . . . 0.547 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.2 OUTLIER -125.53 175.18 7.71 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.89 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 2190 ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' 2191 ' ' THR . 0.1 OUTLIER -170.82 158.12 5.78 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 118.649 -1.22 . . . . 0.0 110.01 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 2191 ' ' THR . . . . . 0.564 ' O ' HG22 ' A' 2191 ' ' THR . 18.8 m -129.51 78.98 1.88 Allowed 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2192 ' ' CYS . . . . . 0.64 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 1.2 m -47.84 177.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -0.915 . . . . 0.0 109.412 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2193 ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.2 OUTLIER -49.56 113.76 0.9 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.756 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 2194 ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.7 tp10 -32.23 129.36 0.19 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.535 0.683 . . . . 0.0 110.907 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.78 0.38 10.91 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2196 ' ' PHE . . . . . 0.675 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.8 OUTLIER -111.19 -162.85 0.81 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.257 -1.143 . . . . 0.0 110.367 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 2197 ' ' GLU . . . . . 0.58 ' N ' ' CG ' ' A' 2196 ' ' PHE . 2.0 mm-40 -147.52 98.04 3.97 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2198 ' ' PRO . . . . . 0.675 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.9 Cg_endo -68.71 -158.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.292 1.995 . . . . 0.0 111.292 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -138.57 -173.97 13.22 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.66 -57.83 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.14 1.893 . . . . 0.0 110.937 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A 2201 ' ' MET . . . . . 0.515 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -157.84 49.08 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 110.266 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A 2202 ' ' MET . . . . . 0.524 ' O ' ' CE2' ' A' 2188 ' ' PHE . 2.7 mmt -119.73 -89.58 0.6 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.043 -1.035 . . . . 0.0 109.979 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2203 ' ' THR . . . . . 0.435 HG23 ' N ' ' A' 2204 ' ' CYS . 6.1 t -157.88 -164.27 1.49 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.208 -0.933 . . . . 0.0 109.404 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2204 ' ' CYS . . . . . 0.532 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 3.9 t -74.08 139.63 44.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.134 -0.979 . . . . 0.0 109.04 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A 2205 ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' 2197 ' ' GLU . 3.2 pt-20 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.631 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2129 ' ' ASP . . . . . 0.519 ' O ' ' CB ' ' A' 2130 ' ' GLU . 18.1 t0 . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2130 ' ' GLU . . . . . 0.625 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 1.7 mt-10 82.14 -46.97 0.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.741 -0.599 . . . . 0.0 110.537 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2131 ' ' CYS . . . . . 0.497 ' HA ' HG11 ' A' 2136 ' ' VAL . 11.2 p -90.42 -28.51 18.59 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.947 -1.096 . . . . 0.0 109.472 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2132 ' ' LYS . . . . . 0.491 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.1 OUTLIER -81.46 7.4 11.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.323 -0.86 . . . . 0.0 109.357 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 2133 ' ' GLU . . . . . 0.578 ' OE1' HG21 ' A' 2136 ' ' VAL . 44.8 mt-10 -69.57 149.93 96.91 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 121.297 -0.877 . . . . 0.0 109.158 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2134 ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' 2133 ' ' GLU . 1.7 Cg_endo -65.38 -2.47 6.07 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.631 2.221 . . . . 0.0 111.74 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2135 ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' 2135 ' ' ASP . 17.6 p30 -134.3 6.26 3.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.682 -1.261 . . . . 0.0 110.633 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2136 ' ' VAL . . . . . 0.657 HG12 ' N ' ' A' 2137 ' ' CYS . 53.4 t -101.22 -94.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.924 -1.11 . . . . 0.0 109.851 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2137 ' ' CYS . . . . . 0.657 ' N ' HG12 ' A' 2136 ' ' VAL . 0.1 OUTLIER -81.02 -72.77 0.41 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.988 -1.07 . . . . 0.0 109.364 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 2138 ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' 2137 ' ' CYS . 0.1 OUTLIER 65.48 100.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 110.079 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 2139 ' ' HIS . . . . . 0.506 ' O ' ' HB3' ' A' 2164 ' ' CYS . 57.6 m-70 67.29 55.2 0.68 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 110.026 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -153.96 174.9 32.4 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -105.03 82.96 1.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -1.159 . . . . 0.0 108.963 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2142 ' ' CYS . . . . . 0.489 ' C ' HD12 ' A' 2143 ' ' ILE . 17.3 p -88.32 177.09 6.95 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.37 -0.831 . . . . 0.0 110.345 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2143 ' ' ILE . . . . . 0.489 HD12 ' C ' ' A' 2142 ' ' CYS . 4.0 mp -134.24 101.83 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2144 ' ' ASN . . . . . . . . . . . . . 17.0 t30 -58.37 116.87 3.9 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.197 -0.939 . . . . 0.0 110.522 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2145 ' ' THR . . . . . 0.418 ' OG1' ' C ' ' A' 2148 ' ' SER . 0.2 OUTLIER -103.73 174.25 5.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.469 -0.769 . . . . 0.0 108.955 179.142 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.64 -71.15 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.367 -0.833 . . . . 0.0 109.599 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2147 ' ' GLY . . . . . 0.483 ' O ' ' CB ' ' A' 2148 ' ' SER . . . -121.29 62.06 0.52 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2148 ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' 2147 ' ' GLY . 0.3 OUTLIER 166.83 -162.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -1.113 . . . . 0.0 109.546 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 2149 ' ' TYR . . . . . 0.625 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 51.4 p90 -169.1 -170.27 1.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 0.0 109.568 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2150 ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -160.86 112.07 1.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.38 -0.825 . . . . 0.0 109.18 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 1.5 m -75.42 90.21 2.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.9 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -105.58 99.56 9.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 108.878 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2153 ' ' CYS . . . . . 0.539 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -67.64 153.55 94.83 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.249 -0.907 . . . . 0.0 109.9 -179.472 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 2154 ' ' PRO . . . . . 0.482 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.7 Cg_endo -66.06 -167.23 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.593 2.195 . . . . 0.0 111.318 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 81.6 t80 -90.44 102.61 15.34 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.86 -13.88 5.52 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2157 ' ' TYR . . . . . 0.539 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 7.6 m-85 -108.78 -169.87 1.57 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.439 -1.036 . . . . 0.0 110.016 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2158 ' ' ILE . . . . . 0.841 HD11 HG23 ' A' 2165 ' ' VAL . 0.1 OUTLIER -154.76 -163.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 2159 ' ' LEU . . . . . . . . . . . . . 29.6 tp -141.74 122.12 14.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.199 -0.938 . . . . 0.0 109.718 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -99.58 53.34 0.94 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.307 -0.871 . . . . 0.0 109.265 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2161 ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 87.36 -12.31 63.14 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2162 ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' 2136 ' ' VAL . 1.3 m-20 168.95 -44.85 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.303 -1.116 . . . . 0.0 109.382 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -71.5 114.5 9.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 109.144 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2164 ' ' CYS . . . . . 0.562 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -92.26 139.07 30.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 109.539 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 2165 ' ' VAL . . . . . 0.841 HG23 HD11 ' A' 2158 ' ' ILE . 3.7 m -156.99 -168.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.953 . . . . 0.0 109.569 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2166 ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 13.8 t70 -90.16 155.78 18.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.019 -1.051 . . . . 0.0 109.909 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2167 ' ' THR . . . . . 0.867 HG23 ' OE1' ' A' 2169 ' ' GLU . 10.0 t -98.41 174.96 6.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -0.842 . . . . 0.0 109.248 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2168 ' ' ASP . . . . . 0.454 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 44.4 t0 -93.46 95.17 9.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.077 -1.014 . . . . 0.0 108.935 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2169 ' ' GLU . . . . . 0.867 ' OE1' HG23 ' A' 2167 ' ' THR . 0.6 OUTLIER -69.05 -32.26 71.61 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.318 -0.864 . . . . 0.0 109.573 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 2170 ' ' CYS . . . . . 0.537 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.1 t -65.22 -12.23 49.23 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.61 4.64 10.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.184 -0.947 . . . . 0.0 109.696 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 55.0 t -105.38 -79.03 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.21 -0.931 . . . . 0.0 109.857 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2173 ' ' GLY . . . . . 0.467 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -153.95 135.0 4.57 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2174 ' ' ASN . . . . . 0.609 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 26.0 p-10 -41.68 101.61 0.25 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.41 -1.053 . . . . 0.0 110.092 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2175 ' ' PRO . . . . . 0.577 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 1.1 Cg_endo -65.99 -21.87 56.13 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.827 1.685 . . . . 0.0 109.719 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2176 ' ' CYS . . . . . 0.593 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.1 OUTLIER -52.77 -35.76 57.0 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.169 -0.957 . . . . 0.0 109.308 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 114.4 -14.0 20.8 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2178 ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' 2179 ' ' GLY . 5.0 p-10 -171.48 -47.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.456 -1.026 . . . . 0.0 109.557 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2179 ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -52.47 -114.64 0.01 OUTLIER Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2180 ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' 2190 ' ' CYS . 0.8 OUTLIER -150.48 158.54 44.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -1.186 . . . . 0.0 109.371 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 2181 ' ' CYS . . . . . 0.609 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 16.0 p -90.3 166.14 13.49 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 122.368 1.08 . . . . 0.0 111.23 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2182 ' ' LYS . . . . . 0.635 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 11.3 tptt -143.84 155.81 44.25 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2183 ' ' ASN . . . . . 0.454 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 60.7 t30 -98.78 132.44 44.14 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.483 -1.385 . . . . 0.0 109.734 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2184 ' ' VAL . . . . . 0.827 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -140.8 -171.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.601 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 2185 ' ' ILE . . . . . 0.588 ' N ' HG13 ' A' 2184 ' ' VAL . 4.5 mp -104.85 135.67 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.85 -1.156 . . . . 0.0 110.387 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 72.68 13.53 78.14 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2187 ' ' GLY . . . . . 0.579 ' C ' HG12 ' A' 2184 ' ' VAL . . . 166.21 -121.18 0.97 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2188 ' ' PHE . . . . . 0.827 ' N ' HG12 ' A' 2184 ' ' VAL . 4.3 p90 -176.4 173.71 2.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.355 -1.085 . . . . 0.0 108.966 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2189 ' ' GLU . . . . . 0.635 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 3.1 tt0 -120.9 178.07 4.86 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2190 ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' 2180 ' ' THR . 7.6 p -170.9 152.17 3.54 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.861 -1.149 . . . . 0.0 109.436 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2191 ' ' THR . . . . . . . . . . . . . 46.0 m -122.37 91.21 3.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 0.0 110.032 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2192 ' ' CYS . . . . . 0.628 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -54.49 177.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.033 -1.042 . . . . 0.0 108.383 179.173 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 2193 ' ' GLU . . . . . 0.469 ' O ' ' C ' ' A' 2194 ' ' GLU . 7.4 tt0 -54.66 119.34 5.17 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 178.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2194 ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' 2193 ' ' GLU . 2.1 tt0 -35.08 131.58 0.4 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.536 0.684 . . . . 0.0 110.857 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.49 3.76 10.17 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2196 ' ' PHE . . . . . 0.678 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.0 OUTLIER -116.87 -163.89 0.94 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.224 -1.162 . . . . 0.0 110.489 -179.573 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 2197 ' ' GLU . . . . . 0.567 ' N ' ' CG ' ' A' 2196 ' ' PHE . 20.8 mt-10 -145.31 96.67 4.85 Favored Pre-proline 0 C--N 1.305 -1.364 0 O-C-N 121.633 -0.667 . . . . 0.0 109.512 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2198 ' ' PRO . . . . . 0.678 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.0 Cg_endo -68.69 -164.17 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.149 1.9 . . . . 0.0 111.012 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -133.29 -171.0 12.57 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.39 -81.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.028 1.819 . . . . 0.0 110.431 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2201 ' ' MET . . . . . 0.486 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.0 OUTLIER -133.99 49.97 2.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.089 -1.007 . . . . 0.0 109.684 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 1.7 mmm -122.1 -75.84 0.59 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.336 -0.853 . . . . 0.0 109.601 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A 2203 ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' 2175 ' ' PRO . 14.9 t -173.21 -173.69 0.95 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 109.748 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A 2204 ' ' CYS . . . . . 0.593 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -108.73 151.63 25.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.371 -0.831 . . . . 0.0 109.149 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.049 -0.976 . . . . 0.0 109.544 -179.984 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A 2129 ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' 2130 ' ' GLU . 19.1 t0 . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2130 ' ' GLU . . . . . 0.7 ' O ' HG21 ' A' 2136 ' ' VAL . 0.7 OUTLIER 81.52 -41.25 0.15 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.491 -0.756 . . . . 0.0 111.503 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 2131 ' ' CYS . . . . . 0.492 ' HB3' ' HB2' ' A' 2149 ' ' TYR . 14.5 p -90.57 -36.66 14.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.629 -1.294 . . . . 0.0 110.263 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2132 ' ' LYS . . . . . 0.503 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -81.62 7.62 11.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.164 -0.96 . . . . 0.0 109.798 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 2133 ' ' GLU . . . . . 0.414 ' OE2' ' HA ' ' A' 2130 ' ' GLU . 10.0 mt-10 -72.7 153.48 91.44 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.208 -0.933 . . . . 0.0 109.29 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2134 ' ' PRO . . . . . 0.571 ' HA ' ' CG ' ' A' 2138 ' ' LYS . 1.3 Cg_endo -63.72 -8.24 14.97 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.274 1.983 . . . . 0.0 110.667 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2135 ' ' ASP . . . . . 0.632 ' OD1' HG23 ' A' 2136 ' ' VAL . 1.0 OUTLIER -104.34 -20.87 13.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.05 -1.031 . . . . 0.0 110.071 -179.577 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 2136 ' ' VAL . . . . . 0.931 HG11 ' CE1' ' A' 2149 ' ' TYR . 2.0 t -109.86 -140.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.1 -1.0 . . . . 0.0 108.98 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2137 ' ' CYS . . . . . 0.45 ' H ' HG12 ' A' 2136 ' ' VAL . 0.8 OUTLIER -45.7 96.38 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.897 -1.127 . . . . 0.0 108.984 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 2138 ' ' LYS . . . . . 0.571 ' CG ' ' HA ' ' A' 2134 ' ' PRO . 5.0 mtmt -102.12 26.85 7.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.253 -0.904 . . . . 0.0 110.118 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2139 ' ' HIS . . . . . 0.496 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.0 OUTLIER 165.4 48.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.023 -1.048 . . . . 0.0 110.027 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 2140 ' ' GLY . . . . . 0.475 ' HA2' ' HD3' ' A' 2154 ' ' PRO . . . -152.97 -179.65 28.67 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -100.89 72.03 1.47 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.409 -1.054 . . . . 0.0 109.289 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2142 ' ' CYS . . . . . 0.534 ' C ' HD12 ' A' 2143 ' ' ILE . 7.4 p -62.9 -169.22 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.355 -0.84 . . . . 0.0 110.05 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2143 ' ' ILE . . . . . 0.534 HD12 ' C ' ' A' 2142 ' ' CYS . 4.0 mp -141.54 103.09 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2144 ' ' ASN . . . . . . . . . . . . . 23.6 t30 -62.25 116.99 5.48 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.216 -0.927 . . . . 0.0 110.468 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2145 ' ' THR . . . . . 0.48 ' HG1' ' C ' ' A' 2148 ' ' SER . 2.2 p -107.23 -170.6 1.73 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.429 -0.795 . . . . 0.0 108.949 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.79 85.25 4.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.286 -0.883 . . . . 0.0 109.735 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 96.89 -55.58 1.34 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2148 ' ' SER . . . . . 0.48 ' C ' ' HG1' ' A' 2145 ' ' THR . 0.4 OUTLIER -84.72 -158.99 0.39 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -1.097 . . . . 0.0 109.828 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 2149 ' ' TYR . . . . . 0.931 ' CE1' HG11 ' A' 2136 ' ' VAL . 41.2 p90 -178.82 -167.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.489 -0.757 . . . . 0.0 109.375 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2150 ' ' ARG . . . . . 0.49 ' CB ' ' CZ ' ' A' 2150 ' ' ARG . 0.0 OUTLIER -169.02 115.07 0.6 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 109.321 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 2151 ' ' CYS . . . . . 0.486 ' SG ' HD13 ' A' 2159 ' ' LEU . 43.3 t -81.55 113.1 19.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.704 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.48 84.29 2.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.011 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2153 ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -47.4 155.57 0.71 Allowed Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.259 -0.901 . . . . 0.0 109.798 -179.52 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 2154 ' ' PRO . . . . . 0.475 ' HD3' ' HA2' ' A' 2140 ' ' GLY . 1.1 Cg_endo -64.23 -168.8 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.73 2.286 . . . . 0.0 111.703 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 43.9 t80 -88.48 102.81 15.27 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.66 -14.76 5.51 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2157 ' ' TYR . . . . . 0.527 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 7.5 m-85 -109.05 -170.03 1.59 Allowed 'General case' 0 N--CA 1.483 1.222 0 O-C-N 121.574 -0.957 . . . . 0.0 109.74 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2158 ' ' ILE . . . . . 0.731 HD13 ' N ' ' A' 2158 ' ' ILE . 0.2 OUTLIER -156.95 -160.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.579 -0.701 . . . . 0.0 109.563 179.736 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 2159 ' ' LEU . . . . . 0.486 HD13 ' SG ' ' A' 2151 ' ' CYS . 29.4 tp -145.57 124.17 12.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.414 -0.804 . . . . 0.0 109.377 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -99.02 51.54 0.96 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.353 -0.842 . . . . 0.0 109.486 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 90.26 -22.76 24.93 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2162 ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' 2135 ' ' ASP . 1.4 m-20 -176.03 -45.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.125 -1.22 . . . . 0.0 109.953 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -75.52 127.14 32.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.048 -1.033 . . . . 0.0 109.614 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2164 ' ' CYS . . . . . 0.703 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -99.74 140.38 34.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.69 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 2165 ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' 2164 ' ' CYS . 0.9 OUTLIER -161.82 -166.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.374 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 2166 ' ' ASP . . . . . 0.487 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 23.1 t70 -90.13 159.27 16.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.068 -1.02 . . . . 0.0 109.863 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2167 ' ' THR . . . . . 0.569 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 5.5 t -99.88 -167.42 1.46 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.185 -0.947 . . . . 0.0 109.362 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2168 ' ' ASP . . . . . 0.479 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 57.6 t0 -108.92 99.79 9.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.183 -0.948 . . . . 0.0 109.325 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2169 ' ' GLU . . . . . 0.595 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.6 OUTLIER -74.38 -30.68 62.08 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.21 -0.931 . . . . 0.0 109.446 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 2170 ' ' CYS . . . . . 0.467 ' O ' ' SG ' ' A' 2181 ' ' CYS . 3.1 t -66.85 -8.32 28.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.282 -0.886 . . . . 0.0 109.023 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2171 ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -70.33 -3.8 19.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.066 -1.021 . . . . 0.0 109.541 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 2172 ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' 2169 ' ' GLU . 17.7 t -86.27 -72.51 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 109.569 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2173 ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' 2174 ' ' ASN . . . 166.2 77.94 0.04 OUTLIER Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.641 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2174 ' ' ASN . . . . . 0.623 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 11.0 p-10 36.56 89.12 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.537 -0.978 . . . . 0.0 110.993 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2175 ' ' PRO . . . . . 0.601 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 5.8 Cg_endo -67.5 -12.71 36.67 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.153 1.902 . . . . 0.0 109.227 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2176 ' ' CYS . . . . . 0.479 ' HB3' ' SG ' ' A' 2192 ' ' CYS . 0.9 OUTLIER -55.92 -58.02 9.63 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.834 0.826 . . . . 0.0 109.543 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 146.84 -26.22 1.62 Allowed Glycine 0 N--CA 1.484 1.854 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2178 ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.4 OUTLIER -157.05 -39.39 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.306 -1.114 . . . . 0.0 109.845 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 2179 ' ' GLY . . . . . 0.67 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -59.43 -140.02 0.01 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2180 ' ' THR . . . . . 0.408 ' HA ' ' HB3' ' A' 2174 ' ' ASN . 1.5 p -133.19 148.0 52.04 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.53 -0.982 . . . . 0.0 109.4 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2181 ' ' CYS . . . . . 0.623 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 11.8 p -82.1 167.37 18.83 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.372 1.082 . . . . 0.0 111.439 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2182 ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 6.9 tttm -142.39 161.61 37.6 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2183 ' ' ASN . . . . . 0.479 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 46.6 t30 -101.12 128.78 47.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.412 -1.43 . . . . 0.0 110.108 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2184 ' ' VAL . . . . . 0.84 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -137.41 -175.57 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 2185 ' ' ILE . . . . . 0.525 ' N ' HG13 ' A' 2184 ' ' VAL . 3.7 mp -100.05 140.85 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.114 -0.991 . . . . 0.0 110.053 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 70.62 8.4 63.2 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2187 ' ' GLY . . . . . 0.577 ' C ' HG12 ' A' 2184 ' ' VAL . . . 167.72 -121.4 0.96 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2188 ' ' PHE . . . . . 0.84 ' N ' HG12 ' A' 2184 ' ' VAL . 2.3 p90 -169.04 178.61 4.39 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.272 -1.134 . . . . 0.0 109.295 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2189 ' ' GLU . . . . . 0.566 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.4 tt0 -124.19 -179.67 4.53 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2190 ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' 2191 ' ' THR . 0.5 OUTLIER -171.05 157.74 5.33 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 118.959 -1.096 . . . . 0.0 110.17 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 2191 ' ' THR . . . . . 0.514 ' N ' ' SG ' ' A' 2190 ' ' CYS . 80.3 m -128.75 80.27 1.96 Allowed 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2192 ' ' CYS . . . . . 0.67 ' HA ' ' HA3' ' A' 2179 ' ' GLY . 1.2 m -54.16 175.64 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.224 -0.922 . . . . 0.0 110.149 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2193 ' ' GLU . . . . . 0.508 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.5 tt0 -47.11 108.8 0.16 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2194 ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.4 OUTLIER -28.5 125.72 0.1 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.45 0.643 . . . . 0.0 111.237 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.78 4.22 9.7 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2196 ' ' PHE . . . . . 0.675 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.8 OUTLIER -112.71 -164.26 0.91 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.252 -1.146 . . . . 0.0 110.498 -179.628 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 2197 ' ' GLU . . . . . 0.556 ' N ' ' CG ' ' A' 2196 ' ' PHE . 16.6 mt-10 -145.39 97.29 4.74 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2198 ' ' PRO . . . . . 0.675 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.0 Cg_endo -68.47 -159.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.026 1.818 . . . . 0.0 110.999 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -136.05 -174.88 13.54 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.534 -1.827 . . . . 0.0 108.534 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.63 -52.79 1.64 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.114 1.876 . . . . 0.0 110.622 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A 2201 ' ' MET . . . . . 0.535 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -163.93 57.69 0.16 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.399 -0.813 . . . . 0.0 109.462 -179.52 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -127.99 -84.09 0.59 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 110.002 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2203 ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' 2175 ' ' PRO . 13.3 t -163.36 -164.15 0.91 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.346 -0.846 . . . . 0.0 108.827 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2204 ' ' CYS . . . . . 0.565 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 3.3 t -74.26 140.86 45.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.953 -1.092 . . . . 0.0 109.329 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A 2205 ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' 2197 ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.514 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2129 ' ' ASP . . . . . 0.46 ' OD1' ' SG ' ' A' 2131 ' ' CYS . 53.5 t0 . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2130 ' ' GLU . . . . . 0.668 ' O ' HG11 ' A' 2136 ' ' VAL . 22.7 mp0 -49.11 -26.93 3.04 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.289 -0.882 . . . . 0.0 110.547 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2131 ' ' CYS . . . . . 0.493 ' O ' ' HB2' ' A' 2137 ' ' CYS . 0.8 OUTLIER -78.47 -36.1 45.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.701 -1.25 . . . . 0.0 109.678 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 2132 ' ' LYS . . . . . 0.447 ' HB2' ' CG ' ' A' 2129 ' ' ASP . 0.0 OUTLIER -85.53 44.8 1.13 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.003 -1.061 . . . . 0.0 108.623 178.685 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 2133 ' ' GLU . . . . . 0.558 ' CB ' ' HD2' ' A' 2134 ' ' PRO . 1.4 mt-10 -104.59 173.56 3.26 Favored Pre-proline 0 N--CA 1.486 1.349 0 O-C-N 121.466 -0.771 . . . . 0.0 109.765 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2134 ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' 2133 ' ' GLU . 3.1 Cg_exo -60.41 -11.62 17.32 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.584 2.189 . . . . 0.0 112.542 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2135 ' ' ASP . . . . . 0.581 ' O ' ' C ' ' A' 2136 ' ' VAL . 26.8 m-20 -145.95 -77.41 0.19 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.274 -1.516 . . . . 0.0 111.502 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2136 ' ' VAL . . . . . 0.973 HG23 ' CE1' ' A' 2149 ' ' TYR . 0.1 OUTLIER -12.77 -78.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 120.89 0.376 . . . . 0.0 111.057 -178.527 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 2137 ' ' CYS . . . . . 0.747 ' N ' HG22 ' A' 2136 ' ' VAL . 13.0 m -121.11 146.07 47.13 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.689 -1.257 . . . . 0.0 108.949 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2138 ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' 2137 ' ' CYS . 2.4 mtpt -161.08 115.99 2.11 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.092 -1.005 . . . . 0.0 109.807 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2139 ' ' HIS . . . . . 0.465 ' O ' ' HB3' ' A' 2164 ' ' CYS . 20.6 m80 71.42 46.63 0.41 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.212 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -154.17 174.9 32.56 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -89.81 86.14 6.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -1.159 . . . . 0.0 108.513 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2142 ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' 2150 ' ' ARG . 13.4 p -85.26 178.84 7.35 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.285 -0.884 . . . . 0.0 110.811 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2143 ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' 2145 ' ' THR . 4.0 mp -140.02 88.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2144 ' ' ASN . . . . . . . . . . . . . 44.1 t30 -53.94 116.08 2.36 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.515 0.674 . . . . 0.0 110.515 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2145 ' ' THR . . . . . 0.435 HG23 ' O ' ' A' 2143 ' ' ILE . 56.4 p -107.75 -171.31 1.85 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2146 ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' 2145 ' ' THR . 0.4 OUTLIER -45.4 -79.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 109.284 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -115.45 -33.61 1.57 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2148 ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.77 -162.13 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -1.138 . . . . 0.0 109.44 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2149 ' ' TYR . . . . . 0.973 ' CE1' HG23 ' A' 2136 ' ' VAL . 12.9 p90 -172.58 -172.72 0.93 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.373 -0.83 . . . . 0.0 109.312 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2150 ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' A' 2149 ' ' TYR . 11.6 mtt180 -159.6 113.79 2.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.392 -0.818 . . . . 0.0 109.24 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2151 ' ' CYS . . . . . 0.527 ' HB2' HD13 ' A' 2159 ' ' LEU . 4.1 m -84.03 68.21 9.96 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.492 -0.755 . . . . 0.0 109.275 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -79.49 134.74 36.52 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.314 -0.866 . . . . 0.0 108.983 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2153 ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -101.53 154.23 37.38 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.245 -0.909 . . . . 0.0 109.772 -179.574 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 2154 ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' 2157 ' ' TYR . 1.5 Cg_endo -64.4 -166.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.505 2.137 . . . . 0.0 110.906 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 65.8 t80 -90.34 102.53 15.26 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.26 -13.9 5.42 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.169 -1.973 . . . . 0.0 108.169 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2157 ' ' TYR . . . . . 0.533 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 7.4 m-85 -108.21 -167.92 1.3 Allowed 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.533 -0.981 . . . . 0.0 109.901 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2158 ' ' ILE . . . . . 0.979 HD11 HG23 ' A' 2165 ' ' VAL . 0.2 OUTLIER -156.21 -166.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.6 -0.687 . . . . 0.0 109.193 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 2159 ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' 2151 ' ' CYS . 9.5 tp -143.17 130.4 20.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.313 -0.867 . . . . 0.0 109.332 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -101.4 46.6 0.93 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.261 -0.899 . . . . 0.0 108.921 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2161 ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' 2162 ' ' ASN . . . 86.36 -9.28 70.95 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2162 ' ' ASN . . . . . 0.509 ' CA ' ' O ' ' A' 2136 ' ' VAL . 12.7 p-10 178.05 -47.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.248 . . . . 0.0 109.882 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2163 ' ' GLU . . . . . 0.423 ' N ' ' CG ' ' A' 2162 ' ' ASN . 11.5 tt0 -77.82 116.54 18.41 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.7 -0.625 . . . . 0.0 109.867 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2164 ' ' CYS . . . . . 0.589 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -93.21 140.72 29.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.93 . . . . 0.0 109.457 179.743 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 2165 ' ' VAL . . . . . 0.979 HG23 HD11 ' A' 2158 ' ' ILE . 1.4 m -157.12 -165.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.105 -0.997 . . . . 0.0 109.562 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2166 ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 35.0 t70 -89.13 165.75 14.29 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.936 -1.102 . . . . 0.0 110.226 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2167 ' ' THR . . . . . 0.556 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 1.6 t -113.56 -169.94 1.6 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.408 -0.808 . . . . 0.0 109.407 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2168 ' ' ASP . . . . . 0.512 ' N ' HG23 ' A' 2167 ' ' THR . 55.7 t0 -109.3 98.85 8.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.249 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2169 ' ' GLU . . . . . 0.593 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.6 OUTLIER -73.47 -31.61 63.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.366 -0.834 . . . . 0.0 109.33 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 2170 ' ' CYS . . . . . 0.444 ' O ' ' SG ' ' A' 2170 ' ' CYS . 1.7 t -66.27 -9.47 32.91 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.342 -0.849 . . . . 0.0 108.735 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.52 7.92 8.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.363 -0.836 . . . . 0.0 110.234 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 57.4 t -112.42 -80.23 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.0 -1.062 . . . . 0.0 109.772 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2173 ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -147.63 131.73 3.99 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2174 ' ' ASN . . . . . 0.607 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 26.9 p-10 -43.78 102.66 0.29 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.301 -1.117 . . . . 0.0 109.577 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2175 ' ' PRO . . . . . 0.592 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 2.7 Cg_endo -70.65 -20.24 30.9 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.807 1.671 . . . . 0.0 110.015 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2176 ' ' CYS . . . . . 0.58 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.1 OUTLIER -50.88 -31.12 16.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -0.989 . . . . 0.0 109.3 -179.463 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 112.63 -23.72 14.69 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -168.67 -34.57 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.577 -0.955 . . . . 0.0 110.028 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2179 ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -63.65 -127.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 2.8 p -135.71 157.79 46.0 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.527 -0.984 . . . . 0.0 109.133 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2181 ' ' CYS . . . . . 0.607 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 12.9 p -95.46 162.31 13.7 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.053 -1.03 . . . . 0.0 111.186 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2182 ' ' LYS . . . . . 0.575 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 5.3 tptm -142.23 165.28 27.87 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2183 ' ' ASN . . . . . 0.46 ' N ' ' HG3' ' A' 2182 ' ' LYS . 63.1 t30 -100.74 138.15 38.18 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.505 -1.372 . . . . 0.0 110.09 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2184 ' ' VAL . . . . . 0.889 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -147.33 165.88 6.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 2185 ' ' ILE . . . . . 0.528 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 3.2 mp -86.85 131.47 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.071 -1.018 . . . . 0.0 110.224 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 86.43 6.34 81.0 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2187 ' ' GLY . . . . . 0.547 ' C ' HG12 ' A' 2184 ' ' VAL . . . 162.73 -113.63 0.57 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2188 ' ' PHE . . . . . 0.889 ' N ' HG12 ' A' 2184 ' ' VAL . 2.9 p90 -173.3 179.48 2.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.171 -1.194 . . . . 0.0 109.352 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2189 ' ' GLU . . . . . 0.575 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.6 tt0 -125.71 173.24 9.16 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 3.5 p -170.87 148.01 2.8 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.653 -1.279 . . . . 0.0 110.016 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2191 ' ' THR . . . . . . . . . . . . . 60.6 m -118.67 87.87 2.81 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.376 -0.828 . . . . 0.0 109.291 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2192 ' ' CYS . . . . . 0.617 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.0 OUTLIER -51.81 178.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.299 -0.876 . . . . 0.0 108.92 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 2193 ' ' GLU . . . . . 0.46 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.0 OUTLIER -53.33 118.22 3.65 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.494 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 2194 ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.4 mt-10 -34.2 128.94 0.38 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.444 0.64 . . . . 0.0 110.991 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.77 4.04 9.79 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2196 ' ' PHE . . . . . 0.672 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.1 p90 -115.06 -164.01 0.91 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.306 -1.114 . . . . 0.0 110.487 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2197 ' ' GLU . . . . . 0.555 ' N ' ' CG ' ' A' 2196 ' ' PHE . 14.5 mt-10 -145.58 96.64 4.76 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.652 -0.655 . . . . 0.0 109.444 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2198 ' ' PRO . . . . . 0.672 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.1 Cg_endo -68.42 -166.3 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.249 1.966 . . . . 0.0 111.44 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -133.25 -173.82 13.39 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.75 -78.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.005 1.803 . . . . 0.0 110.751 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2201 ' ' MET . . . . . 0.478 ' SD ' ' O ' ' A' 2185 ' ' ILE . 0.0 OUTLIER -138.73 40.76 2.18 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.224 -0.922 . . . . 0.0 109.634 -179.271 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 1.6 mmm -112.41 -69.25 0.88 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.131 -0.98 . . . . 0.0 109.721 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2203 ' ' THR . . . . . . . . . . . . . 7.0 t -175.48 -168.27 0.3 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.854 . . . . 0.0 109.504 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A 2204 ' ' CYS . . . . . 0.58 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -114.81 153.93 29.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 108.936 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.563 -179.892 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A 2129 ' ' ASP . . . . . 0.53 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 25.3 t0 . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2130 ' ' GLU . . . . . 0.765 ' O ' HG21 ' A' 2136 ' ' VAL . 1.7 mt-10 81.26 -38.67 0.13 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.754 -0.592 . . . . 0.0 110.452 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2131 ' ' CYS . . . . . 0.487 ' O ' ' HB2' ' A' 2137 ' ' CYS . 5.2 p -90.71 -40.36 11.9 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.752 -1.217 . . . . 0.0 110.02 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2132 ' ' LYS . . . . . 0.483 ' N ' ' SG ' ' A' 2131 ' ' CYS . 0.0 OUTLIER -75.6 7.11 3.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.099 -1.001 . . . . 0.0 110.465 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 2133 ' ' GLU . . . . . 0.482 ' HB2' HG23 ' A' 2136 ' ' VAL . 7.3 mm-40 -69.22 151.5 96.99 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.989 -1.069 . . . . 0.0 109.448 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2134 ' ' PRO . . . . . 0.511 ' HA ' ' HE2' ' A' 2138 ' ' LYS . 1.4 Cg_endo -64.47 -6.45 11.98 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.392 2.061 . . . . 0.0 110.889 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2135 ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' 2162 ' ' ASN . 10.6 m-20 -118.15 -25.85 6.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.929 -1.107 . . . . 0.0 110.407 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2136 ' ' VAL . . . . . 0.765 HG21 ' O ' ' A' 2130 ' ' GLU . 16.4 t -83.48 -119.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.076 -1.015 . . . . 0.0 108.813 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2137 ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' 2131 ' ' CYS . 59.3 m -67.4 145.89 54.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.554 -1.341 . . . . 0.0 108.392 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2138 ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' 2134 ' ' PRO . 4.1 mttm -149.99 28.43 0.76 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.045 -1.035 . . . . 0.0 110.139 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2139 ' ' HIS . . . . . 0.491 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.1 OUTLIER 162.72 36.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.221 -0.925 . . . . 0.0 109.804 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -150.88 -176.09 23.45 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.62 111.72 24.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -1.066 . . . . 0.0 109.541 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2142 ' ' CYS . . . . . 0.645 ' C ' HD12 ' A' 2143 ' ' ILE . 11.0 p -99.39 -167.81 1.53 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.301 -0.874 . . . . 0.0 109.594 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2143 ' ' ILE . . . . . 0.69 ' O ' HG23 ' A' 2145 ' ' THR . 3.4 mp -149.89 101.09 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 109.259 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2144 ' ' ASN . . . . . 0.53 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 11.2 t-20 -52.65 113.99 1.25 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.3 -0.875 . . . . 0.0 110.189 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2145 ' ' THR . . . . . 0.69 HG23 ' O ' ' A' 2143 ' ' ILE . 5.0 p -117.41 -179.81 3.83 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.372 -0.83 . . . . 0.0 109.083 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.56 117.9 31.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.309 -0.869 . . . . 0.0 109.558 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 73.61 18.75 79.56 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2148 ' ' SER . . . . . 0.477 ' C ' ' HG1' ' A' 2145 ' ' THR . 0.0 OUTLIER -174.81 -171.1 0.52 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -1.147 . . . . 0.0 109.566 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 2149 ' ' TYR . . . . . 0.487 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 7.0 p90 -164.11 -168.43 1.57 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.86 . . . . 0.0 109.408 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2150 ' ' ARG . . . . . 0.489 ' HB2' ' HB ' ' A' 2143 ' ' ILE . 0.0 OUTLIER -130.65 -165.0 1.49 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.869 . . . . 0.0 109.562 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 176.79 38.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.417 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.83 147.19 30.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.356 -0.84 . . . . 0.0 109.364 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2153 ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -110.16 160.77 27.06 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.335 -0.853 . . . . 0.0 109.536 -179.69 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 2154 ' ' PRO . . . . . 0.495 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 2.3 Cg_endo -61.72 -174.46 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.664 2.243 . . . . 0.0 111.669 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 4.4 t80 -81.44 103.19 11.01 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.92 -19.74 4.9 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 107.182 -2.367 . . . . 0.0 107.182 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2157 ' ' TYR . . . . . 0.512 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 20.1 m-85 -108.35 178.71 4.41 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.806 -0.82 . . . . 0.0 109.794 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2158 ' ' ILE . . . . . 0.763 HD13 ' N ' ' A' 2158 ' ' ILE . 0.2 OUTLIER -157.61 -166.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 2159 ' ' LEU . . . . . 0.413 ' HG ' ' N ' ' A' 2160 ' ' ALA . 11.4 tp -131.31 144.98 51.67 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.245 -0.91 . . . . 0.0 109.835 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2160 ' ' ALA . . . . . 0.413 ' N ' ' HG ' ' A' 2159 ' ' LEU . . . -121.11 53.82 1.13 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.389 -0.819 . . . . 0.0 109.013 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 93.59 -21.39 41.29 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2162 ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' 2135 ' ' ASP . 4.0 m-20 173.04 -40.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.357 -1.084 . . . . 0.0 109.502 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -77.87 122.27 25.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 0.0 109.295 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2164 ' ' CYS . . . . . 0.68 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -92.41 143.38 26.43 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 0.0 109.397 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 2165 ' ' VAL . . . . . 0.68 HG13 ' O ' ' A' 2164 ' ' CYS . 1.5 m -160.89 -168.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.12 -0.987 . . . . 0.0 109.485 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2166 ' ' ASP . . . . . 0.43 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 1.1 t0 -90.61 144.85 25.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.001 -1.062 . . . . 0.0 109.747 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2167 ' ' THR . . . . . 0.613 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 9.1 t -91.96 179.64 5.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.886 . . . . 0.0 109.528 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2168 ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' 2171 ' ' SER . 33.2 t0 -86.74 95.6 9.88 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2169 ' ' GLU . . . . . 0.612 ' O ' HG23 ' A' 2172 ' ' VAL . 0.4 OUTLIER -66.22 -27.89 68.32 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.135 -0.978 . . . . 0.0 110.418 -179.006 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 2170 ' ' CYS . . . . . 0.439 ' HB3' ' OD1' ' A' 2168 ' ' ASP . 0.7 OUTLIER -58.13 -13.18 4.37 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.901 -1.125 . . . . 0.0 108.891 178.493 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 2171 ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -61.24 -10.66 7.19 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.137 -0.977 . . . . 0.0 110.159 -179.335 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 2172 ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' 2169 ' ' GLU . 17.4 t -77.06 -69.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.173 -0.954 . . . . 0.0 109.406 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2173 ' ' GLY . . . . . . . . . . . . . . . 156.36 92.96 0.09 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2174 ' ' ASN . . . . . . . . . . . . . 1.3 t-20 45.68 87.79 0.11 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.199 -1.177 . . . . 0.0 110.027 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2175 ' ' PRO . . . . . 0.661 ' CB ' ' CD1' ' A' 2188 ' ' PHE . 1.6 Cg_endo -63.02 -23.45 73.91 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.896 1.731 . . . . 0.0 110.212 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2176 ' ' CYS . . . . . 0.47 ' HB3' ' SG ' ' A' 2192 ' ' CYS . 0.4 OUTLIER -76.83 -68.11 0.64 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 109.288 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 159.81 -20.89 0.26 Allowed Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 1.3 t30 -166.55 -30.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.156 -1.202 . . . . 0.0 110.853 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2179 ' ' GLY . . . . . 0.589 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -61.72 -103.91 0.01 OUTLIER Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.6 -1.286 . . . . 0.0 109.937 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2180 ' ' THR . . . . . 0.411 HG23 ' O ' ' A' 2179 ' ' GLY . 1.1 p -153.75 162.33 41.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.467 -1.019 . . . . 0.0 109.027 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2181 ' ' CYS . . . . . 0.555 ' HB3' ' HD3' ' A' 2175 ' ' PRO . 27.3 p -97.05 161.63 13.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.11 -0.994 . . . . 0.0 110.41 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2182 ' ' LYS . . . . . 0.622 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.2 OUTLIER -146.65 155.12 42.2 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.338 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 64.0 t30 -101.12 127.85 47.48 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.685 -1.259 . . . . 0.0 109.106 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2184 ' ' VAL . . . . . 0.632 HG12 ' N ' ' A' 2188 ' ' PHE . 0.6 OUTLIER -134.33 -166.76 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.419 -0.801 . . . . 0.0 109.367 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 2185 ' ' ILE . . . . . 0.615 ' N ' HG13 ' A' 2184 ' ' VAL . 3.9 mp -105.89 134.57 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.0 110.032 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2186 ' ' GLY . . . . . 0.426 ' O ' ' SD ' ' A' 2201 ' ' MET . . . 78.8 4.16 87.99 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2187 ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 170.54 -116.96 0.67 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.457 -1.354 . . . . 0.0 109.985 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2188 ' ' PHE . . . . . 0.661 ' CD1' ' CB ' ' A' 2175 ' ' PRO . 5.0 p90 -168.25 173.13 8.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.39 -1.065 . . . . 0.0 109.184 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2189 ' ' GLU . . . . . 0.622 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.2 tp10 -127.02 155.69 42.83 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2190 ' ' CYS . . . . . 0.408 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 25.4 p -151.25 145.79 25.61 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.711 -1.243 . . . . 0.0 110.035 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2191 ' ' THR . . . . . 0.494 ' O ' ' HA3' ' A' 2179 ' ' GLY . 23.3 m -112.24 84.67 2.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.379 -0.826 . . . . 0.0 109.847 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2192 ' ' CYS . . . . . 0.628 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.1 m -48.79 -179.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.293 -0.879 . . . . 0.0 109.608 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2193 ' ' GLU . . . . . 0.476 ' O ' ' C ' ' A' 2194 ' ' GLU . 19.1 tt0 -50.65 116.49 1.96 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2194 ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.3 OUTLIER -34.85 125.69 0.54 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.71 -0.619 . . . . 0.0 110.723 -179.256 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.16 1.24 10.41 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2196 ' ' PHE . . . . . 0.675 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.3 p90 -108.89 -163.28 0.86 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.199 -1.177 . . . . 0.0 109.987 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2197 ' ' GLU . . . . . 0.529 ' N ' ' CG ' ' A' 2196 ' ' PHE . 16.8 mt-10 -145.62 95.58 4.92 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 121.496 -0.753 . . . . 0.0 109.556 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2198 ' ' PRO . . . . . 0.675 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.8 Cg_endo -68.71 -165.23 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.213 1.942 . . . . 0.0 111.259 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -133.13 -169.09 12.09 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.71 -81.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.998 1.799 . . . . 0.0 110.563 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A 2201 ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.0 OUTLIER -137.08 56.38 1.79 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.974 . . . . 0.0 109.952 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A 2202 ' ' MET . . . . . 0.439 ' O ' ' HB ' ' A' 2203 ' ' THR . 2.4 mmt -123.81 -72.25 0.69 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.271 -0.893 . . . . 0.0 109.615 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2203 ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' 2202 ' ' MET . 11.3 t -180.0 -170.84 0.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.844 . . . . 0.0 109.432 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2204 ' ' CYS . . . . . 0.478 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.4 t -70.27 146.83 50.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 109.565 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.385 179.977 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A 2129 ' ' ASP . . . . . 0.521 ' O ' ' CB ' ' A' 2130 ' ' GLU . 20.1 t0 . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2130 ' ' GLU . . . . . 0.592 ' O ' HG21 ' A' 2136 ' ' VAL . 1.5 mt-10 80.85 -41.15 0.17 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.651 -0.656 . . . . 0.0 110.943 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2131 ' ' CYS . . . . . 0.496 ' HB2' ' SG ' ' A' 2137 ' ' CYS . 9.8 p -90.23 -33.07 16.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.664 -1.273 . . . . 0.0 110.005 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2132 ' ' LYS . . . . . 0.474 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -81.53 6.86 13.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.135 -0.978 . . . . 0.0 109.225 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -69.71 154.04 95.09 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.254 -0.904 . . . . 0.0 109.343 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2134 ' ' PRO . . . . . 0.486 ' O ' ' HD2' ' A' 2138 ' ' LYS . 3.7 Cg_endo -68.5 1.49 3.61 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.504 2.136 . . . . 0.0 111.536 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -134.36 0.05 3.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.602 -1.311 . . . . 0.0 110.733 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2136 ' ' VAL . . . . . 0.592 HG21 ' O ' ' A' 2130 ' ' GLU . 21.7 t -106.3 -119.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.818 -1.176 . . . . 0.0 109.594 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2137 ' ' CYS . . . . . 0.532 ' N ' HG12 ' A' 2136 ' ' VAL . 3.8 m -76.74 111.45 12.27 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.754 -1.216 . . . . 0.0 108.799 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2138 ' ' LYS . . . . . 0.486 ' HD2' ' O ' ' A' 2134 ' ' PRO . 6.2 mtpp -116.37 112.58 21.71 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.242 -0.911 . . . . 0.0 110.096 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2139 ' ' HIS . . . . . 0.491 ' O ' ' HB3' ' A' 2164 ' ' CYS . 2.1 m-70 74.14 56.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.884 . . . . 0.0 109.944 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -159.7 -176.98 32.37 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -103.6 91.14 3.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -1.122 . . . . 0.0 109.043 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2142 ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' 2150 ' ' ARG . 26.7 p -86.48 -178.94 6.54 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.228 -0.92 . . . . 0.0 110.2 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2143 ' ' ILE . . . . . 0.654 ' O ' HG23 ' A' 2145 ' ' THR . 3.6 mp -141.45 94.24 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.441 -0.787 . . . . 0.0 108.886 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2144 ' ' ASN . . . . . 0.401 ' OD1' ' HA ' ' A' 2129 ' ' ASP . 8.2 t30 -47.95 117.83 2.07 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.36 -0.837 . . . . 0.0 110.054 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2145 ' ' THR . . . . . 0.654 HG23 ' O ' ' A' 2143 ' ' ILE . 70.9 p -116.49 -174.66 2.6 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.431 -0.793 . . . . 0.0 109.046 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.31 118.44 25.75 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.341 -0.849 . . . . 0.0 109.602 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2147 ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' 2148 ' ' SER . . . 53.62 42.3 66.73 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2148 ' ' SER . . . . . 0.466 ' O ' ' OE1' ' A' 2130 ' ' GLU . 1.8 t 178.16 -162.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -1.109 . . . . 0.0 109.66 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2149 ' ' TYR . . . . . 0.574 ' CD2' ' HB3' ' A' 2130 ' ' GLU . 45.2 p90 179.66 -169.5 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.806 . . . . 0.0 109.336 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2150 ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' 2149 ' ' TYR . 12.4 mtt180 -160.46 119.67 2.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.493 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 82.3 m -83.18 69.76 9.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.328 -0.857 . . . . 0.0 109.234 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -80.47 109.18 14.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.522 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2153 ' ' CYS . . . . . 0.51 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -82.38 152.66 67.76 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 121.148 -0.97 . . . . 0.0 109.356 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 2154 ' ' PRO . . . . . 0.43 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.2 Cg_endo -64.58 -168.54 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.493 2.128 . . . . 0.0 111.207 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 9.1 t80 -90.19 103.25 15.94 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2156 ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' 2167 ' ' THR . . . 130.93 -14.17 5.49 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 -178.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2157 ' ' TYR . . . . . 0.741 ' OH ' HG23 ' A' 2185 ' ' ILE . 7.7 m-85 -107.86 -169.37 1.51 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.516 -0.99 . . . . 0.0 109.945 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2158 ' ' ILE . . . . . 0.97 HD11 HG23 ' A' 2165 ' ' VAL . 0.1 OUTLIER -155.78 -165.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.452 -0.78 . . . . 0.0 109.458 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 2159 ' ' LEU . . . . . 0.449 ' N ' HG12 ' A' 2158 ' ' ILE . 28.7 tp -141.35 125.76 17.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.365 -0.834 . . . . 0.0 109.574 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -101.92 52.67 0.82 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.899 . . . . 0.0 109.261 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2161 ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 88.28 -9.66 74.32 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2162 ' ' ASN . . . . . 0.529 ' ND2' ' HA ' ' A' 2136 ' ' VAL . 1.7 m-20 167.04 -47.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -1.195 . . . . 0.0 109.444 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2163 ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' A' 2138 ' ' LYS . 25.5 tt0 -70.28 115.94 10.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.304 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2164 ' ' CYS . . . . . 0.616 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -92.33 144.55 25.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.52 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 2165 ' ' VAL . . . . . 0.97 HG23 HD11 ' A' 2158 ' ' ILE . 0.4 OUTLIER -159.17 -167.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.426 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 2166 ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' 2184 ' ' VAL . 35.6 t70 -85.95 166.59 15.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.956 -1.09 . . . . 0.0 109.796 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2167 ' ' THR . . . . . 0.549 ' CG2' ' OE1' ' A' 2169 ' ' GLU . 5.6 t -113.73 -168.82 1.4 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.391 -0.818 . . . . 0.0 109.46 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2168 ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' 2168 ' ' ASP . 61.0 t0 -110.39 103.58 12.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.0 109.602 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2169 ' ' GLU . . . . . 0.641 ' O ' HG23 ' A' 2172 ' ' VAL . 0.5 OUTLIER -79.99 -30.58 39.72 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.323 -0.86 . . . . 0.0 109.157 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 2170 ' ' CYS . . . . . 0.533 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 0.5 OUTLIER -64.74 -11.24 34.24 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.371 -0.831 . . . . 0.0 109.008 179.545 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -6.48 26.19 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.195 -0.94 . . . . 0.0 109.445 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2172 ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' 2169 ' ' GLU . 19.0 t -78.58 -70.5 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.196 -0.94 . . . . 0.0 109.051 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2173 ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' 2174 ' ' ASN . . . 161.78 77.04 0.03 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2174 ' ' ASN . . . . . 0.478 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 9.4 t-20 43.85 82.36 0.23 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.257 -1.143 . . . . 0.0 109.835 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2175 ' ' PRO . . . . . 0.614 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 0.9 OUTLIER -64.6 -20.86 65.79 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.289 1.993 . . . . 0.0 110.141 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 2176 ' ' CYS . . . . . 0.508 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.1 OUTLIER -55.63 -58.01 9.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.051 -1.031 . . . . 0.0 108.758 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 143.77 -19.59 2.19 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 1.1 t30 -160.6 -34.95 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -1.172 . . . . 0.0 110.539 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2179 ' ' GLY . . . . . 0.612 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -66.15 -125.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.034 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 2.5 p -140.92 162.22 35.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.491 -1.005 . . . . 0.0 109.252 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2181 ' ' CYS . . . . . 0.596 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 24.5 p -99.7 151.16 21.53 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.09 0.948 . . . . 0.0 111.341 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2182 ' ' LYS . . . . . 0.529 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 4.9 tptt -134.36 157.0 47.51 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 58.5 t30 -95.9 139.71 31.71 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.361 -1.462 . . . . 0.0 109.862 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2184 ' ' VAL . . . . . 0.681 HG12 ' CA ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -147.78 176.7 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.528 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 2185 ' ' ILE . . . . . 0.741 HG23 ' OH ' ' A' 2157 ' ' TYR . 1.2 mp -93.77 139.06 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.01 -1.056 . . . . 0.0 110.118 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 74.75 8.63 82.15 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2187 ' ' GLY . . . . . 0.58 ' C ' HG12 ' A' 2184 ' ' VAL . . . 161.94 -128.76 1.95 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2188 ' ' PHE . . . . . 0.681 ' CA ' HG12 ' A' 2184 ' ' VAL . 1.2 p90 -158.7 -178.78 7.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -1.15 . . . . 0.0 109.532 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2189 ' ' GLU . . . . . 0.529 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.6 OUTLIER -131.85 111.14 11.34 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 2190 ' ' CYS . . . . . 0.45 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 31.2 p -110.65 137.48 48.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.785 -1.197 . . . . 0.0 109.774 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2191 ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' 2192 ' ' CYS . 59.5 m -111.1 87.39 2.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.283 -0.886 . . . . 0.0 109.175 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2192 ' ' CYS . . . . . 0.614 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.0 OUTLIER -48.33 -179.01 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.671 0.748 . . . . 0.0 109.703 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 2193 ' ' GLU . . . . . 0.475 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.6 OUTLIER -59.15 123.83 17.94 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.712 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 2194 ' ' GLU . . . . . 0.475 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.6 OUTLIER -34.74 129.5 0.43 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.43 0.633 . . . . 0.0 110.878 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.47 1.51 10.04 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2196 ' ' PHE . . . . . 0.673 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.8 OUTLIER -116.33 -164.54 0.98 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.184 -1.186 . . . . 0.0 110.192 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 2197 ' ' GLU . . . . . 0.564 ' N ' ' CG ' ' A' 2196 ' ' PHE . 0.3 OUTLIER -146.14 98.15 4.39 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.605 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 2198 ' ' PRO . . . . . 0.673 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.9 Cg_endo -68.68 -164.44 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.242 1.962 . . . . 0.0 111.174 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -132.49 -173.71 13.4 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2200 ' ' PRO . . . . . 0.405 ' C ' ' HG2' ' A' 2201 ' ' MET . 1.2 Cg_endo -64.4 -54.63 0.75 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.919 1.746 . . . . 0.0 110.629 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2201 ' ' MET . . . . . 0.503 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -159.8 49.57 0.3 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 0.0 109.566 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 2.1 mmm -118.63 -79.3 0.59 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.253 -0.904 . . . . 0.0 109.674 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A 2203 ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' 2175 ' ' PRO . 6.7 t -173.51 -166.36 0.32 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.306 -0.871 . . . . 0.0 109.228 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2204 ' ' CYS . . . . . 0.548 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.2 t -70.31 141.63 52.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.073 -1.017 . . . . 0.0 109.541 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A 2205 ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' 2197 ' ' GLU . 23.0 pt-20 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.35 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2129 ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' A' 2130 ' ' GLU . 1.3 t0 . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2130 ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' 2129 ' ' ASP . 0.1 OUTLIER 81.29 -67.59 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.792 -0.568 . . . . 0.0 110.46 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 2131 ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' 2137 ' ' CYS . 1.7 t -81.28 -9.82 59.69 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.133 -0.979 . . . . 0.0 109.828 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2132 ' ' LYS . . . . . 0.503 ' CB ' ' HB3' ' A' 2129 ' ' ASP . 0.0 OUTLIER -72.42 -15.02 61.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.787 -1.196 . . . . 0.0 109.785 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 2133 ' ' GLU . . . . . 0.602 ' HB2' HG23 ' A' 2136 ' ' VAL . 3.7 mt-10 -74.3 146.5 84.32 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.152 -0.968 . . . . 0.0 109.631 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2134 ' ' PRO . . . . . 0.473 ' HA ' ' CG ' ' A' 2138 ' ' LYS . 1.2 Cg_endo -65.22 -11.98 32.65 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.273 1.982 . . . . 0.0 110.133 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2135 ' ' ASP . . . . . 0.511 ' O ' ' ND2' ' A' 2162 ' ' ASN . 0.4 OUTLIER -110.35 21.57 16.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.95 . . . . 0.0 109.483 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 2136 ' ' VAL . . . . . 0.602 HG23 ' HB2' ' A' 2133 ' ' GLU . 18.5 t -136.86 109.75 7.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2137 ' ' CYS . . . . . 0.543 ' CA ' ' O ' ' A' 2162 ' ' ASN . 56.4 m 64.92 -89.65 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2138 ' ' LYS . . . . . 0.514 ' O ' ' CB ' ' A' 2139 ' ' HIS . 0.0 OUTLIER 68.11 28.29 6.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.963 -1.086 . . . . 0.0 111.268 178.089 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 2139 ' ' HIS . . . . . 0.521 ' CB ' ' HB3' ' A' 2164 ' ' CYS . 0.1 OUTLIER 164.36 41.09 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.842 -1.161 . . . . 0.0 110.287 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 2140 ' ' GLY . . . . . 0.507 ' HA2' ' HD3' ' A' 2154 ' ' PRO . . . -166.41 175.73 41.77 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2141 ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' 2152 ' ' GLU . 0.2 OUTLIER -89.38 96.66 10.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.184 -1.186 . . . . 0.0 108.259 179.29 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 2142 ' ' CYS . . . . . 0.797 ' C ' HD12 ' A' 2143 ' ' ILE . 0.0 OUTLIER -96.32 174.07 7.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -0.86 . . . . 0.0 110.223 -178.658 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 2143 ' ' ILE . . . . . 0.797 HD12 ' C ' ' A' 2142 ' ' CYS . 4.0 mp -137.2 111.91 10.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2144 ' ' ASN . . . . . 0.428 ' OD1' ' C ' ' A' 2129 ' ' ASP . 0.6 OUTLIER -60.17 118.09 5.93 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.207 -0.933 . . . . 0.0 109.756 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 2145 ' ' THR . . . . . 0.678 HG23 ' HA ' ' A' 2149 ' ' TYR . 3.1 p -103.97 -179.5 3.97 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.157 -0.965 . . . . 0.0 109.011 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.13 -74.12 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.356 -0.84 . . . . 0.0 109.771 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -117.27 41.49 2.07 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2148 ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' 2130 ' ' GLU . 0.6 OUTLIER -174.13 -171.85 0.65 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -1.18 . . . . 0.0 109.831 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 2149 ' ' TYR . . . . . 0.678 ' HA ' HG23 ' A' 2145 ' ' THR . 42.0 p90 -153.05 -171.84 4.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 109.474 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2150 ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' 2149 ' ' TYR . 28.5 mtm180 -155.86 98.41 1.9 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.374 -0.829 . . . . 0.0 110.041 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2151 ' ' CYS . . . . . 0.646 ' HB2' HD22 ' A' 2159 ' ' LEU . 70.7 m -63.02 87.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.527 -0.733 . . . . 0.0 109.069 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2152 ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' 2141 ' ' GLN . 0.0 OUTLIER -87.09 70.32 10.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.503 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 2153 ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' 2158 ' ' ILE . 93.1 m -48.33 147.88 3.65 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 121.379 -0.826 . . . . 0.0 109.177 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2154 ' ' PRO . . . . . 0.507 ' HD3' ' HA2' ' A' 2140 ' ' GLY . 1.4 Cg_endo -63.48 -169.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.541 2.161 . . . . 0.0 111.25 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 75.2 t80 -89.22 102.01 14.67 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.28 -11.63 5.54 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2157 ' ' TYR . . . . . 0.476 ' CD2' ' O ' ' A' 2165 ' ' VAL . 5.7 m-85 -108.17 -170.69 1.72 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.399 -1.059 . . . . 0.0 109.801 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2158 ' ' ILE . . . . . 1.028 HD11 HG23 ' A' 2165 ' ' VAL . 0.2 OUTLIER -156.38 -173.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.061 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 2159 ' ' LEU . . . . . 0.646 HD22 ' HB2' ' A' 2151 ' ' CYS . 21.6 tp -130.89 143.52 50.79 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.276 -0.89 . . . . 0.0 109.85 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -120.52 47.71 1.73 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 0.0 109.175 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2161 ' ' GLY . . . . . 0.427 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 94.35 -16.8 60.26 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2162 ' ' ASN . . . . . 0.543 ' O ' ' CA ' ' A' 2137 ' ' CYS . 1.3 m-20 169.47 -30.34 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.342 -1.093 . . . . 0.0 109.171 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -88.21 119.63 28.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 108.749 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2164 ' ' CYS . . . . . 0.868 ' O ' HG13 ' A' 2165 ' ' VAL . 38.2 t -95.78 159.47 14.97 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.173 -0.955 . . . . 0.0 109.239 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2165 ' ' VAL . . . . . 1.028 HG23 HD11 ' A' 2158 ' ' ILE . 0.6 OUTLIER -169.15 -167.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 2166 ' ' ASP . . . . . 0.461 ' OD2' ' O ' ' A' 2184 ' ' VAL . 34.7 t70 -88.88 165.12 14.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.049 -1.032 . . . . 0.0 109.454 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2167 ' ' THR . . . . . 0.641 HG23 ' OE1' ' A' 2169 ' ' GLU . 6.3 t -111.35 -172.92 2.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.39 -0.818 . . . . 0.0 109.371 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2168 ' ' ASP . . . . . 0.472 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 51.8 t0 -107.48 100.96 10.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.409 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2169 ' ' GLU . . . . . 0.641 ' OE1' HG23 ' A' 2167 ' ' THR . 0.6 OUTLIER -76.33 -31.92 58.39 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.496 -0.752 . . . . 0.0 109.288 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 2170 ' ' CYS . . . . . 0.491 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 2.0 t -66.77 -9.68 39.37 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.314 -0.866 . . . . 0.0 108.877 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2171 ' ' SER . . . . . 0.417 ' HB2' ' CG ' ' A' 2168 ' ' ASP . 0.2 OUTLIER -81.23 7.83 10.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.855 . . . . 0.0 109.894 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 49.5 t -108.22 -72.34 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.07 -1.019 . . . . 0.0 109.536 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2173 ' ' GLY . . . . . 0.476 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -163.08 133.81 3.2 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2174 ' ' ASN . . . . . 0.624 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 18.9 p-10 -40.25 99.86 0.21 Allowed Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.461 -1.023 . . . . 0.0 109.959 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2175 ' ' PRO . . . . . 0.591 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 1.4 Cg_endo -68.66 -22.01 38.33 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.798 1.665 . . . . 0.0 109.85 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2176 ' ' CYS . . . . . 0.583 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -48.61 -40.36 27.28 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.305 -0.872 . . . . 0.0 109.206 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 123.0 -16.5 8.2 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -175.44 -34.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.481 -1.011 . . . . 0.0 109.71 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2179 ' ' GLY . . . . . 0.601 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -63.15 -122.24 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.51 154.63 44.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.39 -1.065 . . . . 0.0 109.708 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2181 ' ' CYS . . . . . 0.624 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 21.4 p -92.52 161.39 14.63 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.352 1.072 . . . . 0.0 111.286 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2182 ' ' LYS . . . . . 0.586 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 43.3 tptt -141.48 163.33 33.22 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2183 ' ' ASN . . . . . 0.473 ' N ' ' HG3' ' A' 2182 ' ' LYS . 62.9 t30 -101.13 140.07 35.94 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.618 -1.301 . . . . 0.0 110.006 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2184 ' ' VAL . . . . . 0.794 HG12 ' CA ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -148.91 -177.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.566 -0.709 . . . . 0.0 109.308 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 2185 ' ' ILE . . . . . 0.471 ' H ' HG22 ' A' 2184 ' ' VAL . 2.4 mp -97.83 135.7 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.02 -1.05 . . . . 0.0 110.196 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 75.15 10.62 84.26 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2187 ' ' GLY . . . . . 0.559 ' C ' HG12 ' A' 2184 ' ' VAL . . . 163.42 -121.04 0.98 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2188 ' ' PHE . . . . . 0.794 ' CA ' HG12 ' A' 2184 ' ' VAL . 2.3 p90 -169.17 -179.67 3.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -1.168 . . . . 0.0 109.526 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2189 ' ' GLU . . . . . 0.586 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 4.5 tt0 -124.67 170.21 11.19 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 6.0 p -170.58 145.56 2.57 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.461 -1.399 . . . . 0.0 109.949 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2191 ' ' THR . . . . . . . . . . . . . 17.9 m -117.98 92.98 3.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.422 -0.799 . . . . 0.0 109.728 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2192 ' ' CYS . . . . . 0.611 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -54.82 179.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 0.0 108.795 179.56 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 2193 ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' 2194 ' ' GLU . 4.2 tt0 -56.64 121.22 9.24 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2194 ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' 2193 ' ' GLU . 2.2 mt-10 -34.65 127.52 0.48 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.672 -0.643 . . . . 0.0 110.877 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.11 8.58 7.16 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2196 ' ' PHE . . . . . 0.664 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.4 p90 -119.91 -161.54 0.88 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.251 -1.146 . . . . 0.0 110.301 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2197 ' ' GLU . . . . . 0.582 ' N ' ' CG ' ' A' 2196 ' ' PHE . 1.8 mm-40 -146.13 96.03 4.67 Favored Pre-proline 0 C--N 1.305 -1.339 0 O-C-N 121.64 -0.663 . . . . 0.0 109.763 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2198 ' ' PRO . . . . . 0.664 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.0 Cg_endo -68.1 -159.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.389 2.059 . . . . 0.0 111.4 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -143.99 -169.87 13.15 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -65.31 -81.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.993 1.796 . . . . 0.0 110.844 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2201 ' ' MET . . . . . 0.501 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -135.29 41.73 2.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 110.024 -179.308 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 5.0 mtm -112.33 -78.59 0.58 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.182 -0.948 . . . . 0.0 109.582 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A 2203 ' ' THR . . . . . 0.438 HG23 ' N ' ' A' 2204 ' ' CYS . 6.0 t -168.24 -164.43 0.53 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.477 -0.764 . . . . 0.0 109.175 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A 2204 ' ' CYS . . . . . 0.583 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -115.91 144.97 43.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 108.943 -179.696 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.581 -179.724 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A 2129 ' ' ASP . . . . . 0.55 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 48.5 t0 . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2130 ' ' GLU . . . . . 0.681 ' O ' HG21 ' A' 2136 ' ' VAL . 2.0 mt-10 82.4 -44.57 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.85 -0.531 . . . . 0.0 110.027 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2131 ' ' CYS . . . . . 0.532 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 14.4 p -90.71 -24.72 20.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.007 -1.058 . . . . 0.0 109.288 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2132 ' ' LYS . . . . . 0.416 ' HB2' ' CB ' ' A' 2129 ' ' ASP . 0.0 OUTLIER -68.92 -8.98 49.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 109.851 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 2133 ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' 2134 ' ' PRO . 6.3 mt-10 -72.12 144.47 87.44 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.082 -1.011 . . . . 0.0 109.171 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2134 ' ' PRO . . . . . 0.589 ' HA ' ' CG ' ' A' 2138 ' ' LYS . 1.9 Cg_endo -67.53 -4.12 11.41 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.239 1.959 . . . . 0.0 110.882 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2135 ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' 2135 ' ' ASP . 2.6 m-20 -116.29 4.96 13.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.011 -1.056 . . . . 0.0 110.03 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2136 ' ' VAL . . . . . 0.681 HG21 ' O ' ' A' 2130 ' ' GLU . 75.4 t -110.32 -91.92 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.988 -1.07 . . . . 0.0 109.695 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2137 ' ' CYS . . . . . 0.542 ' N ' HG12 ' A' 2136 ' ' VAL . 0.5 OUTLIER -79.98 -74.43 0.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.115 -0.991 . . . . 0.0 109.572 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 2138 ' ' LYS . . . . . 0.589 ' CG ' ' HA ' ' A' 2134 ' ' PRO . 0.0 OUTLIER 65.46 89.42 0.1 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.377 -0.827 . . . . 0.0 109.963 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 2139 ' ' HIS . . . . . 0.524 ' O ' ' HB3' ' A' 2164 ' ' CYS . 3.5 m170 75.56 51.1 0.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.349 -0.844 . . . . 0.0 110.125 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -151.68 173.38 30.99 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -104.11 89.58 3.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -1.139 . . . . 0.0 108.966 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2142 ' ' CYS . . . . . 0.481 ' HB3' ' SG ' ' A' 2137 ' ' CYS . 9.0 p -88.86 -177.0 5.39 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.347 -0.846 . . . . 0.0 110.345 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.29 93.04 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2144 ' ' ASN . . . . . 0.55 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 21.2 t-20 -46.11 115.61 1.04 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.516 -0.74 . . . . 0.0 110.963 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2145 ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' 2149 ' ' TYR . 0.4 OUTLIER -113.37 -178.7 3.44 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.282 -0.886 . . . . 0.0 108.936 178.743 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.59 110.15 17.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.379 -0.826 . . . . 0.0 109.769 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 65.85 25.77 71.97 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2148 ' ' SER . . . . . 0.443 ' O ' ' OG1' ' A' 2145 ' ' THR . 0.0 OUTLIER -173.66 -178.72 1.66 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.123 -1.222 . . . . 0.0 109.738 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 2149 ' ' TYR . . . . . 0.599 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 17.8 p90 -160.31 -172.37 3.55 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.443 -0.786 . . . . 0.0 109.446 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2150 ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' 2149 ' ' TYR . 1.8 mtt-85 -156.52 107.16 2.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.414 -0.804 . . . . 0.0 109.142 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 1.6 m -74.33 107.17 6.33 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.489 -0.757 . . . . 0.0 110.431 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.63 -178.63 3.49 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2153 ' ' CYS . . . . . 0.551 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -148.24 152.37 39.16 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 120.952 -1.093 . . . . 0.0 109.672 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 2154 ' ' PRO . . . . . 0.48 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.4 Cg_endo -64.22 -166.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.604 2.203 . . . . 0.0 111.478 -178.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 13.4 t80 -89.8 101.96 14.66 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2156 ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' 2166 ' ' ASP . . . 130.81 -14.08 5.52 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.169 -1.973 . . . . 0.0 108.169 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2157 ' ' TYR . . . . . 0.691 ' OH ' HG23 ' A' 2185 ' ' ILE . 8.4 m-85 -108.3 -174.28 2.48 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.532 -0.981 . . . . 0.0 110.288 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2158 ' ' ILE . . . . . 0.729 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -157.65 -165.89 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 2159 ' ' LEU . . . . . . . . . . . . . 27.7 tp -131.92 127.74 37.05 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.408 -0.807 . . . . 0.0 109.574 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -107.06 49.23 0.81 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 0.0 109.327 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 95.67 -20.25 50.55 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2162 ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' 2136 ' ' VAL . 1.3 t-20 172.8 -38.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -1.172 . . . . 0.0 109.447 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2163 ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' 2137 ' ' CYS . 2.1 tt0 -79.09 111.02 14.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.416 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2164 ' ' CYS . . . . . 0.668 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -85.93 137.55 32.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.895 . . . . 0.0 109.089 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 2165 ' ' VAL . . . . . 0.668 HG13 ' O ' ' A' 2164 ' ' CYS . 6.7 m -160.53 -166.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.145 -0.972 . . . . 0.0 109.539 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2166 ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 1.3 t0 -90.23 144.8 25.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.875 -1.141 . . . . 0.0 109.773 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2167 ' ' THR . . . . . 0.568 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 12.7 t -85.09 169.62 13.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.257 -0.902 . . . . 0.0 109.017 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2168 ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' A' 2171 ' ' SER . 60.2 t0 -82.11 96.78 7.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.865 -1.147 . . . . 0.0 109.175 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2169 ' ' GLU . . . . . 0.699 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 40.2 mp0 -70.09 -37.07 75.33 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.474 -0.766 . . . . 0.0 109.186 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2170 ' ' CYS . . . . . 0.499 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 0.6 OUTLIER -68.19 -7.86 33.87 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.249 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 2171 ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.2 OUTLIER -74.09 -1.5 20.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.357 -0.839 . . . . 0.0 109.452 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 12.2 t -99.04 -72.55 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.17 -0.956 . . . . 0.0 109.671 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2173 ' ' GLY . . . . . 0.482 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -169.46 138.48 5.09 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2174 ' ' ASN . . . . . 0.575 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 22.7 p-10 -36.97 97.67 0.14 Allowed Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.721 -0.87 . . . . 0.0 110.335 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2175 ' ' PRO . . . . . 0.558 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 1.5 Cg_endo -63.2 -22.23 72.56 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.821 1.681 . . . . 0.0 109.998 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2176 ' ' CYS . . . . . 0.543 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -52.12 -54.99 23.83 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 141.96 -21.95 2.47 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -162.93 -34.84 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.336 -1.097 . . . . 0.0 110.176 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2179 ' ' GLY . . . . . 0.6 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -62.48 -119.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.96 153.65 41.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.466 -1.02 . . . . 0.0 109.14 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2181 ' ' CYS . . . . . 0.575 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 11.5 p -82.06 164.95 21.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.086 -1.009 . . . . 0.0 110.813 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2182 ' ' LYS . . . . . 0.604 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.4 OUTLIER -144.63 155.05 43.42 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 64.1 t30 -100.16 138.59 37.03 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.543 -1.348 . . . . 0.0 109.544 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2184 ' ' VAL . . . . . 0.688 HG13 ' N ' ' A' 2185 ' ' ILE . 0.6 OUTLIER -145.94 -162.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.329 -179.401 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A 2185 ' ' ILE . . . . . 0.691 HG23 ' OH ' ' A' 2157 ' ' TYR . 3.0 mp -108.28 134.23 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.036 -1.04 . . . . 0.0 110.356 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 68.56 8.7 56.93 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2187 ' ' GLY . . . . . 0.67 ' C ' HG12 ' A' 2184 ' ' VAL . . . 174.12 -137.59 4.07 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2188 ' ' PHE . . . . . 0.699 ' HB3' ' HB2' ' A' 2169 ' ' GLU . 5.5 p90 -161.02 169.5 22.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -1.151 . . . . 0.0 109.271 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2189 ' ' GLU . . . . . 0.604 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 2.8 tt0 -118.2 178.63 4.37 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 30.3 p -169.39 143.26 2.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.702 -1.249 . . . . 0.0 109.584 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2191 ' ' THR . . . . . . . . . . . . . 20.1 m -109.91 85.81 2.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.316 -0.865 . . . . 0.0 109.696 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2192 ' ' CYS . . . . . 0.604 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.1 m -51.23 177.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.205 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2193 ' ' GLU . . . . . 0.474 ' O ' ' C ' ' A' 2194 ' ' GLU . 7.4 tt0 -50.97 116.48 2.01 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2194 ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.8 mt-10 -33.93 127.77 0.39 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.484 0.659 . . . . 0.0 111.043 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.08 5.22 8.97 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2196 ' ' PHE . . . . . 0.674 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.3 p90 -114.82 -163.22 0.86 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.234 -1.156 . . . . 0.0 110.268 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2197 ' ' GLU . . . . . 0.519 ' N ' ' CG ' ' A' 2196 ' ' PHE . 1.8 mm-40 -144.58 95.98 5.28 Favored Pre-proline 0 C--N 1.304 -1.37 0 O-C-N 121.526 -0.733 . . . . 0.0 109.597 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2198 ' ' PRO . . . . . 0.674 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 8.1 Cg_endo -66.94 -162.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.279 1.986 . . . . 0.0 111.075 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -137.0 -175.08 13.59 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.63 -72.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.991 1.794 . . . . 0.0 110.675 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A 2201 ' ' MET . . . . . 0.492 ' HA ' ' O ' ' A' 2188 ' ' PHE . 7.3 ptp -141.07 48.62 1.68 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.186 -0.947 . . . . 0.0 110.107 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2202 ' ' MET . . . . . 0.412 ' O ' ' CE1' ' A' 2188 ' ' PHE . 2.1 mmt -120.19 -85.03 0.66 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.081 -1.012 . . . . 0.0 109.845 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2203 ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' 2175 ' ' PRO . 7.3 t -168.66 -168.32 0.88 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.249 -0.907 . . . . 0.0 109.568 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2204 ' ' CYS . . . . . 0.575 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.7 t -71.59 144.81 49.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.934 . . . . 0.0 109.484 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A 2205 ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' 2197 ' ' GLU . 19.0 pt-20 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.457 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2129 ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' 2130 ' ' GLU . 27.5 t0 . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2130 ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' 2129 ' ' ASP . 1.5 mt-10 81.21 -48.74 0.26 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.668 -0.645 . . . . 0.0 110.427 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2131 ' ' CYS . . . . . 0.488 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 13.7 p -90.97 -26.58 19.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.882 -1.136 . . . . 0.0 109.715 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2132 ' ' LYS . . . . . 0.529 ' HB2' ' CB ' ' A' 2129 ' ' ASP . 0.0 OUTLIER -65.34 -11.45 42.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.839 -1.163 . . . . 0.0 109.137 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -70.28 148.75 95.82 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.399 -0.813 . . . . 0.0 109.413 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2134 ' ' PRO . . . . . 0.537 ' HA ' ' CD ' ' A' 2138 ' ' LYS . 1.2 Cg_endo -64.67 -7.8 15.69 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.232 1.954 . . . . 0.0 110.726 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.91 16.94 15.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.044 -1.035 . . . . 0.0 109.841 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2136 ' ' VAL . . . . . 0.64 ' CG1' ' CE1' ' A' 2149 ' ' TYR . 22.1 t -143.09 118.84 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.134 -0.979 . . . . 0.0 109.314 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2137 ' ' CYS . . . . . 0.47 ' SG ' HG12 ' A' 2136 ' ' VAL . 1.9 m 41.64 71.05 0.22 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.331 -0.856 . . . . 0.0 109.252 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2138 ' ' LYS . . . . . 0.537 ' CD ' ' HA ' ' A' 2134 ' ' PRO . 0.0 OUTLIER -98.35 129.24 45.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 0.0 109.928 -179.427 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 2139 ' ' HIS . . . . . 0.48 ' O ' ' HB3' ' A' 2164 ' ' CYS . 0.7 OUTLIER 67.95 52.2 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.499 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -161.52 -160.77 11.11 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2141 ' ' GLN . . . . . 0.436 ' HB3' ' O ' ' A' 2152 ' ' GLU . 1.6 tt0 -119.03 94.49 4.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.321 -1.105 . . . . 0.0 109.405 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2142 ' ' CYS . . . . . 0.514 ' C ' HD12 ' A' 2143 ' ' ILE . 10.9 p -90.47 177.7 6.31 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.294 -0.879 . . . . 0.0 110.011 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2143 ' ' ILE . . . . . 0.514 HD12 ' C ' ' A' 2142 ' ' CYS . 3.6 mp -132.16 117.22 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2144 ' ' ASN . . . . . . . . . . . . . 31.7 t30 -75.32 113.61 12.9 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.096 -1.002 . . . . 0.0 111.367 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2145 ' ' THR . . . . . 0.441 ' OG1' ' C ' ' A' 2148 ' ' SER . 16.2 p -99.87 179.53 4.49 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -59.14 -47.94 83.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 109.849 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -142.58 57.71 0.56 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2148 ' ' SER . . . . . 0.467 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER 174.92 -160.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -1.116 . . . . 0.0 109.287 -179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 2149 ' ' TYR . . . . . 0.64 ' CE1' ' CG1' ' A' 2136 ' ' VAL . 43.2 p90 -174.11 -170.9 0.58 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.35 -0.844 . . . . 0.0 109.336 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2150 ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' 2149 ' ' TYR . 26.8 mtt180 -160.04 107.61 1.66 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.339 -0.851 . . . . 0.0 109.435 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 36.2 m -64.82 89.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.464 -0.772 . . . . 0.0 109.746 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2152 ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' 2141 ' ' GLN . 2.0 mt-10 -102.16 86.18 2.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.034 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2153 ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -59.24 153.38 47.61 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.297 -0.877 . . . . 0.0 109.973 -179.407 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 2154 ' ' PRO . . . . . 0.439 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.1 Cg_endo -65.16 -167.56 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.624 2.216 . . . . 0.0 111.205 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 17.9 t80 -90.15 104.89 17.42 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.03 -17.91 5.1 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2157 ' ' TYR . . . . . 0.521 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 12.0 m-85 -107.98 -175.38 2.77 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.673 -0.898 . . . . 0.0 109.574 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2158 ' ' ILE . . . . . 0.771 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -153.6 -163.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.661 -0.65 . . . . 0.0 109.319 179.429 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 2159 ' ' LEU . . . . . 0.434 ' HA ' HD12 ' A' 2159 ' ' LEU . 24.4 tp -135.41 136.36 41.33 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.195 -0.941 . . . . 0.0 110.073 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -113.99 44.14 1.71 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.411 -0.806 . . . . 0.0 109.255 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 100.42 -28.31 16.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2162 ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -179.46 -35.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -1.109 . . . . 0.0 109.47 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -81.66 113.62 19.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 0.0 109.254 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2164 ' ' CYS . . . . . 0.541 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -87.37 135.59 33.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.919 . . . . 0.0 109.854 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 2165 ' ' VAL . . . . . 0.584 ' O ' HD13 ' A' 2158 ' ' ILE . 0.3 OUTLIER -158.42 -168.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.416 -0.802 . . . . 0.0 108.848 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 2166 ' ' ASP . . . . . 0.485 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 0.6 OUTLIER -90.46 140.04 30.1 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.895 -1.128 . . . . 0.0 109.405 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 2167 ' ' THR . . . . . 0.635 ' HB ' HG21 ' A' 2158 ' ' ILE . 7.6 t -93.13 161.33 14.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.252 -0.905 . . . . 0.0 109.373 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2168 ' ' ASP . . . . . 0.503 ' O ' ' HB2' ' A' 2171 ' ' SER . 59.7 t0 -69.92 95.38 0.92 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.831 -1.168 . . . . 0.0 109.517 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2169 ' ' GLU . . . . . 0.601 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 41.2 mp0 -69.35 -35.85 76.29 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.489 -0.757 . . . . 0.0 109.399 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2170 ' ' CYS . . . . . 0.499 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 0.2 OUTLIER -65.01 -8.7 17.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.451 -0.781 . . . . 0.0 109.057 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 2171 ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -72.18 -0.6 12.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.962 -1.087 . . . . 0.0 109.781 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 9.9 t -98.82 -74.04 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.092 -1.005 . . . . 0.0 109.914 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2173 ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -166.61 138.92 5.46 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2174 ' ' ASN . . . . . 0.579 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 18.5 p-10 -38.64 99.31 0.19 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.694 -0.886 . . . . 0.0 110.245 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2175 ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' 2181 ' ' CYS . 1.8 Cg_endo -61.87 -27.94 80.73 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.053 1.835 . . . . 0.0 110.182 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2176 ' ' CYS . . . . . 0.55 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -46.14 -50.48 15.47 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 133.14 -16.92 4.62 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2178 ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.4 OUTLIER -162.86 -40.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -1.111 . . . . 0.0 109.911 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 2179 ' ' GLY . . . . . 0.603 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -60.85 -119.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.3 p -143.11 160.42 40.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.432 -1.04 . . . . 0.0 109.469 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2181 ' ' CYS . . . . . 0.59 ' HB3' ' HD3' ' A' 2175 ' ' PRO . 16.7 p -88.1 166.42 14.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.137 -0.977 . . . . 0.0 110.794 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2182 ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.2 OUTLIER -145.62 156.01 43.39 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.604 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 61.3 t30 -100.59 131.33 46.55 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.698 -1.251 . . . . 0.0 109.506 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2184 ' ' VAL . . . . . 0.689 HG12 ' N ' ' A' 2188 ' ' PHE . 0.6 OUTLIER -140.89 -166.8 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.515 -0.741 . . . . 0.0 109.368 -179.566 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 2185 ' ' ILE . . . . . 0.614 ' N ' HG13 ' A' 2184 ' ' VAL . 4.0 mp -107.36 136.41 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.029 -1.045 . . . . 0.0 109.909 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 72.92 6.93 68.96 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2187 ' ' GLY . . . . . 0.646 ' C ' HG12 ' A' 2184 ' ' VAL . . . 169.81 -129.76 1.9 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2188 ' ' PHE . . . . . 0.689 ' N ' HG12 ' A' 2184 ' ' VAL . 3.2 p90 -164.38 173.16 12.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -1.157 . . . . 0.0 108.997 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2189 ' ' GLU . . . . . 0.617 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 2.6 tt0 -120.54 159.33 25.42 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 22.4 p -149.18 145.34 27.11 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.738 -1.226 . . . . 0.0 109.917 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2191 ' ' THR . . . . . . . . . . . . . 25.2 m -113.9 85.96 2.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.299 -0.875 . . . . 0.0 109.564 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2192 ' ' CYS . . . . . 0.617 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.9 OUTLIER -51.01 178.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 109.273 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 2193 ' ' GLU . . . . . 0.49 ' O ' ' C ' ' A' 2194 ' ' GLU . 2.0 tm-20 -52.71 117.79 3.17 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2194 ' ' GLU . . . . . 0.49 ' C ' ' O ' ' A' 2193 ' ' GLU . 5.7 mt-10 -34.15 127.73 0.42 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.494 0.664 . . . . 0.0 110.833 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.59 4.61 8.82 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2196 ' ' PHE . . . . . 0.669 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.1 p90 -114.99 -162.77 0.84 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.193 -1.181 . . . . 0.0 110.1 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2197 ' ' GLU . . . . . 0.542 ' N ' ' CG ' ' A' 2196 ' ' PHE . 25.3 mt-10 -145.42 95.55 5.0 Favored Pre-proline 0 C--N 1.304 -1.386 0 O-C-N 121.46 -0.775 . . . . 0.0 109.481 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2198 ' ' PRO . . . . . 0.669 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 8.3 Cg_endo -67.38 -159.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.27 1.98 . . . . 0.0 111.098 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -140.62 -170.49 12.1 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.47 -81.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 121.919 1.746 . . . . 0.0 110.531 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2201 ' ' MET . . . . . 0.493 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.4 OUTLIER -135.02 56.52 1.84 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.819 -179.475 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 2202 ' ' MET . . . . . 0.405 ' O ' ' HB ' ' A' 2203 ' ' THR . 0.2 OUTLIER -124.53 -78.63 0.6 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.22 -0.925 . . . . 0.0 109.654 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A 2203 ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' 2175 ' ' PRO . 6.7 t -178.5 -165.56 0.09 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.382 -0.824 . . . . 0.0 109.196 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2204 ' ' CYS . . . . . 0.564 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.4 t -75.08 144.79 42.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 0.0 109.462 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.563 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2129 ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' A' 2132 ' ' LYS . 17.5 t0 . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2130 ' ' GLU . . . . . 0.606 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 42.4 mp0 -56.11 -24.76 42.58 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.43 -0.794 . . . . 0.0 110.529 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2131 ' ' CYS . . . . . . . . . . . . . 1.8 t -84.49 -26.72 27.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.653 -1.279 . . . . 0.0 109.094 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2132 ' ' LYS . . . . . 0.479 ' HB2' ' HB3' ' A' 2129 ' ' ASP . 0.0 OUTLIER -84.75 13.05 6.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.07 -1.019 . . . . 0.0 109.089 179.445 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 2133 ' ' GLU . . . . . 0.548 ' HB2' ' CG2' ' A' 2136 ' ' VAL . 7.7 mt-10 -70.66 165.04 49.81 Favored Pre-proline 0 N--CA 1.486 1.365 0 O-C-N 121.346 -0.847 . . . . 0.0 109.498 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2134 ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' 2133 ' ' GLU . 2.6 Cg_endo -65.85 -27.76 51.3 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.57 2.18 . . . . 0.0 112.342 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -138.91 39.36 2.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.53 -1.356 . . . . 0.0 111.487 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2136 ' ' VAL . . . . . 0.781 HG12 ' N ' ' A' 2137 ' ' CYS . 46.5 t -102.84 -100.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.834 -1.167 . . . . 0.0 109.248 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2137 ' ' CYS . . . . . 0.781 ' N ' HG12 ' A' 2136 ' ' VAL . 16.2 m -89.46 -65.48 1.01 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.767 -1.208 . . . . 0.0 108.696 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2138 ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' 2137 ' ' CYS . 0.3 OUTLIER 61.17 124.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.373 -0.829 . . . . 0.0 110.383 178.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 2139 ' ' HIS . . . . . 0.484 ' O ' ' HB3' ' A' 2164 ' ' CYS . 0.7 OUTLIER 63.18 40.83 8.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.335 -0.853 . . . . 0.0 110.366 179.074 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -154.79 162.15 30.65 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.04 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -94.44 87.9 5.32 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.493 -1.004 . . . . 0.0 108.727 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2142 ' ' CYS . . . . . 0.825 ' C ' HD12 ' A' 2143 ' ' ILE . 0.8 OUTLIER -88.22 -166.83 1.69 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.3 -0.875 . . . . 0.0 109.769 -179.136 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 2143 ' ' ILE . . . . . 0.825 HD12 ' C ' ' A' 2142 ' ' CYS . 4.1 mp -144.72 103.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2144 ' ' ASN . . . . . . . . . . . . . 35.6 t30 -57.63 116.02 3.14 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.302 -0.874 . . . . 0.0 110.3 -178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2145 ' ' THR . . . . . 0.432 ' HG1' ' C ' ' A' 2148 ' ' SER . 1.3 p -104.48 -177.46 3.37 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.381 -0.825 . . . . 0.0 109.196 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.86 -72.96 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.331 -0.856 . . . . 0.0 109.675 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -128.21 38.28 2.11 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2148 ' ' SER . . . . . 0.468 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER -155.0 -160.06 1.02 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.245 -1.15 . . . . 0.0 109.513 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 2149 ' ' TYR . . . . . 0.694 ' CE2' HG13 ' A' 2136 ' ' VAL . 8.5 p90 -163.38 -169.72 2.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.658 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2150 ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' 2142 ' ' CYS . 32.4 mtt180 -157.81 99.51 1.7 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.388 -0.82 . . . . 0.0 109.374 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 30.6 m -70.09 111.97 6.13 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.252 -0.905 . . . . 0.0 109.17 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.03 84.8 2.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.239 -0.913 . . . . 0.0 109.416 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2153 ' ' CYS . . . . . 0.518 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -54.88 148.1 29.29 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.341 -0.849 . . . . 0.0 109.207 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 2154 ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.93 -167.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.405 2.07 . . . . 0.0 111.018 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 6.5 t80 -90.08 104.72 17.27 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.23 -16.14 5.24 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2157 ' ' TYR . . . . . 0.538 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 6.4 m-85 -105.52 -169.24 1.56 Allowed 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.564 -0.963 . . . . 0.0 110.155 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2158 ' ' ILE . . . . . 0.711 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -153.46 -167.35 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.617 -0.677 . . . . 0.0 109.206 179.481 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 2159 ' ' LEU . . . . . . . . . . . . . 37.9 tp -139.52 127.42 22.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.372 -0.83 . . . . 0.0 109.463 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -103.93 44.17 1.04 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.366 -0.834 . . . . 0.0 109.605 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2161 ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' 2162 ' ' ASN . . . 93.87 -17.79 57.96 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2162 ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' 2136 ' ' VAL . 4.0 p-10 179.72 -49.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -1.142 . . . . 0.0 109.469 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2163 ' ' GLU . . . . . 0.456 ' N ' ' CG ' ' A' 2162 ' ' ASN . 0.6 OUTLIER -73.45 120.07 18.55 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.56 -0.712 . . . . 0.0 109.255 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 2164 ' ' CYS . . . . . 0.603 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -97.08 139.4 33.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 109.456 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 2165 ' ' VAL . . . . . 0.679 HG23 HD11 ' A' 2158 ' ' ILE . 1.6 m -158.39 -172.27 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.064 -1.023 . . . . 0.0 109.475 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2166 ' ' ASP . . . . . 0.403 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 7.6 t70 -88.11 152.65 21.86 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.952 -1.092 . . . . 0.0 109.562 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2167 ' ' THR . . . . . 0.583 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 5.5 t -92.19 -168.16 1.93 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 109.13 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2168 ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' 2171 ' ' SER . 58.5 t0 -111.36 100.0 8.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.085 -1.009 . . . . 0.0 109.213 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2169 ' ' GLU . . . . . 0.607 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.7 OUTLIER -74.0 -33.28 63.75 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.448 -0.783 . . . . 0.0 109.22 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 2170 ' ' CYS . . . . . 0.464 ' HB2' ' N ' ' A' 2182 ' ' LYS . 1.8 t -69.59 -9.62 54.81 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2171 ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -72.72 -12.86 61.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 0.0 109.549 -179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 21.7 t -84.76 -71.99 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.146 -0.971 . . . . 0.0 109.288 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2173 ' ' GLY . . . . . 0.465 ' O ' ' SG ' ' A' 2181 ' ' CYS . . . -154.09 -127.58 1.16 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2174 ' ' ASN . . . . . 0.572 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 26.5 p-10 -130.28 97.79 21.93 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.075 -1.25 . . . . 0.0 109.213 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2175 ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' 2181 ' ' CYS . 1.6 Cg_endo -66.58 -18.97 54.6 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 121.918 1.745 . . . . 0.0 109.967 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2176 ' ' CYS . . . . . 0.542 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.1 OUTLIER -51.39 -49.12 62.19 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.06 0.933 . . . . 0.0 108.926 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 128.64 -21.05 5.41 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 108.326 -1.909 . . . . 0.0 108.326 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -166.52 -34.09 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.498 -1.001 . . . . 0.0 110.045 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2179 ' ' GLY . . . . . 0.613 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -69.26 -130.51 0.05 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.6 p -131.97 157.0 45.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.605 -0.938 . . . . 0.0 109.193 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2181 ' ' CYS . . . . . 0.572 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 24.7 p -89.17 167.09 13.39 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.336 1.065 . . . . 0.0 110.899 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2182 ' ' LYS . . . . . 0.542 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 3.9 tttp -146.4 160.79 41.6 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2183 ' ' ASN . . . . . 0.416 ' N ' ' CG ' ' A' 2182 ' ' LYS . 56.3 t30 -100.59 126.32 47.05 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.602 -1.311 . . . . 0.0 110.014 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2184 ' ' VAL . . . . . 0.89 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -132.46 -176.32 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 2185 ' ' ILE . . . . . 0.538 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 4.0 mp -100.29 140.29 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.019 -1.051 . . . . 0.0 110.008 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 70.64 12.19 69.92 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2187 ' ' GLY . . . . . 0.592 ' C ' HG12 ' A' 2184 ' ' VAL . . . 164.39 -117.92 0.78 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2188 ' ' PHE . . . . . 0.89 ' N ' HG12 ' A' 2184 ' ' VAL . 2.2 p90 -170.57 -179.27 2.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -1.19 . . . . 0.0 109.902 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2189 ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.3 OUTLIER -127.63 169.53 13.66 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.187 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 11.7 p -170.56 146.69 2.78 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.498 -1.376 . . . . 0.0 110.229 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2191 ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' 2192 ' ' CYS . 89.2 m -114.84 86.61 2.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.533 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2192 ' ' CYS . . . . . 0.622 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -50.27 -179.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.044 -1.035 . . . . 0.0 108.865 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 2193 ' ' GLU . . . . . 0.489 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.5 tt0 -55.15 113.92 1.56 Allowed 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2194 ' ' GLU . . . . . 0.489 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.2 tt0 -31.1 129.18 0.14 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.589 0.709 . . . . 0.0 111.029 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.61 4.27 9.81 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2196 ' ' PHE . . . . . 0.67 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.3 p90 -114.93 -163.63 0.89 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.229 -1.159 . . . . 0.0 110.385 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2197 ' ' GLU . . . . . 0.55 ' N ' ' CG ' ' A' 2196 ' ' PHE . 7.1 mt-10 -145.32 95.54 5.04 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 121.615 -0.678 . . . . 0.0 109.596 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2198 ' ' PRO . . . . . 0.67 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.2 Cg_endo -67.63 -162.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.349 2.033 . . . . 0.0 111.42 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -138.27 -174.82 13.58 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.54 -71.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.055 1.837 . . . . 0.0 110.726 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2201 ' ' MET . . . . . 0.471 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.1 OUTLIER -144.4 42.35 1.38 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.756 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.35 -77.11 0.58 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.217 -0.927 . . . . 0.0 109.532 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A 2203 ' ' THR . . . . . . . . . . . . . 12.2 t -168.32 -168.69 0.96 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.409 -0.807 . . . . 0.0 109.094 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A 2204 ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.0 OUTLIER -115.04 149.7 37.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.895 . . . . 0.0 108.989 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.077 -0.964 . . . . 0.0 109.564 179.919 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A 2129 ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' 2130 ' ' GLU . 16.3 t0 . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2130 ' ' GLU . . . . . 0.635 ' O ' HG21 ' A' 2136 ' ' VAL . 2.5 mt-10 82.86 -51.15 0.17 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.857 -0.527 . . . . 0.0 110.265 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2131 ' ' CYS . . . . . 0.55 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 12.0 p -89.51 -25.05 21.63 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.094 -1.004 . . . . 0.0 109.614 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2132 ' ' LYS . . . . . 0.485 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -85.2 41.11 0.86 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.177 -0.952 . . . . 0.0 109.539 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -112.65 155.93 43.18 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.295 -0.878 . . . . 0.0 109.2 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2134 ' ' PRO . . . . . 0.457 ' O ' ' HD2' ' A' 2138 ' ' LYS . 1.5 Cg_endo -64.67 -5.46 10.34 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.361 2.041 . . . . 0.0 111.262 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2135 ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' 2162 ' ' ASN . 2.9 t0 -124.18 -29.5 3.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.802 -1.186 . . . . 0.0 110.216 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2136 ' ' VAL . . . . . 0.635 HG21 ' O ' ' A' 2130 ' ' GLU . 61.7 t -77.82 -106.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.041 -1.037 . . . . 0.0 109.146 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2137 ' ' CYS . . . . . 0.508 ' N ' HG12 ' A' 2136 ' ' VAL . 0.1 OUTLIER -84.2 138.66 32.86 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.771 -1.206 . . . . 0.0 108.813 179.526 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 2138 ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' 2139 ' ' HIS . 0.5 OUTLIER -139.6 23.86 2.47 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.1 -1.0 . . . . 0.0 110.017 -179.269 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 2139 ' ' HIS . . . . . 0.541 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.1 OUTLIER 162.27 42.36 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.314 -0.867 . . . . 0.0 110.036 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -144.76 170.99 26.15 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.256 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2141 ' ' GLN . . . . . 0.416 ' O ' ' HG3' ' A' 2141 ' ' GLN . 5.7 pt20 -92.09 65.78 4.81 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.441 -1.035 . . . . 0.0 109.166 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2142 ' ' CYS . . . . . 0.466 ' HB3' ' SG ' ' A' 2137 ' ' CYS . 21.5 p -62.44 -174.13 0.06 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.368 -0.833 . . . . 0.0 110.274 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2143 ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' 2143 ' ' ILE . 1.7 mp -148.71 83.09 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2144 ' ' ASN . . . . . 0.525 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 2.9 t30 -59.08 113.28 2.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.253 -0.904 . . . . 0.0 109.584 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2145 ' ' THR . . . . . . . . . . . . . 27.7 p -97.26 -151.79 0.37 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.371 -0.83 . . . . 0.0 109.415 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.76 -79.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 110.123 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -120.64 22.26 8.27 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2148 ' ' SER . . . . . 0.494 ' N ' ' OE2' ' A' 2130 ' ' GLU . 0.1 OUTLIER -144.85 -161.8 1.37 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -1.16 . . . . 0.0 109.214 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 2149 ' ' TYR . . . . . 0.555 ' CE2' ' CG1' ' A' 2136 ' ' VAL . 24.3 p90 179.6 -164.21 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.695 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2150 ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' 2149 ' ' TYR . 0.1 OUTLIER -166.58 119.45 1.03 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 109.358 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 13.2 m -89.03 106.67 18.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.885 . . . . 0.0 109.81 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -119.49 97.7 5.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 108.909 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2153 ' ' CYS . . . . . 0.524 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -58.22 152.95 39.09 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.21 -0.931 . . . . 0.0 109.817 -179.481 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 2154 ' ' PRO . . . . . 0.487 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 2.0 Cg_endo -66.11 -167.12 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.525 2.15 . . . . 0.0 111.023 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 22.1 t80 -90.59 104.72 17.27 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2156 ' ' GLY . . . . . 0.657 ' O ' HG22 ' A' 2167 ' ' THR . . . 131.05 -16.37 5.27 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.045 -2.022 . . . . 0.0 108.045 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2157 ' ' TYR . . . . . 0.524 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 8.2 m-85 -107.39 -169.69 1.58 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.599 -0.942 . . . . 0.0 110.005 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2158 ' ' ILE . . . . . 1.13 HD11 HG23 ' A' 2165 ' ' VAL . 0.1 OUTLIER -151.24 -163.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.594 -0.691 . . . . 0.0 109.398 179.42 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 2159 ' ' LEU . . . . . 0.49 ' N ' HG12 ' A' 2158 ' ' ILE . 25.0 tp -145.51 113.26 6.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.413 -0.804 . . . . 0.0 109.297 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -95.55 60.66 2.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.323 -0.861 . . . . 0.0 109.715 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2161 ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 88.59 -19.49 36.37 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2162 ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' A' 2135 ' ' ASP . 0.9 OUTLIER 167.98 -34.08 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.361 -1.082 . . . . 0.0 109.357 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -76.49 111.62 12.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 109.15 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2164 ' ' CYS . . . . . 0.725 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -87.83 144.74 26.43 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.301 -0.874 . . . . 0.0 109.69 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 2165 ' ' VAL . . . . . 1.13 HG23 HD11 ' A' 2158 ' ' ILE . 1.4 m -161.96 -169.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.292 -0.88 . . . . 0.0 109.54 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2166 ' ' ASP . . . . . 0.451 ' OD1' ' HA ' ' A' 2185 ' ' ILE . 34.7 t70 -78.54 164.35 24.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 110.179 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2167 ' ' THR . . . . . 0.657 HG22 ' O ' ' A' 2156 ' ' GLY . 6.0 t -117.25 -173.57 2.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.643 -0.661 . . . . 0.0 109.295 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2168 ' ' ASP . . . . . . . . . . . . . 42.0 t0 -101.6 102.47 13.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.197 -0.94 . . . . 0.0 108.976 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2169 ' ' GLU . . . . . 0.566 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.3 OUTLIER -75.54 -23.89 56.67 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.276 -0.89 . . . . 0.0 110.359 -179.122 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 2170 ' ' CYS . . . . . 0.449 ' O ' ' SG ' ' A' 2170 ' ' CYS . 2.8 t -59.49 -12.34 6.1 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.784 -1.197 . . . . 0.0 108.805 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.48 -10.74 12.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.258 -0.901 . . . . 0.0 110.091 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2172 ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' 2169 ' ' GLU . 25.3 t -74.9 -68.21 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.232 -0.918 . . . . 0.0 109.422 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2173 ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' 2174 ' ' ASN . . . 162.54 78.28 0.03 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2174 ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' 2173 ' ' GLY . 1.0 OUTLIER 44.22 91.9 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.275 -1.132 . . . . 0.0 109.557 -179.78 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 2175 ' ' PRO . . . . . 0.611 ' CB ' ' CE2' ' A' 2188 ' ' PHE . 1.3 Cg_endo -66.68 -21.12 52.29 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.104 1.869 . . . . 0.0 110.238 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2176 ' ' CYS . . . . . 0.546 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -65.44 -60.0 3.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 109.521 -179.682 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 141.62 -18.09 2.62 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.74 -31.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.662 -0.905 . . . . 0.0 109.731 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2179 ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -60.68 -114.02 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.1 p -145.65 154.73 42.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.397 -1.061 . . . . 0.0 109.096 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2181 ' ' CYS . . . . . 0.521 ' HB3' ' HD2' ' A' 2175 ' ' PRO . 26.1 p -96.08 160.07 14.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.072 -1.018 . . . . 0.0 110.621 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2182 ' ' LYS . . . . . 0.568 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 3.6 tptm -146.06 156.65 43.61 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2183 ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' 2167 ' ' THR . 59.7 t30 -100.68 140.14 35.38 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.6 -1.313 . . . . 0.0 109.443 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2184 ' ' VAL . . . . . 0.666 HG12 ' N ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -146.95 168.21 5.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.456 -0.777 . . . . 0.0 109.124 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 2185 ' ' ILE . . . . . 0.521 HG23 ' OH ' ' A' 2157 ' ' TYR . 2.3 mp -80.64 140.32 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 110.755 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2186 ' ' GLY . . . . . 0.436 ' O ' ' SD ' ' A' 2201 ' ' MET . . . 69.81 9.26 62.26 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2187 ' ' GLY . . . . . 0.588 ' C ' HG12 ' A' 2184 ' ' VAL . . . 165.51 -136.66 4.29 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2188 ' ' PHE . . . . . 0.666 ' N ' HG12 ' A' 2184 ' ' VAL . 1.2 p90 -153.06 179.26 8.86 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.199 -1.177 . . . . 0.0 109.055 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2189 ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.2 tp10 -131.49 171.27 13.61 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 7.8 p -170.79 148.8 2.98 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.78 -1.2 . . . . 0.0 109.876 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2191 ' ' THR . . . . . . . . . . . . . 10.1 m -118.39 88.94 3.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.908 . . . . 0.0 109.965 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2192 ' ' CYS . . . . . 0.622 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.7 OUTLIER -51.58 -179.48 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.171 -0.956 . . . . 0.0 109.219 179.586 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 2193 ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' 2194 ' ' GLU . 4.7 tt0 -57.2 118.17 4.8 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2194 ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.5 OUTLIER -32.21 128.49 0.22 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.409 0.623 . . . . 0.0 111.006 -178.933 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.41 4.69 8.94 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2196 ' ' PHE . . . . . 0.672 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.9 OUTLIER -117.37 -165.98 1.14 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.259 -1.142 . . . . 0.0 110.313 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 2197 ' ' GLU . . . . . 0.535 ' N ' ' CG ' ' A' 2196 ' ' PHE . 4.9 mm-40 -143.86 95.98 5.63 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.635 -0.666 . . . . 0.0 109.388 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2198 ' ' PRO . . . . . 0.672 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 6.8 Cg_endo -65.95 -167.17 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.187 1.925 . . . . 0.0 111.273 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -134.65 -171.33 12.47 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.1 -76.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.111 1.874 . . . . 0.0 110.822 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2201 ' ' MET . . . . . 0.547 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -140.26 52.2 1.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.485 -0.759 . . . . 0.0 109.997 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 8.8 mmm -126.37 -73.84 0.61 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.002 -1.062 . . . . 0.0 110.062 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A 2203 ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' 2175 ' ' PRO . 7.0 t -170.78 -169.12 0.74 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.218 -0.926 . . . . 0.0 109.746 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A 2204 ' ' CYS . . . . . 0.571 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.0 OUTLIER -112.46 148.03 35.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.47 -0.769 . . . . 0.0 108.974 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.43 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2129 ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' A' 2132 ' ' LYS . 5.2 t0 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2130 ' ' GLU . . . . . 0.585 ' O ' HG21 ' A' 2136 ' ' VAL . 2.1 mt-10 83.03 -61.29 0.13 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.757 -0.589 . . . . 0.0 110.831 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2131 ' ' CYS . . . . . 0.772 ' HA ' HG11 ' A' 2136 ' ' VAL . 29.5 p -85.45 -5.78 59.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.961 -1.087 . . . . 0.0 110.047 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2132 ' ' LYS . . . . . 0.541 ' HB3' ' HB3' ' A' 2129 ' ' ASP . 13.7 tttt -94.89 3.18 55.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -0.976 . . . . 0.0 109.34 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2133 ' ' GLU . . . . . 0.494 ' HB2' HG23 ' A' 2136 ' ' VAL . 5.3 mt-10 -69.61 147.24 96.52 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 120.99 -1.069 . . . . 0.0 109.188 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2134 ' ' PRO . . . . . 0.529 ' HA ' ' CG ' ' A' 2138 ' ' LYS . 1.4 Cg_endo -63.9 -6.13 10.44 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.278 1.985 . . . . 0.0 110.935 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.16 -3.73 12.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.983 -1.073 . . . . 0.0 110.078 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2136 ' ' VAL . . . . . 0.772 HG11 ' HA ' ' A' 2131 ' ' CYS . 76.9 t -96.86 -101.03 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.037 -1.04 . . . . 0.0 109.788 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2137 ' ' CYS . . . . . 0.65 ' N ' HG12 ' A' 2136 ' ' VAL . 0.5 OUTLIER -73.27 -72.58 0.25 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.868 -1.145 . . . . 0.0 109.523 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 2138 ' ' LYS . . . . . 0.529 ' CG ' ' HA ' ' A' 2134 ' ' PRO . 1.1 mtmt 63.53 100.57 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.296 -0.878 . . . . 0.0 109.805 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2139 ' ' HIS . . . . . 0.509 ' CB ' ' O ' ' A' 2138 ' ' LYS . 7.7 m-70 76.54 26.68 0.85 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -0.893 . . . . 0.0 109.579 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -132.34 166.82 23.23 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2141 ' ' GLN . . . . . 0.521 ' O ' ' CG ' ' A' 2152 ' ' GLU . 0.9 OUTLIER -103.86 71.51 1.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -1.17 . . . . 0.0 109.022 179.803 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 2142 ' ' CYS . . . . . 0.47 ' HB3' ' SG ' ' A' 2137 ' ' CYS . 25.4 p -70.17 -164.33 0.08 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.865 0.841 . . . . 0.0 110.449 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2143 ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' 2143 ' ' ILE . 2.5 mp -151.68 84.58 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2144 ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 3.2 t30 -61.74 113.64 2.86 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.54 -0.725 . . . . 0.0 110.362 -178.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2145 ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' 2146 ' ' ASP . 16.5 p -101.1 -157.2 0.59 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.531 -0.731 . . . . 0.0 109.324 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2146 ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' 2146 ' ' ASP . 0.6 OUTLIER -48.37 -94.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.625 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -108.04 16.99 35.57 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2148 ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.69 -166.37 1.77 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.202 -1.175 . . . . 0.0 109.165 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2149 ' ' TYR . . . . . 0.558 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 40.5 p90 -176.4 -176.86 0.8 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.655 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2150 ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.09 134.9 23.58 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -102.25 119.67 39.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.086 -1.009 . . . . 0.0 109.937 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2152 ' ' GLU . . . . . 0.521 ' CG ' ' O ' ' A' 2141 ' ' GLN . 0.8 OUTLIER -134.68 178.64 6.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 109.389 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 2153 ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -142.09 158.34 61.84 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.302 -179.822 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 2154 ' ' PRO . . . . . 0.501 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.8 Cg_endo -62.93 -171.08 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.457 2.104 . . . . 0.0 111.52 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.18 102.47 14.49 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.39 -16.7 5.4 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2157 ' ' TYR . . . . . 0.537 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 5.2 m-85 -105.25 -170.44 1.75 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.682 -0.893 . . . . 0.0 109.898 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2158 ' ' ILE . . . . . 0.638 HD13 ' N ' ' A' 2158 ' ' ILE . 0.2 OUTLIER -158.91 -161.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.624 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 2159 ' ' LEU . . . . . 0.505 ' N ' HG12 ' A' 2158 ' ' ILE . 26.3 tp -136.55 123.34 21.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.831 . . . . 0.0 109.499 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -96.39 51.78 1.21 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.359 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 90.36 -29.62 6.53 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2162 ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' 2136 ' ' VAL . 2.8 p-10 -171.13 -48.84 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.153 -1.204 . . . . 0.0 109.331 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2163 ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' 2137 ' ' CYS . 53.8 tt0 -72.57 121.78 20.27 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.543 -0.723 . . . . 0.0 109.273 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2164 ' ' CYS . . . . . 0.632 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -90.94 138.88 31.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 109.593 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 2165 ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' 2164 ' ' CYS . 0.7 OUTLIER -159.84 -167.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.941 . . . . 0.0 109.297 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 2166 ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 8.7 t70 -89.97 155.73 18.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.975 -1.078 . . . . 0.0 109.786 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2167 ' ' THR . . . . . 0.607 HG23 ' OE1' ' A' 2169 ' ' GLU . 7.2 t -90.99 -169.49 2.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 109.449 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2168 ' ' ASP . . . . . 0.478 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 64.9 t0 -109.15 102.44 11.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.218 -0.926 . . . . 0.0 109.836 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2169 ' ' GLU . . . . . 0.613 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.5 OUTLIER -74.95 -32.65 61.79 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.361 -0.837 . . . . 0.0 109.066 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 2170 ' ' CYS . . . . . 0.538 ' HB2' ' N ' ' A' 2182 ' ' LYS . 0.6 OUTLIER -64.6 -11.55 36.1 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.776 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.35 5.22 13.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.845 . . . . 0.0 109.383 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 40.5 t -103.61 -65.88 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.355 -0.84 . . . . 0.0 109.402 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2173 ' ' GLY . . . . . . . . . . . . . . . -153.53 -135.18 2.1 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2174 ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -122.85 102.69 37.85 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.316 -1.109 . . . . 0.0 109.07 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2175 ' ' PRO . . . . . 0.645 ' CB ' ' CE2' ' A' 2188 ' ' PHE . 3.4 Cg_endo -69.07 -18.58 40.19 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.695 1.597 . . . . 0.0 109.839 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2176 ' ' CYS . . . . . 0.578 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -69.77 -50.36 44.05 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.127 -0.983 . . . . 0.0 109.653 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 124.75 -17.94 7.2 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -166.37 -37.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -1.079 . . . . 0.0 110.12 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2179 ' ' GLY . . . . . 0.585 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -63.95 -120.55 0.01 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.4 p -141.55 161.29 38.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.54 -0.976 . . . . 0.0 109.198 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2181 ' ' CYS . . . . . 0.572 ' HB3' ' HD2' ' A' 2175 ' ' PRO . 26.7 p -97.81 160.76 14.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.043 -1.036 . . . . 0.0 110.593 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2182 ' ' LYS . . . . . 0.576 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 2.5 tppt? -145.46 155.67 43.26 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2183 ' ' ASN . . . . . 0.478 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 32.4 t30 -92.71 137.34 32.45 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.52 -1.363 . . . . 0.0 110.203 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2184 ' ' VAL . . . . . 0.847 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -140.92 -167.63 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 2185 ' ' ILE . . . . . 0.695 ' N ' HG13 ' A' 2184 ' ' VAL . 1.5 mp -107.17 141.42 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.106 -0.996 . . . . 0.0 110.461 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 64.7 13.48 56.11 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2187 ' ' GLY . . . . . 0.566 ' C ' HG12 ' A' 2184 ' ' VAL . . . 167.24 -118.85 0.81 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2188 ' ' PHE . . . . . 0.847 ' N ' HG12 ' A' 2184 ' ' VAL . 1.5 p90 -171.84 -179.19 2.38 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.367 -1.078 . . . . 0.0 109.497 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2189 ' ' GLU . . . . . 0.576 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.5 OUTLIER -128.87 169.19 14.9 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.387 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 8.9 p -170.53 147.66 2.96 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.789 -1.194 . . . . 0.0 109.749 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2191 ' ' THR . . . . . . . . . . . . . 25.2 m -118.18 90.97 3.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.644 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2192 ' ' CYS . . . . . 0.631 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.8 OUTLIER -52.99 -179.88 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.031 -1.043 . . . . 0.0 108.783 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 2193 ' ' GLU . . . . . 0.499 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.6 tt0 -52.45 112.76 0.87 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2194 ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -31.34 125.73 0.21 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.439 0.637 . . . . 0.0 111.136 -178.601 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.53 11.18 6.17 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2196 ' ' PHE . . . . . 0.686 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.8 p90 -118.33 -162.34 0.88 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.135 -1.215 . . . . 0.0 110.489 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2197 ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' 2196 ' ' PHE . 18.4 mt-10 -142.28 92.54 7.45 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 121.434 -0.792 . . . . 0.0 110.058 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2198 ' ' PRO . . . . . 0.686 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.0 Cg_endo -67.05 -160.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.303 2.002 . . . . 0.0 111.273 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -140.21 -175.74 14.63 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A 2200 ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' 2189 ' ' GLU . 2.0 Cg_endo -62.14 -74.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 121.702 1.601 . . . . 0.0 110.61 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2201 ' ' MET . . . . . 0.475 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -143.44 46.47 1.5 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.213 -0.929 . . . . 0.0 109.458 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 2202 ' ' MET . . . . . 0.432 ' O ' ' HB ' ' A' 2203 ' ' THR . 0.1 OUTLIER -116.95 -65.59 1.17 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.303 -0.873 . . . . 0.0 109.779 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 2203 ' ' THR . . . . . 0.432 ' HB ' ' O ' ' A' 2202 ' ' MET . 13.3 t -179.9 -171.45 0.18 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A 2204 ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.0 OUTLIER -112.44 143.51 43.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.086 -1.009 . . . . 0.0 109.269 -179.552 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.495 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2129 ' ' ASP . . . . . 0.62 ' O ' ' HB2' ' A' 2130 ' ' GLU . 4.5 t0 . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2130 ' ' GLU . . . . . 0.62 ' HB2' ' O ' ' A' 2129 ' ' ASP . 1.8 mp0 75.81 -57.52 0.57 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 120.92 0.391 . . . . 0.0 111.45 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2131 ' ' CYS . . . . . 0.567 ' HB2' ' CB ' ' A' 2137 ' ' CYS . 0.5 OUTLIER -84.43 -19.31 33.67 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.765 -1.209 . . . . 0.0 109.974 -178.904 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 2132 ' ' LYS . . . . . 0.53 ' HB3' ' HB3' ' A' 2129 ' ' ASP . 4.4 tttt -68.4 -9.92 51.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.13 -0.981 . . . . 0.0 109.838 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2133 ' ' GLU . . . . . 0.929 ' HB2' HG23 ' A' 2136 ' ' VAL . 6.7 mt-10 -69.13 147.62 97.54 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.329 -0.857 . . . . 0.0 109.921 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2134 ' ' PRO . . . . . 0.497 ' O ' ' HD2' ' A' 2138 ' ' LYS . 3.8 Cg_endo -69.27 3.25 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.499 2.132 . . . . 0.0 111.17 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2135 ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' 2162 ' ' ASN . 0.6 OUTLIER -127.08 -6.08 6.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.638 -1.289 . . . . 0.0 110.3 -179.551 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 2136 ' ' VAL . . . . . 0.929 HG23 ' HB2' ' A' 2133 ' ' GLU . 2.4 t -102.31 -143.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.866 -1.146 . . . . 0.0 108.117 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2137 ' ' CYS . . . . . 0.567 ' CB ' ' HB2' ' A' 2131 ' ' CYS . 2.6 t -49.97 128.94 19.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.548 -1.345 . . . . 0.0 108.336 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2138 ' ' LYS . . . . . 0.516 ' O ' ' CB ' ' A' 2139 ' ' HIS . 2.9 mtpt -135.4 28.8 3.34 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.119 -0.988 . . . . 0.0 110.353 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2139 ' ' HIS . . . . . 0.516 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.1 OUTLIER 162.21 45.43 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.311 -0.868 . . . . 0.0 109.698 179.582 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -153.92 179.76 29.91 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -88.8 82.62 6.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -1.135 . . . . 0.0 109.171 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2142 ' ' CYS . . . . . 0.525 ' C ' HD13 ' A' 2143 ' ' ILE . 21.4 p -78.67 147.63 33.46 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.366 -0.834 . . . . 0.0 110.032 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2143 ' ' ILE . . . . . 0.525 HD13 ' C ' ' A' 2142 ' ' CYS . 5.0 mm -113.37 129.03 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2144 ' ' ASN . . . . . . . . . . . . . 45.5 t30 -84.16 103.47 13.4 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 110.545 -178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2145 ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' 2146 ' ' ASP . 4.1 p -94.45 -167.19 1.61 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2146 ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' 2145 ' ' THR . 0.4 OUTLIER -45.78 -93.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 109.342 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -108.12 -7.6 30.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2148 ' ' SER . . . . . 0.438 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.2 OUTLIER -100.24 -162.61 0.96 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -1.129 . . . . 0.0 109.471 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 2149 ' ' TYR . . . . . 0.598 ' CD2' ' HB3' ' A' 2130 ' ' GLU . 29.6 p90 -164.85 -171.12 2.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.193 -0.942 . . . . 0.0 109.577 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2150 ' ' ARG . . . . . 0.531 ' CG ' ' O ' ' A' 2149 ' ' TYR . 18.0 mtt180 -160.55 104.5 1.41 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.465 -0.772 . . . . 0.0 109.412 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 41.9 t -86.68 78.82 9.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.351 -0.843 . . . . 0.0 109.482 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.86 98.12 11.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.921 . . . . 0.0 109.209 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2153 ' ' CYS . . . . . 0.546 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -58.08 157.46 16.29 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.335 -0.853 . . . . 0.0 109.748 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 2154 ' ' PRO . . . . . 0.499 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.2 Cg_endo -65.22 -166.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.703 2.269 . . . . 0.0 111.278 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 8.4 t80 -90.43 102.34 15.08 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.82 -15.4 5.42 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 107.742 -2.143 . . . . 0.0 107.742 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2157 ' ' TYR . . . . . 0.546 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 9.0 m-85 -109.3 -171.19 1.79 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.647 -0.913 . . . . 0.0 109.724 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2158 ' ' ILE . . . . . 0.741 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -157.34 -161.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.641 -0.662 . . . . 0.0 109.597 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 2159 ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' 2159 ' ' LEU . 15.5 tp -134.35 120.72 20.23 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.326 -0.859 . . . . 0.0 109.67 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -97.1 57.47 1.47 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.2 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2161 ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 86.94 -14.0 57.96 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2162 ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' 2135 ' ' ASP . 1.6 m-20 165.44 -41.81 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.253 -1.145 . . . . 0.0 109.683 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -73.63 118.38 16.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.372 -0.83 . . . . 0.0 109.223 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2164 ' ' CYS . . . . . 0.776 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -85.24 138.78 32.12 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.26 -0.9 . . . . 0.0 109.642 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 2165 ' ' VAL . . . . . 0.776 HG13 ' O ' ' A' 2164 ' ' CYS . 1.6 m -164.63 -170.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 0.0 109.07 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2166 ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' 2184 ' ' VAL . 3.0 t70 -89.74 147.66 23.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.991 -1.068 . . . . 0.0 109.465 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2167 ' ' THR . . . . . 0.602 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 6.8 t -89.72 -173.72 4.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.363 -0.836 . . . . 0.0 109.111 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2168 ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' 2171 ' ' SER . 44.5 t0 -98.94 97.02 8.24 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.266 -0.896 . . . . 0.0 108.649 178.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2169 ' ' GLU . . . . . 0.577 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.6 OUTLIER -72.58 -31.18 65.03 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.185 -0.947 . . . . 0.0 109.443 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 2170 ' ' CYS . . . . . 0.522 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 3.3 t -70.59 -4.7 24.49 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.301 -0.874 . . . . 0.0 108.894 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2171 ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.1 OUTLIER -65.62 -8.52 20.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.831 -1.168 . . . . 0.0 109.413 179.572 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 24.9 t -83.11 -71.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.156 -0.965 . . . . 0.0 109.571 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2173 ' ' GLY . . . . . 0.459 ' O ' ' SG ' ' A' 2181 ' ' CYS . . . -172.72 -70.21 0.05 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2174 ' ' ASN . . . . . 0.549 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 27.5 p-10 -171.47 95.58 0.41 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.221 -1.164 . . . . 0.0 109.021 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2175 ' ' PRO . . . . . 0.611 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.5 Cg_endo -63.98 -19.75 66.96 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.915 1.743 . . . . 0.0 110.253 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2176 ' ' CYS . . . . . 0.523 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -56.04 -58.69 6.86 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.052 -1.03 . . . . 0.0 108.239 179.697 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 148.1 -18.21 1.37 Allowed Glycine 0 N--CA 1.483 1.826 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2178 ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.2 OUTLIER -169.48 -32.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -1.131 . . . . 0.0 110.297 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 2179 ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -61.18 -115.6 0.01 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2180 ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' 2190 ' ' CYS . 1.1 p -151.3 152.51 33.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -1.07 . . . . 0.0 109.486 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2181 ' ' CYS . . . . . 0.59 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 20.7 p -87.83 164.29 15.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.974 -1.079 . . . . 0.0 110.896 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2182 ' ' LYS . . . . . 0.598 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.0 OUTLIER -145.16 158.97 43.68 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.467 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 2183 ' ' ASN . . . . . 0.471 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 57.2 t30 -99.72 129.9 45.88 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.446 -1.408 . . . . 0.0 109.735 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2184 ' ' VAL . . . . . 0.793 HG12 ' N ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -140.08 -170.3 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 2185 ' ' ILE . . . . . 0.544 ' N ' HG13 ' A' 2184 ' ' VAL . 4.6 mp -101.6 136.78 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.96 -1.087 . . . . 0.0 110.448 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 76.33 -2.23 57.97 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2187 ' ' GLY . . . . . 0.533 ' C ' ' CD1' ' A' 2188 ' ' PHE . . . 178.27 -113.67 0.42 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2188 ' ' PHE . . . . . 0.793 ' N ' HG12 ' A' 2184 ' ' VAL . 3.0 p90 -176.19 176.42 1.71 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.384 -1.068 . . . . 0.0 108.876 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2189 ' ' GLU . . . . . 0.598 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 8.1 tt0 -124.26 133.67 53.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.125 -0.984 . . . . 0.0 108.685 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2190 ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' 2180 ' ' THR . 20.7 p -128.16 136.99 51.88 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.906 -1.121 . . . . 0.0 109.869 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2191 ' ' THR . . . . . 0.491 ' O ' ' HA3' ' A' 2179 ' ' GLY . 17.9 m -109.86 87.95 2.63 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.38 -0.825 . . . . 0.0 109.243 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2192 ' ' CYS . . . . . 0.622 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 1.2 m -48.91 -179.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.414 -0.804 . . . . 0.0 109.167 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2193 ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' 2194 ' ' GLU . 20.5 tt0 -56.26 122.35 11.6 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2194 ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -36.7 130.17 0.76 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.616 -0.678 . . . . 0.0 110.585 -178.886 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.31 0.02 10.44 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2196 ' ' PHE . . . . . 0.683 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.2 p90 -112.1 -162.47 0.8 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.277 -1.131 . . . . 0.0 110.015 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2197 ' ' GLU . . . . . 0.551 ' N ' ' CG ' ' A' 2196 ' ' PHE . 9.3 mt-10 -145.96 94.33 5.01 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.429 -0.795 . . . . 0.0 109.872 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2198 ' ' PRO . . . . . 0.683 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 7.9 Cg_endo -67.65 -158.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.444 2.096 . . . . 0.0 111.355 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -146.44 -167.4 12.78 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.13 -79.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.874 1.716 . . . . 0.0 110.634 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A 2201 ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' 2188 ' ' PHE . 5.0 ptp -136.93 62.31 1.6 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.823 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -127.69 -86.1 0.58 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.236 -0.915 . . . . 0.0 109.933 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2203 ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' 2175 ' ' PRO . 15.1 t -175.7 -170.42 0.4 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.387 -0.821 . . . . 0.0 108.961 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A 2204 ' ' CYS . . . . . 0.54 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.7 OUTLIER -61.66 135.98 57.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.011 -1.055 . . . . 0.0 108.972 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A 2205 ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' 2197 ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.579 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2129 ' ' ASP . . . . . 0.537 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 19.3 t0 . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2130 ' ' GLU . . . . . 0.737 ' O ' HG21 ' A' 2136 ' ' VAL . 1.3 mt-10 80.3 -43.96 0.25 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.925 -0.484 . . . . 0.0 111.066 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2131 ' ' CYS . . . . . 0.512 ' O ' ' HB2' ' A' 2137 ' ' CYS . 10.4 p -91.0 -42.19 10.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.66 -1.275 . . . . 0.0 110.111 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2132 ' ' LYS . . . . . 0.507 ' N ' ' SG ' ' A' 2131 ' ' CYS . 0.0 OUTLIER -67.27 -2.4 5.91 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.993 -1.067 . . . . 0.0 110.52 -179.571 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -68.75 153.56 95.76 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 120.963 -1.086 . . . . 0.0 109.459 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2134 ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -65.52 -3.81 8.43 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.533 2.155 . . . . 0.0 111.101 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2135 ' ' ASP . . . . . 0.848 ' OD1' HG23 ' A' 2136 ' ' VAL . 53.6 p-10 -119.26 3.13 11.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.861 -1.15 . . . . 0.0 110.346 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2136 ' ' VAL . . . . . 0.848 HG23 ' OD1' ' A' 2135 ' ' ASP . 19.1 t -121.82 -119.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.827 -1.171 . . . . 0.0 109.785 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2137 ' ' CYS . . . . . 0.514 ' N ' HG12 ' A' 2136 ' ' VAL . 0.1 OUTLIER -50.78 -56.19 13.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.624 -1.298 . . . . 0.0 109.488 -179.609 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 2138 ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' 2137 ' ' CYS . 3.8 mttt 72.64 -81.91 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.4 -0.813 . . . . 0.0 109.866 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2139 ' ' HIS . . . . . 0.515 ' O ' ' HB3' ' A' 2164 ' ' CYS . 21.2 m80 -115.27 58.87 0.71 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.052 -1.03 . . . . 0.0 110.186 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -141.7 -166.74 10.97 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.04 93.75 3.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -1.153 . . . . 0.0 109.037 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2142 ' ' CYS . . . . . 0.878 ' C ' HD12 ' A' 2143 ' ' ILE . 12.8 p -91.52 -152.25 0.29 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.235 -0.916 . . . . 0.0 110.491 -179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2143 ' ' ILE . . . . . 0.878 HD12 ' C ' ' A' 2142 ' ' CYS . 2.9 mp -148.46 90.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2144 ' ' ASN . . . . . 0.537 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 30.2 t-20 -39.33 108.5 0.09 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.404 0.621 . . . . 0.0 110.826 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2145 ' ' THR . . . . . 0.416 ' OG1' ' C ' ' A' 2148 ' ' SER . 0.1 OUTLIER -98.67 170.35 8.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.401 -0.812 . . . . 0.0 108.994 179.302 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.92 -84.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.797 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -107.08 50.83 0.77 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2148 ' ' SER . . . . . 0.466 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER -178.06 -162.68 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -1.153 . . . . 0.0 109.714 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 2149 ' ' TYR . . . . . 0.642 ' CE2' HG11 ' A' 2136 ' ' VAL . 42.0 p90 -169.77 -169.49 0.9 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.454 -0.779 . . . . 0.0 109.737 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2150 ' ' ARG . . . . . 0.456 ' C ' ' HB2' ' A' 2142 ' ' CYS . 0.4 OUTLIER -144.18 -160.78 1.17 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 2151 ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' 2150 ' ' ARG . 1.2 m -169.77 69.9 0.06 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.072 -1.017 . . . . 0.0 109.66 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -89.89 137.71 32.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.408 -0.807 . . . . 0.0 109.151 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2153 ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -112.07 158.54 36.61 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.192 -0.943 . . . . 0.0 109.501 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 2154 ' ' PRO . . . . . 0.485 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 2.7 Cg_endo -61.61 -176.03 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.68 2.253 . . . . 0.0 111.817 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 12.7 t80 -82.29 103.15 11.67 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.54 -19.03 5.11 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 107.119 -2.393 . . . . 0.0 107.119 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2157 ' ' TYR . . . . . 0.525 ' C ' HG23 ' A' 2158 ' ' ILE . 18.2 m-85 -108.2 176.42 5.13 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.824 -0.81 . . . . 0.0 109.601 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2158 ' ' ILE . . . . . 0.737 HD13 ' N ' ' A' 2158 ' ' ILE . 0.1 OUTLIER -158.08 -163.74 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.658 -0.651 . . . . 0.0 109.403 -179.764 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 2159 ' ' LEU . . . . . 0.449 HD11 ' O ' ' A' 2162 ' ' ASN . 19.4 tp -131.34 122.78 26.97 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.435 -0.79 . . . . 0.0 109.481 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -93.47 43.01 1.11 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.299 -0.875 . . . . 0.0 109.129 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2161 ' ' GLY . . . . . 0.451 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 97.42 -8.94 64.63 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2162 ' ' ASN . . . . . 0.532 ' ND2' ' HA ' ' A' 2136 ' ' VAL . 1.3 m-20 167.93 -43.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -1.167 . . . . 0.0 109.635 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -79.42 118.83 21.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 109.376 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2164 ' ' CYS . . . . . 0.816 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -88.53 137.77 32.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.418 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 2165 ' ' VAL . . . . . 0.816 HG13 ' O ' ' A' 2164 ' ' CYS . 1.8 m -166.43 -166.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.374 -0.829 . . . . 0.0 108.92 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2166 ' ' ASP . . . . . 0.425 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 0.7 OUTLIER -83.82 139.18 32.84 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.733 -1.23 . . . . 0.0 109.453 179.83 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 2167 ' ' THR . . . . . 0.636 ' HB ' HD12 ' A' 2158 ' ' ILE . 9.9 t -97.44 178.31 5.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.354 -0.841 . . . . 0.0 109.362 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2168 ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' 2171 ' ' SER . 51.3 t0 -88.55 96.04 10.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.164 -0.96 . . . . 0.0 109.024 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2169 ' ' GLU . . . . . 0.59 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.4 OUTLIER -66.67 -34.14 77.21 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.296 -0.877 . . . . 0.0 109.228 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 2170 ' ' CYS . . . . . 0.459 ' O ' ' SG ' ' A' 2170 ' ' CYS . 1.7 t -68.67 -9.08 48.0 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.327 -0.858 . . . . 0.0 108.753 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2171 ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -78.32 5.84 9.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.372 -0.83 . . . . 0.0 110.574 -179.176 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 5.6 t -112.3 -76.93 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.903 -1.123 . . . . 0.0 109.87 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2173 ' ' GLY . . . . . 0.469 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -150.7 137.53 6.15 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2174 ' ' ASN . . . . . 0.629 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 23.2 p-10 -47.03 104.51 0.41 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.312 -1.111 . . . . 0.0 109.969 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2175 ' ' PRO . . . . . 0.583 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 1.7 Cg_endo -70.42 -23.55 27.66 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.879 1.719 . . . . 0.0 109.763 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2176 ' ' CYS . . . . . 0.554 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -47.33 -30.97 3.52 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.395 -0.815 . . . . 0.0 109.492 -179.585 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 114.49 -23.47 12.21 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.3 -34.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.606 -0.937 . . . . 0.0 109.791 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2179 ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -62.47 -127.81 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.3 p -134.64 156.76 48.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.601 -0.941 . . . . 0.0 109.549 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2181 ' ' CYS . . . . . 0.629 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 14.6 p -94.12 163.06 13.62 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.199 1.0 . . . . 0.0 111.258 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2182 ' ' LYS . . . . . 0.586 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 5.9 tttp -143.06 156.9 44.92 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2183 ' ' ASN . . . . . 0.408 ' N ' ' HG3' ' A' 2182 ' ' LYS . 60.9 t30 -99.31 133.09 44.12 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.3 -1.5 . . . . 0.0 109.967 -179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2184 ' ' VAL . . . . . 0.81 HG12 ' N ' ' A' 2188 ' ' PHE . 0.4 OUTLIER -140.37 -176.77 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.635 -0.666 . . . . 0.0 109.227 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 2185 ' ' ILE . . . . . 0.457 ' N ' HG13 ' A' 2184 ' ' VAL . 1.9 mp -95.8 143.51 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.117 -0.989 . . . . 0.0 110.131 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 65.07 12.33 54.59 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2187 ' ' GLY . . . . . 0.627 ' C ' HG12 ' A' 2184 ' ' VAL . . . 165.12 -129.25 1.92 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2188 ' ' PHE . . . . . 0.81 ' N ' HG12 ' A' 2184 ' ' VAL . 1.4 p90 -164.11 -179.32 6.1 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.3 -1.118 . . . . 0.0 108.81 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2189 ' ' GLU . . . . . 0.586 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.2 OUTLIER -125.48 174.2 8.38 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.39 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 1.8 p -171.61 147.71 2.36 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.769 -1.207 . . . . 0.0 109.81 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2191 ' ' THR . . . . . 0.474 ' O ' ' O ' ' A' 2192 ' ' CYS . 13.6 m -123.06 89.9 3.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.0 109.898 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2192 ' ' CYS . . . . . 0.614 ' HA ' ' HA3' ' A' 2179 ' ' GLY . 0.8 OUTLIER -48.91 -179.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.341 -0.85 . . . . 0.0 109.32 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 2193 ' ' GLU . . . . . 0.462 ' O ' ' C ' ' A' 2194 ' ' GLU . 3.3 tt0 -61.12 125.43 23.7 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2194 ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -34.86 129.76 0.43 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.344 0.592 . . . . 0.0 110.842 -179.244 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.21 5.39 8.77 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2196 ' ' PHE . . . . . 0.672 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.9 OUTLIER -121.5 -163.5 1.05 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.289 -1.124 . . . . 0.0 110.195 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 2197 ' ' GLU . . . . . 0.584 ' N ' ' CG ' ' A' 2196 ' ' PHE . 24.4 mt-10 -148.15 98.07 3.8 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.619 -0.675 . . . . 0.0 109.428 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2198 ' ' PRO . . . . . 0.672 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.8 Cg_endo -69.01 -166.31 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.339 2.026 . . . . 0.0 111.597 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -135.84 -170.35 12.04 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.17 -83.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.21 1.94 . . . . 0.0 110.994 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A 2201 ' ' MET . . . . . 0.64 ' HG2' HG11 ' A' 2184 ' ' VAL . 8.4 mtt -132.77 52.22 2.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.991 -1.068 . . . . 0.0 109.975 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2202 ' ' MET . . . . . 0.451 ' O ' ' HB ' ' A' 2203 ' ' THR . 1.0 OUTLIER -122.98 -71.23 0.73 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.21 -0.931 . . . . 0.0 109.791 -179.775 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 2203 ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' 2202 ' ' MET . 11.7 t 179.33 -167.82 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.458 -0.776 . . . . 0.0 109.048 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A 2204 ' ' CYS . . . . . 0.554 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -111.52 150.17 30.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.095 -1.003 . . . . 0.0 109.215 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 117.896 -1.049 . . . . 0.0 109.572 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2129 ' ' ASP . . . . . 0.59 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 1.3 p30 . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2130 ' ' GLU . . . . . 0.794 ' O ' HG21 ' A' 2136 ' ' VAL . 1.4 mt-10 80.44 -42.86 0.22 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 122.015 -0.428 . . . . 0.0 111.292 177.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2131 ' ' CYS . . . . . 0.599 ' HA ' HG11 ' A' 2136 ' ' VAL . 17.5 p -90.82 27.16 1.86 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.922 -1.111 . . . . 0.0 110.204 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2132 ' ' LYS . . . . . 0.525 ' N ' ' OD1' ' A' 2129 ' ' ASP . 0.6 OUTLIER -131.94 -6.25 3.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.91 . . . . 0.0 109.728 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 2133 ' ' GLU . . . . . 0.468 ' HB3' ' HD2' ' A' 2134 ' ' PRO . 5.8 mt-10 -70.03 158.74 86.62 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.141 -0.974 . . . . 0.0 109.323 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2134 ' ' PRO . . . . . 0.507 ' O ' ' HD2' ' A' 2138 ' ' LYS . 2.8 Cg_endo -67.27 -1.53 6.54 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.379 2.053 . . . . 0.0 110.804 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.07 4.65 9.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.8 -1.188 . . . . 0.0 110.088 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2136 ' ' VAL . . . . . 0.794 HG21 ' O ' ' A' 2130 ' ' GLU . 55.0 t -107.46 -107.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.869 -1.145 . . . . 0.0 110.116 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2137 ' ' CYS . . . . . 0.531 ' N ' HG12 ' A' 2136 ' ' VAL . 1.3 m -56.21 -77.39 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.796 -1.19 . . . . 0.0 109.599 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2138 ' ' LYS . . . . . 0.58 ' O ' ' CG ' ' A' 2139 ' ' HIS . 0.1 OUTLIER 68.7 3.05 3.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.584 -0.698 . . . . 0.0 111.12 179.188 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 2139 ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' 2138 ' ' LYS . 0.8 OUTLIER 168.64 40.43 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.701 -1.249 . . . . 0.0 110.835 178.933 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -158.21 160.65 31.03 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.116 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -89.51 124.22 34.32 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2142 ' ' CYS . . . . . 0.883 ' C ' HD12 ' A' 2143 ' ' ILE . 22.8 p -111.86 -166.85 1.11 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.131 -0.98 . . . . 0.0 111.237 -178.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2143 ' ' ILE . . . . . 0.883 HD12 ' C ' ' A' 2142 ' ' CYS . 4.2 mp -150.24 98.1 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2144 ' ' ASN . . . . . 0.59 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 26.6 t-20 -46.86 114.54 0.86 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.452 -0.78 . . . . 0.0 111.254 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2145 ' ' THR . . . . . 0.48 ' OG1' ' HA ' ' A' 2149 ' ' TYR . 0.1 OUTLIER -108.54 175.55 5.43 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.236 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.25 105.64 9.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.349 -0.844 . . . . 0.0 110.055 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 73.01 8.77 74.69 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2148 ' ' SER . . . . . 0.488 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.5 OUTLIER -152.68 -173.6 4.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.977 -1.308 . . . . 0.0 109.951 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 2149 ' ' TYR . . . . . 0.636 ' CD2' ' CB ' ' A' 2130 ' ' GLU . 50.7 p90 -165.66 -168.4 1.31 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.522 -0.736 . . . . 0.0 109.168 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2150 ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' 2142 ' ' CYS . 0.4 OUTLIER -168.93 124.98 0.92 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.324 -0.86 . . . . 0.0 108.914 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 2.1 t -105.49 107.2 18.07 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.149 -0.969 . . . . 0.0 110.278 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.77 134.15 42.08 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2153 ' ' CYS . . . . . 0.508 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -97.54 161.07 27.15 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.071 -1.018 . . . . 0.0 109.955 -179.149 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 2154 ' ' PRO . . . . . 0.5 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.8 Cg_endo -61.43 -169.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 122.812 2.342 . . . . 0.0 111.812 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 3.4 t80 -86.12 99.86 11.79 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.09 -13.17 5.77 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2157 ' ' TYR . . . . . 0.536 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 5.1 m-85 -107.16 -173.5 2.31 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.503 -0.998 . . . . 0.0 110.205 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2158 ' ' ILE . . . . . 0.707 HD13 ' N ' ' A' 2158 ' ' ILE . 0.1 OUTLIER -159.36 -166.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 2159 ' ' LEU . . . . . 0.636 HD11 ' O ' ' A' 2162 ' ' ASN . 31.4 tp -133.67 119.64 19.62 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.333 -0.854 . . . . 0.0 109.236 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -89.89 55.83 3.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 109.664 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2161 ' ' GLY . . . . . 0.505 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 80.08 -2.31 76.23 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2162 ' ' ASN . . . . . 0.636 ' O ' HD11 ' A' 2159 ' ' LEU . 2.5 m-20 166.51 -58.48 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.1 -1.236 . . . . 0.0 109.69 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -69.66 115.5 8.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.873 . . . . 0.0 109.49 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2164 ' ' CYS . . . . . 0.83 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -86.2 140.32 30.26 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.307 -0.871 . . . . 0.0 109.273 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 2165 ' ' VAL . . . . . 0.83 HG13 ' O ' ' A' 2164 ' ' CYS . 1.0 OUTLIER -166.35 -166.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.483 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 2166 ' ' ASP . . . . . 0.49 ' OD1' ' CE1' ' A' 2157 ' ' TYR . 0.7 OUTLIER -89.93 142.04 28.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.949 -1.095 . . . . 0.0 109.606 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 2167 ' ' THR . . . . . 0.693 HG23 ' OE1' ' A' 2169 ' ' GLU . 12.8 t -81.67 175.75 10.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 0.0 108.972 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2168 ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' 2171 ' ' SER . 56.6 t0 -95.38 94.59 7.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.102 -0.999 . . . . 0.0 109.248 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2169 ' ' GLU . . . . . 0.693 ' OE1' HG23 ' A' 2167 ' ' THR . 0.8 OUTLIER -69.28 -33.82 73.79 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.407 -0.808 . . . . 0.0 109.363 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 2170 ' ' CYS . . . . . 0.527 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 2.3 t -69.62 -6.01 28.46 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.373 -0.83 . . . . 0.0 109.044 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2171 ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -79.59 7.59 8.03 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.992 -1.067 . . . . 0.0 109.941 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 24.1 t -112.87 -79.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.031 -1.043 . . . . 0.0 110.008 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2173 ' ' GLY . . . . . 0.473 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -152.45 139.74 7.22 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2174 ' ' ASN . . . . . 0.593 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 29.9 p-10 -45.9 104.19 0.39 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.51 -0.994 . . . . 0.0 110.249 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2175 ' ' PRO . . . . . 0.577 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 3.1 Cg_endo -67.29 -18.37 50.23 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.977 1.785 . . . . 0.0 110.324 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2176 ' ' CYS . . . . . 0.569 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -61.1 -10.52 6.36 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.111 -0.993 . . . . 0.0 110.185 -179.519 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 96.35 -31.47 7.4 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.272 -1.442 . . . . 0.0 109.58 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2178 ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.1 OUTLIER -158.26 -37.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -1.098 . . . . 0.0 109.962 -179.647 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 2179 ' ' GLY . . . . . 0.609 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -57.41 -113.25 0.01 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2180 ' ' THR . . . . . 0.436 HG23 ' O ' ' A' 2179 ' ' GLY . 1.4 p -154.23 168.71 25.65 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.411 -1.052 . . . . 0.0 109.305 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2181 ' ' CYS . . . . . 0.593 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 24.6 p -101.66 163.5 12.23 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.066 0.936 . . . . 0.0 111.414 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2182 ' ' LYS . . . . . 0.569 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.2 OUTLIER -144.68 158.34 43.82 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 178.542 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 58.2 t30 -100.35 128.67 46.36 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.555 -1.341 . . . . 0.0 108.957 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2184 ' ' VAL . . . . . 0.864 HG12 ' CA ' ' A' 2188 ' ' PHE . 0.9 OUTLIER -137.24 -166.53 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.632 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 2185 ' ' ILE . . . . . 0.638 ' H ' HG22 ' A' 2184 ' ' VAL . 4.7 mp -101.08 140.53 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 110.176 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 71.02 4.16 54.47 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2187 ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 167.23 -116.13 0.66 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2188 ' ' PHE . . . . . 0.864 ' CA ' HG12 ' A' 2184 ' ' VAL . 2.4 p90 -166.85 -177.76 3.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.052 -1.263 . . . . 0.0 110.083 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2189 ' ' GLU . . . . . 0.569 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 7.5 tt0 -129.84 139.45 51.2 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2190 ' ' CYS . . . . . 0.44 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 13.7 p -128.48 144.06 51.08 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.606 -1.309 . . . . 0.0 110.179 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2191 ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' 2192 ' ' CYS . 73.3 m -111.17 84.23 1.9 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.86 . . . . 0.0 109.701 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2192 ' ' CYS . . . . . 0.611 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.8 OUTLIER -49.93 179.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 109.047 179.763 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 2193 ' ' GLU . . . . . 0.493 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.3 OUTLIER -54.83 115.76 2.36 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.788 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 2194 ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.3 OUTLIER -30.17 126.8 0.14 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.375 0.607 . . . . 0.0 111.072 -179.033 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.37 5.58 8.55 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2196 ' ' PHE . . . . . 0.671 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.8 OUTLIER -117.51 -164.17 0.98 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.212 -1.169 . . . . 0.0 110.283 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A 2197 ' ' GLU . . . . . 0.557 ' N ' ' CG ' ' A' 2196 ' ' PHE . 2.1 mm-40 -145.48 98.21 4.61 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2198 ' ' PRO . . . . . 0.671 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.1 Cg_endo -68.08 -160.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.066 1.844 . . . . 0.0 110.726 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -135.52 -170.33 12.07 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.63 -74.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 121.96 1.773 . . . . 0.0 110.711 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A 2201 ' ' MET . . . . . 0.489 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 4.5 ptt? -146.22 60.51 1.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.15 -0.969 . . . . 0.0 110.118 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2202 ' ' MET . . . . . 0.452 ' O ' ' HB ' ' A' 2203 ' ' THR . 1.9 mmt -129.55 -68.97 0.7 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.102 -0.999 . . . . 0.0 109.75 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2203 ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' 2202 ' ' MET . 10.7 t 179.02 -168.74 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.414 -0.804 . . . . 0.0 109.138 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2204 ' ' CYS . . . . . 0.569 ' HB2' ' O ' ' A' 2176 ' ' CYS . 4.4 t -74.25 143.79 44.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.002 -1.061 . . . . 0.0 109.685 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.352 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2129 ' ' ASP . . . . . 0.657 ' O ' ' HB2' ' A' 2130 ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2130 ' ' GLU . . . . . 0.657 ' HB2' ' O ' ' A' 2129 ' ' ASP . 1.9 mt-10 76.57 -69.48 0.16 Allowed 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.032 0.444 . . . . 0.0 110.457 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2131 ' ' CYS . . . . . 0.458 ' O ' ' SG ' ' A' 2131 ' ' CYS . 47.5 t -78.69 8.22 5.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.998 -1.064 . . . . 0.0 110.199 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2132 ' ' LYS . . . . . 0.514 ' HB3' ' HB3' ' A' 2129 ' ' ASP . 0.0 OUTLIER -109.89 40.37 1.93 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.952 -1.093 . . . . 0.0 110.096 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 2133 ' ' GLU . . . . . 0.891 ' HB2' HG23 ' A' 2136 ' ' VAL . 2.0 mt-10 -129.69 140.62 39.17 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.09 -1.006 . . . . 0.0 109.509 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2134 ' ' PRO . . . . . 0.521 ' O ' ' CD ' ' A' 2138 ' ' LYS . 3.3 Cg_endo -68.83 -3.96 12.39 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.065 1.843 . . . . 0.0 109.964 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2135 ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' 2162 ' ' ASN . 5.7 p-10 -107.23 0.12 23.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.11 -0.993 . . . . 0.0 110.03 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2136 ' ' VAL . . . . . 0.957 HG12 ' SG ' ' A' 2151 ' ' CYS . 11.1 t -97.63 -121.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.062 -1.024 . . . . 0.0 108.641 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2137 ' ' CYS . . . . . 0.499 ' N ' ' SG ' ' A' 2151 ' ' CYS . 8.7 m -56.61 -68.6 0.2 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.579 -1.326 . . . . 0.0 109.297 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2138 ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' 2134 ' ' PRO . 1.9 mtmt 70.32 21.13 5.88 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.04 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2139 ' ' HIS . . . . . 0.478 ' CB ' ' O ' ' A' 2164 ' ' CYS . 0.0 OUTLIER 169.8 -42.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.485 -0.759 . . . . 0.0 109.323 179.591 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -86.31 175.06 47.62 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -93.52 123.54 36.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.148 -1.207 . . . . 0.0 109.539 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2142 ' ' CYS . . . . . 0.774 ' C ' HD12 ' A' 2143 ' ' ILE . 0.1 OUTLIER -112.72 178.82 4.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.558 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 2143 ' ' ILE . . . . . 0.774 HD12 ' C ' ' A' 2142 ' ' CYS . 4.6 mp -142.51 129.27 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2144 ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' 2129 ' ' ASP . 0.7 OUTLIER -71.88 118.23 14.46 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.097 -1.002 . . . . 0.0 110.037 -179.142 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 2145 ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' 2148 ' ' SER . 40.4 p -117.69 -161.04 0.8 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.225 -0.922 . . . . 0.0 108.682 178.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.23 102.86 12.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.082 -1.011 . . . . 0.0 110.279 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 59.31 27.84 63.62 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2148 ' ' SER . . . . . 0.468 ' O ' ' OG1' ' A' 2145 ' ' THR . 0.4 OUTLIER -166.45 179.14 5.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.059 -1.259 . . . . 0.0 109.773 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 2149 ' ' TYR . . . . . 0.527 ' HB3' ' HB3' ' A' 2130 ' ' GLU . 0.6 OUTLIER -139.85 -169.8 2.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.321 -0.862 . . . . 0.0 109.577 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 2150 ' ' ARG . . . . . 0.506 ' O ' ' C ' ' A' 2151 ' ' CYS . 9.1 mmt180 -139.07 27.74 2.35 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.3 -0.875 . . . . 0.0 109.34 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2151 ' ' CYS . . . . . 0.957 ' SG ' HG12 ' A' 2136 ' ' VAL . 0.8 OUTLIER -28.99 109.42 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.875 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -130.34 125.92 35.85 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2153 ' ' CYS . . . . . 0.535 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -84.14 155.93 63.59 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 121.167 -0.958 . . . . 0.0 110.339 -178.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 2154 ' ' PRO . . . . . 0.483 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.2 Cg_endo -63.44 -168.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.801 2.334 . . . . 0.0 111.794 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -88.01 102.31 14.63 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.54 -15.85 5.45 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 107.75 -2.14 . . . . 0.0 107.75 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2157 ' ' TYR . . . . . 0.535 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 6.5 m-85 -107.13 -174.81 2.62 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 121.655 -0.909 . . . . 0.0 109.828 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2158 ' ' ILE . . . . . 0.849 ' H ' HD13 ' A' 2158 ' ' ILE . 0.2 OUTLIER -146.03 -155.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.447 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 2159 ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' 2163 ' ' GLU . 25.9 tp -148.84 127.0 12.07 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.376 -0.828 . . . . 0.0 109.281 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -102.27 62.05 0.86 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.376 -0.828 . . . . 0.0 109.293 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 86.96 -43.96 3.28 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2162 ' ' ASN . . . . . 0.494 ' HB3' ' O ' ' A' 2135 ' ' ASP . 0.7 OUTLIER -158.33 -45.82 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.43 -1.041 . . . . 0.0 109.149 179.753 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 2163 ' ' GLU . . . . . 0.741 ' O ' HD12 ' A' 2159 ' ' LEU . 65.5 tt0 -62.64 159.85 15.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.344 -0.848 . . . . 0.0 109.229 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2164 ' ' CYS . . . . . 0.512 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -131.64 137.05 48.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.13 -0.981 . . . . 0.0 109.638 -179.873 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 2165 ' ' VAL . . . . . 0.607 HG23 HD11 ' A' 2158 ' ' ILE . 1.2 m -156.1 -170.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.87 . . . . 0.0 109.282 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2166 ' ' ASP . . . . . 0.458 ' OD2' ' O ' ' A' 2184 ' ' VAL . 39.2 t70 -85.8 166.13 16.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.938 -1.101 . . . . 0.0 109.627 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2167 ' ' THR . . . . . 0.847 HG23 ' OE1' ' A' 2169 ' ' GLU . 11.6 t -106.8 167.86 9.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 0.0 109.423 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2168 ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' 2171 ' ' SER . 56.4 t0 -92.99 98.75 11.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.115 -0.991 . . . . 0.0 109.348 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2169 ' ' GLU . . . . . 0.847 ' OE1' HG23 ' A' 2167 ' ' THR . 0.8 OUTLIER -73.64 -32.11 63.86 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.426 -0.796 . . . . 0.0 109.415 -179.782 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 2170 ' ' CYS . . . . . 0.526 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.2 t -67.58 -8.1 31.56 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.319 -0.863 . . . . 0.0 108.981 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2171 ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -69.95 -4.59 21.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.168 -0.957 . . . . 0.0 109.537 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 9.3 t -100.55 -74.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.197 -0.939 . . . . 0.0 110.006 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2173 ' ' GLY . . . . . 0.488 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -168.82 141.48 6.78 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2174 ' ' ASN . . . . . 0.621 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 24.6 p-10 -36.61 97.31 0.13 Allowed Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.733 -0.863 . . . . 0.0 110.534 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2175 ' ' PRO . . . . . 0.602 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.8 Cg_endo -66.25 -20.31 55.82 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.982 1.788 . . . . 0.0 110.54 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2176 ' ' CYS . . . . . 0.551 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -51.54 -58.96 4.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.069 -1.019 . . . . 0.0 108.322 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 146.33 -20.82 1.72 Allowed Glycine 0 C--N 1.294 -1.781 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 4.1 t30 -160.53 -35.44 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -1.093 . . . . 0.0 110.127 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2179 ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -63.97 -119.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2180 ' ' THR . . . . . 0.498 ' HA ' ' HB3' ' A' 2174 ' ' ASN . 2.9 p -148.11 161.81 40.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.439 -1.036 . . . . 0.0 109.595 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2181 ' ' CYS . . . . . 0.621 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 27.0 p -93.64 160.8 14.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 110.906 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2182 ' ' LYS . . . . . 0.54 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 10.4 tttt -146.89 157.28 43.6 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2183 ' ' ASN . . . . . 0.474 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 59.0 t30 -93.4 129.09 39.67 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.453 -1.405 . . . . 0.0 110.13 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2184 ' ' VAL . . . . . 0.864 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -132.81 -168.73 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 2185 ' ' ILE . . . . . 0.679 ' N ' HG13 ' A' 2184 ' ' VAL . 3.9 mp -105.56 140.53 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.956 -1.09 . . . . 0.0 110.282 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 64.48 14.36 57.17 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2187 ' ' GLY . . . . . 0.591 ' C ' HG12 ' A' 2184 ' ' VAL . . . 167.94 -117.98 0.76 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2188 ' ' PHE . . . . . 0.864 ' N ' HG12 ' A' 2184 ' ' VAL . 2.0 p90 -172.92 177.1 2.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.173 -1.193 . . . . 0.0 109.609 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2189 ' ' GLU . . . . . 0.54 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.5 OUTLIER -123.28 139.57 53.9 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 2190 ' ' CYS . . . . . 0.45 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 22.9 p -135.73 137.33 41.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.765 -1.209 . . . . 0.0 109.721 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2191 ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' 2192 ' ' CYS . 25.3 m -108.79 83.45 1.76 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.412 -0.805 . . . . 0.0 109.478 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2192 ' ' CYS . . . . . 0.619 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -47.42 -179.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.934 0.873 . . . . 0.0 109.672 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 2193 ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' 2194 ' ' GLU . 11.3 tp10 -55.89 119.44 5.82 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2194 ' ' GLU . . . . . 0.494 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.5 OUTLIER -33.75 130.91 0.27 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.496 0.665 . . . . 0.0 110.675 -178.904 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.34 -0.67 10.48 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2196 ' ' PHE . . . . . 0.661 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.7 OUTLIER -114.37 -166.7 1.13 Allowed 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.264 -1.139 . . . . 0.0 110.109 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 2197 ' ' GLU . . . . . 0.554 ' N ' ' CG ' ' A' 2196 ' ' PHE . 1.7 mm-40 -145.31 98.02 4.68 Favored Pre-proline 0 C--N 1.299 -1.629 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2198 ' ' PRO . . . . . 0.661 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 7.9 Cg_endo -67.77 -161.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.118 1.879 . . . . 0.0 110.876 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -138.1 -170.4 11.86 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.75 -71.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.033 1.822 . . . . 0.0 110.547 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2201 ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.1 OUTLIER -139.18 53.53 1.74 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 110.192 -179.436 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 2.5 mmm -122.3 -93.68 0.51 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.048 -1.033 . . . . 0.0 109.995 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A 2203 ' ' THR . . . . . 0.487 ' OG1' ' O ' ' A' 2175 ' ' PRO . 6.0 t -169.42 -163.3 0.39 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.23 -0.919 . . . . 0.0 109.176 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2204 ' ' CYS . . . . . 0.551 ' HB2' ' O ' ' A' 2176 ' ' CYS . 1.9 t -67.82 138.35 56.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.09 -1.006 . . . . 0.0 109.306 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A 2205 ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' 2205 ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.515 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2129 ' ' ASP . . . . . 0.479 ' OD2' ' HB2' ' A' 2132 ' ' LYS . 22.9 t0 . . . . . 0 N--CA 1.488 1.433 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2130 ' ' GLU . . . . . 0.556 ' O ' HG21 ' A' 2136 ' ' VAL . 30.5 mp0 -63.39 -21.6 66.38 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.407 -0.808 . . . . 0.0 110.398 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2131 ' ' CYS . . . . . 0.516 ' HB3' ' HB2' ' A' 2149 ' ' TYR . 5.8 p -88.07 -40.86 13.47 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 120.758 -1.214 . . . . 0.0 109.699 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2132 ' ' LYS . . . . . 0.502 ' N ' ' SG ' ' A' 2131 ' ' CYS . 0.0 OUTLIER -85.51 43.58 1.04 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.206 -0.934 . . . . 0.0 108.921 179.323 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 2133 ' ' GLU . . . . . 0.514 ' CB ' ' HD2' ' A' 2134 ' ' PRO . 4.8 mt-10 -94.39 171.91 6.26 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.331 -0.855 . . . . 0.0 109.537 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2134 ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' 2133 ' ' GLU . 1.3 Cg_endo -63.81 -17.93 61.89 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.51 2.14 . . . . 0.0 112.029 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 4.0 t70 -144.72 32.28 1.16 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.568 -1.332 . . . . 0.0 111.283 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2136 ' ' VAL . . . . . 0.556 HG21 ' O ' ' A' 2130 ' ' GLU . 46.9 t -112.75 -110.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.777 -1.202 . . . . 0.0 109.901 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2137 ' ' CYS . . . . . 0.551 ' N ' HG12 ' A' 2136 ' ' VAL . 64.5 m -74.11 -65.07 0.89 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.766 -1.209 . . . . 0.0 109.486 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2138 ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' 2137 ' ' CYS . 21.6 mttt 62.53 124.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.806 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2139 ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' A' 2164 ' ' CYS . 2.6 m170 44.26 48.58 7.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.83 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -140.11 168.8 24.97 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.46 56.0 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -1.197 . . . . 0.0 108.842 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2142 ' ' CYS . . . . . 0.452 ' HA ' ' O ' ' A' 2150 ' ' ARG . 26.3 p -65.82 174.76 2.22 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.349 -0.845 . . . . 0.0 110.56 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 3.3 mp -135.01 87.56 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2144 ' ' ASN . . . . . . . . . . . . . 48.1 t30 -48.28 113.5 0.76 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.642 -0.661 . . . . 0.0 110.864 -178.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2145 ' ' THR . . . . . . . . . . . . . 13.6 p -95.16 -174.65 3.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.405 -0.809 . . . . 0.0 109.021 179.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2146 ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' 2146 ' ' ASP . 2.9 p30 -91.13 41.41 1.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.181 -0.949 . . . . 0.0 109.531 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2147 ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' A' 2148 ' ' SER . . . 145.55 41.01 0.05 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2148 ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' 2147 ' ' GLY . 0.3 OUTLIER 168.34 -163.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -1.191 . . . . 0.0 109.362 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 2149 ' ' TYR . . . . . 0.516 ' HB2' ' HB3' ' A' 2131 ' ' CYS . 43.9 p90 -169.03 -173.25 1.74 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 110.132 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2150 ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' 2142 ' ' CYS . 0.0 OUTLIER -159.43 110.31 2.0 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 58.8 m -86.78 61.99 7.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 109.947 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2152 ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' 2153 ' ' CYS . 0.3 OUTLIER -87.27 80.61 8.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.114 -0.991 . . . . 0.0 108.837 179.396 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 2153 ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -43.16 153.12 0.36 Allowed Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.355 -0.841 . . . . 0.0 109.993 -179.352 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 2154 ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' 2157 ' ' TYR . 1.7 Cg_endo -65.91 -166.67 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.589 2.192 . . . . 0.0 111.258 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 8.1 t80 -90.39 104.41 16.99 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2156 ' ' GLY . . . . . 0.437 ' O ' HG22 ' A' 2167 ' ' THR . . . 130.69 -16.66 5.33 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 107.897 -2.081 . . . . 0.0 107.897 -178.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2157 ' ' TYR . . . . . 0.642 ' OH ' HG23 ' A' 2185 ' ' ILE . 7.6 m-85 -106.12 -166.79 1.23 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.551 -0.97 . . . . 0.0 109.783 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2158 ' ' ILE . . . . . 0.916 HD11 HG23 ' A' 2165 ' ' VAL . 0.2 OUTLIER -155.27 -163.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.534 -0.729 . . . . 0.0 109.468 179.723 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 2159 ' ' LEU . . . . . 0.492 ' N ' HG12 ' A' 2158 ' ' ILE . 30.5 tp -146.86 117.27 7.43 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.408 -0.807 . . . . 0.0 109.685 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -94.95 57.48 2.1 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.577 -0.702 . . . . 0.0 109.461 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2161 ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 87.18 -14.98 56.21 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2162 ' ' ASN . . . . . 0.448 ' O ' ' O ' ' A' 2136 ' ' VAL . 1.1 m-20 168.81 -46.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.405 -1.056 . . . . 0.0 109.092 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -63.77 126.02 26.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 108.685 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2164 ' ' CYS . . . . . 0.592 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -104.32 139.78 38.82 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.912 -1.117 . . . . 0.0 109.953 -179.608 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 2165 ' ' VAL . . . . . 0.916 HG23 HD11 ' A' 2158 ' ' ILE . 3.7 m -158.56 -177.8 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 109.441 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2166 ' ' ASP . . . . . 0.457 ' OD2' ' O ' ' A' 2184 ' ' VAL . 29.1 t70 -74.85 167.27 22.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.642 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2167 ' ' THR . . . . . 0.591 HG23 ' OE1' ' A' 2169 ' ' GLU . 4.9 t -114.26 -177.71 3.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.4 -0.812 . . . . 0.0 109.109 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2168 ' ' ASP . . . . . 0.489 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 51.9 t0 -103.29 100.64 10.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.087 -1.008 . . . . 0.0 109.74 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2169 ' ' GLU . . . . . 0.598 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.7 OUTLIER -77.01 -32.63 57.29 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.385 -0.822 . . . . 0.0 109.143 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 2170 ' ' CYS . . . . . 0.508 ' HB2' ' N ' ' A' 2182 ' ' LYS . 1.7 t -67.23 -10.07 46.85 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.94 -10.62 59.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.34 -0.85 . . . . 0.0 109.72 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 21.9 t -86.35 -71.58 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.544 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2173 ' ' GLY . . . . . . . . . . . . . . . -149.29 -114.95 0.75 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2174 ' ' ASN . . . . . 0.507 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 6.9 t30 -146.67 97.3 4.29 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.39 -1.065 . . . . 0.0 109.49 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2175 ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' A' 2181 ' ' CYS . 1.3 Cg_endo -68.38 -24.63 36.77 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.93 1.754 . . . . 0.0 110.58 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2176 ' ' CYS . . . . . 0.585 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.1 OUTLIER -48.6 -43.86 36.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.122 -0.986 . . . . 0.0 109.391 -179.352 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 2177 ' ' GLY . . . . . 0.5 ' H ' ' ND2' ' A' 2174 ' ' ASN . . . 120.45 -19.24 9.23 Favored Glycine 0 C--N 1.292 -1.861 0 N-CA-C 108.221 -1.952 . . . . 0.0 108.221 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -171.97 -32.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.462 -1.022 . . . . 0.0 110.259 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2179 ' ' GLY . . . . . 0.652 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -69.75 -128.06 0.05 OUTLIER Glycine 0 N--CA 1.491 2.335 0 O-C-N 120.932 -1.105 . . . . 0.0 110.358 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 2.0 p -132.58 153.85 50.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.549 -0.971 . . . . 0.0 109.631 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2181 ' ' CYS . . . . . 0.555 ' HB3' ' HD2' ' A' 2175 ' ' PRO . 25.0 p -92.48 161.85 14.46 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.125 0.964 . . . . 0.0 110.976 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2182 ' ' LYS . . . . . 0.563 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 44.0 tptt -144.2 166.77 24.1 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2183 ' ' ASN . . . . . 0.499 ' N ' ' HG3' ' A' 2182 ' ' LYS . 62.6 t30 -100.94 138.74 37.59 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.616 -1.302 . . . . 0.0 109.676 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2184 ' ' VAL . . . . . 0.849 HG12 ' N ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -144.42 -168.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.484 -0.76 . . . . 0.0 109.246 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 2185 ' ' ILE . . . . . 0.642 HG23 ' OH ' ' A' 2157 ' ' TYR . 2.7 mp -104.64 137.28 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.111 -0.993 . . . . 0.0 110.24 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 69.85 10.36 64.38 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2187 ' ' GLY . . . . . 0.57 ' C ' HG12 ' A' 2184 ' ' VAL . . . 168.99 -116.7 0.68 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2188 ' ' PHE . . . . . 0.849 ' N ' HG12 ' A' 2184 ' ' VAL . 1.0 OUTLIER -171.87 -178.51 2.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.204 -1.174 . . . . 0.0 109.461 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 2189 ' ' GLU . . . . . 0.563 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 2.5 tt0 -128.33 174.13 9.57 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 2.6 p -171.08 149.7 2.93 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.621 -1.232 . . . . 0.0 110.41 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2191 ' ' THR . . . . . 0.415 ' O ' ' O ' ' A' 2192 ' ' CYS . 50.8 m -117.41 83.81 2.05 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.568 -0.708 . . . . 0.0 109.355 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2192 ' ' CYS . . . . . 0.652 ' HA ' ' HA3' ' A' 2179 ' ' GLY . 0.8 OUTLIER -50.54 178.27 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.09 -1.006 . . . . 0.0 109.189 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 2193 ' ' GLU . . . . . 0.486 ' O ' ' C ' ' A' 2194 ' ' GLU . 31.8 tt0 -53.97 116.38 2.53 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2194 ' ' GLU . . . . . 0.486 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -32.61 129.37 0.21 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.526 0.679 . . . . 0.0 110.917 -178.674 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.95 4.5 9.42 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2196 ' ' PHE . . . . . 0.681 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.9 OUTLIER -116.65 -164.51 0.98 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.197 -1.178 . . . . 0.0 110.169 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 2197 ' ' GLU . . . . . 0.556 ' N ' ' CG ' ' A' 2196 ' ' PHE . 14.0 mt-10 -145.81 96.95 4.63 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.596 -0.69 . . . . 0.0 109.373 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2198 ' ' PRO . . . . . 0.681 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.2 Cg_endo -68.68 -169.78 0.29 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.272 1.981 . . . . 0.0 111.084 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -124.89 178.06 16.65 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.93 -72.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 121.844 1.696 . . . . 0.0 110.306 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A 2201 ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.1 OUTLIER -132.78 33.27 3.74 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.14 -0.975 . . . . 0.0 109.791 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 2202 ' ' MET . . . . . 0.46 ' O ' ' CE2' ' A' 2188 ' ' PHE . 0.2 OUTLIER -105.6 -92.51 0.38 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.165 -0.959 . . . . 0.0 109.706 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 2203 ' ' THR . . . . . 0.472 HG23 ' N ' ' A' 2204 ' ' CYS . 6.0 t -159.68 -162.93 1.08 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.142 -0.974 . . . . 0.0 109.182 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A 2204 ' ' CYS . . . . . 0.585 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -115.71 155.82 27.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.126 -0.984 . . . . 0.0 109.145 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.41 179.98 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A 2129 ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' 2130 ' ' GLU . 24.4 t0 . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2130 ' ' GLU . . . . . 0.569 ' O ' HG21 ' A' 2136 ' ' VAL . 1.9 mt-10 82.73 -50.77 0.18 Allowed 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.133 0.492 . . . . 0.0 110.065 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2131 ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' 2137 ' ' CYS . 7.7 t -80.47 -41.91 23.53 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.025 -1.047 . . . . 0.0 109.461 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2132 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.28 -26.59 3.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.436 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2133 ' ' GLU . . . . . 0.482 ' HB2' HG23 ' A' 2136 ' ' VAL . 1.3 mt-10 -73.28 137.53 78.44 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.162 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2134 ' ' PRO . . . . . 0.544 ' CA ' ' HD3' ' A' 2138 ' ' LYS . 5.5 Cg_endo -69.96 -2.39 10.23 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.177 1.918 . . . . 0.0 110.821 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -99.19 -11.7 21.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.001 -1.062 . . . . 0.0 110.395 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2136 ' ' VAL . . . . . 0.569 HG21 ' O ' ' A' 2130 ' ' GLU . 2.2 t -107.39 -136.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.061 -1.024 . . . . 0.0 109.005 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2137 ' ' CYS . . . . . 0.555 ' CB ' ' HB3' ' A' 2142 ' ' CYS . 8.7 m -50.35 104.83 0.08 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.964 -1.085 . . . . 0.0 108.638 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2138 ' ' LYS . . . . . 0.544 ' HD3' ' CA ' ' A' 2134 ' ' PRO . 3.6 mtmt -124.07 140.54 52.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.912 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2139 ' ' HIS . . . . . 0.499 ' HB2' ' O ' ' A' 2164 ' ' CYS . 10.6 m80 56.3 39.16 30.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.986 -1.071 . . . . 0.0 109.548 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -165.07 176.16 40.85 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -90.28 143.81 26.42 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.071 -1.253 . . . . 0.0 108.525 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2142 ' ' CYS . . . . . 0.555 ' HB3' ' CB ' ' A' 2137 ' ' CYS . 0.6 OUTLIER -126.54 153.95 44.5 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.072 -1.017 . . . . 0.0 110.535 -178.882 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 2143 ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' 2145 ' ' THR . 4.3 mp -116.5 89.76 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2144 ' ' ASN . . . . . . . . . . . . . 10.2 t30 -47.21 114.94 0.96 Allowed 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.455 0.645 . . . . 0.0 110.66 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2145 ' ' THR . . . . . 0.502 HG23 ' O ' ' A' 2143 ' ' ILE . 23.0 p -107.68 -171.67 1.92 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.472 -0.767 . . . . 0.0 108.933 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.4 97.45 10.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.411 -0.806 . . . . 0.0 109.46 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 72.54 33.5 60.93 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2148 ' ' SER . . . . . 0.424 ' HB3' ' OG1' ' A' 2145 ' ' THR . 0.4 OUTLIER -173.11 -160.73 0.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -1.117 . . . . 0.0 109.792 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 2149 ' ' TYR . . . . . . . . . . . . . 7.8 p90 -168.43 -170.33 1.23 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.542 -0.724 . . . . 0.0 109.429 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2150 ' ' ARG . . . . . 0.547 ' O ' ' C ' ' A' 2151 ' ' CYS . 0.0 OUTLIER -153.1 33.38 0.47 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 109.0 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 2151 ' ' CYS . . . . . 0.547 ' C ' ' O ' ' A' 2150 ' ' ARG . 35.9 m -12.83 89.94 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.231 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -97.57 169.84 9.44 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2153 ' ' CYS . . . . . 0.517 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -131.77 159.14 73.24 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 120.934 -1.104 . . . . 0.0 109.831 -179.499 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 2154 ' ' PRO . . . . . 0.494 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.5 Cg_endo -62.65 -168.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 122.63 2.22 . . . . 0.0 111.568 -178.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 39.4 t80 -88.17 101.19 13.58 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 129.92 -13.61 5.78 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 107.927 -2.069 . . . . 0.0 107.927 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2157 ' ' TYR . . . . . 0.517 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 5.8 m-85 -108.62 -172.5 2.07 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.661 -0.905 . . . . 0.0 109.961 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2158 ' ' ILE . . . . . 0.769 HD12 ' HB ' ' A' 2167 ' ' THR . 0.2 OUTLIER -156.29 -158.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.453 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 2159 ' ' LEU . . . . . 0.506 ' HG ' ' N ' ' A' 2160 ' ' ALA . 13.7 tp -142.19 146.8 35.64 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 109.768 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2160 ' ' ALA . . . . . 0.506 ' N ' ' HG ' ' A' 2159 ' ' LEU . . . -122.02 48.53 1.71 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.237 -0.914 . . . . 0.0 109.443 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 95.55 -35.76 4.15 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2162 ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -168.44 -34.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.242 . . . . 0.0 109.911 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2163 ' ' GLU . . . . . 0.479 ' OE1' ' HE2' ' A' 2138 ' ' LYS . 1.2 tp10 -88.59 111.26 21.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 0.0 109.837 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2164 ' ' CYS . . . . . 0.904 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -82.13 147.83 28.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.442 -0.786 . . . . 0.0 109.362 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 2165 ' ' VAL . . . . . 0.904 HG13 ' O ' ' A' 2164 ' ' CYS . 0.3 OUTLIER -170.86 -168.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 2166 ' ' ASP . . . . . . . . . . . . . 1.6 t70 -90.4 143.63 26.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.901 -1.124 . . . . 0.0 109.179 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2167 ' ' THR . . . . . 0.769 ' HB ' HD12 ' A' 2158 ' ' ILE . 9.7 t -95.05 171.65 8.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.402 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2168 ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' 2171 ' ' SER . 62.5 t0 -85.73 96.29 9.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.948 -1.095 . . . . 0.0 109.352 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2169 ' ' GLU . . . . . 0.597 ' OE1' HG23 ' A' 2167 ' ' THR . 0.5 OUTLIER -67.3 -33.93 76.32 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.414 -0.804 . . . . 0.0 109.598 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 2170 ' ' CYS . . . . . 0.51 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.6 t -69.24 -7.49 37.21 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.172 -0.955 . . . . 0.0 108.915 179.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2171 ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.2 OUTLIER -77.09 3.13 13.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.086 -1.009 . . . . 0.0 109.663 179.847 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 48.5 t -105.6 -70.55 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.101 -1.0 . . . . 0.0 109.826 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2173 ' ' GLY . . . . . 0.477 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -168.97 138.17 4.95 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2174 ' ' ASN . . . . . 0.589 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 18.6 p-10 -39.38 99.31 0.19 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.517 -0.99 . . . . 0.0 110.22 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2175 ' ' PRO . . . . . 0.615 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.5 Cg_endo -65.47 -25.17 55.92 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.046 1.831 . . . . 0.0 110.487 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2176 ' ' CYS . . . . . 0.565 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -47.13 -50.89 19.41 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.069 -1.019 . . . . 0.0 108.588 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 138.25 -22.29 3.07 Favored Glycine 0 C--N 1.292 -1.9 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2178 ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.0 OUTLIER -162.53 -35.97 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.447 -1.031 . . . . 0.0 109.993 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 2179 ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -61.59 -119.21 0.01 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.34 160.36 42.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.378 -1.072 . . . . 0.0 109.637 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2181 ' ' CYS . . . . . 0.589 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 22.5 p -92.08 163.95 13.77 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.198 0.999 . . . . 0.0 111.306 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2182 ' ' LYS . . . . . 0.6 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.0 OUTLIER -142.56 155.88 45.05 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.963 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 57.7 t30 -100.55 140.56 34.65 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.39 -1.444 . . . . 0.0 109.883 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2184 ' ' VAL . . . . . 0.633 HG12 ' CA ' ' A' 2188 ' ' PHE . 0.8 OUTLIER -154.52 174.48 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A 2185 ' ' ILE . . . . . . . . . . . . . 4.3 mp -91.77 136.73 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.051 -1.031 . . . . 0.0 109.882 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 80.39 5.45 89.78 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2187 ' ' GLY . . . . . 0.524 ' C ' HG12 ' A' 2184 ' ' VAL . . . 163.06 -131.32 2.45 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2188 ' ' PHE . . . . . 0.633 ' CA ' HG12 ' A' 2184 ' ' VAL . 5.6 p90 -160.94 173.31 15.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.353 -1.087 . . . . 0.0 109.165 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2189 ' ' GLU . . . . . 0.6 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.7 tt0 -121.61 138.98 54.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.3 -0.875 . . . . 0.0 108.826 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2190 ' ' CYS . . . . . 0.435 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 15.4 p -130.64 143.53 50.81 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.66 -1.275 . . . . 0.0 109.997 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2191 ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' 2192 ' ' CYS . 61.3 m -117.51 85.31 2.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.348 -0.845 . . . . 0.0 109.505 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2192 ' ' CYS . . . . . 0.602 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.1 m -49.09 179.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 109.242 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2193 ' ' GLU . . . . . 0.45 ' O ' ' C ' ' A' 2194 ' ' GLU . 18.5 tt0 -56.98 126.9 29.25 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2194 ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.2 tt0 -38.81 130.16 1.46 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.487 -0.758 . . . . 0.0 110.591 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.24 3.04 9.82 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2196 ' ' PHE . . . . . 0.683 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.2 p90 -116.56 -161.43 0.8 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.144 -1.209 . . . . 0.0 110.16 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2197 ' ' GLU . . . . . 0.561 ' N ' ' CG ' ' A' 2196 ' ' PHE . 34.8 mm-40 -146.09 95.14 4.82 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 121.53 -0.731 . . . . 0.0 109.82 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2198 ' ' PRO . . . . . 0.683 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 6.5 Cg_endo -66.91 -163.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.119 1.88 . . . . 0.0 111.021 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -138.22 -171.65 12.26 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.88 -80.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.004 1.802 . . . . 0.0 110.727 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A 2201 ' ' MET . . . . . 0.492 ' HA ' ' O ' ' A' 2188 ' ' PHE . 6.6 mtt -132.0 47.17 2.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.166 -0.959 . . . . 0.0 110.033 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2202 ' ' MET . . . . . 0.515 ' O ' ' CE2' ' A' 2188 ' ' PHE . 1.9 mmt -117.13 -88.42 0.6 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.238 -0.914 . . . . 0.0 109.849 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2203 ' ' THR . . . . . 0.469 HG23 ' N ' ' A' 2204 ' ' CYS . 5.8 t -169.33 -162.59 0.36 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.278 -0.889 . . . . 0.0 109.49 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2204 ' ' CYS . . . . . 0.569 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 5.2 t -76.28 145.06 39.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 109.39 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A 2205 ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' 2197 ' ' GLU . 8.6 pt-20 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.951 -1.024 . . . . 0.0 109.409 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2129 ' ' ASP . . . . . 0.568 ' O ' ' HB2' ' A' 2130 ' ' GLU . 11.5 t0 . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2130 ' ' GLU . . . . . 0.61 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 1.5 mt-10 80.58 -55.47 0.34 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.915 -0.491 . . . . 0.0 111.158 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2131 ' ' CYS . . . . . 0.565 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 8.0 p -91.34 -14.59 30.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.761 -1.212 . . . . 0.0 110.503 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2132 ' ' LYS . . . . . 0.507 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -88.93 6.57 38.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.996 -1.065 . . . . 0.0 109.218 179.534 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 2133 ' ' GLU . . . . . 0.49 ' HB3' ' HD2' ' A' 2134 ' ' PRO . 36.3 mt-10 -81.11 159.41 68.16 Favored Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.242 -0.911 . . . . 0.0 109.337 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2134 ' ' PRO . . . . . 0.493 ' O ' ' HD2' ' A' 2138 ' ' LYS . 4.7 Cg_endo -68.54 -1.88 8.24 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.341 2.027 . . . . 0.0 110.451 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2135 ' ' ASP . . . . . 0.506 ' O ' ' ND2' ' A' 2162 ' ' ASN . 0.4 OUTLIER -123.11 14.16 9.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.934 -1.104 . . . . 0.0 109.887 -179.57 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 2136 ' ' VAL . . . . . 0.637 ' CG1' ' CE2' ' A' 2149 ' ' TYR . 43.3 t -146.99 126.01 4.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.04 -1.038 . . . . 0.0 108.867 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2137 ' ' CYS . . . . . 0.542 ' CA ' ' O ' ' A' 2162 ' ' ASN . 0.5 OUTLIER 69.67 -84.78 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.428 -0.795 . . . . 0.0 109.969 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 2138 ' ' LYS . . . . . 0.493 ' HD2' ' O ' ' A' 2134 ' ' PRO . 0.8 OUTLIER 63.62 109.67 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.571 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 2139 ' ' HIS . . . . . 0.501 ' O ' ' HB3' ' A' 2164 ' ' CYS . 11.6 m170 62.03 50.39 4.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.866 . . . . 0.0 109.892 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -148.85 168.39 29.35 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -106.43 78.68 1.3 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -1.137 . . . . 0.0 109.13 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2142 ' ' CYS . . . . . 0.954 ' C ' HD13 ' A' 2143 ' ' ILE . 25.3 p -82.96 -177.65 6.84 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.306 -0.871 . . . . 0.0 110.634 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2143 ' ' ILE . . . . . 0.954 HD13 ' C ' ' A' 2142 ' ' CYS . 3.0 mm -127.63 122.6 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2144 ' ' ASN . . . . . 0.4 ' OD1' ' O ' ' A' 2129 ' ' ASP . 37.6 t30 -78.04 113.49 16.02 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.34 -0.85 . . . . 0.0 110.912 -178.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2145 ' ' THR . . . . . 0.465 HG23 ' HA ' ' A' 2149 ' ' TYR . 2.7 p -92.68 -162.79 0.97 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 1.3 p30 -86.7 -32.52 20.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.98 . . . . 0.0 110.449 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -129.77 -34.39 0.48 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.161 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2148 ' ' SER . . . . . 0.432 ' O ' ' OG1' ' A' 2145 ' ' THR . 0.5 OUTLIER -111.79 -164.44 0.92 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.144 -1.21 . . . . 0.0 110.035 -179.479 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 2149 ' ' TYR . . . . . 0.637 ' CE2' ' CG1' ' A' 2136 ' ' VAL . 13.5 p90 -148.67 -176.55 5.37 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2150 ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' 2149 ' ' TYR . 0.1 OUTLIER -148.32 116.48 6.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.476 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 6.2 m -87.32 118.62 26.87 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.338 -0.851 . . . . 0.0 109.545 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.01 81.05 1.94 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.869 . . . . 0.0 109.139 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2153 ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -54.25 156.24 5.92 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.276 -0.89 . . . . 0.0 109.257 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 2154 ' ' PRO . . . . . 0.483 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.3 Cg_endo -63.06 -171.76 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.417 2.078 . . . . 0.0 111.306 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -88.0 102.84 15.13 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.37 -14.79 5.59 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 107.885 -2.086 . . . . 0.0 107.885 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2157 ' ' TYR . . . . . 0.547 ' CD2' ' C ' ' A' 2165 ' ' VAL . 5.6 m-85 -106.01 -168.23 1.41 Allowed 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.635 -0.921 . . . . 0.0 109.549 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2158 ' ' ILE . . . . . 0.639 HD11 HG23 ' A' 2165 ' ' VAL . 0.2 OUTLIER -156.93 -164.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.859 . . . . 0.0 109.923 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 2159 ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' 2163 ' ' GLU . 39.5 tp -142.38 114.16 8.03 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -90.57 56.87 3.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.883 . . . . 0.0 109.589 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 89.11 -29.2 6.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2162 ' ' ASN . . . . . 0.542 ' O ' ' CA ' ' A' 2137 ' ' CYS . 1.5 m-20 -171.47 -46.69 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.241 -1.152 . . . . 0.0 109.332 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2163 ' ' GLU . . . . . 0.523 ' O ' HD12 ' A' 2159 ' ' LEU . 14.5 tt0 -66.17 147.78 52.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.118 -0.989 . . . . 0.0 109.248 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2164 ' ' CYS . . . . . 0.693 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -122.82 137.58 54.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.049 -1.032 . . . . 0.0 109.394 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 2165 ' ' VAL . . . . . 0.693 HG13 ' O ' ' A' 2164 ' ' CYS . 0.7 OUTLIER -161.1 -169.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.121 -0.987 . . . . 0.0 109.779 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 2166 ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' 2184 ' ' VAL . 36.8 t70 -77.02 166.94 22.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.167 -0.958 . . . . 0.0 110.035 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2167 ' ' THR . . . . . 0.538 ' HB ' HG23 ' A' 2158 ' ' ILE . 1.2 t -115.99 -170.6 1.82 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.355 -0.84 . . . . 0.0 109.414 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2168 ' ' ASP . . . . . 0.536 ' N ' HG23 ' A' 2167 ' ' THR . 64.6 t0 -109.4 101.26 10.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.945 . . . . 0.0 109.511 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2169 ' ' GLU . . . . . 0.624 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.5 OUTLIER -76.22 -30.93 58.14 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.347 -0.845 . . . . 0.0 109.337 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 2170 ' ' CYS . . . . . 0.526 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 0.1 OUTLIER -64.87 -12.32 47.47 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.578 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.76 -22.54 29.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 0.0 109.623 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 31.3 t -75.9 -68.56 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.33 -0.856 . . . . 0.0 109.448 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2173 ' ' GLY . . . . . 0.441 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -159.87 140.37 6.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2174 ' ' ASN . . . . . 0.497 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 1.6 t-20 -45.0 104.49 0.39 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.411 -1.052 . . . . 0.0 109.616 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2175 ' ' PRO . . . . . 0.648 ' CB ' ' CE2' ' A' 2188 ' ' PHE . 2.1 Cg_endo -68.92 -19.94 39.59 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.837 1.692 . . . . 0.0 110.03 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2176 ' ' CYS . . . . . 0.601 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -71.43 -24.08 61.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.152 -0.967 . . . . 0.0 109.902 -179.516 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 105.84 -25.79 22.99 Favored Glycine 0 N--CA 1.483 1.779 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2178 ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.1 OUTLIER -170.59 -31.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.295 -1.121 . . . . 0.0 110.611 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 2179 ' ' GLY . . . . . 0.583 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -59.77 -120.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.3 p -136.03 151.18 49.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.44 -1.035 . . . . 0.0 109.336 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2181 ' ' CYS . . . . . 0.549 ' HB3' ' HD2' ' A' 2175 ' ' PRO . 26.1 p -99.35 155.63 17.42 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.12 -0.987 . . . . 0.0 110.716 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2182 ' ' LYS . . . . . 0.55 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 8.5 tttp -140.67 159.07 43.01 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2183 ' ' ASN . . . . . 0.432 ' CG ' ' HA ' ' A' 2168 ' ' ASP . 53.5 t30 -100.26 129.64 46.28 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.562 -1.336 . . . . 0.0 110.175 -179.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2184 ' ' VAL . . . . . 0.914 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -134.41 -179.42 3.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 2185 ' ' ILE . . . . . 0.444 ' N ' HG13 ' A' 2184 ' ' VAL . 4.1 mp -95.01 141.13 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.764 -1.21 . . . . 0.0 110.424 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 67.94 10.92 59.89 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2187 ' ' GLY . . . . . 0.575 ' C ' HG12 ' A' 2184 ' ' VAL . . . 168.14 -118.77 0.8 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2188 ' ' PHE . . . . . 0.914 ' N ' HG12 ' A' 2184 ' ' VAL . 2.6 p90 -175.23 178.58 1.68 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -1.109 . . . . 0.0 109.72 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2189 ' ' GLU . . . . . 0.55 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 5.6 tp10 -124.54 168.1 13.56 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 3.1 p -170.51 145.89 2.67 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.547 -1.345 . . . . 0.0 110.453 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2191 ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' 2192 ' ' CYS . 88.6 m -117.88 88.34 2.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.504 -0.748 . . . . 0.0 109.614 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2192 ' ' CYS . . . . . 0.63 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.5 OUTLIER -49.6 -178.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.167 -0.958 . . . . 0.0 109.049 179.786 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 2193 ' ' GLU . . . . . 0.548 ' O ' ' C ' ' A' 2194 ' ' GLU . 7.2 tt0 -55.24 102.27 0.06 Allowed 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2194 ' ' GLU . . . . . 0.548 ' C ' ' O ' ' A' 2193 ' ' GLU . 2.3 mt-10 -20.14 124.89 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.365 0.602 . . . . 0.0 111.716 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.71 11.35 6.0 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2196 ' ' PHE . . . . . 0.686 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.5 p90 -120.06 -161.93 0.9 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.357 -1.084 . . . . 0.0 110.165 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2197 ' ' GLU . . . . . 0.52 ' N ' ' CG ' ' A' 2196 ' ' PHE . 12.9 mt-10 -144.47 94.87 5.54 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 121.475 -0.766 . . . . 0.0 109.659 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2198 ' ' PRO . . . . . 0.686 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.2 Cg_endo -69.36 -162.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.353 2.035 . . . . 0.0 111.192 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -133.66 -177.02 14.66 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -62.36 -65.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.006 1.804 . . . . 0.0 110.618 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2201 ' ' MET . . . . . 0.496 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -147.29 41.11 1.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 109.58 -179.674 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 2202 ' ' MET . . . . . 0.431 ' O ' ' CE2' ' A' 2188 ' ' PHE . 0.0 OUTLIER -112.88 -84.4 0.59 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.208 -0.932 . . . . 0.0 109.613 -179.807 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 2203 ' ' THR . . . . . . . . . . . . . 11.5 t -162.6 -172.62 3.2 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.23 -0.918 . . . . 0.0 109.406 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A 2204 ' ' CYS . . . . . 0.601 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -110.42 144.94 38.44 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.285 -0.885 . . . . 0.0 108.933 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.548 -179.864 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A 2129 ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' 2130 ' ' GLU . 11.3 t70 . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2130 ' ' GLU . . . . . 0.638 ' O ' HG21 ' A' 2136 ' ' VAL . 6.4 mt-10 82.56 -43.16 0.13 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.856 -0.528 . . . . 0.0 109.798 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2131 ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.11 -23.02 21.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.176 -0.952 . . . . 0.0 109.086 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2132 ' ' LYS . . . . . 0.432 ' HB2' ' CB ' ' A' 2129 ' ' ASP . 0.3 OUTLIER -87.6 40.25 0.92 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 109.144 179.561 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 2133 ' ' GLU . . . . . 0.525 ' HB2' HG23 ' A' 2136 ' ' VAL . 80.3 mt-10 -108.09 160.17 27.92 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.33 -0.856 . . . . 0.0 109.66 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2134 ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' 2133 ' ' GLU . 1.2 Cg_endo -66.02 0.51 3.12 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.539 2.159 . . . . 0.0 111.771 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2135 ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' 2162 ' ' ASN . 67.1 m-20 -130.03 -10.65 4.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.478 -1.389 . . . . 0.0 110.564 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2136 ' ' VAL . . . . . 0.638 HG21 ' O ' ' A' 2130 ' ' GLU . 3.4 t -100.13 -131.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.927 -1.108 . . . . 0.0 108.492 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2137 ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' 2142 ' ' CYS . 5.0 t -58.45 131.46 50.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.521 -1.362 . . . . 0.0 108.65 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2138 ' ' LYS . . . . . 0.515 ' O ' ' CB ' ' A' 2139 ' ' HIS . 32.0 mtpt -139.64 43.03 1.99 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.185 -0.947 . . . . 0.0 110.061 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2139 ' ' HIS . . . . . 0.515 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.0 OUTLIER 163.73 -34.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.052 -1.03 . . . . 0.0 110.099 179.473 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -83.67 173.65 51.21 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -91.91 94.68 9.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.265 -1.138 . . . . 0.0 109.163 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2142 ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' 2137 ' ' CYS . 10.4 t -91.0 161.47 15.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.292 -0.88 . . . . 0.0 109.725 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 2.6 mp -122.72 98.59 5.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2144 ' ' ASN . . . . . 0.479 ' HB2' ' OD1' ' A' 2129 ' ' ASP . 3.2 t30 -60.02 112.85 2.03 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.273 -0.892 . . . . 0.0 109.712 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2145 ' ' THR . . . . . . . . . . . . . 30.5 p -90.73 -166.28 1.54 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.378 -0.826 . . . . 0.0 109.376 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 5.6 t0 -62.63 -72.48 0.13 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.817 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -118.12 37.0 3.41 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2148 ' ' SER . . . . . 0.451 ' O ' ' HB3' ' A' 2149 ' ' TYR . 0.8 OUTLIER -165.13 -160.89 0.51 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -1.157 . . . . 0.0 109.629 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 2149 ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' 2148 ' ' SER . 27.2 p90 170.8 -175.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.49 -0.756 . . . . 0.0 109.217 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2150 ' ' ARG . . . . . 0.433 ' C ' ' SG ' ' A' 2142 ' ' CYS . 11.6 ptt180 -167.93 95.05 0.41 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.951 . . . . 0.0 109.831 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2151 ' ' CYS . . . . . 0.465 ' HA ' ' SG ' ' A' 2142 ' ' CYS . 42.5 t -57.64 102.56 0.1 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.615 -0.678 . . . . 0.0 109.447 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -104.47 108.02 19.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.314 -0.866 . . . . 0.0 109.256 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2153 ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -70.06 158.78 86.55 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.168 -0.957 . . . . 0.0 109.664 -179.657 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 2154 ' ' PRO . . . . . 0.474 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.1 Cg_endo -63.85 -168.97 0.1 OUTLIER 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.858 2.372 . . . . 0.0 112.03 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -86.48 101.79 13.5 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 129.95 -15.49 5.63 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 107.821 -2.112 . . . . 0.0 107.821 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2157 ' ' TYR . . . . . 0.593 ' OH ' HG23 ' A' 2185 ' ' ILE . 5.4 m-85 -106.34 -170.79 1.78 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.682 -0.893 . . . . 0.0 110.053 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2158 ' ' ILE . . . . . 0.744 HD13 ' N ' ' A' 2158 ' ' ILE . 0.2 OUTLIER -156.93 -160.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.522 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 2159 ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' 2163 ' ' GLU . 33.2 tp -147.55 122.81 10.24 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.187 -0.945 . . . . 0.0 109.942 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2160 ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' 2162 ' ' ASN . . . -90.22 -152.12 0.26 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2161 ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' 2160 ' ' ALA . . . -42.13 -25.95 0.29 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2162 ' ' ASN . . . . . 0.503 ' O ' HD11 ' A' 2159 ' ' LEU . 1.5 t-20 178.75 -29.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.133 -1.216 . . . . 0.0 110.179 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2163 ' ' GLU . . . . . 0.517 ' O ' HD12 ' A' 2159 ' ' LEU . 74.5 tt0 -76.23 152.58 36.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.084 -1.01 . . . . 0.0 109.514 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2164 ' ' CYS . . . . . 0.804 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -111.82 145.08 40.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.122 -0.986 . . . . 0.0 109.374 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 2165 ' ' VAL . . . . . 0.804 HG13 ' O ' ' A' 2164 ' ' CYS . 1.6 m -164.81 -170.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 109.425 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2166 ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 3.3 t70 -90.41 149.69 22.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.002 -1.061 . . . . 0.0 109.706 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2167 ' ' THR . . . . . 0.912 HG23 ' OE1' ' A' 2169 ' ' GLU . 8.7 t -87.84 175.38 7.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 109.511 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2168 ' ' ASP . . . . . 0.469 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 57.9 t0 -95.77 92.67 6.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.296 -0.877 . . . . 0.0 108.752 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2169 ' ' GLU . . . . . 0.912 ' OE1' HG23 ' A' 2167 ' ' THR . 0.7 OUTLIER -65.68 -32.15 73.55 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.331 -0.856 . . . . 0.0 109.883 -179.409 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 2170 ' ' CYS . . . . . 0.559 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.3 t -66.34 -12.04 54.44 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.165 -0.959 . . . . 0.0 108.891 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2171 ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.1 OUTLIER -73.68 -2.28 22.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.243 179.447 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 2172 ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' 2169 ' ' GLU . 34.4 t -84.23 -69.71 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.21 -0.931 . . . . 0.0 109.549 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2173 ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' 2174 ' ' ASN . . . 164.26 76.46 0.03 OUTLIER Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.069 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2174 ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' 2178 ' ' ASN . 3.5 t-20 43.2 83.78 0.2 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.253 -1.145 . . . . 0.0 109.613 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2175 ' ' PRO . . . . . 0.633 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.4 Cg_endo -66.76 -20.03 52.7 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.257 1.971 . . . . 0.0 110.537 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2176 ' ' CYS . . . . . 0.532 ' SG ' ' HB3' ' A' 2204 ' ' CYS . 1.4 m -64.79 -55.41 19.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.926 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 160.2 -28.94 0.35 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2178 ' ' ASN . . . . . 0.503 ' N ' ' OD1' ' A' 2174 ' ' ASN . 1.5 t-20 -171.05 -26.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -1.185 . . . . 0.0 110.966 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2179 ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -59.66 -124.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.787 -1.196 . . . . 0.0 110.309 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2180 ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' 2190 ' ' CYS . 1.1 p -136.64 151.07 48.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.394 -1.062 . . . . 0.0 109.227 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2181 ' ' CYS . . . . . 0.568 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 23.0 p -99.54 150.19 22.48 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.089 -1.007 . . . . 0.0 111.468 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2182 ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' 2189 ' ' GLU . 0.5 OUTLIER -132.4 160.79 35.35 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.381 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 2183 ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 57.0 t30 -100.28 123.7 44.83 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.579 -1.326 . . . . 0.0 109.21 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2184 ' ' VAL . . . . . 0.828 HG12 ' N ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -130.89 -174.96 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.371 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 2185 ' ' ILE . . . . . 0.593 HG23 ' OH ' ' A' 2157 ' ' TYR . 3.3 mp -94.62 139.26 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.028 -1.045 . . . . 0.0 110.287 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 69.78 10.06 63.59 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2187 ' ' GLY . . . . . 0.532 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 166.2 -118.11 0.78 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.514 -1.326 . . . . 0.0 110.078 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2188 ' ' PHE . . . . . 0.828 ' N ' HG12 ' A' 2184 ' ' VAL . 1.8 p90 -166.46 -179.45 4.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -1.139 . . . . 0.0 109.889 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2189 ' ' GLU . . . . . 0.591 ' OE1' HG21 ' A' 2184 ' ' VAL . 0.1 OUTLIER -132.09 94.04 3.39 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.406 -0.808 . . . . 0.0 109.286 178.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 2190 ' ' CYS . . . . . 0.527 ' HB3' ' HA ' ' A' 2181 ' ' CYS . 9.1 p -114.26 139.26 49.56 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.92 -1.112 . . . . 0.0 109.802 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2191 ' ' THR . . . . . 0.526 ' O ' ' HA3' ' A' 2179 ' ' GLY . 1.8 m -113.85 106.58 14.62 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2192 ' ' CYS . . . . . 0.669 ' HB2' ' CD2' ' A' 2196 ' ' PHE . 0.5 OUTLIER -53.54 -172.36 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.057 -1.027 . . . . 0.0 110.157 -178.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 2193 ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.2 tp10 -68.03 136.43 53.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.656 -0.652 . . . . 0.0 110.1 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2194 ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -40.37 131.5 2.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.523 -0.736 . . . . 0.0 110.203 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 116.75 12.76 8.37 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2196 ' ' PHE . . . . . 0.701 ' CD2' ' HB2' ' A' 2204 ' ' CYS . 8.0 p90 -128.99 -158.71 0.9 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.575 -0.956 . . . . 0.0 110.22 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2197 ' ' GLU . . . . . 0.555 ' N ' ' CD2' ' A' 2196 ' ' PHE . 25.7 mt-10 -147.16 96.7 4.21 Favored Pre-proline 0 C--N 1.306 -1.319 0 O-C-N 121.565 -0.709 . . . . 0.0 109.496 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2198 ' ' PRO . . . . . 0.633 ' CD ' ' CE2' ' A' 2196 ' ' PHE . 2.2 Cg_endo -62.41 -170.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.356 2.037 . . . . 0.0 111.148 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -147.58 -168.02 13.74 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.04 -80.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.259 1.973 . . . . 0.0 110.929 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2201 ' ' MET . . . . . 0.532 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -142.54 42.11 1.6 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 110.115 -179.237 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 2.0 mmm -114.23 -72.28 0.71 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.411 -0.806 . . . . 0.0 109.502 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A 2203 ' ' THR . . . . . 0.486 ' OG1' ' HA ' ' A' 2176 ' ' CYS . 11.8 t -166.84 -165.91 0.78 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2204 ' ' CYS . . . . . 0.701 ' HB2' ' CD2' ' A' 2196 ' ' PHE . 31.3 p -104.1 114.14 28.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.853 -1.155 . . . . 0.0 110.232 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A 2205 ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' 2205 ' ' GLU . 9.1 pt-20 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.513 179.239 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 2129 ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' 2130 ' ' GLU . 16.6 t0 . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 2130 ' ' GLU . . . . . 0.598 ' HB3' ' CD2' ' A' 2149 ' ' TYR . 2.0 mt-10 82.87 -47.11 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.845 -0.534 . . . . 0.0 109.942 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2131 ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' 2137 ' ' CYS . 0.0 OUTLIER -80.9 -46.14 15.67 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.963 -1.086 . . . . 0.0 109.152 179.968 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 2132 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -16.31 4.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.14 -0.975 . . . . 0.0 109.79 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2133 ' ' GLU . . . . . 0.437 ' HG3' ' C ' ' A' 2130 ' ' GLU . 7.5 mt-10 -69.95 146.06 94.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 110.204 -179.569 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2134 ' ' PRO . . . . . 0.528 ' O ' ' CE ' ' A' 2138 ' ' LYS . 6.4 Cg_endo -72.55 2.27 5.37 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.597 2.198 . . . . 0.0 110.309 179.113 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2135 ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' 2162 ' ' ASN . 36.3 t70 -108.43 -14.29 14.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.96 -1.087 . . . . 0.0 109.693 -179.399 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2136 ' ' VAL . . . . . 0.576 ' CG1' ' CE1' ' A' 2149 ' ' TYR . 2.3 t -112.21 -136.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.093 -1.005 . . . . 0.0 109.074 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2137 ' ' CYS . . . . . 0.497 ' HB3' ' SG ' ' A' 2131 ' ' CYS . 1.9 t -44.54 105.72 0.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.018 -1.051 . . . . 0.0 108.68 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2138 ' ' LYS . . . . . 0.528 ' CE ' ' O ' ' A' 2134 ' ' PRO . 3.7 mttm -114.22 18.35 17.09 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.336 -0.852 . . . . 0.0 110.332 -178.715 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2139 ' ' HIS . . . . . 0.492 ' O ' ' HB3' ' A' 2164 ' ' CYS . 0.9 OUTLIER 171.77 50.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.892 -1.13 . . . . 0.0 110.461 179.773 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -169.83 -175.22 38.7 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -89.78 142.8 27.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.348 -1.09 . . . . 0.0 108.611 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 2142 ' ' CYS . . . . . 0.678 ' C ' HD12 ' A' 2143 ' ' ILE . 0.8 OUTLIER -128.78 175.93 8.22 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.092 -1.005 . . . . 0.0 110.492 -178.972 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 2143 ' ' ILE . . . . . 0.678 HD12 ' C ' ' A' 2142 ' ' CYS . 4.9 mp -139.51 107.92 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2144 ' ' ASN . . . . . . . . . . . . . 14.5 t30 -64.18 119.08 9.54 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.346 -0.846 . . . . 0.0 110.886 -178.368 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 2145 ' ' THR . . . . . 0.423 ' OG1' ' C ' ' A' 2148 ' ' SER . 72.4 p -116.07 -179.08 3.56 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.823 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.35 109.75 21.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.957 . . . . 0.0 109.59 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 89.81 13.94 60.21 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 2148 ' ' SER . . . . . 0.423 ' C ' ' OG1' ' A' 2145 ' ' THR . 0.1 OUTLIER -178.72 -160.62 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.239 -1.153 . . . . 0.0 109.688 -179.866 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 2149 ' ' TYR . . . . . 0.598 ' CD2' ' HB3' ' A' 2130 ' ' GLU . 22.2 p90 -171.31 -174.43 1.45 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.397 -0.814 . . . . 0.0 108.979 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2150 ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' 2142 ' ' CYS . 0.0 OUTLIER -157.4 112.62 2.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.119 -0.988 . . . . 0.0 109.636 179.604 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 40.1 t -98.5 87.06 3.73 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.582 -0.699 . . . . 0.0 109.505 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -86.57 105.98 17.23 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.198 -0.938 . . . . 0.0 109.322 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 2153 ' ' CYS . . . . . 0.507 ' SG ' ' HD2' ' A' 2154 ' ' PRO . 0.0 OUTLIER -66.64 159.9 71.17 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 109.649 -179.624 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 2154 ' ' PRO . . . . . 0.507 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 0.9 OUTLIER -64.46 -166.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.61 2.207 . . . . 0.0 111.276 -179.024 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 21.0 t80 -90.21 103.42 16.1 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.802 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.81 -17.19 5.24 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 107.909 -2.076 . . . . 0.0 107.909 -178.393 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 2157 ' ' TYR . . . . . 0.56 ' OH ' HG23 ' A' 2185 ' ' ILE . 9.7 m-85 -107.81 -172.34 2.05 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.625 -0.927 . . . . 0.0 109.799 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2158 ' ' ILE . . . . . 0.76 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -155.5 -165.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.555 -0.716 . . . . 0.0 109.796 179.418 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 2159 ' ' LEU . . . . . 0.52 HD12 ' O ' ' A' 2163 ' ' GLU . 27.9 tp -141.9 121.8 13.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.387 -0.821 . . . . 0.0 109.508 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -94.63 50.94 1.37 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.357 -0.84 . . . . 0.0 109.83 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 91.32 -18.43 51.97 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.394 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 2162 ' ' ASN . . . . . 0.523 ' OD1' HG13 ' A' 2136 ' ' VAL . 1.6 m-20 -178.03 -47.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.023 -1.281 . . . . 0.0 109.851 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2163 ' ' GLU . . . . . 0.52 ' O ' HD12 ' A' 2159 ' ' LEU . 78.7 tt0 -75.31 146.05 41.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.898 . . . . 0.0 109.035 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2164 ' ' CYS . . . . . 0.722 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -115.35 140.9 48.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.031 -1.043 . . . . 0.0 109.395 -179.958 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 2165 ' ' VAL . . . . . 0.722 HG13 ' O ' ' A' 2164 ' ' CYS . 4.7 m -162.42 -170.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 0.0 109.767 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2166 ' ' ASP . . . . . 0.478 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 1.3 t0 -89.78 144.77 25.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 109.415 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2167 ' ' THR . . . . . 0.707 HG23 ' OE1' ' A' 2169 ' ' GLU . 8.9 t -85.39 170.74 12.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.306 -0.871 . . . . 0.0 109.682 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2168 ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' 2171 ' ' SER . 66.9 t0 -81.67 94.5 6.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.196 -0.94 . . . . 0.0 108.592 179.115 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2169 ' ' GLU . . . . . 0.707 ' OE1' HG23 ' A' 2167 ' ' THR . 0.4 OUTLIER -65.56 -26.42 67.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 110.532 -179.012 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 2170 ' ' CYS . . . . . 0.43 ' HB2' ' HB2' ' A' 2181 ' ' CYS . 1.3 t -57.92 -12.82 3.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.912 -1.117 . . . . 0.0 108.77 178.461 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2171 ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.1 OUTLIER -59.44 -13.12 7.47 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.195 -0.94 . . . . 0.0 109.881 -179.553 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 2172 ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' 2169 ' ' GLU . 22.1 t -73.14 -67.95 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.312 -0.867 . . . . 0.0 109.242 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2173 ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' 2174 ' ' ASN . . . 154.95 85.55 0.05 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2174 ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' 2173 ' ' GLY . 1.1 t-20 47.31 91.55 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.26 -1.141 . . . . 0.0 109.421 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2175 ' ' PRO . . . . . 0.64 ' CB ' ' CD1' ' A' 2188 ' ' PHE . 1.0 OUTLIER -62.95 -21.95 73.5 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.078 1.852 . . . . 0.0 110.222 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 2176 ' ' CYS . . . . . 0.528 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.1 OUTLIER -75.97 -64.67 1.04 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -0.996 . . . . 0.0 108.926 179.68 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 147.93 -14.84 1.35 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -166.93 -34.76 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.205 -1.173 . . . . 0.0 110.106 -179.689 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2179 ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -61.48 -108.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.451 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.18 157.19 42.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.393 -1.063 . . . . 0.0 109.307 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2181 ' ' CYS . . . . . 0.548 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 26.7 p -93.65 159.93 15.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.026 -1.046 . . . . 0.0 110.237 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2182 ' ' LYS . . . . . 0.546 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.0 OUTLIER -146.5 154.24 41.33 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.365 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 2183 ' ' ASN . . . . . 0.469 ' N ' ' HG3' ' A' 2182 ' ' LYS . 56.0 t30 -98.48 121.46 40.45 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.685 -1.259 . . . . 0.0 109.413 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2184 ' ' VAL . . . . . 0.738 HG13 ' N ' ' A' 2185 ' ' ILE . 0.3 OUTLIER -123.45 -162.78 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.524 -0.735 . . . . 0.0 109.558 -179.28 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 2185 ' ' ILE . . . . . 0.738 ' N ' HG13 ' A' 2184 ' ' VAL . 2.7 mp -108.52 138.36 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.186 -0.946 . . . . 0.0 110.213 -179.248 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 64.83 16.31 61.34 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.34 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 2187 ' ' GLY . . . . . 0.526 ' C ' HG12 ' A' 2184 ' ' VAL . . . 167.56 -128.08 1.67 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2188 ' ' PHE . . . . . 0.659 ' N ' HG12 ' A' 2184 ' ' VAL . 5.7 p90 -162.6 170.4 18.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.218 -1.166 . . . . 0.0 109.374 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2189 ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.6 OUTLIER -120.57 151.28 39.63 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.314 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 17.8 p -149.96 141.03 22.98 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.756 -1.215 . . . . 0.0 109.794 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 2191 ' ' THR . . . . . 0.493 ' O ' ' HA3' ' A' 2179 ' ' GLY . 22.2 m -114.92 88.03 2.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.915 . . . . 0.0 109.773 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2192 ' ' CYS . . . . . 0.628 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -51.5 -178.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -0.873 . . . . 0.0 109.119 179.654 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 2193 ' ' GLU . . . . . 0.464 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.6 OUTLIER -58.15 123.59 16.51 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.374 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 2194 ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.8 OUTLIER -37.76 131.81 0.97 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.436 -0.79 . . . . 0.0 110.506 -178.796 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.03 -0.18 10.73 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 2196 ' ' PHE . . . . . 0.68 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.9 OUTLIER -113.69 -164.43 0.93 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.272 -1.134 . . . . 0.0 110.227 -179.904 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 2197 ' ' GLU . . . . . 0.532 ' N ' ' CG ' ' A' 2196 ' ' PHE . 2.5 mm-40 -145.33 96.31 4.9 Favored Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.541 -0.724 . . . . 0.0 109.665 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2198 ' ' PRO . . . . . 0.68 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 7.8 Cg_endo -67.79 -160.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.162 1.908 . . . . 0.0 111.138 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -140.29 -177.24 15.75 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.02 -57.44 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.051 1.834 . . . . 0.0 110.399 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 2201 ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.4 OUTLIER -158.41 60.74 0.44 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.615 -179.858 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 2202 ' ' MET . . . . . 0.464 ' O ' ' CE1' ' A' 2188 ' ' PHE . 0.8 OUTLIER -129.21 -77.16 0.55 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.192 -0.943 . . . . 0.0 109.542 -179.589 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A 2203 ' ' THR . . . . . . . . . . . . . 12.7 t -177.15 -173.91 0.48 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.398 -0.814 . . . . 0.0 109.485 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A 2204 ' ' CYS . . . . . 0.528 ' HB2' ' CA ' ' A' 2176 ' ' CYS . 7.7 t -71.99 148.82 45.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.459 -0.776 . . . . 0.0 109.467 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A 2205 ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' 2197 ' ' GLU . 14.7 pt-20 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.539 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 2129 ' ' ASP . . . . . 0.555 ' HB3' ' CG ' ' A' 2132 ' ' LYS . 10.7 t70 . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 2130 ' ' GLU . . . . . 0.738 ' O ' HG21 ' A' 2136 ' ' VAL . 1.7 mt-10 80.43 -41.55 0.2 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.021 0.438 . . . . 0.0 110.197 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2131 ' ' CYS . . . . . 0.485 ' SG ' ' HB3' ' A' 2137 ' ' CYS . 0.7 OUTLIER -90.93 -27.18 18.89 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.263 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A 2132 ' ' LYS . . . . . 0.555 ' CG ' ' HB3' ' A' 2129 ' ' ASP . 0.0 OUTLIER -56.7 -19.94 19.19 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.304 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A 2133 ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' 2134 ' ' PRO . 0.8 OUTLIER -70.06 137.86 87.25 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.519 -0.738 . . . . 0.0 109.443 -179.819 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A 2134 ' ' PRO . . . . . 0.472 ' O ' ' HD2' ' A' 2138 ' ' LYS . 4.3 Cg_endo -69.38 0.08 5.86 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.346 2.03 . . . . 0.0 111.181 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 22.7 t70 -124.14 1.07 8.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.766 -1.209 . . . . 0.0 110.344 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 2136 ' ' VAL . . . . . 0.738 HG21 ' O ' ' A' 2130 ' ' GLU . 40.5 t -91.73 -95.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.895 -1.128 . . . . 0.0 109.537 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2137 ' ' CYS . . . . . 0.737 ' N ' HG12 ' A' 2136 ' ' VAL . 48.3 t -84.3 -73.24 0.43 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.995 -1.065 . . . . 0.0 109.23 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2138 ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' 2164 ' ' CYS . 0.0 OUTLIER 64.98 127.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 110.34 179.344 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A 2139 ' ' HIS . . . . . 0.512 ' O ' ' HB3' ' A' 2164 ' ' CYS . 9.6 m-70 51.03 26.4 2.74 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.371 -0.831 . . . . 0.0 110.934 178.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2140 ' ' GLY . . . . . 0.434 ' HA3' ' SG ' ' A' 2137 ' ' CYS . . . -128.98 166.89 21.28 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.399 -1.381 . . . . 0.0 110.197 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -89.45 47.87 1.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -1.142 . . . . 0.0 109.003 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 2142 ' ' CYS . . . . . 0.786 ' O ' HD13 ' A' 2143 ' ' ILE . 1.6 p -49.23 160.58 0.22 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.625 -0.672 . . . . 0.0 110.184 -179.727 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2143 ' ' ILE . . . . . 0.786 HD13 ' O ' ' A' 2142 ' ' CYS . 38.1 mm -133.35 121.3 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2144 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.33 116.51 6.12 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.343 -0.848 . . . . 0.0 110.864 -179.088 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2145 ' ' THR . . . . . 0.522 ' OG1' ' HA ' ' A' 2149 ' ' TYR . 0.0 OUTLIER -108.89 175.4 5.48 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.455 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A 2146 ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' 2146 ' ' ASP . 4.2 p30 -70.08 103.06 2.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 110.042 -179.608 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 65.79 10.89 52.39 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 2148 ' ' SER . . . . . 0.459 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.0 OUTLIER -145.84 -174.7 4.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.112 -1.228 . . . . 0.0 109.607 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A 2149 ' ' TYR . . . . . 0.649 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 38.7 p90 -161.78 -170.02 2.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 109.519 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2150 ' ' ARG . . . . . 0.449 ' CB ' ' CZ ' ' A' 2150 ' ' ARG . 0.0 OUTLIER -170.75 104.18 0.25 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.485 -0.759 . . . . 0.0 109.51 179.531 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A 2151 ' ' CYS . . . . . 0.504 ' SG ' HD13 ' A' 2159 ' ' LEU . 36.5 t -72.14 84.09 1.01 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.37 -0.831 . . . . 0.0 109.151 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -93.47 87.48 5.58 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.364 -0.835 . . . . 0.0 109.208 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 2153 ' ' CYS . . . . . 0.54 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -49.79 152.87 2.37 Favored Pre-proline 0 C--N 1.302 -1.49 0 O-C-N 121.397 -0.815 . . . . 0.0 109.723 -179.625 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A 2154 ' ' PRO . . . . . 0.456 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 2.8 Cg_endo -65.4 -165.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.585 2.19 . . . . 0.0 111.018 -179.254 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 77.7 t80 -91.19 101.94 14.67 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.744 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.14 -11.88 5.56 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 -178.704 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 2157 ' ' TYR . . . . . 0.54 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 7.5 m-85 -110.16 -166.84 1.12 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.41 -1.053 . . . . 0.0 109.873 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2158 ' ' ILE . . . . . 0.921 HD11 HG23 ' A' 2165 ' ' VAL . 0.1 OUTLIER -156.5 -165.23 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.507 -0.745 . . . . 0.0 109.395 179.243 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A 2159 ' ' LEU . . . . . 0.504 HD13 ' SG ' ' A' 2151 ' ' CYS . 28.5 tp -142.75 117.2 9.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.259 -0.9 . . . . 0.0 109.639 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -89.89 49.71 1.76 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.387 -0.821 . . . . 0.0 109.417 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 2161 ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' 2162 ' ' ASN . . . 90.62 -17.79 52.94 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2162 ' ' ASN . . . . . 0.489 ' CG ' ' N ' ' A' 2163 ' ' GLU . 5.8 p30 -178.89 -49.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.105 -1.233 . . . . 0.0 109.793 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2163 ' ' GLU . . . . . 0.489 ' N ' ' CG ' ' A' 2162 ' ' ASN . 5.5 tt0 -70.87 133.41 46.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.505 -0.747 . . . . 0.0 109.236 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2164 ' ' CYS . . . . . 0.512 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -106.97 137.23 45.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.024 -1.047 . . . . 0.0 109.73 -179.628 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A 2165 ' ' VAL . . . . . 0.921 HG23 HD11 ' A' 2158 ' ' ILE . 1.9 m -152.07 -170.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.165 -0.959 . . . . 0.0 109.723 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2166 ' ' ASP . . . . . . . . . . . . . 27.0 t70 -76.75 166.94 22.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.366 -0.834 . . . . 0.0 110.164 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 2167 ' ' THR . . . . . 0.536 ' CG2' ' OE1' ' A' 2169 ' ' GLU . 1.4 t -116.83 -169.21 1.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.435 -0.791 . . . . 0.0 109.138 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2168 ' ' ASP . . . . . 0.522 ' N ' HG23 ' A' 2167 ' ' THR . 56.1 t0 -108.94 101.26 10.37 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.15 -0.969 . . . . 0.0 109.492 179.513 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2169 ' ' GLU . . . . . 0.588 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.9 OUTLIER -81.8 -29.75 32.56 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.413 -0.804 . . . . 0.0 109.396 179.916 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A 2170 ' ' CYS . . . . . 0.532 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 2.0 t -71.71 -4.82 29.64 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.456 -0.777 . . . . 0.0 109.07 179.458 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.65 -9.3 34.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.516 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 20.6 t -82.22 -70.33 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.941 . . . . 0.0 109.554 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 2173 ' ' GLY . . . . . 0.419 ' O ' ' SG ' ' A' 2181 ' ' CYS . . . -173.48 -73.84 0.05 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2174 ' ' ASN . . . . . 0.5 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 0.1 OUTLIER -167.09 96.18 0.67 Allowed Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.21 -1.17 . . . . 0.0 109.089 -179.465 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A 2175 ' ' PRO . . . . . 0.586 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 2.2 Cg_endo -63.22 -27.94 72.72 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.952 1.768 . . . . 0.0 110.615 -179.654 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2176 ' ' CYS . . . . . 0.55 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -51.46 -54.96 21.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.037 -1.039 . . . . 0.0 108.596 -179.974 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 138.6 -17.43 3.28 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 2178 ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' 2179 ' ' GLY . 1.6 t-20 -164.49 -37.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -1.091 . . . . 0.0 109.98 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2179 ' ' GLY . . . . . 0.57 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -60.17 -116.07 0.01 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.377 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 3.0 p -149.59 162.7 39.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.402 -1.057 . . . . 0.0 109.423 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 2181 ' ' CYS . . . . . 0.586 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 21.6 p -97.83 156.41 16.6 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.045 -1.034 . . . . 0.0 111.074 -179.382 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2182 ' ' LYS . . . . . 0.571 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 2.4 tppt? -137.97 159.58 41.63 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 178.556 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 60.1 t30 -100.66 126.64 47.19 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.46 -1.4 . . . . 0.0 109.471 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 2184 ' ' VAL . . . . . 0.927 HG12 ' N ' ' A' 2188 ' ' PHE . 0.7 OUTLIER -137.61 162.38 32.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.521 -0.737 . . . . 0.0 109.242 -179.656 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A 2185 ' ' ILE . . . . . 0.522 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 3.2 mp -76.64 130.51 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 110.258 -179.255 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 89.86 -8.51 79.69 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 2187 ' ' GLY . . . . . 0.493 ' C ' HG12 ' A' 2184 ' ' VAL . . . 174.2 -109.41 0.3 Allowed Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.588 -1.292 . . . . 0.0 109.925 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2188 ' ' PHE . . . . . 0.927 ' N ' HG12 ' A' 2184 ' ' VAL . 3.4 p90 -171.16 178.58 3.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -1.132 . . . . 0.0 109.488 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2189 ' ' GLU . . . . . 0.571 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 3.1 tt0 -128.13 131.98 48.96 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.243 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2190 ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 18.3 p -124.07 137.5 54.57 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.576 -1.328 . . . . 0.0 110.039 -179.144 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2191 ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' 2192 ' ' CYS . 25.6 m -108.8 85.28 2.07 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.334 -0.854 . . . . 0.0 109.552 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2192 ' ' CYS . . . . . 0.61 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.9 OUTLIER -49.23 179.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.515 -0.741 . . . . 0.0 109.19 179.893 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A 2193 ' ' GLU . . . . . 0.509 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.3 tt0 -55.22 112.87 1.18 Allowed 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.658 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2194 ' ' GLU . . . . . 0.509 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.8 OUTLIER -28.26 127.43 0.08 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.446 0.641 . . . . 0.0 111.263 -178.775 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.18 6.65 8.16 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 2196 ' ' PHE . . . . . 0.67 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.2 p90 -117.89 -163.26 0.93 Allowed 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.288 -1.125 . . . . 0.0 110.231 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2197 ' ' GLU . . . . . 0.549 ' N ' ' CG ' ' A' 2196 ' ' PHE . 11.8 mt-10 -144.57 95.82 5.32 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 121.507 -0.746 . . . . 0.0 109.527 -179.699 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2198 ' ' PRO . . . . . 0.67 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 8.3 Cg_endo -67.52 -165.13 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.274 1.983 . . . . 0.0 111.199 -179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -129.37 -171.59 12.98 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.79 -58.41 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.154 1.902 . . . . 0.0 111.169 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A 2201 ' ' MET . . . . . 0.517 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.0 OUTLIER -157.18 43.1 0.34 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.091 -1.006 . . . . 0.0 110.52 -179.119 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A 2202 ' ' MET . . . . . 0.451 ' O ' ' CE2' ' A' 2188 ' ' PHE . 17.2 mmm -115.82 -82.9 0.62 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.12 -0.987 . . . . 0.0 109.888 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2203 ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' 2175 ' ' PRO . 9.7 t -165.11 -169.97 1.8 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.182 -0.949 . . . . 0.0 109.604 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2204 ' ' CYS . . . . . 0.576 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.6 t -71.69 146.35 48.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.616 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.334 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -151.63 125.95 9.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.889 . . . . 0.0 109.447 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 5.7 p -108.6 146.89 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.205 -0.935 . . . . 0.0 109.394 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2127 ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.14 149.48 47.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.16 -0.962 . . . . 0.0 109.585 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.37 134.58 50.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.271 -0.893 . . . . 0.0 109.391 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2129 ' ' ASP . . . . . 0.525 ' O ' ' CB ' ' A' 2130 ' ' GLU . 17.2 t0 -66.88 -46.39 75.09 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.229 -0.919 . . . . 0.0 108.607 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2130 ' ' GLU . . . . . 0.591 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 2.0 mt-10 81.89 -44.91 0.18 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.864 -0.523 . . . . 0.0 110.511 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2131 ' ' CYS . . . . . 0.509 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 6.6 p -91.26 -31.92 15.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.038 -1.039 . . . . 0.0 110.041 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2132 ' ' LYS . . . . . 0.458 ' HB2' ' CG ' ' A' 2129 ' ' ASP . 0.1 OUTLIER -69.66 -7.47 39.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.088 -1.008 . . . . 0.0 109.622 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -70.32 151.87 95.68 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.378 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2134 ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -66.19 -7.46 17.36 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.374 2.049 . . . . 0.0 110.619 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2135 ' ' ASP . . . . . 0.518 ' O ' ' ND2' ' A' 2162 ' ' ASN . 0.5 OUTLIER -117.44 19.66 13.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.031 -1.043 . . . . 0.0 109.917 -179.551 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2136 ' ' VAL . . . . . 0.533 ' CB ' ' O ' ' A' 2130 ' ' GLU . 21.4 t -144.55 127.94 11.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2137 ' ' CYS . . . . . 0.523 ' O ' ' HB2' ' A' 2138 ' ' LYS . 85.9 m 55.99 -90.28 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2138 ' ' LYS . . . . . 0.53 ' O ' ' CB ' ' A' 2139 ' ' HIS . 0.0 OUTLIER 70.0 19.39 6.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.397 -0.814 . . . . 0.0 109.983 179.121 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2139 ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.3 OUTLIER 163.26 42.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.99 -1.069 . . . . 0.0 110.222 179.388 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -157.39 172.58 34.8 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.523 -1.323 . . . . 0.0 110.345 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2141 ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' 2152 ' ' GLU . 13.4 tt0 -89.71 98.08 11.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -1.1 . . . . 0.0 109.146 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2142 ' ' CYS . . . . . 0.54 ' C ' HD12 ' A' 2143 ' ' ILE . 24.0 p -89.04 177.81 6.55 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.312 -0.868 . . . . 0.0 110.204 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2143 ' ' ILE . . . . . 0.54 HD12 ' C ' ' A' 2142 ' ' CYS . 2.6 mp -134.97 99.84 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2144 ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' A' 2129 ' ' ASP . 14.8 t30 -56.66 112.69 1.36 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.303 -0.873 . . . . 0.0 110.77 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2145 ' ' THR . . . . . 0.519 HG23 ' HA ' ' A' 2149 ' ' TYR . 14.4 p -96.24 178.95 5.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.313 -0.867 . . . . 0.0 108.962 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -65.04 -48.8 72.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.225 -0.922 . . . . 0.0 109.703 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2147 ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' 2148 ' ' SER . . . -132.3 49.81 0.91 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2148 ' ' SER . . . . . 0.465 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER 171.56 -160.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -1.19 . . . . 0.0 109.54 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2149 ' ' TYR . . . . . 0.591 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 3.9 p90 -158.13 -177.82 6.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.424 -0.798 . . . . 0.0 109.468 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2150 ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -151.52 99.38 2.61 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.17 -0.956 . . . . 0.0 109.706 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.86 136.21 56.62 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.561 -0.712 . . . . 0.0 109.778 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2152 ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' 2141 ' ' GLN . 0.1 OUTLIER -141.95 90.39 2.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.887 . . . . 0.0 109.241 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2153 ' ' CYS . . . . . 0.543 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -69.38 149.26 97.29 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 109.496 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2154 ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.2 -167.03 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.507 2.138 . . . . 0.0 111.112 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.05 105.52 17.87 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.6 -17.29 5.01 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 107.762 -2.135 . . . . 0.0 107.762 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2157 ' ' TYR . . . . . 0.543 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 9.0 m-85 -108.08 -171.46 1.87 Allowed 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.559 -0.965 . . . . 0.0 110.087 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2158 ' ' ILE . . . . . 0.716 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -156.17 -166.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2159 ' ' LEU . . . . . 0.43 ' HA ' HD12 ' A' 2159 ' ' LEU . 33.9 tp -138.33 118.7 13.73 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.634 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -97.02 49.14 1.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.431 -0.793 . . . . 0.0 109.439 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 94.57 -28.82 10.09 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2162 ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' 2135 ' ' ASP . 1.4 m-20 -172.5 -43.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -1.116 . . . . 0.0 109.435 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -73.19 125.82 28.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.333 -0.855 . . . . 0.0 109.282 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2164 ' ' CYS . . . . . 0.687 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -102.74 137.88 40.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 108.956 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2165 ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' 2164 ' ' CYS . 0.6 OUTLIER -160.63 -166.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.05 -1.031 . . . . 0.0 109.97 -179.595 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2166 ' ' ASP . . . . . 0.496 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 0.5 OUTLIER -88.56 150.62 22.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.973 . . . . 0.0 110.358 -179.15 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2167 ' ' THR . . . . . 0.64 HG23 ' OE1' ' A' 2169 ' ' GLU . 13.2 t -92.39 -175.9 4.15 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2168 ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' 2171 ' ' SER . 54.0 t0 -94.31 94.44 8.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.943 -1.098 . . . . 0.0 108.89 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2169 ' ' GLU . . . . . 0.691 ' O ' HG23 ' A' 2172 ' ' VAL . 0.8 OUTLIER -70.77 -30.59 67.12 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.289 -0.882 . . . . 0.0 109.644 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2170 ' ' CYS . . . . . 0.469 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.6 t -65.14 -11.29 38.55 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.231 -0.918 . . . . 0.0 108.616 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2171 ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.1 OUTLIER -68.99 -6.11 25.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.126 -0.984 . . . . 0.0 109.354 179.426 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2172 ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' 2169 ' ' GLU . 23.8 t -76.17 -67.98 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.291 -0.881 . . . . 0.0 109.247 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2173 ' ' GLY . . . . . . . . . . . . . . . 156.51 66.98 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2174 ' ' ASN . . . . . 0.502 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 2.8 t-20 49.75 84.92 0.2 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.22 -1.165 . . . . 0.0 109.573 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2175 ' ' PRO . . . . . 0.608 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 5.0 Cg_endo -68.9 -14.25 38.36 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.07 1.846 . . . . 0.0 109.548 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2176 ' ' CYS . . . . . 0.481 ' HB2' ' ND2' ' A' 2174 ' ' ASN . 1.0 OUTLIER -57.91 -62.01 2.12 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.972 0.891 . . . . 0.0 109.316 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 154.55 -21.27 0.62 Allowed Glycine 0 N--CA 1.482 1.744 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2178 ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' 2179 ' ' GLY . 1.2 t30 -165.1 -38.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -1.172 . . . . 0.0 110.148 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2179 ' ' GLY . . . . . 0.615 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -58.06 -141.8 0.01 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 2.3 p -127.46 154.67 44.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -1.139 . . . . 0.0 109.015 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2181 ' ' CYS . . . . . 0.588 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 9.5 p -95.21 163.22 13.37 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.238 1.018 . . . . 0.0 111.327 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2182 ' ' LYS . . . . . 0.547 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.6 OUTLIER -143.0 157.82 44.18 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2183 ' ' ASN . . . . . 0.447 ' CG ' ' HA ' ' A' 2168 ' ' ASP . 44.5 t30 -94.64 131.14 40.74 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.349 -1.47 . . . . 0.0 110.007 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2184 ' ' VAL . . . . . 0.76 HG13 ' N ' ' A' 2185 ' ' ILE . 0.3 OUTLIER -135.97 -163.23 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.589 -0.695 . . . . 0.0 109.481 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2185 ' ' ILE . . . . . 0.76 ' N ' HG13 ' A' 2184 ' ' VAL . 2.8 mp -107.85 142.48 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.147 -0.971 . . . . 0.0 110.39 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2186 ' ' GLY . . . . . 0.406 ' O ' ' SD ' ' A' 2201 ' ' MET . . . 67.33 8.67 51.94 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2187 ' ' GLY . . . . . 0.515 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 166.59 -115.31 0.62 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2188 ' ' PHE . . . . . 0.749 ' N ' HG12 ' A' 2184 ' ' VAL . 1.7 p90 -167.34 -178.62 4.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -1.116 . . . . 0.0 109.676 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2189 ' ' GLU . . . . . 0.547 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.2 OUTLIER -125.53 175.18 7.71 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2190 ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' 2191 ' ' THR . 0.1 OUTLIER -170.82 158.12 5.78 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 118.649 -1.22 . . . . 0.0 110.01 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2191 ' ' THR . . . . . 0.564 ' O ' HG22 ' A' 2191 ' ' THR . 18.8 m -129.51 78.98 1.88 Allowed 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2192 ' ' CYS . . . . . 0.64 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 1.2 m -47.84 177.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -0.915 . . . . 0.0 109.412 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2193 ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.2 OUTLIER -49.56 113.76 0.9 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.756 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2194 ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.7 tp10 -32.23 129.36 0.19 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.535 0.683 . . . . 0.0 110.907 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.78 0.38 10.91 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2196 ' ' PHE . . . . . 0.675 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.8 OUTLIER -111.19 -162.85 0.81 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.257 -1.143 . . . . 0.0 110.367 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2197 ' ' GLU . . . . . 0.58 ' N ' ' CG ' ' A' 2196 ' ' PHE . 2.0 mm-40 -147.52 98.04 3.97 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2198 ' ' PRO . . . . . 0.675 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.9 Cg_endo -68.71 -158.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.292 1.995 . . . . 0.0 111.292 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -138.57 -173.97 13.22 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.66 -57.83 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.14 1.893 . . . . 0.0 110.937 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2201 ' ' MET . . . . . 0.515 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -157.84 49.08 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 110.266 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A 2202 ' ' MET . . . . . 0.524 ' O ' ' CE2' ' A' 2188 ' ' PHE . 2.7 mmt -119.73 -89.58 0.6 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.043 -1.035 . . . . 0.0 109.979 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2203 ' ' THR . . . . . 0.435 HG23 ' N ' ' A' 2204 ' ' CYS . 6.1 t -157.88 -164.27 1.49 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.208 -0.933 . . . . 0.0 109.404 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2204 ' ' CYS . . . . . 0.532 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 3.9 t -74.08 139.63 44.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.134 -0.979 . . . . 0.0 109.04 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A 2205 ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' 2197 ' ' GLU . 3.2 pt-20 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.631 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -59.83 107.34 0.6 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 109.495 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2126 ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' 2127 ' ' ASP . 60.2 t -75.25 165.86 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.571 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2127 ' ' ASP . . . . . 0.587 ' N ' HG12 ' A' 2126 ' ' VAL . 7.3 t70 -80.65 135.65 36.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -0.85 . . . . 0.0 109.443 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 7.8 mmm -45.14 136.8 4.77 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.237 -0.915 . . . . 0.0 109.778 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2129 ' ' ASP . . . . . 0.519 ' O ' ' CB ' ' A' 2130 ' ' GLU . 18.1 t0 -70.06 -49.55 50.05 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2130 ' ' GLU . . . . . 0.625 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 1.7 mt-10 82.14 -46.97 0.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.741 -0.599 . . . . 0.0 110.537 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2131 ' ' CYS . . . . . 0.497 ' HA ' HG11 ' A' 2136 ' ' VAL . 11.2 p -90.42 -28.51 18.59 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.947 -1.096 . . . . 0.0 109.472 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2132 ' ' LYS . . . . . 0.491 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.1 OUTLIER -81.46 7.4 11.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.323 -0.86 . . . . 0.0 109.357 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 2133 ' ' GLU . . . . . 0.578 ' OE1' HG21 ' A' 2136 ' ' VAL . 44.8 mt-10 -69.57 149.93 96.91 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 121.297 -0.877 . . . . 0.0 109.158 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2134 ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' 2133 ' ' GLU . 1.7 Cg_endo -65.38 -2.47 6.07 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.631 2.221 . . . . 0.0 111.74 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2135 ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' 2135 ' ' ASP . 17.6 p30 -134.3 6.26 3.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.682 -1.261 . . . . 0.0 110.633 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2136 ' ' VAL . . . . . 0.657 HG12 ' N ' ' A' 2137 ' ' CYS . 53.4 t -101.22 -94.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.924 -1.11 . . . . 0.0 109.851 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2137 ' ' CYS . . . . . 0.657 ' N ' HG12 ' A' 2136 ' ' VAL . 0.1 OUTLIER -81.02 -72.77 0.41 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.988 -1.07 . . . . 0.0 109.364 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 2138 ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' 2137 ' ' CYS . 0.1 OUTLIER 65.48 100.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 110.079 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 2139 ' ' HIS . . . . . 0.506 ' O ' ' HB3' ' A' 2164 ' ' CYS . 57.6 m-70 67.29 55.2 0.68 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 110.026 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -153.96 174.9 32.4 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -105.03 82.96 1.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -1.159 . . . . 0.0 108.963 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2142 ' ' CYS . . . . . 0.489 ' C ' HD12 ' A' 2143 ' ' ILE . 17.3 p -88.32 177.09 6.95 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.37 -0.831 . . . . 0.0 110.345 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2143 ' ' ILE . . . . . 0.489 HD12 ' C ' ' A' 2142 ' ' CYS . 4.0 mp -134.24 101.83 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2144 ' ' ASN . . . . . . . . . . . . . 17.0 t30 -58.37 116.87 3.9 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.197 -0.939 . . . . 0.0 110.522 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2145 ' ' THR . . . . . 0.418 ' OG1' ' C ' ' A' 2148 ' ' SER . 0.2 OUTLIER -103.73 174.25 5.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.469 -0.769 . . . . 0.0 108.955 179.142 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.64 -71.15 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.367 -0.833 . . . . 0.0 109.599 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2147 ' ' GLY . . . . . 0.483 ' O ' ' CB ' ' A' 2148 ' ' SER . . . -121.29 62.06 0.52 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2148 ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' 2147 ' ' GLY . 0.3 OUTLIER 166.83 -162.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -1.113 . . . . 0.0 109.546 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 2149 ' ' TYR . . . . . 0.625 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 51.4 p90 -169.1 -170.27 1.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 0.0 109.568 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2150 ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -160.86 112.07 1.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.38 -0.825 . . . . 0.0 109.18 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 1.5 m -75.42 90.21 2.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.9 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -105.58 99.56 9.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 108.878 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2153 ' ' CYS . . . . . 0.539 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -67.64 153.55 94.83 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.249 -0.907 . . . . 0.0 109.9 -179.472 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 2154 ' ' PRO . . . . . 0.482 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.7 Cg_endo -66.06 -167.23 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.593 2.195 . . . . 0.0 111.318 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 81.6 t80 -90.44 102.61 15.34 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.86 -13.88 5.52 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2157 ' ' TYR . . . . . 0.539 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 7.6 m-85 -108.78 -169.87 1.57 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.439 -1.036 . . . . 0.0 110.016 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2158 ' ' ILE . . . . . 0.841 HD11 HG23 ' A' 2165 ' ' VAL . 0.1 OUTLIER -154.76 -163.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 2159 ' ' LEU . . . . . . . . . . . . . 29.6 tp -141.74 122.12 14.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.199 -0.938 . . . . 0.0 109.718 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -99.58 53.34 0.94 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.307 -0.871 . . . . 0.0 109.265 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2161 ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 87.36 -12.31 63.14 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2162 ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' 2136 ' ' VAL . 1.3 m-20 168.95 -44.85 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.303 -1.116 . . . . 0.0 109.382 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -71.5 114.5 9.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 109.144 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2164 ' ' CYS . . . . . 0.562 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -92.26 139.07 30.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 109.539 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 2165 ' ' VAL . . . . . 0.841 HG23 HD11 ' A' 2158 ' ' ILE . 3.7 m -156.99 -168.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.953 . . . . 0.0 109.569 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2166 ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 13.8 t70 -90.16 155.78 18.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.019 -1.051 . . . . 0.0 109.909 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2167 ' ' THR . . . . . 0.867 HG23 ' OE1' ' A' 2169 ' ' GLU . 10.0 t -98.41 174.96 6.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -0.842 . . . . 0.0 109.248 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2168 ' ' ASP . . . . . 0.454 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 44.4 t0 -93.46 95.17 9.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.077 -1.014 . . . . 0.0 108.935 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2169 ' ' GLU . . . . . 0.867 ' OE1' HG23 ' A' 2167 ' ' THR . 0.6 OUTLIER -69.05 -32.26 71.61 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.318 -0.864 . . . . 0.0 109.573 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 2170 ' ' CYS . . . . . 0.537 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.1 t -65.22 -12.23 49.23 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.61 4.64 10.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.184 -0.947 . . . . 0.0 109.696 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 55.0 t -105.38 -79.03 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.21 -0.931 . . . . 0.0 109.857 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2173 ' ' GLY . . . . . 0.467 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -153.95 135.0 4.57 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2174 ' ' ASN . . . . . 0.609 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 26.0 p-10 -41.68 101.61 0.25 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.41 -1.053 . . . . 0.0 110.092 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2175 ' ' PRO . . . . . 0.577 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 1.1 Cg_endo -65.99 -21.87 56.13 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.827 1.685 . . . . 0.0 109.719 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2176 ' ' CYS . . . . . 0.593 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.1 OUTLIER -52.77 -35.76 57.0 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.169 -0.957 . . . . 0.0 109.308 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 114.4 -14.0 20.8 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2178 ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' 2179 ' ' GLY . 5.0 p-10 -171.48 -47.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.456 -1.026 . . . . 0.0 109.557 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2179 ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -52.47 -114.64 0.01 OUTLIER Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2180 ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' 2190 ' ' CYS . 0.8 OUTLIER -150.48 158.54 44.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -1.186 . . . . 0.0 109.371 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 2181 ' ' CYS . . . . . 0.609 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 16.0 p -90.3 166.14 13.49 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 122.368 1.08 . . . . 0.0 111.23 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2182 ' ' LYS . . . . . 0.635 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 11.3 tptt -143.84 155.81 44.25 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2183 ' ' ASN . . . . . 0.454 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 60.7 t30 -98.78 132.44 44.14 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.483 -1.385 . . . . 0.0 109.734 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2184 ' ' VAL . . . . . 0.827 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -140.8 -171.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.601 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 2185 ' ' ILE . . . . . 0.588 ' N ' HG13 ' A' 2184 ' ' VAL . 4.5 mp -104.85 135.67 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.85 -1.156 . . . . 0.0 110.387 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 72.68 13.53 78.14 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2187 ' ' GLY . . . . . 0.579 ' C ' HG12 ' A' 2184 ' ' VAL . . . 166.21 -121.18 0.97 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2188 ' ' PHE . . . . . 0.827 ' N ' HG12 ' A' 2184 ' ' VAL . 4.3 p90 -176.4 173.71 2.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.355 -1.085 . . . . 0.0 108.966 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2189 ' ' GLU . . . . . 0.635 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 3.1 tt0 -120.9 178.07 4.86 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2190 ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' 2180 ' ' THR . 7.6 p -170.9 152.17 3.54 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.861 -1.149 . . . . 0.0 109.436 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2191 ' ' THR . . . . . . . . . . . . . 46.0 m -122.37 91.21 3.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 0.0 110.032 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2192 ' ' CYS . . . . . 0.628 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -54.49 177.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.033 -1.042 . . . . 0.0 108.383 179.173 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 2193 ' ' GLU . . . . . 0.469 ' O ' ' C ' ' A' 2194 ' ' GLU . 7.4 tt0 -54.66 119.34 5.17 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 178.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2194 ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' 2193 ' ' GLU . 2.1 tt0 -35.08 131.58 0.4 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.536 0.684 . . . . 0.0 110.857 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.49 3.76 10.17 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2196 ' ' PHE . . . . . 0.678 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.0 OUTLIER -116.87 -163.89 0.94 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.224 -1.162 . . . . 0.0 110.489 -179.573 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 2197 ' ' GLU . . . . . 0.567 ' N ' ' CG ' ' A' 2196 ' ' PHE . 20.8 mt-10 -145.31 96.67 4.85 Favored Pre-proline 0 C--N 1.305 -1.364 0 O-C-N 121.633 -0.667 . . . . 0.0 109.512 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2198 ' ' PRO . . . . . 0.678 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.0 Cg_endo -68.69 -164.17 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.149 1.9 . . . . 0.0 111.012 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -133.29 -171.0 12.57 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.39 -81.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.028 1.819 . . . . 0.0 110.431 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2201 ' ' MET . . . . . 0.486 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.0 OUTLIER -133.99 49.97 2.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.089 -1.007 . . . . 0.0 109.684 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 1.7 mmm -122.1 -75.84 0.59 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.336 -0.853 . . . . 0.0 109.601 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 2203 ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' 2175 ' ' PRO . 14.9 t -173.21 -173.69 0.95 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 109.748 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A 2204 ' ' CYS . . . . . 0.593 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -108.73 151.63 25.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.371 -0.831 . . . . 0.0 109.149 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.049 -0.976 . . . . 0.0 109.544 -179.984 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 93.3 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . 58.0 43.75 20.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.474 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 8.6 p -170.17 143.99 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.853 . . . . 0.0 109.389 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2127 ' ' ASP . . . . . . . . . . . . . 12.0 t70 -80.36 143.77 33.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 109.47 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 1.3 ttt -48.25 113.53 0.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 109.459 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2129 ' ' ASP . . . . . 0.524 ' O ' ' ND2' ' A' 2144 ' ' ASN . 19.1 t0 -66.1 -58.76 4.73 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.25 -0.907 . . . . 0.0 109.011 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2130 ' ' GLU . . . . . 0.7 ' O ' HG21 ' A' 2136 ' ' VAL . 0.7 OUTLIER 81.52 -41.25 0.15 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.491 -0.756 . . . . 0.0 111.503 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 2131 ' ' CYS . . . . . 0.492 ' HB3' ' HB2' ' A' 2149 ' ' TYR . 14.5 p -90.57 -36.66 14.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.629 -1.294 . . . . 0.0 110.263 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2132 ' ' LYS . . . . . 0.503 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -81.62 7.62 11.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.164 -0.96 . . . . 0.0 109.798 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 2133 ' ' GLU . . . . . 0.414 ' OE2' ' HA ' ' A' 2130 ' ' GLU . 10.0 mt-10 -72.7 153.48 91.44 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.208 -0.933 . . . . 0.0 109.29 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2134 ' ' PRO . . . . . 0.571 ' HA ' ' CG ' ' A' 2138 ' ' LYS . 1.3 Cg_endo -63.72 -8.24 14.97 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.274 1.983 . . . . 0.0 110.667 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2135 ' ' ASP . . . . . 0.632 ' OD1' HG23 ' A' 2136 ' ' VAL . 1.0 OUTLIER -104.34 -20.87 13.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.05 -1.031 . . . . 0.0 110.071 -179.577 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 2136 ' ' VAL . . . . . 0.931 HG11 ' CE1' ' A' 2149 ' ' TYR . 2.0 t -109.86 -140.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.1 -1.0 . . . . 0.0 108.98 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2137 ' ' CYS . . . . . 0.45 ' H ' HG12 ' A' 2136 ' ' VAL . 0.8 OUTLIER -45.7 96.38 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.897 -1.127 . . . . 0.0 108.984 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 2138 ' ' LYS . . . . . 0.571 ' CG ' ' HA ' ' A' 2134 ' ' PRO . 5.0 mtmt -102.12 26.85 7.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.253 -0.904 . . . . 0.0 110.118 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2139 ' ' HIS . . . . . 0.496 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.0 OUTLIER 165.4 48.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.023 -1.048 . . . . 0.0 110.027 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 2140 ' ' GLY . . . . . 0.475 ' HA2' ' HD3' ' A' 2154 ' ' PRO . . . -152.97 -179.65 28.67 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -100.89 72.03 1.47 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.409 -1.054 . . . . 0.0 109.289 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2142 ' ' CYS . . . . . 0.534 ' C ' HD12 ' A' 2143 ' ' ILE . 7.4 p -62.9 -169.22 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.355 -0.84 . . . . 0.0 110.05 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2143 ' ' ILE . . . . . 0.534 HD12 ' C ' ' A' 2142 ' ' CYS . 4.0 mp -141.54 103.09 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2144 ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' 2129 ' ' ASP . 6.6 t-20 -62.25 116.99 5.48 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.216 -0.927 . . . . 0.0 110.468 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2145 ' ' THR . . . . . 0.48 ' HG1' ' C ' ' A' 2148 ' ' SER . 2.2 p -107.23 -170.6 1.73 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.429 -0.795 . . . . 0.0 108.949 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.79 85.25 4.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.286 -0.883 . . . . 0.0 109.735 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 96.89 -55.58 1.34 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2148 ' ' SER . . . . . 0.48 ' C ' ' HG1' ' A' 2145 ' ' THR . 0.4 OUTLIER -84.72 -158.99 0.39 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -1.097 . . . . 0.0 109.828 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 2149 ' ' TYR . . . . . 0.931 ' CE1' HG11 ' A' 2136 ' ' VAL . 41.2 p90 -178.82 -167.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.489 -0.757 . . . . 0.0 109.375 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2150 ' ' ARG . . . . . 0.49 ' CB ' ' CZ ' ' A' 2150 ' ' ARG . 0.0 OUTLIER -169.02 115.07 0.6 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 109.321 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 2151 ' ' CYS . . . . . 0.486 ' SG ' HD13 ' A' 2159 ' ' LEU . 43.3 t -81.55 113.1 19.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.704 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.48 84.29 2.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.011 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2153 ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -47.4 155.57 0.71 Allowed Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.259 -0.901 . . . . 0.0 109.798 -179.52 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 2154 ' ' PRO . . . . . 0.475 ' HD3' ' HA2' ' A' 2140 ' ' GLY . 1.1 Cg_endo -64.23 -168.8 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.73 2.286 . . . . 0.0 111.703 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 43.9 t80 -88.48 102.81 15.27 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.66 -14.76 5.51 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2157 ' ' TYR . . . . . 0.527 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 7.5 m-85 -109.05 -170.03 1.59 Allowed 'General case' 0 N--CA 1.483 1.222 0 O-C-N 121.574 -0.957 . . . . 0.0 109.74 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2158 ' ' ILE . . . . . 0.731 HD13 ' N ' ' A' 2158 ' ' ILE . 0.2 OUTLIER -156.95 -160.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.579 -0.701 . . . . 0.0 109.563 179.736 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 2159 ' ' LEU . . . . . 0.486 HD13 ' SG ' ' A' 2151 ' ' CYS . 29.4 tp -145.57 124.17 12.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.414 -0.804 . . . . 0.0 109.377 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -99.02 51.54 0.96 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.353 -0.842 . . . . 0.0 109.486 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 90.26 -22.76 24.93 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2162 ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' 2135 ' ' ASP . 1.4 m-20 -176.03 -45.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.125 -1.22 . . . . 0.0 109.953 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -75.52 127.14 32.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.048 -1.033 . . . . 0.0 109.614 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2164 ' ' CYS . . . . . 0.703 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -99.74 140.38 34.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.69 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 2165 ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' 2164 ' ' CYS . 0.9 OUTLIER -161.82 -166.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.374 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 2166 ' ' ASP . . . . . 0.487 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 23.1 t70 -90.13 159.27 16.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.068 -1.02 . . . . 0.0 109.863 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2167 ' ' THR . . . . . 0.569 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 5.5 t -99.88 -167.42 1.46 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.185 -0.947 . . . . 0.0 109.362 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2168 ' ' ASP . . . . . 0.479 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 57.6 t0 -108.92 99.79 9.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.183 -0.948 . . . . 0.0 109.325 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2169 ' ' GLU . . . . . 0.595 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.6 OUTLIER -74.38 -30.68 62.08 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.21 -0.931 . . . . 0.0 109.446 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 2170 ' ' CYS . . . . . 0.467 ' O ' ' SG ' ' A' 2181 ' ' CYS . 3.1 t -66.85 -8.32 28.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.282 -0.886 . . . . 0.0 109.023 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2171 ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -70.33 -3.8 19.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.066 -1.021 . . . . 0.0 109.541 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 2172 ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' 2169 ' ' GLU . 17.7 t -86.27 -72.51 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 109.569 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2173 ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' 2174 ' ' ASN . . . 166.2 77.94 0.04 OUTLIER Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.641 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2174 ' ' ASN . . . . . 0.623 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 11.0 p-10 36.56 89.12 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.537 -0.978 . . . . 0.0 110.993 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2175 ' ' PRO . . . . . 0.601 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 5.8 Cg_endo -67.5 -12.71 36.67 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.153 1.902 . . . . 0.0 109.227 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2176 ' ' CYS . . . . . 0.479 ' HB3' ' SG ' ' A' 2192 ' ' CYS . 0.9 OUTLIER -55.92 -58.02 9.63 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.834 0.826 . . . . 0.0 109.543 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 146.84 -26.22 1.62 Allowed Glycine 0 N--CA 1.484 1.854 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2178 ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.4 OUTLIER -157.05 -39.39 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.306 -1.114 . . . . 0.0 109.845 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 2179 ' ' GLY . . . . . 0.67 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -59.43 -140.02 0.01 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2180 ' ' THR . . . . . 0.408 ' HA ' ' HB3' ' A' 2174 ' ' ASN . 1.5 p -133.19 148.0 52.04 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.53 -0.982 . . . . 0.0 109.4 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2181 ' ' CYS . . . . . 0.623 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 11.8 p -82.1 167.37 18.83 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.372 1.082 . . . . 0.0 111.439 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2182 ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 6.9 tttm -142.39 161.61 37.6 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2183 ' ' ASN . . . . . 0.479 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 46.6 t30 -101.12 128.78 47.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.412 -1.43 . . . . 0.0 110.108 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2184 ' ' VAL . . . . . 0.84 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -137.41 -175.57 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.855 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 2185 ' ' ILE . . . . . 0.525 ' N ' HG13 ' A' 2184 ' ' VAL . 3.7 mp -100.05 140.85 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.114 -0.991 . . . . 0.0 110.053 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 70.62 8.4 63.2 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2187 ' ' GLY . . . . . 0.577 ' C ' HG12 ' A' 2184 ' ' VAL . . . 167.72 -121.4 0.96 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2188 ' ' PHE . . . . . 0.84 ' N ' HG12 ' A' 2184 ' ' VAL . 2.3 p90 -169.04 178.61 4.39 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.272 -1.134 . . . . 0.0 109.295 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2189 ' ' GLU . . . . . 0.566 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.4 tt0 -124.19 -179.67 4.53 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2190 ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' 2191 ' ' THR . 0.5 OUTLIER -171.05 157.74 5.33 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 118.959 -1.096 . . . . 0.0 110.17 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 2191 ' ' THR . . . . . 0.514 ' N ' ' SG ' ' A' 2190 ' ' CYS . 80.3 m -128.75 80.27 1.96 Allowed 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2192 ' ' CYS . . . . . 0.67 ' HA ' ' HA3' ' A' 2179 ' ' GLY . 1.2 m -54.16 175.64 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.224 -0.922 . . . . 0.0 110.149 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2193 ' ' GLU . . . . . 0.508 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.5 tt0 -47.11 108.8 0.16 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2194 ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.4 OUTLIER -28.5 125.72 0.1 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.45 0.643 . . . . 0.0 111.237 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.78 4.22 9.7 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2196 ' ' PHE . . . . . 0.675 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.8 OUTLIER -112.71 -164.26 0.91 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.252 -1.146 . . . . 0.0 110.498 -179.628 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 2197 ' ' GLU . . . . . 0.556 ' N ' ' CG ' ' A' 2196 ' ' PHE . 16.6 mt-10 -145.39 97.29 4.74 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2198 ' ' PRO . . . . . 0.675 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.0 Cg_endo -68.47 -159.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.026 1.818 . . . . 0.0 110.999 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -136.05 -174.88 13.54 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.534 -1.827 . . . . 0.0 108.534 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.63 -52.79 1.64 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.114 1.876 . . . . 0.0 110.622 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 2201 ' ' MET . . . . . 0.535 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -163.93 57.69 0.16 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.399 -0.813 . . . . 0.0 109.462 -179.52 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -127.99 -84.09 0.59 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 110.002 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2203 ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' 2175 ' ' PRO . 13.3 t -163.36 -164.15 0.91 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.346 -0.846 . . . . 0.0 108.827 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2204 ' ' CYS . . . . . 0.565 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 3.3 t -74.26 140.86 45.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.953 -1.092 . . . . 0.0 109.329 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2205 ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' 2197 ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.514 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -99.07 107.04 19.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.718 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2126 ' ' VAL . . . . . 0.774 ' O ' HG13 ' A' 2126 ' ' VAL . 13.3 p -110.49 95.33 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.902 . . . . 0.0 109.444 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2127 ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' 2128 ' ' MET . 11.4 t0 -47.12 -39.3 13.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.53 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2128 ' ' MET . . . . . 0.507 ' CB ' ' O ' ' A' 2127 ' ' ASP . 1.5 ttm 76.28 109.85 0.07 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 109.724 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2129 ' ' ASP . . . . . 0.525 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 53.5 t0 -85.39 80.74 9.02 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2130 ' ' GLU . . . . . 0.668 ' O ' HG11 ' A' 2136 ' ' VAL . 22.7 mp0 -49.11 -26.93 3.04 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.289 -0.882 . . . . 0.0 110.547 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2131 ' ' CYS . . . . . 0.493 ' O ' ' HB2' ' A' 2137 ' ' CYS . 0.8 OUTLIER -78.47 -36.1 45.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.701 -1.25 . . . . 0.0 109.678 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 2132 ' ' LYS . . . . . 0.447 ' HB2' ' CG ' ' A' 2129 ' ' ASP . 0.0 OUTLIER -85.53 44.8 1.13 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.003 -1.061 . . . . 0.0 108.623 178.685 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 2133 ' ' GLU . . . . . 0.558 ' CB ' ' HD2' ' A' 2134 ' ' PRO . 1.4 mt-10 -104.59 173.56 3.26 Favored Pre-proline 0 N--CA 1.486 1.349 0 O-C-N 121.466 -0.771 . . . . 0.0 109.765 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2134 ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' 2133 ' ' GLU . 3.1 Cg_exo -60.41 -11.62 17.32 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.584 2.189 . . . . 0.0 112.542 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2135 ' ' ASP . . . . . 0.581 ' O ' ' C ' ' A' 2136 ' ' VAL . 26.8 m-20 -145.95 -77.41 0.19 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.274 -1.516 . . . . 0.0 111.502 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2136 ' ' VAL . . . . . 0.973 HG23 ' CE1' ' A' 2149 ' ' TYR . 0.1 OUTLIER -12.77 -78.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 120.89 0.376 . . . . 0.0 111.057 -178.527 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 2137 ' ' CYS . . . . . 0.747 ' N ' HG22 ' A' 2136 ' ' VAL . 13.0 m -121.11 146.07 47.13 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.689 -1.257 . . . . 0.0 108.949 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2138 ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' 2137 ' ' CYS . 2.4 mtpt -161.08 115.99 2.11 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.092 -1.005 . . . . 0.0 109.807 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2139 ' ' HIS . . . . . 0.465 ' O ' ' HB3' ' A' 2164 ' ' CYS . 20.6 m80 71.42 46.63 0.41 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.212 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -154.17 174.9 32.56 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -89.81 86.14 6.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -1.159 . . . . 0.0 108.513 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2142 ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' 2150 ' ' ARG . 13.4 p -85.26 178.84 7.35 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.285 -0.884 . . . . 0.0 110.811 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2143 ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' 2145 ' ' THR . 4.0 mp -140.02 88.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2144 ' ' ASN . . . . . 0.525 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 8.0 t-20 -53.94 116.08 2.36 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.515 0.674 . . . . 0.0 110.515 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2145 ' ' THR . . . . . 0.435 HG23 ' O ' ' A' 2143 ' ' ILE . 56.4 p -107.75 -171.31 1.85 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2146 ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' 2145 ' ' THR . 0.4 OUTLIER -45.4 -79.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 109.284 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -115.45 -33.61 1.57 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2148 ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.77 -162.13 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -1.138 . . . . 0.0 109.44 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2149 ' ' TYR . . . . . 0.973 ' CE1' HG23 ' A' 2136 ' ' VAL . 12.9 p90 -172.58 -172.72 0.93 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.373 -0.83 . . . . 0.0 109.312 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2150 ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' A' 2149 ' ' TYR . 11.6 mtt180 -159.6 113.79 2.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.392 -0.818 . . . . 0.0 109.24 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2151 ' ' CYS . . . . . 0.527 ' HB2' HD13 ' A' 2159 ' ' LEU . 4.1 m -84.03 68.21 9.96 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.492 -0.755 . . . . 0.0 109.275 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -79.49 134.74 36.52 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.314 -0.866 . . . . 0.0 108.983 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2153 ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -101.53 154.23 37.38 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.245 -0.909 . . . . 0.0 109.772 -179.574 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 2154 ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' 2157 ' ' TYR . 1.5 Cg_endo -64.4 -166.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.505 2.137 . . . . 0.0 110.906 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 65.8 t80 -90.34 102.53 15.26 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.26 -13.9 5.42 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.169 -1.973 . . . . 0.0 108.169 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2157 ' ' TYR . . . . . 0.533 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 7.4 m-85 -108.21 -167.92 1.3 Allowed 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.533 -0.981 . . . . 0.0 109.901 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2158 ' ' ILE . . . . . 0.979 HD11 HG23 ' A' 2165 ' ' VAL . 0.2 OUTLIER -156.21 -166.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.6 -0.687 . . . . 0.0 109.193 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 2159 ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' 2151 ' ' CYS . 9.5 tp -143.17 130.4 20.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.313 -0.867 . . . . 0.0 109.332 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -101.4 46.6 0.93 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.261 -0.899 . . . . 0.0 108.921 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2161 ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' 2162 ' ' ASN . . . 86.36 -9.28 70.95 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2162 ' ' ASN . . . . . 0.509 ' CA ' ' O ' ' A' 2136 ' ' VAL . 12.7 p-10 178.05 -47.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.248 . . . . 0.0 109.882 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2163 ' ' GLU . . . . . 0.423 ' N ' ' CG ' ' A' 2162 ' ' ASN . 11.5 tt0 -77.82 116.54 18.41 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.7 -0.625 . . . . 0.0 109.867 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2164 ' ' CYS . . . . . 0.589 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -93.21 140.72 29.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.93 . . . . 0.0 109.457 179.743 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 2165 ' ' VAL . . . . . 0.979 HG23 HD11 ' A' 2158 ' ' ILE . 1.4 m -157.12 -165.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.105 -0.997 . . . . 0.0 109.562 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2166 ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 35.0 t70 -89.13 165.75 14.29 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.936 -1.102 . . . . 0.0 110.226 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2167 ' ' THR . . . . . 0.556 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 1.6 t -113.56 -169.94 1.6 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.408 -0.808 . . . . 0.0 109.407 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2168 ' ' ASP . . . . . 0.512 ' N ' HG23 ' A' 2167 ' ' THR . 55.7 t0 -109.3 98.85 8.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.249 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2169 ' ' GLU . . . . . 0.593 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.6 OUTLIER -73.47 -31.61 63.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.366 -0.834 . . . . 0.0 109.33 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 2170 ' ' CYS . . . . . 0.444 ' O ' ' SG ' ' A' 2170 ' ' CYS . 1.7 t -66.27 -9.47 32.91 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.342 -0.849 . . . . 0.0 108.735 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.52 7.92 8.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.363 -0.836 . . . . 0.0 110.234 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 57.4 t -112.42 -80.23 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.0 -1.062 . . . . 0.0 109.772 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2173 ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -147.63 131.73 3.99 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2174 ' ' ASN . . . . . 0.607 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 26.9 p-10 -43.78 102.66 0.29 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.301 -1.117 . . . . 0.0 109.577 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2175 ' ' PRO . . . . . 0.592 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 2.7 Cg_endo -70.65 -20.24 30.9 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.807 1.671 . . . . 0.0 110.015 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2176 ' ' CYS . . . . . 0.58 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.1 OUTLIER -50.88 -31.12 16.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -0.989 . . . . 0.0 109.3 -179.463 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 112.63 -23.72 14.69 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -168.67 -34.57 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.577 -0.955 . . . . 0.0 110.028 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2179 ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -63.65 -127.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 2.8 p -135.71 157.79 46.0 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.527 -0.984 . . . . 0.0 109.133 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2181 ' ' CYS . . . . . 0.607 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 12.9 p -95.46 162.31 13.7 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.053 -1.03 . . . . 0.0 111.186 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2182 ' ' LYS . . . . . 0.575 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 5.3 tptm -142.23 165.28 27.87 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2183 ' ' ASN . . . . . 0.46 ' N ' ' HG3' ' A' 2182 ' ' LYS . 63.1 t30 -100.74 138.15 38.18 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.505 -1.372 . . . . 0.0 110.09 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2184 ' ' VAL . . . . . 0.889 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -147.33 165.88 6.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 2185 ' ' ILE . . . . . 0.528 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 3.2 mp -86.85 131.47 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.071 -1.018 . . . . 0.0 110.224 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 86.43 6.34 81.0 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2187 ' ' GLY . . . . . 0.547 ' C ' HG12 ' A' 2184 ' ' VAL . . . 162.73 -113.63 0.57 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2188 ' ' PHE . . . . . 0.889 ' N ' HG12 ' A' 2184 ' ' VAL . 2.9 p90 -173.3 179.48 2.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.171 -1.194 . . . . 0.0 109.352 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2189 ' ' GLU . . . . . 0.575 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.6 tt0 -125.71 173.24 9.16 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 3.5 p -170.87 148.01 2.8 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.653 -1.279 . . . . 0.0 110.016 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2191 ' ' THR . . . . . . . . . . . . . 60.6 m -118.67 87.87 2.81 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.376 -0.828 . . . . 0.0 109.291 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2192 ' ' CYS . . . . . 0.617 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.0 OUTLIER -51.81 178.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.299 -0.876 . . . . 0.0 108.92 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 2193 ' ' GLU . . . . . 0.46 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.0 OUTLIER -53.33 118.22 3.65 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.494 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 2194 ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.4 mt-10 -34.2 128.94 0.38 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.444 0.64 . . . . 0.0 110.991 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.77 4.04 9.79 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2196 ' ' PHE . . . . . 0.672 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.1 p90 -115.06 -164.01 0.91 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.306 -1.114 . . . . 0.0 110.487 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2197 ' ' GLU . . . . . 0.555 ' N ' ' CG ' ' A' 2196 ' ' PHE . 14.5 mt-10 -145.58 96.64 4.76 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.652 -0.655 . . . . 0.0 109.444 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2198 ' ' PRO . . . . . 0.672 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.1 Cg_endo -68.42 -166.3 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.249 1.966 . . . . 0.0 111.44 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -133.25 -173.82 13.39 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.75 -78.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.005 1.803 . . . . 0.0 110.751 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2201 ' ' MET . . . . . 0.478 ' SD ' ' O ' ' A' 2185 ' ' ILE . 0.0 OUTLIER -138.73 40.76 2.18 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.224 -0.922 . . . . 0.0 109.634 -179.271 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 1.6 mmm -112.41 -69.25 0.88 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.131 -0.98 . . . . 0.0 109.721 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2203 ' ' THR . . . . . . . . . . . . . 7.0 t -175.48 -168.27 0.3 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.854 . . . . 0.0 109.504 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 2204 ' ' CYS . . . . . 0.58 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -114.81 153.93 29.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 108.936 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.563 -179.892 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -150.58 -60.97 0.19 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.393 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2126 ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' 2127 ' ' ASP . 11.4 p -68.53 162.6 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.5 -0.75 . . . . 0.0 109.365 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2127 ' ' ASP . . . . . 0.481 ' N ' HG22 ' A' 2126 ' ' VAL . 63.9 t0 -68.66 -60.68 2.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.245 -0.909 . . . . 0.0 109.719 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 3.6 ttm 63.31 117.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.212 -0.93 . . . . 0.0 109.317 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2129 ' ' ASP . . . . . 0.53 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 25.3 t0 -58.85 -53.19 61.15 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2130 ' ' GLU . . . . . 0.765 ' O ' HG21 ' A' 2136 ' ' VAL . 1.7 mt-10 81.26 -38.67 0.13 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.754 -0.592 . . . . 0.0 110.452 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2131 ' ' CYS . . . . . 0.487 ' O ' ' HB2' ' A' 2137 ' ' CYS . 5.2 p -90.71 -40.36 11.9 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.752 -1.217 . . . . 0.0 110.02 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2132 ' ' LYS . . . . . 0.483 ' N ' ' SG ' ' A' 2131 ' ' CYS . 0.0 OUTLIER -75.6 7.11 3.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.099 -1.001 . . . . 0.0 110.465 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 2133 ' ' GLU . . . . . 0.482 ' HB2' HG23 ' A' 2136 ' ' VAL . 7.3 mm-40 -69.22 151.5 96.99 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.989 -1.069 . . . . 0.0 109.448 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2134 ' ' PRO . . . . . 0.511 ' HA ' ' HE2' ' A' 2138 ' ' LYS . 1.4 Cg_endo -64.47 -6.45 11.98 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.392 2.061 . . . . 0.0 110.889 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2135 ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' 2162 ' ' ASN . 10.6 m-20 -118.15 -25.85 6.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.929 -1.107 . . . . 0.0 110.407 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2136 ' ' VAL . . . . . 0.765 HG21 ' O ' ' A' 2130 ' ' GLU . 16.4 t -83.48 -119.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.076 -1.015 . . . . 0.0 108.813 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2137 ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' 2131 ' ' CYS . 59.3 m -67.4 145.89 54.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.554 -1.341 . . . . 0.0 108.392 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2138 ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' 2134 ' ' PRO . 4.1 mttm -149.99 28.43 0.76 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.045 -1.035 . . . . 0.0 110.139 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2139 ' ' HIS . . . . . 0.491 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.1 OUTLIER 162.72 36.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.221 -0.925 . . . . 0.0 109.804 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -150.88 -176.09 23.45 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.62 111.72 24.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -1.066 . . . . 0.0 109.541 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2142 ' ' CYS . . . . . 0.645 ' C ' HD12 ' A' 2143 ' ' ILE . 11.0 p -99.39 -167.81 1.53 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.301 -0.874 . . . . 0.0 109.594 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2143 ' ' ILE . . . . . 0.69 ' O ' HG23 ' A' 2145 ' ' THR . 3.4 mp -149.89 101.09 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 109.259 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2144 ' ' ASN . . . . . 0.53 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 11.2 t-20 -52.65 113.99 1.25 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.3 -0.875 . . . . 0.0 110.189 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2145 ' ' THR . . . . . 0.69 HG23 ' O ' ' A' 2143 ' ' ILE . 5.0 p -117.41 -179.81 3.83 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.372 -0.83 . . . . 0.0 109.083 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.56 117.9 31.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.309 -0.869 . . . . 0.0 109.558 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 73.61 18.75 79.56 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2148 ' ' SER . . . . . 0.477 ' C ' ' HG1' ' A' 2145 ' ' THR . 0.0 OUTLIER -174.81 -171.1 0.52 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -1.147 . . . . 0.0 109.566 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 2149 ' ' TYR . . . . . 0.487 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 7.0 p90 -164.11 -168.43 1.57 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.86 . . . . 0.0 109.408 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2150 ' ' ARG . . . . . 0.489 ' HB2' ' HB ' ' A' 2143 ' ' ILE . 0.0 OUTLIER -130.65 -165.0 1.49 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.869 . . . . 0.0 109.562 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 176.79 38.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.417 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.83 147.19 30.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.356 -0.84 . . . . 0.0 109.364 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2153 ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -110.16 160.77 27.06 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.335 -0.853 . . . . 0.0 109.536 -179.69 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 2154 ' ' PRO . . . . . 0.495 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 2.3 Cg_endo -61.72 -174.46 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.664 2.243 . . . . 0.0 111.669 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 4.4 t80 -81.44 103.19 11.01 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.92 -19.74 4.9 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 107.182 -2.367 . . . . 0.0 107.182 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2157 ' ' TYR . . . . . 0.512 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 20.1 m-85 -108.35 178.71 4.41 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.806 -0.82 . . . . 0.0 109.794 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2158 ' ' ILE . . . . . 0.763 HD13 ' N ' ' A' 2158 ' ' ILE . 0.2 OUTLIER -157.61 -166.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 2159 ' ' LEU . . . . . 0.413 ' HG ' ' N ' ' A' 2160 ' ' ALA . 11.4 tp -131.31 144.98 51.67 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.245 -0.91 . . . . 0.0 109.835 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2160 ' ' ALA . . . . . 0.413 ' N ' ' HG ' ' A' 2159 ' ' LEU . . . -121.11 53.82 1.13 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.389 -0.819 . . . . 0.0 109.013 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 93.59 -21.39 41.29 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2162 ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' 2135 ' ' ASP . 4.0 m-20 173.04 -40.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.357 -1.084 . . . . 0.0 109.502 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -77.87 122.27 25.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 0.0 109.295 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2164 ' ' CYS . . . . . 0.68 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -92.41 143.38 26.43 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 0.0 109.397 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 2165 ' ' VAL . . . . . 0.68 HG13 ' O ' ' A' 2164 ' ' CYS . 1.5 m -160.89 -168.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.12 -0.987 . . . . 0.0 109.485 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2166 ' ' ASP . . . . . 0.43 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 1.1 t0 -90.61 144.85 25.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.001 -1.062 . . . . 0.0 109.747 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2167 ' ' THR . . . . . 0.613 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 9.1 t -91.96 179.64 5.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.886 . . . . 0.0 109.528 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2168 ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' 2171 ' ' SER . 33.2 t0 -86.74 95.6 9.88 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2169 ' ' GLU . . . . . 0.612 ' O ' HG23 ' A' 2172 ' ' VAL . 0.4 OUTLIER -66.22 -27.89 68.32 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.135 -0.978 . . . . 0.0 110.418 -179.006 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 2170 ' ' CYS . . . . . 0.439 ' HB3' ' OD1' ' A' 2168 ' ' ASP . 0.7 OUTLIER -58.13 -13.18 4.37 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.901 -1.125 . . . . 0.0 108.891 178.493 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 2171 ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -61.24 -10.66 7.19 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.137 -0.977 . . . . 0.0 110.159 -179.335 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 2172 ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' 2169 ' ' GLU . 17.4 t -77.06 -69.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.173 -0.954 . . . . 0.0 109.406 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2173 ' ' GLY . . . . . . . . . . . . . . . 156.36 92.96 0.09 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2174 ' ' ASN . . . . . . . . . . . . . 1.3 t-20 45.68 87.79 0.11 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.199 -1.177 . . . . 0.0 110.027 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2175 ' ' PRO . . . . . 0.661 ' CB ' ' CD1' ' A' 2188 ' ' PHE . 1.6 Cg_endo -63.02 -23.45 73.91 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.896 1.731 . . . . 0.0 110.212 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2176 ' ' CYS . . . . . 0.47 ' HB3' ' SG ' ' A' 2192 ' ' CYS . 0.4 OUTLIER -76.83 -68.11 0.64 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 109.288 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 159.81 -20.89 0.26 Allowed Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 1.3 t30 -166.55 -30.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.156 -1.202 . . . . 0.0 110.853 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2179 ' ' GLY . . . . . 0.589 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -61.72 -103.91 0.01 OUTLIER Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.6 -1.286 . . . . 0.0 109.937 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2180 ' ' THR . . . . . 0.411 HG23 ' O ' ' A' 2179 ' ' GLY . 1.1 p -153.75 162.33 41.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.467 -1.019 . . . . 0.0 109.027 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2181 ' ' CYS . . . . . 0.555 ' HB3' ' HD3' ' A' 2175 ' ' PRO . 27.3 p -97.05 161.63 13.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.11 -0.994 . . . . 0.0 110.41 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2182 ' ' LYS . . . . . 0.622 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.2 OUTLIER -146.65 155.12 42.2 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.338 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 64.0 t30 -101.12 127.85 47.48 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.685 -1.259 . . . . 0.0 109.106 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2184 ' ' VAL . . . . . 0.632 HG12 ' N ' ' A' 2188 ' ' PHE . 0.6 OUTLIER -134.33 -166.76 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.419 -0.801 . . . . 0.0 109.367 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 2185 ' ' ILE . . . . . 0.615 ' N ' HG13 ' A' 2184 ' ' VAL . 3.9 mp -105.89 134.57 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.0 110.032 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2186 ' ' GLY . . . . . 0.426 ' O ' ' SD ' ' A' 2201 ' ' MET . . . 78.8 4.16 87.99 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2187 ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 170.54 -116.96 0.67 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.457 -1.354 . . . . 0.0 109.985 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2188 ' ' PHE . . . . . 0.661 ' CD1' ' CB ' ' A' 2175 ' ' PRO . 5.0 p90 -168.25 173.13 8.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.39 -1.065 . . . . 0.0 109.184 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2189 ' ' GLU . . . . . 0.622 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.2 tp10 -127.02 155.69 42.83 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2190 ' ' CYS . . . . . 0.408 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 25.4 p -151.25 145.79 25.61 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.711 -1.243 . . . . 0.0 110.035 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2191 ' ' THR . . . . . 0.494 ' O ' ' HA3' ' A' 2179 ' ' GLY . 23.3 m -112.24 84.67 2.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.379 -0.826 . . . . 0.0 109.847 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2192 ' ' CYS . . . . . 0.628 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.1 m -48.79 -179.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.293 -0.879 . . . . 0.0 109.608 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2193 ' ' GLU . . . . . 0.476 ' O ' ' C ' ' A' 2194 ' ' GLU . 19.1 tt0 -50.65 116.49 1.96 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2194 ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.3 OUTLIER -34.85 125.69 0.54 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.71 -0.619 . . . . 0.0 110.723 -179.256 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.16 1.24 10.41 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2196 ' ' PHE . . . . . 0.675 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.3 p90 -108.89 -163.28 0.86 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.199 -1.177 . . . . 0.0 109.987 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2197 ' ' GLU . . . . . 0.529 ' N ' ' CG ' ' A' 2196 ' ' PHE . 16.8 mt-10 -145.62 95.58 4.92 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 121.496 -0.753 . . . . 0.0 109.556 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2198 ' ' PRO . . . . . 0.675 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.8 Cg_endo -68.71 -165.23 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.213 1.942 . . . . 0.0 111.259 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -133.13 -169.09 12.09 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.71 -81.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.998 1.799 . . . . 0.0 110.563 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 2201 ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.0 OUTLIER -137.08 56.38 1.79 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.974 . . . . 0.0 109.952 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A 2202 ' ' MET . . . . . 0.439 ' O ' ' HB ' ' A' 2203 ' ' THR . 2.4 mmt -123.81 -72.25 0.69 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.271 -0.893 . . . . 0.0 109.615 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2203 ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' 2202 ' ' MET . 11.3 t -180.0 -170.84 0.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.844 . . . . 0.0 109.432 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2204 ' ' CYS . . . . . 0.478 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.4 t -70.27 146.83 50.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 109.565 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.385 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 2124 ' ' SER . . . . . 0.451 ' O ' ' HB3' ' A' 2125 ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2125 ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' 2124 ' ' SER . . . 61.96 76.46 0.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.463 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2126 ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' 2126 ' ' VAL . 12.4 p -124.16 130.41 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -0.902 . . . . 0.0 109.383 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2127 ' ' ASP . . . . . 0.418 ' OD1' ' C ' ' A' 2127 ' ' ASP . 2.9 p30 -58.34 -177.28 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.326 -0.859 . . . . 0.0 109.563 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 1.5 ttt -44.32 125.47 4.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.384 -0.823 . . . . 0.0 109.661 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2129 ' ' ASP . . . . . 0.55 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 20.1 t0 -66.14 -54.87 20.16 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.386 -0.821 . . . . 0.0 108.902 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2130 ' ' GLU . . . . . 0.592 ' O ' HG21 ' A' 2136 ' ' VAL . 1.5 mt-10 80.85 -41.15 0.17 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.651 -0.656 . . . . 0.0 110.943 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2131 ' ' CYS . . . . . 0.496 ' HB2' ' SG ' ' A' 2137 ' ' CYS . 9.8 p -90.23 -33.07 16.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.664 -1.273 . . . . 0.0 110.005 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2132 ' ' LYS . . . . . 0.474 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -81.53 6.86 13.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.135 -0.978 . . . . 0.0 109.225 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -69.71 154.04 95.09 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.254 -0.904 . . . . 0.0 109.343 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2134 ' ' PRO . . . . . 0.486 ' O ' ' HD2' ' A' 2138 ' ' LYS . 3.7 Cg_endo -68.5 1.49 3.61 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.504 2.136 . . . . 0.0 111.536 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -134.36 0.05 3.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.602 -1.311 . . . . 0.0 110.733 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2136 ' ' VAL . . . . . 0.592 HG21 ' O ' ' A' 2130 ' ' GLU . 21.7 t -106.3 -119.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.818 -1.176 . . . . 0.0 109.594 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2137 ' ' CYS . . . . . 0.532 ' N ' HG12 ' A' 2136 ' ' VAL . 3.8 m -76.74 111.45 12.27 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.754 -1.216 . . . . 0.0 108.799 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2138 ' ' LYS . . . . . 0.486 ' HD2' ' O ' ' A' 2134 ' ' PRO . 6.2 mtpp -116.37 112.58 21.71 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.242 -0.911 . . . . 0.0 110.096 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2139 ' ' HIS . . . . . 0.491 ' O ' ' HB3' ' A' 2164 ' ' CYS . 2.1 m-70 74.14 56.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.884 . . . . 0.0 109.944 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -159.7 -176.98 32.37 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -103.6 91.14 3.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -1.122 . . . . 0.0 109.043 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2142 ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' 2150 ' ' ARG . 26.7 p -86.48 -178.94 6.54 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.228 -0.92 . . . . 0.0 110.2 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2143 ' ' ILE . . . . . 0.654 ' O ' HG23 ' A' 2145 ' ' THR . 3.6 mp -141.45 94.24 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.441 -0.787 . . . . 0.0 108.886 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2144 ' ' ASN . . . . . 0.55 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 11.1 t-20 -47.95 117.83 2.07 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.36 -0.837 . . . . 0.0 110.054 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2145 ' ' THR . . . . . 0.654 HG23 ' O ' ' A' 2143 ' ' ILE . 70.9 p -116.49 -174.66 2.6 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.431 -0.793 . . . . 0.0 109.046 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.31 118.44 25.75 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.341 -0.849 . . . . 0.0 109.602 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2147 ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' 2148 ' ' SER . . . 53.62 42.3 66.73 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2148 ' ' SER . . . . . 0.466 ' O ' ' OE1' ' A' 2130 ' ' GLU . 1.8 t 178.16 -162.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -1.109 . . . . 0.0 109.66 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2149 ' ' TYR . . . . . 0.574 ' CD2' ' HB3' ' A' 2130 ' ' GLU . 45.2 p90 179.66 -169.5 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.806 . . . . 0.0 109.336 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2150 ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' 2149 ' ' TYR . 12.4 mtt180 -160.46 119.67 2.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.493 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 82.3 m -83.18 69.76 9.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.328 -0.857 . . . . 0.0 109.234 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -80.47 109.18 14.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.522 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2153 ' ' CYS . . . . . 0.51 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -82.38 152.66 67.76 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 121.148 -0.97 . . . . 0.0 109.356 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 2154 ' ' PRO . . . . . 0.43 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.2 Cg_endo -64.58 -168.54 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.493 2.128 . . . . 0.0 111.207 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 9.1 t80 -90.19 103.25 15.94 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2156 ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' 2167 ' ' THR . . . 130.93 -14.17 5.49 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 -178.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2157 ' ' TYR . . . . . 0.741 ' OH ' HG23 ' A' 2185 ' ' ILE . 7.7 m-85 -107.86 -169.37 1.51 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.516 -0.99 . . . . 0.0 109.945 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2158 ' ' ILE . . . . . 0.97 HD11 HG23 ' A' 2165 ' ' VAL . 0.1 OUTLIER -155.78 -165.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.452 -0.78 . . . . 0.0 109.458 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 2159 ' ' LEU . . . . . 0.449 ' N ' HG12 ' A' 2158 ' ' ILE . 28.7 tp -141.35 125.76 17.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.365 -0.834 . . . . 0.0 109.574 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -101.92 52.67 0.82 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.899 . . . . 0.0 109.261 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2161 ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 88.28 -9.66 74.32 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2162 ' ' ASN . . . . . 0.529 ' ND2' ' HA ' ' A' 2136 ' ' VAL . 1.7 m-20 167.04 -47.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -1.195 . . . . 0.0 109.444 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2163 ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' A' 2138 ' ' LYS . 25.5 tt0 -70.28 115.94 10.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.304 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2164 ' ' CYS . . . . . 0.616 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -92.33 144.55 25.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.52 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 2165 ' ' VAL . . . . . 0.97 HG23 HD11 ' A' 2158 ' ' ILE . 0.4 OUTLIER -159.17 -167.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.426 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 2166 ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' 2184 ' ' VAL . 35.6 t70 -85.95 166.59 15.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.956 -1.09 . . . . 0.0 109.796 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2167 ' ' THR . . . . . 0.549 ' CG2' ' OE1' ' A' 2169 ' ' GLU . 5.6 t -113.73 -168.82 1.4 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.391 -0.818 . . . . 0.0 109.46 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2168 ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' 2168 ' ' ASP . 61.0 t0 -110.39 103.58 12.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.0 109.602 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2169 ' ' GLU . . . . . 0.641 ' O ' HG23 ' A' 2172 ' ' VAL . 0.5 OUTLIER -79.99 -30.58 39.72 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.323 -0.86 . . . . 0.0 109.157 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 2170 ' ' CYS . . . . . 0.533 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 0.5 OUTLIER -64.74 -11.24 34.24 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.371 -0.831 . . . . 0.0 109.008 179.545 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -6.48 26.19 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.195 -0.94 . . . . 0.0 109.445 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2172 ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' 2169 ' ' GLU . 19.0 t -78.58 -70.5 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.196 -0.94 . . . . 0.0 109.051 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2173 ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' 2174 ' ' ASN . . . 161.78 77.04 0.03 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2174 ' ' ASN . . . . . 0.478 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 9.4 t-20 43.85 82.36 0.23 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.257 -1.143 . . . . 0.0 109.835 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2175 ' ' PRO . . . . . 0.614 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 0.9 OUTLIER -64.6 -20.86 65.79 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.289 1.993 . . . . 0.0 110.141 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 2176 ' ' CYS . . . . . 0.508 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.1 OUTLIER -55.63 -58.01 9.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.051 -1.031 . . . . 0.0 108.758 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 143.77 -19.59 2.19 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 1.1 t30 -160.6 -34.95 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -1.172 . . . . 0.0 110.539 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2179 ' ' GLY . . . . . 0.612 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -66.15 -125.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.034 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 2.5 p -140.92 162.22 35.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.491 -1.005 . . . . 0.0 109.252 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2181 ' ' CYS . . . . . 0.596 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 24.5 p -99.7 151.16 21.53 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.09 0.948 . . . . 0.0 111.341 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2182 ' ' LYS . . . . . 0.529 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 4.9 tptt -134.36 157.0 47.51 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 58.5 t30 -95.9 139.71 31.71 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.361 -1.462 . . . . 0.0 109.862 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2184 ' ' VAL . . . . . 0.681 HG12 ' CA ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -147.78 176.7 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.528 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 2185 ' ' ILE . . . . . 0.741 HG23 ' OH ' ' A' 2157 ' ' TYR . 1.2 mp -93.77 139.06 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.01 -1.056 . . . . 0.0 110.118 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 74.75 8.63 82.15 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2187 ' ' GLY . . . . . 0.58 ' C ' HG12 ' A' 2184 ' ' VAL . . . 161.94 -128.76 1.95 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2188 ' ' PHE . . . . . 0.681 ' CA ' HG12 ' A' 2184 ' ' VAL . 1.2 p90 -158.7 -178.78 7.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -1.15 . . . . 0.0 109.532 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2189 ' ' GLU . . . . . 0.529 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.6 OUTLIER -131.85 111.14 11.34 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 2190 ' ' CYS . . . . . 0.45 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 31.2 p -110.65 137.48 48.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.785 -1.197 . . . . 0.0 109.774 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2191 ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' 2192 ' ' CYS . 59.5 m -111.1 87.39 2.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.283 -0.886 . . . . 0.0 109.175 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2192 ' ' CYS . . . . . 0.614 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.0 OUTLIER -48.33 -179.01 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.671 0.748 . . . . 0.0 109.703 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 2193 ' ' GLU . . . . . 0.475 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.6 OUTLIER -59.15 123.83 17.94 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.712 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 2194 ' ' GLU . . . . . 0.475 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.6 OUTLIER -34.74 129.5 0.43 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.43 0.633 . . . . 0.0 110.878 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.47 1.51 10.04 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2196 ' ' PHE . . . . . 0.673 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.8 OUTLIER -116.33 -164.54 0.98 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.184 -1.186 . . . . 0.0 110.192 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 2197 ' ' GLU . . . . . 0.564 ' N ' ' CG ' ' A' 2196 ' ' PHE . 0.3 OUTLIER -146.14 98.15 4.39 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.605 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 2198 ' ' PRO . . . . . 0.673 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.9 Cg_endo -68.68 -164.44 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.242 1.962 . . . . 0.0 111.174 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -132.49 -173.71 13.4 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2200 ' ' PRO . . . . . 0.405 ' C ' ' HG2' ' A' 2201 ' ' MET . 1.2 Cg_endo -64.4 -54.63 0.75 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.919 1.746 . . . . 0.0 110.629 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2201 ' ' MET . . . . . 0.503 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -159.8 49.57 0.3 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 0.0 109.566 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 2.1 mmm -118.63 -79.3 0.59 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.253 -0.904 . . . . 0.0 109.674 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2203 ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' 2175 ' ' PRO . 6.7 t -173.51 -166.36 0.32 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.306 -0.871 . . . . 0.0 109.228 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2204 ' ' CYS . . . . . 0.548 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.2 t -70.31 141.63 52.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.073 -1.017 . . . . 0.0 109.541 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A 2205 ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' 2197 ' ' GLU . 23.0 pt-20 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.35 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 59.5 p . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -120.22 174.4 6.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.418 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2126 ' ' VAL . . . . . 0.63 HG12 ' H ' ' A' 2128 ' ' MET . 21.6 t -47.04 117.83 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 109.49 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2127 ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' 2128 ' ' MET . 0.5 OUTLIER -89.05 17.69 5.6 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.111 -0.993 . . . . 0.0 109.573 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 2128 ' ' MET . . . . . 0.63 ' H ' HG12 ' A' 2126 ' ' VAL . 0.1 OUTLIER 70.06 133.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 109.706 179.78 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 2129 ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' A' 2130 ' ' GLU . 1.3 t0 -51.72 -22.58 3.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.501 -0.749 . . . . 0.0 109.201 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2130 ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' 2129 ' ' ASP . 0.1 OUTLIER 81.29 -67.59 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.792 -0.568 . . . . 0.0 110.46 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 2131 ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' 2137 ' ' CYS . 1.7 t -81.28 -9.82 59.69 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.133 -0.979 . . . . 0.0 109.828 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2132 ' ' LYS . . . . . 0.503 ' CB ' ' HB3' ' A' 2129 ' ' ASP . 0.0 OUTLIER -72.42 -15.02 61.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.787 -1.196 . . . . 0.0 109.785 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 2133 ' ' GLU . . . . . 0.602 ' HB2' HG23 ' A' 2136 ' ' VAL . 3.7 mt-10 -74.3 146.5 84.32 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.152 -0.968 . . . . 0.0 109.631 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2134 ' ' PRO . . . . . 0.473 ' HA ' ' CG ' ' A' 2138 ' ' LYS . 1.2 Cg_endo -65.22 -11.98 32.65 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.273 1.982 . . . . 0.0 110.133 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2135 ' ' ASP . . . . . 0.511 ' O ' ' ND2' ' A' 2162 ' ' ASN . 0.4 OUTLIER -110.35 21.57 16.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.95 . . . . 0.0 109.483 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 2136 ' ' VAL . . . . . 0.602 HG23 ' HB2' ' A' 2133 ' ' GLU . 18.5 t -136.86 109.75 7.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2137 ' ' CYS . . . . . 0.543 ' CA ' ' O ' ' A' 2162 ' ' ASN . 56.4 m 64.92 -89.65 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2138 ' ' LYS . . . . . 0.514 ' O ' ' CB ' ' A' 2139 ' ' HIS . 0.0 OUTLIER 68.11 28.29 6.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.963 -1.086 . . . . 0.0 111.268 178.089 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 2139 ' ' HIS . . . . . 0.521 ' CB ' ' HB3' ' A' 2164 ' ' CYS . 0.1 OUTLIER 164.36 41.09 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.842 -1.161 . . . . 0.0 110.287 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 2140 ' ' GLY . . . . . 0.507 ' HA2' ' HD3' ' A' 2154 ' ' PRO . . . -166.41 175.73 41.77 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2141 ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' 2152 ' ' GLU . 0.2 OUTLIER -89.38 96.66 10.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.184 -1.186 . . . . 0.0 108.259 179.29 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 2142 ' ' CYS . . . . . 0.797 ' C ' HD12 ' A' 2143 ' ' ILE . 0.0 OUTLIER -96.32 174.07 7.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -0.86 . . . . 0.0 110.223 -178.658 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 2143 ' ' ILE . . . . . 0.797 HD12 ' C ' ' A' 2142 ' ' CYS . 4.0 mp -137.2 111.91 10.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2144 ' ' ASN . . . . . 0.493 ' OD1' ' O ' ' A' 2128 ' ' MET . 0.6 OUTLIER -60.17 118.09 5.93 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.207 -0.933 . . . . 0.0 109.756 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 2145 ' ' THR . . . . . 0.678 HG23 ' HA ' ' A' 2149 ' ' TYR . 3.1 p -103.97 -179.5 3.97 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.157 -0.965 . . . . 0.0 109.011 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.13 -74.12 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.356 -0.84 . . . . 0.0 109.771 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -117.27 41.49 2.07 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2148 ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' 2130 ' ' GLU . 0.6 OUTLIER -174.13 -171.85 0.65 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -1.18 . . . . 0.0 109.831 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 2149 ' ' TYR . . . . . 0.678 ' HA ' HG23 ' A' 2145 ' ' THR . 42.0 p90 -153.05 -171.84 4.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 109.474 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2150 ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' 2149 ' ' TYR . 28.5 mtm180 -155.86 98.41 1.9 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.374 -0.829 . . . . 0.0 110.041 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2151 ' ' CYS . . . . . 0.646 ' HB2' HD22 ' A' 2159 ' ' LEU . 70.7 m -63.02 87.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.527 -0.733 . . . . 0.0 109.069 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2152 ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' 2141 ' ' GLN . 0.0 OUTLIER -87.09 70.32 10.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.503 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 2153 ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' 2158 ' ' ILE . 93.1 m -48.33 147.88 3.65 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 121.379 -0.826 . . . . 0.0 109.177 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2154 ' ' PRO . . . . . 0.507 ' HD3' ' HA2' ' A' 2140 ' ' GLY . 1.4 Cg_endo -63.48 -169.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.541 2.161 . . . . 0.0 111.25 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 75.2 t80 -89.22 102.01 14.67 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.28 -11.63 5.54 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2157 ' ' TYR . . . . . 0.476 ' CD2' ' O ' ' A' 2165 ' ' VAL . 5.7 m-85 -108.17 -170.69 1.72 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.399 -1.059 . . . . 0.0 109.801 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2158 ' ' ILE . . . . . 1.028 HD11 HG23 ' A' 2165 ' ' VAL . 0.2 OUTLIER -156.38 -173.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.061 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 2159 ' ' LEU . . . . . 0.646 HD22 ' HB2' ' A' 2151 ' ' CYS . 21.6 tp -130.89 143.52 50.79 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.276 -0.89 . . . . 0.0 109.85 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -120.52 47.71 1.73 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 0.0 109.175 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2161 ' ' GLY . . . . . 0.427 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 94.35 -16.8 60.26 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2162 ' ' ASN . . . . . 0.543 ' O ' ' CA ' ' A' 2137 ' ' CYS . 1.3 m-20 169.47 -30.34 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.342 -1.093 . . . . 0.0 109.171 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -88.21 119.63 28.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 108.749 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2164 ' ' CYS . . . . . 0.868 ' O ' HG13 ' A' 2165 ' ' VAL . 38.2 t -95.78 159.47 14.97 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.173 -0.955 . . . . 0.0 109.239 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2165 ' ' VAL . . . . . 1.028 HG23 HD11 ' A' 2158 ' ' ILE . 0.6 OUTLIER -169.15 -167.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 2166 ' ' ASP . . . . . 0.461 ' OD2' ' O ' ' A' 2184 ' ' VAL . 34.7 t70 -88.88 165.12 14.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.049 -1.032 . . . . 0.0 109.454 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2167 ' ' THR . . . . . 0.641 HG23 ' OE1' ' A' 2169 ' ' GLU . 6.3 t -111.35 -172.92 2.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.39 -0.818 . . . . 0.0 109.371 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2168 ' ' ASP . . . . . 0.472 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 51.8 t0 -107.48 100.96 10.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.409 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2169 ' ' GLU . . . . . 0.641 ' OE1' HG23 ' A' 2167 ' ' THR . 0.6 OUTLIER -76.33 -31.92 58.39 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.496 -0.752 . . . . 0.0 109.288 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 2170 ' ' CYS . . . . . 0.491 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 2.0 t -66.77 -9.68 39.37 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.314 -0.866 . . . . 0.0 108.877 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2171 ' ' SER . . . . . 0.417 ' HB2' ' CG ' ' A' 2168 ' ' ASP . 0.2 OUTLIER -81.23 7.83 10.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.855 . . . . 0.0 109.894 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 49.5 t -108.22 -72.34 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.07 -1.019 . . . . 0.0 109.536 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2173 ' ' GLY . . . . . 0.476 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -163.08 133.81 3.2 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2174 ' ' ASN . . . . . 0.624 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 18.9 p-10 -40.25 99.86 0.21 Allowed Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.461 -1.023 . . . . 0.0 109.959 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2175 ' ' PRO . . . . . 0.591 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 1.4 Cg_endo -68.66 -22.01 38.33 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.798 1.665 . . . . 0.0 109.85 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2176 ' ' CYS . . . . . 0.583 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -48.61 -40.36 27.28 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.305 -0.872 . . . . 0.0 109.206 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 123.0 -16.5 8.2 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -175.44 -34.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.481 -1.011 . . . . 0.0 109.71 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2179 ' ' GLY . . . . . 0.601 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -63.15 -122.24 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.51 154.63 44.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.39 -1.065 . . . . 0.0 109.708 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2181 ' ' CYS . . . . . 0.624 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 21.4 p -92.52 161.39 14.63 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.352 1.072 . . . . 0.0 111.286 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2182 ' ' LYS . . . . . 0.586 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 43.3 tptt -141.48 163.33 33.22 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2183 ' ' ASN . . . . . 0.473 ' N ' ' HG3' ' A' 2182 ' ' LYS . 62.9 t30 -101.13 140.07 35.94 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.618 -1.301 . . . . 0.0 110.006 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2184 ' ' VAL . . . . . 0.794 HG12 ' CA ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -148.91 -177.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.566 -0.709 . . . . 0.0 109.308 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 2185 ' ' ILE . . . . . 0.471 ' H ' HG22 ' A' 2184 ' ' VAL . 2.4 mp -97.83 135.7 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.02 -1.05 . . . . 0.0 110.196 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 75.15 10.62 84.26 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2187 ' ' GLY . . . . . 0.559 ' C ' HG12 ' A' 2184 ' ' VAL . . . 163.42 -121.04 0.98 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2188 ' ' PHE . . . . . 0.794 ' CA ' HG12 ' A' 2184 ' ' VAL . 2.3 p90 -169.17 -179.67 3.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -1.168 . . . . 0.0 109.526 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2189 ' ' GLU . . . . . 0.586 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 4.5 tt0 -124.67 170.21 11.19 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 6.0 p -170.58 145.56 2.57 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.461 -1.399 . . . . 0.0 109.949 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2191 ' ' THR . . . . . . . . . . . . . 17.9 m -117.98 92.98 3.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.422 -0.799 . . . . 0.0 109.728 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2192 ' ' CYS . . . . . 0.611 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -54.82 179.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 0.0 108.795 179.56 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 2193 ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' 2194 ' ' GLU . 4.2 tt0 -56.64 121.22 9.24 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2194 ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' 2193 ' ' GLU . 2.2 mt-10 -34.65 127.52 0.48 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.672 -0.643 . . . . 0.0 110.877 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.11 8.58 7.16 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2196 ' ' PHE . . . . . 0.664 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.4 p90 -119.91 -161.54 0.88 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.251 -1.146 . . . . 0.0 110.301 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2197 ' ' GLU . . . . . 0.582 ' N ' ' CG ' ' A' 2196 ' ' PHE . 1.8 mm-40 -146.13 96.03 4.67 Favored Pre-proline 0 C--N 1.305 -1.339 0 O-C-N 121.64 -0.663 . . . . 0.0 109.763 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2198 ' ' PRO . . . . . 0.664 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.0 Cg_endo -68.1 -159.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.389 2.059 . . . . 0.0 111.4 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -143.99 -169.87 13.15 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -65.31 -81.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.993 1.796 . . . . 0.0 110.844 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2201 ' ' MET . . . . . 0.501 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -135.29 41.73 2.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 110.024 -179.308 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 5.0 mtm -112.33 -78.59 0.58 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.182 -0.948 . . . . 0.0 109.582 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 2203 ' ' THR . . . . . 0.438 HG23 ' N ' ' A' 2204 ' ' CYS . 6.0 t -168.24 -164.43 0.53 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.477 -0.764 . . . . 0.0 109.175 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A 2204 ' ' CYS . . . . . 0.583 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -115.91 144.97 43.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 108.943 -179.696 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.581 -179.724 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 2124 ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' 2126 ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . 47.48 -92.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.588 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2126 ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' 2124 ' ' SER . 24.7 t -70.36 137.24 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 109.246 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2127 ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' 2128 ' ' MET . 12.8 t70 -87.84 120.3 29.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 109.775 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2128 ' ' MET . . . . . 0.422 ' C ' ' O ' ' A' 2127 ' ' ASP . 1.2 mtt -43.69 125.36 4.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 109.538 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2129 ' ' ASP . . . . . 0.55 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 48.5 t0 -66.2 -38.98 89.3 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2130 ' ' GLU . . . . . 0.681 ' O ' HG21 ' A' 2136 ' ' VAL . 2.0 mt-10 82.4 -44.57 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.85 -0.531 . . . . 0.0 110.027 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2131 ' ' CYS . . . . . 0.532 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 14.4 p -90.71 -24.72 20.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.007 -1.058 . . . . 0.0 109.288 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2132 ' ' LYS . . . . . 0.416 ' HB2' ' CB ' ' A' 2129 ' ' ASP . 0.0 OUTLIER -68.92 -8.98 49.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 109.851 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 2133 ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' 2134 ' ' PRO . 6.3 mt-10 -72.12 144.47 87.44 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.082 -1.011 . . . . 0.0 109.171 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2134 ' ' PRO . . . . . 0.589 ' HA ' ' CG ' ' A' 2138 ' ' LYS . 1.9 Cg_endo -67.53 -4.12 11.41 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.239 1.959 . . . . 0.0 110.882 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2135 ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' 2135 ' ' ASP . 2.6 m-20 -116.29 4.96 13.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.011 -1.056 . . . . 0.0 110.03 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2136 ' ' VAL . . . . . 0.681 HG21 ' O ' ' A' 2130 ' ' GLU . 75.4 t -110.32 -91.92 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.988 -1.07 . . . . 0.0 109.695 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2137 ' ' CYS . . . . . 0.542 ' N ' HG12 ' A' 2136 ' ' VAL . 0.5 OUTLIER -79.98 -74.43 0.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.115 -0.991 . . . . 0.0 109.572 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 2138 ' ' LYS . . . . . 0.589 ' CG ' ' HA ' ' A' 2134 ' ' PRO . 0.0 OUTLIER 65.46 89.42 0.1 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.377 -0.827 . . . . 0.0 109.963 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 2139 ' ' HIS . . . . . 0.524 ' O ' ' HB3' ' A' 2164 ' ' CYS . 3.5 m170 75.56 51.1 0.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.349 -0.844 . . . . 0.0 110.125 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -151.68 173.38 30.99 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -104.11 89.58 3.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -1.139 . . . . 0.0 108.966 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2142 ' ' CYS . . . . . 0.481 ' HB3' ' SG ' ' A' 2137 ' ' CYS . 9.0 p -88.86 -177.0 5.39 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.347 -0.846 . . . . 0.0 110.345 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.29 93.04 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2144 ' ' ASN . . . . . 0.55 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 21.2 t-20 -46.11 115.61 1.04 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.516 -0.74 . . . . 0.0 110.963 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2145 ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' 2149 ' ' TYR . 0.4 OUTLIER -113.37 -178.7 3.44 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.282 -0.886 . . . . 0.0 108.936 178.743 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.59 110.15 17.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.379 -0.826 . . . . 0.0 109.769 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 65.85 25.77 71.97 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2148 ' ' SER . . . . . 0.443 ' O ' ' OG1' ' A' 2145 ' ' THR . 0.0 OUTLIER -173.66 -178.72 1.66 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.123 -1.222 . . . . 0.0 109.738 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 2149 ' ' TYR . . . . . 0.599 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 17.8 p90 -160.31 -172.37 3.55 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.443 -0.786 . . . . 0.0 109.446 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2150 ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' 2149 ' ' TYR . 1.8 mtt-85 -156.52 107.16 2.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.414 -0.804 . . . . 0.0 109.142 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 1.6 m -74.33 107.17 6.33 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.489 -0.757 . . . . 0.0 110.431 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.63 -178.63 3.49 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2153 ' ' CYS . . . . . 0.551 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -148.24 152.37 39.16 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 120.952 -1.093 . . . . 0.0 109.672 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 2154 ' ' PRO . . . . . 0.48 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.4 Cg_endo -64.22 -166.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.604 2.203 . . . . 0.0 111.478 -178.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 13.4 t80 -89.8 101.96 14.66 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2156 ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' 2166 ' ' ASP . . . 130.81 -14.08 5.52 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.169 -1.973 . . . . 0.0 108.169 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2157 ' ' TYR . . . . . 0.691 ' OH ' HG23 ' A' 2185 ' ' ILE . 8.4 m-85 -108.3 -174.28 2.48 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.532 -0.981 . . . . 0.0 110.288 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2158 ' ' ILE . . . . . 0.729 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -157.65 -165.89 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 2159 ' ' LEU . . . . . . . . . . . . . 27.7 tp -131.92 127.74 37.05 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.408 -0.807 . . . . 0.0 109.574 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -107.06 49.23 0.81 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 0.0 109.327 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 95.67 -20.25 50.55 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2162 ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' 2136 ' ' VAL . 1.3 t-20 172.8 -38.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -1.172 . . . . 0.0 109.447 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2163 ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' 2137 ' ' CYS . 2.1 tt0 -79.09 111.02 14.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.416 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2164 ' ' CYS . . . . . 0.668 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -85.93 137.55 32.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.895 . . . . 0.0 109.089 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 2165 ' ' VAL . . . . . 0.668 HG13 ' O ' ' A' 2164 ' ' CYS . 6.7 m -160.53 -166.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.145 -0.972 . . . . 0.0 109.539 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2166 ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 1.3 t0 -90.23 144.8 25.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.875 -1.141 . . . . 0.0 109.773 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2167 ' ' THR . . . . . 0.568 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 12.7 t -85.09 169.62 13.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.257 -0.902 . . . . 0.0 109.017 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2168 ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' A' 2171 ' ' SER . 60.2 t0 -82.11 96.78 7.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.865 -1.147 . . . . 0.0 109.175 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2169 ' ' GLU . . . . . 0.699 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 40.2 mp0 -70.09 -37.07 75.33 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.474 -0.766 . . . . 0.0 109.186 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2170 ' ' CYS . . . . . 0.499 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 0.6 OUTLIER -68.19 -7.86 33.87 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.249 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 2171 ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.2 OUTLIER -74.09 -1.5 20.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.357 -0.839 . . . . 0.0 109.452 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 12.2 t -99.04 -72.55 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.17 -0.956 . . . . 0.0 109.671 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2173 ' ' GLY . . . . . 0.482 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -169.46 138.48 5.09 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2174 ' ' ASN . . . . . 0.575 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 22.7 p-10 -36.97 97.67 0.14 Allowed Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.721 -0.87 . . . . 0.0 110.335 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2175 ' ' PRO . . . . . 0.558 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 1.5 Cg_endo -63.2 -22.23 72.56 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.821 1.681 . . . . 0.0 109.998 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2176 ' ' CYS . . . . . 0.543 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -52.12 -54.99 23.83 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 141.96 -21.95 2.47 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -162.93 -34.84 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.336 -1.097 . . . . 0.0 110.176 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2179 ' ' GLY . . . . . 0.6 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -62.48 -119.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.96 153.65 41.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.466 -1.02 . . . . 0.0 109.14 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2181 ' ' CYS . . . . . 0.575 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 11.5 p -82.06 164.95 21.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.086 -1.009 . . . . 0.0 110.813 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2182 ' ' LYS . . . . . 0.604 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.4 OUTLIER -144.63 155.05 43.42 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 64.1 t30 -100.16 138.59 37.03 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.543 -1.348 . . . . 0.0 109.544 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2184 ' ' VAL . . . . . 0.688 HG13 ' N ' ' A' 2185 ' ' ILE . 0.6 OUTLIER -145.94 -162.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.329 -179.401 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A 2185 ' ' ILE . . . . . 0.691 HG23 ' OH ' ' A' 2157 ' ' TYR . 3.0 mp -108.28 134.23 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.036 -1.04 . . . . 0.0 110.356 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 68.56 8.7 56.93 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2187 ' ' GLY . . . . . 0.67 ' C ' HG12 ' A' 2184 ' ' VAL . . . 174.12 -137.59 4.07 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2188 ' ' PHE . . . . . 0.699 ' HB3' ' HB2' ' A' 2169 ' ' GLU . 5.5 p90 -161.02 169.5 22.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -1.151 . . . . 0.0 109.271 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2189 ' ' GLU . . . . . 0.604 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 2.8 tt0 -118.2 178.63 4.37 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 30.3 p -169.39 143.26 2.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.702 -1.249 . . . . 0.0 109.584 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2191 ' ' THR . . . . . . . . . . . . . 20.1 m -109.91 85.81 2.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.316 -0.865 . . . . 0.0 109.696 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2192 ' ' CYS . . . . . 0.604 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.1 m -51.23 177.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.205 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2193 ' ' GLU . . . . . 0.474 ' O ' ' C ' ' A' 2194 ' ' GLU . 7.4 tt0 -50.97 116.48 2.01 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2194 ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.8 mt-10 -33.93 127.77 0.39 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.484 0.659 . . . . 0.0 111.043 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.08 5.22 8.97 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2196 ' ' PHE . . . . . 0.674 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.3 p90 -114.82 -163.22 0.86 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.234 -1.156 . . . . 0.0 110.268 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2197 ' ' GLU . . . . . 0.519 ' N ' ' CG ' ' A' 2196 ' ' PHE . 1.8 mm-40 -144.58 95.98 5.28 Favored Pre-proline 0 C--N 1.304 -1.37 0 O-C-N 121.526 -0.733 . . . . 0.0 109.597 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2198 ' ' PRO . . . . . 0.674 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 8.1 Cg_endo -66.94 -162.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.279 1.986 . . . . 0.0 111.075 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -137.0 -175.08 13.59 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.63 -72.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.991 1.794 . . . . 0.0 110.675 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2201 ' ' MET . . . . . 0.492 ' HA ' ' O ' ' A' 2188 ' ' PHE . 7.3 ptp -141.07 48.62 1.68 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.186 -0.947 . . . . 0.0 110.107 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2202 ' ' MET . . . . . 0.412 ' O ' ' CE1' ' A' 2188 ' ' PHE . 2.1 mmt -120.19 -85.03 0.66 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.081 -1.012 . . . . 0.0 109.845 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2203 ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' 2175 ' ' PRO . 7.3 t -168.66 -168.32 0.88 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.249 -0.907 . . . . 0.0 109.568 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2204 ' ' CYS . . . . . 0.575 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.7 t -71.59 144.81 49.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.934 . . . . 0.0 109.484 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A 2205 ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' 2197 ' ' GLU . 19.0 pt-20 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.457 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 58.6 m . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -113.37 114.48 26.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.423 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 24.6 t -101.81 145.84 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.506 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2127 ' ' ASP . . . . . . . . . . . . . 15.6 t70 -97.26 109.29 22.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.49 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.76 130.57 47.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.878 . . . . 0.0 109.717 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2129 ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' 2130 ' ' GLU . 27.5 t0 -67.35 -38.98 85.69 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2130 ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' 2129 ' ' ASP . 1.5 mt-10 81.21 -48.74 0.26 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.668 -0.645 . . . . 0.0 110.427 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2131 ' ' CYS . . . . . 0.488 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 13.7 p -90.97 -26.58 19.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.882 -1.136 . . . . 0.0 109.715 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2132 ' ' LYS . . . . . 0.529 ' HB2' ' CB ' ' A' 2129 ' ' ASP . 0.0 OUTLIER -65.34 -11.45 42.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.839 -1.163 . . . . 0.0 109.137 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -70.28 148.75 95.82 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.399 -0.813 . . . . 0.0 109.413 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2134 ' ' PRO . . . . . 0.537 ' HA ' ' CD ' ' A' 2138 ' ' LYS . 1.2 Cg_endo -64.67 -7.8 15.69 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.232 1.954 . . . . 0.0 110.726 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.91 16.94 15.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.044 -1.035 . . . . 0.0 109.841 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2136 ' ' VAL . . . . . 0.64 ' CG1' ' CE1' ' A' 2149 ' ' TYR . 22.1 t -143.09 118.84 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.134 -0.979 . . . . 0.0 109.314 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2137 ' ' CYS . . . . . 0.47 ' SG ' HG12 ' A' 2136 ' ' VAL . 1.9 m 41.64 71.05 0.22 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.331 -0.856 . . . . 0.0 109.252 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2138 ' ' LYS . . . . . 0.537 ' CD ' ' HA ' ' A' 2134 ' ' PRO . 0.0 OUTLIER -98.35 129.24 45.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 0.0 109.928 -179.427 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 2139 ' ' HIS . . . . . 0.48 ' O ' ' HB3' ' A' 2164 ' ' CYS . 0.7 OUTLIER 67.95 52.2 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.499 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -161.52 -160.77 11.11 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2141 ' ' GLN . . . . . 0.436 ' HB3' ' O ' ' A' 2152 ' ' GLU . 1.6 tt0 -119.03 94.49 4.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.321 -1.105 . . . . 0.0 109.405 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2142 ' ' CYS . . . . . 0.514 ' C ' HD12 ' A' 2143 ' ' ILE . 10.9 p -90.47 177.7 6.31 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.294 -0.879 . . . . 0.0 110.011 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2143 ' ' ILE . . . . . 0.514 HD12 ' C ' ' A' 2142 ' ' CYS . 3.6 mp -132.16 117.22 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2144 ' ' ASN . . . . . . . . . . . . . 31.7 t30 -75.32 113.61 12.9 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.096 -1.002 . . . . 0.0 111.367 -178.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2145 ' ' THR . . . . . 0.441 ' OG1' ' C ' ' A' 2148 ' ' SER . 16.2 p -99.87 179.53 4.49 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -59.14 -47.94 83.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 109.849 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -142.58 57.71 0.56 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2148 ' ' SER . . . . . 0.467 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER 174.92 -160.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -1.116 . . . . 0.0 109.287 -179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 2149 ' ' TYR . . . . . 0.64 ' CE1' ' CG1' ' A' 2136 ' ' VAL . 43.2 p90 -174.11 -170.9 0.58 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.35 -0.844 . . . . 0.0 109.336 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2150 ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' 2149 ' ' TYR . 26.8 mtt180 -160.04 107.61 1.66 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.339 -0.851 . . . . 0.0 109.435 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 36.2 m -64.82 89.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.464 -0.772 . . . . 0.0 109.746 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2152 ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' 2141 ' ' GLN . 2.0 mt-10 -102.16 86.18 2.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.034 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2153 ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -59.24 153.38 47.61 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.297 -0.877 . . . . 0.0 109.973 -179.407 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 2154 ' ' PRO . . . . . 0.439 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.1 Cg_endo -65.16 -167.56 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.624 2.216 . . . . 0.0 111.205 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 17.9 t80 -90.15 104.89 17.42 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.03 -17.91 5.1 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2157 ' ' TYR . . . . . 0.521 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 12.0 m-85 -107.98 -175.38 2.77 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.673 -0.898 . . . . 0.0 109.574 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2158 ' ' ILE . . . . . 0.771 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -153.6 -163.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.661 -0.65 . . . . 0.0 109.319 179.429 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 2159 ' ' LEU . . . . . 0.434 ' HA ' HD12 ' A' 2159 ' ' LEU . 24.4 tp -135.41 136.36 41.33 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.195 -0.941 . . . . 0.0 110.073 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -113.99 44.14 1.71 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.411 -0.806 . . . . 0.0 109.255 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 100.42 -28.31 16.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2162 ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -179.46 -35.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -1.109 . . . . 0.0 109.47 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -81.66 113.62 19.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 0.0 109.254 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2164 ' ' CYS . . . . . 0.541 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -87.37 135.59 33.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.919 . . . . 0.0 109.854 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 2165 ' ' VAL . . . . . 0.584 ' O ' HD13 ' A' 2158 ' ' ILE . 0.3 OUTLIER -158.42 -168.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.416 -0.802 . . . . 0.0 108.848 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 2166 ' ' ASP . . . . . 0.485 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 0.6 OUTLIER -90.46 140.04 30.1 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.895 -1.128 . . . . 0.0 109.405 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 2167 ' ' THR . . . . . 0.635 ' HB ' HG21 ' A' 2158 ' ' ILE . 7.6 t -93.13 161.33 14.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.252 -0.905 . . . . 0.0 109.373 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2168 ' ' ASP . . . . . 0.503 ' O ' ' HB2' ' A' 2171 ' ' SER . 59.7 t0 -69.92 95.38 0.92 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.831 -1.168 . . . . 0.0 109.517 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2169 ' ' GLU . . . . . 0.601 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 41.2 mp0 -69.35 -35.85 76.29 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.489 -0.757 . . . . 0.0 109.399 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2170 ' ' CYS . . . . . 0.499 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 0.2 OUTLIER -65.01 -8.7 17.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.451 -0.781 . . . . 0.0 109.057 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 2171 ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -72.18 -0.6 12.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.962 -1.087 . . . . 0.0 109.781 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 9.9 t -98.82 -74.04 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.092 -1.005 . . . . 0.0 109.914 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2173 ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -166.61 138.92 5.46 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2174 ' ' ASN . . . . . 0.579 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 18.5 p-10 -38.64 99.31 0.19 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.694 -0.886 . . . . 0.0 110.245 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2175 ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' 2181 ' ' CYS . 1.8 Cg_endo -61.87 -27.94 80.73 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.053 1.835 . . . . 0.0 110.182 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2176 ' ' CYS . . . . . 0.55 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -46.14 -50.48 15.47 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 133.14 -16.92 4.62 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2178 ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.4 OUTLIER -162.86 -40.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -1.111 . . . . 0.0 109.911 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 2179 ' ' GLY . . . . . 0.603 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -60.85 -119.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.3 p -143.11 160.42 40.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.432 -1.04 . . . . 0.0 109.469 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2181 ' ' CYS . . . . . 0.59 ' HB3' ' HD3' ' A' 2175 ' ' PRO . 16.7 p -88.1 166.42 14.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.137 -0.977 . . . . 0.0 110.794 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2182 ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.2 OUTLIER -145.62 156.01 43.39 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.604 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 61.3 t30 -100.59 131.33 46.55 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.698 -1.251 . . . . 0.0 109.506 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2184 ' ' VAL . . . . . 0.689 HG12 ' N ' ' A' 2188 ' ' PHE . 0.6 OUTLIER -140.89 -166.8 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.515 -0.741 . . . . 0.0 109.368 -179.566 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 2185 ' ' ILE . . . . . 0.614 ' N ' HG13 ' A' 2184 ' ' VAL . 4.0 mp -107.36 136.41 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.029 -1.045 . . . . 0.0 109.909 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 72.92 6.93 68.96 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2187 ' ' GLY . . . . . 0.646 ' C ' HG12 ' A' 2184 ' ' VAL . . . 169.81 -129.76 1.9 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2188 ' ' PHE . . . . . 0.689 ' N ' HG12 ' A' 2184 ' ' VAL . 3.2 p90 -164.38 173.16 12.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -1.157 . . . . 0.0 108.997 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2189 ' ' GLU . . . . . 0.617 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 2.6 tt0 -120.54 159.33 25.42 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 22.4 p -149.18 145.34 27.11 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.738 -1.226 . . . . 0.0 109.917 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2191 ' ' THR . . . . . . . . . . . . . 25.2 m -113.9 85.96 2.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.299 -0.875 . . . . 0.0 109.564 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2192 ' ' CYS . . . . . 0.617 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.9 OUTLIER -51.01 178.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 109.273 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 2193 ' ' GLU . . . . . 0.49 ' O ' ' C ' ' A' 2194 ' ' GLU . 2.0 tm-20 -52.71 117.79 3.17 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2194 ' ' GLU . . . . . 0.49 ' C ' ' O ' ' A' 2193 ' ' GLU . 5.7 mt-10 -34.15 127.73 0.42 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.494 0.664 . . . . 0.0 110.833 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.59 4.61 8.82 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2196 ' ' PHE . . . . . 0.669 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.1 p90 -114.99 -162.77 0.84 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.193 -1.181 . . . . 0.0 110.1 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2197 ' ' GLU . . . . . 0.542 ' N ' ' CG ' ' A' 2196 ' ' PHE . 25.3 mt-10 -145.42 95.55 5.0 Favored Pre-proline 0 C--N 1.304 -1.386 0 O-C-N 121.46 -0.775 . . . . 0.0 109.481 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2198 ' ' PRO . . . . . 0.669 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 8.3 Cg_endo -67.38 -159.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.27 1.98 . . . . 0.0 111.098 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -140.62 -170.49 12.1 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.47 -81.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 121.919 1.746 . . . . 0.0 110.531 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2201 ' ' MET . . . . . 0.493 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.4 OUTLIER -135.02 56.52 1.84 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.819 -179.475 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 2202 ' ' MET . . . . . 0.405 ' O ' ' HB ' ' A' 2203 ' ' THR . 0.2 OUTLIER -124.53 -78.63 0.6 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.22 -0.925 . . . . 0.0 109.654 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A 2203 ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' 2175 ' ' PRO . 6.7 t -178.5 -165.56 0.09 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.382 -0.824 . . . . 0.0 109.196 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2204 ' ' CYS . . . . . 0.564 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.4 t -75.08 144.79 42.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 0.0 109.462 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.563 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.276 0.56 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 2125 ' ' ALA . . . . . 0.414 ' O ' ' HB ' ' A' 2126 ' ' VAL . . . -141.58 26.6 1.93 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.536 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2126 ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' 2125 ' ' ALA . 44.4 t 58.85 100.9 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 0.0 109.551 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2127 ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' 2128 ' ' MET . 25.9 t70 -44.32 147.19 0.58 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.94 . . . . 0.0 109.556 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2128 ' ' MET . . . . . 0.422 ' C ' ' O ' ' A' 2127 ' ' ASP . 1.8 ttt -43.13 103.1 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.347 -0.846 . . . . 0.0 109.688 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2129 ' ' ASP . . . . . 0.54 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 17.5 t0 -82.69 89.04 6.7 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2130 ' ' GLU . . . . . 0.606 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 42.4 mp0 -56.11 -24.76 42.58 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.43 -0.794 . . . . 0.0 110.529 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2131 ' ' CYS . . . . . . . . . . . . . 1.8 t -84.49 -26.72 27.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.653 -1.279 . . . . 0.0 109.094 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2132 ' ' LYS . . . . . 0.479 ' HB2' ' HB3' ' A' 2129 ' ' ASP . 0.0 OUTLIER -84.75 13.05 6.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.07 -1.019 . . . . 0.0 109.089 179.445 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 2133 ' ' GLU . . . . . 0.548 ' HB2' ' CG2' ' A' 2136 ' ' VAL . 7.7 mt-10 -70.66 165.04 49.81 Favored Pre-proline 0 N--CA 1.486 1.365 0 O-C-N 121.346 -0.847 . . . . 0.0 109.498 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2134 ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' 2133 ' ' GLU . 2.6 Cg_endo -65.85 -27.76 51.3 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.57 2.18 . . . . 0.0 112.342 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -138.91 39.36 2.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.53 -1.356 . . . . 0.0 111.487 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2136 ' ' VAL . . . . . 0.781 HG12 ' N ' ' A' 2137 ' ' CYS . 46.5 t -102.84 -100.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.834 -1.167 . . . . 0.0 109.248 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2137 ' ' CYS . . . . . 0.781 ' N ' HG12 ' A' 2136 ' ' VAL . 16.2 m -89.46 -65.48 1.01 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.767 -1.208 . . . . 0.0 108.696 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2138 ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' 2137 ' ' CYS . 0.3 OUTLIER 61.17 124.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.373 -0.829 . . . . 0.0 110.383 178.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 2139 ' ' HIS . . . . . 0.484 ' O ' ' HB3' ' A' 2164 ' ' CYS . 0.7 OUTLIER 63.18 40.83 8.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.335 -0.853 . . . . 0.0 110.366 179.074 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -154.79 162.15 30.65 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.04 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -94.44 87.9 5.32 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.493 -1.004 . . . . 0.0 108.727 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2142 ' ' CYS . . . . . 0.825 ' C ' HD12 ' A' 2143 ' ' ILE . 0.8 OUTLIER -88.22 -166.83 1.69 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.3 -0.875 . . . . 0.0 109.769 -179.136 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 2143 ' ' ILE . . . . . 0.825 HD12 ' C ' ' A' 2142 ' ' CYS . 4.1 mp -144.72 103.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2144 ' ' ASN . . . . . 0.54 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 5.7 t-20 -57.63 116.02 3.14 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.302 -0.874 . . . . 0.0 110.3 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2145 ' ' THR . . . . . 0.432 ' HG1' ' C ' ' A' 2148 ' ' SER . 1.3 p -104.48 -177.46 3.37 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.381 -0.825 . . . . 0.0 109.196 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.86 -72.96 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.331 -0.856 . . . . 0.0 109.675 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -128.21 38.28 2.11 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2148 ' ' SER . . . . . 0.468 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER -155.0 -160.06 1.02 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.245 -1.15 . . . . 0.0 109.513 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 2149 ' ' TYR . . . . . 0.694 ' CE2' HG13 ' A' 2136 ' ' VAL . 8.5 p90 -163.38 -169.72 2.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.658 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2150 ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' 2142 ' ' CYS . 32.4 mtt180 -157.81 99.51 1.7 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.388 -0.82 . . . . 0.0 109.374 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 30.6 m -70.09 111.97 6.13 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.252 -0.905 . . . . 0.0 109.17 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.03 84.8 2.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.239 -0.913 . . . . 0.0 109.416 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2153 ' ' CYS . . . . . 0.518 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -54.88 148.1 29.29 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.341 -0.849 . . . . 0.0 109.207 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 2154 ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.93 -167.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.405 2.07 . . . . 0.0 111.018 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 6.5 t80 -90.08 104.72 17.27 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.23 -16.14 5.24 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2157 ' ' TYR . . . . . 0.538 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 6.4 m-85 -105.52 -169.24 1.56 Allowed 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.564 -0.963 . . . . 0.0 110.155 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2158 ' ' ILE . . . . . 0.711 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -153.46 -167.35 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.617 -0.677 . . . . 0.0 109.206 179.481 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 2159 ' ' LEU . . . . . . . . . . . . . 37.9 tp -139.52 127.42 22.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.372 -0.83 . . . . 0.0 109.463 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -103.93 44.17 1.04 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.366 -0.834 . . . . 0.0 109.605 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2161 ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' 2162 ' ' ASN . . . 93.87 -17.79 57.96 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2162 ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' 2136 ' ' VAL . 4.0 p-10 179.72 -49.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -1.142 . . . . 0.0 109.469 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2163 ' ' GLU . . . . . 0.456 ' N ' ' CG ' ' A' 2162 ' ' ASN . 0.6 OUTLIER -73.45 120.07 18.55 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.56 -0.712 . . . . 0.0 109.255 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 2164 ' ' CYS . . . . . 0.603 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -97.08 139.4 33.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 109.456 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 2165 ' ' VAL . . . . . 0.679 HG23 HD11 ' A' 2158 ' ' ILE . 1.6 m -158.39 -172.27 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.064 -1.023 . . . . 0.0 109.475 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2166 ' ' ASP . . . . . 0.403 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 7.6 t70 -88.11 152.65 21.86 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.952 -1.092 . . . . 0.0 109.562 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2167 ' ' THR . . . . . 0.583 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 5.5 t -92.19 -168.16 1.93 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 109.13 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2168 ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' 2171 ' ' SER . 58.5 t0 -111.36 100.0 8.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.085 -1.009 . . . . 0.0 109.213 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2169 ' ' GLU . . . . . 0.607 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.7 OUTLIER -74.0 -33.28 63.75 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.448 -0.783 . . . . 0.0 109.22 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 2170 ' ' CYS . . . . . 0.464 ' HB2' ' N ' ' A' 2182 ' ' LYS . 1.8 t -69.59 -9.62 54.81 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2171 ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -72.72 -12.86 61.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 0.0 109.549 -179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 21.7 t -84.76 -71.99 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.146 -0.971 . . . . 0.0 109.288 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2173 ' ' GLY . . . . . 0.465 ' O ' ' SG ' ' A' 2181 ' ' CYS . . . -154.09 -127.58 1.16 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2174 ' ' ASN . . . . . 0.572 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 26.5 p-10 -130.28 97.79 21.93 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.075 -1.25 . . . . 0.0 109.213 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2175 ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' 2181 ' ' CYS . 1.6 Cg_endo -66.58 -18.97 54.6 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 121.918 1.745 . . . . 0.0 109.967 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2176 ' ' CYS . . . . . 0.542 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.1 OUTLIER -51.39 -49.12 62.19 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.06 0.933 . . . . 0.0 108.926 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 128.64 -21.05 5.41 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 108.326 -1.909 . . . . 0.0 108.326 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -166.52 -34.09 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.498 -1.001 . . . . 0.0 110.045 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2179 ' ' GLY . . . . . 0.613 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -69.26 -130.51 0.05 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.6 p -131.97 157.0 45.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.605 -0.938 . . . . 0.0 109.193 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2181 ' ' CYS . . . . . 0.572 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 24.7 p -89.17 167.09 13.39 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.336 1.065 . . . . 0.0 110.899 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2182 ' ' LYS . . . . . 0.542 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 3.9 tttp -146.4 160.79 41.6 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2183 ' ' ASN . . . . . 0.416 ' N ' ' CG ' ' A' 2182 ' ' LYS . 56.3 t30 -100.59 126.32 47.05 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.602 -1.311 . . . . 0.0 110.014 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2184 ' ' VAL . . . . . 0.89 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -132.46 -176.32 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 2185 ' ' ILE . . . . . 0.538 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 4.0 mp -100.29 140.29 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.019 -1.051 . . . . 0.0 110.008 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 70.64 12.19 69.92 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2187 ' ' GLY . . . . . 0.592 ' C ' HG12 ' A' 2184 ' ' VAL . . . 164.39 -117.92 0.78 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2188 ' ' PHE . . . . . 0.89 ' N ' HG12 ' A' 2184 ' ' VAL . 2.2 p90 -170.57 -179.27 2.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -1.19 . . . . 0.0 109.902 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2189 ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.3 OUTLIER -127.63 169.53 13.66 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.187 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 11.7 p -170.56 146.69 2.78 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.498 -1.376 . . . . 0.0 110.229 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2191 ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' 2192 ' ' CYS . 89.2 m -114.84 86.61 2.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.533 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2192 ' ' CYS . . . . . 0.622 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -50.27 -179.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.044 -1.035 . . . . 0.0 108.865 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 2193 ' ' GLU . . . . . 0.489 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.5 tt0 -55.15 113.92 1.56 Allowed 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2194 ' ' GLU . . . . . 0.489 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.2 tt0 -31.1 129.18 0.14 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.589 0.709 . . . . 0.0 111.029 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.61 4.27 9.81 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2196 ' ' PHE . . . . . 0.67 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.3 p90 -114.93 -163.63 0.89 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.229 -1.159 . . . . 0.0 110.385 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2197 ' ' GLU . . . . . 0.55 ' N ' ' CG ' ' A' 2196 ' ' PHE . 7.1 mt-10 -145.32 95.54 5.04 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 121.615 -0.678 . . . . 0.0 109.596 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2198 ' ' PRO . . . . . 0.67 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.2 Cg_endo -67.63 -162.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.349 2.033 . . . . 0.0 111.42 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -138.27 -174.82 13.58 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.54 -71.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.055 1.837 . . . . 0.0 110.726 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2201 ' ' MET . . . . . 0.471 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.1 OUTLIER -144.4 42.35 1.38 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.756 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.35 -77.11 0.58 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.217 -0.927 . . . . 0.0 109.532 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A 2203 ' ' THR . . . . . . . . . . . . . 12.2 t -168.32 -168.69 0.96 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.409 -0.807 . . . . 0.0 109.094 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 2204 ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.0 OUTLIER -115.04 149.7 37.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.895 . . . . 0.0 108.989 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.077 -0.964 . . . . 0.0 109.564 179.919 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.265 0.555 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -154.79 -52.5 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.867 . . . . 0.0 109.433 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 12.5 m -66.15 162.56 2.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.321 -0.862 . . . . 0.0 109.584 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2127 ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' 2128 ' ' MET . 15.5 t70 -60.08 152.17 24.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.622 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2128 ' ' MET . . . . . 0.467 ' O ' ' HG3' ' A' 2130 ' ' GLU . 0.3 OUTLIER -43.88 132.43 5.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 109.569 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 2129 ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' 2130 ' ' GLU . 16.3 t0 -62.17 -41.84 98.7 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.413 -0.804 . . . . 0.0 108.856 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2130 ' ' GLU . . . . . 0.635 ' O ' HG21 ' A' 2136 ' ' VAL . 2.5 mt-10 82.86 -51.15 0.17 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.857 -0.527 . . . . 0.0 110.265 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2131 ' ' CYS . . . . . 0.55 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 12.0 p -89.51 -25.05 21.63 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.094 -1.004 . . . . 0.0 109.614 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2132 ' ' LYS . . . . . 0.485 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -85.2 41.11 0.86 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.177 -0.952 . . . . 0.0 109.539 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -112.65 155.93 43.18 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.295 -0.878 . . . . 0.0 109.2 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2134 ' ' PRO . . . . . 0.457 ' O ' ' HD2' ' A' 2138 ' ' LYS . 1.5 Cg_endo -64.67 -5.46 10.34 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.361 2.041 . . . . 0.0 111.262 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2135 ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' 2162 ' ' ASN . 2.9 t0 -124.18 -29.5 3.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.802 -1.186 . . . . 0.0 110.216 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2136 ' ' VAL . . . . . 0.635 HG21 ' O ' ' A' 2130 ' ' GLU . 61.7 t -77.82 -106.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.041 -1.037 . . . . 0.0 109.146 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2137 ' ' CYS . . . . . 0.508 ' N ' HG12 ' A' 2136 ' ' VAL . 0.1 OUTLIER -84.2 138.66 32.86 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.771 -1.206 . . . . 0.0 108.813 179.526 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 2138 ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' 2139 ' ' HIS . 0.5 OUTLIER -139.6 23.86 2.47 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.1 -1.0 . . . . 0.0 110.017 -179.269 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 2139 ' ' HIS . . . . . 0.541 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.1 OUTLIER 162.27 42.36 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.314 -0.867 . . . . 0.0 110.036 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -144.76 170.99 26.15 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.256 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2141 ' ' GLN . . . . . 0.416 ' O ' ' HG3' ' A' 2141 ' ' GLN . 5.7 pt20 -92.09 65.78 4.81 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.441 -1.035 . . . . 0.0 109.166 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2142 ' ' CYS . . . . . 0.466 ' HB3' ' SG ' ' A' 2137 ' ' CYS . 21.5 p -62.44 -174.13 0.06 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.368 -0.833 . . . . 0.0 110.274 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2143 ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' 2143 ' ' ILE . 1.7 mp -148.71 83.09 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2144 ' ' ASN . . . . . 0.525 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 2.9 t30 -59.08 113.28 2.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.253 -0.904 . . . . 0.0 109.584 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2145 ' ' THR . . . . . . . . . . . . . 27.7 p -97.26 -151.79 0.37 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.371 -0.83 . . . . 0.0 109.415 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.76 -79.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 110.123 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -120.64 22.26 8.27 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2148 ' ' SER . . . . . 0.494 ' N ' ' OE2' ' A' 2130 ' ' GLU . 0.1 OUTLIER -144.85 -161.8 1.37 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -1.16 . . . . 0.0 109.214 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 2149 ' ' TYR . . . . . 0.555 ' CE2' ' CG1' ' A' 2136 ' ' VAL . 24.3 p90 179.6 -164.21 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.695 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2150 ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' 2149 ' ' TYR . 0.1 OUTLIER -166.58 119.45 1.03 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 109.358 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 13.2 m -89.03 106.67 18.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.885 . . . . 0.0 109.81 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -119.49 97.7 5.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 108.909 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2153 ' ' CYS . . . . . 0.524 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -58.22 152.95 39.09 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.21 -0.931 . . . . 0.0 109.817 -179.481 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 2154 ' ' PRO . . . . . 0.487 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 2.0 Cg_endo -66.11 -167.12 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.525 2.15 . . . . 0.0 111.023 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 22.1 t80 -90.59 104.72 17.27 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2156 ' ' GLY . . . . . 0.657 ' O ' HG22 ' A' 2167 ' ' THR . . . 131.05 -16.37 5.27 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.045 -2.022 . . . . 0.0 108.045 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2157 ' ' TYR . . . . . 0.524 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 8.2 m-85 -107.39 -169.69 1.58 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.599 -0.942 . . . . 0.0 110.005 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2158 ' ' ILE . . . . . 1.13 HD11 HG23 ' A' 2165 ' ' VAL . 0.1 OUTLIER -151.24 -163.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.594 -0.691 . . . . 0.0 109.398 179.42 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 2159 ' ' LEU . . . . . 0.49 ' N ' HG12 ' A' 2158 ' ' ILE . 25.0 tp -145.51 113.26 6.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.413 -0.804 . . . . 0.0 109.297 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -95.55 60.66 2.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.323 -0.861 . . . . 0.0 109.715 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2161 ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 88.59 -19.49 36.37 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2162 ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' A' 2135 ' ' ASP . 0.9 OUTLIER 167.98 -34.08 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.361 -1.082 . . . . 0.0 109.357 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -76.49 111.62 12.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 109.15 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2164 ' ' CYS . . . . . 0.725 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -87.83 144.74 26.43 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.301 -0.874 . . . . 0.0 109.69 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 2165 ' ' VAL . . . . . 1.13 HG23 HD11 ' A' 2158 ' ' ILE . 1.4 m -161.96 -169.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.292 -0.88 . . . . 0.0 109.54 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2166 ' ' ASP . . . . . 0.451 ' OD1' ' HA ' ' A' 2185 ' ' ILE . 34.7 t70 -78.54 164.35 24.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 110.179 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2167 ' ' THR . . . . . 0.657 HG22 ' O ' ' A' 2156 ' ' GLY . 6.0 t -117.25 -173.57 2.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.643 -0.661 . . . . 0.0 109.295 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2168 ' ' ASP . . . . . . . . . . . . . 42.0 t0 -101.6 102.47 13.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.197 -0.94 . . . . 0.0 108.976 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2169 ' ' GLU . . . . . 0.566 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.3 OUTLIER -75.54 -23.89 56.67 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.276 -0.89 . . . . 0.0 110.359 -179.122 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 2170 ' ' CYS . . . . . 0.449 ' O ' ' SG ' ' A' 2170 ' ' CYS . 2.8 t -59.49 -12.34 6.1 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.784 -1.197 . . . . 0.0 108.805 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.48 -10.74 12.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.258 -0.901 . . . . 0.0 110.091 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2172 ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' 2169 ' ' GLU . 25.3 t -74.9 -68.21 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.232 -0.918 . . . . 0.0 109.422 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2173 ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' 2174 ' ' ASN . . . 162.54 78.28 0.03 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2174 ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' 2173 ' ' GLY . 1.0 OUTLIER 44.22 91.9 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.275 -1.132 . . . . 0.0 109.557 -179.78 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 2175 ' ' PRO . . . . . 0.611 ' CB ' ' CE2' ' A' 2188 ' ' PHE . 1.3 Cg_endo -66.68 -21.12 52.29 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.104 1.869 . . . . 0.0 110.238 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2176 ' ' CYS . . . . . 0.546 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -65.44 -60.0 3.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 109.521 -179.682 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 141.62 -18.09 2.62 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.74 -31.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.662 -0.905 . . . . 0.0 109.731 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2179 ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -60.68 -114.02 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.1 p -145.65 154.73 42.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.397 -1.061 . . . . 0.0 109.096 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2181 ' ' CYS . . . . . 0.521 ' HB3' ' HD2' ' A' 2175 ' ' PRO . 26.1 p -96.08 160.07 14.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.072 -1.018 . . . . 0.0 110.621 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2182 ' ' LYS . . . . . 0.568 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 3.6 tptm -146.06 156.65 43.61 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2183 ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' 2167 ' ' THR . 59.7 t30 -100.68 140.14 35.38 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.6 -1.313 . . . . 0.0 109.443 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2184 ' ' VAL . . . . . 0.666 HG12 ' N ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -146.95 168.21 5.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.456 -0.777 . . . . 0.0 109.124 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 2185 ' ' ILE . . . . . 0.521 HG23 ' OH ' ' A' 2157 ' ' TYR . 2.3 mp -80.64 140.32 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 110.755 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2186 ' ' GLY . . . . . 0.436 ' O ' ' SD ' ' A' 2201 ' ' MET . . . 69.81 9.26 62.26 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2187 ' ' GLY . . . . . 0.588 ' C ' HG12 ' A' 2184 ' ' VAL . . . 165.51 -136.66 4.29 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2188 ' ' PHE . . . . . 0.666 ' N ' HG12 ' A' 2184 ' ' VAL . 1.2 p90 -153.06 179.26 8.86 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.199 -1.177 . . . . 0.0 109.055 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2189 ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.2 tp10 -131.49 171.27 13.61 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 7.8 p -170.79 148.8 2.98 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.78 -1.2 . . . . 0.0 109.876 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2191 ' ' THR . . . . . . . . . . . . . 10.1 m -118.39 88.94 3.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.908 . . . . 0.0 109.965 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2192 ' ' CYS . . . . . 0.622 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.7 OUTLIER -51.58 -179.48 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.171 -0.956 . . . . 0.0 109.219 179.586 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 2193 ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' 2194 ' ' GLU . 4.7 tt0 -57.2 118.17 4.8 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2194 ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.5 OUTLIER -32.21 128.49 0.22 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.409 0.623 . . . . 0.0 111.006 -178.933 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.41 4.69 8.94 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2196 ' ' PHE . . . . . 0.672 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.9 OUTLIER -117.37 -165.98 1.14 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.259 -1.142 . . . . 0.0 110.313 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 2197 ' ' GLU . . . . . 0.535 ' N ' ' CG ' ' A' 2196 ' ' PHE . 4.9 mm-40 -143.86 95.98 5.63 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.635 -0.666 . . . . 0.0 109.388 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2198 ' ' PRO . . . . . 0.672 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 6.8 Cg_endo -65.95 -167.17 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.187 1.925 . . . . 0.0 111.273 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -134.65 -171.33 12.47 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.1 -76.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.111 1.874 . . . . 0.0 110.822 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2201 ' ' MET . . . . . 0.547 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -140.26 52.2 1.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.485 -0.759 . . . . 0.0 109.997 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 8.8 mmm -126.37 -73.84 0.61 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.002 -1.062 . . . . 0.0 110.062 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2203 ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' 2175 ' ' PRO . 7.0 t -170.78 -169.12 0.74 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.218 -0.926 . . . . 0.0 109.746 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A 2204 ' ' CYS . . . . . 0.571 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.0 OUTLIER -112.46 148.03 35.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.47 -0.769 . . . . 0.0 108.974 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.43 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -176.37 -34.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.908 . . . . 0.0 109.374 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 2.7 t -109.25 78.94 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.911 . . . . 0.0 109.315 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2127 ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' 2127 ' ' ASP . 9.5 t0 -76.81 -28.16 55.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.364 -0.835 . . . . 0.0 109.661 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 3.2 mtt 66.31 117.83 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 109.629 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2129 ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' A' 2132 ' ' LYS . 5.2 t0 -68.28 -40.3 81.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.43 -0.794 . . . . 0.0 109.229 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2130 ' ' GLU . . . . . 0.585 ' O ' HG21 ' A' 2136 ' ' VAL . 2.1 mt-10 83.03 -61.29 0.13 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.757 -0.589 . . . . 0.0 110.831 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2131 ' ' CYS . . . . . 0.772 ' HA ' HG11 ' A' 2136 ' ' VAL . 29.5 p -85.45 -5.78 59.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.961 -1.087 . . . . 0.0 110.047 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2132 ' ' LYS . . . . . 0.541 ' HB3' ' HB3' ' A' 2129 ' ' ASP . 13.7 tttt -94.89 3.18 55.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -0.976 . . . . 0.0 109.34 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2133 ' ' GLU . . . . . 0.494 ' HB2' HG23 ' A' 2136 ' ' VAL . 5.3 mt-10 -69.61 147.24 96.52 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 120.99 -1.069 . . . . 0.0 109.188 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2134 ' ' PRO . . . . . 0.529 ' HA ' ' CG ' ' A' 2138 ' ' LYS . 1.4 Cg_endo -63.9 -6.13 10.44 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.278 1.985 . . . . 0.0 110.935 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.16 -3.73 12.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.983 -1.073 . . . . 0.0 110.078 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2136 ' ' VAL . . . . . 0.772 HG11 ' HA ' ' A' 2131 ' ' CYS . 76.9 t -96.86 -101.03 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.037 -1.04 . . . . 0.0 109.788 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2137 ' ' CYS . . . . . 0.65 ' N ' HG12 ' A' 2136 ' ' VAL . 0.5 OUTLIER -73.27 -72.58 0.25 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.868 -1.145 . . . . 0.0 109.523 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 2138 ' ' LYS . . . . . 0.529 ' CG ' ' HA ' ' A' 2134 ' ' PRO . 1.1 mtmt 63.53 100.57 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.296 -0.878 . . . . 0.0 109.805 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2139 ' ' HIS . . . . . 0.509 ' CB ' ' O ' ' A' 2138 ' ' LYS . 7.7 m-70 76.54 26.68 0.85 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -0.893 . . . . 0.0 109.579 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -132.34 166.82 23.23 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2141 ' ' GLN . . . . . 0.521 ' O ' ' CG ' ' A' 2152 ' ' GLU . 0.9 OUTLIER -103.86 71.51 1.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -1.17 . . . . 0.0 109.022 179.803 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 2142 ' ' CYS . . . . . 0.47 ' HB3' ' SG ' ' A' 2137 ' ' CYS . 25.4 p -70.17 -164.33 0.08 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.865 0.841 . . . . 0.0 110.449 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2143 ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' 2143 ' ' ILE . 2.5 mp -151.68 84.58 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2144 ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 3.2 t30 -61.74 113.64 2.86 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.54 -0.725 . . . . 0.0 110.362 -178.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2145 ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' 2146 ' ' ASP . 16.5 p -101.1 -157.2 0.59 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.531 -0.731 . . . . 0.0 109.324 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2146 ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' 2146 ' ' ASP . 0.6 OUTLIER -48.37 -94.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.625 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -108.04 16.99 35.57 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2148 ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.69 -166.37 1.77 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.202 -1.175 . . . . 0.0 109.165 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2149 ' ' TYR . . . . . 0.558 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 40.5 p90 -176.4 -176.86 0.8 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.655 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2150 ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.09 134.9 23.58 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -102.25 119.67 39.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.086 -1.009 . . . . 0.0 109.937 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2152 ' ' GLU . . . . . 0.521 ' CG ' ' O ' ' A' 2141 ' ' GLN . 0.8 OUTLIER -134.68 178.64 6.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 109.389 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 2153 ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -142.09 158.34 61.84 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.302 -179.822 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 2154 ' ' PRO . . . . . 0.501 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.8 Cg_endo -62.93 -171.08 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.457 2.104 . . . . 0.0 111.52 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.18 102.47 14.49 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.39 -16.7 5.4 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2157 ' ' TYR . . . . . 0.537 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 5.2 m-85 -105.25 -170.44 1.75 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.682 -0.893 . . . . 0.0 109.898 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2158 ' ' ILE . . . . . 0.638 HD13 ' N ' ' A' 2158 ' ' ILE . 0.2 OUTLIER -158.91 -161.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.624 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 2159 ' ' LEU . . . . . 0.505 ' N ' HG12 ' A' 2158 ' ' ILE . 26.3 tp -136.55 123.34 21.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.831 . . . . 0.0 109.499 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -96.39 51.78 1.21 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.359 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 90.36 -29.62 6.53 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2162 ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' 2136 ' ' VAL . 2.8 p-10 -171.13 -48.84 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.153 -1.204 . . . . 0.0 109.331 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2163 ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' 2137 ' ' CYS . 53.8 tt0 -72.57 121.78 20.27 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.543 -0.723 . . . . 0.0 109.273 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2164 ' ' CYS . . . . . 0.632 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -90.94 138.88 31.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 109.593 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 2165 ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' 2164 ' ' CYS . 0.7 OUTLIER -159.84 -167.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.941 . . . . 0.0 109.297 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 2166 ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 8.7 t70 -89.97 155.73 18.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.975 -1.078 . . . . 0.0 109.786 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2167 ' ' THR . . . . . 0.607 HG23 ' OE1' ' A' 2169 ' ' GLU . 7.2 t -90.99 -169.49 2.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 109.449 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2168 ' ' ASP . . . . . 0.478 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 64.9 t0 -109.15 102.44 11.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.218 -0.926 . . . . 0.0 109.836 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2169 ' ' GLU . . . . . 0.613 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.5 OUTLIER -74.95 -32.65 61.79 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.361 -0.837 . . . . 0.0 109.066 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 2170 ' ' CYS . . . . . 0.538 ' HB2' ' N ' ' A' 2182 ' ' LYS . 0.6 OUTLIER -64.6 -11.55 36.1 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.776 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.35 5.22 13.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.845 . . . . 0.0 109.383 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 40.5 t -103.61 -65.88 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.355 -0.84 . . . . 0.0 109.402 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2173 ' ' GLY . . . . . . . . . . . . . . . -153.53 -135.18 2.1 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2174 ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -122.85 102.69 37.85 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.316 -1.109 . . . . 0.0 109.07 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2175 ' ' PRO . . . . . 0.645 ' CB ' ' CE2' ' A' 2188 ' ' PHE . 3.4 Cg_endo -69.07 -18.58 40.19 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.695 1.597 . . . . 0.0 109.839 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2176 ' ' CYS . . . . . 0.578 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -69.77 -50.36 44.05 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.127 -0.983 . . . . 0.0 109.653 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 124.75 -17.94 7.2 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -166.37 -37.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -1.079 . . . . 0.0 110.12 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2179 ' ' GLY . . . . . 0.585 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -63.95 -120.55 0.01 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.4 p -141.55 161.29 38.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.54 -0.976 . . . . 0.0 109.198 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2181 ' ' CYS . . . . . 0.572 ' HB3' ' HD2' ' A' 2175 ' ' PRO . 26.7 p -97.81 160.76 14.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.043 -1.036 . . . . 0.0 110.593 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2182 ' ' LYS . . . . . 0.576 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 2.5 tppt? -145.46 155.67 43.26 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2183 ' ' ASN . . . . . 0.478 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 32.4 t30 -92.71 137.34 32.45 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.52 -1.363 . . . . 0.0 110.203 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2184 ' ' VAL . . . . . 0.847 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -140.92 -167.63 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 2185 ' ' ILE . . . . . 0.695 ' N ' HG13 ' A' 2184 ' ' VAL . 1.5 mp -107.17 141.42 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.106 -0.996 . . . . 0.0 110.461 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 64.7 13.48 56.11 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2187 ' ' GLY . . . . . 0.566 ' C ' HG12 ' A' 2184 ' ' VAL . . . 167.24 -118.85 0.81 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2188 ' ' PHE . . . . . 0.847 ' N ' HG12 ' A' 2184 ' ' VAL . 1.5 p90 -171.84 -179.19 2.38 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.367 -1.078 . . . . 0.0 109.497 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2189 ' ' GLU . . . . . 0.576 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.5 OUTLIER -128.87 169.19 14.9 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.387 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 8.9 p -170.53 147.66 2.96 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.789 -1.194 . . . . 0.0 109.749 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2191 ' ' THR . . . . . . . . . . . . . 25.2 m -118.18 90.97 3.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.644 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2192 ' ' CYS . . . . . 0.631 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.8 OUTLIER -52.99 -179.88 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.031 -1.043 . . . . 0.0 108.783 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 2193 ' ' GLU . . . . . 0.499 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.6 tt0 -52.45 112.76 0.87 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2194 ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -31.34 125.73 0.21 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.439 0.637 . . . . 0.0 111.136 -178.601 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.53 11.18 6.17 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2196 ' ' PHE . . . . . 0.686 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.8 p90 -118.33 -162.34 0.88 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.135 -1.215 . . . . 0.0 110.489 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2197 ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' 2196 ' ' PHE . 18.4 mt-10 -142.28 92.54 7.45 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 121.434 -0.792 . . . . 0.0 110.058 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2198 ' ' PRO . . . . . 0.686 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.0 Cg_endo -67.05 -160.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.303 2.002 . . . . 0.0 111.273 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -140.21 -175.74 14.63 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2200 ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' 2189 ' ' GLU . 2.0 Cg_endo -62.14 -74.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 121.702 1.601 . . . . 0.0 110.61 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2201 ' ' MET . . . . . 0.475 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -143.44 46.47 1.5 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.213 -0.929 . . . . 0.0 109.458 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 2202 ' ' MET . . . . . 0.432 ' O ' ' HB ' ' A' 2203 ' ' THR . 0.1 OUTLIER -116.95 -65.59 1.17 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.303 -0.873 . . . . 0.0 109.779 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 2203 ' ' THR . . . . . 0.432 ' HB ' ' O ' ' A' 2202 ' ' MET . 13.3 t -179.9 -171.45 0.18 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A 2204 ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.0 OUTLIER -112.44 143.51 43.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.086 -1.009 . . . . 0.0 109.269 -179.552 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.495 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2125 ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' 2126 ' ' VAL . . . -125.36 29.48 6.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.895 . . . . 0.0 109.562 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2126 ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' 2125 ' ' ALA . 45.3 t 57.25 106.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.268 -0.895 . . . . 0.0 109.457 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2127 ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' 2128 ' ' MET . 2.8 p30 -83.66 -161.25 0.5 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.324 -0.86 . . . . 0.0 109.272 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2128 ' ' MET . . . . . 0.422 ' C ' ' O ' ' A' 2127 ' ' ASP . 0.0 OUTLIER -45.15 116.96 1.22 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.136 -0.978 . . . . 0.0 109.254 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 2129 ' ' ASP . . . . . 0.62 ' O ' ' HB2' ' A' 2130 ' ' GLU . 4.5 t0 -65.62 -27.48 68.42 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.349 -0.844 . . . . 0.0 108.8 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2130 ' ' GLU . . . . . 0.62 ' HB2' ' O ' ' A' 2129 ' ' ASP . 1.8 mp0 75.81 -57.52 0.57 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 120.92 0.391 . . . . 0.0 111.45 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2131 ' ' CYS . . . . . 0.567 ' HB2' ' CB ' ' A' 2137 ' ' CYS . 0.5 OUTLIER -84.43 -19.31 33.67 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.765 -1.209 . . . . 0.0 109.974 -178.904 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 2132 ' ' LYS . . . . . 0.53 ' HB3' ' HB3' ' A' 2129 ' ' ASP . 4.4 tttt -68.4 -9.92 51.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.13 -0.981 . . . . 0.0 109.838 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2133 ' ' GLU . . . . . 0.929 ' HB2' HG23 ' A' 2136 ' ' VAL . 6.7 mt-10 -69.13 147.62 97.54 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.329 -0.857 . . . . 0.0 109.921 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2134 ' ' PRO . . . . . 0.497 ' O ' ' HD2' ' A' 2138 ' ' LYS . 3.8 Cg_endo -69.27 3.25 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.499 2.132 . . . . 0.0 111.17 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2135 ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' 2162 ' ' ASN . 0.6 OUTLIER -127.08 -6.08 6.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.638 -1.289 . . . . 0.0 110.3 -179.551 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 2136 ' ' VAL . . . . . 0.929 HG23 ' HB2' ' A' 2133 ' ' GLU . 2.4 t -102.31 -143.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.866 -1.146 . . . . 0.0 108.117 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2137 ' ' CYS . . . . . 0.567 ' CB ' ' HB2' ' A' 2131 ' ' CYS . 2.6 t -49.97 128.94 19.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.548 -1.345 . . . . 0.0 108.336 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2138 ' ' LYS . . . . . 0.516 ' O ' ' CB ' ' A' 2139 ' ' HIS . 2.9 mtpt -135.4 28.8 3.34 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.119 -0.988 . . . . 0.0 110.353 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2139 ' ' HIS . . . . . 0.516 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.1 OUTLIER 162.21 45.43 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.311 -0.868 . . . . 0.0 109.698 179.582 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -153.92 179.76 29.91 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -88.8 82.62 6.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -1.135 . . . . 0.0 109.171 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2142 ' ' CYS . . . . . 0.525 ' C ' HD13 ' A' 2143 ' ' ILE . 21.4 p -78.67 147.63 33.46 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.366 -0.834 . . . . 0.0 110.032 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2143 ' ' ILE . . . . . 0.525 HD13 ' C ' ' A' 2142 ' ' CYS . 5.0 mm -113.37 129.03 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2144 ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' 2129 ' ' ASP . 4.0 t-20 -84.16 103.47 13.4 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 110.545 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2145 ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' 2146 ' ' ASP . 4.1 p -94.45 -167.19 1.61 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2146 ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' 2145 ' ' THR . 0.4 OUTLIER -45.78 -93.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 109.342 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -108.12 -7.6 30.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2148 ' ' SER . . . . . 0.438 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.2 OUTLIER -100.24 -162.61 0.96 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -1.129 . . . . 0.0 109.471 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 2149 ' ' TYR . . . . . 0.598 ' CD2' ' HB3' ' A' 2130 ' ' GLU . 29.6 p90 -164.85 -171.12 2.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.193 -0.942 . . . . 0.0 109.577 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2150 ' ' ARG . . . . . 0.531 ' CG ' ' O ' ' A' 2149 ' ' TYR . 18.0 mtt180 -160.55 104.5 1.41 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.465 -0.772 . . . . 0.0 109.412 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 41.9 t -86.68 78.82 9.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.351 -0.843 . . . . 0.0 109.482 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.86 98.12 11.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.921 . . . . 0.0 109.209 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2153 ' ' CYS . . . . . 0.546 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -58.08 157.46 16.29 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.335 -0.853 . . . . 0.0 109.748 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 2154 ' ' PRO . . . . . 0.499 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.2 Cg_endo -65.22 -166.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.703 2.269 . . . . 0.0 111.278 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 8.4 t80 -90.43 102.34 15.08 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.82 -15.4 5.42 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 107.742 -2.143 . . . . 0.0 107.742 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2157 ' ' TYR . . . . . 0.546 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 9.0 m-85 -109.3 -171.19 1.79 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.647 -0.913 . . . . 0.0 109.724 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2158 ' ' ILE . . . . . 0.741 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -157.34 -161.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.641 -0.662 . . . . 0.0 109.597 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 2159 ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' 2159 ' ' LEU . 15.5 tp -134.35 120.72 20.23 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.326 -0.859 . . . . 0.0 109.67 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -97.1 57.47 1.47 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.2 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2161 ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 86.94 -14.0 57.96 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2162 ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' 2135 ' ' ASP . 1.6 m-20 165.44 -41.81 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.253 -1.145 . . . . 0.0 109.683 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -73.63 118.38 16.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.372 -0.83 . . . . 0.0 109.223 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2164 ' ' CYS . . . . . 0.776 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -85.24 138.78 32.12 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.26 -0.9 . . . . 0.0 109.642 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 2165 ' ' VAL . . . . . 0.776 HG13 ' O ' ' A' 2164 ' ' CYS . 1.6 m -164.63 -170.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 0.0 109.07 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2166 ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' 2184 ' ' VAL . 3.0 t70 -89.74 147.66 23.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.991 -1.068 . . . . 0.0 109.465 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2167 ' ' THR . . . . . 0.602 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 6.8 t -89.72 -173.72 4.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.363 -0.836 . . . . 0.0 109.111 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2168 ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' 2171 ' ' SER . 44.5 t0 -98.94 97.02 8.24 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.266 -0.896 . . . . 0.0 108.649 178.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2169 ' ' GLU . . . . . 0.577 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.6 OUTLIER -72.58 -31.18 65.03 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.185 -0.947 . . . . 0.0 109.443 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 2170 ' ' CYS . . . . . 0.522 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 3.3 t -70.59 -4.7 24.49 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.301 -0.874 . . . . 0.0 108.894 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2171 ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.1 OUTLIER -65.62 -8.52 20.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.831 -1.168 . . . . 0.0 109.413 179.572 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 24.9 t -83.11 -71.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.156 -0.965 . . . . 0.0 109.571 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2173 ' ' GLY . . . . . 0.459 ' O ' ' SG ' ' A' 2181 ' ' CYS . . . -172.72 -70.21 0.05 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2174 ' ' ASN . . . . . 0.549 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 27.5 p-10 -171.47 95.58 0.41 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.221 -1.164 . . . . 0.0 109.021 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2175 ' ' PRO . . . . . 0.611 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.5 Cg_endo -63.98 -19.75 66.96 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.915 1.743 . . . . 0.0 110.253 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2176 ' ' CYS . . . . . 0.523 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -56.04 -58.69 6.86 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.052 -1.03 . . . . 0.0 108.239 179.697 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 148.1 -18.21 1.37 Allowed Glycine 0 N--CA 1.483 1.826 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2178 ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.2 OUTLIER -169.48 -32.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -1.131 . . . . 0.0 110.297 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 2179 ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -61.18 -115.6 0.01 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2180 ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' 2190 ' ' CYS . 1.1 p -151.3 152.51 33.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -1.07 . . . . 0.0 109.486 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2181 ' ' CYS . . . . . 0.59 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 20.7 p -87.83 164.29 15.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.974 -1.079 . . . . 0.0 110.896 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2182 ' ' LYS . . . . . 0.598 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.0 OUTLIER -145.16 158.97 43.68 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.467 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 2183 ' ' ASN . . . . . 0.471 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 57.2 t30 -99.72 129.9 45.88 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.446 -1.408 . . . . 0.0 109.735 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2184 ' ' VAL . . . . . 0.793 HG12 ' N ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -140.08 -170.3 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 2185 ' ' ILE . . . . . 0.544 ' N ' HG13 ' A' 2184 ' ' VAL . 4.6 mp -101.6 136.78 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.96 -1.087 . . . . 0.0 110.448 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 76.33 -2.23 57.97 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2187 ' ' GLY . . . . . 0.533 ' C ' ' CD1' ' A' 2188 ' ' PHE . . . 178.27 -113.67 0.42 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2188 ' ' PHE . . . . . 0.793 ' N ' HG12 ' A' 2184 ' ' VAL . 3.0 p90 -176.19 176.42 1.71 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.384 -1.068 . . . . 0.0 108.876 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2189 ' ' GLU . . . . . 0.598 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 8.1 tt0 -124.26 133.67 53.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.125 -0.984 . . . . 0.0 108.685 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2190 ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' 2180 ' ' THR . 20.7 p -128.16 136.99 51.88 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.906 -1.121 . . . . 0.0 109.869 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2191 ' ' THR . . . . . 0.491 ' O ' ' HA3' ' A' 2179 ' ' GLY . 17.9 m -109.86 87.95 2.63 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.38 -0.825 . . . . 0.0 109.243 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2192 ' ' CYS . . . . . 0.622 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 1.2 m -48.91 -179.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.414 -0.804 . . . . 0.0 109.167 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2193 ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' 2194 ' ' GLU . 20.5 tt0 -56.26 122.35 11.6 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2194 ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -36.7 130.17 0.76 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.616 -0.678 . . . . 0.0 110.585 -178.886 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.31 0.02 10.44 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2196 ' ' PHE . . . . . 0.683 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.2 p90 -112.1 -162.47 0.8 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.277 -1.131 . . . . 0.0 110.015 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2197 ' ' GLU . . . . . 0.551 ' N ' ' CG ' ' A' 2196 ' ' PHE . 9.3 mt-10 -145.96 94.33 5.01 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.429 -0.795 . . . . 0.0 109.872 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2198 ' ' PRO . . . . . 0.683 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 7.9 Cg_endo -67.65 -158.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.444 2.096 . . . . 0.0 111.355 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -146.44 -167.4 12.78 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.13 -79.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.874 1.716 . . . . 0.0 110.634 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 2201 ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' 2188 ' ' PHE . 5.0 ptp -136.93 62.31 1.6 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.823 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -127.69 -86.1 0.58 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.236 -0.915 . . . . 0.0 109.933 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2203 ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' 2175 ' ' PRO . 15.1 t -175.7 -170.42 0.4 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.387 -0.821 . . . . 0.0 108.961 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2204 ' ' CYS . . . . . 0.54 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.7 OUTLIER -61.66 135.98 57.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.011 -1.055 . . . . 0.0 108.972 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A 2205 ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' 2197 ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.579 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -160.64 -86.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.933 . . . . 0.0 109.409 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 1.1 t -77.63 155.65 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.391 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2127 ' ' ASP . . . . . . . . . . . . . 39.8 t0 -87.84 54.55 3.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 109.516 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2128 ' ' MET . . . . . 0.419 ' O ' ' HG3' ' A' 2130 ' ' GLU . 2.9 mtt -53.54 147.21 11.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.559 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2129 ' ' ASP . . . . . 0.537 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 19.3 t0 -61.64 -44.41 97.02 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2130 ' ' GLU . . . . . 0.737 ' O ' HG21 ' A' 2136 ' ' VAL . 1.3 mt-10 80.3 -43.96 0.25 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.925 -0.484 . . . . 0.0 111.066 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2131 ' ' CYS . . . . . 0.512 ' O ' ' HB2' ' A' 2137 ' ' CYS . 10.4 p -91.0 -42.19 10.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.66 -1.275 . . . . 0.0 110.111 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2132 ' ' LYS . . . . . 0.507 ' N ' ' SG ' ' A' 2131 ' ' CYS . 0.0 OUTLIER -67.27 -2.4 5.91 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.993 -1.067 . . . . 0.0 110.52 -179.571 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -68.75 153.56 95.76 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 120.963 -1.086 . . . . 0.0 109.459 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2134 ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -65.52 -3.81 8.43 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.533 2.155 . . . . 0.0 111.101 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2135 ' ' ASP . . . . . 0.848 ' OD1' HG23 ' A' 2136 ' ' VAL . 53.6 p-10 -119.26 3.13 11.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.861 -1.15 . . . . 0.0 110.346 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2136 ' ' VAL . . . . . 0.848 HG23 ' OD1' ' A' 2135 ' ' ASP . 19.1 t -121.82 -119.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.827 -1.171 . . . . 0.0 109.785 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2137 ' ' CYS . . . . . 0.514 ' N ' HG12 ' A' 2136 ' ' VAL . 0.1 OUTLIER -50.78 -56.19 13.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.624 -1.298 . . . . 0.0 109.488 -179.609 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 2138 ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' 2137 ' ' CYS . 3.8 mttt 72.64 -81.91 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.4 -0.813 . . . . 0.0 109.866 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2139 ' ' HIS . . . . . 0.515 ' O ' ' HB3' ' A' 2164 ' ' CYS . 21.2 m80 -115.27 58.87 0.71 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.052 -1.03 . . . . 0.0 110.186 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -141.7 -166.74 10.97 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.04 93.75 3.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -1.153 . . . . 0.0 109.037 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2142 ' ' CYS . . . . . 0.878 ' C ' HD12 ' A' 2143 ' ' ILE . 12.8 p -91.52 -152.25 0.29 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.235 -0.916 . . . . 0.0 110.491 -179.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2143 ' ' ILE . . . . . 0.878 HD12 ' C ' ' A' 2142 ' ' CYS . 2.9 mp -148.46 90.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2144 ' ' ASN . . . . . 0.537 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 30.2 t-20 -39.33 108.5 0.09 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.404 0.621 . . . . 0.0 110.826 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2145 ' ' THR . . . . . 0.416 ' OG1' ' C ' ' A' 2148 ' ' SER . 0.1 OUTLIER -98.67 170.35 8.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.401 -0.812 . . . . 0.0 108.994 179.302 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.92 -84.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.797 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -107.08 50.83 0.77 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2148 ' ' SER . . . . . 0.466 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER -178.06 -162.68 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -1.153 . . . . 0.0 109.714 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 2149 ' ' TYR . . . . . 0.642 ' CE2' HG11 ' A' 2136 ' ' VAL . 42.0 p90 -169.77 -169.49 0.9 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.454 -0.779 . . . . 0.0 109.737 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2150 ' ' ARG . . . . . 0.456 ' C ' ' HB2' ' A' 2142 ' ' CYS . 0.4 OUTLIER -144.18 -160.78 1.17 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 2151 ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' 2150 ' ' ARG . 1.2 m -169.77 69.9 0.06 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.072 -1.017 . . . . 0.0 109.66 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -89.89 137.71 32.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.408 -0.807 . . . . 0.0 109.151 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2153 ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -112.07 158.54 36.61 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.192 -0.943 . . . . 0.0 109.501 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 2154 ' ' PRO . . . . . 0.485 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 2.7 Cg_endo -61.61 -176.03 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.68 2.253 . . . . 0.0 111.817 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 12.7 t80 -82.29 103.15 11.67 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.54 -19.03 5.11 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 107.119 -2.393 . . . . 0.0 107.119 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2157 ' ' TYR . . . . . 0.525 ' C ' HG23 ' A' 2158 ' ' ILE . 18.2 m-85 -108.2 176.42 5.13 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.824 -0.81 . . . . 0.0 109.601 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2158 ' ' ILE . . . . . 0.737 HD13 ' N ' ' A' 2158 ' ' ILE . 0.1 OUTLIER -158.08 -163.74 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.658 -0.651 . . . . 0.0 109.403 -179.764 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 2159 ' ' LEU . . . . . 0.449 HD11 ' O ' ' A' 2162 ' ' ASN . 19.4 tp -131.34 122.78 26.97 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.435 -0.79 . . . . 0.0 109.481 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -93.47 43.01 1.11 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.299 -0.875 . . . . 0.0 109.129 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2161 ' ' GLY . . . . . 0.451 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 97.42 -8.94 64.63 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2162 ' ' ASN . . . . . 0.532 ' ND2' ' HA ' ' A' 2136 ' ' VAL . 1.3 m-20 167.93 -43.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -1.167 . . . . 0.0 109.635 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -79.42 118.83 21.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 109.376 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2164 ' ' CYS . . . . . 0.816 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -88.53 137.77 32.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.418 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 2165 ' ' VAL . . . . . 0.816 HG13 ' O ' ' A' 2164 ' ' CYS . 1.8 m -166.43 -166.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.374 -0.829 . . . . 0.0 108.92 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2166 ' ' ASP . . . . . 0.425 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 0.7 OUTLIER -83.82 139.18 32.84 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.733 -1.23 . . . . 0.0 109.453 179.83 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 2167 ' ' THR . . . . . 0.636 ' HB ' HD12 ' A' 2158 ' ' ILE . 9.9 t -97.44 178.31 5.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.354 -0.841 . . . . 0.0 109.362 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2168 ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' 2171 ' ' SER . 51.3 t0 -88.55 96.04 10.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.164 -0.96 . . . . 0.0 109.024 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2169 ' ' GLU . . . . . 0.59 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.4 OUTLIER -66.67 -34.14 77.21 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.296 -0.877 . . . . 0.0 109.228 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 2170 ' ' CYS . . . . . 0.459 ' O ' ' SG ' ' A' 2170 ' ' CYS . 1.7 t -68.67 -9.08 48.0 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.327 -0.858 . . . . 0.0 108.753 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2171 ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -78.32 5.84 9.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.372 -0.83 . . . . 0.0 110.574 -179.176 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 5.6 t -112.3 -76.93 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.903 -1.123 . . . . 0.0 109.87 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2173 ' ' GLY . . . . . 0.469 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -150.7 137.53 6.15 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2174 ' ' ASN . . . . . 0.629 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 23.2 p-10 -47.03 104.51 0.41 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.312 -1.111 . . . . 0.0 109.969 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2175 ' ' PRO . . . . . 0.583 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 1.7 Cg_endo -70.42 -23.55 27.66 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.879 1.719 . . . . 0.0 109.763 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2176 ' ' CYS . . . . . 0.554 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -47.33 -30.97 3.52 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.395 -0.815 . . . . 0.0 109.492 -179.585 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 114.49 -23.47 12.21 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.3 -34.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.606 -0.937 . . . . 0.0 109.791 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2179 ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -62.47 -127.81 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.3 p -134.64 156.76 48.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.601 -0.941 . . . . 0.0 109.549 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2181 ' ' CYS . . . . . 0.629 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 14.6 p -94.12 163.06 13.62 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.199 1.0 . . . . 0.0 111.258 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2182 ' ' LYS . . . . . 0.586 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 5.9 tttp -143.06 156.9 44.92 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2183 ' ' ASN . . . . . 0.408 ' N ' ' HG3' ' A' 2182 ' ' LYS . 60.9 t30 -99.31 133.09 44.12 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.3 -1.5 . . . . 0.0 109.967 -179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2184 ' ' VAL . . . . . 0.81 HG12 ' N ' ' A' 2188 ' ' PHE . 0.4 OUTLIER -140.37 -176.77 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.635 -0.666 . . . . 0.0 109.227 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 2185 ' ' ILE . . . . . 0.457 ' N ' HG13 ' A' 2184 ' ' VAL . 1.9 mp -95.8 143.51 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.117 -0.989 . . . . 0.0 110.131 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 65.07 12.33 54.59 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2187 ' ' GLY . . . . . 0.627 ' C ' HG12 ' A' 2184 ' ' VAL . . . 165.12 -129.25 1.92 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2188 ' ' PHE . . . . . 0.81 ' N ' HG12 ' A' 2184 ' ' VAL . 1.4 p90 -164.11 -179.32 6.1 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.3 -1.118 . . . . 0.0 108.81 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2189 ' ' GLU . . . . . 0.586 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.2 OUTLIER -125.48 174.2 8.38 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.39 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 1.8 p -171.61 147.71 2.36 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.769 -1.207 . . . . 0.0 109.81 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2191 ' ' THR . . . . . 0.474 ' O ' ' O ' ' A' 2192 ' ' CYS . 13.6 m -123.06 89.9 3.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.0 109.898 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2192 ' ' CYS . . . . . 0.614 ' HA ' ' HA3' ' A' 2179 ' ' GLY . 0.8 OUTLIER -48.91 -179.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.341 -0.85 . . . . 0.0 109.32 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 2193 ' ' GLU . . . . . 0.462 ' O ' ' C ' ' A' 2194 ' ' GLU . 3.3 tt0 -61.12 125.43 23.7 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2194 ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -34.86 129.76 0.43 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.344 0.592 . . . . 0.0 110.842 -179.244 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.21 5.39 8.77 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2196 ' ' PHE . . . . . 0.672 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.9 OUTLIER -121.5 -163.5 1.05 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.289 -1.124 . . . . 0.0 110.195 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 2197 ' ' GLU . . . . . 0.584 ' N ' ' CG ' ' A' 2196 ' ' PHE . 24.4 mt-10 -148.15 98.07 3.8 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.619 -0.675 . . . . 0.0 109.428 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2198 ' ' PRO . . . . . 0.672 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.8 Cg_endo -69.01 -166.31 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.339 2.026 . . . . 0.0 111.597 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -135.84 -170.35 12.04 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.17 -83.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.21 1.94 . . . . 0.0 110.994 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2201 ' ' MET . . . . . 0.64 ' HG2' HG11 ' A' 2184 ' ' VAL . 8.4 mtt -132.77 52.22 2.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.991 -1.068 . . . . 0.0 109.975 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2202 ' ' MET . . . . . 0.451 ' O ' ' HB ' ' A' 2203 ' ' THR . 1.0 OUTLIER -122.98 -71.23 0.73 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.21 -0.931 . . . . 0.0 109.791 -179.775 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 2203 ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' 2202 ' ' MET . 11.7 t 179.33 -167.82 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.458 -0.776 . . . . 0.0 109.048 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A 2204 ' ' CYS . . . . . 0.554 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -111.52 150.17 30.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.095 -1.003 . . . . 0.0 109.215 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 117.896 -1.049 . . . . 0.0 109.572 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -176.08 50.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 109.401 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.43 159.88 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.38 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2127 ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' 2128 ' ' MET . 9.6 t70 -85.51 97.51 10.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.281 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2128 ' ' MET . . . . . 0.467 ' O ' ' HG3' ' A' 2130 ' ' GLU . 0.3 OUTLIER -41.37 120.07 1.34 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.458 -0.776 . . . . 0.0 109.587 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 2129 ' ' ASP . . . . . 0.59 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 1.3 p30 -65.78 -39.08 90.62 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2130 ' ' GLU . . . . . 0.794 ' O ' HG21 ' A' 2136 ' ' VAL . 1.4 mt-10 80.44 -42.86 0.22 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 122.015 -0.428 . . . . 0.0 111.292 177.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2131 ' ' CYS . . . . . 0.599 ' HA ' HG11 ' A' 2136 ' ' VAL . 17.5 p -90.82 27.16 1.86 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.922 -1.111 . . . . 0.0 110.204 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2132 ' ' LYS . . . . . 0.525 ' N ' ' OD1' ' A' 2129 ' ' ASP . 0.6 OUTLIER -131.94 -6.25 3.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.91 . . . . 0.0 109.728 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 2133 ' ' GLU . . . . . 0.468 ' HB3' ' HD2' ' A' 2134 ' ' PRO . 5.8 mt-10 -70.03 158.74 86.62 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.141 -0.974 . . . . 0.0 109.323 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2134 ' ' PRO . . . . . 0.507 ' O ' ' HD2' ' A' 2138 ' ' LYS . 2.8 Cg_endo -67.27 -1.53 6.54 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.379 2.053 . . . . 0.0 110.804 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.07 4.65 9.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.8 -1.188 . . . . 0.0 110.088 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2136 ' ' VAL . . . . . 0.794 HG21 ' O ' ' A' 2130 ' ' GLU . 55.0 t -107.46 -107.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.869 -1.145 . . . . 0.0 110.116 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2137 ' ' CYS . . . . . 0.531 ' N ' HG12 ' A' 2136 ' ' VAL . 1.3 m -56.21 -77.39 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.796 -1.19 . . . . 0.0 109.599 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2138 ' ' LYS . . . . . 0.58 ' O ' ' CG ' ' A' 2139 ' ' HIS . 0.1 OUTLIER 68.7 3.05 3.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.584 -0.698 . . . . 0.0 111.12 179.188 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 2139 ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' 2138 ' ' LYS . 0.8 OUTLIER 168.64 40.43 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.701 -1.249 . . . . 0.0 110.835 178.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -158.21 160.65 31.03 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.116 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -89.51 124.22 34.32 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2142 ' ' CYS . . . . . 0.883 ' C ' HD12 ' A' 2143 ' ' ILE . 22.8 p -111.86 -166.85 1.11 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.131 -0.98 . . . . 0.0 111.237 -178.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2143 ' ' ILE . . . . . 0.883 HD12 ' C ' ' A' 2142 ' ' CYS . 4.2 mp -150.24 98.1 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2144 ' ' ASN . . . . . 0.59 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 26.6 t-20 -46.86 114.54 0.86 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.452 -0.78 . . . . 0.0 111.254 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2145 ' ' THR . . . . . 0.48 ' OG1' ' HA ' ' A' 2149 ' ' TYR . 0.1 OUTLIER -108.54 175.55 5.43 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.236 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.25 105.64 9.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.349 -0.844 . . . . 0.0 110.055 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 73.01 8.77 74.69 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2148 ' ' SER . . . . . 0.488 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.5 OUTLIER -152.68 -173.6 4.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.977 -1.308 . . . . 0.0 109.951 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 2149 ' ' TYR . . . . . 0.636 ' CD2' ' CB ' ' A' 2130 ' ' GLU . 50.7 p90 -165.66 -168.4 1.31 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.522 -0.736 . . . . 0.0 109.168 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2150 ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' 2142 ' ' CYS . 0.4 OUTLIER -168.93 124.98 0.92 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.324 -0.86 . . . . 0.0 108.914 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 2.1 t -105.49 107.2 18.07 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.149 -0.969 . . . . 0.0 110.278 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.77 134.15 42.08 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2153 ' ' CYS . . . . . 0.508 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -97.54 161.07 27.15 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.071 -1.018 . . . . 0.0 109.955 -179.149 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 2154 ' ' PRO . . . . . 0.5 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.8 Cg_endo -61.43 -169.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 122.812 2.342 . . . . 0.0 111.812 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 3.4 t80 -86.12 99.86 11.79 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.09 -13.17 5.77 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2157 ' ' TYR . . . . . 0.536 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 5.1 m-85 -107.16 -173.5 2.31 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.503 -0.998 . . . . 0.0 110.205 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2158 ' ' ILE . . . . . 0.707 HD13 ' N ' ' A' 2158 ' ' ILE . 0.1 OUTLIER -159.36 -166.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 2159 ' ' LEU . . . . . 0.636 HD11 ' O ' ' A' 2162 ' ' ASN . 31.4 tp -133.67 119.64 19.62 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.333 -0.854 . . . . 0.0 109.236 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -89.89 55.83 3.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 109.664 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2161 ' ' GLY . . . . . 0.505 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 80.08 -2.31 76.23 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2162 ' ' ASN . . . . . 0.636 ' O ' HD11 ' A' 2159 ' ' LEU . 2.5 m-20 166.51 -58.48 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.1 -1.236 . . . . 0.0 109.69 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -69.66 115.5 8.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.873 . . . . 0.0 109.49 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2164 ' ' CYS . . . . . 0.83 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -86.2 140.32 30.26 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.307 -0.871 . . . . 0.0 109.273 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 2165 ' ' VAL . . . . . 0.83 HG13 ' O ' ' A' 2164 ' ' CYS . 1.0 OUTLIER -166.35 -166.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.483 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 2166 ' ' ASP . . . . . 0.49 ' OD1' ' CE1' ' A' 2157 ' ' TYR . 0.7 OUTLIER -89.93 142.04 28.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.949 -1.095 . . . . 0.0 109.606 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 2167 ' ' THR . . . . . 0.693 HG23 ' OE1' ' A' 2169 ' ' GLU . 12.8 t -81.67 175.75 10.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 0.0 108.972 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2168 ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' 2171 ' ' SER . 56.6 t0 -95.38 94.59 7.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.102 -0.999 . . . . 0.0 109.248 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2169 ' ' GLU . . . . . 0.693 ' OE1' HG23 ' A' 2167 ' ' THR . 0.8 OUTLIER -69.28 -33.82 73.79 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.407 -0.808 . . . . 0.0 109.363 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 2170 ' ' CYS . . . . . 0.527 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 2.3 t -69.62 -6.01 28.46 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.373 -0.83 . . . . 0.0 109.044 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2171 ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -79.59 7.59 8.03 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.992 -1.067 . . . . 0.0 109.941 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 24.1 t -112.87 -79.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.031 -1.043 . . . . 0.0 110.008 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2173 ' ' GLY . . . . . 0.473 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -152.45 139.74 7.22 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2174 ' ' ASN . . . . . 0.593 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 29.9 p-10 -45.9 104.19 0.39 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.51 -0.994 . . . . 0.0 110.249 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2175 ' ' PRO . . . . . 0.577 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 3.1 Cg_endo -67.29 -18.37 50.23 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.977 1.785 . . . . 0.0 110.324 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2176 ' ' CYS . . . . . 0.569 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -61.1 -10.52 6.36 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.111 -0.993 . . . . 0.0 110.185 -179.519 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 96.35 -31.47 7.4 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.272 -1.442 . . . . 0.0 109.58 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2178 ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.1 OUTLIER -158.26 -37.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -1.098 . . . . 0.0 109.962 -179.647 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 2179 ' ' GLY . . . . . 0.609 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -57.41 -113.25 0.01 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2180 ' ' THR . . . . . 0.436 HG23 ' O ' ' A' 2179 ' ' GLY . 1.4 p -154.23 168.71 25.65 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.411 -1.052 . . . . 0.0 109.305 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2181 ' ' CYS . . . . . 0.593 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 24.6 p -101.66 163.5 12.23 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.066 0.936 . . . . 0.0 111.414 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2182 ' ' LYS . . . . . 0.569 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.2 OUTLIER -144.68 158.34 43.82 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 178.542 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 58.2 t30 -100.35 128.67 46.36 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.555 -1.341 . . . . 0.0 108.957 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2184 ' ' VAL . . . . . 0.864 HG12 ' CA ' ' A' 2188 ' ' PHE . 0.9 OUTLIER -137.24 -166.53 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.632 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 2185 ' ' ILE . . . . . 0.638 ' H ' HG22 ' A' 2184 ' ' VAL . 4.7 mp -101.08 140.53 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 110.176 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 71.02 4.16 54.47 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2187 ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 167.23 -116.13 0.66 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2188 ' ' PHE . . . . . 0.864 ' CA ' HG12 ' A' 2184 ' ' VAL . 2.4 p90 -166.85 -177.76 3.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.052 -1.263 . . . . 0.0 110.083 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2189 ' ' GLU . . . . . 0.569 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 7.5 tt0 -129.84 139.45 51.2 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2190 ' ' CYS . . . . . 0.44 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 13.7 p -128.48 144.06 51.08 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.606 -1.309 . . . . 0.0 110.179 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2191 ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' 2192 ' ' CYS . 73.3 m -111.17 84.23 1.9 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.86 . . . . 0.0 109.701 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2192 ' ' CYS . . . . . 0.611 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.8 OUTLIER -49.93 179.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 109.047 179.763 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 2193 ' ' GLU . . . . . 0.493 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.3 OUTLIER -54.83 115.76 2.36 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.788 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 2194 ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.3 OUTLIER -30.17 126.8 0.14 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.375 0.607 . . . . 0.0 111.072 -179.033 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.37 5.58 8.55 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2196 ' ' PHE . . . . . 0.671 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.8 OUTLIER -117.51 -164.17 0.98 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.212 -1.169 . . . . 0.0 110.283 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A 2197 ' ' GLU . . . . . 0.557 ' N ' ' CG ' ' A' 2196 ' ' PHE . 2.1 mm-40 -145.48 98.21 4.61 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2198 ' ' PRO . . . . . 0.671 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.1 Cg_endo -68.08 -160.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.066 1.844 . . . . 0.0 110.726 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -135.52 -170.33 12.07 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.63 -74.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 121.96 1.773 . . . . 0.0 110.711 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2201 ' ' MET . . . . . 0.489 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 4.5 ptt? -146.22 60.51 1.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.15 -0.969 . . . . 0.0 110.118 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2202 ' ' MET . . . . . 0.452 ' O ' ' HB ' ' A' 2203 ' ' THR . 1.9 mmt -129.55 -68.97 0.7 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.102 -0.999 . . . . 0.0 109.75 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2203 ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' 2202 ' ' MET . 10.7 t 179.02 -168.74 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.414 -0.804 . . . . 0.0 109.138 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2204 ' ' CYS . . . . . 0.569 ' HB2' ' O ' ' A' 2176 ' ' CYS . 4.4 t -74.25 143.79 44.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.002 -1.061 . . . . 0.0 109.685 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.352 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 2124 ' ' SER . . . . . 0.634 ' O ' ' HB3' ' A' 2125 ' ' ALA . 18.6 m . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.298 0.57 . . . . 0.0 109.559 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2125 ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' 2124 ' ' SER . . . 71.11 89.35 0.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.394 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 49.7 t -97.42 84.87 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.527 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2127 ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' 2128 ' ' MET . 0.9 OUTLIER -95.67 88.62 5.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.276 -0.89 . . . . 0.0 109.75 -179.864 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2128 ' ' MET . . . . . 0.43 ' O ' ' O ' ' A' 2127 ' ' ASP . 0.1 OUTLIER 62.34 130.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.635 179.719 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2129 ' ' ASP . . . . . 0.657 ' O ' ' HB2' ' A' 2130 ' ' GLU . 0.7 OUTLIER -68.16 -20.15 64.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 109.444 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2130 ' ' GLU . . . . . 0.657 ' HB2' ' O ' ' A' 2129 ' ' ASP . 1.9 mt-10 76.57 -69.48 0.16 Allowed 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.032 0.444 . . . . 0.0 110.457 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2131 ' ' CYS . . . . . 0.458 ' O ' ' SG ' ' A' 2131 ' ' CYS . 47.5 t -78.69 8.22 5.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.998 -1.064 . . . . 0.0 110.199 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2132 ' ' LYS . . . . . 0.514 ' HB3' ' HB3' ' A' 2129 ' ' ASP . 0.0 OUTLIER -109.89 40.37 1.93 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.952 -1.093 . . . . 0.0 110.096 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2133 ' ' GLU . . . . . 0.891 ' HB2' HG23 ' A' 2136 ' ' VAL . 2.0 mt-10 -129.69 140.62 39.17 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.09 -1.006 . . . . 0.0 109.509 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2134 ' ' PRO . . . . . 0.521 ' O ' ' CD ' ' A' 2138 ' ' LYS . 3.3 Cg_endo -68.83 -3.96 12.39 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.065 1.843 . . . . 0.0 109.964 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2135 ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' 2162 ' ' ASN . 5.7 p-10 -107.23 0.12 23.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.11 -0.993 . . . . 0.0 110.03 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2136 ' ' VAL . . . . . 0.957 HG12 ' SG ' ' A' 2151 ' ' CYS . 11.1 t -97.63 -121.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.062 -1.024 . . . . 0.0 108.641 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2137 ' ' CYS . . . . . 0.499 ' N ' ' SG ' ' A' 2151 ' ' CYS . 8.7 m -56.61 -68.6 0.2 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.579 -1.326 . . . . 0.0 109.297 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2138 ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' 2134 ' ' PRO . 1.9 mtmt 70.32 21.13 5.88 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.04 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2139 ' ' HIS . . . . . 0.478 ' CB ' ' O ' ' A' 2164 ' ' CYS . 0.0 OUTLIER 169.8 -42.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.485 -0.759 . . . . 0.0 109.323 179.591 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -86.31 175.06 47.62 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -93.52 123.54 36.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.148 -1.207 . . . . 0.0 109.539 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2142 ' ' CYS . . . . . 0.774 ' C ' HD12 ' A' 2143 ' ' ILE . 0.1 OUTLIER -112.72 178.82 4.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.558 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2143 ' ' ILE . . . . . 0.774 HD12 ' C ' ' A' 2142 ' ' CYS . 4.6 mp -142.51 129.27 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2144 ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' 2129 ' ' ASP . 0.7 OUTLIER -71.88 118.23 14.46 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.097 -1.002 . . . . 0.0 110.037 -179.142 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2145 ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' 2148 ' ' SER . 40.4 p -117.69 -161.04 0.8 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.225 -0.922 . . . . 0.0 108.682 178.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.23 102.86 12.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.082 -1.011 . . . . 0.0 110.279 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 59.31 27.84 63.62 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2148 ' ' SER . . . . . 0.468 ' O ' ' OG1' ' A' 2145 ' ' THR . 0.4 OUTLIER -166.45 179.14 5.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.059 -1.259 . . . . 0.0 109.773 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2149 ' ' TYR . . . . . 0.527 ' HB3' ' HB3' ' A' 2130 ' ' GLU . 0.6 OUTLIER -139.85 -169.8 2.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.321 -0.862 . . . . 0.0 109.577 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2150 ' ' ARG . . . . . 0.506 ' O ' ' C ' ' A' 2151 ' ' CYS . 9.1 mmt180 -139.07 27.74 2.35 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.3 -0.875 . . . . 0.0 109.34 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2151 ' ' CYS . . . . . 0.957 ' SG ' HG12 ' A' 2136 ' ' VAL . 0.8 OUTLIER -28.99 109.42 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.875 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -130.34 125.92 35.85 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2153 ' ' CYS . . . . . 0.535 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -84.14 155.93 63.59 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 121.167 -0.958 . . . . 0.0 110.339 -178.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2154 ' ' PRO . . . . . 0.483 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.2 Cg_endo -63.44 -168.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.801 2.334 . . . . 0.0 111.794 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -88.01 102.31 14.63 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.54 -15.85 5.45 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 107.75 -2.14 . . . . 0.0 107.75 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2157 ' ' TYR . . . . . 0.535 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 6.5 m-85 -107.13 -174.81 2.62 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 121.655 -0.909 . . . . 0.0 109.828 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2158 ' ' ILE . . . . . 0.849 ' H ' HD13 ' A' 2158 ' ' ILE . 0.2 OUTLIER -146.03 -155.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.447 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2159 ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' 2163 ' ' GLU . 25.9 tp -148.84 127.0 12.07 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.376 -0.828 . . . . 0.0 109.281 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -102.27 62.05 0.86 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.376 -0.828 . . . . 0.0 109.293 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 86.96 -43.96 3.28 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2162 ' ' ASN . . . . . 0.494 ' HB3' ' O ' ' A' 2135 ' ' ASP . 0.7 OUTLIER -158.33 -45.82 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.43 -1.041 . . . . 0.0 109.149 179.753 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2163 ' ' GLU . . . . . 0.741 ' O ' HD12 ' A' 2159 ' ' LEU . 65.5 tt0 -62.64 159.85 15.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.344 -0.848 . . . . 0.0 109.229 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2164 ' ' CYS . . . . . 0.512 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -131.64 137.05 48.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.13 -0.981 . . . . 0.0 109.638 -179.873 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2165 ' ' VAL . . . . . 0.607 HG23 HD11 ' A' 2158 ' ' ILE . 1.2 m -156.1 -170.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.87 . . . . 0.0 109.282 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2166 ' ' ASP . . . . . 0.458 ' OD2' ' O ' ' A' 2184 ' ' VAL . 39.2 t70 -85.8 166.13 16.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.938 -1.101 . . . . 0.0 109.627 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2167 ' ' THR . . . . . 0.847 HG23 ' OE1' ' A' 2169 ' ' GLU . 11.6 t -106.8 167.86 9.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 0.0 109.423 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2168 ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' 2171 ' ' SER . 56.4 t0 -92.99 98.75 11.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.115 -0.991 . . . . 0.0 109.348 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2169 ' ' GLU . . . . . 0.847 ' OE1' HG23 ' A' 2167 ' ' THR . 0.8 OUTLIER -73.64 -32.11 63.86 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.426 -0.796 . . . . 0.0 109.415 -179.782 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2170 ' ' CYS . . . . . 0.526 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.2 t -67.58 -8.1 31.56 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.319 -0.863 . . . . 0.0 108.981 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2171 ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -69.95 -4.59 21.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.168 -0.957 . . . . 0.0 109.537 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 9.3 t -100.55 -74.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.197 -0.939 . . . . 0.0 110.006 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2173 ' ' GLY . . . . . 0.488 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -168.82 141.48 6.78 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2174 ' ' ASN . . . . . 0.621 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 24.6 p-10 -36.61 97.31 0.13 Allowed Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.733 -0.863 . . . . 0.0 110.534 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2175 ' ' PRO . . . . . 0.602 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.8 Cg_endo -66.25 -20.31 55.82 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.982 1.788 . . . . 0.0 110.54 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2176 ' ' CYS . . . . . 0.551 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -51.54 -58.96 4.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.069 -1.019 . . . . 0.0 108.322 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 146.33 -20.82 1.72 Allowed Glycine 0 C--N 1.294 -1.781 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 4.1 t30 -160.53 -35.44 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -1.093 . . . . 0.0 110.127 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2179 ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -63.97 -119.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2180 ' ' THR . . . . . 0.498 ' HA ' ' HB3' ' A' 2174 ' ' ASN . 2.9 p -148.11 161.81 40.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.439 -1.036 . . . . 0.0 109.595 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2181 ' ' CYS . . . . . 0.621 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 27.0 p -93.64 160.8 14.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 110.906 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2182 ' ' LYS . . . . . 0.54 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 10.4 tttt -146.89 157.28 43.6 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2183 ' ' ASN . . . . . 0.474 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 59.0 t30 -93.4 129.09 39.67 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.453 -1.405 . . . . 0.0 110.13 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2184 ' ' VAL . . . . . 0.864 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -132.81 -168.73 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2185 ' ' ILE . . . . . 0.679 ' N ' HG13 ' A' 2184 ' ' VAL . 3.9 mp -105.56 140.53 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.956 -1.09 . . . . 0.0 110.282 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 64.48 14.36 57.17 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2187 ' ' GLY . . . . . 0.591 ' C ' HG12 ' A' 2184 ' ' VAL . . . 167.94 -117.98 0.76 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2188 ' ' PHE . . . . . 0.864 ' N ' HG12 ' A' 2184 ' ' VAL . 2.0 p90 -172.92 177.1 2.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.173 -1.193 . . . . 0.0 109.609 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2189 ' ' GLU . . . . . 0.54 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.5 OUTLIER -123.28 139.57 53.9 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2190 ' ' CYS . . . . . 0.45 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 22.9 p -135.73 137.33 41.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.765 -1.209 . . . . 0.0 109.721 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2191 ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' 2192 ' ' CYS . 25.3 m -108.79 83.45 1.76 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.412 -0.805 . . . . 0.0 109.478 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2192 ' ' CYS . . . . . 0.619 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -47.42 -179.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.934 0.873 . . . . 0.0 109.672 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2193 ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' 2194 ' ' GLU . 11.3 tp10 -55.89 119.44 5.82 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2194 ' ' GLU . . . . . 0.494 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.5 OUTLIER -33.75 130.91 0.27 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.496 0.665 . . . . 0.0 110.675 -178.904 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.34 -0.67 10.48 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2196 ' ' PHE . . . . . 0.661 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.7 OUTLIER -114.37 -166.7 1.13 Allowed 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.264 -1.139 . . . . 0.0 110.109 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2197 ' ' GLU . . . . . 0.554 ' N ' ' CG ' ' A' 2196 ' ' PHE . 1.7 mm-40 -145.31 98.02 4.68 Favored Pre-proline 0 C--N 1.299 -1.629 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2198 ' ' PRO . . . . . 0.661 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 7.9 Cg_endo -67.77 -161.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.118 1.879 . . . . 0.0 110.876 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -138.1 -170.4 11.86 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.75 -71.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.033 1.822 . . . . 0.0 110.547 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2201 ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.1 OUTLIER -139.18 53.53 1.74 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 110.192 -179.436 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 2.5 mmm -122.3 -93.68 0.51 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.048 -1.033 . . . . 0.0 109.995 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 2203 ' ' THR . . . . . 0.487 ' OG1' ' O ' ' A' 2175 ' ' PRO . 6.0 t -169.42 -163.3 0.39 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.23 -0.919 . . . . 0.0 109.176 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2204 ' ' CYS . . . . . 0.551 ' HB2' ' O ' ' A' 2176 ' ' CYS . 1.9 t -67.82 138.35 56.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.09 -1.006 . . . . 0.0 109.306 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2205 ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' 2205 ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.515 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.245 0.545 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -134.72 156.66 48.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.49 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2126 ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' 2127 ' ' ASP . 7.3 p -143.31 133.07 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.253 -0.905 . . . . 0.0 109.48 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2127 ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' 2126 ' ' VAL . 2.7 p30 -52.87 -173.68 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.374 -0.829 . . . . 0.0 109.587 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.54 117.2 3.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 0.0 109.855 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2129 ' ' ASP . . . . . 0.526 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 22.9 t0 -86.49 92.48 8.88 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.282 -0.886 . . . . 0.0 108.906 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2130 ' ' GLU . . . . . 0.556 ' O ' HG21 ' A' 2136 ' ' VAL . 30.5 mp0 -63.39 -21.6 66.38 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.407 -0.808 . . . . 0.0 110.398 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2131 ' ' CYS . . . . . 0.516 ' HB3' ' HB2' ' A' 2149 ' ' TYR . 5.8 p -88.07 -40.86 13.47 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 120.758 -1.214 . . . . 0.0 109.699 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2132 ' ' LYS . . . . . 0.502 ' N ' ' SG ' ' A' 2131 ' ' CYS . 0.0 OUTLIER -85.51 43.58 1.04 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.206 -0.934 . . . . 0.0 108.921 179.323 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 2133 ' ' GLU . . . . . 0.514 ' CB ' ' HD2' ' A' 2134 ' ' PRO . 4.8 mt-10 -94.39 171.91 6.26 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.331 -0.855 . . . . 0.0 109.537 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2134 ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' 2133 ' ' GLU . 1.3 Cg_endo -63.81 -17.93 61.89 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.51 2.14 . . . . 0.0 112.029 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 4.0 t70 -144.72 32.28 1.16 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.568 -1.332 . . . . 0.0 111.283 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2136 ' ' VAL . . . . . 0.556 HG21 ' O ' ' A' 2130 ' ' GLU . 46.9 t -112.75 -110.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.777 -1.202 . . . . 0.0 109.901 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2137 ' ' CYS . . . . . 0.551 ' N ' HG12 ' A' 2136 ' ' VAL . 64.5 m -74.11 -65.07 0.89 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.766 -1.209 . . . . 0.0 109.486 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2138 ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' 2137 ' ' CYS . 21.6 mttt 62.53 124.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.806 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2139 ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' A' 2164 ' ' CYS . 2.6 m170 44.26 48.58 7.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.83 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -140.11 168.8 24.97 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.46 56.0 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -1.197 . . . . 0.0 108.842 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2142 ' ' CYS . . . . . 0.452 ' HA ' ' O ' ' A' 2150 ' ' ARG . 26.3 p -65.82 174.76 2.22 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.349 -0.845 . . . . 0.0 110.56 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 3.3 mp -135.01 87.56 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2144 ' ' ASN . . . . . 0.526 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 8.4 t-20 -48.28 113.5 0.76 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.642 -0.661 . . . . 0.0 110.864 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2145 ' ' THR . . . . . . . . . . . . . 13.6 p -95.16 -174.65 3.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.405 -0.809 . . . . 0.0 109.021 179.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2146 ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' 2146 ' ' ASP . 2.9 p30 -91.13 41.41 1.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.181 -0.949 . . . . 0.0 109.531 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2147 ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' A' 2148 ' ' SER . . . 145.55 41.01 0.05 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2148 ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' 2147 ' ' GLY . 0.3 OUTLIER 168.34 -163.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -1.191 . . . . 0.0 109.362 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 2149 ' ' TYR . . . . . 0.516 ' HB2' ' HB3' ' A' 2131 ' ' CYS . 43.9 p90 -169.03 -173.25 1.74 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 110.132 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2150 ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' 2142 ' ' CYS . 0.0 OUTLIER -159.43 110.31 2.0 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 58.8 m -86.78 61.99 7.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 109.947 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2152 ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' 2153 ' ' CYS . 0.3 OUTLIER -87.27 80.61 8.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.114 -0.991 . . . . 0.0 108.837 179.396 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 2153 ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -43.16 153.12 0.36 Allowed Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.355 -0.841 . . . . 0.0 109.993 -179.352 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 2154 ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' 2157 ' ' TYR . 1.7 Cg_endo -65.91 -166.67 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.589 2.192 . . . . 0.0 111.258 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 8.1 t80 -90.39 104.41 16.99 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2156 ' ' GLY . . . . . 0.437 ' O ' HG22 ' A' 2167 ' ' THR . . . 130.69 -16.66 5.33 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 107.897 -2.081 . . . . 0.0 107.897 -178.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2157 ' ' TYR . . . . . 0.642 ' OH ' HG23 ' A' 2185 ' ' ILE . 7.6 m-85 -106.12 -166.79 1.23 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.551 -0.97 . . . . 0.0 109.783 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2158 ' ' ILE . . . . . 0.916 HD11 HG23 ' A' 2165 ' ' VAL . 0.2 OUTLIER -155.27 -163.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.534 -0.729 . . . . 0.0 109.468 179.723 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 2159 ' ' LEU . . . . . 0.492 ' N ' HG12 ' A' 2158 ' ' ILE . 30.5 tp -146.86 117.27 7.43 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.408 -0.807 . . . . 0.0 109.685 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -94.95 57.48 2.1 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.577 -0.702 . . . . 0.0 109.461 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2161 ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 87.18 -14.98 56.21 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2162 ' ' ASN . . . . . 0.448 ' O ' ' O ' ' A' 2136 ' ' VAL . 1.1 m-20 168.81 -46.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.405 -1.056 . . . . 0.0 109.092 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -63.77 126.02 26.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 108.685 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2164 ' ' CYS . . . . . 0.592 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -104.32 139.78 38.82 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.912 -1.117 . . . . 0.0 109.953 -179.608 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 2165 ' ' VAL . . . . . 0.916 HG23 HD11 ' A' 2158 ' ' ILE . 3.7 m -158.56 -177.8 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 109.441 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2166 ' ' ASP . . . . . 0.457 ' OD2' ' O ' ' A' 2184 ' ' VAL . 29.1 t70 -74.85 167.27 22.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.642 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2167 ' ' THR . . . . . 0.591 HG23 ' OE1' ' A' 2169 ' ' GLU . 4.9 t -114.26 -177.71 3.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.4 -0.812 . . . . 0.0 109.109 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2168 ' ' ASP . . . . . 0.489 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 51.9 t0 -103.29 100.64 10.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.087 -1.008 . . . . 0.0 109.74 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2169 ' ' GLU . . . . . 0.598 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.7 OUTLIER -77.01 -32.63 57.29 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.385 -0.822 . . . . 0.0 109.143 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 2170 ' ' CYS . . . . . 0.508 ' HB2' ' N ' ' A' 2182 ' ' LYS . 1.7 t -67.23 -10.07 46.85 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.94 -10.62 59.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.34 -0.85 . . . . 0.0 109.72 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 21.9 t -86.35 -71.58 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.544 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2173 ' ' GLY . . . . . . . . . . . . . . . -149.29 -114.95 0.75 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2174 ' ' ASN . . . . . 0.507 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 6.9 t30 -146.67 97.3 4.29 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.39 -1.065 . . . . 0.0 109.49 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2175 ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' A' 2181 ' ' CYS . 1.3 Cg_endo -68.38 -24.63 36.77 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.93 1.754 . . . . 0.0 110.58 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2176 ' ' CYS . . . . . 0.585 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.1 OUTLIER -48.6 -43.86 36.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.122 -0.986 . . . . 0.0 109.391 -179.352 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 2177 ' ' GLY . . . . . 0.5 ' H ' ' ND2' ' A' 2174 ' ' ASN . . . 120.45 -19.24 9.23 Favored Glycine 0 C--N 1.292 -1.861 0 N-CA-C 108.221 -1.952 . . . . 0.0 108.221 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -171.97 -32.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.462 -1.022 . . . . 0.0 110.259 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2179 ' ' GLY . . . . . 0.652 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -69.75 -128.06 0.05 OUTLIER Glycine 0 N--CA 1.491 2.335 0 O-C-N 120.932 -1.105 . . . . 0.0 110.358 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 2.0 p -132.58 153.85 50.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.549 -0.971 . . . . 0.0 109.631 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2181 ' ' CYS . . . . . 0.555 ' HB3' ' HD2' ' A' 2175 ' ' PRO . 25.0 p -92.48 161.85 14.46 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.125 0.964 . . . . 0.0 110.976 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2182 ' ' LYS . . . . . 0.563 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 44.0 tptt -144.2 166.77 24.1 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2183 ' ' ASN . . . . . 0.499 ' N ' ' HG3' ' A' 2182 ' ' LYS . 62.6 t30 -100.94 138.74 37.59 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.616 -1.302 . . . . 0.0 109.676 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2184 ' ' VAL . . . . . 0.849 HG12 ' N ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -144.42 -168.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.484 -0.76 . . . . 0.0 109.246 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 2185 ' ' ILE . . . . . 0.642 HG23 ' OH ' ' A' 2157 ' ' TYR . 2.7 mp -104.64 137.28 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.111 -0.993 . . . . 0.0 110.24 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 69.85 10.36 64.38 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2187 ' ' GLY . . . . . 0.57 ' C ' HG12 ' A' 2184 ' ' VAL . . . 168.99 -116.7 0.68 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2188 ' ' PHE . . . . . 0.849 ' N ' HG12 ' A' 2184 ' ' VAL . 1.0 OUTLIER -171.87 -178.51 2.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.204 -1.174 . . . . 0.0 109.461 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 2189 ' ' GLU . . . . . 0.563 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 2.5 tt0 -128.33 174.13 9.57 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 2.6 p -171.08 149.7 2.93 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.621 -1.232 . . . . 0.0 110.41 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2191 ' ' THR . . . . . 0.415 ' O ' ' O ' ' A' 2192 ' ' CYS . 50.8 m -117.41 83.81 2.05 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.568 -0.708 . . . . 0.0 109.355 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2192 ' ' CYS . . . . . 0.652 ' HA ' ' HA3' ' A' 2179 ' ' GLY . 0.8 OUTLIER -50.54 178.27 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.09 -1.006 . . . . 0.0 109.189 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 2193 ' ' GLU . . . . . 0.486 ' O ' ' C ' ' A' 2194 ' ' GLU . 31.8 tt0 -53.97 116.38 2.53 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2194 ' ' GLU . . . . . 0.486 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -32.61 129.37 0.21 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.526 0.679 . . . . 0.0 110.917 -178.674 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.95 4.5 9.42 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2196 ' ' PHE . . . . . 0.681 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.9 OUTLIER -116.65 -164.51 0.98 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.197 -1.178 . . . . 0.0 110.169 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 2197 ' ' GLU . . . . . 0.556 ' N ' ' CG ' ' A' 2196 ' ' PHE . 14.0 mt-10 -145.81 96.95 4.63 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.596 -0.69 . . . . 0.0 109.373 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2198 ' ' PRO . . . . . 0.681 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.2 Cg_endo -68.68 -169.78 0.29 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.272 1.981 . . . . 0.0 111.084 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -124.89 178.06 16.65 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.93 -72.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 121.844 1.696 . . . . 0.0 110.306 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 2201 ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.1 OUTLIER -132.78 33.27 3.74 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.14 -0.975 . . . . 0.0 109.791 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 2202 ' ' MET . . . . . 0.46 ' O ' ' CE2' ' A' 2188 ' ' PHE . 0.2 OUTLIER -105.6 -92.51 0.38 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.165 -0.959 . . . . 0.0 109.706 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 2203 ' ' THR . . . . . 0.472 HG23 ' N ' ' A' 2204 ' ' CYS . 6.0 t -159.68 -162.93 1.08 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.142 -0.974 . . . . 0.0 109.182 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A 2204 ' ' CYS . . . . . 0.585 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -115.71 155.82 27.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.126 -0.984 . . . . 0.0 109.145 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.41 179.98 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 2124 ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' 2125 ' ' ALA . 8.4 t . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2125 ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' 2124 ' ' SER . . . 60.78 -90.71 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.423 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2126 ' ' VAL . . . . . 0.566 ' O ' HG12 ' A' 2126 ' ' VAL . 58.1 t 51.0 76.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.331 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2127 ' ' ASP . . . . . . . . . . . . . 27.1 t70 -90.65 120.59 31.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 109.791 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -47.7 127.91 12.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.338 -0.851 . . . . 0.0 109.893 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2129 ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' 2130 ' ' GLU . 24.4 t0 -66.56 -44.15 83.08 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2130 ' ' GLU . . . . . 0.569 ' O ' HG21 ' A' 2136 ' ' VAL . 1.9 mt-10 82.73 -50.77 0.18 Allowed 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.133 0.492 . . . . 0.0 110.065 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2131 ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' 2137 ' ' CYS . 7.7 t -80.47 -41.91 23.53 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.025 -1.047 . . . . 0.0 109.461 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2132 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.28 -26.59 3.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.436 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2133 ' ' GLU . . . . . 0.482 ' HB2' HG23 ' A' 2136 ' ' VAL . 1.3 mt-10 -73.28 137.53 78.44 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.162 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2134 ' ' PRO . . . . . 0.544 ' CA ' ' HD3' ' A' 2138 ' ' LYS . 5.5 Cg_endo -69.96 -2.39 10.23 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.177 1.918 . . . . 0.0 110.821 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -99.19 -11.7 21.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.001 -1.062 . . . . 0.0 110.395 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2136 ' ' VAL . . . . . 0.569 HG21 ' O ' ' A' 2130 ' ' GLU . 2.2 t -107.39 -136.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.061 -1.024 . . . . 0.0 109.005 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2137 ' ' CYS . . . . . 0.555 ' CB ' ' HB3' ' A' 2142 ' ' CYS . 8.7 m -50.35 104.83 0.08 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.964 -1.085 . . . . 0.0 108.638 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2138 ' ' LYS . . . . . 0.544 ' HD3' ' CA ' ' A' 2134 ' ' PRO . 3.6 mtmt -124.07 140.54 52.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.912 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2139 ' ' HIS . . . . . 0.499 ' HB2' ' O ' ' A' 2164 ' ' CYS . 10.6 m80 56.3 39.16 30.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.986 -1.071 . . . . 0.0 109.548 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -165.07 176.16 40.85 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -90.28 143.81 26.42 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.071 -1.253 . . . . 0.0 108.525 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2142 ' ' CYS . . . . . 0.555 ' HB3' ' CB ' ' A' 2137 ' ' CYS . 0.6 OUTLIER -126.54 153.95 44.5 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.072 -1.017 . . . . 0.0 110.535 -178.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 2143 ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' 2145 ' ' THR . 4.3 mp -116.5 89.76 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2144 ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' 2129 ' ' ASP . 9.4 t-20 -47.21 114.94 0.96 Allowed 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.455 0.645 . . . . 0.0 110.66 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2145 ' ' THR . . . . . 0.502 HG23 ' O ' ' A' 2143 ' ' ILE . 23.0 p -107.68 -171.67 1.92 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.472 -0.767 . . . . 0.0 108.933 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.4 97.45 10.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.411 -0.806 . . . . 0.0 109.46 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 72.54 33.5 60.93 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2148 ' ' SER . . . . . 0.424 ' HB3' ' OG1' ' A' 2145 ' ' THR . 0.4 OUTLIER -173.11 -160.73 0.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -1.117 . . . . 0.0 109.792 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 2149 ' ' TYR . . . . . . . . . . . . . 7.8 p90 -168.43 -170.33 1.23 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.542 -0.724 . . . . 0.0 109.429 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2150 ' ' ARG . . . . . 0.547 ' O ' ' C ' ' A' 2151 ' ' CYS . 0.0 OUTLIER -153.1 33.38 0.47 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 109.0 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 2151 ' ' CYS . . . . . 0.547 ' C ' ' O ' ' A' 2150 ' ' ARG . 35.9 m -12.83 89.94 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.231 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -97.57 169.84 9.44 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2153 ' ' CYS . . . . . 0.517 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -131.77 159.14 73.24 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 120.934 -1.104 . . . . 0.0 109.831 -179.499 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 2154 ' ' PRO . . . . . 0.494 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.5 Cg_endo -62.65 -168.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 122.63 2.22 . . . . 0.0 111.568 -178.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 39.4 t80 -88.17 101.19 13.58 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 129.92 -13.61 5.78 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 107.927 -2.069 . . . . 0.0 107.927 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2157 ' ' TYR . . . . . 0.517 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 5.8 m-85 -108.62 -172.5 2.07 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.661 -0.905 . . . . 0.0 109.961 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2158 ' ' ILE . . . . . 0.769 HD12 ' HB ' ' A' 2167 ' ' THR . 0.2 OUTLIER -156.29 -158.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.453 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 2159 ' ' LEU . . . . . 0.506 ' HG ' ' N ' ' A' 2160 ' ' ALA . 13.7 tp -142.19 146.8 35.64 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 109.768 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2160 ' ' ALA . . . . . 0.506 ' N ' ' HG ' ' A' 2159 ' ' LEU . . . -122.02 48.53 1.71 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.237 -0.914 . . . . 0.0 109.443 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 95.55 -35.76 4.15 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2162 ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -168.44 -34.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.242 . . . . 0.0 109.911 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2163 ' ' GLU . . . . . 0.479 ' OE1' ' HE2' ' A' 2138 ' ' LYS . 1.2 tp10 -88.59 111.26 21.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 0.0 109.837 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2164 ' ' CYS . . . . . 0.904 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -82.13 147.83 28.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.442 -0.786 . . . . 0.0 109.362 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 2165 ' ' VAL . . . . . 0.904 HG13 ' O ' ' A' 2164 ' ' CYS . 0.3 OUTLIER -170.86 -168.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 2166 ' ' ASP . . . . . . . . . . . . . 1.6 t70 -90.4 143.63 26.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.901 -1.124 . . . . 0.0 109.179 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2167 ' ' THR . . . . . 0.769 ' HB ' HD12 ' A' 2158 ' ' ILE . 9.7 t -95.05 171.65 8.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.402 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2168 ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' 2171 ' ' SER . 62.5 t0 -85.73 96.29 9.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.948 -1.095 . . . . 0.0 109.352 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2169 ' ' GLU . . . . . 0.597 ' OE1' HG23 ' A' 2167 ' ' THR . 0.5 OUTLIER -67.3 -33.93 76.32 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.414 -0.804 . . . . 0.0 109.598 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 2170 ' ' CYS . . . . . 0.51 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.6 t -69.24 -7.49 37.21 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.172 -0.955 . . . . 0.0 108.915 179.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2171 ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.2 OUTLIER -77.09 3.13 13.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.086 -1.009 . . . . 0.0 109.663 179.847 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 48.5 t -105.6 -70.55 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.101 -1.0 . . . . 0.0 109.826 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2173 ' ' GLY . . . . . 0.477 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -168.97 138.17 4.95 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2174 ' ' ASN . . . . . 0.589 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 18.6 p-10 -39.38 99.31 0.19 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.517 -0.99 . . . . 0.0 110.22 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2175 ' ' PRO . . . . . 0.615 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.5 Cg_endo -65.47 -25.17 55.92 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.046 1.831 . . . . 0.0 110.487 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2176 ' ' CYS . . . . . 0.565 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -47.13 -50.89 19.41 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.069 -1.019 . . . . 0.0 108.588 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 138.25 -22.29 3.07 Favored Glycine 0 C--N 1.292 -1.9 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2178 ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.0 OUTLIER -162.53 -35.97 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.447 -1.031 . . . . 0.0 109.993 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 2179 ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -61.59 -119.21 0.01 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.34 160.36 42.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.378 -1.072 . . . . 0.0 109.637 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2181 ' ' CYS . . . . . 0.589 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 22.5 p -92.08 163.95 13.77 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.198 0.999 . . . . 0.0 111.306 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2182 ' ' LYS . . . . . 0.6 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.0 OUTLIER -142.56 155.88 45.05 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 57.7 t30 -100.55 140.56 34.65 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.39 -1.444 . . . . 0.0 109.883 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2184 ' ' VAL . . . . . 0.633 HG12 ' CA ' ' A' 2188 ' ' PHE . 0.8 OUTLIER -154.52 174.48 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A 2185 ' ' ILE . . . . . . . . . . . . . 4.3 mp -91.77 136.73 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.051 -1.031 . . . . 0.0 109.882 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 80.39 5.45 89.78 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2187 ' ' GLY . . . . . 0.524 ' C ' HG12 ' A' 2184 ' ' VAL . . . 163.06 -131.32 2.45 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2188 ' ' PHE . . . . . 0.633 ' CA ' HG12 ' A' 2184 ' ' VAL . 5.6 p90 -160.94 173.31 15.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.353 -1.087 . . . . 0.0 109.165 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2189 ' ' GLU . . . . . 0.6 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.7 tt0 -121.61 138.98 54.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.3 -0.875 . . . . 0.0 108.826 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2190 ' ' CYS . . . . . 0.435 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 15.4 p -130.64 143.53 50.81 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.66 -1.275 . . . . 0.0 109.997 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2191 ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' 2192 ' ' CYS . 61.3 m -117.51 85.31 2.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.348 -0.845 . . . . 0.0 109.505 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2192 ' ' CYS . . . . . 0.602 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.1 m -49.09 179.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 109.242 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2193 ' ' GLU . . . . . 0.45 ' O ' ' C ' ' A' 2194 ' ' GLU . 18.5 tt0 -56.98 126.9 29.25 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2194 ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.2 tt0 -38.81 130.16 1.46 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.487 -0.758 . . . . 0.0 110.591 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.24 3.04 9.82 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2196 ' ' PHE . . . . . 0.683 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.2 p90 -116.56 -161.43 0.8 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.144 -1.209 . . . . 0.0 110.16 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2197 ' ' GLU . . . . . 0.561 ' N ' ' CG ' ' A' 2196 ' ' PHE . 34.8 mm-40 -146.09 95.14 4.82 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 121.53 -0.731 . . . . 0.0 109.82 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2198 ' ' PRO . . . . . 0.683 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 6.5 Cg_endo -66.91 -163.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.119 1.88 . . . . 0.0 111.021 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -138.22 -171.65 12.26 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.88 -80.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.004 1.802 . . . . 0.0 110.727 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2201 ' ' MET . . . . . 0.492 ' HA ' ' O ' ' A' 2188 ' ' PHE . 6.6 mtt -132.0 47.17 2.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.166 -0.959 . . . . 0.0 110.033 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2202 ' ' MET . . . . . 0.515 ' O ' ' CE2' ' A' 2188 ' ' PHE . 1.9 mmt -117.13 -88.42 0.6 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.238 -0.914 . . . . 0.0 109.849 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2203 ' ' THR . . . . . 0.469 HG23 ' N ' ' A' 2204 ' ' CYS . 5.8 t -169.33 -162.59 0.36 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.278 -0.889 . . . . 0.0 109.49 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2204 ' ' CYS . . . . . 0.569 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 5.2 t -76.28 145.06 39.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 109.39 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A 2205 ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' 2197 ' ' GLU . 8.6 pt-20 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.951 -1.024 . . . . 0.0 109.409 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 2124 ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' 2125 ' ' ALA . 79.6 p . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2125 ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' 2124 ' ' SER . . . 61.25 131.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.341 -0.849 . . . . 0.0 109.6 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 91.9 t -109.43 125.34 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 109.439 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2127 ' ' ASP . . . . . . . . . . . . . 23.5 t0 -55.97 93.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 109.589 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 8.3 mtp -64.42 147.6 52.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 109.503 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2129 ' ' ASP . . . . . 0.568 ' O ' ' HB2' ' A' 2130 ' ' GLU . 11.5 t0 -70.31 -42.04 72.49 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.339 -0.851 . . . . 0.0 108.86 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2130 ' ' GLU . . . . . 0.61 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 1.5 mt-10 80.58 -55.47 0.34 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.915 -0.491 . . . . 0.0 111.158 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2131 ' ' CYS . . . . . 0.565 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 8.0 p -91.34 -14.59 30.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.761 -1.212 . . . . 0.0 110.503 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2132 ' ' LYS . . . . . 0.507 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -88.93 6.57 38.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.996 -1.065 . . . . 0.0 109.218 179.534 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 2133 ' ' GLU . . . . . 0.49 ' HB3' ' HD2' ' A' 2134 ' ' PRO . 36.3 mt-10 -81.11 159.41 68.16 Favored Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.242 -0.911 . . . . 0.0 109.337 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2134 ' ' PRO . . . . . 0.493 ' O ' ' HD2' ' A' 2138 ' ' LYS . 4.7 Cg_endo -68.54 -1.88 8.24 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.341 2.027 . . . . 0.0 110.451 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2135 ' ' ASP . . . . . 0.506 ' O ' ' ND2' ' A' 2162 ' ' ASN . 0.4 OUTLIER -123.11 14.16 9.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.934 -1.104 . . . . 0.0 109.887 -179.57 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 2136 ' ' VAL . . . . . 0.637 ' CG1' ' CE2' ' A' 2149 ' ' TYR . 43.3 t -146.99 126.01 4.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.04 -1.038 . . . . 0.0 108.867 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2137 ' ' CYS . . . . . 0.542 ' CA ' ' O ' ' A' 2162 ' ' ASN . 0.5 OUTLIER 69.67 -84.78 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.428 -0.795 . . . . 0.0 109.969 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 2138 ' ' LYS . . . . . 0.493 ' HD2' ' O ' ' A' 2134 ' ' PRO . 0.8 OUTLIER 63.62 109.67 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.571 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 2139 ' ' HIS . . . . . 0.501 ' O ' ' HB3' ' A' 2164 ' ' CYS . 11.6 m170 62.03 50.39 4.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.866 . . . . 0.0 109.892 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -148.85 168.39 29.35 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -106.43 78.68 1.3 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -1.137 . . . . 0.0 109.13 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2142 ' ' CYS . . . . . 0.954 ' C ' HD13 ' A' 2143 ' ' ILE . 25.3 p -82.96 -177.65 6.84 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.306 -0.871 . . . . 0.0 110.634 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2143 ' ' ILE . . . . . 0.954 HD13 ' C ' ' A' 2142 ' ' CYS . 3.0 mm -127.63 122.6 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2144 ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' 2129 ' ' ASP . 4.3 t-20 -78.04 113.49 16.02 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.34 -0.85 . . . . 0.0 110.912 -178.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2145 ' ' THR . . . . . 0.465 HG23 ' HA ' ' A' 2149 ' ' TYR . 2.7 p -92.68 -162.79 0.97 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 1.3 p30 -86.7 -32.52 20.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.98 . . . . 0.0 110.449 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -129.77 -34.39 0.48 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.161 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2148 ' ' SER . . . . . 0.432 ' O ' ' OG1' ' A' 2145 ' ' THR . 0.5 OUTLIER -111.79 -164.44 0.92 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.144 -1.21 . . . . 0.0 110.035 -179.479 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 2149 ' ' TYR . . . . . 0.637 ' CE2' ' CG1' ' A' 2136 ' ' VAL . 13.5 p90 -148.67 -176.55 5.37 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2150 ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' 2149 ' ' TYR . 0.1 OUTLIER -148.32 116.48 6.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.476 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 6.2 m -87.32 118.62 26.87 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.338 -0.851 . . . . 0.0 109.545 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.01 81.05 1.94 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.869 . . . . 0.0 109.139 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2153 ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -54.25 156.24 5.92 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.276 -0.89 . . . . 0.0 109.257 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 2154 ' ' PRO . . . . . 0.483 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.3 Cg_endo -63.06 -171.76 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.417 2.078 . . . . 0.0 111.306 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -88.0 102.84 15.13 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.37 -14.79 5.59 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 107.885 -2.086 . . . . 0.0 107.885 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2157 ' ' TYR . . . . . 0.547 ' CD2' ' C ' ' A' 2165 ' ' VAL . 5.6 m-85 -106.01 -168.23 1.41 Allowed 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.635 -0.921 . . . . 0.0 109.549 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2158 ' ' ILE . . . . . 0.639 HD11 HG23 ' A' 2165 ' ' VAL . 0.2 OUTLIER -156.93 -164.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.859 . . . . 0.0 109.923 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 2159 ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' 2163 ' ' GLU . 39.5 tp -142.38 114.16 8.03 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -90.57 56.87 3.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.883 . . . . 0.0 109.589 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 89.11 -29.2 6.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2162 ' ' ASN . . . . . 0.542 ' O ' ' CA ' ' A' 2137 ' ' CYS . 1.5 m-20 -171.47 -46.69 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.241 -1.152 . . . . 0.0 109.332 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2163 ' ' GLU . . . . . 0.523 ' O ' HD12 ' A' 2159 ' ' LEU . 14.5 tt0 -66.17 147.78 52.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.118 -0.989 . . . . 0.0 109.248 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2164 ' ' CYS . . . . . 0.693 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -122.82 137.58 54.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.049 -1.032 . . . . 0.0 109.394 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 2165 ' ' VAL . . . . . 0.693 HG13 ' O ' ' A' 2164 ' ' CYS . 0.7 OUTLIER -161.1 -169.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.121 -0.987 . . . . 0.0 109.779 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 2166 ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' 2184 ' ' VAL . 36.8 t70 -77.02 166.94 22.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.167 -0.958 . . . . 0.0 110.035 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2167 ' ' THR . . . . . 0.538 ' HB ' HG23 ' A' 2158 ' ' ILE . 1.2 t -115.99 -170.6 1.82 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.355 -0.84 . . . . 0.0 109.414 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2168 ' ' ASP . . . . . 0.536 ' N ' HG23 ' A' 2167 ' ' THR . 64.6 t0 -109.4 101.26 10.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.945 . . . . 0.0 109.511 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2169 ' ' GLU . . . . . 0.624 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.5 OUTLIER -76.22 -30.93 58.14 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.347 -0.845 . . . . 0.0 109.337 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 2170 ' ' CYS . . . . . 0.526 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 0.1 OUTLIER -64.87 -12.32 47.47 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.578 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.76 -22.54 29.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 0.0 109.623 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 31.3 t -75.9 -68.56 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.33 -0.856 . . . . 0.0 109.448 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2173 ' ' GLY . . . . . 0.441 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -159.87 140.37 6.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2174 ' ' ASN . . . . . 0.497 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 1.6 t-20 -45.0 104.49 0.39 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.411 -1.052 . . . . 0.0 109.616 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2175 ' ' PRO . . . . . 0.648 ' CB ' ' CE2' ' A' 2188 ' ' PHE . 2.1 Cg_endo -68.92 -19.94 39.59 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.837 1.692 . . . . 0.0 110.03 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2176 ' ' CYS . . . . . 0.601 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -71.43 -24.08 61.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.152 -0.967 . . . . 0.0 109.902 -179.516 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 105.84 -25.79 22.99 Favored Glycine 0 N--CA 1.483 1.779 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2178 ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.1 OUTLIER -170.59 -31.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.295 -1.121 . . . . 0.0 110.611 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 2179 ' ' GLY . . . . . 0.583 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -59.77 -120.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.3 p -136.03 151.18 49.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.44 -1.035 . . . . 0.0 109.336 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2181 ' ' CYS . . . . . 0.549 ' HB3' ' HD2' ' A' 2175 ' ' PRO . 26.1 p -99.35 155.63 17.42 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.12 -0.987 . . . . 0.0 110.716 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2182 ' ' LYS . . . . . 0.55 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 8.5 tttp -140.67 159.07 43.01 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2183 ' ' ASN . . . . . 0.432 ' CG ' ' HA ' ' A' 2168 ' ' ASP . 53.5 t30 -100.26 129.64 46.28 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.562 -1.336 . . . . 0.0 110.175 -179.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2184 ' ' VAL . . . . . 0.914 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -134.41 -179.42 3.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 2185 ' ' ILE . . . . . 0.444 ' N ' HG13 ' A' 2184 ' ' VAL . 4.1 mp -95.01 141.13 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.764 -1.21 . . . . 0.0 110.424 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 67.94 10.92 59.89 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2187 ' ' GLY . . . . . 0.575 ' C ' HG12 ' A' 2184 ' ' VAL . . . 168.14 -118.77 0.8 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2188 ' ' PHE . . . . . 0.914 ' N ' HG12 ' A' 2184 ' ' VAL . 2.6 p90 -175.23 178.58 1.68 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -1.109 . . . . 0.0 109.72 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2189 ' ' GLU . . . . . 0.55 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 5.6 tp10 -124.54 168.1 13.56 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 3.1 p -170.51 145.89 2.67 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.547 -1.345 . . . . 0.0 110.453 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2191 ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' 2192 ' ' CYS . 88.6 m -117.88 88.34 2.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.504 -0.748 . . . . 0.0 109.614 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2192 ' ' CYS . . . . . 0.63 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.5 OUTLIER -49.6 -178.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.167 -0.958 . . . . 0.0 109.049 179.786 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 2193 ' ' GLU . . . . . 0.548 ' O ' ' C ' ' A' 2194 ' ' GLU . 7.2 tt0 -55.24 102.27 0.06 Allowed 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2194 ' ' GLU . . . . . 0.548 ' C ' ' O ' ' A' 2193 ' ' GLU . 2.3 mt-10 -20.14 124.89 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.365 0.602 . . . . 0.0 111.716 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.71 11.35 6.0 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2196 ' ' PHE . . . . . 0.686 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.5 p90 -120.06 -161.93 0.9 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.357 -1.084 . . . . 0.0 110.165 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2197 ' ' GLU . . . . . 0.52 ' N ' ' CG ' ' A' 2196 ' ' PHE . 12.9 mt-10 -144.47 94.87 5.54 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 121.475 -0.766 . . . . 0.0 109.659 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2198 ' ' PRO . . . . . 0.686 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.2 Cg_endo -69.36 -162.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.353 2.035 . . . . 0.0 111.192 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -133.66 -177.02 14.66 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -62.36 -65.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.006 1.804 . . . . 0.0 110.618 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2201 ' ' MET . . . . . 0.496 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -147.29 41.11 1.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 109.58 -179.674 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 2202 ' ' MET . . . . . 0.431 ' O ' ' CE2' ' A' 2188 ' ' PHE . 0.0 OUTLIER -112.88 -84.4 0.59 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.208 -0.932 . . . . 0.0 109.613 -179.807 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 2203 ' ' THR . . . . . . . . . . . . . 11.5 t -162.6 -172.62 3.2 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.23 -0.918 . . . . 0.0 109.406 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 2204 ' ' CYS . . . . . 0.601 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -110.42 144.94 38.44 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.285 -0.885 . . . . 0.0 108.933 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.548 -179.864 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -167.58 103.19 0.5 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 109.316 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2126 ' ' VAL . . . . . 0.489 HG13 ' H ' ' A' 2128 ' ' MET . 10.0 p -139.2 148.92 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 109.489 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2127 ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' 2127 ' ' ASP . 24.0 t70 -91.39 30.4 1.3 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.187 -0.946 . . . . 0.0 109.403 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2128 ' ' MET . . . . . 0.489 ' H ' HG13 ' A' 2126 ' ' VAL . 1.8 mtp 59.9 106.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.199 -0.938 . . . . 0.0 109.2 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2129 ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' 2130 ' ' GLU . 11.3 t70 -60.65 -46.24 91.08 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2130 ' ' GLU . . . . . 0.638 ' O ' HG21 ' A' 2136 ' ' VAL . 6.4 mt-10 82.56 -43.16 0.13 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.856 -0.528 . . . . 0.0 109.798 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2131 ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.11 -23.02 21.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.176 -0.952 . . . . 0.0 109.086 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2132 ' ' LYS . . . . . 0.432 ' HB2' ' CB ' ' A' 2129 ' ' ASP . 0.3 OUTLIER -87.6 40.25 0.92 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 109.144 179.561 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 2133 ' ' GLU . . . . . 0.525 ' HB2' HG23 ' A' 2136 ' ' VAL . 80.3 mt-10 -108.09 160.17 27.92 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.33 -0.856 . . . . 0.0 109.66 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2134 ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' 2133 ' ' GLU . 1.2 Cg_endo -66.02 0.51 3.12 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.539 2.159 . . . . 0.0 111.771 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2135 ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' 2162 ' ' ASN . 67.1 m-20 -130.03 -10.65 4.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.478 -1.389 . . . . 0.0 110.564 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2136 ' ' VAL . . . . . 0.638 HG21 ' O ' ' A' 2130 ' ' GLU . 3.4 t -100.13 -131.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.927 -1.108 . . . . 0.0 108.492 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2137 ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' 2142 ' ' CYS . 5.0 t -58.45 131.46 50.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.521 -1.362 . . . . 0.0 108.65 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2138 ' ' LYS . . . . . 0.515 ' O ' ' CB ' ' A' 2139 ' ' HIS . 32.0 mtpt -139.64 43.03 1.99 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.185 -0.947 . . . . 0.0 110.061 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2139 ' ' HIS . . . . . 0.515 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.0 OUTLIER 163.73 -34.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.052 -1.03 . . . . 0.0 110.099 179.473 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -83.67 173.65 51.21 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -91.91 94.68 9.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.265 -1.138 . . . . 0.0 109.163 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2142 ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' 2137 ' ' CYS . 10.4 t -91.0 161.47 15.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.292 -0.88 . . . . 0.0 109.725 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 2.6 mp -122.72 98.59 5.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2144 ' ' ASN . . . . . 0.479 ' HB2' ' OD1' ' A' 2129 ' ' ASP . 3.2 t30 -60.02 112.85 2.03 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.273 -0.892 . . . . 0.0 109.712 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2145 ' ' THR . . . . . . . . . . . . . 30.5 p -90.73 -166.28 1.54 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.378 -0.826 . . . . 0.0 109.376 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 5.6 t0 -62.63 -72.48 0.13 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.817 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -118.12 37.0 3.41 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2148 ' ' SER . . . . . 0.451 ' O ' ' HB3' ' A' 2149 ' ' TYR . 0.8 OUTLIER -165.13 -160.89 0.51 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -1.157 . . . . 0.0 109.629 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 2149 ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' 2148 ' ' SER . 27.2 p90 170.8 -175.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.49 -0.756 . . . . 0.0 109.217 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2150 ' ' ARG . . . . . 0.433 ' C ' ' SG ' ' A' 2142 ' ' CYS . 11.6 ptt180 -167.93 95.05 0.41 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.951 . . . . 0.0 109.831 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2151 ' ' CYS . . . . . 0.465 ' HA ' ' SG ' ' A' 2142 ' ' CYS . 42.5 t -57.64 102.56 0.1 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.615 -0.678 . . . . 0.0 109.447 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -104.47 108.02 19.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.314 -0.866 . . . . 0.0 109.256 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2153 ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -70.06 158.78 86.55 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.168 -0.957 . . . . 0.0 109.664 -179.657 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 2154 ' ' PRO . . . . . 0.474 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.1 Cg_endo -63.85 -168.97 0.1 OUTLIER 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.858 2.372 . . . . 0.0 112.03 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -86.48 101.79 13.5 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 129.95 -15.49 5.63 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 107.821 -2.112 . . . . 0.0 107.821 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2157 ' ' TYR . . . . . 0.593 ' OH ' HG23 ' A' 2185 ' ' ILE . 5.4 m-85 -106.34 -170.79 1.78 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.682 -0.893 . . . . 0.0 110.053 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2158 ' ' ILE . . . . . 0.744 HD13 ' N ' ' A' 2158 ' ' ILE . 0.2 OUTLIER -156.93 -160.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.522 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 2159 ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' 2163 ' ' GLU . 33.2 tp -147.55 122.81 10.24 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.187 -0.945 . . . . 0.0 109.942 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2160 ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' 2162 ' ' ASN . . . -90.22 -152.12 0.26 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2161 ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' 2160 ' ' ALA . . . -42.13 -25.95 0.29 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2162 ' ' ASN . . . . . 0.503 ' O ' HD11 ' A' 2159 ' ' LEU . 1.5 t-20 178.75 -29.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.133 -1.216 . . . . 0.0 110.179 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2163 ' ' GLU . . . . . 0.517 ' O ' HD12 ' A' 2159 ' ' LEU . 74.5 tt0 -76.23 152.58 36.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.084 -1.01 . . . . 0.0 109.514 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2164 ' ' CYS . . . . . 0.804 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -111.82 145.08 40.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.122 -0.986 . . . . 0.0 109.374 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 2165 ' ' VAL . . . . . 0.804 HG13 ' O ' ' A' 2164 ' ' CYS . 1.6 m -164.81 -170.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 109.425 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2166 ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 3.3 t70 -90.41 149.69 22.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.002 -1.061 . . . . 0.0 109.706 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2167 ' ' THR . . . . . 0.912 HG23 ' OE1' ' A' 2169 ' ' GLU . 8.7 t -87.84 175.38 7.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 109.511 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2168 ' ' ASP . . . . . 0.469 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 57.9 t0 -95.77 92.67 6.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.296 -0.877 . . . . 0.0 108.752 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2169 ' ' GLU . . . . . 0.912 ' OE1' HG23 ' A' 2167 ' ' THR . 0.7 OUTLIER -65.68 -32.15 73.55 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.331 -0.856 . . . . 0.0 109.883 -179.409 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 2170 ' ' CYS . . . . . 0.559 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.3 t -66.34 -12.04 54.44 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.165 -0.959 . . . . 0.0 108.891 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2171 ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.1 OUTLIER -73.68 -2.28 22.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.243 179.447 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 2172 ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' 2169 ' ' GLU . 34.4 t -84.23 -69.71 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.21 -0.931 . . . . 0.0 109.549 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2173 ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' 2174 ' ' ASN . . . 164.26 76.46 0.03 OUTLIER Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.069 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2174 ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' 2178 ' ' ASN . 3.5 t-20 43.2 83.78 0.2 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.253 -1.145 . . . . 0.0 109.613 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2175 ' ' PRO . . . . . 0.633 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.4 Cg_endo -66.76 -20.03 52.7 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.257 1.971 . . . . 0.0 110.537 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2176 ' ' CYS . . . . . 0.532 ' SG ' ' HB3' ' A' 2204 ' ' CYS . 1.4 m -64.79 -55.41 19.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.926 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 160.2 -28.94 0.35 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2178 ' ' ASN . . . . . 0.503 ' N ' ' OD1' ' A' 2174 ' ' ASN . 1.5 t-20 -171.05 -26.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -1.185 . . . . 0.0 110.966 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2179 ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -59.66 -124.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.787 -1.196 . . . . 0.0 110.309 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2180 ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' 2190 ' ' CYS . 1.1 p -136.64 151.07 48.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.394 -1.062 . . . . 0.0 109.227 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2181 ' ' CYS . . . . . 0.568 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 23.0 p -99.54 150.19 22.48 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.089 -1.007 . . . . 0.0 111.468 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2182 ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' 2189 ' ' GLU . 0.5 OUTLIER -132.4 160.79 35.35 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.381 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 2183 ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 57.0 t30 -100.28 123.7 44.83 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.579 -1.326 . . . . 0.0 109.21 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2184 ' ' VAL . . . . . 0.828 HG12 ' N ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -130.89 -174.96 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.371 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 2185 ' ' ILE . . . . . 0.593 HG23 ' OH ' ' A' 2157 ' ' TYR . 3.3 mp -94.62 139.26 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.028 -1.045 . . . . 0.0 110.287 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 69.78 10.06 63.59 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2187 ' ' GLY . . . . . 0.532 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 166.2 -118.11 0.78 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.514 -1.326 . . . . 0.0 110.078 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2188 ' ' PHE . . . . . 0.828 ' N ' HG12 ' A' 2184 ' ' VAL . 1.8 p90 -166.46 -179.45 4.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -1.139 . . . . 0.0 109.889 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2189 ' ' GLU . . . . . 0.591 ' OE1' HG21 ' A' 2184 ' ' VAL . 0.1 OUTLIER -132.09 94.04 3.39 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.406 -0.808 . . . . 0.0 109.286 178.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 2190 ' ' CYS . . . . . 0.527 ' HB3' ' HA ' ' A' 2181 ' ' CYS . 9.1 p -114.26 139.26 49.56 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.92 -1.112 . . . . 0.0 109.802 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2191 ' ' THR . . . . . 0.526 ' O ' ' HA3' ' A' 2179 ' ' GLY . 1.8 m -113.85 106.58 14.62 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2192 ' ' CYS . . . . . 0.669 ' HB2' ' CD2' ' A' 2196 ' ' PHE . 0.5 OUTLIER -53.54 -172.36 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.057 -1.027 . . . . 0.0 110.157 -178.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 2193 ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.2 tp10 -68.03 136.43 53.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.656 -0.652 . . . . 0.0 110.1 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2194 ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -40.37 131.5 2.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.523 -0.736 . . . . 0.0 110.203 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 116.75 12.76 8.37 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2196 ' ' PHE . . . . . 0.701 ' CD2' ' HB2' ' A' 2204 ' ' CYS . 8.0 p90 -128.99 -158.71 0.9 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.575 -0.956 . . . . 0.0 110.22 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2197 ' ' GLU . . . . . 0.555 ' N ' ' CD2' ' A' 2196 ' ' PHE . 25.7 mt-10 -147.16 96.7 4.21 Favored Pre-proline 0 C--N 1.306 -1.319 0 O-C-N 121.565 -0.709 . . . . 0.0 109.496 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2198 ' ' PRO . . . . . 0.633 ' CD ' ' CE2' ' A' 2196 ' ' PHE . 2.2 Cg_endo -62.41 -170.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.356 2.037 . . . . 0.0 111.148 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -147.58 -168.02 13.74 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.04 -80.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.259 1.973 . . . . 0.0 110.929 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2201 ' ' MET . . . . . 0.532 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -142.54 42.11 1.6 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 110.115 -179.237 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 2.0 mmm -114.23 -72.28 0.71 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.411 -0.806 . . . . 0.0 109.502 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2203 ' ' THR . . . . . 0.486 ' OG1' ' HA ' ' A' 2176 ' ' CYS . 11.8 t -166.84 -165.91 0.78 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2204 ' ' CYS . . . . . 0.701 ' HB2' ' CD2' ' A' 2196 ' ' PHE . 31.3 p -104.1 114.14 28.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.853 -1.155 . . . . 0.0 110.232 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A 2205 ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' 2205 ' ' GLU . 9.1 pt-20 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.513 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A 2124 ' ' SER . . . . . 0.685 ' O ' ' HB2' ' A' 2125 ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2125 ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' 2124 ' ' SER . . . 164.84 -87.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 109.475 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 38.7 t -119.39 156.32 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.278 -0.889 . . . . 0.0 109.521 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 2127 ' ' ASP . . . . . . . . . . . . . 2.8 p30 -75.39 -161.72 0.16 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.268 -0.895 . . . . 0.0 109.713 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 9.4 mtt -53.9 141.7 26.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.37 -0.831 . . . . 0.0 109.855 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 2129 ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' 2130 ' ' GLU . 16.6 t0 -69.6 -44.98 69.65 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.413 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2130 ' ' GLU . . . . . 0.598 ' HB3' ' CD2' ' A' 2149 ' ' TYR . 2.0 mt-10 82.87 -47.11 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.845 -0.534 . . . . 0.0 109.942 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2131 ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' 2137 ' ' CYS . 0.0 OUTLIER -80.9 -46.14 15.67 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.963 -1.086 . . . . 0.0 109.152 179.968 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 2132 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -16.31 4.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.14 -0.975 . . . . 0.0 109.79 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2133 ' ' GLU . . . . . 0.437 ' HG3' ' C ' ' A' 2130 ' ' GLU . 7.5 mt-10 -69.95 146.06 94.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 110.204 -179.569 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2134 ' ' PRO . . . . . 0.528 ' O ' ' CE ' ' A' 2138 ' ' LYS . 6.4 Cg_endo -72.55 2.27 5.37 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.597 2.198 . . . . 0.0 110.309 179.113 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2135 ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' 2162 ' ' ASN . 36.3 t70 -108.43 -14.29 14.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.96 -1.087 . . . . 0.0 109.693 -179.399 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2136 ' ' VAL . . . . . 0.576 ' CG1' ' CE1' ' A' 2149 ' ' TYR . 2.3 t -112.21 -136.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.093 -1.005 . . . . 0.0 109.074 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2137 ' ' CYS . . . . . 0.497 ' HB3' ' SG ' ' A' 2131 ' ' CYS . 1.9 t -44.54 105.72 0.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.018 -1.051 . . . . 0.0 108.68 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2138 ' ' LYS . . . . . 0.528 ' CE ' ' O ' ' A' 2134 ' ' PRO . 3.7 mttm -114.22 18.35 17.09 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.336 -0.852 . . . . 0.0 110.332 -178.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2139 ' ' HIS . . . . . 0.492 ' O ' ' HB3' ' A' 2164 ' ' CYS . 0.9 OUTLIER 171.77 50.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.892 -1.13 . . . . 0.0 110.461 179.773 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -169.83 -175.22 38.7 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -89.78 142.8 27.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.348 -1.09 . . . . 0.0 108.611 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 2142 ' ' CYS . . . . . 0.678 ' C ' HD12 ' A' 2143 ' ' ILE . 0.8 OUTLIER -128.78 175.93 8.22 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.092 -1.005 . . . . 0.0 110.492 -178.972 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 2143 ' ' ILE . . . . . 0.678 HD12 ' C ' ' A' 2142 ' ' CYS . 4.9 mp -139.51 107.92 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2144 ' ' ASN . . . . . . . . . . . . . 14.5 t30 -64.18 119.08 9.54 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.346 -0.846 . . . . 0.0 110.886 -178.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 2145 ' ' THR . . . . . 0.423 ' OG1' ' C ' ' A' 2148 ' ' SER . 72.4 p -116.07 -179.08 3.56 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.823 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.35 109.75 21.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.957 . . . . 0.0 109.59 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 89.81 13.94 60.21 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 2148 ' ' SER . . . . . 0.423 ' C ' ' OG1' ' A' 2145 ' ' THR . 0.1 OUTLIER -178.72 -160.62 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.239 -1.153 . . . . 0.0 109.688 -179.866 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 2149 ' ' TYR . . . . . 0.598 ' CD2' ' HB3' ' A' 2130 ' ' GLU . 22.2 p90 -171.31 -174.43 1.45 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.397 -0.814 . . . . 0.0 108.979 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2150 ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' 2142 ' ' CYS . 0.0 OUTLIER -157.4 112.62 2.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.119 -0.988 . . . . 0.0 109.636 179.604 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 40.1 t -98.5 87.06 3.73 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.582 -0.699 . . . . 0.0 109.505 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -86.57 105.98 17.23 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.198 -0.938 . . . . 0.0 109.322 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 2153 ' ' CYS . . . . . 0.507 ' SG ' ' HD2' ' A' 2154 ' ' PRO . 0.0 OUTLIER -66.64 159.9 71.17 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 109.649 -179.624 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 2154 ' ' PRO . . . . . 0.507 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 0.9 OUTLIER -64.46 -166.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.61 2.207 . . . . 0.0 111.276 -179.024 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 21.0 t80 -90.21 103.42 16.1 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.81 -17.19 5.24 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 107.909 -2.076 . . . . 0.0 107.909 -178.393 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 2157 ' ' TYR . . . . . 0.56 ' OH ' HG23 ' A' 2185 ' ' ILE . 9.7 m-85 -107.81 -172.34 2.05 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.625 -0.927 . . . . 0.0 109.799 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2158 ' ' ILE . . . . . 0.76 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -155.5 -165.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.555 -0.716 . . . . 0.0 109.796 179.418 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 2159 ' ' LEU . . . . . 0.52 HD12 ' O ' ' A' 2163 ' ' GLU . 27.9 tp -141.9 121.8 13.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.387 -0.821 . . . . 0.0 109.508 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -94.63 50.94 1.37 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.357 -0.84 . . . . 0.0 109.83 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 91.32 -18.43 51.97 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.394 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 2162 ' ' ASN . . . . . 0.523 ' OD1' HG13 ' A' 2136 ' ' VAL . 1.6 m-20 -178.03 -47.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.023 -1.281 . . . . 0.0 109.851 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2163 ' ' GLU . . . . . 0.52 ' O ' HD12 ' A' 2159 ' ' LEU . 78.7 tt0 -75.31 146.05 41.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.898 . . . . 0.0 109.035 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2164 ' ' CYS . . . . . 0.722 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -115.35 140.9 48.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.031 -1.043 . . . . 0.0 109.395 -179.958 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 2165 ' ' VAL . . . . . 0.722 HG13 ' O ' ' A' 2164 ' ' CYS . 4.7 m -162.42 -170.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 0.0 109.767 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2166 ' ' ASP . . . . . 0.478 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 1.3 t0 -89.78 144.77 25.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 109.415 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2167 ' ' THR . . . . . 0.707 HG23 ' OE1' ' A' 2169 ' ' GLU . 8.9 t -85.39 170.74 12.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.306 -0.871 . . . . 0.0 109.682 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2168 ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' 2171 ' ' SER . 66.9 t0 -81.67 94.5 6.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.196 -0.94 . . . . 0.0 108.592 179.115 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2169 ' ' GLU . . . . . 0.707 ' OE1' HG23 ' A' 2167 ' ' THR . 0.4 OUTLIER -65.56 -26.42 67.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 110.532 -179.012 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 2170 ' ' CYS . . . . . 0.43 ' HB2' ' HB2' ' A' 2181 ' ' CYS . 1.3 t -57.92 -12.82 3.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.912 -1.117 . . . . 0.0 108.77 178.461 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2171 ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.1 OUTLIER -59.44 -13.12 7.47 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.195 -0.94 . . . . 0.0 109.881 -179.553 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 2172 ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' 2169 ' ' GLU . 22.1 t -73.14 -67.95 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.312 -0.867 . . . . 0.0 109.242 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2173 ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' 2174 ' ' ASN . . . 154.95 85.55 0.05 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2174 ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' 2173 ' ' GLY . 1.1 t-20 47.31 91.55 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.26 -1.141 . . . . 0.0 109.421 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2175 ' ' PRO . . . . . 0.64 ' CB ' ' CD1' ' A' 2188 ' ' PHE . 1.0 OUTLIER -62.95 -21.95 73.5 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.078 1.852 . . . . 0.0 110.222 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 2176 ' ' CYS . . . . . 0.528 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.1 OUTLIER -75.97 -64.67 1.04 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -0.996 . . . . 0.0 108.926 179.68 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 147.93 -14.84 1.35 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -166.93 -34.76 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.205 -1.173 . . . . 0.0 110.106 -179.689 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2179 ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -61.48 -108.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.451 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.18 157.19 42.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.393 -1.063 . . . . 0.0 109.307 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2181 ' ' CYS . . . . . 0.548 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 26.7 p -93.65 159.93 15.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.026 -1.046 . . . . 0.0 110.237 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2182 ' ' LYS . . . . . 0.546 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.0 OUTLIER -146.5 154.24 41.33 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.365 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 2183 ' ' ASN . . . . . 0.469 ' N ' ' HG3' ' A' 2182 ' ' LYS . 56.0 t30 -98.48 121.46 40.45 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.685 -1.259 . . . . 0.0 109.413 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2184 ' ' VAL . . . . . 0.738 HG13 ' N ' ' A' 2185 ' ' ILE . 0.3 OUTLIER -123.45 -162.78 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.524 -0.735 . . . . 0.0 109.558 -179.28 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 2185 ' ' ILE . . . . . 0.738 ' N ' HG13 ' A' 2184 ' ' VAL . 2.7 mp -108.52 138.36 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.186 -0.946 . . . . 0.0 110.213 -179.248 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 64.83 16.31 61.34 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.34 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 2187 ' ' GLY . . . . . 0.526 ' C ' HG12 ' A' 2184 ' ' VAL . . . 167.56 -128.08 1.67 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2188 ' ' PHE . . . . . 0.659 ' N ' HG12 ' A' 2184 ' ' VAL . 5.7 p90 -162.6 170.4 18.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.218 -1.166 . . . . 0.0 109.374 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2189 ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.6 OUTLIER -120.57 151.28 39.63 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.314 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 17.8 p -149.96 141.03 22.98 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.756 -1.215 . . . . 0.0 109.794 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 2191 ' ' THR . . . . . 0.493 ' O ' ' HA3' ' A' 2179 ' ' GLY . 22.2 m -114.92 88.03 2.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.915 . . . . 0.0 109.773 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2192 ' ' CYS . . . . . 0.628 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -51.5 -178.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -0.873 . . . . 0.0 109.119 179.654 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 2193 ' ' GLU . . . . . 0.464 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.6 OUTLIER -58.15 123.59 16.51 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.374 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 2194 ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.8 OUTLIER -37.76 131.81 0.97 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.436 -0.79 . . . . 0.0 110.506 -178.796 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.03 -0.18 10.73 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 2196 ' ' PHE . . . . . 0.68 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.9 OUTLIER -113.69 -164.43 0.93 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.272 -1.134 . . . . 0.0 110.227 -179.904 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 2197 ' ' GLU . . . . . 0.532 ' N ' ' CG ' ' A' 2196 ' ' PHE . 2.5 mm-40 -145.33 96.31 4.9 Favored Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.541 -0.724 . . . . 0.0 109.665 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2198 ' ' PRO . . . . . 0.68 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 7.8 Cg_endo -67.79 -160.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.162 1.908 . . . . 0.0 111.138 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -140.29 -177.24 15.75 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.02 -57.44 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.051 1.834 . . . . 0.0 110.399 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 2201 ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.4 OUTLIER -158.41 60.74 0.44 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.615 -179.858 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 2202 ' ' MET . . . . . 0.464 ' O ' ' CE1' ' A' 2188 ' ' PHE . 0.8 OUTLIER -129.21 -77.16 0.55 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.192 -0.943 . . . . 0.0 109.542 -179.589 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A 2203 ' ' THR . . . . . . . . . . . . . 12.7 t -177.15 -173.91 0.48 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.398 -0.814 . . . . 0.0 109.485 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 2204 ' ' CYS . . . . . 0.528 ' HB2' ' CA ' ' A' 2176 ' ' CYS . 7.7 t -71.99 148.82 45.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.459 -0.776 . . . . 0.0 109.467 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A 2205 ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' 2197 ' ' GLU . 14.7 pt-20 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.539 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A 2125 ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' 2126 ' ' VAL . . . -78.59 145.82 34.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.38 -0.825 . . . . 0.0 109.483 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2126 ' ' VAL . . . . . 0.792 HG23 ' N ' ' A' 2127 ' ' ASP . 0.8 OUTLIER 37.69 -160.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 O-C-N 121.63 -0.669 . . . . 0.0 110.389 179.283 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A 2127 ' ' ASP . . . . . 0.792 ' N ' HG23 ' A' 2126 ' ' VAL . 12.6 t0 -80.91 -47.27 13.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2128 ' ' MET . . . . . 0.504 ' H ' HG23 ' A' 2126 ' ' VAL . 0.0 OUTLIER 73.57 99.77 0.07 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.944 . . . . 0.0 109.117 -179.68 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A 2129 ' ' ASP . . . . . 0.555 ' HB3' ' CG ' ' A' 2132 ' ' LYS . 10.7 t70 -56.0 -42.65 76.7 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.398 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2130 ' ' GLU . . . . . 0.738 ' O ' HG21 ' A' 2136 ' ' VAL . 1.7 mt-10 80.43 -41.55 0.2 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.021 0.438 . . . . 0.0 110.197 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2131 ' ' CYS . . . . . 0.485 ' SG ' ' HB3' ' A' 2137 ' ' CYS . 0.7 OUTLIER -90.93 -27.18 18.89 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.263 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A 2132 ' ' LYS . . . . . 0.555 ' CG ' ' HB3' ' A' 2129 ' ' ASP . 0.0 OUTLIER -56.7 -19.94 19.19 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.304 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A 2133 ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' 2134 ' ' PRO . 0.8 OUTLIER -70.06 137.86 87.25 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.519 -0.738 . . . . 0.0 109.443 -179.819 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A 2134 ' ' PRO . . . . . 0.472 ' O ' ' HD2' ' A' 2138 ' ' LYS . 4.3 Cg_endo -69.38 0.08 5.86 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.346 2.03 . . . . 0.0 111.181 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 22.7 t70 -124.14 1.07 8.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.766 -1.209 . . . . 0.0 110.344 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 2136 ' ' VAL . . . . . 0.738 HG21 ' O ' ' A' 2130 ' ' GLU . 40.5 t -91.73 -95.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.895 -1.128 . . . . 0.0 109.537 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2137 ' ' CYS . . . . . 0.737 ' N ' HG12 ' A' 2136 ' ' VAL . 48.3 t -84.3 -73.24 0.43 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.995 -1.065 . . . . 0.0 109.23 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2138 ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' 2164 ' ' CYS . 0.0 OUTLIER 64.98 127.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 110.34 179.344 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A 2139 ' ' HIS . . . . . 0.512 ' O ' ' HB3' ' A' 2164 ' ' CYS . 9.6 m-70 51.03 26.4 2.74 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.371 -0.831 . . . . 0.0 110.934 178.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2140 ' ' GLY . . . . . 0.434 ' HA3' ' SG ' ' A' 2137 ' ' CYS . . . -128.98 166.89 21.28 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.399 -1.381 . . . . 0.0 110.197 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -89.45 47.87 1.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -1.142 . . . . 0.0 109.003 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 2142 ' ' CYS . . . . . 0.786 ' O ' HD13 ' A' 2143 ' ' ILE . 1.6 p -49.23 160.58 0.22 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.625 -0.672 . . . . 0.0 110.184 -179.727 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2143 ' ' ILE . . . . . 0.786 HD13 ' O ' ' A' 2142 ' ' CYS . 38.1 mm -133.35 121.3 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2144 ' ' ASN . . . . . 0.498 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 13.3 t-20 -64.33 116.51 6.12 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.343 -0.848 . . . . 0.0 110.864 -179.088 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2145 ' ' THR . . . . . 0.522 ' OG1' ' HA ' ' A' 2149 ' ' TYR . 0.0 OUTLIER -108.89 175.4 5.48 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.455 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A 2146 ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' 2146 ' ' ASP . 4.2 p30 -70.08 103.06 2.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 110.042 -179.608 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 65.79 10.89 52.39 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 2148 ' ' SER . . . . . 0.459 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.0 OUTLIER -145.84 -174.7 4.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.112 -1.228 . . . . 0.0 109.607 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A 2149 ' ' TYR . . . . . 0.649 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 38.7 p90 -161.78 -170.02 2.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 109.519 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2150 ' ' ARG . . . . . 0.449 ' CZ ' ' CB ' ' A' 2150 ' ' ARG . 0.0 OUTLIER -170.75 104.18 0.25 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.485 -0.759 . . . . 0.0 109.51 179.531 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A 2151 ' ' CYS . . . . . 0.504 ' SG ' HD13 ' A' 2159 ' ' LEU . 36.5 t -72.14 84.09 1.01 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.37 -0.831 . . . . 0.0 109.151 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -93.47 87.48 5.58 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.364 -0.835 . . . . 0.0 109.208 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 2153 ' ' CYS . . . . . 0.54 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -49.79 152.87 2.37 Favored Pre-proline 0 C--N 1.302 -1.49 0 O-C-N 121.397 -0.815 . . . . 0.0 109.723 -179.625 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A 2154 ' ' PRO . . . . . 0.456 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 2.8 Cg_endo -65.4 -165.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.585 2.19 . . . . 0.0 111.018 -179.254 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 77.7 t80 -91.19 101.94 14.67 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.744 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.14 -11.88 5.56 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 -178.704 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 2157 ' ' TYR . . . . . 0.54 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 7.5 m-85 -110.16 -166.84 1.12 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.41 -1.053 . . . . 0.0 109.873 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2158 ' ' ILE . . . . . 0.921 HD11 HG23 ' A' 2165 ' ' VAL . 0.1 OUTLIER -156.5 -165.23 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.507 -0.745 . . . . 0.0 109.395 179.243 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A 2159 ' ' LEU . . . . . 0.504 HD13 ' SG ' ' A' 2151 ' ' CYS . 28.5 tp -142.75 117.2 9.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.259 -0.9 . . . . 0.0 109.639 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -89.89 49.71 1.76 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.387 -0.821 . . . . 0.0 109.417 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 2161 ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' 2162 ' ' ASN . . . 90.62 -17.79 52.94 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2162 ' ' ASN . . . . . 0.489 ' CG ' ' N ' ' A' 2163 ' ' GLU . 5.8 p30 -178.89 -49.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.105 -1.233 . . . . 0.0 109.793 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2163 ' ' GLU . . . . . 0.489 ' N ' ' CG ' ' A' 2162 ' ' ASN . 5.5 tt0 -70.87 133.41 46.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.505 -0.747 . . . . 0.0 109.236 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2164 ' ' CYS . . . . . 0.512 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -106.97 137.23 45.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.024 -1.047 . . . . 0.0 109.73 -179.628 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A 2165 ' ' VAL . . . . . 0.921 HG23 HD11 ' A' 2158 ' ' ILE . 1.9 m -152.07 -170.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.165 -0.959 . . . . 0.0 109.723 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2166 ' ' ASP . . . . . . . . . . . . . 27.0 t70 -76.75 166.94 22.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.366 -0.834 . . . . 0.0 110.164 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 2167 ' ' THR . . . . . 0.536 ' CG2' ' OE1' ' A' 2169 ' ' GLU . 1.4 t -116.83 -169.21 1.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.435 -0.791 . . . . 0.0 109.138 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2168 ' ' ASP . . . . . 0.522 ' N ' HG23 ' A' 2167 ' ' THR . 56.1 t0 -108.94 101.26 10.37 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.15 -0.969 . . . . 0.0 109.492 179.513 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2169 ' ' GLU . . . . . 0.588 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.9 OUTLIER -81.8 -29.75 32.56 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.413 -0.804 . . . . 0.0 109.396 179.916 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A 2170 ' ' CYS . . . . . 0.532 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 2.0 t -71.71 -4.82 29.64 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.456 -0.777 . . . . 0.0 109.07 179.458 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.65 -9.3 34.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.516 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 20.6 t -82.22 -70.33 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.941 . . . . 0.0 109.554 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 2173 ' ' GLY . . . . . 0.419 ' O ' ' SG ' ' A' 2181 ' ' CYS . . . -173.48 -73.84 0.05 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2174 ' ' ASN . . . . . 0.5 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 0.1 OUTLIER -167.09 96.18 0.67 Allowed Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.21 -1.17 . . . . 0.0 109.089 -179.465 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A 2175 ' ' PRO . . . . . 0.586 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 2.2 Cg_endo -63.22 -27.94 72.72 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.952 1.768 . . . . 0.0 110.615 -179.654 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2176 ' ' CYS . . . . . 0.55 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -51.46 -54.96 21.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.037 -1.039 . . . . 0.0 108.596 -179.974 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 138.6 -17.43 3.28 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 2178 ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' 2179 ' ' GLY . 1.6 t-20 -164.49 -37.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -1.091 . . . . 0.0 109.98 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2179 ' ' GLY . . . . . 0.57 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -60.17 -116.07 0.01 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.377 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 3.0 p -149.59 162.7 39.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.402 -1.057 . . . . 0.0 109.423 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 2181 ' ' CYS . . . . . 0.586 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 21.6 p -97.83 156.41 16.6 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.045 -1.034 . . . . 0.0 111.074 -179.382 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2182 ' ' LYS . . . . . 0.571 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 2.4 tppt? -137.97 159.58 41.63 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 178.556 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 60.1 t30 -100.66 126.64 47.19 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.46 -1.4 . . . . 0.0 109.471 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 2184 ' ' VAL . . . . . 0.927 HG12 ' N ' ' A' 2188 ' ' PHE . 0.7 OUTLIER -137.61 162.38 32.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.521 -0.737 . . . . 0.0 109.242 -179.656 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A 2185 ' ' ILE . . . . . 0.522 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 3.2 mp -76.64 130.51 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 110.258 -179.255 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 89.86 -8.51 79.69 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 2187 ' ' GLY . . . . . 0.493 ' C ' HG12 ' A' 2184 ' ' VAL . . . 174.2 -109.41 0.3 Allowed Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.588 -1.292 . . . . 0.0 109.925 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2188 ' ' PHE . . . . . 0.927 ' N ' HG12 ' A' 2184 ' ' VAL . 3.4 p90 -171.16 178.58 3.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -1.132 . . . . 0.0 109.488 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2189 ' ' GLU . . . . . 0.571 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 3.1 tt0 -128.13 131.98 48.96 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.243 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2190 ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 18.3 p -124.07 137.5 54.57 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.576 -1.328 . . . . 0.0 110.039 -179.144 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2191 ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' 2192 ' ' CYS . 25.6 m -108.8 85.28 2.07 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.334 -0.854 . . . . 0.0 109.552 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2192 ' ' CYS . . . . . 0.61 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.9 OUTLIER -49.23 179.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.515 -0.741 . . . . 0.0 109.19 179.893 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A 2193 ' ' GLU . . . . . 0.509 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.3 tt0 -55.22 112.87 1.18 Allowed 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.658 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2194 ' ' GLU . . . . . 0.509 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.8 OUTLIER -28.26 127.43 0.08 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.446 0.641 . . . . 0.0 111.263 -178.775 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.18 6.65 8.16 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 2196 ' ' PHE . . . . . 0.67 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.2 p90 -117.89 -163.26 0.93 Allowed 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.288 -1.125 . . . . 0.0 110.231 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2197 ' ' GLU . . . . . 0.549 ' N ' ' CG ' ' A' 2196 ' ' PHE . 11.8 mt-10 -144.57 95.82 5.32 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 121.507 -0.746 . . . . 0.0 109.527 -179.699 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2198 ' ' PRO . . . . . 0.67 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 8.3 Cg_endo -67.52 -165.13 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.274 1.983 . . . . 0.0 111.199 -179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -129.37 -171.59 12.98 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.79 -58.41 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.154 1.902 . . . . 0.0 111.169 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 2201 ' ' MET . . . . . 0.517 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.0 OUTLIER -157.18 43.1 0.34 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.091 -1.006 . . . . 0.0 110.52 -179.119 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A 2202 ' ' MET . . . . . 0.451 ' O ' ' CE2' ' A' 2188 ' ' PHE . 17.2 mmm -115.82 -82.9 0.62 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.12 -0.987 . . . . 0.0 109.888 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2203 ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' 2175 ' ' PRO . 9.7 t -165.11 -169.97 1.8 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.182 -0.949 . . . . 0.0 109.604 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2204 ' ' CYS . . . . . 0.576 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.6 t -71.69 146.35 48.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.616 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.334 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A 2129 ' ' ASP . . . . . 0.55 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 17.2 t0 . . . . . 0 N--CA 1.485 1.325 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2130 ' ' GLU . . . . . 0.591 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 2.0 mt-10 81.89 -44.91 0.18 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.864 -0.523 . . . . 0.0 110.511 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2131 ' ' CYS . . . . . 0.509 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 6.6 p -91.26 -31.92 15.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.038 -1.039 . . . . 0.0 110.041 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2132 ' ' LYS . . . . . 0.458 ' HB2' ' CG ' ' A' 2129 ' ' ASP . 0.1 OUTLIER -69.66 -7.47 39.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.088 -1.008 . . . . 0.0 109.622 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -70.32 151.87 95.68 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.378 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2134 ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -66.19 -7.46 17.36 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.374 2.049 . . . . 0.0 110.619 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2135 ' ' ASP . . . . . 0.518 ' O ' ' ND2' ' A' 2162 ' ' ASN . 0.5 OUTLIER -117.44 19.66 13.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.031 -1.043 . . . . 0.0 109.917 -179.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 2136 ' ' VAL . . . . . 0.533 ' CB ' ' O ' ' A' 2130 ' ' GLU . 21.4 t -144.55 127.94 11.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2137 ' ' CYS . . . . . 0.523 ' O ' ' HB2' ' A' 2138 ' ' LYS . 85.9 m 55.99 -90.28 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2138 ' ' LYS . . . . . 0.53 ' O ' ' CB ' ' A' 2139 ' ' HIS . 0.0 OUTLIER 70.0 19.39 6.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.397 -0.814 . . . . 0.0 109.983 179.121 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 2139 ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.3 OUTLIER 163.26 42.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.99 -1.069 . . . . 0.0 110.222 179.388 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -157.39 172.58 34.8 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.523 -1.323 . . . . 0.0 110.345 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2141 ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' 2152 ' ' GLU . 13.4 tt0 -89.71 98.08 11.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -1.1 . . . . 0.0 109.146 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2142 ' ' CYS . . . . . 0.54 ' C ' HD12 ' A' 2143 ' ' ILE . 24.0 p -89.04 177.81 6.55 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.312 -0.868 . . . . 0.0 110.204 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2143 ' ' ILE . . . . . 0.54 HD12 ' C ' ' A' 2142 ' ' CYS . 2.6 mp -134.97 99.84 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2144 ' ' ASN . . . . . 0.55 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 6.5 t-20 -56.66 112.69 1.36 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.303 -0.873 . . . . 0.0 110.77 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2145 ' ' THR . . . . . 0.519 HG23 ' HA ' ' A' 2149 ' ' TYR . 14.4 p -96.24 178.95 5.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.313 -0.867 . . . . 0.0 108.962 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -65.04 -48.8 72.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.225 -0.922 . . . . 0.0 109.703 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2147 ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' 2148 ' ' SER . . . -132.3 49.81 0.91 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2148 ' ' SER . . . . . 0.465 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER 171.56 -160.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -1.19 . . . . 0.0 109.54 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 2149 ' ' TYR . . . . . 0.591 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 3.9 p90 -158.13 -177.82 6.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.424 -0.798 . . . . 0.0 109.468 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2150 ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -151.52 99.38 2.61 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.17 -0.956 . . . . 0.0 109.706 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.86 136.21 56.62 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.561 -0.712 . . . . 0.0 109.778 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2152 ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' 2141 ' ' GLN . 0.1 OUTLIER -141.95 90.39 2.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.887 . . . . 0.0 109.241 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 2153 ' ' CYS . . . . . 0.543 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -69.38 149.26 97.29 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 109.496 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 2154 ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.2 -167.03 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.507 2.138 . . . . 0.0 111.112 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.05 105.52 17.87 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.6 -17.29 5.01 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 107.762 -2.135 . . . . 0.0 107.762 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2157 ' ' TYR . . . . . 0.543 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 9.0 m-85 -108.08 -171.46 1.87 Allowed 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.559 -0.965 . . . . 0.0 110.087 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2158 ' ' ILE . . . . . 0.716 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -156.17 -166.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 2159 ' ' LEU . . . . . 0.43 ' HA ' HD12 ' A' 2159 ' ' LEU . 33.9 tp -138.33 118.7 13.73 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.634 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -97.02 49.14 1.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.431 -0.793 . . . . 0.0 109.439 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 94.57 -28.82 10.09 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2162 ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' 2135 ' ' ASP . 1.4 m-20 -172.5 -43.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -1.116 . . . . 0.0 109.435 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -73.19 125.82 28.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.333 -0.855 . . . . 0.0 109.282 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2164 ' ' CYS . . . . . 0.687 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -102.74 137.88 40.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 108.956 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 2165 ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' 2164 ' ' CYS . 0.6 OUTLIER -160.63 -166.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.05 -1.031 . . . . 0.0 109.97 -179.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 2166 ' ' ASP . . . . . 0.496 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 0.5 OUTLIER -88.56 150.62 22.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.973 . . . . 0.0 110.358 -179.15 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 2167 ' ' THR . . . . . 0.64 HG23 ' OE1' ' A' 2169 ' ' GLU . 13.2 t -92.39 -175.9 4.15 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2168 ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' 2171 ' ' SER . 54.0 t0 -94.31 94.44 8.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.943 -1.098 . . . . 0.0 108.89 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2169 ' ' GLU . . . . . 0.691 ' O ' HG23 ' A' 2172 ' ' VAL . 0.8 OUTLIER -70.77 -30.59 67.12 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.289 -0.882 . . . . 0.0 109.644 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 2170 ' ' CYS . . . . . 0.469 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.6 t -65.14 -11.29 38.55 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.231 -0.918 . . . . 0.0 108.616 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2171 ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.1 OUTLIER -68.99 -6.11 25.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.126 -0.984 . . . . 0.0 109.354 179.426 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 2172 ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' 2169 ' ' GLU . 23.8 t -76.17 -67.98 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.291 -0.881 . . . . 0.0 109.247 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2173 ' ' GLY . . . . . . . . . . . . . . . 156.51 66.98 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2174 ' ' ASN . . . . . 0.502 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 2.8 t-20 49.75 84.92 0.2 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.22 -1.165 . . . . 0.0 109.573 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2175 ' ' PRO . . . . . 0.608 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 5.0 Cg_endo -68.9 -14.25 38.36 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.07 1.846 . . . . 0.0 109.548 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2176 ' ' CYS . . . . . 0.481 ' HB2' ' ND2' ' A' 2174 ' ' ASN . 1.0 OUTLIER -57.91 -62.01 2.12 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.972 0.891 . . . . 0.0 109.316 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 154.55 -21.27 0.62 Allowed Glycine 0 N--CA 1.482 1.744 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2178 ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' 2179 ' ' GLY . 1.2 t30 -165.1 -38.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -1.172 . . . . 0.0 110.148 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2179 ' ' GLY . . . . . 0.615 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -58.06 -141.8 0.01 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 2.3 p -127.46 154.67 44.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -1.139 . . . . 0.0 109.015 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2181 ' ' CYS . . . . . 0.588 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 9.5 p -95.21 163.22 13.37 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.238 1.018 . . . . 0.0 111.327 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2182 ' ' LYS . . . . . 0.547 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.6 OUTLIER -143.0 157.82 44.18 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 2183 ' ' ASN . . . . . 0.447 ' CG ' ' HA ' ' A' 2168 ' ' ASP . 44.5 t30 -94.64 131.14 40.74 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.349 -1.47 . . . . 0.0 110.007 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2184 ' ' VAL . . . . . 0.76 HG13 ' N ' ' A' 2185 ' ' ILE . 0.3 OUTLIER -135.97 -163.23 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.589 -0.695 . . . . 0.0 109.481 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 2185 ' ' ILE . . . . . 0.76 ' N ' HG13 ' A' 2184 ' ' VAL . 2.8 mp -107.85 142.48 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.147 -0.971 . . . . 0.0 110.39 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2186 ' ' GLY . . . . . 0.406 ' O ' ' SD ' ' A' 2201 ' ' MET . . . 67.33 8.67 51.94 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2187 ' ' GLY . . . . . 0.515 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 166.59 -115.31 0.62 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2188 ' ' PHE . . . . . 0.749 ' N ' HG12 ' A' 2184 ' ' VAL . 1.7 p90 -167.34 -178.62 4.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -1.116 . . . . 0.0 109.676 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2189 ' ' GLU . . . . . 0.547 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.2 OUTLIER -125.53 175.18 7.71 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 2190 ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' 2191 ' ' THR . 0.1 OUTLIER -170.82 158.12 5.78 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 118.649 -1.22 . . . . 0.0 110.01 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 2191 ' ' THR . . . . . 0.564 ' O ' HG22 ' A' 2191 ' ' THR . 18.8 m -129.51 78.98 1.88 Allowed 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2192 ' ' CYS . . . . . 0.64 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 1.2 m -47.84 177.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -0.915 . . . . 0.0 109.412 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2193 ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.2 OUTLIER -49.56 113.76 0.9 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 2194 ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.7 tp10 -32.23 129.36 0.19 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.535 0.683 . . . . 0.0 110.907 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.78 0.38 10.91 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2196 ' ' PHE . . . . . 0.675 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.8 OUTLIER -111.19 -162.85 0.81 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.257 -1.143 . . . . 0.0 110.367 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 2197 ' ' GLU . . . . . 0.58 ' N ' ' CG ' ' A' 2196 ' ' PHE . 2.0 mm-40 -147.52 98.04 3.97 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2198 ' ' PRO . . . . . 0.675 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.9 Cg_endo -68.71 -158.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.292 1.995 . . . . 0.0 111.292 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -138.57 -173.97 13.22 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.66 -57.83 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.14 1.893 . . . . 0.0 110.937 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A 2201 ' ' MET . . . . . 0.515 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -157.84 49.08 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 110.266 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A 2202 ' ' MET . . . . . 0.524 ' O ' ' CE2' ' A' 2188 ' ' PHE . 2.7 mmt -119.73 -89.58 0.6 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.043 -1.035 . . . . 0.0 109.979 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2203 ' ' THR . . . . . 0.435 HG23 ' N ' ' A' 2204 ' ' CYS . 6.1 t -157.88 -164.27 1.49 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.208 -0.933 . . . . 0.0 109.404 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2204 ' ' CYS . . . . . 0.532 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 3.9 t -74.08 139.63 44.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.134 -0.979 . . . . 0.0 109.04 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A 2205 ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' 2197 ' ' GLU . 3.2 pt-20 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.631 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2129 ' ' ASP . . . . . 0.519 ' O ' ' CB ' ' A' 2130 ' ' GLU . 18.1 t0 . . . . . 0 N--CA 1.486 1.343 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2130 ' ' GLU . . . . . 0.625 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 1.7 mt-10 82.14 -46.97 0.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.741 -0.599 . . . . 0.0 110.537 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2131 ' ' CYS . . . . . 0.497 ' HA ' HG11 ' A' 2136 ' ' VAL . 11.2 p -90.42 -28.51 18.59 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.947 -1.096 . . . . 0.0 109.472 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2132 ' ' LYS . . . . . 0.491 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.1 OUTLIER -81.46 7.4 11.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.323 -0.86 . . . . 0.0 109.357 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 2133 ' ' GLU . . . . . 0.578 ' OE1' HG21 ' A' 2136 ' ' VAL . 44.8 mt-10 -69.57 149.93 96.91 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 121.297 -0.877 . . . . 0.0 109.158 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2134 ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' 2133 ' ' GLU . 1.7 Cg_endo -65.38 -2.47 6.07 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.631 2.221 . . . . 0.0 111.74 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2135 ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' 2135 ' ' ASP . 17.6 p30 -134.3 6.26 3.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.682 -1.261 . . . . 0.0 110.633 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2136 ' ' VAL . . . . . 0.657 HG12 ' N ' ' A' 2137 ' ' CYS . 53.4 t -101.22 -94.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.924 -1.11 . . . . 0.0 109.851 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2137 ' ' CYS . . . . . 0.657 ' N ' HG12 ' A' 2136 ' ' VAL . 0.1 OUTLIER -81.02 -72.77 0.41 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.988 -1.07 . . . . 0.0 109.364 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 2138 ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' 2137 ' ' CYS . 0.1 OUTLIER 65.48 100.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 110.079 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 2139 ' ' HIS . . . . . 0.506 ' O ' ' HB3' ' A' 2164 ' ' CYS . 57.6 m-70 67.29 55.2 0.68 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 110.026 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -153.96 174.9 32.4 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -105.03 82.96 1.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -1.159 . . . . 0.0 108.963 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2142 ' ' CYS . . . . . 0.489 ' C ' HD12 ' A' 2143 ' ' ILE . 17.3 p -88.32 177.09 6.95 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.37 -0.831 . . . . 0.0 110.345 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2143 ' ' ILE . . . . . 0.489 HD12 ' C ' ' A' 2142 ' ' CYS . 4.0 mp -134.24 101.83 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2144 ' ' ASN . . . . . 0.463 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 6.6 t-20 -58.37 116.87 3.9 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.197 -0.939 . . . . 0.0 110.522 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2145 ' ' THR . . . . . 0.418 ' OG1' ' C ' ' A' 2148 ' ' SER . 0.2 OUTLIER -103.73 174.25 5.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.469 -0.769 . . . . 0.0 108.955 179.142 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.64 -71.15 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.367 -0.833 . . . . 0.0 109.599 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2147 ' ' GLY . . . . . 0.483 ' O ' ' CB ' ' A' 2148 ' ' SER . . . -121.29 62.06 0.52 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2148 ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' 2147 ' ' GLY . 0.3 OUTLIER 166.83 -162.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -1.113 . . . . 0.0 109.546 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 2149 ' ' TYR . . . . . 0.625 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 51.4 p90 -169.1 -170.27 1.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 0.0 109.568 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2150 ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -160.86 112.07 1.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.38 -0.825 . . . . 0.0 109.18 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 1.5 m -75.42 90.21 2.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.9 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -105.58 99.56 9.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 108.878 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2153 ' ' CYS . . . . . 0.539 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -67.64 153.55 94.83 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.249 -0.907 . . . . 0.0 109.9 -179.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 2154 ' ' PRO . . . . . 0.482 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.7 Cg_endo -66.06 -167.23 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.593 2.195 . . . . 0.0 111.318 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 81.6 t80 -90.44 102.61 15.34 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.86 -13.88 5.52 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2157 ' ' TYR . . . . . 0.539 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 7.6 m-85 -108.78 -169.87 1.57 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.439 -1.036 . . . . 0.0 110.016 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2158 ' ' ILE . . . . . 0.841 HD11 HG23 ' A' 2165 ' ' VAL . 0.1 OUTLIER -154.76 -163.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 2159 ' ' LEU . . . . . . . . . . . . . 29.6 tp -141.74 122.12 14.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.199 -0.938 . . . . 0.0 109.718 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -99.58 53.34 0.94 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.307 -0.871 . . . . 0.0 109.265 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2161 ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 87.36 -12.31 63.14 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2162 ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' 2136 ' ' VAL . 1.3 m-20 168.95 -44.85 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.303 -1.116 . . . . 0.0 109.382 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -71.5 114.5 9.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 109.144 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2164 ' ' CYS . . . . . 0.562 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -92.26 139.07 30.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 109.539 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 2165 ' ' VAL . . . . . 0.841 HG23 HD11 ' A' 2158 ' ' ILE . 3.7 m -156.99 -168.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.953 . . . . 0.0 109.569 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2166 ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 13.8 t70 -90.16 155.78 18.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.019 -1.051 . . . . 0.0 109.909 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2167 ' ' THR . . . . . 0.867 HG23 ' OE1' ' A' 2169 ' ' GLU . 10.0 t -98.41 174.96 6.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -0.842 . . . . 0.0 109.248 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2168 ' ' ASP . . . . . 0.454 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 44.4 t0 -93.46 95.17 9.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.077 -1.014 . . . . 0.0 108.935 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2169 ' ' GLU . . . . . 0.867 ' OE1' HG23 ' A' 2167 ' ' THR . 0.6 OUTLIER -69.05 -32.26 71.61 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.318 -0.864 . . . . 0.0 109.573 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 2170 ' ' CYS . . . . . 0.537 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.1 t -65.22 -12.23 49.23 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.61 4.64 10.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.184 -0.947 . . . . 0.0 109.696 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 55.0 t -105.38 -79.03 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.21 -0.931 . . . . 0.0 109.857 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2173 ' ' GLY . . . . . 0.467 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -153.95 135.0 4.57 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2174 ' ' ASN . . . . . 0.609 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 26.0 p-10 -41.68 101.61 0.25 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.41 -1.053 . . . . 0.0 110.092 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2175 ' ' PRO . . . . . 0.577 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 1.1 Cg_endo -65.99 -21.87 56.13 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.827 1.685 . . . . 0.0 109.719 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2176 ' ' CYS . . . . . 0.593 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.1 OUTLIER -52.77 -35.76 57.0 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.169 -0.957 . . . . 0.0 109.308 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 114.4 -14.0 20.8 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2178 ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' 2179 ' ' GLY . 5.0 p-10 -171.48 -47.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.456 -1.026 . . . . 0.0 109.557 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2179 ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -52.47 -114.64 0.01 OUTLIER Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2180 ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' 2190 ' ' CYS . 0.8 OUTLIER -150.48 158.54 44.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -1.186 . . . . 0.0 109.371 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 2181 ' ' CYS . . . . . 0.609 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 16.0 p -90.3 166.14 13.49 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 122.368 1.08 . . . . 0.0 111.23 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2182 ' ' LYS . . . . . 0.635 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 11.3 tptt -143.84 155.81 44.25 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2183 ' ' ASN . . . . . 0.454 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 60.7 t30 -98.78 132.44 44.14 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.483 -1.385 . . . . 0.0 109.734 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2184 ' ' VAL . . . . . 0.827 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -140.8 -171.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 2185 ' ' ILE . . . . . 0.588 ' N ' HG13 ' A' 2184 ' ' VAL . 4.5 mp -104.85 135.67 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.85 -1.156 . . . . 0.0 110.387 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 72.68 13.53 78.14 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2187 ' ' GLY . . . . . 0.579 ' C ' HG12 ' A' 2184 ' ' VAL . . . 166.21 -121.18 0.97 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2188 ' ' PHE . . . . . 0.827 ' N ' HG12 ' A' 2184 ' ' VAL . 4.3 p90 -176.4 173.71 2.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.355 -1.085 . . . . 0.0 108.966 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2189 ' ' GLU . . . . . 0.635 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 3.1 tt0 -120.9 178.07 4.86 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2190 ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' 2180 ' ' THR . 7.6 p -170.9 152.17 3.54 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.861 -1.149 . . . . 0.0 109.436 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2191 ' ' THR . . . . . . . . . . . . . 46.0 m -122.37 91.21 3.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 0.0 110.032 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2192 ' ' CYS . . . . . 0.628 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -54.49 177.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.033 -1.042 . . . . 0.0 108.383 179.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 2193 ' ' GLU . . . . . 0.469 ' O ' ' C ' ' A' 2194 ' ' GLU . 7.4 tt0 -54.66 119.34 5.17 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 178.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2194 ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' 2193 ' ' GLU . 2.1 tt0 -35.08 131.58 0.4 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.536 0.684 . . . . 0.0 110.857 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.49 3.76 10.17 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2196 ' ' PHE . . . . . 0.678 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.0 OUTLIER -116.87 -163.89 0.94 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.224 -1.162 . . . . 0.0 110.489 -179.573 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 2197 ' ' GLU . . . . . 0.567 ' N ' ' CG ' ' A' 2196 ' ' PHE . 20.8 mt-10 -145.31 96.67 4.85 Favored Pre-proline 0 C--N 1.305 -1.364 0 O-C-N 121.633 -0.667 . . . . 0.0 109.512 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2198 ' ' PRO . . . . . 0.678 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.0 Cg_endo -68.69 -164.17 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.149 1.9 . . . . 0.0 111.012 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -133.29 -171.0 12.57 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.39 -81.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.028 1.819 . . . . 0.0 110.431 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2201 ' ' MET . . . . . 0.486 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.0 OUTLIER -133.99 49.97 2.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.089 -1.007 . . . . 0.0 109.684 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 1.7 mmm -122.1 -75.84 0.59 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.336 -0.853 . . . . 0.0 109.601 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A 2203 ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' 2175 ' ' PRO . 14.9 t -173.21 -173.69 0.95 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 109.748 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A 2204 ' ' CYS . . . . . 0.593 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -108.73 151.63 25.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.371 -0.831 . . . . 0.0 109.149 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.049 -0.976 . . . . 0.0 109.544 -179.984 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A 2129 ' ' ASP . . . . . 0.524 ' O ' ' ND2' ' A' 2144 ' ' ASN . 19.1 t0 . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2130 ' ' GLU . . . . . 0.7 ' O ' HG21 ' A' 2136 ' ' VAL . 0.7 OUTLIER 81.52 -41.25 0.15 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.491 -0.756 . . . . 0.0 111.503 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 2131 ' ' CYS . . . . . 0.492 ' HB3' ' HB2' ' A' 2149 ' ' TYR . 14.5 p -90.57 -36.66 14.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.629 -1.294 . . . . 0.0 110.263 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2132 ' ' LYS . . . . . 0.503 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -81.62 7.62 11.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.164 -0.96 . . . . 0.0 109.798 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 2133 ' ' GLU . . . . . 0.414 ' OE2' ' HA ' ' A' 2130 ' ' GLU . 10.0 mt-10 -72.7 153.48 91.44 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.208 -0.933 . . . . 0.0 109.29 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2134 ' ' PRO . . . . . 0.571 ' HA ' ' CG ' ' A' 2138 ' ' LYS . 1.3 Cg_endo -63.72 -8.24 14.97 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.274 1.983 . . . . 0.0 110.667 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2135 ' ' ASP . . . . . 0.632 ' OD1' HG23 ' A' 2136 ' ' VAL . 1.0 OUTLIER -104.34 -20.87 13.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.05 -1.031 . . . . 0.0 110.071 -179.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 2136 ' ' VAL . . . . . 0.931 HG11 ' CE1' ' A' 2149 ' ' TYR . 2.0 t -109.86 -140.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.1 -1.0 . . . . 0.0 108.98 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2137 ' ' CYS . . . . . 0.45 ' H ' HG12 ' A' 2136 ' ' VAL . 0.8 OUTLIER -45.7 96.38 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.897 -1.127 . . . . 0.0 108.984 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 2138 ' ' LYS . . . . . 0.571 ' CG ' ' HA ' ' A' 2134 ' ' PRO . 5.0 mtmt -102.12 26.85 7.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.253 -0.904 . . . . 0.0 110.118 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2139 ' ' HIS . . . . . 0.496 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.1 OUTLIER 165.4 48.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.023 -1.048 . . . . 0.0 110.027 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 2140 ' ' GLY . . . . . 0.475 ' HA2' ' HD3' ' A' 2154 ' ' PRO . . . -152.97 -179.65 28.67 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -100.89 72.03 1.47 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.409 -1.054 . . . . 0.0 109.289 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2142 ' ' CYS . . . . . 0.534 ' C ' HD12 ' A' 2143 ' ' ILE . 7.4 p -62.9 -169.22 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.355 -0.84 . . . . 0.0 110.05 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2143 ' ' ILE . . . . . 0.534 HD12 ' C ' ' A' 2142 ' ' CYS . 4.0 mp -141.54 103.09 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2144 ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' 2129 ' ' ASP . 6.6 t-20 -62.25 116.99 5.48 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.216 -0.927 . . . . 0.0 110.468 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2145 ' ' THR . . . . . 0.48 ' HG1' ' C ' ' A' 2148 ' ' SER . 2.2 p -107.23 -170.6 1.73 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.429 -0.795 . . . . 0.0 108.949 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.79 85.25 4.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.286 -0.883 . . . . 0.0 109.735 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 96.89 -55.58 1.34 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2148 ' ' SER . . . . . 0.48 ' C ' ' HG1' ' A' 2145 ' ' THR . 0.4 OUTLIER -84.72 -158.99 0.39 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -1.097 . . . . 0.0 109.828 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 2149 ' ' TYR . . . . . 0.931 ' CE1' HG11 ' A' 2136 ' ' VAL . 41.2 p90 -178.82 -167.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.489 -0.757 . . . . 0.0 109.375 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2150 ' ' ARG . . . . . 0.49 ' CB ' ' CZ ' ' A' 2150 ' ' ARG . 0.0 OUTLIER -169.02 115.07 0.6 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 109.321 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 2151 ' ' CYS . . . . . 0.486 ' SG ' HD13 ' A' 2159 ' ' LEU . 43.3 t -81.55 113.1 19.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.704 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.48 84.29 2.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.011 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2153 ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -47.4 155.57 0.71 Allowed Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.259 -0.901 . . . . 0.0 109.798 -179.52 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 2154 ' ' PRO . . . . . 0.475 ' HD3' ' HA2' ' A' 2140 ' ' GLY . 1.1 Cg_endo -64.23 -168.8 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.73 2.286 . . . . 0.0 111.703 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 43.9 t80 -88.48 102.81 15.27 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.66 -14.76 5.51 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2157 ' ' TYR . . . . . 0.527 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 7.5 m-85 -109.05 -170.03 1.59 Allowed 'General case' 0 N--CA 1.483 1.222 0 O-C-N 121.574 -0.957 . . . . 0.0 109.74 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2158 ' ' ILE . . . . . 0.731 HD13 ' N ' ' A' 2158 ' ' ILE . 0.2 OUTLIER -156.95 -160.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.579 -0.701 . . . . 0.0 109.563 179.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 2159 ' ' LEU . . . . . 0.486 HD13 ' SG ' ' A' 2151 ' ' CYS . 29.4 tp -145.57 124.17 12.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.414 -0.804 . . . . 0.0 109.377 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -99.02 51.54 0.96 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.353 -0.842 . . . . 0.0 109.486 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 90.26 -22.76 24.93 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2162 ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' 2135 ' ' ASP . 1.4 m-20 -176.03 -45.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.125 -1.22 . . . . 0.0 109.953 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -75.52 127.14 32.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.048 -1.033 . . . . 0.0 109.614 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2164 ' ' CYS . . . . . 0.703 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -99.74 140.38 34.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.69 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 2165 ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' 2164 ' ' CYS . 0.9 OUTLIER -161.82 -166.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.374 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 2166 ' ' ASP . . . . . 0.487 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 23.1 t70 -90.13 159.27 16.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.068 -1.02 . . . . 0.0 109.863 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2167 ' ' THR . . . . . 0.569 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 5.5 t -99.88 -167.42 1.46 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.185 -0.947 . . . . 0.0 109.362 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2168 ' ' ASP . . . . . 0.479 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 57.6 t0 -108.92 99.79 9.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.183 -0.948 . . . . 0.0 109.325 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2169 ' ' GLU . . . . . 0.595 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.6 OUTLIER -74.38 -30.68 62.08 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.21 -0.931 . . . . 0.0 109.446 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 2170 ' ' CYS . . . . . 0.467 ' O ' ' SG ' ' A' 2181 ' ' CYS . 3.1 t -66.85 -8.32 28.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.282 -0.886 . . . . 0.0 109.023 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2171 ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -70.33 -3.8 19.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.066 -1.021 . . . . 0.0 109.541 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 2172 ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' 2169 ' ' GLU . 17.7 t -86.27 -72.51 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 109.569 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2173 ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' 2174 ' ' ASN . . . 166.2 77.94 0.04 OUTLIER Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.641 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2174 ' ' ASN . . . . . 0.623 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 11.0 p-10 36.56 89.12 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.537 -0.978 . . . . 0.0 110.993 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2175 ' ' PRO . . . . . 0.601 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 5.8 Cg_endo -67.5 -12.71 36.67 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.153 1.902 . . . . 0.0 109.227 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2176 ' ' CYS . . . . . 0.479 ' HB3' ' SG ' ' A' 2192 ' ' CYS . 0.9 OUTLIER -55.92 -58.02 9.63 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.834 0.826 . . . . 0.0 109.543 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 146.84 -26.22 1.62 Allowed Glycine 0 N--CA 1.484 1.854 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2178 ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.4 OUTLIER -157.05 -39.39 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.306 -1.114 . . . . 0.0 109.845 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 2179 ' ' GLY . . . . . 0.67 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -59.43 -140.02 0.01 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2180 ' ' THR . . . . . 0.408 ' HA ' ' HB3' ' A' 2174 ' ' ASN . 1.5 p -133.19 148.0 52.04 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.53 -0.982 . . . . 0.0 109.4 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2181 ' ' CYS . . . . . 0.623 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 11.8 p -82.1 167.37 18.83 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.372 1.082 . . . . 0.0 111.439 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2182 ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 6.9 tttm -142.39 161.61 37.6 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2183 ' ' ASN . . . . . 0.479 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 46.6 t30 -101.12 128.78 47.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.412 -1.43 . . . . 0.0 110.108 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2184 ' ' VAL . . . . . 0.84 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -137.41 -175.57 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 2185 ' ' ILE . . . . . 0.525 ' N ' HG13 ' A' 2184 ' ' VAL . 3.7 mp -100.05 140.85 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.114 -0.991 . . . . 0.0 110.053 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 70.62 8.4 63.2 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2187 ' ' GLY . . . . . 0.577 ' C ' HG12 ' A' 2184 ' ' VAL . . . 167.72 -121.4 0.96 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2188 ' ' PHE . . . . . 0.84 ' N ' HG12 ' A' 2184 ' ' VAL . 2.3 p90 -169.04 178.61 4.39 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.272 -1.134 . . . . 0.0 109.295 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2189 ' ' GLU . . . . . 0.566 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.4 tt0 -124.19 -179.67 4.53 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2190 ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' 2191 ' ' THR . 0.5 OUTLIER -171.05 157.74 5.33 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 118.959 -1.096 . . . . 0.0 110.17 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 2191 ' ' THR . . . . . 0.514 ' N ' ' SG ' ' A' 2190 ' ' CYS . 80.3 m -128.75 80.27 1.96 Allowed 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2192 ' ' CYS . . . . . 0.67 ' HA ' ' HA3' ' A' 2179 ' ' GLY . 1.2 m -54.16 175.64 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.224 -0.922 . . . . 0.0 110.149 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2193 ' ' GLU . . . . . 0.508 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.5 tt0 -47.11 108.8 0.16 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2194 ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.4 OUTLIER -28.5 125.72 0.1 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.45 0.643 . . . . 0.0 111.237 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.78 4.22 9.7 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2196 ' ' PHE . . . . . 0.675 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.8 OUTLIER -112.71 -164.26 0.91 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.252 -1.146 . . . . 0.0 110.498 -179.628 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 2197 ' ' GLU . . . . . 0.556 ' N ' ' CG ' ' A' 2196 ' ' PHE . 16.6 mt-10 -145.39 97.29 4.74 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2198 ' ' PRO . . . . . 0.675 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.0 Cg_endo -68.47 -159.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.026 1.818 . . . . 0.0 110.999 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -136.05 -174.88 13.54 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.534 -1.827 . . . . 0.0 108.534 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.63 -52.79 1.64 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.114 1.876 . . . . 0.0 110.622 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A 2201 ' ' MET . . . . . 0.535 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -163.93 57.69 0.16 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.399 -0.813 . . . . 0.0 109.462 -179.52 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -127.99 -84.09 0.59 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 110.002 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2203 ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' 2175 ' ' PRO . 13.3 t -163.36 -164.15 0.91 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.346 -0.846 . . . . 0.0 108.827 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2204 ' ' CYS . . . . . 0.565 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 3.3 t -74.26 140.86 45.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.953 -1.092 . . . . 0.0 109.329 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A 2205 ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' 2197 ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.514 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2129 ' ' ASP . . . . . 0.525 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 53.5 t0 . . . . . 0 N--CA 1.488 1.442 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2130 ' ' GLU . . . . . 0.668 ' O ' HG11 ' A' 2136 ' ' VAL . 22.7 mp0 -49.11 -26.93 3.04 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.289 -0.882 . . . . 0.0 110.547 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2131 ' ' CYS . . . . . 0.493 ' O ' ' HB2' ' A' 2137 ' ' CYS . 0.8 OUTLIER -78.47 -36.1 45.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.701 -1.25 . . . . 0.0 109.678 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 2132 ' ' LYS . . . . . 0.447 ' HB2' ' CG ' ' A' 2129 ' ' ASP . 0.0 OUTLIER -85.53 44.8 1.13 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.003 -1.061 . . . . 0.0 108.623 178.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 2133 ' ' GLU . . . . . 0.558 ' CB ' ' HD2' ' A' 2134 ' ' PRO . 1.4 mt-10 -104.59 173.56 3.26 Favored Pre-proline 0 N--CA 1.486 1.349 0 O-C-N 121.466 -0.771 . . . . 0.0 109.765 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2134 ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' 2133 ' ' GLU . 3.1 Cg_exo -60.41 -11.62 17.32 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.584 2.189 . . . . 0.0 112.542 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2135 ' ' ASP . . . . . 0.581 ' O ' ' C ' ' A' 2136 ' ' VAL . 26.8 m-20 -145.95 -77.41 0.19 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.274 -1.516 . . . . 0.0 111.502 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2136 ' ' VAL . . . . . 0.973 HG23 ' CE1' ' A' 2149 ' ' TYR . 0.1 OUTLIER -12.77 -78.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 120.89 0.376 . . . . 0.0 111.057 -178.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 2137 ' ' CYS . . . . . 0.747 ' N ' HG22 ' A' 2136 ' ' VAL . 13.0 m -121.11 146.07 47.13 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.689 -1.257 . . . . 0.0 108.949 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2138 ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' 2137 ' ' CYS . 2.4 mtpt -161.08 115.99 2.11 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.092 -1.005 . . . . 0.0 109.807 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2139 ' ' HIS . . . . . 0.465 ' O ' ' HB3' ' A' 2164 ' ' CYS . 20.6 m80 71.42 46.63 0.41 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.212 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -154.17 174.9 32.56 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -89.81 86.14 6.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -1.159 . . . . 0.0 108.513 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2142 ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' 2150 ' ' ARG . 13.4 p -85.26 178.84 7.35 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.285 -0.884 . . . . 0.0 110.811 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2143 ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' 2145 ' ' THR . 4.0 mp -140.02 88.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2144 ' ' ASN . . . . . 0.525 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 8.0 t-20 -53.94 116.08 2.36 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.515 0.674 . . . . 0.0 110.515 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2145 ' ' THR . . . . . 0.435 HG23 ' O ' ' A' 2143 ' ' ILE . 56.4 p -107.75 -171.31 1.85 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2146 ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' 2145 ' ' THR . 0.4 OUTLIER -45.4 -79.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 109.284 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -115.45 -33.61 1.57 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2148 ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.77 -162.13 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -1.138 . . . . 0.0 109.44 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2149 ' ' TYR . . . . . 0.973 ' CE1' HG23 ' A' 2136 ' ' VAL . 12.9 p90 -172.58 -172.72 0.93 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.373 -0.83 . . . . 0.0 109.312 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2150 ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' A' 2149 ' ' TYR . 11.6 mtt180 -159.6 113.79 2.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.392 -0.818 . . . . 0.0 109.24 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2151 ' ' CYS . . . . . 0.527 ' HB2' HD13 ' A' 2159 ' ' LEU . 4.1 m -84.03 68.21 9.96 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.492 -0.755 . . . . 0.0 109.275 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -79.49 134.74 36.52 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.314 -0.866 . . . . 0.0 108.983 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2153 ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -101.53 154.23 37.38 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.245 -0.909 . . . . 0.0 109.772 -179.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 2154 ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' 2157 ' ' TYR . 1.5 Cg_endo -64.4 -166.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.505 2.137 . . . . 0.0 110.906 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 65.8 t80 -90.34 102.53 15.26 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.26 -13.9 5.42 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.169 -1.973 . . . . 0.0 108.169 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2157 ' ' TYR . . . . . 0.533 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 7.4 m-85 -108.21 -167.92 1.3 Allowed 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.533 -0.981 . . . . 0.0 109.901 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2158 ' ' ILE . . . . . 0.979 HD11 HG23 ' A' 2165 ' ' VAL . 0.2 OUTLIER -156.21 -166.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.6 -0.687 . . . . 0.0 109.193 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 2159 ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' 2151 ' ' CYS . 9.5 tp -143.17 130.4 20.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.313 -0.867 . . . . 0.0 109.332 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -101.4 46.6 0.93 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.261 -0.899 . . . . 0.0 108.921 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2161 ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' 2162 ' ' ASN . . . 86.36 -9.28 70.95 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2162 ' ' ASN . . . . . 0.509 ' CA ' ' O ' ' A' 2136 ' ' VAL . 12.7 p-10 178.05 -47.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.248 . . . . 0.0 109.882 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2163 ' ' GLU . . . . . 0.423 ' N ' ' CG ' ' A' 2162 ' ' ASN . 11.5 tt0 -77.82 116.54 18.41 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.7 -0.625 . . . . 0.0 109.867 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2164 ' ' CYS . . . . . 0.589 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -93.21 140.72 29.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.93 . . . . 0.0 109.457 179.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 2165 ' ' VAL . . . . . 0.979 HG23 HD11 ' A' 2158 ' ' ILE . 1.4 m -157.12 -165.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.105 -0.997 . . . . 0.0 109.562 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2166 ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 35.0 t70 -89.13 165.75 14.29 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.936 -1.102 . . . . 0.0 110.226 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2167 ' ' THR . . . . . 0.556 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 1.6 t -113.56 -169.94 1.6 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.408 -0.808 . . . . 0.0 109.407 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2168 ' ' ASP . . . . . 0.512 ' N ' HG23 ' A' 2167 ' ' THR . 55.7 t0 -109.3 98.85 8.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.249 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2169 ' ' GLU . . . . . 0.593 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.6 OUTLIER -73.47 -31.61 63.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.366 -0.834 . . . . 0.0 109.33 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 2170 ' ' CYS . . . . . 0.444 ' O ' ' SG ' ' A' 2170 ' ' CYS . 1.7 t -66.27 -9.47 32.91 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.342 -0.849 . . . . 0.0 108.735 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.52 7.92 8.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.363 -0.836 . . . . 0.0 110.234 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 57.4 t -112.42 -80.23 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.0 -1.062 . . . . 0.0 109.772 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2173 ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -147.63 131.73 3.99 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2174 ' ' ASN . . . . . 0.607 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 26.9 p-10 -43.78 102.66 0.29 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.301 -1.117 . . . . 0.0 109.577 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2175 ' ' PRO . . . . . 0.592 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 2.7 Cg_endo -70.65 -20.24 30.9 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.807 1.671 . . . . 0.0 110.015 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2176 ' ' CYS . . . . . 0.58 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.1 OUTLIER -50.88 -31.12 16.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -0.989 . . . . 0.0 109.3 -179.463 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 112.63 -23.72 14.69 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.67 -34.57 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.577 -0.955 . . . . 0.0 110.028 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2179 ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -63.65 -127.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 2.8 p -135.71 157.79 46.0 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.527 -0.984 . . . . 0.0 109.133 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2181 ' ' CYS . . . . . 0.607 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 12.9 p -95.46 162.31 13.7 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.053 -1.03 . . . . 0.0 111.186 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2182 ' ' LYS . . . . . 0.575 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 5.3 tptm -142.23 165.28 27.87 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2183 ' ' ASN . . . . . 0.46 ' N ' ' HG3' ' A' 2182 ' ' LYS . 63.1 t30 -100.74 138.15 38.18 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.505 -1.372 . . . . 0.0 110.09 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2184 ' ' VAL . . . . . 0.889 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -147.33 165.88 6.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 2185 ' ' ILE . . . . . 0.528 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 3.2 mp -86.85 131.47 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.071 -1.018 . . . . 0.0 110.224 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 86.43 6.34 81.0 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2187 ' ' GLY . . . . . 0.547 ' C ' HG12 ' A' 2184 ' ' VAL . . . 162.73 -113.63 0.57 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2188 ' ' PHE . . . . . 0.889 ' N ' HG12 ' A' 2184 ' ' VAL . 2.9 p90 -173.3 179.48 2.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.171 -1.194 . . . . 0.0 109.352 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2189 ' ' GLU . . . . . 0.575 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.6 tt0 -125.71 173.24 9.16 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 3.5 p -170.87 148.01 2.8 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.653 -1.279 . . . . 0.0 110.016 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2191 ' ' THR . . . . . . . . . . . . . 60.6 m -118.67 87.87 2.81 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.376 -0.828 . . . . 0.0 109.291 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2192 ' ' CYS . . . . . 0.617 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.0 OUTLIER -51.81 178.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.299 -0.876 . . . . 0.0 108.92 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 2193 ' ' GLU . . . . . 0.46 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.0 OUTLIER -53.33 118.22 3.65 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 2194 ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.4 mt-10 -34.2 128.94 0.38 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.444 0.64 . . . . 0.0 110.991 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.77 4.04 9.79 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2196 ' ' PHE . . . . . 0.672 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.1 p90 -115.06 -164.01 0.91 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.306 -1.114 . . . . 0.0 110.487 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2197 ' ' GLU . . . . . 0.555 ' N ' ' CG ' ' A' 2196 ' ' PHE . 14.5 mt-10 -145.58 96.64 4.76 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.652 -0.655 . . . . 0.0 109.444 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2198 ' ' PRO . . . . . 0.672 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.1 Cg_endo -68.42 -166.3 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.249 1.966 . . . . 0.0 111.44 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -133.25 -173.82 13.39 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.75 -78.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.005 1.803 . . . . 0.0 110.751 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2201 ' ' MET . . . . . 0.478 ' SD ' ' O ' ' A' 2185 ' ' ILE . 0.0 OUTLIER -138.73 40.76 2.18 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.224 -0.922 . . . . 0.0 109.634 -179.271 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 1.6 mmm -112.41 -69.25 0.88 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.131 -0.98 . . . . 0.0 109.721 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2203 ' ' THR . . . . . . . . . . . . . 7.0 t -175.48 -168.27 0.3 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.854 . . . . 0.0 109.504 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A 2204 ' ' CYS . . . . . 0.58 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -114.81 153.93 29.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 108.936 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.563 -179.892 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A 2129 ' ' ASP . . . . . 0.53 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 25.3 t0 . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2130 ' ' GLU . . . . . 0.765 ' O ' HG21 ' A' 2136 ' ' VAL . 1.7 mt-10 81.26 -38.67 0.13 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.754 -0.592 . . . . 0.0 110.452 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2131 ' ' CYS . . . . . 0.487 ' O ' ' HB2' ' A' 2137 ' ' CYS . 5.2 p -90.71 -40.36 11.9 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.752 -1.217 . . . . 0.0 110.02 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2132 ' ' LYS . . . . . 0.483 ' N ' ' SG ' ' A' 2131 ' ' CYS . 0.0 OUTLIER -75.6 7.11 3.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.099 -1.001 . . . . 0.0 110.465 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 2133 ' ' GLU . . . . . 0.482 ' HB2' HG23 ' A' 2136 ' ' VAL . 7.3 mm-40 -69.22 151.5 96.99 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.989 -1.069 . . . . 0.0 109.448 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2134 ' ' PRO . . . . . 0.511 ' HA ' ' HE2' ' A' 2138 ' ' LYS . 1.4 Cg_endo -64.47 -6.45 11.98 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.392 2.061 . . . . 0.0 110.889 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2135 ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' 2162 ' ' ASN . 10.6 m-20 -118.15 -25.85 6.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.929 -1.107 . . . . 0.0 110.407 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2136 ' ' VAL . . . . . 0.765 HG21 ' O ' ' A' 2130 ' ' GLU . 16.4 t -83.48 -119.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.076 -1.015 . . . . 0.0 108.813 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2137 ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' 2131 ' ' CYS . 59.3 m -67.4 145.89 54.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.554 -1.341 . . . . 0.0 108.392 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2138 ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' 2134 ' ' PRO . 4.1 mttm -149.99 28.43 0.76 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.045 -1.035 . . . . 0.0 110.139 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2139 ' ' HIS . . . . . 0.491 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.1 OUTLIER 162.72 36.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.221 -0.925 . . . . 0.0 109.804 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -150.88 -176.09 23.45 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.62 111.72 24.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -1.066 . . . . 0.0 109.541 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2142 ' ' CYS . . . . . 0.645 ' C ' HD12 ' A' 2143 ' ' ILE . 11.0 p -99.39 -167.81 1.53 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.301 -0.874 . . . . 0.0 109.594 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2143 ' ' ILE . . . . . 0.69 ' O ' HG23 ' A' 2145 ' ' THR . 3.4 mp -149.89 101.09 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 109.259 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2144 ' ' ASN . . . . . 0.53 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 11.2 t-20 -52.65 113.99 1.25 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.3 -0.875 . . . . 0.0 110.189 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2145 ' ' THR . . . . . 0.69 HG23 ' O ' ' A' 2143 ' ' ILE . 5.0 p -117.41 -179.81 3.83 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.372 -0.83 . . . . 0.0 109.083 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.56 117.9 31.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.309 -0.869 . . . . 0.0 109.558 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 73.61 18.75 79.56 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2148 ' ' SER . . . . . 0.477 ' C ' ' HG1' ' A' 2145 ' ' THR . 0.0 OUTLIER -174.81 -171.1 0.52 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -1.147 . . . . 0.0 109.566 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 2149 ' ' TYR . . . . . 0.487 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 7.0 p90 -164.11 -168.43 1.57 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.86 . . . . 0.0 109.408 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2150 ' ' ARG . . . . . 0.489 ' HB2' ' HB ' ' A' 2143 ' ' ILE . 0.0 OUTLIER -130.65 -165.0 1.49 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.869 . . . . 0.0 109.562 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 176.79 38.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.417 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.83 147.19 30.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.356 -0.84 . . . . 0.0 109.364 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2153 ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -110.16 160.77 27.06 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.335 -0.853 . . . . 0.0 109.536 -179.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 2154 ' ' PRO . . . . . 0.495 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 2.3 Cg_endo -61.72 -174.46 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.664 2.243 . . . . 0.0 111.669 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 4.4 t80 -81.44 103.19 11.01 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.92 -19.74 4.9 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 107.182 -2.367 . . . . 0.0 107.182 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2157 ' ' TYR . . . . . 0.512 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 20.1 m-85 -108.35 178.71 4.41 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.806 -0.82 . . . . 0.0 109.794 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2158 ' ' ILE . . . . . 0.763 HD13 ' N ' ' A' 2158 ' ' ILE . 0.2 OUTLIER -157.61 -166.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 2159 ' ' LEU . . . . . 0.413 ' HG ' ' N ' ' A' 2160 ' ' ALA . 11.4 tp -131.31 144.98 51.67 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.245 -0.91 . . . . 0.0 109.835 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2160 ' ' ALA . . . . . 0.413 ' N ' ' HG ' ' A' 2159 ' ' LEU . . . -121.11 53.82 1.13 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.389 -0.819 . . . . 0.0 109.013 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 93.59 -21.39 41.29 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2162 ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' 2135 ' ' ASP . 4.0 m-20 173.04 -40.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.357 -1.084 . . . . 0.0 109.502 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -77.87 122.27 25.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 0.0 109.295 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2164 ' ' CYS . . . . . 0.68 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -92.41 143.38 26.43 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 0.0 109.397 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 2165 ' ' VAL . . . . . 0.68 HG13 ' O ' ' A' 2164 ' ' CYS . 1.5 m -160.89 -168.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.12 -0.987 . . . . 0.0 109.485 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2166 ' ' ASP . . . . . 0.43 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 1.1 t0 -90.61 144.85 25.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.001 -1.062 . . . . 0.0 109.747 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2167 ' ' THR . . . . . 0.613 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 9.1 t -91.96 179.64 5.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.886 . . . . 0.0 109.528 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2168 ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' 2171 ' ' SER . 33.2 t0 -86.74 95.6 9.88 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2169 ' ' GLU . . . . . 0.612 ' O ' HG23 ' A' 2172 ' ' VAL . 0.4 OUTLIER -66.22 -27.89 68.32 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.135 -0.978 . . . . 0.0 110.418 -179.006 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 2170 ' ' CYS . . . . . 0.439 ' HB3' ' OD1' ' A' 2168 ' ' ASP . 0.7 OUTLIER -58.13 -13.18 4.37 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.901 -1.125 . . . . 0.0 108.891 178.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 2171 ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -61.24 -10.66 7.19 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.137 -0.977 . . . . 0.0 110.159 -179.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 2172 ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' 2169 ' ' GLU . 17.4 t -77.06 -69.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.173 -0.954 . . . . 0.0 109.406 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2173 ' ' GLY . . . . . . . . . . . . . . . 156.36 92.96 0.09 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2174 ' ' ASN . . . . . . . . . . . . . 1.3 t-20 45.68 87.79 0.11 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.199 -1.177 . . . . 0.0 110.027 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2175 ' ' PRO . . . . . 0.661 ' CB ' ' CD1' ' A' 2188 ' ' PHE . 1.6 Cg_endo -63.02 -23.45 73.91 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.896 1.731 . . . . 0.0 110.212 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2176 ' ' CYS . . . . . 0.47 ' HB3' ' SG ' ' A' 2192 ' ' CYS . 0.4 OUTLIER -76.83 -68.11 0.64 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 109.288 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 159.81 -20.89 0.26 Allowed Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 1.3 t30 -166.55 -30.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.156 -1.202 . . . . 0.0 110.853 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2179 ' ' GLY . . . . . 0.589 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -61.72 -103.91 0.01 OUTLIER Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.6 -1.286 . . . . 0.0 109.937 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2180 ' ' THR . . . . . 0.411 HG23 ' O ' ' A' 2179 ' ' GLY . 1.1 p -153.75 162.33 41.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.467 -1.019 . . . . 0.0 109.027 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2181 ' ' CYS . . . . . 0.555 ' HB3' ' HD3' ' A' 2175 ' ' PRO . 27.3 p -97.05 161.63 13.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.11 -0.994 . . . . 0.0 110.41 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2182 ' ' LYS . . . . . 0.622 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.2 OUTLIER -146.65 155.12 42.2 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.338 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 64.0 t30 -101.12 127.85 47.48 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.685 -1.259 . . . . 0.0 109.106 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2184 ' ' VAL . . . . . 0.632 HG12 ' N ' ' A' 2188 ' ' PHE . 0.6 OUTLIER -134.33 -166.76 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.419 -0.801 . . . . 0.0 109.367 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 2185 ' ' ILE . . . . . 0.615 ' N ' HG13 ' A' 2184 ' ' VAL . 3.9 mp -105.89 134.57 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.0 110.032 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2186 ' ' GLY . . . . . 0.426 ' O ' ' SD ' ' A' 2201 ' ' MET . . . 78.8 4.16 87.99 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2187 ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 170.54 -116.96 0.67 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.457 -1.354 . . . . 0.0 109.985 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2188 ' ' PHE . . . . . 0.661 ' CD1' ' CB ' ' A' 2175 ' ' PRO . 5.0 p90 -168.25 173.13 8.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.39 -1.065 . . . . 0.0 109.184 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2189 ' ' GLU . . . . . 0.622 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.2 tp10 -127.02 155.69 42.83 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2190 ' ' CYS . . . . . 0.408 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 25.4 p -151.25 145.79 25.61 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.711 -1.243 . . . . 0.0 110.035 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2191 ' ' THR . . . . . 0.494 ' O ' ' HA3' ' A' 2179 ' ' GLY . 23.3 m -112.24 84.67 2.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.379 -0.826 . . . . 0.0 109.847 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2192 ' ' CYS . . . . . 0.628 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.1 m -48.79 -179.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.293 -0.879 . . . . 0.0 109.608 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2193 ' ' GLU . . . . . 0.476 ' O ' ' C ' ' A' 2194 ' ' GLU . 19.1 tt0 -50.65 116.49 1.96 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2194 ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.3 OUTLIER -34.85 125.69 0.54 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.71 -0.619 . . . . 0.0 110.723 -179.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.16 1.24 10.41 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2196 ' ' PHE . . . . . 0.675 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.3 p90 -108.89 -163.28 0.86 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.199 -1.177 . . . . 0.0 109.987 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2197 ' ' GLU . . . . . 0.529 ' N ' ' CG ' ' A' 2196 ' ' PHE . 16.8 mt-10 -145.62 95.58 4.92 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 121.496 -0.753 . . . . 0.0 109.556 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2198 ' ' PRO . . . . . 0.675 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.8 Cg_endo -68.71 -165.23 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.213 1.942 . . . . 0.0 111.259 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -133.13 -169.09 12.09 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.71 -81.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.998 1.799 . . . . 0.0 110.563 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A 2201 ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.0 OUTLIER -137.08 56.38 1.79 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.974 . . . . 0.0 109.952 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A 2202 ' ' MET . . . . . 0.439 ' O ' ' HB ' ' A' 2203 ' ' THR . 2.4 mmt -123.81 -72.25 0.69 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.271 -0.893 . . . . 0.0 109.615 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2203 ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' 2202 ' ' MET . 11.3 t -180.0 -170.84 0.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.844 . . . . 0.0 109.432 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2204 ' ' CYS . . . . . 0.478 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.4 t -70.27 146.83 50.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 109.565 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.385 179.977 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A 2129 ' ' ASP . . . . . 0.55 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 20.1 t0 . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2130 ' ' GLU . . . . . 0.592 ' O ' HG21 ' A' 2136 ' ' VAL . 1.5 mt-10 80.85 -41.15 0.17 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.651 -0.656 . . . . 0.0 110.943 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2131 ' ' CYS . . . . . 0.496 ' HB2' ' SG ' ' A' 2137 ' ' CYS . 9.8 p -90.23 -33.07 16.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.664 -1.273 . . . . 0.0 110.005 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2132 ' ' LYS . . . . . 0.474 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -81.53 6.86 13.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.135 -0.978 . . . . 0.0 109.225 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -69.71 154.04 95.09 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.254 -0.904 . . . . 0.0 109.343 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2134 ' ' PRO . . . . . 0.486 ' O ' ' HD2' ' A' 2138 ' ' LYS . 3.7 Cg_endo -68.5 1.49 3.61 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.504 2.136 . . . . 0.0 111.536 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -134.36 0.05 3.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.602 -1.311 . . . . 0.0 110.733 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2136 ' ' VAL . . . . . 0.592 HG21 ' O ' ' A' 2130 ' ' GLU . 21.7 t -106.3 -119.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.818 -1.176 . . . . 0.0 109.594 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2137 ' ' CYS . . . . . 0.532 ' N ' HG12 ' A' 2136 ' ' VAL . 3.8 m -76.74 111.45 12.27 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.754 -1.216 . . . . 0.0 108.799 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2138 ' ' LYS . . . . . 0.486 ' HD2' ' O ' ' A' 2134 ' ' PRO . 6.2 mtpp -116.37 112.58 21.71 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.242 -0.911 . . . . 0.0 110.096 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2139 ' ' HIS . . . . . 0.491 ' O ' ' HB3' ' A' 2164 ' ' CYS . 2.1 m-70 74.14 56.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.884 . . . . 0.0 109.944 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -159.7 -176.98 32.37 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -103.6 91.14 3.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -1.122 . . . . 0.0 109.043 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2142 ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' 2150 ' ' ARG . 26.7 p -86.48 -178.94 6.54 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.228 -0.92 . . . . 0.0 110.2 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2143 ' ' ILE . . . . . 0.654 ' O ' HG23 ' A' 2145 ' ' THR . 3.6 mp -141.45 94.24 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.441 -0.787 . . . . 0.0 108.886 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2144 ' ' ASN . . . . . 0.55 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 11.1 t-20 -47.95 117.83 2.07 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.36 -0.837 . . . . 0.0 110.054 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2145 ' ' THR . . . . . 0.654 HG23 ' O ' ' A' 2143 ' ' ILE . 70.9 p -116.49 -174.66 2.6 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.431 -0.793 . . . . 0.0 109.046 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.31 118.44 25.75 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.341 -0.849 . . . . 0.0 109.602 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2147 ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' 2148 ' ' SER . . . 53.62 42.3 66.73 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2148 ' ' SER . . . . . 0.466 ' O ' ' OE1' ' A' 2130 ' ' GLU . 1.8 t 178.16 -162.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -1.109 . . . . 0.0 109.66 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2149 ' ' TYR . . . . . 0.574 ' CD2' ' HB3' ' A' 2130 ' ' GLU . 45.2 p90 179.66 -169.5 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.806 . . . . 0.0 109.336 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2150 ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' 2149 ' ' TYR . 12.4 mtt180 -160.46 119.67 2.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.493 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 82.3 m -83.18 69.76 9.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.328 -0.857 . . . . 0.0 109.234 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -80.47 109.18 14.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.522 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2153 ' ' CYS . . . . . 0.51 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -82.38 152.66 67.76 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 121.148 -0.97 . . . . 0.0 109.356 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 2154 ' ' PRO . . . . . 0.43 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.2 Cg_endo -64.58 -168.54 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.493 2.128 . . . . 0.0 111.207 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 9.1 t80 -90.19 103.25 15.94 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2156 ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' 2167 ' ' THR . . . 130.93 -14.17 5.49 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 -178.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2157 ' ' TYR . . . . . 0.741 ' OH ' HG23 ' A' 2185 ' ' ILE . 7.7 m-85 -107.86 -169.37 1.51 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.516 -0.99 . . . . 0.0 109.945 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2158 ' ' ILE . . . . . 0.97 HD11 HG23 ' A' 2165 ' ' VAL . 0.1 OUTLIER -155.78 -165.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.452 -0.78 . . . . 0.0 109.458 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 2159 ' ' LEU . . . . . 0.449 ' N ' HG12 ' A' 2158 ' ' ILE . 28.7 tp -141.35 125.76 17.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.365 -0.834 . . . . 0.0 109.574 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -101.92 52.67 0.82 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.899 . . . . 0.0 109.261 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2161 ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 88.28 -9.66 74.32 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2162 ' ' ASN . . . . . 0.529 ' ND2' ' HA ' ' A' 2136 ' ' VAL . 1.7 m-20 167.04 -47.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -1.195 . . . . 0.0 109.444 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2163 ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' A' 2138 ' ' LYS . 25.5 tt0 -70.28 115.94 10.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.304 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2164 ' ' CYS . . . . . 0.616 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -92.33 144.55 25.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.52 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 2165 ' ' VAL . . . . . 0.97 HG23 HD11 ' A' 2158 ' ' ILE . 0.4 OUTLIER -159.17 -167.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.426 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 2166 ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' 2184 ' ' VAL . 35.6 t70 -85.95 166.59 15.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.956 -1.09 . . . . 0.0 109.796 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2167 ' ' THR . . . . . 0.549 ' CG2' ' OE1' ' A' 2169 ' ' GLU . 5.6 t -113.73 -168.82 1.4 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.391 -0.818 . . . . 0.0 109.46 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2168 ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' 2168 ' ' ASP . 61.0 t0 -110.39 103.58 12.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.0 109.602 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2169 ' ' GLU . . . . . 0.641 ' O ' HG23 ' A' 2172 ' ' VAL . 0.5 OUTLIER -79.99 -30.58 39.72 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.323 -0.86 . . . . 0.0 109.157 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 2170 ' ' CYS . . . . . 0.533 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 0.5 OUTLIER -64.74 -11.24 34.24 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.371 -0.831 . . . . 0.0 109.008 179.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -6.48 26.19 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.195 -0.94 . . . . 0.0 109.445 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2172 ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' 2169 ' ' GLU . 19.0 t -78.58 -70.5 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.196 -0.94 . . . . 0.0 109.051 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2173 ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' 2174 ' ' ASN . . . 161.78 77.04 0.03 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2174 ' ' ASN . . . . . 0.478 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 9.4 t-20 43.85 82.36 0.23 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.257 -1.143 . . . . 0.0 109.835 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2175 ' ' PRO . . . . . 0.614 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 0.9 OUTLIER -64.6 -20.86 65.79 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.289 1.993 . . . . 0.0 110.141 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 2176 ' ' CYS . . . . . 0.508 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.1 OUTLIER -55.63 -58.01 9.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.051 -1.031 . . . . 0.0 108.758 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 143.77 -19.59 2.19 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 1.1 t30 -160.6 -34.95 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -1.172 . . . . 0.0 110.539 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2179 ' ' GLY . . . . . 0.612 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -66.15 -125.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.034 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 2.5 p -140.92 162.22 35.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.491 -1.005 . . . . 0.0 109.252 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2181 ' ' CYS . . . . . 0.596 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 24.5 p -99.7 151.16 21.53 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.09 0.948 . . . . 0.0 111.341 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2182 ' ' LYS . . . . . 0.529 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 4.9 tptt -134.36 157.0 47.51 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 58.5 t30 -95.9 139.71 31.71 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.361 -1.462 . . . . 0.0 109.862 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2184 ' ' VAL . . . . . 0.681 HG12 ' CA ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -147.78 176.7 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.528 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 2185 ' ' ILE . . . . . 0.741 HG23 ' OH ' ' A' 2157 ' ' TYR . 1.2 mp -93.77 139.06 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.01 -1.056 . . . . 0.0 110.118 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 74.75 8.63 82.15 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2187 ' ' GLY . . . . . 0.58 ' C ' HG12 ' A' 2184 ' ' VAL . . . 161.94 -128.76 1.95 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2188 ' ' PHE . . . . . 0.681 ' CA ' HG12 ' A' 2184 ' ' VAL . 1.2 p90 -158.7 -178.78 7.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -1.15 . . . . 0.0 109.532 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2189 ' ' GLU . . . . . 0.529 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.6 OUTLIER -131.85 111.14 11.34 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 2190 ' ' CYS . . . . . 0.45 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 31.2 p -110.65 137.48 48.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.785 -1.197 . . . . 0.0 109.774 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2191 ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' 2192 ' ' CYS . 59.5 m -111.1 87.39 2.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.283 -0.886 . . . . 0.0 109.175 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2192 ' ' CYS . . . . . 0.614 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.0 OUTLIER -48.33 -179.01 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.671 0.748 . . . . 0.0 109.703 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 2193 ' ' GLU . . . . . 0.475 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.6 OUTLIER -59.15 123.83 17.94 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 2194 ' ' GLU . . . . . 0.475 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.6 OUTLIER -34.74 129.5 0.43 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.43 0.633 . . . . 0.0 110.878 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.47 1.51 10.04 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2196 ' ' PHE . . . . . 0.673 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.8 OUTLIER -116.33 -164.54 0.98 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.184 -1.186 . . . . 0.0 110.192 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 2197 ' ' GLU . . . . . 0.564 ' N ' ' CG ' ' A' 2196 ' ' PHE . 0.3 OUTLIER -146.14 98.15 4.39 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 2198 ' ' PRO . . . . . 0.673 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.9 Cg_endo -68.68 -164.44 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.242 1.962 . . . . 0.0 111.174 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -132.49 -173.71 13.4 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2200 ' ' PRO . . . . . 0.405 ' C ' ' HG2' ' A' 2201 ' ' MET . 1.2 Cg_endo -64.4 -54.63 0.75 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.919 1.746 . . . . 0.0 110.629 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2201 ' ' MET . . . . . 0.503 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -159.8 49.57 0.3 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 0.0 109.566 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 2.1 mmm -118.63 -79.3 0.59 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.253 -0.904 . . . . 0.0 109.674 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A 2203 ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' 2175 ' ' PRO . 6.7 t -173.51 -166.36 0.32 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.306 -0.871 . . . . 0.0 109.228 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2204 ' ' CYS . . . . . 0.548 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.2 t -70.31 141.63 52.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.073 -1.017 . . . . 0.0 109.541 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A 2205 ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' 2197 ' ' GLU . 23.0 pt-20 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.35 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2129 ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' A' 2130 ' ' GLU . 1.3 t0 . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2130 ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' 2129 ' ' ASP . 0.1 OUTLIER 81.29 -67.59 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.792 -0.568 . . . . 0.0 110.46 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 2131 ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' 2137 ' ' CYS . 1.7 t -81.28 -9.82 59.69 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.133 -0.979 . . . . 0.0 109.828 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2132 ' ' LYS . . . . . 0.503 ' CB ' ' HB3' ' A' 2129 ' ' ASP . 0.0 OUTLIER -72.42 -15.02 61.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.787 -1.196 . . . . 0.0 109.785 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 2133 ' ' GLU . . . . . 0.602 ' HB2' HG23 ' A' 2136 ' ' VAL . 3.7 mt-10 -74.3 146.5 84.32 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.152 -0.968 . . . . 0.0 109.631 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2134 ' ' PRO . . . . . 0.473 ' HA ' ' CG ' ' A' 2138 ' ' LYS . 1.2 Cg_endo -65.22 -11.98 32.65 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.273 1.982 . . . . 0.0 110.133 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2135 ' ' ASP . . . . . 0.511 ' O ' ' ND2' ' A' 2162 ' ' ASN . 0.4 OUTLIER -110.35 21.57 16.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.95 . . . . 0.0 109.483 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 2136 ' ' VAL . . . . . 0.602 HG23 ' HB2' ' A' 2133 ' ' GLU . 18.5 t -136.86 109.75 7.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2137 ' ' CYS . . . . . 0.543 ' CA ' ' O ' ' A' 2162 ' ' ASN . 56.4 m 64.92 -89.65 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2138 ' ' LYS . . . . . 0.514 ' O ' ' CB ' ' A' 2139 ' ' HIS . 0.0 OUTLIER 68.11 28.29 6.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.963 -1.086 . . . . 0.0 111.268 178.089 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 2139 ' ' HIS . . . . . 0.521 ' CB ' ' HB3' ' A' 2164 ' ' CYS . 0.2 OUTLIER 164.36 41.09 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.842 -1.161 . . . . 0.0 110.287 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 2140 ' ' GLY . . . . . 0.507 ' HA2' ' HD3' ' A' 2154 ' ' PRO . . . -166.41 175.73 41.77 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2141 ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' 2152 ' ' GLU . 0.2 OUTLIER -89.38 96.66 10.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.184 -1.186 . . . . 0.0 108.259 179.29 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 2142 ' ' CYS . . . . . 0.797 ' C ' HD12 ' A' 2143 ' ' ILE . 0.0 OUTLIER -96.32 174.07 7.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -0.86 . . . . 0.0 110.223 -178.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 2143 ' ' ILE . . . . . 0.797 HD12 ' C ' ' A' 2142 ' ' CYS . 4.0 mp -137.2 111.91 10.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2144 ' ' ASN . . . . . 0.428 ' OD1' ' C ' ' A' 2129 ' ' ASP . 0.6 OUTLIER -60.17 118.09 5.93 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.207 -0.933 . . . . 0.0 109.756 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 2145 ' ' THR . . . . . 0.678 HG23 ' HA ' ' A' 2149 ' ' TYR . 3.1 p -103.97 -179.5 3.97 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.157 -0.965 . . . . 0.0 109.011 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.13 -74.12 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.356 -0.84 . . . . 0.0 109.771 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -117.27 41.49 2.07 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2148 ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' 2130 ' ' GLU . 0.6 OUTLIER -174.13 -171.85 0.65 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -1.18 . . . . 0.0 109.831 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 2149 ' ' TYR . . . . . 0.678 ' HA ' HG23 ' A' 2145 ' ' THR . 42.0 p90 -153.05 -171.84 4.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 109.474 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2150 ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' 2149 ' ' TYR . 28.5 mtm180 -155.86 98.41 1.9 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.374 -0.829 . . . . 0.0 110.041 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2151 ' ' CYS . . . . . 0.646 ' HB2' HD22 ' A' 2159 ' ' LEU . 70.7 m -63.02 87.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.527 -0.733 . . . . 0.0 109.069 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2152 ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' 2141 ' ' GLN . 0.0 OUTLIER -87.09 70.32 10.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.503 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 2153 ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' 2158 ' ' ILE . 93.1 m -48.33 147.88 3.65 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 121.379 -0.826 . . . . 0.0 109.177 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2154 ' ' PRO . . . . . 0.507 ' HD3' ' HA2' ' A' 2140 ' ' GLY . 1.4 Cg_endo -63.48 -169.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.541 2.161 . . . . 0.0 111.25 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 75.2 t80 -89.22 102.01 14.67 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.28 -11.63 5.54 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2157 ' ' TYR . . . . . 0.476 ' CD2' ' O ' ' A' 2165 ' ' VAL . 5.7 m-85 -108.17 -170.69 1.72 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.399 -1.059 . . . . 0.0 109.801 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2158 ' ' ILE . . . . . 1.028 HD11 HG23 ' A' 2165 ' ' VAL . 0.2 OUTLIER -156.38 -173.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.061 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 2159 ' ' LEU . . . . . 0.646 HD22 ' HB2' ' A' 2151 ' ' CYS . 21.6 tp -130.89 143.52 50.79 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.276 -0.89 . . . . 0.0 109.85 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -120.52 47.71 1.73 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 0.0 109.175 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2161 ' ' GLY . . . . . 0.427 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 94.35 -16.8 60.26 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2162 ' ' ASN . . . . . 0.543 ' O ' ' CA ' ' A' 2137 ' ' CYS . 1.3 m-20 169.47 -30.34 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.342 -1.093 . . . . 0.0 109.171 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -88.21 119.63 28.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 108.749 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2164 ' ' CYS . . . . . 0.868 ' O ' HG13 ' A' 2165 ' ' VAL . 38.2 t -95.78 159.47 14.97 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.173 -0.955 . . . . 0.0 109.239 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2165 ' ' VAL . . . . . 1.028 HG23 HD11 ' A' 2158 ' ' ILE . 0.6 OUTLIER -169.15 -167.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 2166 ' ' ASP . . . . . 0.461 ' OD2' ' O ' ' A' 2184 ' ' VAL . 34.7 t70 -88.88 165.12 14.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.049 -1.032 . . . . 0.0 109.454 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2167 ' ' THR . . . . . 0.641 HG23 ' OE1' ' A' 2169 ' ' GLU . 6.3 t -111.35 -172.92 2.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.39 -0.818 . . . . 0.0 109.371 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2168 ' ' ASP . . . . . 0.472 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 51.8 t0 -107.48 100.96 10.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.409 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2169 ' ' GLU . . . . . 0.641 ' OE1' HG23 ' A' 2167 ' ' THR . 0.6 OUTLIER -76.33 -31.92 58.39 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.496 -0.752 . . . . 0.0 109.288 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 2170 ' ' CYS . . . . . 0.491 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 2.0 t -66.77 -9.68 39.37 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.314 -0.866 . . . . 0.0 108.877 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2171 ' ' SER . . . . . 0.417 ' HB2' ' CG ' ' A' 2168 ' ' ASP . 0.2 OUTLIER -81.23 7.83 10.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.855 . . . . 0.0 109.894 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 49.5 t -108.22 -72.34 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.07 -1.019 . . . . 0.0 109.536 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2173 ' ' GLY . . . . . 0.476 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -163.08 133.81 3.2 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2174 ' ' ASN . . . . . 0.624 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 18.9 p-10 -40.25 99.86 0.21 Allowed Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.461 -1.023 . . . . 0.0 109.959 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2175 ' ' PRO . . . . . 0.591 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 1.4 Cg_endo -68.66 -22.01 38.33 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.798 1.665 . . . . 0.0 109.85 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2176 ' ' CYS . . . . . 0.583 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -48.61 -40.36 27.28 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.305 -0.872 . . . . 0.0 109.206 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 123.0 -16.5 8.2 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -175.44 -34.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.481 -1.011 . . . . 0.0 109.71 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2179 ' ' GLY . . . . . 0.601 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -63.15 -122.24 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.51 154.63 44.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.39 -1.065 . . . . 0.0 109.708 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2181 ' ' CYS . . . . . 0.624 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 21.4 p -92.52 161.39 14.63 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.352 1.072 . . . . 0.0 111.286 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2182 ' ' LYS . . . . . 0.586 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 43.3 tptt -141.48 163.33 33.22 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2183 ' ' ASN . . . . . 0.473 ' N ' ' HG3' ' A' 2182 ' ' LYS . 62.9 t30 -101.13 140.07 35.94 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.618 -1.301 . . . . 0.0 110.006 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2184 ' ' VAL . . . . . 0.794 HG12 ' CA ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -148.91 -177.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.566 -0.709 . . . . 0.0 109.308 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 2185 ' ' ILE . . . . . 0.471 ' H ' HG22 ' A' 2184 ' ' VAL . 2.4 mp -97.83 135.7 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.02 -1.05 . . . . 0.0 110.196 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 75.15 10.62 84.26 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2187 ' ' GLY . . . . . 0.559 ' C ' HG12 ' A' 2184 ' ' VAL . . . 163.42 -121.04 0.98 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2188 ' ' PHE . . . . . 0.794 ' CA ' HG12 ' A' 2184 ' ' VAL . 2.3 p90 -169.17 -179.67 3.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -1.168 . . . . 0.0 109.526 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2189 ' ' GLU . . . . . 0.586 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 4.5 tt0 -124.67 170.21 11.19 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 6.0 p -170.58 145.56 2.57 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.461 -1.399 . . . . 0.0 109.949 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2191 ' ' THR . . . . . . . . . . . . . 17.9 m -117.98 92.98 3.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.422 -0.799 . . . . 0.0 109.728 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2192 ' ' CYS . . . . . 0.611 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -54.82 179.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 0.0 108.795 179.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 2193 ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' 2194 ' ' GLU . 4.2 tt0 -56.64 121.22 9.24 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2194 ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' 2193 ' ' GLU . 2.2 mt-10 -34.65 127.52 0.48 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.672 -0.643 . . . . 0.0 110.877 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.11 8.58 7.16 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2196 ' ' PHE . . . . . 0.664 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.4 p90 -119.91 -161.54 0.88 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.251 -1.146 . . . . 0.0 110.301 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2197 ' ' GLU . . . . . 0.582 ' N ' ' CG ' ' A' 2196 ' ' PHE . 1.8 mm-40 -146.13 96.03 4.67 Favored Pre-proline 0 C--N 1.305 -1.339 0 O-C-N 121.64 -0.663 . . . . 0.0 109.763 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2198 ' ' PRO . . . . . 0.664 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.0 Cg_endo -68.1 -159.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.389 2.059 . . . . 0.0 111.4 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -143.99 -169.87 13.15 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -65.31 -81.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.993 1.796 . . . . 0.0 110.844 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2201 ' ' MET . . . . . 0.501 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -135.29 41.73 2.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 110.024 -179.308 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 5.0 mtm -112.33 -78.59 0.58 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.182 -0.948 . . . . 0.0 109.582 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A 2203 ' ' THR . . . . . 0.438 HG23 ' N ' ' A' 2204 ' ' CYS . 6.0 t -168.24 -164.43 0.53 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.477 -0.764 . . . . 0.0 109.175 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A 2204 ' ' CYS . . . . . 0.583 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -115.91 144.97 43.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 108.943 -179.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.581 -179.724 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A 2129 ' ' ASP . . . . . 0.55 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 48.5 t0 . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2130 ' ' GLU . . . . . 0.681 ' O ' HG21 ' A' 2136 ' ' VAL . 2.0 mt-10 82.4 -44.57 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.85 -0.531 . . . . 0.0 110.027 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2131 ' ' CYS . . . . . 0.532 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 14.4 p -90.71 -24.72 20.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.007 -1.058 . . . . 0.0 109.288 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2132 ' ' LYS . . . . . 0.416 ' HB2' ' CB ' ' A' 2129 ' ' ASP . 0.0 OUTLIER -68.92 -8.98 49.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 109.851 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 2133 ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' 2134 ' ' PRO . 6.3 mt-10 -72.12 144.47 87.44 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.082 -1.011 . . . . 0.0 109.171 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2134 ' ' PRO . . . . . 0.589 ' HA ' ' CG ' ' A' 2138 ' ' LYS . 1.9 Cg_endo -67.53 -4.12 11.41 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.239 1.959 . . . . 0.0 110.882 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2135 ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' 2135 ' ' ASP . 2.6 m-20 -116.29 4.96 13.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.011 -1.056 . . . . 0.0 110.03 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2136 ' ' VAL . . . . . 0.681 HG21 ' O ' ' A' 2130 ' ' GLU . 75.4 t -110.32 -91.92 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.988 -1.07 . . . . 0.0 109.695 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2137 ' ' CYS . . . . . 0.542 ' N ' HG12 ' A' 2136 ' ' VAL . 0.5 OUTLIER -79.98 -74.43 0.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.115 -0.991 . . . . 0.0 109.572 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 2138 ' ' LYS . . . . . 0.589 ' CG ' ' HA ' ' A' 2134 ' ' PRO . 0.0 OUTLIER 65.46 89.42 0.1 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.377 -0.827 . . . . 0.0 109.963 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 2139 ' ' HIS . . . . . 0.524 ' O ' ' HB3' ' A' 2164 ' ' CYS . 3.5 m170 75.56 51.1 0.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.349 -0.844 . . . . 0.0 110.125 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -151.68 173.38 30.99 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -104.11 89.58 3.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -1.139 . . . . 0.0 108.966 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2142 ' ' CYS . . . . . 0.481 ' HB3' ' SG ' ' A' 2137 ' ' CYS . 9.0 p -88.86 -177.0 5.39 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.347 -0.846 . . . . 0.0 110.345 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.29 93.04 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2144 ' ' ASN . . . . . 0.55 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 21.2 t-20 -46.11 115.61 1.04 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.516 -0.74 . . . . 0.0 110.963 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2145 ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' 2149 ' ' TYR . 0.4 OUTLIER -113.37 -178.7 3.44 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.282 -0.886 . . . . 0.0 108.936 178.743 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.59 110.15 17.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.379 -0.826 . . . . 0.0 109.769 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 65.85 25.77 71.97 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2148 ' ' SER . . . . . 0.443 ' O ' ' OG1' ' A' 2145 ' ' THR . 0.0 OUTLIER -173.66 -178.72 1.66 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.123 -1.222 . . . . 0.0 109.738 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 2149 ' ' TYR . . . . . 0.599 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 17.8 p90 -160.31 -172.37 3.55 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.443 -0.786 . . . . 0.0 109.446 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2150 ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' 2149 ' ' TYR . 1.8 mtt-85 -156.52 107.16 2.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.414 -0.804 . . . . 0.0 109.142 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 1.6 m -74.33 107.17 6.33 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.489 -0.757 . . . . 0.0 110.431 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.63 -178.63 3.49 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2153 ' ' CYS . . . . . 0.551 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -148.24 152.37 39.16 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 120.952 -1.093 . . . . 0.0 109.672 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 2154 ' ' PRO . . . . . 0.48 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.4 Cg_endo -64.22 -166.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.604 2.203 . . . . 0.0 111.478 -178.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 13.4 t80 -89.8 101.96 14.66 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2156 ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' 2166 ' ' ASP . . . 130.81 -14.08 5.52 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.169 -1.973 . . . . 0.0 108.169 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2157 ' ' TYR . . . . . 0.691 ' OH ' HG23 ' A' 2185 ' ' ILE . 8.4 m-85 -108.3 -174.28 2.48 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.532 -0.981 . . . . 0.0 110.288 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2158 ' ' ILE . . . . . 0.729 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -157.65 -165.89 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 2159 ' ' LEU . . . . . . . . . . . . . 27.7 tp -131.92 127.74 37.05 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.408 -0.807 . . . . 0.0 109.574 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -107.06 49.23 0.81 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 0.0 109.327 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 95.67 -20.25 50.55 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2162 ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' 2136 ' ' VAL . 1.3 t-20 172.8 -38.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -1.172 . . . . 0.0 109.447 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2163 ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' 2137 ' ' CYS . 2.1 tt0 -79.09 111.02 14.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.416 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2164 ' ' CYS . . . . . 0.668 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -85.93 137.55 32.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.895 . . . . 0.0 109.089 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 2165 ' ' VAL . . . . . 0.668 HG13 ' O ' ' A' 2164 ' ' CYS . 6.7 m -160.53 -166.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.145 -0.972 . . . . 0.0 109.539 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2166 ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 1.3 t0 -90.23 144.8 25.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.875 -1.141 . . . . 0.0 109.773 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2167 ' ' THR . . . . . 0.568 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 12.7 t -85.09 169.62 13.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.257 -0.902 . . . . 0.0 109.017 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2168 ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' A' 2171 ' ' SER . 60.2 t0 -82.11 96.78 7.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.865 -1.147 . . . . 0.0 109.175 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2169 ' ' GLU . . . . . 0.699 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 40.2 mp0 -70.09 -37.07 75.33 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.474 -0.766 . . . . 0.0 109.186 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2170 ' ' CYS . . . . . 0.499 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 0.6 OUTLIER -68.19 -7.86 33.87 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.249 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 2171 ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.2 OUTLIER -74.09 -1.5 20.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.357 -0.839 . . . . 0.0 109.452 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 12.2 t -99.04 -72.55 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.17 -0.956 . . . . 0.0 109.671 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2173 ' ' GLY . . . . . 0.482 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -169.46 138.48 5.09 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2174 ' ' ASN . . . . . 0.575 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 22.7 p-10 -36.97 97.67 0.14 Allowed Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.721 -0.87 . . . . 0.0 110.335 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2175 ' ' PRO . . . . . 0.558 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 1.5 Cg_endo -63.2 -22.23 72.56 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.821 1.681 . . . . 0.0 109.998 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2176 ' ' CYS . . . . . 0.543 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -52.12 -54.99 23.83 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 141.96 -21.95 2.47 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -162.93 -34.84 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.336 -1.097 . . . . 0.0 110.176 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2179 ' ' GLY . . . . . 0.6 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -62.48 -119.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.96 153.65 41.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.466 -1.02 . . . . 0.0 109.14 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2181 ' ' CYS . . . . . 0.575 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 11.5 p -82.06 164.95 21.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.086 -1.009 . . . . 0.0 110.813 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2182 ' ' LYS . . . . . 0.604 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.4 OUTLIER -144.63 155.05 43.42 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 64.1 t30 -100.16 138.59 37.03 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.543 -1.348 . . . . 0.0 109.544 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2184 ' ' VAL . . . . . 0.688 HG13 ' N ' ' A' 2185 ' ' ILE . 0.6 OUTLIER -145.94 -162.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.329 -179.401 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A 2185 ' ' ILE . . . . . 0.691 HG23 ' OH ' ' A' 2157 ' ' TYR . 3.0 mp -108.28 134.23 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.036 -1.04 . . . . 0.0 110.356 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 68.56 8.7 56.93 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2187 ' ' GLY . . . . . 0.67 ' C ' HG12 ' A' 2184 ' ' VAL . . . 174.12 -137.59 4.07 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2188 ' ' PHE . . . . . 0.699 ' HB3' ' HB2' ' A' 2169 ' ' GLU . 5.5 p90 -161.02 169.5 22.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -1.151 . . . . 0.0 109.271 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2189 ' ' GLU . . . . . 0.604 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 2.8 tt0 -118.2 178.63 4.37 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 30.3 p -169.39 143.26 2.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.702 -1.249 . . . . 0.0 109.584 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2191 ' ' THR . . . . . . . . . . . . . 20.1 m -109.91 85.81 2.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.316 -0.865 . . . . 0.0 109.696 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2192 ' ' CYS . . . . . 0.604 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.1 m -51.23 177.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.205 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2193 ' ' GLU . . . . . 0.474 ' O ' ' C ' ' A' 2194 ' ' GLU . 7.4 tt0 -50.97 116.48 2.01 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2194 ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.8 mt-10 -33.93 127.77 0.39 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.484 0.659 . . . . 0.0 111.043 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.08 5.22 8.97 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2196 ' ' PHE . . . . . 0.674 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.3 p90 -114.82 -163.22 0.86 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.234 -1.156 . . . . 0.0 110.268 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2197 ' ' GLU . . . . . 0.519 ' N ' ' CG ' ' A' 2196 ' ' PHE . 1.8 mm-40 -144.58 95.98 5.28 Favored Pre-proline 0 C--N 1.304 -1.37 0 O-C-N 121.526 -0.733 . . . . 0.0 109.597 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2198 ' ' PRO . . . . . 0.674 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 8.1 Cg_endo -66.94 -162.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.279 1.986 . . . . 0.0 111.075 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -137.0 -175.08 13.59 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.63 -72.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.991 1.794 . . . . 0.0 110.675 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A 2201 ' ' MET . . . . . 0.492 ' HA ' ' O ' ' A' 2188 ' ' PHE . 7.3 ptp -141.07 48.62 1.68 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.186 -0.947 . . . . 0.0 110.107 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2202 ' ' MET . . . . . 0.412 ' O ' ' CE1' ' A' 2188 ' ' PHE . 2.1 mmt -120.19 -85.03 0.66 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.081 -1.012 . . . . 0.0 109.845 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2203 ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' 2175 ' ' PRO . 7.3 t -168.66 -168.32 0.88 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.249 -0.907 . . . . 0.0 109.568 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2204 ' ' CYS . . . . . 0.575 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.7 t -71.59 144.81 49.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.934 . . . . 0.0 109.484 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A 2205 ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' 2197 ' ' GLU . 19.0 pt-20 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.457 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2129 ' ' ASP . . . . . 0.544 ' O ' ' ND2' ' A' 2144 ' ' ASN . 27.5 t0 . . . . . 0 N--CA 1.484 1.273 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2130 ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' 2129 ' ' ASP . 1.5 mt-10 81.21 -48.74 0.26 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.668 -0.645 . . . . 0.0 110.427 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2131 ' ' CYS . . . . . 0.488 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 13.7 p -90.97 -26.58 19.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.882 -1.136 . . . . 0.0 109.715 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2132 ' ' LYS . . . . . 0.529 ' HB2' ' CB ' ' A' 2129 ' ' ASP . 0.0 OUTLIER -65.34 -11.45 42.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.839 -1.163 . . . . 0.0 109.137 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -70.28 148.75 95.82 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.399 -0.813 . . . . 0.0 109.413 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2134 ' ' PRO . . . . . 0.537 ' HA ' ' CD ' ' A' 2138 ' ' LYS . 1.2 Cg_endo -64.67 -7.8 15.69 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.232 1.954 . . . . 0.0 110.726 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.91 16.94 15.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.044 -1.035 . . . . 0.0 109.841 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2136 ' ' VAL . . . . . 0.64 ' CG1' ' CE1' ' A' 2149 ' ' TYR . 22.1 t -143.09 118.84 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.134 -0.979 . . . . 0.0 109.314 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2137 ' ' CYS . . . . . 0.47 ' SG ' HG12 ' A' 2136 ' ' VAL . 1.9 m 41.64 71.05 0.22 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.331 -0.856 . . . . 0.0 109.252 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2138 ' ' LYS . . . . . 0.537 ' CD ' ' HA ' ' A' 2134 ' ' PRO . 0.0 OUTLIER -98.35 129.24 45.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 0.0 109.928 -179.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 2139 ' ' HIS . . . . . 0.48 ' O ' ' HB3' ' A' 2164 ' ' CYS . 0.7 OUTLIER 67.95 52.2 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.499 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -161.52 -160.77 11.11 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2141 ' ' GLN . . . . . 0.436 ' HB3' ' O ' ' A' 2152 ' ' GLU . 1.6 tt0 -119.03 94.49 4.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.321 -1.105 . . . . 0.0 109.405 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2142 ' ' CYS . . . . . 0.514 ' C ' HD12 ' A' 2143 ' ' ILE . 10.9 p -90.47 177.7 6.31 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.294 -0.879 . . . . 0.0 110.011 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2143 ' ' ILE . . . . . 0.514 HD12 ' C ' ' A' 2142 ' ' CYS . 3.6 mp -132.16 117.22 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2144 ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' 2129 ' ' ASP . 5.2 t-20 -75.32 113.61 12.9 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.096 -1.002 . . . . 0.0 111.367 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2145 ' ' THR . . . . . 0.441 ' OG1' ' C ' ' A' 2148 ' ' SER . 16.2 p -99.87 179.53 4.49 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -59.14 -47.94 83.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 109.849 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -142.58 57.71 0.56 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2148 ' ' SER . . . . . 0.467 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER 174.92 -160.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -1.116 . . . . 0.0 109.287 -179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 2149 ' ' TYR . . . . . 0.64 ' CE1' ' CG1' ' A' 2136 ' ' VAL . 43.2 p90 -174.11 -170.9 0.58 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.35 -0.844 . . . . 0.0 109.336 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2150 ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' 2149 ' ' TYR . 26.8 mtt180 -160.04 107.61 1.66 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.339 -0.851 . . . . 0.0 109.435 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 36.2 m -64.82 89.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.464 -0.772 . . . . 0.0 109.746 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2152 ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' 2141 ' ' GLN . 2.0 mt-10 -102.16 86.18 2.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.034 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2153 ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -59.24 153.38 47.61 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.297 -0.877 . . . . 0.0 109.973 -179.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 2154 ' ' PRO . . . . . 0.439 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.1 Cg_endo -65.16 -167.56 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.624 2.216 . . . . 0.0 111.205 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 17.9 t80 -90.15 104.89 17.42 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.03 -17.91 5.1 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2157 ' ' TYR . . . . . 0.521 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 12.0 m-85 -107.98 -175.38 2.77 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.673 -0.898 . . . . 0.0 109.574 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2158 ' ' ILE . . . . . 0.771 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -153.6 -163.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.661 -0.65 . . . . 0.0 109.319 179.429 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 2159 ' ' LEU . . . . . 0.434 ' HA ' HD12 ' A' 2159 ' ' LEU . 24.4 tp -135.41 136.36 41.33 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.195 -0.941 . . . . 0.0 110.073 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -113.99 44.14 1.71 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.411 -0.806 . . . . 0.0 109.255 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 100.42 -28.31 16.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2162 ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -179.46 -35.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -1.109 . . . . 0.0 109.47 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -81.66 113.62 19.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 0.0 109.254 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2164 ' ' CYS . . . . . 0.541 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -87.37 135.59 33.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.919 . . . . 0.0 109.854 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 2165 ' ' VAL . . . . . 0.584 ' O ' HD13 ' A' 2158 ' ' ILE . 0.3 OUTLIER -158.42 -168.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.416 -0.802 . . . . 0.0 108.848 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 2166 ' ' ASP . . . . . 0.485 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 0.6 OUTLIER -90.46 140.04 30.1 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.895 -1.128 . . . . 0.0 109.405 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 2167 ' ' THR . . . . . 0.635 ' HB ' HG21 ' A' 2158 ' ' ILE . 7.6 t -93.13 161.33 14.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.252 -0.905 . . . . 0.0 109.373 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2168 ' ' ASP . . . . . 0.503 ' O ' ' HB2' ' A' 2171 ' ' SER . 59.7 t0 -69.92 95.38 0.92 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.831 -1.168 . . . . 0.0 109.517 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2169 ' ' GLU . . . . . 0.601 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 41.2 mp0 -69.35 -35.85 76.29 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.489 -0.757 . . . . 0.0 109.399 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2170 ' ' CYS . . . . . 0.499 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 0.2 OUTLIER -65.01 -8.7 17.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.451 -0.781 . . . . 0.0 109.057 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 2171 ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -72.18 -0.6 12.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.962 -1.087 . . . . 0.0 109.781 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 9.9 t -98.82 -74.04 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.092 -1.005 . . . . 0.0 109.914 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2173 ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -166.61 138.92 5.46 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2174 ' ' ASN . . . . . 0.579 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 18.5 p-10 -38.64 99.31 0.19 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.694 -0.886 . . . . 0.0 110.245 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2175 ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' 2181 ' ' CYS . 1.8 Cg_endo -61.87 -27.94 80.73 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.053 1.835 . . . . 0.0 110.182 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2176 ' ' CYS . . . . . 0.55 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -46.14 -50.48 15.47 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 133.14 -16.92 4.62 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2178 ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.4 OUTLIER -162.86 -40.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -1.111 . . . . 0.0 109.911 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 2179 ' ' GLY . . . . . 0.603 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -60.85 -119.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.3 p -143.11 160.42 40.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.432 -1.04 . . . . 0.0 109.469 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2181 ' ' CYS . . . . . 0.59 ' HB3' ' HD3' ' A' 2175 ' ' PRO . 16.7 p -88.1 166.42 14.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.137 -0.977 . . . . 0.0 110.794 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2182 ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.2 OUTLIER -145.62 156.01 43.39 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 61.3 t30 -100.59 131.33 46.55 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.698 -1.251 . . . . 0.0 109.506 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2184 ' ' VAL . . . . . 0.689 HG12 ' N ' ' A' 2188 ' ' PHE . 0.6 OUTLIER -140.89 -166.8 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.515 -0.741 . . . . 0.0 109.368 -179.566 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 2185 ' ' ILE . . . . . 0.614 ' N ' HG13 ' A' 2184 ' ' VAL . 4.0 mp -107.36 136.41 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.029 -1.045 . . . . 0.0 109.909 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 72.92 6.93 68.96 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2187 ' ' GLY . . . . . 0.646 ' C ' HG12 ' A' 2184 ' ' VAL . . . 169.81 -129.76 1.9 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2188 ' ' PHE . . . . . 0.689 ' N ' HG12 ' A' 2184 ' ' VAL . 3.2 p90 -164.38 173.16 12.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -1.157 . . . . 0.0 108.997 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2189 ' ' GLU . . . . . 0.617 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 2.6 tt0 -120.54 159.33 25.42 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 22.4 p -149.18 145.34 27.11 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.738 -1.226 . . . . 0.0 109.917 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2191 ' ' THR . . . . . . . . . . . . . 25.2 m -113.9 85.96 2.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.299 -0.875 . . . . 0.0 109.564 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2192 ' ' CYS . . . . . 0.617 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.9 OUTLIER -51.01 178.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 109.273 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 2193 ' ' GLU . . . . . 0.49 ' O ' ' C ' ' A' 2194 ' ' GLU . 2.0 tm-20 -52.71 117.79 3.17 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2194 ' ' GLU . . . . . 0.49 ' C ' ' O ' ' A' 2193 ' ' GLU . 5.7 mt-10 -34.15 127.73 0.42 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.494 0.664 . . . . 0.0 110.833 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.59 4.61 8.82 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2196 ' ' PHE . . . . . 0.669 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.1 p90 -114.99 -162.77 0.84 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.193 -1.181 . . . . 0.0 110.1 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2197 ' ' GLU . . . . . 0.542 ' N ' ' CG ' ' A' 2196 ' ' PHE . 25.3 mt-10 -145.42 95.55 5.0 Favored Pre-proline 0 C--N 1.304 -1.386 0 O-C-N 121.46 -0.775 . . . . 0.0 109.481 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2198 ' ' PRO . . . . . 0.669 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 8.3 Cg_endo -67.38 -159.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.27 1.98 . . . . 0.0 111.098 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -140.62 -170.49 12.1 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.47 -81.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 121.919 1.746 . . . . 0.0 110.531 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2201 ' ' MET . . . . . 0.493 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.4 OUTLIER -135.02 56.52 1.84 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.819 -179.475 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 2202 ' ' MET . . . . . 0.405 ' O ' ' HB ' ' A' 2203 ' ' THR . 0.2 OUTLIER -124.53 -78.63 0.6 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.22 -0.925 . . . . 0.0 109.654 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A 2203 ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' 2175 ' ' PRO . 6.7 t -178.5 -165.56 0.09 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.382 -0.824 . . . . 0.0 109.196 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2204 ' ' CYS . . . . . 0.564 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.4 t -75.08 144.79 42.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 0.0 109.462 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.563 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2129 ' ' ASP . . . . . 0.54 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 17.5 t0 . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2130 ' ' GLU . . . . . 0.606 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 42.4 mp0 -56.11 -24.76 42.58 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.43 -0.794 . . . . 0.0 110.529 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2131 ' ' CYS . . . . . . . . . . . . . 1.8 t -84.49 -26.72 27.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.653 -1.279 . . . . 0.0 109.094 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2132 ' ' LYS . . . . . 0.479 ' HB2' ' HB3' ' A' 2129 ' ' ASP . 0.0 OUTLIER -84.75 13.05 6.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.07 -1.019 . . . . 0.0 109.089 179.445 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 2133 ' ' GLU . . . . . 0.548 ' HB2' ' CG2' ' A' 2136 ' ' VAL . 7.7 mt-10 -70.66 165.04 49.81 Favored Pre-proline 0 N--CA 1.486 1.365 0 O-C-N 121.346 -0.847 . . . . 0.0 109.498 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2134 ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' 2133 ' ' GLU . 2.6 Cg_endo -65.85 -27.76 51.3 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.57 2.18 . . . . 0.0 112.342 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -138.91 39.36 2.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.53 -1.356 . . . . 0.0 111.487 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2136 ' ' VAL . . . . . 0.781 HG12 ' N ' ' A' 2137 ' ' CYS . 46.5 t -102.84 -100.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.834 -1.167 . . . . 0.0 109.248 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2137 ' ' CYS . . . . . 0.781 ' N ' HG12 ' A' 2136 ' ' VAL . 16.2 m -89.46 -65.48 1.01 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.767 -1.208 . . . . 0.0 108.696 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2138 ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' 2137 ' ' CYS . 0.3 OUTLIER 61.17 124.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.373 -0.829 . . . . 0.0 110.383 178.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 2139 ' ' HIS . . . . . 0.484 ' O ' ' HB3' ' A' 2164 ' ' CYS . 0.7 OUTLIER 63.18 40.83 8.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.335 -0.853 . . . . 0.0 110.366 179.074 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -154.79 162.15 30.65 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.04 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -94.44 87.9 5.32 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.493 -1.004 . . . . 0.0 108.727 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2142 ' ' CYS . . . . . 0.825 ' C ' HD12 ' A' 2143 ' ' ILE . 0.8 OUTLIER -88.22 -166.83 1.69 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.3 -0.875 . . . . 0.0 109.769 -179.136 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 2143 ' ' ILE . . . . . 0.825 HD12 ' C ' ' A' 2142 ' ' CYS . 4.1 mp -144.72 103.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2144 ' ' ASN . . . . . 0.54 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 5.7 t-20 -57.63 116.02 3.14 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.302 -0.874 . . . . 0.0 110.3 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2145 ' ' THR . . . . . 0.432 ' HG1' ' C ' ' A' 2148 ' ' SER . 1.3 p -104.48 -177.46 3.37 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.381 -0.825 . . . . 0.0 109.196 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.86 -72.96 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.331 -0.856 . . . . 0.0 109.675 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -128.21 38.28 2.11 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2148 ' ' SER . . . . . 0.468 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER -155.0 -160.06 1.02 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.245 -1.15 . . . . 0.0 109.513 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 2149 ' ' TYR . . . . . 0.694 ' CE2' HG13 ' A' 2136 ' ' VAL . 8.5 p90 -163.38 -169.72 2.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.658 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2150 ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' 2142 ' ' CYS . 32.4 mtt180 -157.81 99.51 1.7 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.388 -0.82 . . . . 0.0 109.374 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 30.6 m -70.09 111.97 6.13 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.252 -0.905 . . . . 0.0 109.17 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.03 84.8 2.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.239 -0.913 . . . . 0.0 109.416 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2153 ' ' CYS . . . . . 0.518 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -54.88 148.1 29.29 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.341 -0.849 . . . . 0.0 109.207 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 2154 ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.93 -167.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.405 2.07 . . . . 0.0 111.018 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 6.5 t80 -90.08 104.72 17.27 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.23 -16.14 5.24 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2157 ' ' TYR . . . . . 0.538 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 6.4 m-85 -105.52 -169.24 1.56 Allowed 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.564 -0.963 . . . . 0.0 110.155 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2158 ' ' ILE . . . . . 0.711 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -153.46 -167.35 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.617 -0.677 . . . . 0.0 109.206 179.481 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 2159 ' ' LEU . . . . . . . . . . . . . 37.9 tp -139.52 127.42 22.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.372 -0.83 . . . . 0.0 109.463 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -103.93 44.17 1.04 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.366 -0.834 . . . . 0.0 109.605 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2161 ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' 2162 ' ' ASN . . . 93.87 -17.79 57.96 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2162 ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' 2136 ' ' VAL . 4.0 p-10 179.72 -49.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -1.142 . . . . 0.0 109.469 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2163 ' ' GLU . . . . . 0.456 ' N ' ' CG ' ' A' 2162 ' ' ASN . 0.6 OUTLIER -73.45 120.07 18.55 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.56 -0.712 . . . . 0.0 109.255 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 2164 ' ' CYS . . . . . 0.603 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -97.08 139.4 33.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 109.456 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 2165 ' ' VAL . . . . . 0.679 HG23 HD11 ' A' 2158 ' ' ILE . 1.6 m -158.39 -172.27 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.064 -1.023 . . . . 0.0 109.475 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2166 ' ' ASP . . . . . 0.403 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 7.6 t70 -88.11 152.65 21.86 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.952 -1.092 . . . . 0.0 109.562 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2167 ' ' THR . . . . . 0.583 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 5.5 t -92.19 -168.16 1.93 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 109.13 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2168 ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' 2171 ' ' SER . 58.5 t0 -111.36 100.0 8.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.085 -1.009 . . . . 0.0 109.213 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2169 ' ' GLU . . . . . 0.607 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.7 OUTLIER -74.0 -33.28 63.75 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.448 -0.783 . . . . 0.0 109.22 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 2170 ' ' CYS . . . . . 0.464 ' HB2' ' N ' ' A' 2182 ' ' LYS . 1.8 t -69.59 -9.62 54.81 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2171 ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -72.72 -12.86 61.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 0.0 109.549 -179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 21.7 t -84.76 -71.99 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.146 -0.971 . . . . 0.0 109.288 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2173 ' ' GLY . . . . . 0.465 ' O ' ' SG ' ' A' 2181 ' ' CYS . . . -154.09 -127.58 1.16 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2174 ' ' ASN . . . . . 0.572 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 26.5 p-10 -130.28 97.79 21.93 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.075 -1.25 . . . . 0.0 109.213 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2175 ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' 2181 ' ' CYS . 1.6 Cg_endo -66.58 -18.97 54.6 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 121.918 1.745 . . . . 0.0 109.967 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2176 ' ' CYS . . . . . 0.542 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.1 OUTLIER -51.39 -49.12 62.19 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.06 0.933 . . . . 0.0 108.926 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 128.64 -21.05 5.41 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 108.326 -1.909 . . . . 0.0 108.326 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -166.52 -34.09 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.498 -1.001 . . . . 0.0 110.045 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2179 ' ' GLY . . . . . 0.613 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -69.26 -130.51 0.05 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.6 p -131.97 157.0 45.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.605 -0.938 . . . . 0.0 109.193 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2181 ' ' CYS . . . . . 0.572 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 24.7 p -89.17 167.09 13.39 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.336 1.065 . . . . 0.0 110.899 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2182 ' ' LYS . . . . . 0.542 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 3.9 tttp -146.4 160.79 41.6 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2183 ' ' ASN . . . . . 0.416 ' N ' ' CG ' ' A' 2182 ' ' LYS . 56.3 t30 -100.59 126.32 47.05 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.602 -1.311 . . . . 0.0 110.014 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2184 ' ' VAL . . . . . 0.89 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -132.46 -176.32 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 2185 ' ' ILE . . . . . 0.538 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 4.0 mp -100.29 140.29 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.019 -1.051 . . . . 0.0 110.008 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 70.64 12.19 69.92 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2187 ' ' GLY . . . . . 0.592 ' C ' HG12 ' A' 2184 ' ' VAL . . . 164.39 -117.92 0.78 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2188 ' ' PHE . . . . . 0.89 ' N ' HG12 ' A' 2184 ' ' VAL . 2.2 p90 -170.57 -179.27 2.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -1.19 . . . . 0.0 109.902 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2189 ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.3 OUTLIER -127.63 169.53 13.66 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.187 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 11.7 p -170.56 146.69 2.78 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.498 -1.376 . . . . 0.0 110.229 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2191 ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' 2192 ' ' CYS . 89.2 m -114.84 86.61 2.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.533 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2192 ' ' CYS . . . . . 0.622 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -50.27 -179.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.044 -1.035 . . . . 0.0 108.865 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 2193 ' ' GLU . . . . . 0.489 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.5 tt0 -55.15 113.92 1.56 Allowed 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2194 ' ' GLU . . . . . 0.489 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.2 tt0 -31.1 129.18 0.14 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.589 0.709 . . . . 0.0 111.029 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.61 4.27 9.81 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2196 ' ' PHE . . . . . 0.67 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.3 p90 -114.93 -163.63 0.89 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.229 -1.159 . . . . 0.0 110.385 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2197 ' ' GLU . . . . . 0.55 ' N ' ' CG ' ' A' 2196 ' ' PHE . 7.1 mt-10 -145.32 95.54 5.04 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 121.615 -0.678 . . . . 0.0 109.596 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2198 ' ' PRO . . . . . 0.67 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.2 Cg_endo -67.63 -162.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.349 2.033 . . . . 0.0 111.42 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -138.27 -174.82 13.58 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.54 -71.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.055 1.837 . . . . 0.0 110.726 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2201 ' ' MET . . . . . 0.471 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.1 OUTLIER -144.4 42.35 1.38 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.756 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.35 -77.11 0.58 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.217 -0.927 . . . . 0.0 109.532 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A 2203 ' ' THR . . . . . . . . . . . . . 12.2 t -168.32 -168.69 0.96 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.409 -0.807 . . . . 0.0 109.094 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A 2204 ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.0 OUTLIER -115.04 149.7 37.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.895 . . . . 0.0 108.989 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.077 -0.964 . . . . 0.0 109.564 179.919 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A 2129 ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' 2130 ' ' GLU . 16.3 t0 . . . . . 0 N--CA 1.487 1.393 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2130 ' ' GLU . . . . . 0.635 ' O ' HG21 ' A' 2136 ' ' VAL . 2.5 mt-10 82.86 -51.15 0.17 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.857 -0.527 . . . . 0.0 110.265 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2131 ' ' CYS . . . . . 0.55 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 12.0 p -89.51 -25.05 21.63 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.094 -1.004 . . . . 0.0 109.614 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2132 ' ' LYS . . . . . 0.485 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -85.2 41.11 0.86 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.177 -0.952 . . . . 0.0 109.539 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -112.65 155.93 43.18 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.295 -0.878 . . . . 0.0 109.2 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2134 ' ' PRO . . . . . 0.457 ' O ' ' HD2' ' A' 2138 ' ' LYS . 1.5 Cg_endo -64.67 -5.46 10.34 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.361 2.041 . . . . 0.0 111.262 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2135 ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' 2162 ' ' ASN . 2.9 t0 -124.18 -29.5 3.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.802 -1.186 . . . . 0.0 110.216 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2136 ' ' VAL . . . . . 0.635 HG21 ' O ' ' A' 2130 ' ' GLU . 61.7 t -77.82 -106.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.041 -1.037 . . . . 0.0 109.146 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2137 ' ' CYS . . . . . 0.508 ' N ' HG12 ' A' 2136 ' ' VAL . 0.1 OUTLIER -84.2 138.66 32.86 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.771 -1.206 . . . . 0.0 108.813 179.526 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 2138 ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' 2139 ' ' HIS . 0.5 OUTLIER -139.6 23.86 2.47 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.1 -1.0 . . . . 0.0 110.017 -179.269 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 2139 ' ' HIS . . . . . 0.541 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.1 OUTLIER 162.27 42.36 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.314 -0.867 . . . . 0.0 110.036 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -144.76 170.99 26.15 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.256 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2141 ' ' GLN . . . . . 0.416 ' O ' ' HG3' ' A' 2141 ' ' GLN . 5.7 pt20 -92.09 65.78 4.81 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.441 -1.035 . . . . 0.0 109.166 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2142 ' ' CYS . . . . . 0.466 ' HB3' ' SG ' ' A' 2137 ' ' CYS . 21.5 p -62.44 -174.13 0.06 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.368 -0.833 . . . . 0.0 110.274 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2143 ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' 2143 ' ' ILE . 1.7 mp -148.71 83.09 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2144 ' ' ASN . . . . . 0.525 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 2.9 t30 -59.08 113.28 2.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.253 -0.904 . . . . 0.0 109.584 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2145 ' ' THR . . . . . . . . . . . . . 27.7 p -97.26 -151.79 0.37 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.371 -0.83 . . . . 0.0 109.415 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.76 -79.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 110.123 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -120.64 22.26 8.27 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2148 ' ' SER . . . . . 0.494 ' N ' ' OE2' ' A' 2130 ' ' GLU . 0.1 OUTLIER -144.85 -161.8 1.37 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -1.16 . . . . 0.0 109.214 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 2149 ' ' TYR . . . . . 0.555 ' CE2' ' CG1' ' A' 2136 ' ' VAL . 24.3 p90 179.6 -164.21 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.695 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2150 ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' 2149 ' ' TYR . 0.1 OUTLIER -166.58 119.45 1.03 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 109.358 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 13.2 m -89.03 106.67 18.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.885 . . . . 0.0 109.81 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -119.49 97.7 5.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 108.909 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2153 ' ' CYS . . . . . 0.524 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -58.22 152.95 39.09 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.21 -0.931 . . . . 0.0 109.817 -179.481 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 2154 ' ' PRO . . . . . 0.487 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 2.0 Cg_endo -66.11 -167.12 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.525 2.15 . . . . 0.0 111.023 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 22.1 t80 -90.59 104.72 17.27 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2156 ' ' GLY . . . . . 0.657 ' O ' HG22 ' A' 2167 ' ' THR . . . 131.05 -16.37 5.27 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.045 -2.022 . . . . 0.0 108.045 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2157 ' ' TYR . . . . . 0.524 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 8.2 m-85 -107.39 -169.69 1.58 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.599 -0.942 . . . . 0.0 110.005 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2158 ' ' ILE . . . . . 1.13 HD11 HG23 ' A' 2165 ' ' VAL . 0.1 OUTLIER -151.24 -163.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.594 -0.691 . . . . 0.0 109.398 179.42 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 2159 ' ' LEU . . . . . 0.49 ' N ' HG12 ' A' 2158 ' ' ILE . 25.0 tp -145.51 113.26 6.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.413 -0.804 . . . . 0.0 109.297 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -95.55 60.66 2.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.323 -0.861 . . . . 0.0 109.715 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2161 ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 88.59 -19.49 36.37 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2162 ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' A' 2135 ' ' ASP . 0.1 OUTLIER 167.98 -34.08 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.361 -1.082 . . . . 0.0 109.357 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -76.49 111.62 12.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 109.15 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2164 ' ' CYS . . . . . 0.725 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -87.83 144.74 26.43 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.301 -0.874 . . . . 0.0 109.69 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 2165 ' ' VAL . . . . . 1.13 HG23 HD11 ' A' 2158 ' ' ILE . 1.4 m -161.96 -169.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.292 -0.88 . . . . 0.0 109.54 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2166 ' ' ASP . . . . . 0.451 ' OD1' ' HA ' ' A' 2185 ' ' ILE . 34.7 t70 -78.54 164.35 24.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 110.179 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2167 ' ' THR . . . . . 0.657 HG22 ' O ' ' A' 2156 ' ' GLY . 6.0 t -117.25 -173.57 2.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.643 -0.661 . . . . 0.0 109.295 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2168 ' ' ASP . . . . . . . . . . . . . 42.0 t0 -101.6 102.47 13.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.197 -0.94 . . . . 0.0 108.976 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2169 ' ' GLU . . . . . 0.566 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.3 OUTLIER -75.54 -23.89 56.67 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.276 -0.89 . . . . 0.0 110.359 -179.122 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 2170 ' ' CYS . . . . . 0.449 ' O ' ' SG ' ' A' 2170 ' ' CYS . 2.8 t -59.49 -12.34 6.1 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.784 -1.197 . . . . 0.0 108.805 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.48 -10.74 12.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.258 -0.901 . . . . 0.0 110.091 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2172 ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' 2169 ' ' GLU . 25.3 t -74.9 -68.21 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.232 -0.918 . . . . 0.0 109.422 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2173 ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' 2174 ' ' ASN . . . 162.54 78.28 0.03 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2174 ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' 2173 ' ' GLY . 1.0 OUTLIER 44.22 91.9 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.275 -1.132 . . . . 0.0 109.557 -179.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 2175 ' ' PRO . . . . . 0.611 ' CB ' ' CE2' ' A' 2188 ' ' PHE . 1.3 Cg_endo -66.68 -21.12 52.29 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.104 1.869 . . . . 0.0 110.238 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2176 ' ' CYS . . . . . 0.546 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -65.44 -60.0 3.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 109.521 -179.682 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 141.62 -18.09 2.62 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.74 -31.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.662 -0.905 . . . . 0.0 109.731 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2179 ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -60.68 -114.02 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.1 p -145.65 154.73 42.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.397 -1.061 . . . . 0.0 109.096 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2181 ' ' CYS . . . . . 0.521 ' HB3' ' HD2' ' A' 2175 ' ' PRO . 26.1 p -96.08 160.07 14.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.072 -1.018 . . . . 0.0 110.621 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2182 ' ' LYS . . . . . 0.568 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 3.6 tptm -146.06 156.65 43.61 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2183 ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' 2167 ' ' THR . 59.7 t30 -100.68 140.14 35.38 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.6 -1.313 . . . . 0.0 109.443 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2184 ' ' VAL . . . . . 0.666 HG12 ' N ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -146.95 168.21 5.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.456 -0.777 . . . . 0.0 109.124 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 2185 ' ' ILE . . . . . 0.521 HG23 ' OH ' ' A' 2157 ' ' TYR . 2.3 mp -80.64 140.32 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 110.755 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2186 ' ' GLY . . . . . 0.436 ' O ' ' SD ' ' A' 2201 ' ' MET . . . 69.81 9.26 62.26 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2187 ' ' GLY . . . . . 0.588 ' C ' HG12 ' A' 2184 ' ' VAL . . . 165.51 -136.66 4.29 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2188 ' ' PHE . . . . . 0.666 ' N ' HG12 ' A' 2184 ' ' VAL . 1.2 p90 -153.06 179.26 8.86 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.199 -1.177 . . . . 0.0 109.055 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2189 ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.2 tp10 -131.49 171.27 13.61 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 7.8 p -170.79 148.8 2.98 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.78 -1.2 . . . . 0.0 109.876 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2191 ' ' THR . . . . . . . . . . . . . 10.1 m -118.39 88.94 3.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.908 . . . . 0.0 109.965 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2192 ' ' CYS . . . . . 0.622 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.7 OUTLIER -51.58 -179.48 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.171 -0.956 . . . . 0.0 109.219 179.586 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 2193 ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' 2194 ' ' GLU . 4.7 tt0 -57.2 118.17 4.8 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2194 ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.5 OUTLIER -32.21 128.49 0.22 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.409 0.623 . . . . 0.0 111.006 -178.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.41 4.69 8.94 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2196 ' ' PHE . . . . . 0.672 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.9 OUTLIER -117.37 -165.98 1.14 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.259 -1.142 . . . . 0.0 110.313 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 2197 ' ' GLU . . . . . 0.535 ' N ' ' CG ' ' A' 2196 ' ' PHE . 4.9 mm-40 -143.86 95.98 5.63 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.635 -0.666 . . . . 0.0 109.388 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2198 ' ' PRO . . . . . 0.672 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 6.8 Cg_endo -65.95 -167.17 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.187 1.925 . . . . 0.0 111.273 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -134.65 -171.33 12.47 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.1 -76.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.111 1.874 . . . . 0.0 110.822 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2201 ' ' MET . . . . . 0.547 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -140.26 52.2 1.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.485 -0.759 . . . . 0.0 109.997 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 8.8 mmm -126.37 -73.84 0.61 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.002 -1.062 . . . . 0.0 110.062 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A 2203 ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' 2175 ' ' PRO . 7.0 t -170.78 -169.12 0.74 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.218 -0.926 . . . . 0.0 109.746 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A 2204 ' ' CYS . . . . . 0.571 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.0 OUTLIER -112.46 148.03 35.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.47 -0.769 . . . . 0.0 108.974 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.43 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2129 ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' A' 2132 ' ' LYS . 5.2 t0 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2130 ' ' GLU . . . . . 0.585 ' O ' HG21 ' A' 2136 ' ' VAL . 2.1 mt-10 83.03 -61.29 0.13 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.757 -0.589 . . . . 0.0 110.831 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2131 ' ' CYS . . . . . 0.772 ' HA ' HG11 ' A' 2136 ' ' VAL . 29.5 p -85.45 -5.78 59.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.961 -1.087 . . . . 0.0 110.047 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2132 ' ' LYS . . . . . 0.541 ' HB3' ' HB3' ' A' 2129 ' ' ASP . 13.7 tttt -94.89 3.18 55.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -0.976 . . . . 0.0 109.34 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2133 ' ' GLU . . . . . 0.494 ' HB2' HG23 ' A' 2136 ' ' VAL . 5.3 mt-10 -69.61 147.24 96.52 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 120.99 -1.069 . . . . 0.0 109.188 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2134 ' ' PRO . . . . . 0.529 ' HA ' ' CG ' ' A' 2138 ' ' LYS . 1.4 Cg_endo -63.9 -6.13 10.44 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.278 1.985 . . . . 0.0 110.935 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.16 -3.73 12.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.983 -1.073 . . . . 0.0 110.078 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2136 ' ' VAL . . . . . 0.772 HG11 ' HA ' ' A' 2131 ' ' CYS . 76.9 t -96.86 -101.03 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.037 -1.04 . . . . 0.0 109.788 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2137 ' ' CYS . . . . . 0.65 ' N ' HG12 ' A' 2136 ' ' VAL . 0.5 OUTLIER -73.27 -72.58 0.25 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.868 -1.145 . . . . 0.0 109.523 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 2138 ' ' LYS . . . . . 0.529 ' CG ' ' HA ' ' A' 2134 ' ' PRO . 1.1 mtmt 63.53 100.57 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.296 -0.878 . . . . 0.0 109.805 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2139 ' ' HIS . . . . . 0.509 ' CB ' ' O ' ' A' 2138 ' ' LYS . 7.7 m-70 76.54 26.68 0.85 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -0.893 . . . . 0.0 109.579 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -132.34 166.82 23.23 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2141 ' ' GLN . . . . . 0.521 ' O ' ' CG ' ' A' 2152 ' ' GLU . 0.9 OUTLIER -103.86 71.51 1.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -1.17 . . . . 0.0 109.022 179.803 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 2142 ' ' CYS . . . . . 0.47 ' HB3' ' SG ' ' A' 2137 ' ' CYS . 25.4 p -70.17 -164.33 0.08 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.865 0.841 . . . . 0.0 110.449 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2143 ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' 2143 ' ' ILE . 2.5 mp -151.68 84.58 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2144 ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 3.2 t30 -61.74 113.64 2.86 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.54 -0.725 . . . . 0.0 110.362 -178.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2145 ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' 2146 ' ' ASP . 16.5 p -101.1 -157.2 0.59 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.531 -0.731 . . . . 0.0 109.324 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2146 ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' 2146 ' ' ASP . 0.6 OUTLIER -48.37 -94.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.625 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -108.04 16.99 35.57 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2148 ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.69 -166.37 1.77 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.202 -1.175 . . . . 0.0 109.165 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2149 ' ' TYR . . . . . 0.558 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 40.5 p90 -176.4 -176.86 0.8 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.655 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2150 ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.09 134.9 23.58 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -102.25 119.67 39.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.086 -1.009 . . . . 0.0 109.937 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2152 ' ' GLU . . . . . 0.521 ' CG ' ' O ' ' A' 2141 ' ' GLN . 0.8 OUTLIER -134.68 178.64 6.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 109.389 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 2153 ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -142.09 158.34 61.84 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.302 -179.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 2154 ' ' PRO . . . . . 0.501 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.8 Cg_endo -62.93 -171.08 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.457 2.104 . . . . 0.0 111.52 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.18 102.47 14.49 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.39 -16.7 5.4 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2157 ' ' TYR . . . . . 0.537 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 5.2 m-85 -105.25 -170.44 1.75 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.682 -0.893 . . . . 0.0 109.898 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2158 ' ' ILE . . . . . 0.638 HD13 ' N ' ' A' 2158 ' ' ILE . 0.2 OUTLIER -158.91 -161.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.624 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 2159 ' ' LEU . . . . . 0.505 ' N ' HG12 ' A' 2158 ' ' ILE . 26.3 tp -136.55 123.34 21.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.831 . . . . 0.0 109.499 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -96.39 51.78 1.21 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.359 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 90.36 -29.62 6.53 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2162 ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' 2136 ' ' VAL . 2.8 p-10 -171.13 -48.84 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.153 -1.204 . . . . 0.0 109.331 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2163 ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' 2137 ' ' CYS . 53.8 tt0 -72.57 121.78 20.27 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.543 -0.723 . . . . 0.0 109.273 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2164 ' ' CYS . . . . . 0.632 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -90.94 138.88 31.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 109.593 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 2165 ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' 2164 ' ' CYS . 0.7 OUTLIER -159.84 -167.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.941 . . . . 0.0 109.297 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 2166 ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 8.7 t70 -89.97 155.73 18.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.975 -1.078 . . . . 0.0 109.786 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2167 ' ' THR . . . . . 0.607 HG23 ' OE1' ' A' 2169 ' ' GLU . 7.2 t -90.99 -169.49 2.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 109.449 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2168 ' ' ASP . . . . . 0.478 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 64.9 t0 -109.15 102.44 11.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.218 -0.926 . . . . 0.0 109.836 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2169 ' ' GLU . . . . . 0.613 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.5 OUTLIER -74.95 -32.65 61.79 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.361 -0.837 . . . . 0.0 109.066 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 2170 ' ' CYS . . . . . 0.538 ' HB2' ' N ' ' A' 2182 ' ' LYS . 0.6 OUTLIER -64.6 -11.55 36.1 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.776 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.35 5.22 13.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.845 . . . . 0.0 109.383 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 40.5 t -103.61 -65.88 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.355 -0.84 . . . . 0.0 109.402 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2173 ' ' GLY . . . . . . . . . . . . . . . -153.53 -135.18 2.1 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2174 ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -122.85 102.69 37.85 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.316 -1.109 . . . . 0.0 109.07 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2175 ' ' PRO . . . . . 0.645 ' CB ' ' CE2' ' A' 2188 ' ' PHE . 3.4 Cg_endo -69.07 -18.58 40.19 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.695 1.597 . . . . 0.0 109.839 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2176 ' ' CYS . . . . . 0.578 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -69.77 -50.36 44.05 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.127 -0.983 . . . . 0.0 109.653 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 124.75 -17.94 7.2 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -166.37 -37.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -1.079 . . . . 0.0 110.12 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2179 ' ' GLY . . . . . 0.585 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -63.95 -120.55 0.01 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.4 p -141.55 161.29 38.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.54 -0.976 . . . . 0.0 109.198 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2181 ' ' CYS . . . . . 0.572 ' HB3' ' HD2' ' A' 2175 ' ' PRO . 26.7 p -97.81 160.76 14.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.043 -1.036 . . . . 0.0 110.593 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2182 ' ' LYS . . . . . 0.576 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 2.5 tppt? -145.46 155.67 43.26 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2183 ' ' ASN . . . . . 0.478 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 32.4 t30 -92.71 137.34 32.45 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.52 -1.363 . . . . 0.0 110.203 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2184 ' ' VAL . . . . . 0.847 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -140.92 -167.63 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 2185 ' ' ILE . . . . . 0.695 ' N ' HG13 ' A' 2184 ' ' VAL . 1.5 mp -107.17 141.42 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.106 -0.996 . . . . 0.0 110.461 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 64.7 13.48 56.11 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2187 ' ' GLY . . . . . 0.566 ' C ' HG12 ' A' 2184 ' ' VAL . . . 167.24 -118.85 0.81 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2188 ' ' PHE . . . . . 0.847 ' N ' HG12 ' A' 2184 ' ' VAL . 1.5 p90 -171.84 -179.19 2.38 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.367 -1.078 . . . . 0.0 109.497 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2189 ' ' GLU . . . . . 0.576 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.5 OUTLIER -128.87 169.19 14.9 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.387 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 8.9 p -170.53 147.66 2.96 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.789 -1.194 . . . . 0.0 109.749 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2191 ' ' THR . . . . . . . . . . . . . 25.2 m -118.18 90.97 3.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.644 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2192 ' ' CYS . . . . . 0.631 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.8 OUTLIER -52.99 -179.88 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.031 -1.043 . . . . 0.0 108.783 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 2193 ' ' GLU . . . . . 0.499 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.6 tt0 -52.45 112.76 0.87 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2194 ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -31.34 125.73 0.21 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.439 0.637 . . . . 0.0 111.136 -178.601 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.53 11.18 6.17 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2196 ' ' PHE . . . . . 0.686 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.8 p90 -118.33 -162.34 0.88 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.135 -1.215 . . . . 0.0 110.489 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2197 ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' 2196 ' ' PHE . 18.4 mt-10 -142.28 92.54 7.45 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 121.434 -0.792 . . . . 0.0 110.058 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2198 ' ' PRO . . . . . 0.686 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.0 Cg_endo -67.05 -160.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.303 2.002 . . . . 0.0 111.273 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -140.21 -175.74 14.63 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A 2200 ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' 2189 ' ' GLU . 2.0 Cg_endo -62.14 -74.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 121.702 1.601 . . . . 0.0 110.61 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2201 ' ' MET . . . . . 0.475 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -143.44 46.47 1.5 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.213 -0.929 . . . . 0.0 109.458 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 2202 ' ' MET . . . . . 0.432 ' O ' ' HB ' ' A' 2203 ' ' THR . 0.1 OUTLIER -116.95 -65.59 1.17 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.303 -0.873 . . . . 0.0 109.779 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 2203 ' ' THR . . . . . 0.432 ' HB ' ' O ' ' A' 2202 ' ' MET . 13.3 t -179.9 -171.45 0.18 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A 2204 ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.0 OUTLIER -112.44 143.51 43.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.086 -1.009 . . . . 0.0 109.269 -179.552 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.495 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2129 ' ' ASP . . . . . 0.62 ' O ' ' HB2' ' A' 2130 ' ' GLU . 4.5 t0 . . . . . 0 N--CA 1.486 1.371 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2130 ' ' GLU . . . . . 0.62 ' HB2' ' O ' ' A' 2129 ' ' ASP . 1.8 mp0 75.81 -57.52 0.57 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 120.92 0.391 . . . . 0.0 111.45 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2131 ' ' CYS . . . . . 0.567 ' HB2' ' CB ' ' A' 2137 ' ' CYS . 0.5 OUTLIER -84.43 -19.31 33.67 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.765 -1.209 . . . . 0.0 109.974 -178.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 2132 ' ' LYS . . . . . 0.53 ' HB3' ' HB3' ' A' 2129 ' ' ASP . 4.4 tttt -68.4 -9.92 51.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.13 -0.981 . . . . 0.0 109.838 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2133 ' ' GLU . . . . . 0.929 ' HB2' HG23 ' A' 2136 ' ' VAL . 6.7 mt-10 -69.13 147.62 97.54 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.329 -0.857 . . . . 0.0 109.921 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2134 ' ' PRO . . . . . 0.497 ' O ' ' HD2' ' A' 2138 ' ' LYS . 3.8 Cg_endo -69.27 3.25 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.499 2.132 . . . . 0.0 111.17 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2135 ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' 2162 ' ' ASN . 0.6 OUTLIER -127.08 -6.08 6.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.638 -1.289 . . . . 0.0 110.3 -179.551 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 2136 ' ' VAL . . . . . 0.929 HG23 ' HB2' ' A' 2133 ' ' GLU . 2.4 t -102.31 -143.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.866 -1.146 . . . . 0.0 108.117 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2137 ' ' CYS . . . . . 0.567 ' CB ' ' HB2' ' A' 2131 ' ' CYS . 2.6 t -49.97 128.94 19.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.548 -1.345 . . . . 0.0 108.336 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2138 ' ' LYS . . . . . 0.516 ' O ' ' CB ' ' A' 2139 ' ' HIS . 2.9 mtpt -135.4 28.8 3.34 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.119 -0.988 . . . . 0.0 110.353 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2139 ' ' HIS . . . . . 0.516 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.1 OUTLIER 162.21 45.43 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.311 -0.868 . . . . 0.0 109.698 179.582 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -153.92 179.76 29.91 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -88.8 82.62 6.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -1.135 . . . . 0.0 109.171 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2142 ' ' CYS . . . . . 0.525 ' C ' HD13 ' A' 2143 ' ' ILE . 21.4 p -78.67 147.63 33.46 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.366 -0.834 . . . . 0.0 110.032 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2143 ' ' ILE . . . . . 0.525 HD13 ' C ' ' A' 2142 ' ' CYS . 5.0 mm -113.37 129.03 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2144 ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' 2129 ' ' ASP . 4.0 t-20 -84.16 103.47 13.4 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 110.545 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2145 ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' 2146 ' ' ASP . 4.1 p -94.45 -167.19 1.61 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2146 ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' 2145 ' ' THR . 0.4 OUTLIER -45.78 -93.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 109.342 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -108.12 -7.6 30.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2148 ' ' SER . . . . . 0.438 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.2 OUTLIER -100.24 -162.61 0.96 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -1.129 . . . . 0.0 109.471 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 2149 ' ' TYR . . . . . 0.598 ' CD2' ' HB3' ' A' 2130 ' ' GLU . 29.6 p90 -164.85 -171.12 2.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.193 -0.942 . . . . 0.0 109.577 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2150 ' ' ARG . . . . . 0.531 ' CG ' ' O ' ' A' 2149 ' ' TYR . 18.0 mtt180 -160.55 104.5 1.41 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.465 -0.772 . . . . 0.0 109.412 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 41.9 t -86.68 78.82 9.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.351 -0.843 . . . . 0.0 109.482 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.86 98.12 11.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.921 . . . . 0.0 109.209 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2153 ' ' CYS . . . . . 0.546 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -58.08 157.46 16.29 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.335 -0.853 . . . . 0.0 109.748 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 2154 ' ' PRO . . . . . 0.499 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.2 Cg_endo -65.22 -166.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.703 2.269 . . . . 0.0 111.278 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 8.4 t80 -90.43 102.34 15.08 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.82 -15.4 5.42 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 107.742 -2.143 . . . . 0.0 107.742 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2157 ' ' TYR . . . . . 0.546 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 9.0 m-85 -109.3 -171.19 1.79 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.647 -0.913 . . . . 0.0 109.724 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2158 ' ' ILE . . . . . 0.741 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -157.34 -161.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.641 -0.662 . . . . 0.0 109.597 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 2159 ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' 2159 ' ' LEU . 15.5 tp -134.35 120.72 20.23 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.326 -0.859 . . . . 0.0 109.67 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -97.1 57.47 1.47 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.2 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2161 ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 86.94 -14.0 57.96 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2162 ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' 2135 ' ' ASP . 1.6 m-20 165.44 -41.81 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.253 -1.145 . . . . 0.0 109.683 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -73.63 118.38 16.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.372 -0.83 . . . . 0.0 109.223 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2164 ' ' CYS . . . . . 0.776 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -85.24 138.78 32.12 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.26 -0.9 . . . . 0.0 109.642 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 2165 ' ' VAL . . . . . 0.776 HG13 ' O ' ' A' 2164 ' ' CYS . 1.6 m -164.63 -170.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 0.0 109.07 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2166 ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' 2184 ' ' VAL . 3.0 t70 -89.74 147.66 23.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.991 -1.068 . . . . 0.0 109.465 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2167 ' ' THR . . . . . 0.602 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 6.8 t -89.72 -173.72 4.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.363 -0.836 . . . . 0.0 109.111 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2168 ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' 2171 ' ' SER . 44.5 t0 -98.94 97.02 8.24 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.266 -0.896 . . . . 0.0 108.649 178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2169 ' ' GLU . . . . . 0.577 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.6 OUTLIER -72.58 -31.18 65.03 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.185 -0.947 . . . . 0.0 109.443 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 2170 ' ' CYS . . . . . 0.522 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 3.3 t -70.59 -4.7 24.49 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.301 -0.874 . . . . 0.0 108.894 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2171 ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.1 OUTLIER -65.62 -8.52 20.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.831 -1.168 . . . . 0.0 109.413 179.572 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 24.9 t -83.11 -71.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.156 -0.965 . . . . 0.0 109.571 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2173 ' ' GLY . . . . . 0.459 ' O ' ' SG ' ' A' 2181 ' ' CYS . . . -172.72 -70.21 0.05 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2174 ' ' ASN . . . . . 0.549 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 27.5 p-10 -171.47 95.58 0.41 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.221 -1.164 . . . . 0.0 109.021 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2175 ' ' PRO . . . . . 0.611 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.5 Cg_endo -63.98 -19.75 66.96 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.915 1.743 . . . . 0.0 110.253 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2176 ' ' CYS . . . . . 0.523 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -56.04 -58.69 6.86 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.052 -1.03 . . . . 0.0 108.239 179.697 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 148.1 -18.21 1.37 Allowed Glycine 0 N--CA 1.483 1.826 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2178 ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.2 OUTLIER -169.48 -32.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -1.131 . . . . 0.0 110.297 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 2179 ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -61.18 -115.6 0.01 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2180 ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' 2190 ' ' CYS . 1.1 p -151.3 152.51 33.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -1.07 . . . . 0.0 109.486 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2181 ' ' CYS . . . . . 0.59 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 20.7 p -87.83 164.29 15.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.974 -1.079 . . . . 0.0 110.896 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2182 ' ' LYS . . . . . 0.598 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.0 OUTLIER -145.16 158.97 43.68 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.467 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 2183 ' ' ASN . . . . . 0.471 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 57.2 t30 -99.72 129.9 45.88 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.446 -1.408 . . . . 0.0 109.735 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2184 ' ' VAL . . . . . 0.793 HG12 ' N ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -140.08 -170.3 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 2185 ' ' ILE . . . . . 0.544 ' N ' HG13 ' A' 2184 ' ' VAL . 4.6 mp -101.6 136.78 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.96 -1.087 . . . . 0.0 110.448 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 76.33 -2.23 57.97 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2187 ' ' GLY . . . . . 0.533 ' C ' ' CD1' ' A' 2188 ' ' PHE . . . 178.27 -113.67 0.42 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2188 ' ' PHE . . . . . 0.793 ' N ' HG12 ' A' 2184 ' ' VAL . 3.0 p90 -176.19 176.42 1.71 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.384 -1.068 . . . . 0.0 108.876 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2189 ' ' GLU . . . . . 0.598 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 8.1 tt0 -124.26 133.67 53.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.125 -0.984 . . . . 0.0 108.685 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2190 ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' 2180 ' ' THR . 20.7 p -128.16 136.99 51.88 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.906 -1.121 . . . . 0.0 109.869 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2191 ' ' THR . . . . . 0.491 ' O ' ' HA3' ' A' 2179 ' ' GLY . 17.9 m -109.86 87.95 2.63 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.38 -0.825 . . . . 0.0 109.243 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2192 ' ' CYS . . . . . 0.622 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 1.2 m -48.91 -179.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.414 -0.804 . . . . 0.0 109.167 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2193 ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' 2194 ' ' GLU . 20.5 tt0 -56.26 122.35 11.6 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2194 ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -36.7 130.17 0.76 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.616 -0.678 . . . . 0.0 110.585 -178.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.31 0.02 10.44 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2196 ' ' PHE . . . . . 0.683 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.2 p90 -112.1 -162.47 0.8 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.277 -1.131 . . . . 0.0 110.015 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2197 ' ' GLU . . . . . 0.551 ' N ' ' CG ' ' A' 2196 ' ' PHE . 9.3 mt-10 -145.96 94.33 5.01 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.429 -0.795 . . . . 0.0 109.872 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2198 ' ' PRO . . . . . 0.683 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 7.9 Cg_endo -67.65 -158.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.444 2.096 . . . . 0.0 111.355 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -146.44 -167.4 12.78 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.13 -79.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.874 1.716 . . . . 0.0 110.634 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A 2201 ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' 2188 ' ' PHE . 5.0 ptp -136.93 62.31 1.6 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.823 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -127.69 -86.1 0.58 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.236 -0.915 . . . . 0.0 109.933 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2203 ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' 2175 ' ' PRO . 15.1 t -175.7 -170.42 0.4 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.387 -0.821 . . . . 0.0 108.961 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A 2204 ' ' CYS . . . . . 0.54 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.7 OUTLIER -61.66 135.98 57.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.011 -1.055 . . . . 0.0 108.972 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A 2205 ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' 2197 ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.579 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2129 ' ' ASP . . . . . 0.537 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 19.3 t0 . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2130 ' ' GLU . . . . . 0.737 ' O ' HG21 ' A' 2136 ' ' VAL . 1.3 mt-10 80.3 -43.96 0.25 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.925 -0.484 . . . . 0.0 111.066 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2131 ' ' CYS . . . . . 0.512 ' O ' ' HB2' ' A' 2137 ' ' CYS . 10.4 p -91.0 -42.19 10.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.66 -1.275 . . . . 0.0 110.111 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2132 ' ' LYS . . . . . 0.507 ' N ' ' SG ' ' A' 2131 ' ' CYS . 0.0 OUTLIER -67.27 -2.4 5.91 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.993 -1.067 . . . . 0.0 110.52 -179.571 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -68.75 153.56 95.76 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 120.963 -1.086 . . . . 0.0 109.459 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2134 ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -65.52 -3.81 8.43 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.533 2.155 . . . . 0.0 111.101 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2135 ' ' ASP . . . . . 0.848 ' OD1' HG23 ' A' 2136 ' ' VAL . 53.6 p-10 -119.26 3.13 11.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.861 -1.15 . . . . 0.0 110.346 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2136 ' ' VAL . . . . . 0.848 HG23 ' OD1' ' A' 2135 ' ' ASP . 19.1 t -121.82 -119.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.827 -1.171 . . . . 0.0 109.785 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2137 ' ' CYS . . . . . 0.514 ' N ' HG12 ' A' 2136 ' ' VAL . 0.1 OUTLIER -50.78 -56.19 13.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.624 -1.298 . . . . 0.0 109.488 -179.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 2138 ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' 2137 ' ' CYS . 3.8 mttt 72.64 -81.91 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.4 -0.813 . . . . 0.0 109.866 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2139 ' ' HIS . . . . . 0.515 ' O ' ' HB3' ' A' 2164 ' ' CYS . 21.2 m80 -115.27 58.87 0.71 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.052 -1.03 . . . . 0.0 110.186 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -141.7 -166.74 10.97 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.04 93.75 3.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -1.153 . . . . 0.0 109.037 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2142 ' ' CYS . . . . . 0.878 ' C ' HD12 ' A' 2143 ' ' ILE . 12.8 p -91.52 -152.25 0.29 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.235 -0.916 . . . . 0.0 110.491 -179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2143 ' ' ILE . . . . . 0.878 HD12 ' C ' ' A' 2142 ' ' CYS . 2.9 mp -148.46 90.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2144 ' ' ASN . . . . . 0.537 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 30.2 t-20 -39.33 108.5 0.09 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.404 0.621 . . . . 0.0 110.826 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2145 ' ' THR . . . . . 0.416 ' OG1' ' C ' ' A' 2148 ' ' SER . 0.1 OUTLIER -98.67 170.35 8.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.401 -0.812 . . . . 0.0 108.994 179.302 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.92 -84.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.797 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -107.08 50.83 0.77 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2148 ' ' SER . . . . . 0.466 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER -178.06 -162.68 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -1.153 . . . . 0.0 109.714 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 2149 ' ' TYR . . . . . 0.642 ' CE2' HG11 ' A' 2136 ' ' VAL . 42.0 p90 -169.77 -169.49 0.9 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.454 -0.779 . . . . 0.0 109.737 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2150 ' ' ARG . . . . . 0.456 ' C ' ' HB2' ' A' 2142 ' ' CYS . 0.4 OUTLIER -144.18 -160.78 1.17 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 2151 ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' 2150 ' ' ARG . 1.2 m -169.77 69.9 0.06 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.072 -1.017 . . . . 0.0 109.66 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -89.89 137.71 32.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.408 -0.807 . . . . 0.0 109.151 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2153 ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -112.07 158.54 36.61 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.192 -0.943 . . . . 0.0 109.501 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 2154 ' ' PRO . . . . . 0.485 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 2.7 Cg_endo -61.61 -176.03 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.68 2.253 . . . . 0.0 111.817 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 12.7 t80 -82.29 103.15 11.67 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.54 -19.03 5.11 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 107.119 -2.393 . . . . 0.0 107.119 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2157 ' ' TYR . . . . . 0.525 ' C ' HG23 ' A' 2158 ' ' ILE . 18.2 m-85 -108.2 176.42 5.13 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.824 -0.81 . . . . 0.0 109.601 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2158 ' ' ILE . . . . . 0.737 HD13 ' N ' ' A' 2158 ' ' ILE . 0.1 OUTLIER -158.08 -163.74 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.658 -0.651 . . . . 0.0 109.403 -179.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 2159 ' ' LEU . . . . . 0.449 HD11 ' O ' ' A' 2162 ' ' ASN . 19.4 tp -131.34 122.78 26.97 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.435 -0.79 . . . . 0.0 109.481 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -93.47 43.01 1.11 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.299 -0.875 . . . . 0.0 109.129 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2161 ' ' GLY . . . . . 0.451 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 97.42 -8.94 64.63 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2162 ' ' ASN . . . . . 0.532 ' ND2' ' HA ' ' A' 2136 ' ' VAL . 1.3 m-20 167.93 -43.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -1.167 . . . . 0.0 109.635 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -79.42 118.83 21.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 109.376 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2164 ' ' CYS . . . . . 0.816 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -88.53 137.77 32.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.418 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 2165 ' ' VAL . . . . . 0.816 HG13 ' O ' ' A' 2164 ' ' CYS . 1.8 m -166.43 -166.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.374 -0.829 . . . . 0.0 108.92 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2166 ' ' ASP . . . . . 0.425 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 0.7 OUTLIER -83.82 139.18 32.84 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.733 -1.23 . . . . 0.0 109.453 179.83 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 2167 ' ' THR . . . . . 0.636 ' HB ' HD12 ' A' 2158 ' ' ILE . 9.9 t -97.44 178.31 5.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.354 -0.841 . . . . 0.0 109.362 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2168 ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' 2171 ' ' SER . 51.3 t0 -88.55 96.04 10.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.164 -0.96 . . . . 0.0 109.024 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2169 ' ' GLU . . . . . 0.59 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.4 OUTLIER -66.67 -34.14 77.21 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.296 -0.877 . . . . 0.0 109.228 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 2170 ' ' CYS . . . . . 0.459 ' O ' ' SG ' ' A' 2170 ' ' CYS . 1.7 t -68.67 -9.08 48.0 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.327 -0.858 . . . . 0.0 108.753 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2171 ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -78.32 5.84 9.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.372 -0.83 . . . . 0.0 110.574 -179.176 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 5.6 t -112.3 -76.93 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.903 -1.123 . . . . 0.0 109.87 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2173 ' ' GLY . . . . . 0.469 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -150.7 137.53 6.15 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2174 ' ' ASN . . . . . 0.629 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 23.2 p-10 -47.03 104.51 0.41 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.312 -1.111 . . . . 0.0 109.969 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2175 ' ' PRO . . . . . 0.583 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 1.7 Cg_endo -70.42 -23.55 27.66 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.879 1.719 . . . . 0.0 109.763 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2176 ' ' CYS . . . . . 0.554 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -47.33 -30.97 3.52 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.395 -0.815 . . . . 0.0 109.492 -179.585 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 114.49 -23.47 12.21 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.3 -34.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.606 -0.937 . . . . 0.0 109.791 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2179 ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -62.47 -127.81 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.3 p -134.64 156.76 48.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.601 -0.941 . . . . 0.0 109.549 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2181 ' ' CYS . . . . . 0.629 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 14.6 p -94.12 163.06 13.62 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.199 1.0 . . . . 0.0 111.258 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2182 ' ' LYS . . . . . 0.586 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 5.9 tttp -143.06 156.9 44.92 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2183 ' ' ASN . . . . . 0.408 ' N ' ' HG3' ' A' 2182 ' ' LYS . 60.9 t30 -99.31 133.09 44.12 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.3 -1.5 . . . . 0.0 109.967 -179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2184 ' ' VAL . . . . . 0.81 HG12 ' N ' ' A' 2188 ' ' PHE . 0.4 OUTLIER -140.37 -176.77 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.635 -0.666 . . . . 0.0 109.227 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 2185 ' ' ILE . . . . . 0.457 ' N ' HG13 ' A' 2184 ' ' VAL . 1.9 mp -95.8 143.51 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.117 -0.989 . . . . 0.0 110.131 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 65.07 12.33 54.59 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2187 ' ' GLY . . . . . 0.627 ' C ' HG12 ' A' 2184 ' ' VAL . . . 165.12 -129.25 1.92 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2188 ' ' PHE . . . . . 0.81 ' N ' HG12 ' A' 2184 ' ' VAL . 1.4 p90 -164.11 -179.32 6.1 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.3 -1.118 . . . . 0.0 108.81 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2189 ' ' GLU . . . . . 0.586 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.2 OUTLIER -125.48 174.2 8.38 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.39 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 1.8 p -171.61 147.71 2.36 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.769 -1.207 . . . . 0.0 109.81 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2191 ' ' THR . . . . . 0.474 ' O ' ' O ' ' A' 2192 ' ' CYS . 13.6 m -123.06 89.9 3.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.0 109.898 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2192 ' ' CYS . . . . . 0.614 ' HA ' ' HA3' ' A' 2179 ' ' GLY . 0.8 OUTLIER -48.91 -179.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.341 -0.85 . . . . 0.0 109.32 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 2193 ' ' GLU . . . . . 0.462 ' O ' ' C ' ' A' 2194 ' ' GLU . 3.3 tt0 -61.12 125.43 23.7 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2194 ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -34.86 129.76 0.43 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.344 0.592 . . . . 0.0 110.842 -179.244 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.21 5.39 8.77 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2196 ' ' PHE . . . . . 0.672 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.9 OUTLIER -121.5 -163.5 1.05 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.289 -1.124 . . . . 0.0 110.195 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 2197 ' ' GLU . . . . . 0.584 ' N ' ' CG ' ' A' 2196 ' ' PHE . 24.4 mt-10 -148.15 98.07 3.8 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.619 -0.675 . . . . 0.0 109.428 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2198 ' ' PRO . . . . . 0.672 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.8 Cg_endo -69.01 -166.31 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.339 2.026 . . . . 0.0 111.597 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -135.84 -170.35 12.04 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.17 -83.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.21 1.94 . . . . 0.0 110.994 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A 2201 ' ' MET . . . . . 0.64 ' HG2' HG11 ' A' 2184 ' ' VAL . 8.4 mtt -132.77 52.22 2.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.991 -1.068 . . . . 0.0 109.975 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2202 ' ' MET . . . . . 0.451 ' O ' ' HB ' ' A' 2203 ' ' THR . 1.0 OUTLIER -122.98 -71.23 0.73 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.21 -0.931 . . . . 0.0 109.791 -179.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 2203 ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' 2202 ' ' MET . 11.7 t 179.33 -167.82 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.458 -0.776 . . . . 0.0 109.048 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A 2204 ' ' CYS . . . . . 0.554 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -111.52 150.17 30.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.095 -1.003 . . . . 0.0 109.215 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 117.896 -1.049 . . . . 0.0 109.572 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2129 ' ' ASP . . . . . 0.59 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 1.3 p30 . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2130 ' ' GLU . . . . . 0.794 ' O ' HG21 ' A' 2136 ' ' VAL . 1.4 mt-10 80.44 -42.86 0.22 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 122.015 -0.428 . . . . 0.0 111.292 177.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2131 ' ' CYS . . . . . 0.599 ' HA ' HG11 ' A' 2136 ' ' VAL . 17.5 p -90.82 27.16 1.86 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.922 -1.111 . . . . 0.0 110.204 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2132 ' ' LYS . . . . . 0.525 ' N ' ' OD1' ' A' 2129 ' ' ASP . 0.6 OUTLIER -131.94 -6.25 3.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.91 . . . . 0.0 109.728 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 2133 ' ' GLU . . . . . 0.468 ' HB3' ' HD2' ' A' 2134 ' ' PRO . 5.8 mt-10 -70.03 158.74 86.62 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.141 -0.974 . . . . 0.0 109.323 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2134 ' ' PRO . . . . . 0.507 ' O ' ' HD2' ' A' 2138 ' ' LYS . 2.8 Cg_endo -67.27 -1.53 6.54 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.379 2.053 . . . . 0.0 110.804 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.07 4.65 9.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.8 -1.188 . . . . 0.0 110.088 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2136 ' ' VAL . . . . . 0.794 HG21 ' O ' ' A' 2130 ' ' GLU . 55.0 t -107.46 -107.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.869 -1.145 . . . . 0.0 110.116 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2137 ' ' CYS . . . . . 0.531 ' N ' HG12 ' A' 2136 ' ' VAL . 1.3 m -56.21 -77.39 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.796 -1.19 . . . . 0.0 109.599 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2138 ' ' LYS . . . . . 0.58 ' O ' ' CG ' ' A' 2139 ' ' HIS . 0.1 OUTLIER 68.7 3.05 3.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.584 -0.698 . . . . 0.0 111.12 179.188 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 2139 ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' 2138 ' ' LYS . 0.8 OUTLIER 168.64 40.43 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.701 -1.249 . . . . 0.0 110.835 178.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -158.21 160.65 31.03 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.116 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -89.51 124.22 34.32 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2142 ' ' CYS . . . . . 0.883 ' C ' HD12 ' A' 2143 ' ' ILE . 22.8 p -111.86 -166.85 1.11 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.131 -0.98 . . . . 0.0 111.237 -178.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2143 ' ' ILE . . . . . 0.883 HD12 ' C ' ' A' 2142 ' ' CYS . 4.2 mp -150.24 98.1 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2144 ' ' ASN . . . . . 0.59 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 26.6 t-20 -46.86 114.54 0.86 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.452 -0.78 . . . . 0.0 111.254 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2145 ' ' THR . . . . . 0.48 ' OG1' ' HA ' ' A' 2149 ' ' TYR . 0.1 OUTLIER -108.54 175.55 5.43 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.236 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.25 105.64 9.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.349 -0.844 . . . . 0.0 110.055 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 73.01 8.77 74.69 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2148 ' ' SER . . . . . 0.488 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.5 OUTLIER -152.68 -173.6 4.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.977 -1.308 . . . . 0.0 109.951 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 2149 ' ' TYR . . . . . 0.636 ' CD2' ' CB ' ' A' 2130 ' ' GLU . 50.7 p90 -165.66 -168.4 1.31 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.522 -0.736 . . . . 0.0 109.168 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2150 ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' 2142 ' ' CYS . 0.4 OUTLIER -168.93 124.98 0.92 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.324 -0.86 . . . . 0.0 108.914 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 2.1 t -105.49 107.2 18.07 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.149 -0.969 . . . . 0.0 110.278 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.77 134.15 42.08 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2153 ' ' CYS . . . . . 0.508 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -97.54 161.07 27.15 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.071 -1.018 . . . . 0.0 109.955 -179.149 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 2154 ' ' PRO . . . . . 0.5 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.8 Cg_endo -61.43 -169.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 122.812 2.342 . . . . 0.0 111.812 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 3.4 t80 -86.12 99.86 11.79 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.09 -13.17 5.77 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2157 ' ' TYR . . . . . 0.536 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 5.1 m-85 -107.16 -173.5 2.31 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.503 -0.998 . . . . 0.0 110.205 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2158 ' ' ILE . . . . . 0.707 HD13 ' N ' ' A' 2158 ' ' ILE . 0.1 OUTLIER -159.36 -166.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 2159 ' ' LEU . . . . . 0.636 HD11 ' O ' ' A' 2162 ' ' ASN . 31.4 tp -133.67 119.64 19.62 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.333 -0.854 . . . . 0.0 109.236 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -89.89 55.83 3.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 109.664 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2161 ' ' GLY . . . . . 0.505 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 80.08 -2.31 76.23 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2162 ' ' ASN . . . . . 0.636 ' O ' HD11 ' A' 2159 ' ' LEU . 0.3 OUTLIER 166.51 -58.48 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.1 -1.236 . . . . 0.0 109.69 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -69.66 115.5 8.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.873 . . . . 0.0 109.49 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2164 ' ' CYS . . . . . 0.83 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -86.2 140.32 30.26 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.307 -0.871 . . . . 0.0 109.273 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 2165 ' ' VAL . . . . . 0.83 HG13 ' O ' ' A' 2164 ' ' CYS . 1.0 OUTLIER -166.35 -166.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.483 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 2166 ' ' ASP . . . . . 0.49 ' OD1' ' CE1' ' A' 2157 ' ' TYR . 0.7 OUTLIER -89.93 142.04 28.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.949 -1.095 . . . . 0.0 109.606 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 2167 ' ' THR . . . . . 0.693 HG23 ' OE1' ' A' 2169 ' ' GLU . 12.8 t -81.67 175.75 10.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 0.0 108.972 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2168 ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' 2171 ' ' SER . 56.6 t0 -95.38 94.59 7.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.102 -0.999 . . . . 0.0 109.248 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2169 ' ' GLU . . . . . 0.693 ' OE1' HG23 ' A' 2167 ' ' THR . 0.8 OUTLIER -69.28 -33.82 73.79 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.407 -0.808 . . . . 0.0 109.363 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 2170 ' ' CYS . . . . . 0.527 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 2.3 t -69.62 -6.01 28.46 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.373 -0.83 . . . . 0.0 109.044 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2171 ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -79.59 7.59 8.03 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.992 -1.067 . . . . 0.0 109.941 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 24.1 t -112.87 -79.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.031 -1.043 . . . . 0.0 110.008 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2173 ' ' GLY . . . . . 0.473 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -152.45 139.74 7.22 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2174 ' ' ASN . . . . . 0.593 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 29.9 p-10 -45.9 104.19 0.39 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.51 -0.994 . . . . 0.0 110.249 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2175 ' ' PRO . . . . . 0.577 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 3.1 Cg_endo -67.29 -18.37 50.23 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.977 1.785 . . . . 0.0 110.324 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2176 ' ' CYS . . . . . 0.569 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -61.1 -10.52 6.36 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.111 -0.993 . . . . 0.0 110.185 -179.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 96.35 -31.47 7.4 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.272 -1.442 . . . . 0.0 109.58 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2178 ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.1 OUTLIER -158.26 -37.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -1.098 . . . . 0.0 109.962 -179.647 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 2179 ' ' GLY . . . . . 0.609 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -57.41 -113.25 0.01 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2180 ' ' THR . . . . . 0.436 HG23 ' O ' ' A' 2179 ' ' GLY . 1.4 p -154.23 168.71 25.65 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.411 -1.052 . . . . 0.0 109.305 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2181 ' ' CYS . . . . . 0.593 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 24.6 p -101.66 163.5 12.23 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.066 0.936 . . . . 0.0 111.414 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2182 ' ' LYS . . . . . 0.569 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.2 OUTLIER -144.68 158.34 43.82 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 178.542 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 58.2 t30 -100.35 128.67 46.36 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.555 -1.341 . . . . 0.0 108.957 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2184 ' ' VAL . . . . . 0.864 HG12 ' CA ' ' A' 2188 ' ' PHE . 0.9 OUTLIER -137.24 -166.53 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.632 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 2185 ' ' ILE . . . . . 0.638 ' H ' HG22 ' A' 2184 ' ' VAL . 4.7 mp -101.08 140.53 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 110.176 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 71.02 4.16 54.47 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2187 ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 167.23 -116.13 0.66 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2188 ' ' PHE . . . . . 0.864 ' CA ' HG12 ' A' 2184 ' ' VAL . 2.4 p90 -166.85 -177.76 3.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.052 -1.263 . . . . 0.0 110.083 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2189 ' ' GLU . . . . . 0.569 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 7.5 tt0 -129.84 139.45 51.2 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2190 ' ' CYS . . . . . 0.44 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 13.7 p -128.48 144.06 51.08 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.606 -1.309 . . . . 0.0 110.179 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2191 ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' 2192 ' ' CYS . 73.3 m -111.17 84.23 1.9 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.86 . . . . 0.0 109.701 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2192 ' ' CYS . . . . . 0.611 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.8 OUTLIER -49.93 179.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 109.047 179.763 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 2193 ' ' GLU . . . . . 0.493 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.3 OUTLIER -54.83 115.76 2.36 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 2194 ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.3 OUTLIER -30.17 126.8 0.14 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.375 0.607 . . . . 0.0 111.072 -179.033 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.37 5.58 8.55 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2196 ' ' PHE . . . . . 0.671 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.8 OUTLIER -117.51 -164.17 0.98 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.212 -1.169 . . . . 0.0 110.283 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A 2197 ' ' GLU . . . . . 0.557 ' N ' ' CG ' ' A' 2196 ' ' PHE . 2.1 mm-40 -145.48 98.21 4.61 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2198 ' ' PRO . . . . . 0.671 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.1 Cg_endo -68.08 -160.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.066 1.844 . . . . 0.0 110.726 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -135.52 -170.33 12.07 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.63 -74.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 121.96 1.773 . . . . 0.0 110.711 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A 2201 ' ' MET . . . . . 0.489 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 4.5 ptt? -146.22 60.51 1.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.15 -0.969 . . . . 0.0 110.118 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2202 ' ' MET . . . . . 0.452 ' O ' ' HB ' ' A' 2203 ' ' THR . 1.9 mmt -129.55 -68.97 0.7 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.102 -0.999 . . . . 0.0 109.75 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2203 ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' 2202 ' ' MET . 10.7 t 179.02 -168.74 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.414 -0.804 . . . . 0.0 109.138 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2204 ' ' CYS . . . . . 0.569 ' HB2' ' O ' ' A' 2176 ' ' CYS . 4.4 t -74.25 143.79 44.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.002 -1.061 . . . . 0.0 109.685 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.352 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2129 ' ' ASP . . . . . 0.657 ' O ' ' HB2' ' A' 2130 ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2130 ' ' GLU . . . . . 0.657 ' HB2' ' O ' ' A' 2129 ' ' ASP . 1.9 mt-10 76.57 -69.48 0.16 Allowed 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.032 0.444 . . . . 0.0 110.457 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2131 ' ' CYS . . . . . 0.458 ' O ' ' SG ' ' A' 2131 ' ' CYS . 47.5 t -78.69 8.22 5.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.998 -1.064 . . . . 0.0 110.199 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2132 ' ' LYS . . . . . 0.514 ' HB3' ' HB3' ' A' 2129 ' ' ASP . 0.0 OUTLIER -109.89 40.37 1.93 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.952 -1.093 . . . . 0.0 110.096 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 2133 ' ' GLU . . . . . 0.891 ' HB2' HG23 ' A' 2136 ' ' VAL . 2.0 mt-10 -129.69 140.62 39.17 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.09 -1.006 . . . . 0.0 109.509 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2134 ' ' PRO . . . . . 0.521 ' O ' ' CD ' ' A' 2138 ' ' LYS . 3.3 Cg_endo -68.83 -3.96 12.39 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.065 1.843 . . . . 0.0 109.964 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2135 ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' 2162 ' ' ASN . 5.7 p-10 -107.23 0.12 23.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.11 -0.993 . . . . 0.0 110.03 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2136 ' ' VAL . . . . . 0.957 HG12 ' SG ' ' A' 2151 ' ' CYS . 11.1 t -97.63 -121.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.062 -1.024 . . . . 0.0 108.641 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2137 ' ' CYS . . . . . 0.499 ' N ' ' SG ' ' A' 2151 ' ' CYS . 8.7 m -56.61 -68.6 0.2 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.579 -1.326 . . . . 0.0 109.297 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2138 ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' 2134 ' ' PRO . 1.9 mtmt 70.32 21.13 5.88 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.04 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2139 ' ' HIS . . . . . 0.478 ' CB ' ' O ' ' A' 2164 ' ' CYS . 0.0 OUTLIER 169.8 -42.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.485 -0.759 . . . . 0.0 109.323 179.591 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -86.31 175.06 47.62 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -93.52 123.54 36.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.148 -1.207 . . . . 0.0 109.539 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2142 ' ' CYS . . . . . 0.774 ' C ' HD12 ' A' 2143 ' ' ILE . 0.1 OUTLIER -112.72 178.82 4.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.558 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 2143 ' ' ILE . . . . . 0.774 HD12 ' C ' ' A' 2142 ' ' CYS . 4.6 mp -142.51 129.27 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2144 ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' 2129 ' ' ASP . 0.7 OUTLIER -71.88 118.23 14.46 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.097 -1.002 . . . . 0.0 110.037 -179.142 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 2145 ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' 2148 ' ' SER . 40.4 p -117.69 -161.04 0.8 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.225 -0.922 . . . . 0.0 108.682 178.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.23 102.86 12.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.082 -1.011 . . . . 0.0 110.279 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 59.31 27.84 63.62 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2148 ' ' SER . . . . . 0.468 ' O ' ' OG1' ' A' 2145 ' ' THR . 0.4 OUTLIER -166.45 179.14 5.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.059 -1.259 . . . . 0.0 109.773 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 2149 ' ' TYR . . . . . 0.527 ' HB3' ' HB3' ' A' 2130 ' ' GLU . 0.6 OUTLIER -139.85 -169.8 2.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.321 -0.862 . . . . 0.0 109.577 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 2150 ' ' ARG . . . . . 0.506 ' O ' ' C ' ' A' 2151 ' ' CYS . 9.1 mmt180 -139.07 27.74 2.35 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.3 -0.875 . . . . 0.0 109.34 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2151 ' ' CYS . . . . . 0.957 ' SG ' HG12 ' A' 2136 ' ' VAL . 0.8 OUTLIER -28.99 109.42 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.875 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -130.34 125.92 35.85 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2153 ' ' CYS . . . . . 0.535 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -84.14 155.93 63.59 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 121.167 -0.958 . . . . 0.0 110.339 -178.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 2154 ' ' PRO . . . . . 0.483 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.2 Cg_endo -63.44 -168.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.801 2.334 . . . . 0.0 111.794 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -88.01 102.31 14.63 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.54 -15.85 5.45 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 107.75 -2.14 . . . . 0.0 107.75 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2157 ' ' TYR . . . . . 0.535 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 6.5 m-85 -107.13 -174.81 2.62 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 121.655 -0.909 . . . . 0.0 109.828 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2158 ' ' ILE . . . . . 0.849 ' H ' HD13 ' A' 2158 ' ' ILE . 0.2 OUTLIER -146.03 -155.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.447 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 2159 ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' 2163 ' ' GLU . 25.9 tp -148.84 127.0 12.07 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.376 -0.828 . . . . 0.0 109.281 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -102.27 62.05 0.86 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.376 -0.828 . . . . 0.0 109.293 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 86.96 -43.96 3.28 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2162 ' ' ASN . . . . . 0.516 ' ND2' ' HA ' ' A' 2136 ' ' VAL . 0.1 OUTLIER -158.33 -45.82 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.43 -1.041 . . . . 0.0 109.149 179.753 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 2163 ' ' GLU . . . . . 0.741 ' O ' HD12 ' A' 2159 ' ' LEU . 65.5 tt0 -62.64 159.85 15.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.344 -0.848 . . . . 0.0 109.229 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2164 ' ' CYS . . . . . 0.512 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -131.64 137.05 48.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.13 -0.981 . . . . 0.0 109.638 -179.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 2165 ' ' VAL . . . . . 0.607 HG23 HD11 ' A' 2158 ' ' ILE . 1.2 m -156.1 -170.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.87 . . . . 0.0 109.282 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2166 ' ' ASP . . . . . 0.458 ' OD2' ' O ' ' A' 2184 ' ' VAL . 39.2 t70 -85.8 166.13 16.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.938 -1.101 . . . . 0.0 109.627 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2167 ' ' THR . . . . . 0.847 HG23 ' OE1' ' A' 2169 ' ' GLU . 11.6 t -106.8 167.86 9.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 0.0 109.423 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2168 ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' 2171 ' ' SER . 56.4 t0 -92.99 98.75 11.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.115 -0.991 . . . . 0.0 109.348 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2169 ' ' GLU . . . . . 0.847 ' OE1' HG23 ' A' 2167 ' ' THR . 0.8 OUTLIER -73.64 -32.11 63.86 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.426 -0.796 . . . . 0.0 109.415 -179.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 2170 ' ' CYS . . . . . 0.526 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.2 t -67.58 -8.1 31.56 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.319 -0.863 . . . . 0.0 108.981 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2171 ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -69.95 -4.59 21.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.168 -0.957 . . . . 0.0 109.537 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 9.3 t -100.55 -74.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.197 -0.939 . . . . 0.0 110.006 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2173 ' ' GLY . . . . . 0.488 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -168.82 141.48 6.78 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2174 ' ' ASN . . . . . 0.621 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 24.6 p-10 -36.61 97.31 0.13 Allowed Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.733 -0.863 . . . . 0.0 110.534 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2175 ' ' PRO . . . . . 0.602 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.8 Cg_endo -66.25 -20.31 55.82 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.982 1.788 . . . . 0.0 110.54 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2176 ' ' CYS . . . . . 0.551 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -51.54 -58.96 4.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.069 -1.019 . . . . 0.0 108.322 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 146.33 -20.82 1.72 Allowed Glycine 0 C--N 1.294 -1.781 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 4.1 t30 -160.53 -35.44 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -1.093 . . . . 0.0 110.127 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2179 ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -63.97 -119.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2180 ' ' THR . . . . . 0.498 ' HA ' ' HB3' ' A' 2174 ' ' ASN . 2.9 p -148.11 161.81 40.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.439 -1.036 . . . . 0.0 109.595 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2181 ' ' CYS . . . . . 0.621 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 27.0 p -93.64 160.8 14.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 110.906 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2182 ' ' LYS . . . . . 0.54 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 10.4 tttt -146.89 157.28 43.6 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2183 ' ' ASN . . . . . 0.474 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 59.0 t30 -93.4 129.09 39.67 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.453 -1.405 . . . . 0.0 110.13 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2184 ' ' VAL . . . . . 0.864 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -132.81 -168.73 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 2185 ' ' ILE . . . . . 0.679 ' N ' HG13 ' A' 2184 ' ' VAL . 3.9 mp -105.56 140.53 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.956 -1.09 . . . . 0.0 110.282 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 64.48 14.36 57.17 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2187 ' ' GLY . . . . . 0.591 ' C ' HG12 ' A' 2184 ' ' VAL . . . 167.94 -117.98 0.76 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2188 ' ' PHE . . . . . 0.864 ' N ' HG12 ' A' 2184 ' ' VAL . 2.0 p90 -172.92 177.1 2.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.173 -1.193 . . . . 0.0 109.609 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2189 ' ' GLU . . . . . 0.54 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.5 OUTLIER -123.28 139.57 53.9 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 2190 ' ' CYS . . . . . 0.45 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 22.9 p -135.73 137.33 41.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.765 -1.209 . . . . 0.0 109.721 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2191 ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' 2192 ' ' CYS . 25.3 m -108.79 83.45 1.76 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.412 -0.805 . . . . 0.0 109.478 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2192 ' ' CYS . . . . . 0.619 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -47.42 -179.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.934 0.873 . . . . 0.0 109.672 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 2193 ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' 2194 ' ' GLU . 11.3 tp10 -55.89 119.44 5.82 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2194 ' ' GLU . . . . . 0.494 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.5 OUTLIER -33.75 130.91 0.27 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.496 0.665 . . . . 0.0 110.675 -178.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.34 -0.67 10.48 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2196 ' ' PHE . . . . . 0.661 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.7 OUTLIER -114.37 -166.7 1.13 Allowed 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.264 -1.139 . . . . 0.0 110.109 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 2197 ' ' GLU . . . . . 0.554 ' N ' ' CG ' ' A' 2196 ' ' PHE . 1.7 mm-40 -145.31 98.02 4.68 Favored Pre-proline 0 C--N 1.299 -1.629 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2198 ' ' PRO . . . . . 0.661 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 7.9 Cg_endo -67.77 -161.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.118 1.879 . . . . 0.0 110.876 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -138.1 -170.4 11.86 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.75 -71.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.033 1.822 . . . . 0.0 110.547 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2201 ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.1 OUTLIER -139.18 53.53 1.74 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 110.192 -179.436 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 2.5 mmm -122.3 -93.68 0.51 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.048 -1.033 . . . . 0.0 109.995 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A 2203 ' ' THR . . . . . 0.487 ' OG1' ' O ' ' A' 2175 ' ' PRO . 6.0 t -169.42 -163.3 0.39 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.23 -0.919 . . . . 0.0 109.176 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2204 ' ' CYS . . . . . 0.551 ' HB2' ' O ' ' A' 2176 ' ' CYS . 1.9 t -67.82 138.35 56.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.09 -1.006 . . . . 0.0 109.306 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A 2205 ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' 2205 ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.515 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2129 ' ' ASP . . . . . 0.526 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 22.9 t0 . . . . . 0 N--CA 1.488 1.433 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2130 ' ' GLU . . . . . 0.556 ' O ' HG21 ' A' 2136 ' ' VAL . 30.5 mp0 -63.39 -21.6 66.38 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.407 -0.808 . . . . 0.0 110.398 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2131 ' ' CYS . . . . . 0.516 ' HB3' ' HB2' ' A' 2149 ' ' TYR . 5.8 p -88.07 -40.86 13.47 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 120.758 -1.214 . . . . 0.0 109.699 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2132 ' ' LYS . . . . . 0.502 ' N ' ' SG ' ' A' 2131 ' ' CYS . 0.0 OUTLIER -85.51 43.58 1.04 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.206 -0.934 . . . . 0.0 108.921 179.323 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 2133 ' ' GLU . . . . . 0.514 ' CB ' ' HD2' ' A' 2134 ' ' PRO . 4.8 mt-10 -94.39 171.91 6.26 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.331 -0.855 . . . . 0.0 109.537 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2134 ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' 2133 ' ' GLU . 1.3 Cg_endo -63.81 -17.93 61.89 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.51 2.14 . . . . 0.0 112.029 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 4.0 t70 -144.72 32.28 1.16 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.568 -1.332 . . . . 0.0 111.283 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2136 ' ' VAL . . . . . 0.556 HG21 ' O ' ' A' 2130 ' ' GLU . 46.9 t -112.75 -110.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.777 -1.202 . . . . 0.0 109.901 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2137 ' ' CYS . . . . . 0.551 ' N ' HG12 ' A' 2136 ' ' VAL . 64.5 m -74.11 -65.07 0.89 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.766 -1.209 . . . . 0.0 109.486 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2138 ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' 2137 ' ' CYS . 21.6 mttt 62.53 124.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.806 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2139 ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' A' 2164 ' ' CYS . 2.6 m170 44.26 48.58 7.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.83 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -140.11 168.8 24.97 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.46 56.0 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -1.197 . . . . 0.0 108.842 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2142 ' ' CYS . . . . . 0.452 ' HA ' ' O ' ' A' 2150 ' ' ARG . 26.3 p -65.82 174.76 2.22 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.349 -0.845 . . . . 0.0 110.56 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 3.3 mp -135.01 87.56 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2144 ' ' ASN . . . . . 0.526 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 8.4 t-20 -48.28 113.5 0.76 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.642 -0.661 . . . . 0.0 110.864 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2145 ' ' THR . . . . . . . . . . . . . 13.6 p -95.16 -174.65 3.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.405 -0.809 . . . . 0.0 109.021 179.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2146 ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' 2146 ' ' ASP . 2.9 p30 -91.13 41.41 1.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.181 -0.949 . . . . 0.0 109.531 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2147 ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' A' 2148 ' ' SER . . . 145.55 41.01 0.05 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2148 ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' 2147 ' ' GLY . 0.3 OUTLIER 168.34 -163.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -1.191 . . . . 0.0 109.362 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 2149 ' ' TYR . . . . . 0.516 ' HB2' ' HB3' ' A' 2131 ' ' CYS . 43.9 p90 -169.03 -173.25 1.74 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 110.132 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2150 ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' 2142 ' ' CYS . 0.0 OUTLIER -159.43 110.31 2.0 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 58.8 m -86.78 61.99 7.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 109.947 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2152 ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' 2153 ' ' CYS . 0.3 OUTLIER -87.27 80.61 8.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.114 -0.991 . . . . 0.0 108.837 179.396 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 2153 ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -43.16 153.12 0.36 Allowed Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.355 -0.841 . . . . 0.0 109.993 -179.352 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 2154 ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' 2157 ' ' TYR . 1.7 Cg_endo -65.91 -166.67 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.589 2.192 . . . . 0.0 111.258 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 8.1 t80 -90.39 104.41 16.99 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2156 ' ' GLY . . . . . 0.437 ' O ' HG22 ' A' 2167 ' ' THR . . . 130.69 -16.66 5.33 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 107.897 -2.081 . . . . 0.0 107.897 -178.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2157 ' ' TYR . . . . . 0.642 ' OH ' HG23 ' A' 2185 ' ' ILE . 7.6 m-85 -106.12 -166.79 1.23 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.551 -0.97 . . . . 0.0 109.783 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2158 ' ' ILE . . . . . 0.916 HD11 HG23 ' A' 2165 ' ' VAL . 0.2 OUTLIER -155.27 -163.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.534 -0.729 . . . . 0.0 109.468 179.723 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 2159 ' ' LEU . . . . . 0.492 ' N ' HG12 ' A' 2158 ' ' ILE . 30.5 tp -146.86 117.27 7.43 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.408 -0.807 . . . . 0.0 109.685 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -94.95 57.48 2.1 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.577 -0.702 . . . . 0.0 109.461 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2161 ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 87.18 -14.98 56.21 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2162 ' ' ASN . . . . . 0.448 ' O ' ' O ' ' A' 2136 ' ' VAL . 0.0 OUTLIER 168.81 -46.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.405 -1.056 . . . . 0.0 109.092 179.71 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -63.77 126.02 26.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 108.685 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2164 ' ' CYS . . . . . 0.592 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -104.32 139.78 38.82 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.912 -1.117 . . . . 0.0 109.953 -179.608 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 2165 ' ' VAL . . . . . 0.916 HG23 HD11 ' A' 2158 ' ' ILE . 3.7 m -158.56 -177.8 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 109.441 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2166 ' ' ASP . . . . . 0.457 ' OD2' ' O ' ' A' 2184 ' ' VAL . 29.1 t70 -74.85 167.27 22.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.642 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2167 ' ' THR . . . . . 0.591 HG23 ' OE1' ' A' 2169 ' ' GLU . 4.9 t -114.26 -177.71 3.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.4 -0.812 . . . . 0.0 109.109 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2168 ' ' ASP . . . . . 0.489 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 51.9 t0 -103.29 100.64 10.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.087 -1.008 . . . . 0.0 109.74 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2169 ' ' GLU . . . . . 0.598 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.7 OUTLIER -77.01 -32.63 57.29 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.385 -0.822 . . . . 0.0 109.143 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 2170 ' ' CYS . . . . . 0.508 ' HB2' ' N ' ' A' 2182 ' ' LYS . 1.7 t -67.23 -10.07 46.85 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.94 -10.62 59.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.34 -0.85 . . . . 0.0 109.72 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 21.9 t -86.35 -71.58 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.544 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2173 ' ' GLY . . . . . . . . . . . . . . . -149.29 -114.95 0.75 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2174 ' ' ASN . . . . . 0.507 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 16.1 t-20 -146.67 97.3 4.29 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.39 -1.065 . . . . 0.0 109.49 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2175 ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' A' 2181 ' ' CYS . 1.3 Cg_endo -68.38 -24.63 36.77 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.93 1.754 . . . . 0.0 110.58 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2176 ' ' CYS . . . . . 0.585 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.1 OUTLIER -48.6 -43.86 36.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.122 -0.986 . . . . 0.0 109.391 -179.352 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 120.45 -19.24 9.23 Favored Glycine 0 C--N 1.292 -1.861 0 N-CA-C 108.221 -1.952 . . . . 0.0 108.221 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -171.97 -32.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.462 -1.022 . . . . 0.0 110.259 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2179 ' ' GLY . . . . . 0.652 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -69.75 -128.06 0.05 OUTLIER Glycine 0 N--CA 1.491 2.335 0 O-C-N 120.932 -1.105 . . . . 0.0 110.358 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 2.0 p -132.58 153.85 50.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.549 -0.971 . . . . 0.0 109.631 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2181 ' ' CYS . . . . . 0.555 ' HB3' ' HD2' ' A' 2175 ' ' PRO . 25.0 p -92.48 161.85 14.46 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.125 0.964 . . . . 0.0 110.976 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2182 ' ' LYS . . . . . 0.563 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 44.0 tptt -144.2 166.77 24.1 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2183 ' ' ASN . . . . . 0.499 ' N ' ' HG3' ' A' 2182 ' ' LYS . 62.6 t30 -100.94 138.74 37.59 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.616 -1.302 . . . . 0.0 109.676 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2184 ' ' VAL . . . . . 0.849 HG12 ' N ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -144.42 -168.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.484 -0.76 . . . . 0.0 109.246 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 2185 ' ' ILE . . . . . 0.642 HG23 ' OH ' ' A' 2157 ' ' TYR . 2.7 mp -104.64 137.28 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.111 -0.993 . . . . 0.0 110.24 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 69.85 10.36 64.38 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2187 ' ' GLY . . . . . 0.57 ' C ' HG12 ' A' 2184 ' ' VAL . . . 168.99 -116.7 0.68 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2188 ' ' PHE . . . . . 0.849 ' N ' HG12 ' A' 2184 ' ' VAL . 1.0 OUTLIER -171.87 -178.51 2.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.204 -1.174 . . . . 0.0 109.461 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 2189 ' ' GLU . . . . . 0.563 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 2.5 tt0 -128.33 174.13 9.57 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 2.6 p -171.08 149.7 2.93 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.621 -1.232 . . . . 0.0 110.41 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2191 ' ' THR . . . . . 0.415 ' O ' ' O ' ' A' 2192 ' ' CYS . 50.8 m -117.41 83.81 2.05 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.568 -0.708 . . . . 0.0 109.355 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2192 ' ' CYS . . . . . 0.652 ' HA ' ' HA3' ' A' 2179 ' ' GLY . 0.8 OUTLIER -50.54 178.27 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.09 -1.006 . . . . 0.0 109.189 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 2193 ' ' GLU . . . . . 0.486 ' O ' ' C ' ' A' 2194 ' ' GLU . 31.8 tt0 -53.97 116.38 2.53 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2194 ' ' GLU . . . . . 0.486 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -32.61 129.37 0.21 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.526 0.679 . . . . 0.0 110.917 -178.674 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.95 4.5 9.42 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2196 ' ' PHE . . . . . 0.681 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.9 OUTLIER -116.65 -164.51 0.98 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.197 -1.178 . . . . 0.0 110.169 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 2197 ' ' GLU . . . . . 0.556 ' N ' ' CG ' ' A' 2196 ' ' PHE . 14.0 mt-10 -145.81 96.95 4.63 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.596 -0.69 . . . . 0.0 109.373 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2198 ' ' PRO . . . . . 0.681 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.2 Cg_endo -68.68 -169.78 0.29 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.272 1.981 . . . . 0.0 111.084 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -124.89 178.06 16.65 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.93 -72.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 121.844 1.696 . . . . 0.0 110.306 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A 2201 ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.1 OUTLIER -132.78 33.27 3.74 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.14 -0.975 . . . . 0.0 109.791 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 2202 ' ' MET . . . . . 0.46 ' O ' ' CE2' ' A' 2188 ' ' PHE . 0.2 OUTLIER -105.6 -92.51 0.38 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.165 -0.959 . . . . 0.0 109.706 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 2203 ' ' THR . . . . . 0.472 HG23 ' N ' ' A' 2204 ' ' CYS . 6.0 t -159.68 -162.93 1.08 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.142 -0.974 . . . . 0.0 109.182 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A 2204 ' ' CYS . . . . . 0.585 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -115.71 155.82 27.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.126 -0.984 . . . . 0.0 109.145 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.41 179.98 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A 2129 ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' 2130 ' ' GLU . 24.4 t0 . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2130 ' ' GLU . . . . . 0.569 ' O ' HG21 ' A' 2136 ' ' VAL . 1.9 mt-10 82.73 -50.77 0.18 Allowed 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.133 0.492 . . . . 0.0 110.065 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2131 ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' 2137 ' ' CYS . 7.7 t -80.47 -41.91 23.53 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.025 -1.047 . . . . 0.0 109.461 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2132 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.28 -26.59 3.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.436 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2133 ' ' GLU . . . . . 0.482 ' HB2' HG23 ' A' 2136 ' ' VAL . 1.3 mt-10 -73.28 137.53 78.44 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.162 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2134 ' ' PRO . . . . . 0.544 ' CA ' ' HD3' ' A' 2138 ' ' LYS . 5.5 Cg_endo -69.96 -2.39 10.23 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.177 1.918 . . . . 0.0 110.821 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -99.19 -11.7 21.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.001 -1.062 . . . . 0.0 110.395 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2136 ' ' VAL . . . . . 0.569 HG21 ' O ' ' A' 2130 ' ' GLU . 2.2 t -107.39 -136.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.061 -1.024 . . . . 0.0 109.005 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2137 ' ' CYS . . . . . 0.555 ' CB ' ' HB3' ' A' 2142 ' ' CYS . 8.7 m -50.35 104.83 0.08 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.964 -1.085 . . . . 0.0 108.638 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2138 ' ' LYS . . . . . 0.544 ' HD3' ' CA ' ' A' 2134 ' ' PRO . 3.6 mtmt -124.07 140.54 52.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.912 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2139 ' ' HIS . . . . . 0.499 ' HB2' ' O ' ' A' 2164 ' ' CYS . 10.6 m80 56.3 39.16 30.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.986 -1.071 . . . . 0.0 109.548 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -165.07 176.16 40.85 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -90.28 143.81 26.42 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.071 -1.253 . . . . 0.0 108.525 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2142 ' ' CYS . . . . . 0.555 ' HB3' ' CB ' ' A' 2137 ' ' CYS . 0.6 OUTLIER -126.54 153.95 44.5 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.072 -1.017 . . . . 0.0 110.535 -178.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 2143 ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' 2145 ' ' THR . 4.3 mp -116.5 89.76 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2144 ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' 2129 ' ' ASP . 9.4 t-20 -47.21 114.94 0.96 Allowed 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.455 0.645 . . . . 0.0 110.66 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2145 ' ' THR . . . . . 0.502 HG23 ' O ' ' A' 2143 ' ' ILE . 23.0 p -107.68 -171.67 1.92 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.472 -0.767 . . . . 0.0 108.933 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.4 97.45 10.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.411 -0.806 . . . . 0.0 109.46 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 72.54 33.5 60.93 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2148 ' ' SER . . . . . 0.424 ' HB3' ' OG1' ' A' 2145 ' ' THR . 0.4 OUTLIER -173.11 -160.73 0.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -1.117 . . . . 0.0 109.792 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 2149 ' ' TYR . . . . . . . . . . . . . 7.8 p90 -168.43 -170.33 1.23 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.542 -0.724 . . . . 0.0 109.429 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2150 ' ' ARG . . . . . 0.547 ' O ' ' C ' ' A' 2151 ' ' CYS . 0.0 OUTLIER -153.1 33.38 0.47 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 109.0 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 2151 ' ' CYS . . . . . 0.547 ' C ' ' O ' ' A' 2150 ' ' ARG . 35.9 m -12.83 89.94 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.231 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -97.57 169.84 9.44 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2153 ' ' CYS . . . . . 0.517 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -131.77 159.14 73.24 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 120.934 -1.104 . . . . 0.0 109.831 -179.499 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 2154 ' ' PRO . . . . . 0.494 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.5 Cg_endo -62.65 -168.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 122.63 2.22 . . . . 0.0 111.568 -178.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 39.4 t80 -88.17 101.19 13.58 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 129.92 -13.61 5.78 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 107.927 -2.069 . . . . 0.0 107.927 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2157 ' ' TYR . . . . . 0.517 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 5.8 m-85 -108.62 -172.5 2.07 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.661 -0.905 . . . . 0.0 109.961 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2158 ' ' ILE . . . . . 0.769 HD12 ' HB ' ' A' 2167 ' ' THR . 0.2 OUTLIER -156.29 -158.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.453 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 2159 ' ' LEU . . . . . 0.506 ' HG ' ' N ' ' A' 2160 ' ' ALA . 13.7 tp -142.19 146.8 35.64 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 109.768 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2160 ' ' ALA . . . . . 0.506 ' N ' ' HG ' ' A' 2159 ' ' LEU . . . -122.02 48.53 1.71 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.237 -0.914 . . . . 0.0 109.443 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 95.55 -35.76 4.15 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2162 ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -168.44 -34.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.242 . . . . 0.0 109.911 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2163 ' ' GLU . . . . . 0.479 ' OE1' ' HE2' ' A' 2138 ' ' LYS . 1.2 tp10 -88.59 111.26 21.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 0.0 109.837 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2164 ' ' CYS . . . . . 0.904 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -82.13 147.83 28.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.442 -0.786 . . . . 0.0 109.362 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 2165 ' ' VAL . . . . . 0.904 HG13 ' O ' ' A' 2164 ' ' CYS . 0.3 OUTLIER -170.86 -168.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 2166 ' ' ASP . . . . . . . . . . . . . 1.6 t70 -90.4 143.63 26.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.901 -1.124 . . . . 0.0 109.179 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2167 ' ' THR . . . . . 0.769 ' HB ' HD12 ' A' 2158 ' ' ILE . 9.7 t -95.05 171.65 8.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.402 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2168 ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' 2171 ' ' SER . 62.5 t0 -85.73 96.29 9.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.948 -1.095 . . . . 0.0 109.352 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2169 ' ' GLU . . . . . 0.597 ' OE1' HG23 ' A' 2167 ' ' THR . 0.5 OUTLIER -67.3 -33.93 76.32 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.414 -0.804 . . . . 0.0 109.598 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 2170 ' ' CYS . . . . . 0.51 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.6 t -69.24 -7.49 37.21 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.172 -0.955 . . . . 0.0 108.915 179.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2171 ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.2 OUTLIER -77.09 3.13 13.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.086 -1.009 . . . . 0.0 109.663 179.847 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 48.5 t -105.6 -70.55 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.101 -1.0 . . . . 0.0 109.826 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2173 ' ' GLY . . . . . 0.477 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -168.97 138.17 4.95 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2174 ' ' ASN . . . . . 0.589 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 18.6 p-10 -39.38 99.31 0.19 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.517 -0.99 . . . . 0.0 110.22 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2175 ' ' PRO . . . . . 0.615 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.5 Cg_endo -65.47 -25.17 55.92 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.046 1.831 . . . . 0.0 110.487 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2176 ' ' CYS . . . . . 0.565 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -47.13 -50.89 19.41 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.069 -1.019 . . . . 0.0 108.588 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 138.25 -22.29 3.07 Favored Glycine 0 C--N 1.292 -1.9 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2178 ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.0 OUTLIER -162.53 -35.97 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.447 -1.031 . . . . 0.0 109.993 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 2179 ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -61.59 -119.21 0.01 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.34 160.36 42.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.378 -1.072 . . . . 0.0 109.637 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2181 ' ' CYS . . . . . 0.589 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 22.5 p -92.08 163.95 13.77 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.198 0.999 . . . . 0.0 111.306 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2182 ' ' LYS . . . . . 0.6 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.0 OUTLIER -142.56 155.88 45.05 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 57.7 t30 -100.55 140.56 34.65 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.39 -1.444 . . . . 0.0 109.883 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2184 ' ' VAL . . . . . 0.633 HG12 ' CA ' ' A' 2188 ' ' PHE . 0.8 OUTLIER -154.52 174.48 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A 2185 ' ' ILE . . . . . . . . . . . . . 4.3 mp -91.77 136.73 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.051 -1.031 . . . . 0.0 109.882 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 80.39 5.45 89.78 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2187 ' ' GLY . . . . . 0.524 ' C ' HG12 ' A' 2184 ' ' VAL . . . 163.06 -131.32 2.45 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2188 ' ' PHE . . . . . 0.633 ' CA ' HG12 ' A' 2184 ' ' VAL . 5.6 p90 -160.94 173.31 15.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.353 -1.087 . . . . 0.0 109.165 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2189 ' ' GLU . . . . . 0.6 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.7 tt0 -121.61 138.98 54.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.3 -0.875 . . . . 0.0 108.826 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2190 ' ' CYS . . . . . 0.435 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 15.4 p -130.64 143.53 50.81 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.66 -1.275 . . . . 0.0 109.997 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2191 ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' 2192 ' ' CYS . 61.3 m -117.51 85.31 2.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.348 -0.845 . . . . 0.0 109.505 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2192 ' ' CYS . . . . . 0.602 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.1 m -49.09 179.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 109.242 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2193 ' ' GLU . . . . . 0.45 ' O ' ' C ' ' A' 2194 ' ' GLU . 18.5 tt0 -56.98 126.9 29.25 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2194 ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.2 tt0 -38.81 130.16 1.46 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.487 -0.758 . . . . 0.0 110.591 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.24 3.04 9.82 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2196 ' ' PHE . . . . . 0.683 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.2 p90 -116.56 -161.43 0.8 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.144 -1.209 . . . . 0.0 110.16 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2197 ' ' GLU . . . . . 0.561 ' N ' ' CG ' ' A' 2196 ' ' PHE . 34.8 mm-40 -146.09 95.14 4.82 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 121.53 -0.731 . . . . 0.0 109.82 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2198 ' ' PRO . . . . . 0.683 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 6.5 Cg_endo -66.91 -163.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.119 1.88 . . . . 0.0 111.021 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -138.22 -171.65 12.26 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.88 -80.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.004 1.802 . . . . 0.0 110.727 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A 2201 ' ' MET . . . . . 0.492 ' HA ' ' O ' ' A' 2188 ' ' PHE . 6.6 mtt -132.0 47.17 2.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.166 -0.959 . . . . 0.0 110.033 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2202 ' ' MET . . . . . 0.515 ' O ' ' CE2' ' A' 2188 ' ' PHE . 1.9 mmt -117.13 -88.42 0.6 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.238 -0.914 . . . . 0.0 109.849 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2203 ' ' THR . . . . . 0.469 HG23 ' N ' ' A' 2204 ' ' CYS . 5.8 t -169.33 -162.59 0.36 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.278 -0.889 . . . . 0.0 109.49 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2204 ' ' CYS . . . . . 0.569 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 5.2 t -76.28 145.06 39.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 109.39 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A 2205 ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' 2197 ' ' GLU . 8.6 pt-20 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.951 -1.024 . . . . 0.0 109.409 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2129 ' ' ASP . . . . . 0.568 ' O ' ' HB2' ' A' 2130 ' ' GLU . 11.5 t0 . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2130 ' ' GLU . . . . . 0.61 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 1.5 mt-10 80.58 -55.47 0.34 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.915 -0.491 . . . . 0.0 111.158 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2131 ' ' CYS . . . . . 0.565 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 8.0 p -91.34 -14.59 30.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.761 -1.212 . . . . 0.0 110.503 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2132 ' ' LYS . . . . . 0.507 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -88.93 6.57 38.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.996 -1.065 . . . . 0.0 109.218 179.534 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 2133 ' ' GLU . . . . . 0.49 ' HB3' ' HD2' ' A' 2134 ' ' PRO . 36.3 mt-10 -81.11 159.41 68.16 Favored Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.242 -0.911 . . . . 0.0 109.337 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2134 ' ' PRO . . . . . 0.493 ' O ' ' HD2' ' A' 2138 ' ' LYS . 4.7 Cg_endo -68.54 -1.88 8.24 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.341 2.027 . . . . 0.0 110.451 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2135 ' ' ASP . . . . . 0.506 ' O ' ' ND2' ' A' 2162 ' ' ASN . 0.4 OUTLIER -123.11 14.16 9.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.934 -1.104 . . . . 0.0 109.887 -179.57 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 2136 ' ' VAL . . . . . 0.637 ' CG1' ' CE2' ' A' 2149 ' ' TYR . 43.3 t -146.99 126.01 4.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.04 -1.038 . . . . 0.0 108.867 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2137 ' ' CYS . . . . . 0.542 ' CA ' ' O ' ' A' 2162 ' ' ASN . 0.5 OUTLIER 69.67 -84.78 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.428 -0.795 . . . . 0.0 109.969 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 2138 ' ' LYS . . . . . 0.493 ' HD2' ' O ' ' A' 2134 ' ' PRO . 0.8 OUTLIER 63.62 109.67 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.571 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 2139 ' ' HIS . . . . . 0.501 ' O ' ' HB3' ' A' 2164 ' ' CYS . 11.6 m170 62.03 50.39 4.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.866 . . . . 0.0 109.892 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -148.85 168.39 29.35 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -106.43 78.68 1.3 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -1.137 . . . . 0.0 109.13 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2142 ' ' CYS . . . . . 0.954 ' C ' HD13 ' A' 2143 ' ' ILE . 25.3 p -82.96 -177.65 6.84 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.306 -0.871 . . . . 0.0 110.634 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2143 ' ' ILE . . . . . 0.954 HD13 ' C ' ' A' 2142 ' ' CYS . 3.0 mm -127.63 122.6 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2144 ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' 2129 ' ' ASP . 4.3 t-20 -78.04 113.49 16.02 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.34 -0.85 . . . . 0.0 110.912 -178.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2145 ' ' THR . . . . . 0.465 HG23 ' HA ' ' A' 2149 ' ' TYR . 2.7 p -92.68 -162.79 0.97 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 1.3 p30 -86.7 -32.52 20.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.98 . . . . 0.0 110.449 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -129.77 -34.39 0.48 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.161 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2148 ' ' SER . . . . . 0.432 ' O ' ' OG1' ' A' 2145 ' ' THR . 0.5 OUTLIER -111.79 -164.44 0.92 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.144 -1.21 . . . . 0.0 110.035 -179.479 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 2149 ' ' TYR . . . . . 0.637 ' CE2' ' CG1' ' A' 2136 ' ' VAL . 13.5 p90 -148.67 -176.55 5.37 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2150 ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' 2149 ' ' TYR . 0.1 OUTLIER -148.32 116.48 6.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.476 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 6.2 m -87.32 118.62 26.87 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.338 -0.851 . . . . 0.0 109.545 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.01 81.05 1.94 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.869 . . . . 0.0 109.139 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2153 ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -54.25 156.24 5.92 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.276 -0.89 . . . . 0.0 109.257 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 2154 ' ' PRO . . . . . 0.483 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.3 Cg_endo -63.06 -171.76 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.417 2.078 . . . . 0.0 111.306 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -88.0 102.84 15.13 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.37 -14.79 5.59 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 107.885 -2.086 . . . . 0.0 107.885 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2157 ' ' TYR . . . . . 0.547 ' CD2' ' C ' ' A' 2165 ' ' VAL . 5.6 m-85 -106.01 -168.23 1.41 Allowed 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.635 -0.921 . . . . 0.0 109.549 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2158 ' ' ILE . . . . . 0.639 HD11 HG23 ' A' 2165 ' ' VAL . 0.2 OUTLIER -156.93 -164.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.859 . . . . 0.0 109.923 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 2159 ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' 2163 ' ' GLU . 39.5 tp -142.38 114.16 8.03 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -90.57 56.87 3.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.883 . . . . 0.0 109.589 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 89.11 -29.2 6.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2162 ' ' ASN . . . . . 0.542 ' O ' ' CA ' ' A' 2137 ' ' CYS . 1.5 m-20 -171.47 -46.69 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.241 -1.152 . . . . 0.0 109.332 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2163 ' ' GLU . . . . . 0.523 ' O ' HD12 ' A' 2159 ' ' LEU . 14.5 tt0 -66.17 147.78 52.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.118 -0.989 . . . . 0.0 109.248 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2164 ' ' CYS . . . . . 0.693 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -122.82 137.58 54.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.049 -1.032 . . . . 0.0 109.394 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 2165 ' ' VAL . . . . . 0.693 HG13 ' O ' ' A' 2164 ' ' CYS . 0.7 OUTLIER -161.1 -169.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.121 -0.987 . . . . 0.0 109.779 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 2166 ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' 2184 ' ' VAL . 36.8 t70 -77.02 166.94 22.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.167 -0.958 . . . . 0.0 110.035 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2167 ' ' THR . . . . . 0.538 ' HB ' HG23 ' A' 2158 ' ' ILE . 1.2 t -115.99 -170.6 1.82 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.355 -0.84 . . . . 0.0 109.414 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2168 ' ' ASP . . . . . 0.536 ' N ' HG23 ' A' 2167 ' ' THR . 64.6 t0 -109.4 101.26 10.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.945 . . . . 0.0 109.511 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2169 ' ' GLU . . . . . 0.624 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.5 OUTLIER -76.22 -30.93 58.14 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.347 -0.845 . . . . 0.0 109.337 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 2170 ' ' CYS . . . . . 0.526 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 0.1 OUTLIER -64.87 -12.32 47.47 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.578 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.76 -22.54 29.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 0.0 109.623 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 31.3 t -75.9 -68.56 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.33 -0.856 . . . . 0.0 109.448 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2173 ' ' GLY . . . . . 0.441 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -159.87 140.37 6.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2174 ' ' ASN . . . . . 0.497 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 1.6 t-20 -45.0 104.49 0.39 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.411 -1.052 . . . . 0.0 109.616 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2175 ' ' PRO . . . . . 0.648 ' CB ' ' CE2' ' A' 2188 ' ' PHE . 2.1 Cg_endo -68.92 -19.94 39.59 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.837 1.692 . . . . 0.0 110.03 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2176 ' ' CYS . . . . . 0.601 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -71.43 -24.08 61.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.152 -0.967 . . . . 0.0 109.902 -179.516 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 105.84 -25.79 22.99 Favored Glycine 0 N--CA 1.483 1.779 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2178 ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.1 OUTLIER -170.59 -31.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.295 -1.121 . . . . 0.0 110.611 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 2179 ' ' GLY . . . . . 0.583 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -59.77 -120.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.3 p -136.03 151.18 49.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.44 -1.035 . . . . 0.0 109.336 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2181 ' ' CYS . . . . . 0.549 ' HB3' ' HD2' ' A' 2175 ' ' PRO . 26.1 p -99.35 155.63 17.42 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.12 -0.987 . . . . 0.0 110.716 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2182 ' ' LYS . . . . . 0.55 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 8.5 tttp -140.67 159.07 43.01 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2183 ' ' ASN . . . . . 0.432 ' CG ' ' HA ' ' A' 2168 ' ' ASP . 53.5 t30 -100.26 129.64 46.28 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.562 -1.336 . . . . 0.0 110.175 -179.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2184 ' ' VAL . . . . . 0.914 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -134.41 -179.42 3.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 2185 ' ' ILE . . . . . 0.444 ' N ' HG13 ' A' 2184 ' ' VAL . 4.1 mp -95.01 141.13 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.764 -1.21 . . . . 0.0 110.424 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 67.94 10.92 59.89 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2187 ' ' GLY . . . . . 0.575 ' C ' HG12 ' A' 2184 ' ' VAL . . . 168.14 -118.77 0.8 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2188 ' ' PHE . . . . . 0.914 ' N ' HG12 ' A' 2184 ' ' VAL . 2.6 p90 -175.23 178.58 1.68 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -1.109 . . . . 0.0 109.72 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2189 ' ' GLU . . . . . 0.55 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 5.6 tp10 -124.54 168.1 13.56 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 3.1 p -170.51 145.89 2.67 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.547 -1.345 . . . . 0.0 110.453 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2191 ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' 2192 ' ' CYS . 88.6 m -117.88 88.34 2.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.504 -0.748 . . . . 0.0 109.614 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2192 ' ' CYS . . . . . 0.63 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.5 OUTLIER -49.6 -178.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.167 -0.958 . . . . 0.0 109.049 179.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 2193 ' ' GLU . . . . . 0.548 ' O ' ' C ' ' A' 2194 ' ' GLU . 7.2 tt0 -55.24 102.27 0.06 Allowed 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2194 ' ' GLU . . . . . 0.548 ' C ' ' O ' ' A' 2193 ' ' GLU . 2.3 mt-10 -20.14 124.89 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.365 0.602 . . . . 0.0 111.716 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.71 11.35 6.0 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2196 ' ' PHE . . . . . 0.686 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.5 p90 -120.06 -161.93 0.9 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.357 -1.084 . . . . 0.0 110.165 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2197 ' ' GLU . . . . . 0.52 ' N ' ' CG ' ' A' 2196 ' ' PHE . 12.9 mt-10 -144.47 94.87 5.54 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 121.475 -0.766 . . . . 0.0 109.659 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2198 ' ' PRO . . . . . 0.686 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.2 Cg_endo -69.36 -162.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.353 2.035 . . . . 0.0 111.192 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -133.66 -177.02 14.66 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -62.36 -65.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.006 1.804 . . . . 0.0 110.618 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2201 ' ' MET . . . . . 0.496 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -147.29 41.11 1.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 109.58 -179.674 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 2202 ' ' MET . . . . . 0.431 ' O ' ' CE2' ' A' 2188 ' ' PHE . 0.0 OUTLIER -112.88 -84.4 0.59 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.208 -0.932 . . . . 0.0 109.613 -179.807 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 2203 ' ' THR . . . . . . . . . . . . . 11.5 t -162.6 -172.62 3.2 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.23 -0.918 . . . . 0.0 109.406 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A 2204 ' ' CYS . . . . . 0.601 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -110.42 144.94 38.44 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.285 -0.885 . . . . 0.0 108.933 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.548 -179.864 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A 2129 ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' 2130 ' ' GLU . 11.3 t70 . . . . . 0 N--CA 1.487 1.388 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2130 ' ' GLU . . . . . 0.638 ' O ' HG21 ' A' 2136 ' ' VAL . 6.4 mt-10 82.56 -43.16 0.13 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.856 -0.528 . . . . 0.0 109.798 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2131 ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.11 -23.02 21.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.176 -0.952 . . . . 0.0 109.086 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2132 ' ' LYS . . . . . 0.432 ' HB2' ' CB ' ' A' 2129 ' ' ASP . 0.3 OUTLIER -87.6 40.25 0.92 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 109.144 179.561 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 2133 ' ' GLU . . . . . 0.525 ' HB2' HG23 ' A' 2136 ' ' VAL . 80.3 mt-10 -108.09 160.17 27.92 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.33 -0.856 . . . . 0.0 109.66 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2134 ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' 2133 ' ' GLU . 1.2 Cg_endo -66.02 0.51 3.12 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.539 2.159 . . . . 0.0 111.771 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2135 ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' 2162 ' ' ASN . 67.1 m-20 -130.03 -10.65 4.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.478 -1.389 . . . . 0.0 110.564 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2136 ' ' VAL . . . . . 0.638 HG21 ' O ' ' A' 2130 ' ' GLU . 3.4 t -100.13 -131.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.927 -1.108 . . . . 0.0 108.492 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2137 ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' 2142 ' ' CYS . 5.0 t -58.45 131.46 50.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.521 -1.362 . . . . 0.0 108.65 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2138 ' ' LYS . . . . . 0.515 ' O ' ' CB ' ' A' 2139 ' ' HIS . 32.0 mtpt -139.64 43.03 1.99 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.185 -0.947 . . . . 0.0 110.061 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2139 ' ' HIS . . . . . 0.515 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.0 OUTLIER 163.73 -34.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.052 -1.03 . . . . 0.0 110.099 179.473 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -83.67 173.65 51.21 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -91.91 94.68 9.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.265 -1.138 . . . . 0.0 109.163 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2142 ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' 2137 ' ' CYS . 10.4 t -91.0 161.47 15.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.292 -0.88 . . . . 0.0 109.725 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 2.6 mp -122.72 98.59 5.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2144 ' ' ASN . . . . . 0.479 ' HB2' ' OD1' ' A' 2129 ' ' ASP . 3.2 t30 -60.02 112.85 2.03 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.273 -0.892 . . . . 0.0 109.712 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2145 ' ' THR . . . . . . . . . . . . . 30.5 p -90.73 -166.28 1.54 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.378 -0.826 . . . . 0.0 109.376 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 5.6 t0 -62.63 -72.48 0.13 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.817 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -118.12 37.0 3.41 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2148 ' ' SER . . . . . 0.451 ' O ' ' HB3' ' A' 2149 ' ' TYR . 0.8 OUTLIER -165.13 -160.89 0.51 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -1.157 . . . . 0.0 109.629 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 2149 ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' 2148 ' ' SER . 27.2 p90 170.8 -175.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.49 -0.756 . . . . 0.0 109.217 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2150 ' ' ARG . . . . . 0.433 ' C ' ' SG ' ' A' 2142 ' ' CYS . 11.6 ptt180 -167.93 95.05 0.41 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.951 . . . . 0.0 109.831 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2151 ' ' CYS . . . . . 0.465 ' HA ' ' SG ' ' A' 2142 ' ' CYS . 42.5 t -57.64 102.56 0.1 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.615 -0.678 . . . . 0.0 109.447 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -104.47 108.02 19.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.314 -0.866 . . . . 0.0 109.256 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2153 ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -70.06 158.78 86.55 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.168 -0.957 . . . . 0.0 109.664 -179.657 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 2154 ' ' PRO . . . . . 0.474 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.1 Cg_endo -63.85 -168.97 0.1 OUTLIER 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.858 2.372 . . . . 0.0 112.03 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -86.48 101.79 13.5 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 129.95 -15.49 5.63 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 107.821 -2.112 . . . . 0.0 107.821 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2157 ' ' TYR . . . . . 0.593 ' OH ' HG23 ' A' 2185 ' ' ILE . 5.4 m-85 -106.34 -170.79 1.78 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.682 -0.893 . . . . 0.0 110.053 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2158 ' ' ILE . . . . . 0.744 HD13 ' N ' ' A' 2158 ' ' ILE . 0.2 OUTLIER -156.93 -160.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.522 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 2159 ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' 2163 ' ' GLU . 33.2 tp -147.55 122.81 10.24 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.187 -0.945 . . . . 0.0 109.942 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2160 ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' 2162 ' ' ASN . . . -90.22 -152.12 0.26 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2161 ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' 2160 ' ' ALA . . . -42.13 -25.95 0.29 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2162 ' ' ASN . . . . . 0.503 ' O ' HD11 ' A' 2159 ' ' LEU . 1.5 t-20 178.75 -29.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.133 -1.216 . . . . 0.0 110.179 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2163 ' ' GLU . . . . . 0.517 ' O ' HD12 ' A' 2159 ' ' LEU . 74.5 tt0 -76.23 152.58 36.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.084 -1.01 . . . . 0.0 109.514 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2164 ' ' CYS . . . . . 0.804 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -111.82 145.08 40.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.122 -0.986 . . . . 0.0 109.374 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 2165 ' ' VAL . . . . . 0.804 HG13 ' O ' ' A' 2164 ' ' CYS . 1.6 m -164.81 -170.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 109.425 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2166 ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 3.3 t70 -90.41 149.69 22.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.002 -1.061 . . . . 0.0 109.706 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2167 ' ' THR . . . . . 0.912 HG23 ' OE1' ' A' 2169 ' ' GLU . 8.7 t -87.84 175.38 7.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 109.511 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2168 ' ' ASP . . . . . 0.469 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 57.9 t0 -95.77 92.67 6.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.296 -0.877 . . . . 0.0 108.752 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2169 ' ' GLU . . . . . 0.912 ' OE1' HG23 ' A' 2167 ' ' THR . 0.7 OUTLIER -65.68 -32.15 73.55 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.331 -0.856 . . . . 0.0 109.883 -179.409 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 2170 ' ' CYS . . . . . 0.559 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.3 t -66.34 -12.04 54.44 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.165 -0.959 . . . . 0.0 108.891 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2171 ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.1 OUTLIER -73.68 -2.28 22.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.243 179.447 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 2172 ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' 2169 ' ' GLU . 34.4 t -84.23 -69.71 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.21 -0.931 . . . . 0.0 109.549 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2173 ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' 2174 ' ' ASN . . . 164.26 76.46 0.03 OUTLIER Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.069 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2174 ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' 2178 ' ' ASN . 3.5 t-20 43.2 83.78 0.2 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.253 -1.145 . . . . 0.0 109.613 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2175 ' ' PRO . . . . . 0.633 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.4 Cg_endo -66.76 -20.03 52.7 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.257 1.971 . . . . 0.0 110.537 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2176 ' ' CYS . . . . . 0.532 ' SG ' ' HB3' ' A' 2204 ' ' CYS . 1.4 m -64.79 -55.41 19.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.926 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 160.2 -28.94 0.35 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2178 ' ' ASN . . . . . 0.503 ' N ' ' OD1' ' A' 2174 ' ' ASN . 1.5 t-20 -171.05 -26.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -1.185 . . . . 0.0 110.966 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2179 ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -59.66 -124.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.787 -1.196 . . . . 0.0 110.309 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2180 ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' 2190 ' ' CYS . 1.1 p -136.64 151.07 48.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.394 -1.062 . . . . 0.0 109.227 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2181 ' ' CYS . . . . . 0.568 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 23.0 p -99.54 150.19 22.48 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.089 -1.007 . . . . 0.0 111.468 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2182 ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' 2189 ' ' GLU . 0.5 OUTLIER -132.4 160.79 35.35 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.381 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 2183 ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 57.0 t30 -100.28 123.7 44.83 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.579 -1.326 . . . . 0.0 109.21 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2184 ' ' VAL . . . . . 0.828 HG12 ' N ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -130.89 -174.96 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.371 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 2185 ' ' ILE . . . . . 0.593 HG23 ' OH ' ' A' 2157 ' ' TYR . 3.3 mp -94.62 139.26 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.028 -1.045 . . . . 0.0 110.287 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 69.78 10.06 63.59 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2187 ' ' GLY . . . . . 0.532 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 166.2 -118.11 0.78 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.514 -1.326 . . . . 0.0 110.078 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2188 ' ' PHE . . . . . 0.828 ' N ' HG12 ' A' 2184 ' ' VAL . 1.8 p90 -166.46 -179.45 4.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -1.139 . . . . 0.0 109.889 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2189 ' ' GLU . . . . . 0.591 ' OE1' HG21 ' A' 2184 ' ' VAL . 0.1 OUTLIER -132.09 94.04 3.39 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.406 -0.808 . . . . 0.0 109.286 178.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 2190 ' ' CYS . . . . . 0.527 ' HB3' ' HA ' ' A' 2181 ' ' CYS . 9.1 p -114.26 139.26 49.56 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.92 -1.112 . . . . 0.0 109.802 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2191 ' ' THR . . . . . 0.526 ' O ' ' HA3' ' A' 2179 ' ' GLY . 1.8 m -113.85 106.58 14.62 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2192 ' ' CYS . . . . . 0.669 ' HB2' ' CD2' ' A' 2196 ' ' PHE . 0.5 OUTLIER -53.54 -172.36 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.057 -1.027 . . . . 0.0 110.157 -178.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 2193 ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.2 tp10 -68.03 136.43 53.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.656 -0.652 . . . . 0.0 110.1 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2194 ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -40.37 131.5 2.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.523 -0.736 . . . . 0.0 110.203 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 116.75 12.76 8.37 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2196 ' ' PHE . . . . . 0.701 ' CD2' ' HB2' ' A' 2204 ' ' CYS . 8.0 p90 -128.99 -158.71 0.9 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.575 -0.956 . . . . 0.0 110.22 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2197 ' ' GLU . . . . . 0.555 ' N ' ' CD2' ' A' 2196 ' ' PHE . 25.7 mt-10 -147.16 96.7 4.21 Favored Pre-proline 0 C--N 1.306 -1.319 0 O-C-N 121.565 -0.709 . . . . 0.0 109.496 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2198 ' ' PRO . . . . . 0.633 ' CD ' ' CE2' ' A' 2196 ' ' PHE . 2.2 Cg_endo -62.41 -170.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.356 2.037 . . . . 0.0 111.148 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -147.58 -168.02 13.74 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.04 -80.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.259 1.973 . . . . 0.0 110.929 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2201 ' ' MET . . . . . 0.532 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -142.54 42.11 1.6 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 110.115 -179.237 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A 2202 ' ' MET . . . . . . . . . . . . . 2.0 mmm -114.23 -72.28 0.71 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.411 -0.806 . . . . 0.0 109.502 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A 2203 ' ' THR . . . . . 0.486 ' OG1' ' HA ' ' A' 2176 ' ' CYS . 11.8 t -166.84 -165.91 0.78 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2204 ' ' CYS . . . . . 0.701 ' HB2' ' CD2' ' A' 2196 ' ' PHE . 31.3 p -104.1 114.14 28.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.853 -1.155 . . . . 0.0 110.232 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A 2205 ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' 2205 ' ' GLU . 9.1 pt-20 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.513 179.239 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 2129 ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' 2130 ' ' GLU . 16.6 t0 . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 2130 ' ' GLU . . . . . 0.598 ' HB3' ' CD2' ' A' 2149 ' ' TYR . 2.0 mt-10 82.87 -47.11 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.845 -0.534 . . . . 0.0 109.942 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2131 ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' 2137 ' ' CYS . 0.0 OUTLIER -80.9 -46.14 15.67 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.963 -1.086 . . . . 0.0 109.152 179.968 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 2132 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -16.31 4.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.14 -0.975 . . . . 0.0 109.79 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2133 ' ' GLU . . . . . 0.437 ' HG3' ' C ' ' A' 2130 ' ' GLU . 7.5 mt-10 -69.95 146.06 94.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 110.204 -179.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2134 ' ' PRO . . . . . 0.528 ' O ' ' CE ' ' A' 2138 ' ' LYS . 6.4 Cg_endo -72.55 2.27 5.37 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.597 2.198 . . . . 0.0 110.309 179.113 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2135 ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' 2162 ' ' ASN . 36.3 t70 -108.43 -14.29 14.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.96 -1.087 . . . . 0.0 109.693 -179.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2136 ' ' VAL . . . . . 0.576 ' CG1' ' CE1' ' A' 2149 ' ' TYR . 2.3 t -112.21 -136.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.093 -1.005 . . . . 0.0 109.074 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2137 ' ' CYS . . . . . 0.497 ' HB3' ' SG ' ' A' 2131 ' ' CYS . 1.9 t -44.54 105.72 0.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.018 -1.051 . . . . 0.0 108.68 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2138 ' ' LYS . . . . . 0.528 ' CE ' ' O ' ' A' 2134 ' ' PRO . 3.7 mttm -114.22 18.35 17.09 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.336 -0.852 . . . . 0.0 110.332 -178.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2139 ' ' HIS . . . . . 0.492 ' O ' ' HB3' ' A' 2164 ' ' CYS . 0.9 OUTLIER 171.77 50.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.892 -1.13 . . . . 0.0 110.461 179.773 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -169.83 -175.22 38.7 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -89.78 142.8 27.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.348 -1.09 . . . . 0.0 108.611 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 2142 ' ' CYS . . . . . 0.678 ' C ' HD12 ' A' 2143 ' ' ILE . 0.8 OUTLIER -128.78 175.93 8.22 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.092 -1.005 . . . . 0.0 110.492 -178.972 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 2143 ' ' ILE . . . . . 0.678 HD12 ' C ' ' A' 2142 ' ' CYS . 4.9 mp -139.51 107.92 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2144 ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' 2129 ' ' ASP . 5.2 t-20 -64.18 119.08 9.54 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.346 -0.846 . . . . 0.0 110.886 -178.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2145 ' ' THR . . . . . 0.423 ' OG1' ' C ' ' A' 2148 ' ' SER . 72.4 p -116.07 -179.08 3.56 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.35 109.75 21.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.957 . . . . 0.0 109.59 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 89.81 13.94 60.21 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 2148 ' ' SER . . . . . 0.423 ' C ' ' OG1' ' A' 2145 ' ' THR . 0.1 OUTLIER -178.72 -160.62 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.239 -1.153 . . . . 0.0 109.688 -179.866 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 2149 ' ' TYR . . . . . 0.598 ' CD2' ' HB3' ' A' 2130 ' ' GLU . 22.2 p90 -171.31 -174.43 1.45 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.397 -0.814 . . . . 0.0 108.979 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2150 ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' 2142 ' ' CYS . 0.0 OUTLIER -157.4 112.62 2.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.119 -0.988 . . . . 0.0 109.636 179.604 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 40.1 t -98.5 87.06 3.73 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.582 -0.699 . . . . 0.0 109.505 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -86.57 105.98 17.23 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.198 -0.938 . . . . 0.0 109.322 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 2153 ' ' CYS . . . . . 0.507 ' SG ' ' HD2' ' A' 2154 ' ' PRO . 0.0 OUTLIER -66.64 159.9 71.17 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 109.649 -179.624 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 2154 ' ' PRO . . . . . 0.507 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 0.9 OUTLIER -64.46 -166.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.61 2.207 . . . . 0.0 111.276 -179.024 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 21.0 t80 -90.21 103.42 16.1 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.81 -17.19 5.24 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 107.909 -2.076 . . . . 0.0 107.909 -178.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 2157 ' ' TYR . . . . . 0.56 ' OH ' HG23 ' A' 2185 ' ' ILE . 9.7 m-85 -107.81 -172.34 2.05 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.625 -0.927 . . . . 0.0 109.799 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2158 ' ' ILE . . . . . 0.76 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -155.5 -165.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.555 -0.716 . . . . 0.0 109.796 179.418 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 2159 ' ' LEU . . . . . 0.52 HD12 ' O ' ' A' 2163 ' ' GLU . 27.9 tp -141.9 121.8 13.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.387 -0.821 . . . . 0.0 109.508 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -94.63 50.94 1.37 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.357 -0.84 . . . . 0.0 109.83 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 91.32 -18.43 51.97 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 2162 ' ' ASN . . . . . 0.523 ' OD1' HG13 ' A' 2136 ' ' VAL . 1.6 m-20 -178.03 -47.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.023 -1.281 . . . . 0.0 109.851 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2163 ' ' GLU . . . . . 0.52 ' O ' HD12 ' A' 2159 ' ' LEU . 78.7 tt0 -75.31 146.05 41.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.898 . . . . 0.0 109.035 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2164 ' ' CYS . . . . . 0.722 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -115.35 140.9 48.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.031 -1.043 . . . . 0.0 109.395 -179.958 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 2165 ' ' VAL . . . . . 0.722 HG13 ' O ' ' A' 2164 ' ' CYS . 4.7 m -162.42 -170.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 0.0 109.767 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2166 ' ' ASP . . . . . 0.478 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 1.3 t0 -89.78 144.77 25.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 109.415 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2167 ' ' THR . . . . . 0.707 HG23 ' OE1' ' A' 2169 ' ' GLU . 8.9 t -85.39 170.74 12.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.306 -0.871 . . . . 0.0 109.682 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2168 ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' 2171 ' ' SER . 66.9 t0 -81.67 94.5 6.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.196 -0.94 . . . . 0.0 108.592 179.115 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2169 ' ' GLU . . . . . 0.707 ' OE1' HG23 ' A' 2167 ' ' THR . 0.4 OUTLIER -65.56 -26.42 67.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 110.532 -179.012 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 2170 ' ' CYS . . . . . 0.43 ' HB2' ' HB2' ' A' 2181 ' ' CYS . 1.3 t -57.92 -12.82 3.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.912 -1.117 . . . . 0.0 108.77 178.461 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2171 ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.1 OUTLIER -59.44 -13.12 7.47 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.195 -0.94 . . . . 0.0 109.881 -179.553 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 2172 ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' 2169 ' ' GLU . 22.1 t -73.14 -67.95 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.312 -0.867 . . . . 0.0 109.242 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2173 ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' 2174 ' ' ASN . . . 154.95 85.55 0.05 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2174 ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' 2173 ' ' GLY . 1.1 t-20 47.31 91.55 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.26 -1.141 . . . . 0.0 109.421 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2175 ' ' PRO . . . . . 0.64 ' CB ' ' CD1' ' A' 2188 ' ' PHE . 1.0 OUTLIER -62.95 -21.95 73.5 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.078 1.852 . . . . 0.0 110.222 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 2176 ' ' CYS . . . . . 0.528 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.1 OUTLIER -75.97 -64.67 1.04 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -0.996 . . . . 0.0 108.926 179.68 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 147.93 -14.84 1.35 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -166.93 -34.76 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.205 -1.173 . . . . 0.0 110.106 -179.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2179 ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -61.48 -108.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.451 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.18 157.19 42.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.393 -1.063 . . . . 0.0 109.307 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2181 ' ' CYS . . . . . 0.548 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 26.7 p -93.65 159.93 15.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.026 -1.046 . . . . 0.0 110.237 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2182 ' ' LYS . . . . . 0.546 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.0 OUTLIER -146.5 154.24 41.33 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.365 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 2183 ' ' ASN . . . . . 0.469 ' N ' ' HG3' ' A' 2182 ' ' LYS . 56.0 t30 -98.48 121.46 40.45 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.685 -1.259 . . . . 0.0 109.413 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2184 ' ' VAL . . . . . 0.738 HG13 ' N ' ' A' 2185 ' ' ILE . 0.3 OUTLIER -123.45 -162.78 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.524 -0.735 . . . . 0.0 109.558 -179.28 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 2185 ' ' ILE . . . . . 0.738 ' N ' HG13 ' A' 2184 ' ' VAL . 2.7 mp -108.52 138.36 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.186 -0.946 . . . . 0.0 110.213 -179.248 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 64.83 16.31 61.34 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.34 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 2187 ' ' GLY . . . . . 0.526 ' C ' HG12 ' A' 2184 ' ' VAL . . . 167.56 -128.08 1.67 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2188 ' ' PHE . . . . . 0.659 ' N ' HG12 ' A' 2184 ' ' VAL . 5.7 p90 -162.6 170.4 18.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.218 -1.166 . . . . 0.0 109.374 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2189 ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.6 OUTLIER -120.57 151.28 39.63 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.314 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 17.8 p -149.96 141.03 22.98 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.756 -1.215 . . . . 0.0 109.794 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 2191 ' ' THR . . . . . 0.493 ' O ' ' HA3' ' A' 2179 ' ' GLY . 22.2 m -114.92 88.03 2.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.915 . . . . 0.0 109.773 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2192 ' ' CYS . . . . . 0.628 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -51.5 -178.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -0.873 . . . . 0.0 109.119 179.654 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 2193 ' ' GLU . . . . . 0.464 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.6 OUTLIER -58.15 123.59 16.51 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.374 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 2194 ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.8 OUTLIER -37.76 131.81 0.97 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.436 -0.79 . . . . 0.0 110.506 -178.796 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.03 -0.18 10.73 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 2196 ' ' PHE . . . . . 0.68 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.9 OUTLIER -113.69 -164.43 0.93 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.272 -1.134 . . . . 0.0 110.227 -179.904 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 2197 ' ' GLU . . . . . 0.532 ' N ' ' CG ' ' A' 2196 ' ' PHE . 2.5 mm-40 -145.33 96.31 4.9 Favored Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.541 -0.724 . . . . 0.0 109.665 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2198 ' ' PRO . . . . . 0.68 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 7.8 Cg_endo -67.79 -160.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.162 1.908 . . . . 0.0 111.138 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -140.29 -177.24 15.75 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.02 -57.44 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.051 1.834 . . . . 0.0 110.399 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 2201 ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.4 OUTLIER -158.41 60.74 0.44 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.615 -179.858 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 2202 ' ' MET . . . . . 0.464 ' O ' ' CE1' ' A' 2188 ' ' PHE . 0.8 OUTLIER -129.21 -77.16 0.55 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.192 -0.943 . . . . 0.0 109.542 -179.589 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A 2203 ' ' THR . . . . . . . . . . . . . 12.7 t -177.15 -173.91 0.48 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.398 -0.814 . . . . 0.0 109.485 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A 2204 ' ' CYS . . . . . 0.528 ' HB2' ' CA ' ' A' 2176 ' ' CYS . 7.7 t -71.99 148.82 45.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.459 -0.776 . . . . 0.0 109.467 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A 2205 ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' 2197 ' ' GLU . 14.7 pt-20 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.539 179.755 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 2129 ' ' ASP . . . . . 0.555 ' HB3' ' CG ' ' A' 2132 ' ' LYS . 10.7 t70 . . . . . 0 N--CA 1.484 1.265 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 2130 ' ' GLU . . . . . 0.738 ' O ' HG21 ' A' 2136 ' ' VAL . 1.7 mt-10 80.43 -41.55 0.2 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.021 0.438 . . . . 0.0 110.197 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2131 ' ' CYS . . . . . 0.485 ' SG ' ' HB3' ' A' 2137 ' ' CYS . 0.7 OUTLIER -90.93 -27.18 18.89 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.263 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A 2132 ' ' LYS . . . . . 0.555 ' CG ' ' HB3' ' A' 2129 ' ' ASP . 0.0 OUTLIER -56.7 -19.94 19.19 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.304 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A 2133 ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' 2134 ' ' PRO . 0.8 OUTLIER -70.06 137.86 87.25 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.519 -0.738 . . . . 0.0 109.443 -179.819 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A 2134 ' ' PRO . . . . . 0.472 ' O ' ' HD2' ' A' 2138 ' ' LYS . 4.3 Cg_endo -69.38 0.08 5.86 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.346 2.03 . . . . 0.0 111.181 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 22.7 t70 -124.14 1.07 8.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.766 -1.209 . . . . 0.0 110.344 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 2136 ' ' VAL . . . . . 0.738 HG21 ' O ' ' A' 2130 ' ' GLU . 40.5 t -91.73 -95.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.895 -1.128 . . . . 0.0 109.537 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2137 ' ' CYS . . . . . 0.737 ' N ' HG12 ' A' 2136 ' ' VAL . 48.3 t -84.3 -73.24 0.43 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.995 -1.065 . . . . 0.0 109.23 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2138 ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' 2164 ' ' CYS . 0.0 OUTLIER 64.98 127.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 110.34 179.344 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A 2139 ' ' HIS . . . . . 0.512 ' O ' ' HB3' ' A' 2164 ' ' CYS . 9.6 m-70 51.03 26.4 2.74 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.371 -0.831 . . . . 0.0 110.934 178.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2140 ' ' GLY . . . . . 0.434 ' HA3' ' SG ' ' A' 2137 ' ' CYS . . . -128.98 166.89 21.28 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.399 -1.381 . . . . 0.0 110.197 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -89.45 47.87 1.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -1.142 . . . . 0.0 109.003 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 2142 ' ' CYS . . . . . 0.786 ' O ' HD13 ' A' 2143 ' ' ILE . 1.6 p -49.23 160.58 0.22 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.625 -0.672 . . . . 0.0 110.184 -179.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2143 ' ' ILE . . . . . 0.786 HD13 ' O ' ' A' 2142 ' ' CYS . 38.1 mm -133.35 121.3 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2144 ' ' ASN . . . . . 0.498 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 13.3 t-20 -64.33 116.51 6.12 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.343 -0.848 . . . . 0.0 110.864 -179.088 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2145 ' ' THR . . . . . 0.522 ' OG1' ' HA ' ' A' 2149 ' ' TYR . 0.0 OUTLIER -108.89 175.4 5.48 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.455 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A 2146 ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' 2146 ' ' ASP . 4.2 p30 -70.08 103.06 2.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 110.042 -179.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 65.79 10.89 52.39 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 2148 ' ' SER . . . . . 0.459 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.0 OUTLIER -145.84 -174.7 4.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.112 -1.228 . . . . 0.0 109.607 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A 2149 ' ' TYR . . . . . 0.649 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 38.7 p90 -161.78 -170.02 2.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 109.519 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2150 ' ' ARG . . . . . 0.449 ' CB ' ' CZ ' ' A' 2150 ' ' ARG . 0.0 OUTLIER -170.75 104.18 0.25 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.485 -0.759 . . . . 0.0 109.51 179.531 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A 2151 ' ' CYS . . . . . 0.504 ' SG ' HD13 ' A' 2159 ' ' LEU . 36.5 t -72.14 84.09 1.01 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.37 -0.831 . . . . 0.0 109.151 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -93.47 87.48 5.58 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.364 -0.835 . . . . 0.0 109.208 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 2153 ' ' CYS . . . . . 0.54 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -49.79 152.87 2.37 Favored Pre-proline 0 C--N 1.302 -1.49 0 O-C-N 121.397 -0.815 . . . . 0.0 109.723 -179.625 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A 2154 ' ' PRO . . . . . 0.456 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 2.8 Cg_endo -65.4 -165.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.585 2.19 . . . . 0.0 111.018 -179.254 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 77.7 t80 -91.19 101.94 14.67 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.14 -11.88 5.56 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 -178.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 2157 ' ' TYR . . . . . 0.54 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 7.5 m-85 -110.16 -166.84 1.12 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.41 -1.053 . . . . 0.0 109.873 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2158 ' ' ILE . . . . . 0.921 HD11 HG23 ' A' 2165 ' ' VAL . 0.1 OUTLIER -156.5 -165.23 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.507 -0.745 . . . . 0.0 109.395 179.243 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A 2159 ' ' LEU . . . . . 0.504 HD13 ' SG ' ' A' 2151 ' ' CYS . 28.5 tp -142.75 117.2 9.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.259 -0.9 . . . . 0.0 109.639 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -89.89 49.71 1.76 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.387 -0.821 . . . . 0.0 109.417 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 2161 ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' 2162 ' ' ASN . . . 90.62 -17.79 52.94 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2162 ' ' ASN . . . . . 0.489 ' CG ' ' N ' ' A' 2163 ' ' GLU . 3.1 p-10 -178.89 -49.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.105 -1.233 . . . . 0.0 109.793 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2163 ' ' GLU . . . . . 0.489 ' N ' ' CG ' ' A' 2162 ' ' ASN . 5.5 tt0 -70.87 133.41 46.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.505 -0.747 . . . . 0.0 109.236 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2164 ' ' CYS . . . . . 0.512 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -106.97 137.23 45.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.024 -1.047 . . . . 0.0 109.73 -179.628 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A 2165 ' ' VAL . . . . . 0.921 HG23 HD11 ' A' 2158 ' ' ILE . 1.9 m -152.07 -170.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.165 -0.959 . . . . 0.0 109.723 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2166 ' ' ASP . . . . . . . . . . . . . 27.0 t70 -76.75 166.94 22.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.366 -0.834 . . . . 0.0 110.164 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 2167 ' ' THR . . . . . 0.536 ' CG2' ' OE1' ' A' 2169 ' ' GLU . 1.4 t -116.83 -169.21 1.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.435 -0.791 . . . . 0.0 109.138 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2168 ' ' ASP . . . . . 0.522 ' N ' HG23 ' A' 2167 ' ' THR . 56.1 t0 -108.94 101.26 10.37 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.15 -0.969 . . . . 0.0 109.492 179.513 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2169 ' ' GLU . . . . . 0.588 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.9 OUTLIER -81.8 -29.75 32.56 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.413 -0.804 . . . . 0.0 109.396 179.916 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A 2170 ' ' CYS . . . . . 0.532 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 2.0 t -71.71 -4.82 29.64 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.456 -0.777 . . . . 0.0 109.07 179.458 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.65 -9.3 34.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.516 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 20.6 t -82.22 -70.33 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.941 . . . . 0.0 109.554 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 2173 ' ' GLY . . . . . 0.419 ' O ' ' SG ' ' A' 2181 ' ' CYS . . . -173.48 -73.84 0.05 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2174 ' ' ASN . . . . . 0.5 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 0.1 OUTLIER -167.09 96.18 0.67 Allowed Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.21 -1.17 . . . . 0.0 109.089 -179.465 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A 2175 ' ' PRO . . . . . 0.586 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 2.2 Cg_endo -63.22 -27.94 72.72 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.952 1.768 . . . . 0.0 110.615 -179.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2176 ' ' CYS . . . . . 0.55 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -51.46 -54.96 21.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.037 -1.039 . . . . 0.0 108.596 -179.974 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 138.6 -17.43 3.28 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 2178 ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' 2179 ' ' GLY . 1.6 t-20 -164.49 -37.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -1.091 . . . . 0.0 109.98 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2179 ' ' GLY . . . . . 0.57 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -60.17 -116.07 0.01 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2180 ' ' THR . . . . . . . . . . . . . 3.0 p -149.59 162.7 39.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.402 -1.057 . . . . 0.0 109.423 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 2181 ' ' CYS . . . . . 0.586 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 21.6 p -97.83 156.41 16.6 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.045 -1.034 . . . . 0.0 111.074 -179.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2182 ' ' LYS . . . . . 0.571 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 2.4 tppt? -137.97 159.58 41.63 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 178.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 60.1 t30 -100.66 126.64 47.19 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.46 -1.4 . . . . 0.0 109.471 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 2184 ' ' VAL . . . . . 0.927 HG12 ' N ' ' A' 2188 ' ' PHE . 0.7 OUTLIER -137.61 162.38 32.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.521 -0.737 . . . . 0.0 109.242 -179.656 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A 2185 ' ' ILE . . . . . 0.522 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 3.2 mp -76.64 130.51 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 110.258 -179.255 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 89.86 -8.51 79.69 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 2187 ' ' GLY . . . . . 0.493 ' C ' HG12 ' A' 2184 ' ' VAL . . . 174.2 -109.41 0.3 Allowed Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.588 -1.292 . . . . 0.0 109.925 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2188 ' ' PHE . . . . . 0.927 ' N ' HG12 ' A' 2184 ' ' VAL . 3.4 p90 -171.16 178.58 3.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -1.132 . . . . 0.0 109.488 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2189 ' ' GLU . . . . . 0.571 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 3.1 tt0 -128.13 131.98 48.96 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.243 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2190 ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 18.3 p -124.07 137.5 54.57 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.576 -1.328 . . . . 0.0 110.039 -179.144 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2191 ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' 2192 ' ' CYS . 25.6 m -108.8 85.28 2.07 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.334 -0.854 . . . . 0.0 109.552 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2192 ' ' CYS . . . . . 0.61 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.9 OUTLIER -49.23 179.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.515 -0.741 . . . . 0.0 109.19 179.893 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A 2193 ' ' GLU . . . . . 0.509 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.3 tt0 -55.22 112.87 1.18 Allowed 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.658 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2194 ' ' GLU . . . . . 0.509 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.8 OUTLIER -28.26 127.43 0.08 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.446 0.641 . . . . 0.0 111.263 -178.775 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.18 6.65 8.16 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 2196 ' ' PHE . . . . . 0.67 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.2 p90 -117.89 -163.26 0.93 Allowed 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.288 -1.125 . . . . 0.0 110.231 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2197 ' ' GLU . . . . . 0.549 ' N ' ' CG ' ' A' 2196 ' ' PHE . 11.8 mt-10 -144.57 95.82 5.32 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 121.507 -0.746 . . . . 0.0 109.527 -179.699 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2198 ' ' PRO . . . . . 0.67 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 8.3 Cg_endo -67.52 -165.13 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.274 1.983 . . . . 0.0 111.199 -179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -129.37 -171.59 12.98 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.79 -58.41 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.154 1.902 . . . . 0.0 111.169 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A 2201 ' ' MET . . . . . 0.517 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.0 OUTLIER -157.18 43.1 0.34 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.091 -1.006 . . . . 0.0 110.52 -179.119 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A 2202 ' ' MET . . . . . 0.451 ' O ' ' CE2' ' A' 2188 ' ' PHE . 17.2 mmm -115.82 -82.9 0.62 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.12 -0.987 . . . . 0.0 109.888 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2203 ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' 2175 ' ' PRO . 9.7 t -165.11 -169.97 1.8 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.182 -0.949 . . . . 0.0 109.604 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2204 ' ' CYS . . . . . 0.576 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.6 t -71.69 146.35 48.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.616 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.334 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -151.63 125.95 9.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.277 -0.889 . . . . 0.0 109.447 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 5.7 p -108.6 146.89 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.205 -0.935 . . . . 0.0 109.394 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2127 ' ' ASP . . . . . . . . . . . . . 28.1 t70 -64.14 149.48 47.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.16 -0.962 . . . . 0.0 109.585 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.37 134.58 50.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.271 -0.893 . . . . 0.0 109.391 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2129 ' ' ASP . . . . . 0.55 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 17.2 t0 -66.88 -46.39 75.09 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.229 -0.919 . . . . 0.0 108.607 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2130 ' ' GLU . . . . . 0.591 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 2.0 mt-10 81.89 -44.91 0.18 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.864 -0.523 . . . . 0.0 110.511 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2131 ' ' CYS . . . . . 0.509 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 6.6 p -91.26 -31.92 15.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.038 -1.039 . . . . 0.0 110.041 -179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2132 ' ' LYS . . . . . 0.458 ' HB2' ' CG ' ' A' 2129 ' ' ASP . 0.1 OUTLIER -69.66 -7.47 39.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.088 -1.008 . . . . 0.0 109.622 179.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -70.32 151.87 95.68 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.895 . . . . 0.0 109.378 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2134 ' ' PRO . . . . . . . . . . . . . 3.1 Cg_endo -66.19 -7.46 17.36 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.374 2.049 . . . . 0.0 110.619 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2135 ' ' ASP . . . . . 0.518 ' O ' ' ND2' ' A' 2162 ' ' ASN . 0.5 OUTLIER -117.44 19.66 13.92 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.031 -1.043 . . . . 0.0 109.917 -179.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2136 ' ' VAL . . . . . 0.533 ' CB ' ' O ' ' A' 2130 ' ' GLU . 21.4 t -144.55 127.94 11.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2137 ' ' CYS . . . . . 0.523 ' O ' ' HB2' ' A' 2138 ' ' LYS . 85.9 m 55.99 -90.28 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2138 ' ' LYS . . . . . 0.53 ' O ' ' CB ' ' A' 2139 ' ' HIS . 0.0 OUTLIER 70.0 19.39 6.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.397 -0.814 . . . . 0.0 109.983 179.121 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2139 ' ' HIS . . . . . 0.53 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.3 OUTLIER 163.26 42.54 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.99 -1.069 . . . . 0.0 110.222 179.388 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -157.39 172.58 34.8 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 119.523 -1.323 . . . . 0.0 110.345 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2141 ' ' GLN . . . . . 0.424 ' O ' ' HB2' ' A' 2152 ' ' GLU . 13.4 tt0 -89.71 98.08 11.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -1.1 . . . . 0.0 109.146 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2142 ' ' CYS . . . . . 0.54 ' C ' HD12 ' A' 2143 ' ' ILE . 24.0 p -89.04 177.81 6.55 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.312 -0.868 . . . . 0.0 110.204 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2143 ' ' ILE . . . . . 0.54 HD12 ' C ' ' A' 2142 ' ' CYS . 2.6 mp -134.97 99.84 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2144 ' ' ASN . . . . . 0.55 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 6.5 t-20 -56.66 112.69 1.36 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.303 -0.873 . . . . 0.0 110.77 -178.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2145 ' ' THR . . . . . 0.519 HG23 ' HA ' ' A' 2149 ' ' TYR . 14.4 p -96.24 178.95 5.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.313 -0.867 . . . . 0.0 108.962 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -65.04 -48.8 72.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.225 -0.922 . . . . 0.0 109.703 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2147 ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' A' 2148 ' ' SER . . . -132.3 49.81 0.91 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2148 ' ' SER . . . . . 0.465 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER 171.56 -160.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.177 -1.19 . . . . 0.0 109.54 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2149 ' ' TYR . . . . . 0.591 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 3.9 p90 -158.13 -177.82 6.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.424 -0.798 . . . . 0.0 109.468 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2150 ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -151.52 99.38 2.61 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.17 -0.956 . . . . 0.0 109.706 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.86 136.21 56.62 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.561 -0.712 . . . . 0.0 109.778 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2152 ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' 2141 ' ' GLN . 0.1 OUTLIER -141.95 90.39 2.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.887 . . . . 0.0 109.241 179.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2153 ' ' CYS . . . . . 0.543 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -69.38 149.26 97.29 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.291 -0.881 . . . . 0.0 109.496 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2154 ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.2 -167.03 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.507 2.138 . . . . 0.0 111.112 -178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -90.05 105.52 17.87 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.6 -17.29 5.01 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 107.762 -2.135 . . . . 0.0 107.762 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2157 ' ' TYR . . . . . 0.543 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 9.0 m-85 -108.08 -171.46 1.87 Allowed 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.559 -0.965 . . . . 0.0 110.087 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2158 ' ' ILE . . . . . 0.716 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -156.17 -166.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2159 ' ' LEU . . . . . 0.43 ' HA ' HD12 ' A' 2159 ' ' LEU . 33.9 tp -138.33 118.7 13.73 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.634 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -97.02 49.14 1.06 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.431 -0.793 . . . . 0.0 109.439 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 94.57 -28.82 10.09 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2162 ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' 2135 ' ' ASP . 1.4 m-20 -172.5 -43.7 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.302 -1.116 . . . . 0.0 109.435 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -73.19 125.82 28.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.333 -0.855 . . . . 0.0 109.282 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2164 ' ' CYS . . . . . 0.687 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -102.74 137.88 40.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 108.956 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2165 ' ' VAL . . . . . 0.687 HG13 ' O ' ' A' 2164 ' ' CYS . 0.6 OUTLIER -160.63 -166.87 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.05 -1.031 . . . . 0.0 109.97 -179.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2166 ' ' ASP . . . . . 0.496 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 0.5 OUTLIER -88.56 150.62 22.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.973 . . . . 0.0 110.358 -179.15 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2167 ' ' THR . . . . . 0.64 HG23 ' OE1' ' A' 2169 ' ' GLU . 13.2 t -92.39 -175.9 4.15 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2168 ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' 2171 ' ' SER . 54.0 t0 -94.31 94.44 8.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.943 -1.098 . . . . 0.0 108.89 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2169 ' ' GLU . . . . . 0.691 ' O ' HG23 ' A' 2172 ' ' VAL . 0.8 OUTLIER -70.77 -30.59 67.12 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.289 -0.882 . . . . 0.0 109.644 -179.584 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2170 ' ' CYS . . . . . 0.469 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.6 t -65.14 -11.29 38.55 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.231 -0.918 . . . . 0.0 108.616 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2171 ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.1 OUTLIER -68.99 -6.11 25.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.126 -0.984 . . . . 0.0 109.354 179.426 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2172 ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' 2169 ' ' GLU . 23.8 t -76.17 -67.98 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.291 -0.881 . . . . 0.0 109.247 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2173 ' ' GLY . . . . . . . . . . . . . . . 156.51 66.98 0.01 OUTLIER Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.775 -1.33 . . . . 0.0 109.775 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2174 ' ' ASN . . . . . 0.502 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 2.8 t-20 49.75 84.92 0.2 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.22 -1.165 . . . . 0.0 109.573 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2175 ' ' PRO . . . . . 0.608 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 5.0 Cg_endo -68.9 -14.25 38.36 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.07 1.846 . . . . 0.0 109.548 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2176 ' ' CYS . . . . . 0.481 ' HB2' ' ND2' ' A' 2174 ' ' ASN . 1.0 OUTLIER -57.91 -62.01 2.12 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.972 0.891 . . . . 0.0 109.316 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 154.55 -21.27 0.62 Allowed Glycine 0 N--CA 1.482 1.744 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2178 ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' 2179 ' ' GLY . 1.2 t30 -165.1 -38.62 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -1.172 . . . . 0.0 110.148 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2179 ' ' GLY . . . . . 0.615 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -58.06 -141.8 0.01 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.427 -1.069 . . . . 0.0 110.427 -179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 2.3 p -127.46 154.67 44.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -1.139 . . . . 0.0 109.015 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2181 ' ' CYS . . . . . 0.588 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 9.5 p -95.21 163.22 13.37 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.238 1.018 . . . . 0.0 111.327 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2182 ' ' LYS . . . . . 0.547 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.6 OUTLIER -143.0 157.82 44.18 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 178.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2183 ' ' ASN . . . . . 0.447 ' CG ' ' HA ' ' A' 2168 ' ' ASP . 44.5 t30 -94.64 131.14 40.74 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.349 -1.47 . . . . 0.0 110.007 -178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2184 ' ' VAL . . . . . 0.76 HG13 ' N ' ' A' 2185 ' ' ILE . 0.3 OUTLIER -135.97 -163.23 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 121.589 -0.695 . . . . 0.0 109.481 -179.719 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2185 ' ' ILE . . . . . 0.76 ' N ' HG13 ' A' 2184 ' ' VAL . 2.8 mp -107.85 142.48 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.147 -0.971 . . . . 0.0 110.39 -179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2186 ' ' GLY . . . . . 0.406 ' O ' ' SD ' ' A' 2201 ' ' MET . . . 67.33 8.67 51.94 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2187 ' ' GLY . . . . . 0.515 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 166.59 -115.31 0.62 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2188 ' ' PHE . . . . . 0.749 ' N ' HG12 ' A' 2184 ' ' VAL . 1.7 p90 -167.34 -178.62 4.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.304 -1.116 . . . . 0.0 109.676 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2189 ' ' GLU . . . . . 0.547 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.2 OUTLIER -125.53 175.18 7.71 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 177.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2190 ' ' CYS . . . . . 0.506 ' SG ' ' N ' ' A' 2191 ' ' THR . 0.1 OUTLIER -170.82 158.12 5.78 Favored 'General case' 0 C--N 1.295 -1.78 0 C-N-CA 118.649 -1.22 . . . . 0.0 110.01 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2191 ' ' THR . . . . . 0.564 ' O ' HG22 ' A' 2191 ' ' THR . 18.8 m -129.51 78.98 1.88 Allowed 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2192 ' ' CYS . . . . . 0.64 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 1.2 m -47.84 177.01 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -0.915 . . . . 0.0 109.412 -179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2193 ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.2 OUTLIER -49.56 113.76 0.9 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2194 ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.7 tp10 -32.23 129.36 0.19 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.535 0.683 . . . . 0.0 110.907 -178.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.78 0.38 10.91 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2196 ' ' PHE . . . . . 0.675 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.8 OUTLIER -111.19 -162.85 0.81 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.257 -1.143 . . . . 0.0 110.367 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2197 ' ' GLU . . . . . 0.58 ' N ' ' CG ' ' A' 2196 ' ' PHE . 2.0 mm-40 -147.52 98.04 3.97 Favored Pre-proline 0 C--N 1.305 -1.356 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2198 ' ' PRO . . . . . 0.675 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.9 Cg_endo -68.71 -158.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.292 1.995 . . . . 0.0 111.292 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -138.57 -173.97 13.22 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.671 -1.772 . . . . 0.0 108.671 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -62.66 -57.83 0.4 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.14 1.893 . . . . 0.0 110.937 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2201 ' ' MET . . . . . 0.515 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -157.84 49.08 0.4 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 110.266 -179.475 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A 2202 ' ' MET . . . . . 0.524 ' O ' ' CE2' ' A' 2188 ' ' PHE . 2.7 mmt -119.73 -89.58 0.6 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.043 -1.035 . . . . 0.0 109.979 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2203 ' ' THR . . . . . 0.435 HG23 ' N ' ' A' 2204 ' ' CYS . 6.1 t -157.88 -164.27 1.49 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.208 -0.933 . . . . 0.0 109.404 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2204 ' ' CYS . . . . . 0.532 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 3.9 t -74.08 139.63 44.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.134 -0.979 . . . . 0.0 109.04 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A 2205 ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' 2197 ' ' GLU . 3.2 pt-20 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.631 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -59.83 107.34 0.6 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.887 . . . . 0.0 109.495 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2126 ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' 2127 ' ' ASP . 60.2 t -75.25 165.86 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.571 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2127 ' ' ASP . . . . . 0.587 ' N ' HG12 ' A' 2126 ' ' VAL . 7.3 t70 -80.65 135.65 36.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.34 -0.85 . . . . 0.0 109.443 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 7.8 mmm -45.14 136.8 4.77 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.237 -0.915 . . . . 0.0 109.778 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2129 ' ' ASP . . . . . 0.519 ' O ' ' CB ' ' A' 2130 ' ' GLU . 18.1 t0 -70.06 -49.55 50.05 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2130 ' ' GLU . . . . . 0.625 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 1.7 mt-10 82.14 -46.97 0.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.741 -0.599 . . . . 0.0 110.537 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2131 ' ' CYS . . . . . 0.497 ' HA ' HG11 ' A' 2136 ' ' VAL . 11.2 p -90.42 -28.51 18.59 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.947 -1.096 . . . . 0.0 109.472 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2132 ' ' LYS . . . . . 0.491 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.1 OUTLIER -81.46 7.4 11.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.323 -0.86 . . . . 0.0 109.357 179.527 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 2133 ' ' GLU . . . . . 0.578 ' OE1' HG21 ' A' 2136 ' ' VAL . 44.8 mt-10 -69.57 149.93 96.91 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 121.297 -0.877 . . . . 0.0 109.158 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2134 ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' 2133 ' ' GLU . 1.7 Cg_endo -65.38 -2.47 6.07 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.631 2.221 . . . . 0.0 111.74 -178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2135 ' ' ASP . . . . . 0.424 ' OD1' ' C ' ' A' 2135 ' ' ASP . 17.6 p30 -134.3 6.26 3.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.682 -1.261 . . . . 0.0 110.633 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2136 ' ' VAL . . . . . 0.657 HG12 ' N ' ' A' 2137 ' ' CYS . 53.4 t -101.22 -94.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.924 -1.11 . . . . 0.0 109.851 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2137 ' ' CYS . . . . . 0.657 ' N ' HG12 ' A' 2136 ' ' VAL . 0.1 OUTLIER -81.02 -72.77 0.41 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.988 -1.07 . . . . 0.0 109.364 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 2138 ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' 2137 ' ' CYS . 0.1 OUTLIER 65.48 100.54 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 110.079 179.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 2139 ' ' HIS . . . . . 0.506 ' O ' ' HB3' ' A' 2164 ' ' CYS . 57.6 m-70 67.29 55.2 0.68 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -0.889 . . . . 0.0 110.026 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -153.96 174.9 32.4 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -105.03 82.96 1.92 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.229 -1.159 . . . . 0.0 108.963 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2142 ' ' CYS . . . . . 0.489 ' C ' HD12 ' A' 2143 ' ' ILE . 17.3 p -88.32 177.09 6.95 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.37 -0.831 . . . . 0.0 110.345 -179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2143 ' ' ILE . . . . . 0.489 HD12 ' C ' ' A' 2142 ' ' CYS . 4.0 mp -134.24 101.83 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2144 ' ' ASN . . . . . 0.463 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 6.6 t-20 -58.37 116.87 3.9 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.197 -0.939 . . . . 0.0 110.522 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2145 ' ' THR . . . . . 0.418 ' OG1' ' C ' ' A' 2148 ' ' SER . 0.2 OUTLIER -103.73 174.25 5.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.469 -0.769 . . . . 0.0 108.955 179.142 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.64 -71.15 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.367 -0.833 . . . . 0.0 109.599 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2147 ' ' GLY . . . . . 0.483 ' O ' ' CB ' ' A' 2148 ' ' SER . . . -121.29 62.06 0.52 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2148 ' ' SER . . . . . 0.483 ' CB ' ' O ' ' A' 2147 ' ' GLY . 0.3 OUTLIER 166.83 -162.7 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -1.113 . . . . 0.0 109.546 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 2149 ' ' TYR . . . . . 0.625 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 51.4 p90 -169.1 -170.27 1.1 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.305 -0.872 . . . . 0.0 109.568 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2150 ' ' ARG . . . . . . . . . . . . . 5.2 ptp180 -160.86 112.07 1.83 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.38 -0.825 . . . . 0.0 109.18 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 1.5 m -75.42 90.21 2.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.9 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -105.58 99.56 9.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.346 -0.846 . . . . 0.0 108.878 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2153 ' ' CYS . . . . . 0.539 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -67.64 153.55 94.83 Favored Pre-proline 0 N--CA 1.488 1.441 0 O-C-N 121.249 -0.907 . . . . 0.0 109.9 -179.472 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 2154 ' ' PRO . . . . . 0.482 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.7 Cg_endo -66.06 -167.23 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.593 2.195 . . . . 0.0 111.318 -179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 81.6 t80 -90.44 102.61 15.34 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.86 -13.88 5.52 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.132 -1.987 . . . . 0.0 108.132 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2157 ' ' TYR . . . . . 0.539 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 7.6 m-85 -108.78 -169.87 1.57 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.439 -1.036 . . . . 0.0 110.016 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2158 ' ' ILE . . . . . 0.841 HD11 HG23 ' A' 2165 ' ' VAL . 0.1 OUTLIER -154.76 -163.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.755 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 2159 ' ' LEU . . . . . . . . . . . . . 29.6 tp -141.74 122.12 14.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.199 -0.938 . . . . 0.0 109.718 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -99.58 53.34 0.94 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.307 -0.871 . . . . 0.0 109.265 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2161 ' ' GLY . . . . . 0.437 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 87.36 -12.31 63.14 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2162 ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' 2136 ' ' VAL . 1.3 m-20 168.95 -44.85 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.303 -1.116 . . . . 0.0 109.382 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -71.5 114.5 9.64 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.343 -0.848 . . . . 0.0 109.144 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2164 ' ' CYS . . . . . 0.562 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -92.26 139.07 30.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -0.899 . . . . 0.0 109.539 -179.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 2165 ' ' VAL . . . . . 0.841 HG23 HD11 ' A' 2158 ' ' ILE . 3.7 m -156.99 -168.0 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.176 -0.953 . . . . 0.0 109.569 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2166 ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 13.8 t70 -90.16 155.78 18.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.019 -1.051 . . . . 0.0 109.909 -179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2167 ' ' THR . . . . . 0.867 HG23 ' OE1' ' A' 2169 ' ' GLU . 10.0 t -98.41 174.96 6.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -0.842 . . . . 0.0 109.248 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2168 ' ' ASP . . . . . 0.454 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 44.4 t0 -93.46 95.17 9.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.077 -1.014 . . . . 0.0 108.935 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2169 ' ' GLU . . . . . 0.867 ' OE1' HG23 ' A' 2167 ' ' THR . 0.6 OUTLIER -69.05 -32.26 71.61 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.318 -0.864 . . . . 0.0 109.573 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 2170 ' ' CYS . . . . . 0.537 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.1 t -65.22 -12.23 49.23 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -77.61 4.64 10.88 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.184 -0.947 . . . . 0.0 109.696 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 55.0 t -105.38 -79.03 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.21 -0.931 . . . . 0.0 109.857 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2173 ' ' GLY . . . . . 0.467 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -153.95 135.0 4.57 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2174 ' ' ASN . . . . . 0.609 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 26.0 p-10 -41.68 101.61 0.25 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.41 -1.053 . . . . 0.0 110.092 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2175 ' ' PRO . . . . . 0.577 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 1.1 Cg_endo -65.99 -21.87 56.13 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.827 1.685 . . . . 0.0 109.719 179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2176 ' ' CYS . . . . . 0.593 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.1 OUTLIER -52.77 -35.76 57.0 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.169 -0.957 . . . . 0.0 109.308 -179.719 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 114.4 -14.0 20.8 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 108.532 -1.827 . . . . 0.0 108.532 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2178 ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' 2179 ' ' GLY . 5.0 p-10 -171.48 -47.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.456 -1.026 . . . . 0.0 109.557 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2179 ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -52.47 -114.64 0.01 OUTLIER Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2180 ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' 2190 ' ' CYS . 0.8 OUTLIER -150.48 158.54 44.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -1.186 . . . . 0.0 109.371 -179.702 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 2181 ' ' CYS . . . . . 0.609 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 16.0 p -90.3 166.14 13.49 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-O 122.368 1.08 . . . . 0.0 111.23 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2182 ' ' LYS . . . . . 0.635 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 11.3 tptt -143.84 155.81 44.25 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 178.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2183 ' ' ASN . . . . . 0.454 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 60.7 t30 -98.78 132.44 44.14 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.483 -1.385 . . . . 0.0 109.734 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2184 ' ' VAL . . . . . 0.827 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -140.8 -171.74 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 2185 ' ' ILE . . . . . 0.588 ' N ' HG13 ' A' 2184 ' ' VAL . 4.5 mp -104.85 135.67 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.85 -1.156 . . . . 0.0 110.387 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 72.68 13.53 78.14 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2187 ' ' GLY . . . . . 0.579 ' C ' HG12 ' A' 2184 ' ' VAL . . . 166.21 -121.18 0.97 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2188 ' ' PHE . . . . . 0.827 ' N ' HG12 ' A' 2184 ' ' VAL . 4.3 p90 -176.4 173.71 2.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.355 -1.085 . . . . 0.0 108.966 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2189 ' ' GLU . . . . . 0.635 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 3.1 tt0 -120.9 178.07 4.86 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2190 ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' 2180 ' ' THR . 7.6 p -170.9 152.17 3.54 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.861 -1.149 . . . . 0.0 109.436 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2191 ' ' THR . . . . . . . . . . . . . 46.0 m -122.37 91.21 3.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.257 -0.902 . . . . 0.0 110.032 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2192 ' ' CYS . . . . . 0.628 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -54.49 177.49 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.033 -1.042 . . . . 0.0 108.383 179.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 2193 ' ' GLU . . . . . 0.469 ' O ' ' C ' ' A' 2194 ' ' GLU . 7.4 tt0 -54.66 119.34 5.17 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 178.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2194 ' ' GLU . . . . . 0.469 ' C ' ' O ' ' A' 2193 ' ' GLU . 2.1 tt0 -35.08 131.58 0.4 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.536 0.684 . . . . 0.0 110.857 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.49 3.76 10.17 Favored Glycine 0 N--CA 1.488 2.167 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2196 ' ' PHE . . . . . 0.678 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.0 OUTLIER -116.87 -163.89 0.94 Allowed 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.224 -1.162 . . . . 0.0 110.489 -179.573 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 2197 ' ' GLU . . . . . 0.567 ' N ' ' CG ' ' A' 2196 ' ' PHE . 20.8 mt-10 -145.31 96.67 4.85 Favored Pre-proline 0 C--N 1.305 -1.364 0 O-C-N 121.633 -0.667 . . . . 0.0 109.512 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2198 ' ' PRO . . . . . 0.678 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.0 Cg_endo -68.69 -164.17 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.149 1.9 . . . . 0.0 111.012 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -133.29 -171.0 12.57 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.347 -1.901 . . . . 0.0 108.347 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.39 -81.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.028 1.819 . . . . 0.0 110.431 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2201 ' ' MET . . . . . 0.486 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.0 OUTLIER -133.99 49.97 2.23 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.089 -1.007 . . . . 0.0 109.684 -179.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 1.7 mmm -122.1 -75.84 0.59 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.336 -0.853 . . . . 0.0 109.601 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 2203 ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' 2175 ' ' PRO . 14.9 t -173.21 -173.69 0.95 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 109.748 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A 2204 ' ' CYS . . . . . 0.593 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -108.73 151.63 25.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.371 -0.831 . . . . 0.0 109.149 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.049 -0.976 . . . . 0.0 109.544 -179.984 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 93.3 p . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . 58.0 43.75 20.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.474 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 8.6 p -170.17 143.99 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.853 . . . . 0.0 109.389 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2127 ' ' ASP . . . . . . . . . . . . . 12.0 t70 -80.36 143.77 33.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.294 -0.879 . . . . 0.0 109.47 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 1.3 ttt -48.25 113.53 0.76 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 109.459 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2129 ' ' ASP . . . . . 0.524 ' O ' ' ND2' ' A' 2144 ' ' ASN . 19.1 t0 -66.1 -58.76 4.73 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.25 -0.907 . . . . 0.0 109.011 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2130 ' ' GLU . . . . . 0.7 ' O ' HG21 ' A' 2136 ' ' VAL . 0.7 OUTLIER 81.52 -41.25 0.15 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.491 -0.756 . . . . 0.0 111.503 178.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 2131 ' ' CYS . . . . . 0.492 ' HB3' ' HB2' ' A' 2149 ' ' TYR . 14.5 p -90.57 -36.66 14.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.629 -1.294 . . . . 0.0 110.263 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2132 ' ' LYS . . . . . 0.503 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -81.62 7.62 11.81 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.164 -0.96 . . . . 0.0 109.798 -179.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 2133 ' ' GLU . . . . . 0.414 ' OE2' ' HA ' ' A' 2130 ' ' GLU . 10.0 mt-10 -72.7 153.48 91.44 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.208 -0.933 . . . . 0.0 109.29 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2134 ' ' PRO . . . . . 0.571 ' HA ' ' CG ' ' A' 2138 ' ' LYS . 1.3 Cg_endo -63.72 -8.24 14.97 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.274 1.983 . . . . 0.0 110.667 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2135 ' ' ASP . . . . . 0.632 ' OD1' HG23 ' A' 2136 ' ' VAL . 1.0 OUTLIER -104.34 -20.87 13.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.05 -1.031 . . . . 0.0 110.071 -179.577 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 2136 ' ' VAL . . . . . 0.931 HG11 ' CE1' ' A' 2149 ' ' TYR . 2.0 t -109.86 -140.17 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.1 -1.0 . . . . 0.0 108.98 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2137 ' ' CYS . . . . . 0.45 ' H ' HG12 ' A' 2136 ' ' VAL . 0.8 OUTLIER -45.7 96.38 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.897 -1.127 . . . . 0.0 108.984 179.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 2138 ' ' LYS . . . . . 0.571 ' CG ' ' HA ' ' A' 2134 ' ' PRO . 5.0 mtmt -102.12 26.85 7.18 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.253 -0.904 . . . . 0.0 110.118 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2139 ' ' HIS . . . . . 0.496 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.1 OUTLIER 165.4 48.06 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.023 -1.048 . . . . 0.0 110.027 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 2140 ' ' GLY . . . . . 0.475 ' HA2' ' HD3' ' A' 2154 ' ' PRO . . . -152.97 -179.65 28.67 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -100.89 72.03 1.47 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.409 -1.054 . . . . 0.0 109.289 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2142 ' ' CYS . . . . . 0.534 ' C ' HD12 ' A' 2143 ' ' ILE . 7.4 p -62.9 -169.22 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.355 -0.84 . . . . 0.0 110.05 -179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2143 ' ' ILE . . . . . 0.534 HD12 ' C ' ' A' 2142 ' ' CYS . 4.0 mp -141.54 103.09 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2144 ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' 2129 ' ' ASP . 6.6 t-20 -62.25 116.99 5.48 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.216 -0.927 . . . . 0.0 110.468 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2145 ' ' THR . . . . . 0.48 ' HG1' ' C ' ' A' 2148 ' ' SER . 2.2 p -107.23 -170.6 1.73 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.429 -0.795 . . . . 0.0 108.949 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.79 85.25 4.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.286 -0.883 . . . . 0.0 109.735 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 96.89 -55.58 1.34 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2148 ' ' SER . . . . . 0.48 ' C ' ' HG1' ' A' 2145 ' ' THR . 0.4 OUTLIER -84.72 -158.99 0.39 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.336 -1.097 . . . . 0.0 109.828 -179.814 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 2149 ' ' TYR . . . . . 0.931 ' CE1' HG11 ' A' 2136 ' ' VAL . 41.2 p90 -178.82 -167.73 0.12 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.489 -0.757 . . . . 0.0 109.375 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2150 ' ' ARG . . . . . 0.49 ' CB ' ' CZ ' ' A' 2150 ' ' ARG . 0.0 OUTLIER -169.02 115.07 0.6 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 109.321 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 2151 ' ' CYS . . . . . 0.486 ' SG ' HD13 ' A' 2159 ' ' LEU . 43.3 t -81.55 113.1 19.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.704 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.48 84.29 2.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.233 -0.917 . . . . 0.0 109.011 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2153 ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -47.4 155.57 0.71 Allowed Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.259 -0.901 . . . . 0.0 109.798 -179.52 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 2154 ' ' PRO . . . . . 0.475 ' HD3' ' HA2' ' A' 2140 ' ' GLY . 1.1 Cg_endo -64.23 -168.8 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.73 2.286 . . . . 0.0 111.703 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 43.9 t80 -88.48 102.81 15.27 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.66 -14.76 5.51 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.837 -2.105 . . . . 0.0 107.837 -178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2157 ' ' TYR . . . . . 0.527 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 7.5 m-85 -109.05 -170.03 1.59 Allowed 'General case' 0 N--CA 1.483 1.222 0 O-C-N 121.574 -0.957 . . . . 0.0 109.74 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2158 ' ' ILE . . . . . 0.731 HD13 ' N ' ' A' 2158 ' ' ILE . 0.2 OUTLIER -156.95 -160.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.579 -0.701 . . . . 0.0 109.563 179.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 2159 ' ' LEU . . . . . 0.486 HD13 ' SG ' ' A' 2151 ' ' CYS . 29.4 tp -145.57 124.17 12.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.414 -0.804 . . . . 0.0 109.377 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -99.02 51.54 0.96 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.353 -0.842 . . . . 0.0 109.486 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 90.26 -22.76 24.93 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2162 ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' 2135 ' ' ASP . 1.4 m-20 -176.03 -45.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.125 -1.22 . . . . 0.0 109.953 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -75.52 127.14 32.43 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.048 -1.033 . . . . 0.0 109.614 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2164 ' ' CYS . . . . . 0.703 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -99.74 140.38 34.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.69 -179.888 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 2165 ' ' VAL . . . . . 0.703 HG13 ' O ' ' A' 2164 ' ' CYS . 0.9 OUTLIER -161.82 -166.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.374 179.907 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 2166 ' ' ASP . . . . . 0.487 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 23.1 t70 -90.13 159.27 16.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.068 -1.02 . . . . 0.0 109.863 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2167 ' ' THR . . . . . 0.569 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 5.5 t -99.88 -167.42 1.46 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.185 -0.947 . . . . 0.0 109.362 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2168 ' ' ASP . . . . . 0.479 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 57.6 t0 -108.92 99.79 9.08 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.183 -0.948 . . . . 0.0 109.325 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2169 ' ' GLU . . . . . 0.595 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.6 OUTLIER -74.38 -30.68 62.08 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.21 -0.931 . . . . 0.0 109.446 -179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 2170 ' ' CYS . . . . . 0.467 ' O ' ' SG ' ' A' 2181 ' ' CYS . 3.1 t -66.85 -8.32 28.04 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.282 -0.886 . . . . 0.0 109.023 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2171 ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -70.33 -3.8 19.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.066 -1.021 . . . . 0.0 109.541 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 2172 ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' 2169 ' ' GLU . 17.7 t -86.27 -72.51 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.201 -0.937 . . . . 0.0 109.569 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2173 ' ' GLY . . . . . 0.463 ' O ' ' OD1' ' A' 2174 ' ' ASN . . . 166.2 77.94 0.04 OUTLIER Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.641 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2174 ' ' ASN . . . . . 0.623 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 11.0 p-10 36.56 89.12 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.537 -0.978 . . . . 0.0 110.993 178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2175 ' ' PRO . . . . . 0.601 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 5.8 Cg_endo -67.5 -12.71 36.67 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.153 1.902 . . . . 0.0 109.227 179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2176 ' ' CYS . . . . . 0.479 ' HB3' ' SG ' ' A' 2192 ' ' CYS . 0.9 OUTLIER -55.92 -58.02 9.63 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 121.834 0.826 . . . . 0.0 109.543 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 146.84 -26.22 1.62 Allowed Glycine 0 N--CA 1.484 1.854 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2178 ' ' ASN . . . . . 0.467 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.4 OUTLIER -157.05 -39.39 0.07 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.306 -1.114 . . . . 0.0 109.845 -179.795 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 2179 ' ' GLY . . . . . 0.67 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -59.43 -140.02 0.01 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.311 -1.116 . . . . 0.0 110.311 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2180 ' ' THR . . . . . 0.408 ' HA ' ' HB3' ' A' 2174 ' ' ASN . 1.5 p -133.19 148.0 52.04 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.53 -0.982 . . . . 0.0 109.4 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2181 ' ' CYS . . . . . 0.623 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 11.8 p -82.1 167.37 18.83 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-O 122.372 1.082 . . . . 0.0 111.439 -179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2182 ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 6.9 tttm -142.39 161.61 37.6 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2183 ' ' ASN . . . . . 0.479 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 46.6 t30 -101.12 128.78 47.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.412 -1.43 . . . . 0.0 110.108 -179.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2184 ' ' VAL . . . . . 0.84 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -137.41 -175.57 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 2185 ' ' ILE . . . . . 0.525 ' N ' HG13 ' A' 2184 ' ' VAL . 3.7 mp -100.05 140.85 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.114 -0.991 . . . . 0.0 110.053 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 70.62 8.4 63.2 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2187 ' ' GLY . . . . . 0.577 ' C ' HG12 ' A' 2184 ' ' VAL . . . 167.72 -121.4 0.96 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2188 ' ' PHE . . . . . 0.84 ' N ' HG12 ' A' 2184 ' ' VAL . 2.3 p90 -169.04 178.61 4.39 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.272 -1.134 . . . . 0.0 109.295 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2189 ' ' GLU . . . . . 0.566 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.4 tt0 -124.19 -179.67 4.53 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2190 ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' 2191 ' ' THR . 0.5 OUTLIER -171.05 157.74 5.33 Favored 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 118.959 -1.096 . . . . 0.0 110.17 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 2191 ' ' THR . . . . . 0.514 ' N ' ' SG ' ' A' 2190 ' ' CYS . 80.3 m -128.75 80.27 1.96 Allowed 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2192 ' ' CYS . . . . . 0.67 ' HA ' ' HA3' ' A' 2179 ' ' GLY . 1.2 m -54.16 175.64 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.224 -0.922 . . . . 0.0 110.149 -179.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2193 ' ' GLU . . . . . 0.508 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.5 tt0 -47.11 108.8 0.16 Allowed 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2194 ' ' GLU . . . . . 0.508 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.4 OUTLIER -28.5 125.72 0.1 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.45 0.643 . . . . 0.0 111.237 -179.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.78 4.22 9.7 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2196 ' ' PHE . . . . . 0.675 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.8 OUTLIER -112.71 -164.26 0.91 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.252 -1.146 . . . . 0.0 110.498 -179.628 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 2197 ' ' GLU . . . . . 0.556 ' N ' ' CG ' ' A' 2196 ' ' PHE . 16.6 mt-10 -145.39 97.29 4.74 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2198 ' ' PRO . . . . . 0.675 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.0 Cg_endo -68.47 -159.88 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.026 1.818 . . . . 0.0 110.999 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -136.05 -174.88 13.54 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.534 -1.827 . . . . 0.0 108.534 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.63 -52.79 1.64 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.114 1.876 . . . . 0.0 110.622 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 2201 ' ' MET . . . . . 0.535 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -163.93 57.69 0.16 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.399 -0.813 . . . . 0.0 109.462 -179.52 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -127.99 -84.09 0.59 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.293 -0.879 . . . . 0.0 110.002 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2203 ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' 2175 ' ' PRO . 13.3 t -163.36 -164.15 0.91 Allowed 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.346 -0.846 . . . . 0.0 108.827 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2204 ' ' CYS . . . . . 0.565 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 3.3 t -74.26 140.86 45.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.953 -1.092 . . . . 0.0 109.329 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2205 ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' 2197 ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.514 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -99.07 107.04 19.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.718 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2126 ' ' VAL . . . . . 0.774 ' O ' HG13 ' A' 2126 ' ' VAL . 13.3 p -110.49 95.33 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.902 . . . . 0.0 109.444 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2127 ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' 2128 ' ' MET . 11.4 t0 -47.12 -39.3 13.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.53 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2128 ' ' MET . . . . . 0.507 ' CB ' ' O ' ' A' 2127 ' ' ASP . 1.5 ttm 76.28 109.85 0.07 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.265 -0.897 . . . . 0.0 109.724 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2129 ' ' ASP . . . . . 0.525 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 53.5 t0 -85.39 80.74 9.02 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2130 ' ' GLU . . . . . 0.668 ' O ' HG11 ' A' 2136 ' ' VAL . 22.7 mp0 -49.11 -26.93 3.04 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.289 -0.882 . . . . 0.0 110.547 -178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2131 ' ' CYS . . . . . 0.493 ' O ' ' HB2' ' A' 2137 ' ' CYS . 0.8 OUTLIER -78.47 -36.1 45.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.701 -1.25 . . . . 0.0 109.678 -179.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 2132 ' ' LYS . . . . . 0.447 ' HB2' ' CG ' ' A' 2129 ' ' ASP . 0.0 OUTLIER -85.53 44.8 1.13 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.003 -1.061 . . . . 0.0 108.623 178.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 2133 ' ' GLU . . . . . 0.558 ' CB ' ' HD2' ' A' 2134 ' ' PRO . 1.4 mt-10 -104.59 173.56 3.26 Favored Pre-proline 0 N--CA 1.486 1.349 0 O-C-N 121.466 -0.771 . . . . 0.0 109.765 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2134 ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' 2133 ' ' GLU . 3.1 Cg_exo -60.41 -11.62 17.32 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.584 2.189 . . . . 0.0 112.542 -179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2135 ' ' ASP . . . . . 0.581 ' O ' ' C ' ' A' 2136 ' ' VAL . 26.8 m-20 -145.95 -77.41 0.19 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.274 -1.516 . . . . 0.0 111.502 -178.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2136 ' ' VAL . . . . . 0.973 HG23 ' CE1' ' A' 2149 ' ' TYR . 0.1 OUTLIER -12.77 -78.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.18 0 CA-C-O 120.89 0.376 . . . . 0.0 111.057 -178.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 2137 ' ' CYS . . . . . 0.747 ' N ' HG22 ' A' 2136 ' ' VAL . 13.0 m -121.11 146.07 47.13 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.689 -1.257 . . . . 0.0 108.949 178.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2138 ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' 2137 ' ' CYS . 2.4 mtpt -161.08 115.99 2.11 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.092 -1.005 . . . . 0.0 109.807 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2139 ' ' HIS . . . . . 0.465 ' O ' ' HB3' ' A' 2164 ' ' CYS . 20.6 m80 71.42 46.63 0.41 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.212 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -154.17 174.9 32.56 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -89.81 86.14 6.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.23 -1.159 . . . . 0.0 108.513 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2142 ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' 2150 ' ' ARG . 13.4 p -85.26 178.84 7.35 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.285 -0.884 . . . . 0.0 110.811 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2143 ' ' ILE . . . . . 0.435 ' O ' HG23 ' A' 2145 ' ' THR . 4.0 mp -140.02 88.97 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2144 ' ' ASN . . . . . 0.525 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 8.0 t-20 -53.94 116.08 2.36 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.515 0.674 . . . . 0.0 110.515 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2145 ' ' THR . . . . . 0.435 HG23 ' O ' ' A' 2143 ' ' ILE . 56.4 p -107.75 -171.31 1.85 Allowed 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2146 ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' 2145 ' ' THR . 0.4 OUTLIER -45.4 -79.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 0.0 109.284 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -115.45 -33.61 1.57 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2148 ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.77 -162.13 0.2 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -1.138 . . . . 0.0 109.44 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2149 ' ' TYR . . . . . 0.973 ' CE1' HG23 ' A' 2136 ' ' VAL . 12.9 p90 -172.58 -172.72 0.93 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.373 -0.83 . . . . 0.0 109.312 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2150 ' ' ARG . . . . . 0.514 ' CG ' ' O ' ' A' 2149 ' ' TYR . 11.6 mtt180 -159.6 113.79 2.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.392 -0.818 . . . . 0.0 109.24 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2151 ' ' CYS . . . . . 0.527 ' HB2' HD13 ' A' 2159 ' ' LEU . 4.1 m -84.03 68.21 9.96 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.492 -0.755 . . . . 0.0 109.275 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -79.49 134.74 36.52 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.314 -0.866 . . . . 0.0 108.983 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2153 ' ' CYS . . . . . 0.533 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -101.53 154.23 37.38 Favored Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.245 -0.909 . . . . 0.0 109.772 -179.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 2154 ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' 2157 ' ' TYR . 1.5 Cg_endo -64.4 -166.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.505 2.137 . . . . 0.0 110.906 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 65.8 t80 -90.34 102.53 15.26 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.26 -13.9 5.42 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.169 -1.973 . . . . 0.0 108.169 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2157 ' ' TYR . . . . . 0.533 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 7.4 m-85 -108.21 -167.92 1.3 Allowed 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.533 -0.981 . . . . 0.0 109.901 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2158 ' ' ILE . . . . . 0.979 HD11 HG23 ' A' 2165 ' ' VAL . 0.2 OUTLIER -156.21 -166.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.6 -0.687 . . . . 0.0 109.193 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 2159 ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' 2151 ' ' CYS . 9.5 tp -143.17 130.4 20.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.313 -0.867 . . . . 0.0 109.332 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -101.4 46.6 0.93 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.261 -0.899 . . . . 0.0 108.921 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2161 ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' 2162 ' ' ASN . . . 86.36 -9.28 70.95 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2162 ' ' ASN . . . . . 0.509 ' CA ' ' O ' ' A' 2136 ' ' VAL . 12.7 p-10 178.05 -47.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.248 . . . . 0.0 109.882 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2163 ' ' GLU . . . . . 0.423 ' N ' ' CG ' ' A' 2162 ' ' ASN . 11.5 tt0 -77.82 116.54 18.41 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.7 -0.625 . . . . 0.0 109.867 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2164 ' ' CYS . . . . . 0.589 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -93.21 140.72 29.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.93 . . . . 0.0 109.457 179.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 2165 ' ' VAL . . . . . 0.979 HG23 HD11 ' A' 2158 ' ' ILE . 1.4 m -157.12 -165.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.105 -0.997 . . . . 0.0 109.562 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2166 ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 35.0 t70 -89.13 165.75 14.29 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.936 -1.102 . . . . 0.0 110.226 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2167 ' ' THR . . . . . 0.556 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 1.6 t -113.56 -169.94 1.6 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.408 -0.808 . . . . 0.0 109.407 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2168 ' ' ASP . . . . . 0.512 ' N ' HG23 ' A' 2167 ' ' THR . 55.7 t0 -109.3 98.85 8.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.249 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2169 ' ' GLU . . . . . 0.593 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.6 OUTLIER -73.47 -31.61 63.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.366 -0.834 . . . . 0.0 109.33 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 2170 ' ' CYS . . . . . 0.444 ' O ' ' SG ' ' A' 2170 ' ' CYS . 1.7 t -66.27 -9.47 32.91 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.342 -0.849 . . . . 0.0 108.735 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.52 7.92 8.88 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.363 -0.836 . . . . 0.0 110.234 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 57.4 t -112.42 -80.23 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.0 -1.062 . . . . 0.0 109.772 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2173 ' ' GLY . . . . . 0.462 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -147.63 131.73 3.99 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2174 ' ' ASN . . . . . 0.607 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 26.9 p-10 -43.78 102.66 0.29 Allowed Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.301 -1.117 . . . . 0.0 109.577 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2175 ' ' PRO . . . . . 0.592 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 2.7 Cg_endo -70.65 -20.24 30.9 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 121.807 1.671 . . . . 0.0 110.015 -179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2176 ' ' CYS . . . . . 0.58 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.1 OUTLIER -50.88 -31.12 16.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.118 -0.989 . . . . 0.0 109.3 -179.463 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 112.63 -23.72 14.69 Favored Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.383 -1.887 . . . . 0.0 108.383 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.67 -34.57 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.577 -0.955 . . . . 0.0 110.028 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2179 ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -63.65 -127.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.079 -1.208 . . . . 0.0 110.079 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 2.8 p -135.71 157.79 46.0 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.527 -0.984 . . . . 0.0 109.133 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2181 ' ' CYS . . . . . 0.607 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 12.9 p -95.46 162.31 13.7 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.053 -1.03 . . . . 0.0 111.186 -179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2182 ' ' LYS . . . . . 0.575 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 5.3 tptm -142.23 165.28 27.87 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2183 ' ' ASN . . . . . 0.46 ' N ' ' HG3' ' A' 2182 ' ' LYS . 63.1 t30 -100.74 138.15 38.18 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.505 -1.372 . . . . 0.0 110.09 -179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2184 ' ' VAL . . . . . 0.889 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -147.33 165.88 6.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 2185 ' ' ILE . . . . . 0.528 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 3.2 mp -86.85 131.47 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.071 -1.018 . . . . 0.0 110.224 -179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 86.43 6.34 81.0 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2187 ' ' GLY . . . . . 0.547 ' C ' HG12 ' A' 2184 ' ' VAL . . . 162.73 -113.63 0.57 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2188 ' ' PHE . . . . . 0.889 ' N ' HG12 ' A' 2184 ' ' VAL . 2.9 p90 -173.3 179.48 2.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.171 -1.194 . . . . 0.0 109.352 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2189 ' ' GLU . . . . . 0.575 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.6 tt0 -125.71 173.24 9.16 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 3.5 p -170.87 148.01 2.8 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.653 -1.279 . . . . 0.0 110.016 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2191 ' ' THR . . . . . . . . . . . . . 60.6 m -118.67 87.87 2.81 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.376 -0.828 . . . . 0.0 109.291 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2192 ' ' CYS . . . . . 0.617 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.0 OUTLIER -51.81 178.39 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.299 -0.876 . . . . 0.0 108.92 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 2193 ' ' GLU . . . . . 0.46 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.0 OUTLIER -53.33 118.22 3.65 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.494 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 2194 ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.4 mt-10 -34.2 128.94 0.38 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.444 0.64 . . . . 0.0 110.991 -178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.77 4.04 9.79 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2196 ' ' PHE . . . . . 0.672 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.1 p90 -115.06 -164.01 0.91 Allowed 'General case' 0 C--N 1.306 -1.31 0 O-C-N 121.306 -1.114 . . . . 0.0 110.487 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2197 ' ' GLU . . . . . 0.555 ' N ' ' CG ' ' A' 2196 ' ' PHE . 14.5 mt-10 -145.58 96.64 4.76 Favored Pre-proline 0 C--N 1.303 -1.419 0 O-C-N 121.652 -0.655 . . . . 0.0 109.444 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2198 ' ' PRO . . . . . 0.672 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.1 Cg_endo -68.42 -166.3 0.15 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.249 1.966 . . . . 0.0 111.44 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -133.25 -173.82 13.39 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.75 -78.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.005 1.803 . . . . 0.0 110.751 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2201 ' ' MET . . . . . 0.478 ' SD ' ' O ' ' A' 2185 ' ' ILE . 0.0 OUTLIER -138.73 40.76 2.18 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.224 -0.922 . . . . 0.0 109.634 -179.271 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 1.6 mmm -112.41 -69.25 0.88 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.131 -0.98 . . . . 0.0 109.721 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2203 ' ' THR . . . . . . . . . . . . . 7.0 t -175.48 -168.27 0.3 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.854 . . . . 0.0 109.504 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 2204 ' ' CYS . . . . . 0.58 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -114.81 153.93 29.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.239 -0.913 . . . . 0.0 108.936 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.563 -179.892 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -150.58 -60.97 0.19 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.393 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2126 ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' 2127 ' ' ASP . 11.4 p -68.53 162.6 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.5 -0.75 . . . . 0.0 109.365 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2127 ' ' ASP . . . . . 0.481 ' N ' HG22 ' A' 2126 ' ' VAL . 63.9 t0 -68.66 -60.68 2.23 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.245 -0.909 . . . . 0.0 109.719 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 3.6 ttm 63.31 117.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.212 -0.93 . . . . 0.0 109.317 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2129 ' ' ASP . . . . . 0.53 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 25.3 t0 -58.85 -53.19 61.15 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2130 ' ' GLU . . . . . 0.765 ' O ' HG21 ' A' 2136 ' ' VAL . 1.7 mt-10 81.26 -38.67 0.13 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.754 -0.592 . . . . 0.0 110.452 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2131 ' ' CYS . . . . . 0.487 ' O ' ' HB2' ' A' 2137 ' ' CYS . 5.2 p -90.71 -40.36 11.9 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.752 -1.217 . . . . 0.0 110.02 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2132 ' ' LYS . . . . . 0.483 ' N ' ' SG ' ' A' 2131 ' ' CYS . 0.0 OUTLIER -75.6 7.11 3.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.099 -1.001 . . . . 0.0 110.465 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 2133 ' ' GLU . . . . . 0.482 ' HB2' HG23 ' A' 2136 ' ' VAL . 7.3 mm-40 -69.22 151.5 96.99 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.989 -1.069 . . . . 0.0 109.448 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2134 ' ' PRO . . . . . 0.511 ' HA ' ' HE2' ' A' 2138 ' ' LYS . 1.4 Cg_endo -64.47 -6.45 11.98 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.392 2.061 . . . . 0.0 110.889 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2135 ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' 2162 ' ' ASN . 10.6 m-20 -118.15 -25.85 6.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.929 -1.107 . . . . 0.0 110.407 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2136 ' ' VAL . . . . . 0.765 HG21 ' O ' ' A' 2130 ' ' GLU . 16.4 t -83.48 -119.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.076 -1.015 . . . . 0.0 108.813 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2137 ' ' CYS . . . . . 0.487 ' HB2' ' O ' ' A' 2131 ' ' CYS . 59.3 m -67.4 145.89 54.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.554 -1.341 . . . . 0.0 108.392 179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2138 ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' 2134 ' ' PRO . 4.1 mttm -149.99 28.43 0.76 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.045 -1.035 . . . . 0.0 110.139 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2139 ' ' HIS . . . . . 0.491 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.1 OUTLIER 162.72 36.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.221 -0.925 . . . . 0.0 109.804 179.478 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -150.88 -176.09 23.45 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.62 111.72 24.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -1.066 . . . . 0.0 109.541 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2142 ' ' CYS . . . . . 0.645 ' C ' HD12 ' A' 2143 ' ' ILE . 11.0 p -99.39 -167.81 1.53 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.301 -0.874 . . . . 0.0 109.594 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2143 ' ' ILE . . . . . 0.69 ' O ' HG23 ' A' 2145 ' ' THR . 3.4 mp -149.89 101.09 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -0.905 . . . . 0.0 109.259 179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2144 ' ' ASN . . . . . 0.53 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 11.2 t-20 -52.65 113.99 1.25 Allowed 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.3 -0.875 . . . . 0.0 110.189 -179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2145 ' ' THR . . . . . 0.69 HG23 ' O ' ' A' 2143 ' ' ILE . 5.0 p -117.41 -179.81 3.83 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.372 -0.83 . . . . 0.0 109.083 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -96.56 117.9 31.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.309 -0.869 . . . . 0.0 109.558 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 73.61 18.75 79.56 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2148 ' ' SER . . . . . 0.477 ' C ' ' HG1' ' A' 2145 ' ' THR . 0.0 OUTLIER -174.81 -171.1 0.52 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -1.147 . . . . 0.0 109.566 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 2149 ' ' TYR . . . . . 0.487 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 7.0 p90 -164.11 -168.43 1.57 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.86 . . . . 0.0 109.408 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2150 ' ' ARG . . . . . 0.489 ' HB2' ' HB ' ' A' 2143 ' ' ILE . 0.0 OUTLIER -130.65 -165.0 1.49 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.309 -0.869 . . . . 0.0 109.562 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 176.79 38.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.281 -0.887 . . . . 0.0 109.417 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.83 147.19 30.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.356 -0.84 . . . . 0.0 109.364 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2153 ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -110.16 160.77 27.06 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.335 -0.853 . . . . 0.0 109.536 -179.69 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 2154 ' ' PRO . . . . . 0.495 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 2.3 Cg_endo -61.72 -174.46 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.664 2.243 . . . . 0.0 111.669 -178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 4.4 t80 -81.44 103.19 11.01 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.92 -19.74 4.9 Favored Glycine 0 N--CA 1.483 1.807 0 N-CA-C 107.182 -2.367 . . . . 0.0 107.182 -177.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2157 ' ' TYR . . . . . 0.512 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 20.1 m-85 -108.35 178.71 4.41 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.806 -0.82 . . . . 0.0 109.794 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2158 ' ' ILE . . . . . 0.763 HD13 ' N ' ' A' 2158 ' ' ILE . 0.2 OUTLIER -157.61 -166.39 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.783 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 2159 ' ' LEU . . . . . 0.413 ' HG ' ' N ' ' A' 2160 ' ' ALA . 11.4 tp -131.31 144.98 51.67 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.245 -0.91 . . . . 0.0 109.835 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2160 ' ' ALA . . . . . 0.413 ' N ' ' HG ' ' A' 2159 ' ' LEU . . . -121.11 53.82 1.13 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.389 -0.819 . . . . 0.0 109.013 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 93.59 -21.39 41.29 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.211 -1.556 . . . . 0.0 109.211 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2162 ' ' ASN . . . . . 0.457 ' HB3' ' O ' ' A' 2135 ' ' ASP . 4.0 m-20 173.04 -40.09 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.357 -1.084 . . . . 0.0 109.502 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -77.87 122.27 25.23 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 0.0 109.295 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2164 ' ' CYS . . . . . 0.68 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -92.41 143.38 26.43 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.243 -0.911 . . . . 0.0 109.397 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 2165 ' ' VAL . . . . . 0.68 HG13 ' O ' ' A' 2164 ' ' CYS . 1.5 m -160.89 -168.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.12 -0.987 . . . . 0.0 109.485 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2166 ' ' ASP . . . . . 0.43 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 1.1 t0 -90.61 144.85 25.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.001 -1.062 . . . . 0.0 109.747 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2167 ' ' THR . . . . . 0.613 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 9.1 t -91.96 179.64 5.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.886 . . . . 0.0 109.528 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2168 ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' 2171 ' ' SER . 33.2 t0 -86.74 95.6 9.88 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2169 ' ' GLU . . . . . 0.612 ' O ' HG23 ' A' 2172 ' ' VAL . 0.4 OUTLIER -66.22 -27.89 68.32 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.135 -0.978 . . . . 0.0 110.418 -179.006 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 2170 ' ' CYS . . . . . 0.439 ' HB3' ' OD1' ' A' 2168 ' ' ASP . 0.7 OUTLIER -58.13 -13.18 4.37 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.901 -1.125 . . . . 0.0 108.891 178.493 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 2171 ' ' SER . . . . . 0.506 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -61.24 -10.66 7.19 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.137 -0.977 . . . . 0.0 110.159 -179.335 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 2172 ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' 2169 ' ' GLU . 17.4 t -77.06 -69.31 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.173 -0.954 . . . . 0.0 109.406 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2173 ' ' GLY . . . . . . . . . . . . . . . 156.36 92.96 0.09 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2174 ' ' ASN . . . . . . . . . . . . . 1.3 t-20 45.68 87.79 0.11 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.199 -1.177 . . . . 0.0 110.027 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2175 ' ' PRO . . . . . 0.661 ' CB ' ' CD1' ' A' 2188 ' ' PHE . 1.6 Cg_endo -63.02 -23.45 73.91 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 121.896 1.731 . . . . 0.0 110.212 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2176 ' ' CYS . . . . . 0.47 ' HB3' ' SG ' ' A' 2192 ' ' CYS . 0.4 OUTLIER -76.83 -68.11 0.64 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.11 -0.994 . . . . 0.0 109.288 179.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 159.81 -20.89 0.26 Allowed Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 1.3 t30 -166.55 -30.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.156 -1.202 . . . . 0.0 110.853 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2179 ' ' GLY . . . . . 0.589 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -61.72 -103.91 0.01 OUTLIER Glycine 0 N--CA 1.491 2.343 0 C-N-CA 119.6 -1.286 . . . . 0.0 109.937 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2180 ' ' THR . . . . . 0.411 HG23 ' O ' ' A' 2179 ' ' GLY . 1.1 p -153.75 162.33 41.33 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.467 -1.019 . . . . 0.0 109.027 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2181 ' ' CYS . . . . . 0.555 ' HB3' ' HD3' ' A' 2175 ' ' PRO . 27.3 p -97.05 161.63 13.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.11 -0.994 . . . . 0.0 110.41 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2182 ' ' LYS . . . . . 0.622 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.2 OUTLIER -146.65 155.12 42.2 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.338 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 64.0 t30 -101.12 127.85 47.48 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.685 -1.259 . . . . 0.0 109.106 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2184 ' ' VAL . . . . . 0.632 HG12 ' N ' ' A' 2188 ' ' PHE . 0.6 OUTLIER -134.33 -166.76 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.419 -0.801 . . . . 0.0 109.367 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 2185 ' ' ILE . . . . . 0.615 ' N ' HG13 ' A' 2184 ' ' VAL . 3.9 mp -105.89 134.57 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.127 -0.983 . . . . 0.0 110.032 -179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2186 ' ' GLY . . . . . 0.426 ' O ' ' SD ' ' A' 2201 ' ' MET . . . 78.8 4.16 87.99 Favored Glycine 0 N--CA 1.485 1.915 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2187 ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 170.54 -116.96 0.67 Allowed Glycine 0 N--CA 1.49 2.293 0 C-N-CA 119.457 -1.354 . . . . 0.0 109.985 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2188 ' ' PHE . . . . . 0.661 ' CD1' ' CB ' ' A' 2175 ' ' PRO . 5.0 p90 -168.25 173.13 8.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.39 -1.065 . . . . 0.0 109.184 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2189 ' ' GLU . . . . . 0.622 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.2 tp10 -127.02 155.69 42.83 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2190 ' ' CYS . . . . . 0.408 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 25.4 p -151.25 145.79 25.61 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.711 -1.243 . . . . 0.0 110.035 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2191 ' ' THR . . . . . 0.494 ' O ' ' HA3' ' A' 2179 ' ' GLY . 23.3 m -112.24 84.67 2.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.379 -0.826 . . . . 0.0 109.847 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2192 ' ' CYS . . . . . 0.628 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.1 m -48.79 -179.01 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.293 -0.879 . . . . 0.0 109.608 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2193 ' ' GLU . . . . . 0.476 ' O ' ' C ' ' A' 2194 ' ' GLU . 19.1 tt0 -50.65 116.49 1.96 Allowed 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2194 ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.3 OUTLIER -34.85 125.69 0.54 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.71 -0.619 . . . . 0.0 110.723 -179.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.16 1.24 10.41 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2196 ' ' PHE . . . . . 0.675 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.3 p90 -108.89 -163.28 0.86 Allowed 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.199 -1.177 . . . . 0.0 109.987 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2197 ' ' GLU . . . . . 0.529 ' N ' ' CG ' ' A' 2196 ' ' PHE . 16.8 mt-10 -145.62 95.58 4.92 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 121.496 -0.753 . . . . 0.0 109.556 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2198 ' ' PRO . . . . . 0.675 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.8 Cg_endo -68.71 -165.23 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.213 1.942 . . . . 0.0 111.259 -179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -133.13 -169.09 12.09 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.375 -1.89 . . . . 0.0 108.375 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.71 -81.91 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.998 1.799 . . . . 0.0 110.563 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 2201 ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.0 OUTLIER -137.08 56.38 1.79 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.974 . . . . 0.0 109.952 -179.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A 2202 ' ' MET . . . . . 0.439 ' O ' ' HB ' ' A' 2203 ' ' THR . 2.4 mmt -123.81 -72.25 0.69 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.271 -0.893 . . . . 0.0 109.615 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2203 ' ' THR . . . . . 0.439 ' HB ' ' O ' ' A' 2202 ' ' MET . 11.3 t -180.0 -170.84 0.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.35 -0.844 . . . . 0.0 109.432 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2204 ' ' CYS . . . . . 0.478 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.4 t -70.27 146.83 50.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.148 -0.97 . . . . 0.0 109.565 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.039 -0.981 . . . . 0.0 109.385 179.977 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 2124 ' ' SER . . . . . 0.451 ' O ' ' HB3' ' A' 2125 ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2125 ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' 2124 ' ' SER . . . 61.96 76.46 0.37 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.463 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2126 ' ' VAL . . . . . 0.444 ' O ' HG13 ' A' 2126 ' ' VAL . 12.4 p -124.16 130.41 73.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -0.902 . . . . 0.0 109.383 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2127 ' ' ASP . . . . . 0.418 ' OD1' ' C ' ' A' 2127 ' ' ASP . 2.9 p30 -58.34 -177.28 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.326 -0.859 . . . . 0.0 109.563 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 1.5 ttt -44.32 125.47 4.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.384 -0.823 . . . . 0.0 109.661 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2129 ' ' ASP . . . . . 0.55 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 20.1 t0 -66.14 -54.87 20.16 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.386 -0.821 . . . . 0.0 108.902 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2130 ' ' GLU . . . . . 0.592 ' O ' HG21 ' A' 2136 ' ' VAL . 1.5 mt-10 80.85 -41.15 0.17 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.651 -0.656 . . . . 0.0 110.943 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2131 ' ' CYS . . . . . 0.496 ' HB2' ' SG ' ' A' 2137 ' ' CYS . 9.8 p -90.23 -33.07 16.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.664 -1.273 . . . . 0.0 110.005 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2132 ' ' LYS . . . . . 0.474 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -81.53 6.86 13.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.135 -0.978 . . . . 0.0 109.225 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -69.71 154.04 95.09 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.254 -0.904 . . . . 0.0 109.343 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2134 ' ' PRO . . . . . 0.486 ' O ' ' HD2' ' A' 2138 ' ' LYS . 3.7 Cg_endo -68.5 1.49 3.61 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.504 2.136 . . . . 0.0 111.536 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -134.36 0.05 3.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.602 -1.311 . . . . 0.0 110.733 -179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2136 ' ' VAL . . . . . 0.592 HG21 ' O ' ' A' 2130 ' ' GLU . 21.7 t -106.3 -119.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.818 -1.176 . . . . 0.0 109.594 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2137 ' ' CYS . . . . . 0.532 ' N ' HG12 ' A' 2136 ' ' VAL . 3.8 m -76.74 111.45 12.27 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.754 -1.216 . . . . 0.0 108.799 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2138 ' ' LYS . . . . . 0.486 ' HD2' ' O ' ' A' 2134 ' ' PRO . 6.2 mtpp -116.37 112.58 21.71 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.242 -0.911 . . . . 0.0 110.096 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2139 ' ' HIS . . . . . 0.491 ' O ' ' HB3' ' A' 2164 ' ' CYS . 2.1 m-70 74.14 56.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.884 . . . . 0.0 109.944 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -159.7 -176.98 32.37 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -103.6 91.14 3.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -1.122 . . . . 0.0 109.043 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2142 ' ' CYS . . . . . 0.455 ' HA ' ' O ' ' A' 2150 ' ' ARG . 26.7 p -86.48 -178.94 6.54 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.228 -0.92 . . . . 0.0 110.2 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2143 ' ' ILE . . . . . 0.654 ' O ' HG23 ' A' 2145 ' ' THR . 3.6 mp -141.45 94.24 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.441 -0.787 . . . . 0.0 108.886 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2144 ' ' ASN . . . . . 0.55 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 11.1 t-20 -47.95 117.83 2.07 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.36 -0.837 . . . . 0.0 110.054 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2145 ' ' THR . . . . . 0.654 HG23 ' O ' ' A' 2143 ' ' ILE . 70.9 p -116.49 -174.66 2.6 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.431 -0.793 . . . . 0.0 109.046 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.31 118.44 25.75 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.341 -0.849 . . . . 0.0 109.602 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2147 ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' 2148 ' ' SER . . . 53.62 42.3 66.73 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2148 ' ' SER . . . . . 0.466 ' O ' ' OE1' ' A' 2130 ' ' GLU . 1.8 t 178.16 -162.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.314 -1.109 . . . . 0.0 109.66 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2149 ' ' TYR . . . . . 0.574 ' CD2' ' HB3' ' A' 2130 ' ' GLU . 45.2 p90 179.66 -169.5 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.41 -0.806 . . . . 0.0 109.336 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2150 ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' 2149 ' ' TYR . 12.4 mtt180 -160.46 119.67 2.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 0.0 109.493 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 82.3 m -83.18 69.76 9.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.328 -0.857 . . . . 0.0 109.234 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -80.47 109.18 14.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.522 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2153 ' ' CYS . . . . . 0.51 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -82.38 152.66 67.76 Favored Pre-proline 0 N--CA 1.486 1.373 0 O-C-N 121.148 -0.97 . . . . 0.0 109.356 179.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 2154 ' ' PRO . . . . . 0.43 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.2 Cg_endo -64.58 -168.54 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.493 2.128 . . . . 0.0 111.207 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 9.1 t80 -90.19 103.25 15.94 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2156 ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' 2167 ' ' THR . . . 130.93 -14.17 5.49 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 -178.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2157 ' ' TYR . . . . . 0.741 ' OH ' HG23 ' A' 2185 ' ' ILE . 7.7 m-85 -107.86 -169.37 1.51 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.516 -0.99 . . . . 0.0 109.945 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2158 ' ' ILE . . . . . 0.97 HD11 HG23 ' A' 2165 ' ' VAL . 0.1 OUTLIER -155.78 -165.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.452 -0.78 . . . . 0.0 109.458 179.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 2159 ' ' LEU . . . . . 0.449 ' N ' HG12 ' A' 2158 ' ' ILE . 28.7 tp -141.35 125.76 17.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.365 -0.834 . . . . 0.0 109.574 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -101.92 52.67 0.82 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.261 -0.899 . . . . 0.0 109.261 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2161 ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 88.28 -9.66 74.32 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2162 ' ' ASN . . . . . 0.529 ' ND2' ' HA ' ' A' 2136 ' ' VAL . 1.7 m-20 167.04 -47.86 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -1.195 . . . . 0.0 109.444 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2163 ' ' GLU . . . . . 0.411 ' HA ' ' HB2' ' A' 2138 ' ' LYS . 25.5 tt0 -70.28 115.94 10.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.304 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2164 ' ' CYS . . . . . 0.616 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -92.33 144.55 25.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.52 -179.787 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 2165 ' ' VAL . . . . . 0.97 HG23 HD11 ' A' 2158 ' ' ILE . 0.4 OUTLIER -159.17 -167.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 0.0 109.426 -179.972 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 2166 ' ' ASP . . . . . 0.419 ' OD2' ' O ' ' A' 2184 ' ' VAL . 35.6 t70 -85.95 166.59 15.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.956 -1.09 . . . . 0.0 109.796 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2167 ' ' THR . . . . . 0.549 ' CG2' ' OE1' ' A' 2169 ' ' GLU . 5.6 t -113.73 -168.82 1.4 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.391 -0.818 . . . . 0.0 109.46 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2168 ' ' ASP . . . . . 0.405 ' C ' ' OD1' ' A' 2168 ' ' ASP . 61.0 t0 -110.39 103.58 12.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.159 -0.963 . . . . 0.0 109.602 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2169 ' ' GLU . . . . . 0.641 ' O ' HG23 ' A' 2172 ' ' VAL . 0.5 OUTLIER -79.99 -30.58 39.72 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.323 -0.86 . . . . 0.0 109.157 179.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 2170 ' ' CYS . . . . . 0.533 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 0.5 OUTLIER -64.74 -11.24 34.24 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.371 -0.831 . . . . 0.0 109.008 179.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.64 -6.48 26.19 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.195 -0.94 . . . . 0.0 109.445 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2172 ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' 2169 ' ' GLU . 19.0 t -78.58 -70.5 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.196 -0.94 . . . . 0.0 109.051 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2173 ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' 2174 ' ' ASN . . . 161.78 77.04 0.03 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 110.114 -1.195 . . . . 0.0 110.114 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2174 ' ' ASN . . . . . 0.478 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 9.4 t-20 43.85 82.36 0.23 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.257 -1.143 . . . . 0.0 109.835 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2175 ' ' PRO . . . . . 0.614 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 0.9 OUTLIER -64.6 -20.86 65.79 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.289 1.993 . . . . 0.0 110.141 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 2176 ' ' CYS . . . . . 0.508 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.1 OUTLIER -55.63 -58.01 9.58 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.051 -1.031 . . . . 0.0 108.758 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 143.77 -19.59 2.19 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 1.1 t30 -160.6 -34.95 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -1.172 . . . . 0.0 110.539 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2179 ' ' GLY . . . . . 0.612 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -66.15 -125.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.649 -1.262 . . . . 0.0 110.034 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 2.5 p -140.92 162.22 35.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.491 -1.005 . . . . 0.0 109.252 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2181 ' ' CYS . . . . . 0.596 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 24.5 p -99.7 151.16 21.53 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 122.09 0.948 . . . . 0.0 111.341 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2182 ' ' LYS . . . . . 0.529 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 4.9 tptt -134.36 157.0 47.51 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 177.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 58.5 t30 -95.9 139.71 31.71 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.361 -1.462 . . . . 0.0 109.862 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2184 ' ' VAL . . . . . 0.681 HG12 ' CA ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -147.78 176.7 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.528 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 2185 ' ' ILE . . . . . 0.741 HG23 ' OH ' ' A' 2157 ' ' TYR . 1.2 mp -93.77 139.06 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.01 -1.056 . . . . 0.0 110.118 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 74.75 8.63 82.15 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2187 ' ' GLY . . . . . 0.58 ' C ' HG12 ' A' 2184 ' ' VAL . . . 161.94 -128.76 1.95 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.349 -1.501 . . . . 0.0 109.349 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2188 ' ' PHE . . . . . 0.681 ' CA ' HG12 ' A' 2184 ' ' VAL . 1.2 p90 -158.7 -178.78 7.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -1.15 . . . . 0.0 109.532 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2189 ' ' GLU . . . . . 0.529 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.6 OUTLIER -131.85 111.14 11.34 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.111 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 2190 ' ' CYS . . . . . 0.45 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 31.2 p -110.65 137.48 48.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.785 -1.197 . . . . 0.0 109.774 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2191 ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' 2192 ' ' CYS . 59.5 m -111.1 87.39 2.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.283 -0.886 . . . . 0.0 109.175 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2192 ' ' CYS . . . . . 0.614 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.0 OUTLIER -48.33 -179.01 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.671 0.748 . . . . 0.0 109.703 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 2193 ' ' GLU . . . . . 0.475 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.6 OUTLIER -59.15 123.83 17.94 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.712 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 2194 ' ' GLU . . . . . 0.475 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.6 OUTLIER -34.74 129.5 0.43 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.43 0.633 . . . . 0.0 110.878 -179.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.47 1.51 10.04 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2196 ' ' PHE . . . . . 0.673 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.8 OUTLIER -116.33 -164.54 0.98 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.184 -1.186 . . . . 0.0 110.192 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 2197 ' ' GLU . . . . . 0.564 ' N ' ' CG ' ' A' 2196 ' ' PHE . 0.3 OUTLIER -146.14 98.15 4.39 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 2198 ' ' PRO . . . . . 0.673 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.9 Cg_endo -68.68 -164.44 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.242 1.962 . . . . 0.0 111.174 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -132.49 -173.71 13.4 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2200 ' ' PRO . . . . . 0.405 ' C ' ' HG2' ' A' 2201 ' ' MET . 1.2 Cg_endo -64.4 -54.63 0.75 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.919 1.746 . . . . 0.0 110.629 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2201 ' ' MET . . . . . 0.503 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -159.8 49.57 0.3 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 0.0 109.566 -179.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 2.1 mmm -118.63 -79.3 0.59 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.253 -0.904 . . . . 0.0 109.674 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2203 ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' 2175 ' ' PRO . 6.7 t -173.51 -166.36 0.32 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.306 -0.871 . . . . 0.0 109.228 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2204 ' ' CYS . . . . . 0.548 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.2 t -70.31 141.63 52.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.073 -1.017 . . . . 0.0 109.541 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A 2205 ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' 2197 ' ' GLU . 23.0 pt-20 . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.35 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 59.5 p . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -120.22 174.4 6.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.418 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2126 ' ' VAL . . . . . 0.63 HG12 ' H ' ' A' 2128 ' ' MET . 21.6 t -47.04 117.83 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.219 -0.926 . . . . 0.0 109.49 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2127 ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' 2128 ' ' MET . 0.5 OUTLIER -89.05 17.69 5.6 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.111 -0.993 . . . . 0.0 109.573 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 2128 ' ' MET . . . . . 0.63 ' H ' HG12 ' A' 2126 ' ' VAL . 0.1 OUTLIER 70.06 133.73 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.223 -0.923 . . . . 0.0 109.706 179.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 2129 ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' A' 2130 ' ' GLU . 1.3 t0 -51.72 -22.58 3.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.501 -0.749 . . . . 0.0 109.201 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2130 ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' 2129 ' ' ASP . 0.1 OUTLIER 81.29 -67.59 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.792 -0.568 . . . . 0.0 110.46 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 2131 ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' 2137 ' ' CYS . 1.7 t -81.28 -9.82 59.69 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.133 -0.979 . . . . 0.0 109.828 -179.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2132 ' ' LYS . . . . . 0.503 ' CB ' ' HB3' ' A' 2129 ' ' ASP . 0.0 OUTLIER -72.42 -15.02 61.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.787 -1.196 . . . . 0.0 109.785 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 2133 ' ' GLU . . . . . 0.602 ' HB2' HG23 ' A' 2136 ' ' VAL . 3.7 mt-10 -74.3 146.5 84.32 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.152 -0.968 . . . . 0.0 109.631 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2134 ' ' PRO . . . . . 0.473 ' HA ' ' CG ' ' A' 2138 ' ' LYS . 1.2 Cg_endo -65.22 -11.98 32.65 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.273 1.982 . . . . 0.0 110.133 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2135 ' ' ASP . . . . . 0.511 ' O ' ' ND2' ' A' 2162 ' ' ASN . 0.4 OUTLIER -110.35 21.57 16.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -0.95 . . . . 0.0 109.483 -179.937 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 2136 ' ' VAL . . . . . 0.602 HG23 ' HB2' ' A' 2133 ' ' GLU . 18.5 t -136.86 109.75 7.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2137 ' ' CYS . . . . . 0.543 ' CA ' ' O ' ' A' 2162 ' ' ASN . 56.4 m 64.92 -89.65 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -179.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2138 ' ' LYS . . . . . 0.514 ' O ' ' CB ' ' A' 2139 ' ' HIS . 0.0 OUTLIER 68.11 28.29 6.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.963 -1.086 . . . . 0.0 111.268 178.089 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 2139 ' ' HIS . . . . . 0.521 ' CB ' ' HB3' ' A' 2164 ' ' CYS . 0.2 OUTLIER 164.36 41.09 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.842 -1.161 . . . . 0.0 110.287 179.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 2140 ' ' GLY . . . . . 0.507 ' HA2' ' HD3' ' A' 2154 ' ' PRO . . . -166.41 175.73 41.77 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2141 ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' 2152 ' ' GLU . 0.2 OUTLIER -89.38 96.66 10.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.184 -1.186 . . . . 0.0 108.259 179.29 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 2142 ' ' CYS . . . . . 0.797 ' C ' HD12 ' A' 2143 ' ' ILE . 0.0 OUTLIER -96.32 174.07 7.06 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -0.86 . . . . 0.0 110.223 -178.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 2143 ' ' ILE . . . . . 0.797 HD12 ' C ' ' A' 2142 ' ' CYS . 4.0 mp -137.2 111.91 10.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2144 ' ' ASN . . . . . 0.493 ' OD1' ' O ' ' A' 2128 ' ' MET . 0.6 OUTLIER -60.17 118.09 5.93 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.207 -0.933 . . . . 0.0 109.756 -179.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 2145 ' ' THR . . . . . 0.678 HG23 ' HA ' ' A' 2149 ' ' TYR . 3.1 p -103.97 -179.5 3.97 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.157 -0.965 . . . . 0.0 109.011 179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.13 -74.12 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.356 -0.84 . . . . 0.0 109.771 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -117.27 41.49 2.07 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2148 ' ' SER . . . . . 0.51 ' O ' ' HG2' ' A' 2130 ' ' GLU . 0.6 OUTLIER -174.13 -171.85 0.65 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -1.18 . . . . 0.0 109.831 179.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 2149 ' ' TYR . . . . . 0.678 ' HA ' HG23 ' A' 2145 ' ' THR . 42.0 p90 -153.05 -171.84 4.06 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 0.0 109.474 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2150 ' ' ARG . . . . . 0.496 ' HG2' ' O ' ' A' 2149 ' ' TYR . 28.5 mtm180 -155.86 98.41 1.9 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.374 -0.829 . . . . 0.0 110.041 179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2151 ' ' CYS . . . . . 0.646 ' HB2' HD22 ' A' 2159 ' ' LEU . 70.7 m -63.02 87.73 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.527 -0.733 . . . . 0.0 109.069 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2152 ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' 2141 ' ' GLN . 0.0 OUTLIER -87.09 70.32 10.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.186 -0.946 . . . . 0.0 109.503 -179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 2153 ' ' CYS . . . . . 0.47 ' SG ' ' O ' ' A' 2158 ' ' ILE . 93.1 m -48.33 147.88 3.65 Favored Pre-proline 0 C--N 1.305 -1.338 0 O-C-N 121.379 -0.826 . . . . 0.0 109.177 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2154 ' ' PRO . . . . . 0.507 ' HD3' ' HA2' ' A' 2140 ' ' GLY . 1.4 Cg_endo -63.48 -169.1 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.541 2.161 . . . . 0.0 111.25 -178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 75.2 t80 -89.22 102.01 14.67 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 178.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.28 -11.63 5.54 Favored Glycine 0 N--CA 1.484 1.878 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2157 ' ' TYR . . . . . 0.476 ' CD2' ' O ' ' A' 2165 ' ' VAL . 5.7 m-85 -108.17 -170.69 1.72 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.399 -1.059 . . . . 0.0 109.801 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2158 ' ' ILE . . . . . 1.028 HD11 HG23 ' A' 2165 ' ' VAL . 0.2 OUTLIER -156.38 -173.71 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.061 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 2159 ' ' LEU . . . . . 0.646 HD22 ' HB2' ' A' 2151 ' ' CYS . 21.6 tp -130.89 143.52 50.79 Favored 'General case' 0 C--N 1.296 -1.761 0 O-C-N 121.276 -0.89 . . . . 0.0 109.85 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -120.52 47.71 1.73 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.388 -0.82 . . . . 0.0 109.175 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2161 ' ' GLY . . . . . 0.427 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 94.35 -16.8 60.26 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2162 ' ' ASN . . . . . 0.543 ' O ' ' CA ' ' A' 2137 ' ' CYS . 1.3 m-20 169.47 -30.34 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.342 -1.093 . . . . 0.0 109.171 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -88.21 119.63 28.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.223 -0.923 . . . . 0.0 108.749 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2164 ' ' CYS . . . . . 0.868 ' O ' HG13 ' A' 2165 ' ' VAL . 38.2 t -95.78 159.47 14.97 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.173 -0.955 . . . . 0.0 109.239 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2165 ' ' VAL . . . . . 1.028 HG23 HD11 ' A' 2158 ' ' ILE . 0.6 OUTLIER -169.15 -167.88 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 2166 ' ' ASP . . . . . 0.461 ' OD2' ' O ' ' A' 2184 ' ' VAL . 34.7 t70 -88.88 165.12 14.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.049 -1.032 . . . . 0.0 109.454 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2167 ' ' THR . . . . . 0.641 HG23 ' OE1' ' A' 2169 ' ' GLU . 6.3 t -111.35 -172.92 2.13 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.39 -0.818 . . . . 0.0 109.371 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2168 ' ' ASP . . . . . 0.472 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 51.8 t0 -107.48 100.96 10.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.409 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2169 ' ' GLU . . . . . 0.641 ' OE1' HG23 ' A' 2167 ' ' THR . 0.6 OUTLIER -76.33 -31.92 58.39 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.496 -0.752 . . . . 0.0 109.288 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 2170 ' ' CYS . . . . . 0.491 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 2.0 t -66.77 -9.68 39.37 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.314 -0.866 . . . . 0.0 108.877 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2171 ' ' SER . . . . . 0.417 ' HB2' ' CG ' ' A' 2168 ' ' ASP . 0.2 OUTLIER -81.23 7.83 10.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.855 . . . . 0.0 109.894 -179.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 49.5 t -108.22 -72.34 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.07 -1.019 . . . . 0.0 109.536 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2173 ' ' GLY . . . . . 0.476 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -163.08 133.81 3.2 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2174 ' ' ASN . . . . . 0.624 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 18.9 p-10 -40.25 99.86 0.21 Allowed Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.461 -1.023 . . . . 0.0 109.959 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2175 ' ' PRO . . . . . 0.591 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 1.4 Cg_endo -68.66 -22.01 38.33 Favored 'Trans proline' 0 C--N 1.315 -1.201 0 C-N-CA 121.798 1.665 . . . . 0.0 109.85 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2176 ' ' CYS . . . . . 0.583 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -48.61 -40.36 27.28 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.305 -0.872 . . . . 0.0 109.206 -179.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 123.0 -16.5 8.2 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -175.44 -34.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.481 -1.011 . . . . 0.0 109.71 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2179 ' ' GLY . . . . . 0.601 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -63.15 -122.24 0.01 OUTLIER Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -142.51 154.63 44.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.39 -1.065 . . . . 0.0 109.708 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2181 ' ' CYS . . . . . 0.624 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 21.4 p -92.52 161.39 14.63 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.352 1.072 . . . . 0.0 111.286 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2182 ' ' LYS . . . . . 0.586 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 43.3 tptt -141.48 163.33 33.22 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 177.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2183 ' ' ASN . . . . . 0.473 ' N ' ' HG3' ' A' 2182 ' ' LYS . 62.9 t30 -101.13 140.07 35.94 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 120.618 -1.301 . . . . 0.0 110.006 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2184 ' ' VAL . . . . . 0.794 HG12 ' CA ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -148.91 -177.03 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.566 -0.709 . . . . 0.0 109.308 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 2185 ' ' ILE . . . . . 0.471 ' H ' HG22 ' A' 2184 ' ' VAL . 2.4 mp -97.83 135.7 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.02 -1.05 . . . . 0.0 110.196 -179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 75.15 10.62 84.26 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2187 ' ' GLY . . . . . 0.559 ' C ' HG12 ' A' 2184 ' ' VAL . . . 163.42 -121.04 0.98 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2188 ' ' PHE . . . . . 0.794 ' CA ' HG12 ' A' 2184 ' ' VAL . 2.3 p90 -169.17 -179.67 3.65 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.215 -1.168 . . . . 0.0 109.526 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2189 ' ' GLU . . . . . 0.586 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 4.5 tt0 -124.67 170.21 11.19 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 6.0 p -170.58 145.56 2.57 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.461 -1.399 . . . . 0.0 109.949 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2191 ' ' THR . . . . . . . . . . . . . 17.9 m -117.98 92.98 3.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.422 -0.799 . . . . 0.0 109.728 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2192 ' ' CYS . . . . . 0.611 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -54.82 179.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.13 -0.981 . . . . 0.0 108.795 179.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 2193 ' ' GLU . . . . . 0.473 ' O ' ' C ' ' A' 2194 ' ' GLU . 4.2 tt0 -56.64 121.22 9.24 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2194 ' ' GLU . . . . . 0.473 ' C ' ' O ' ' A' 2193 ' ' GLU . 2.2 mt-10 -34.65 127.52 0.48 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.672 -0.643 . . . . 0.0 110.877 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.11 8.58 7.16 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2196 ' ' PHE . . . . . 0.664 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.4 p90 -119.91 -161.54 0.88 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.251 -1.146 . . . . 0.0 110.301 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2197 ' ' GLU . . . . . 0.582 ' N ' ' CG ' ' A' 2196 ' ' PHE . 1.8 mm-40 -146.13 96.03 4.67 Favored Pre-proline 0 C--N 1.305 -1.339 0 O-C-N 121.64 -0.663 . . . . 0.0 109.763 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2198 ' ' PRO . . . . . 0.664 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.0 Cg_endo -68.1 -159.93 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.389 2.059 . . . . 0.0 111.4 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -143.99 -169.87 13.15 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.485 -1.846 . . . . 0.0 108.485 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -65.31 -81.2 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.993 1.796 . . . . 0.0 110.844 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2201 ' ' MET . . . . . 0.501 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -135.29 41.73 2.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 110.024 -179.308 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 5.0 mtm -112.33 -78.59 0.58 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.182 -0.948 . . . . 0.0 109.582 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 2203 ' ' THR . . . . . 0.438 HG23 ' N ' ' A' 2204 ' ' CYS . 6.0 t -168.24 -164.43 0.53 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.477 -0.764 . . . . 0.0 109.175 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A 2204 ' ' CYS . . . . . 0.583 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -115.91 144.97 43.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.292 -0.88 . . . . 0.0 108.943 -179.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.581 -179.724 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 2124 ' ' SER . . . . . 0.517 ' O ' ' N ' ' A' 2126 ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . 47.48 -92.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.321 -0.862 . . . . 0.0 109.588 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2126 ' ' VAL . . . . . 0.517 ' N ' ' O ' ' A' 2124 ' ' SER . 24.7 t -70.36 137.24 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.929 . . . . 0.0 109.246 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2127 ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' 2128 ' ' MET . 12.8 t70 -87.84 120.3 29.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.237 -0.915 . . . . 0.0 109.775 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2128 ' ' MET . . . . . 0.422 ' C ' ' O ' ' A' 2127 ' ' ASP . 1.2 mtt -43.69 125.36 4.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 109.538 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2129 ' ' ASP . . . . . 0.55 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 48.5 t0 -66.2 -38.98 89.3 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2130 ' ' GLU . . . . . 0.681 ' O ' HG21 ' A' 2136 ' ' VAL . 2.0 mt-10 82.4 -44.57 0.15 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.85 -0.531 . . . . 0.0 110.027 179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2131 ' ' CYS . . . . . 0.532 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 14.4 p -90.71 -24.72 20.34 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.007 -1.058 . . . . 0.0 109.288 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2132 ' ' LYS . . . . . 0.416 ' HB2' ' CB ' ' A' 2129 ' ' ASP . 0.0 OUTLIER -68.92 -8.98 49.28 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.435 -0.791 . . . . 0.0 109.851 -179.812 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 2133 ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' 2134 ' ' PRO . 6.3 mt-10 -72.12 144.47 87.44 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.082 -1.011 . . . . 0.0 109.171 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2134 ' ' PRO . . . . . 0.589 ' HA ' ' CG ' ' A' 2138 ' ' LYS . 1.9 Cg_endo -67.53 -4.12 11.41 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.239 1.959 . . . . 0.0 110.882 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2135 ' ' ASP . . . . . 0.414 ' N ' ' OD1' ' A' 2135 ' ' ASP . 2.6 m-20 -116.29 4.96 13.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.011 -1.056 . . . . 0.0 110.03 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2136 ' ' VAL . . . . . 0.681 HG21 ' O ' ' A' 2130 ' ' GLU . 75.4 t -110.32 -91.92 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.988 -1.07 . . . . 0.0 109.695 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2137 ' ' CYS . . . . . 0.542 ' N ' HG12 ' A' 2136 ' ' VAL . 0.5 OUTLIER -79.98 -74.43 0.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.115 -0.991 . . . . 0.0 109.572 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 2138 ' ' LYS . . . . . 0.589 ' CG ' ' HA ' ' A' 2134 ' ' PRO . 0.0 OUTLIER 65.46 89.42 0.1 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.377 -0.827 . . . . 0.0 109.963 179.645 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 2139 ' ' HIS . . . . . 0.524 ' O ' ' HB3' ' A' 2164 ' ' CYS . 3.5 m170 75.56 51.1 0.07 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.349 -0.844 . . . . 0.0 110.125 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -151.68 173.38 30.99 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -104.11 89.58 3.32 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.264 -1.139 . . . . 0.0 108.966 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2142 ' ' CYS . . . . . 0.481 ' HB3' ' SG ' ' A' 2137 ' ' CYS . 9.0 p -88.86 -177.0 5.39 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.347 -0.846 . . . . 0.0 110.345 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.29 93.04 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2144 ' ' ASN . . . . . 0.55 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 21.2 t-20 -46.11 115.61 1.04 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.516 -0.74 . . . . 0.0 110.963 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2145 ' ' THR . . . . . 0.497 ' OG1' ' HA ' ' A' 2149 ' ' TYR . 0.4 OUTLIER -113.37 -178.7 3.44 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.282 -0.886 . . . . 0.0 108.936 178.743 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -82.59 110.15 17.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.379 -0.826 . . . . 0.0 109.769 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 65.85 25.77 71.97 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2148 ' ' SER . . . . . 0.443 ' O ' ' OG1' ' A' 2145 ' ' THR . 0.0 OUTLIER -173.66 -178.72 1.66 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.123 -1.222 . . . . 0.0 109.738 179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 2149 ' ' TYR . . . . . 0.599 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 17.8 p90 -160.31 -172.37 3.55 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.443 -0.786 . . . . 0.0 109.446 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2150 ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' 2149 ' ' TYR . 1.8 mtt-85 -156.52 107.16 2.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.414 -0.804 . . . . 0.0 109.142 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 1.6 m -74.33 107.17 6.33 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.489 -0.757 . . . . 0.0 110.431 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.63 -178.63 3.49 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2153 ' ' CYS . . . . . 0.551 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -148.24 152.37 39.16 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 120.952 -1.093 . . . . 0.0 109.672 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 2154 ' ' PRO . . . . . 0.48 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.4 Cg_endo -64.22 -166.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.604 2.203 . . . . 0.0 111.478 -178.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 13.4 t80 -89.8 101.96 14.66 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2156 ' ' GLY . . . . . 0.461 ' O ' ' OD1' ' A' 2166 ' ' ASP . . . 130.81 -14.08 5.52 Favored Glycine 0 N--CA 1.485 1.925 0 N-CA-C 108.169 -1.973 . . . . 0.0 108.169 -178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2157 ' ' TYR . . . . . 0.691 ' OH ' HG23 ' A' 2185 ' ' ILE . 8.4 m-85 -108.3 -174.28 2.48 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.532 -0.981 . . . . 0.0 110.288 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2158 ' ' ILE . . . . . 0.729 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -157.65 -165.89 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.794 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 2159 ' ' LEU . . . . . . . . . . . . . 27.7 tp -131.92 127.74 37.05 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.408 -0.807 . . . . 0.0 109.574 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -107.06 49.23 0.81 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.885 . . . . 0.0 109.327 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 95.67 -20.25 50.55 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2162 ' ' ASN . . . . . 0.523 ' CB ' ' O ' ' A' 2136 ' ' VAL . 1.3 t-20 172.8 -38.72 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.207 -1.172 . . . . 0.0 109.447 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2163 ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' 2137 ' ' CYS . 2.1 tt0 -79.09 111.02 14.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 0.0 109.416 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2164 ' ' CYS . . . . . 0.668 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -85.93 137.55 32.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.895 . . . . 0.0 109.089 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 2165 ' ' VAL . . . . . 0.668 HG13 ' O ' ' A' 2164 ' ' CYS . 6.7 m -160.53 -166.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.145 -0.972 . . . . 0.0 109.539 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2166 ' ' ASP . . . . . 0.472 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 1.3 t0 -90.23 144.8 25.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.875 -1.141 . . . . 0.0 109.773 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2167 ' ' THR . . . . . 0.568 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 12.7 t -85.09 169.62 13.74 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.257 -0.902 . . . . 0.0 109.017 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2168 ' ' ASP . . . . . 0.498 ' O ' ' HB2' ' A' 2171 ' ' SER . 60.2 t0 -82.11 96.78 7.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.865 -1.147 . . . . 0.0 109.175 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2169 ' ' GLU . . . . . 0.699 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 40.2 mp0 -70.09 -37.07 75.33 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.474 -0.766 . . . . 0.0 109.186 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2170 ' ' CYS . . . . . 0.499 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 0.6 OUTLIER -68.19 -7.86 33.87 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.249 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 2171 ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.2 OUTLIER -74.09 -1.5 20.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.357 -0.839 . . . . 0.0 109.452 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 12.2 t -99.04 -72.55 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.17 -0.956 . . . . 0.0 109.671 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2173 ' ' GLY . . . . . 0.482 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -169.46 138.48 5.09 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2174 ' ' ASN . . . . . 0.575 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 22.7 p-10 -36.97 97.67 0.14 Allowed Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.721 -0.87 . . . . 0.0 110.335 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2175 ' ' PRO . . . . . 0.558 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 1.5 Cg_endo -63.2 -22.23 72.56 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 121.821 1.681 . . . . 0.0 109.998 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2176 ' ' CYS . . . . . 0.543 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -52.12 -54.99 23.83 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 141.96 -21.95 2.47 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 109.046 -1.622 . . . . 0.0 109.046 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -162.93 -34.84 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.336 -1.097 . . . . 0.0 110.176 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2179 ' ' GLY . . . . . 0.6 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -62.48 -119.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 -179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.96 153.65 41.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.466 -1.02 . . . . 0.0 109.14 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2181 ' ' CYS . . . . . 0.575 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 11.5 p -82.06 164.95 21.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.086 -1.009 . . . . 0.0 110.813 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2182 ' ' LYS . . . . . 0.604 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.4 OUTLIER -144.63 155.05 43.42 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 64.1 t30 -100.16 138.59 37.03 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 120.543 -1.348 . . . . 0.0 109.544 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2184 ' ' VAL . . . . . 0.688 HG13 ' N ' ' A' 2185 ' ' ILE . 0.6 OUTLIER -145.94 -162.58 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.329 -179.401 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A 2185 ' ' ILE . . . . . 0.691 HG23 ' OH ' ' A' 2157 ' ' TYR . 3.0 mp -108.28 134.23 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.036 -1.04 . . . . 0.0 110.356 -179.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 68.56 8.7 56.93 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.99 -1.244 . . . . 0.0 109.99 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2187 ' ' GLY . . . . . 0.67 ' C ' HG12 ' A' 2184 ' ' VAL . . . 174.12 -137.59 4.07 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2188 ' ' PHE . . . . . 0.699 ' HB3' ' HB2' ' A' 2169 ' ' GLU . 5.5 p90 -161.02 169.5 22.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.243 -1.151 . . . . 0.0 109.271 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2189 ' ' GLU . . . . . 0.604 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 2.8 tt0 -118.2 178.63 4.37 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 30.3 p -169.39 143.26 2.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.702 -1.249 . . . . 0.0 109.584 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2191 ' ' THR . . . . . . . . . . . . . 20.1 m -109.91 85.81 2.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.316 -0.865 . . . . 0.0 109.696 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2192 ' ' CYS . . . . . 0.604 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.1 m -51.23 177.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.255 -0.903 . . . . 0.0 109.205 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2193 ' ' GLU . . . . . 0.474 ' O ' ' C ' ' A' 2194 ' ' GLU . 7.4 tt0 -50.97 116.48 2.01 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2194 ' ' GLU . . . . . 0.474 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.8 mt-10 -33.93 127.77 0.39 Allowed 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.484 0.659 . . . . 0.0 111.043 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.08 5.22 8.97 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2196 ' ' PHE . . . . . 0.674 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.3 p90 -114.82 -163.22 0.86 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.234 -1.156 . . . . 0.0 110.268 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2197 ' ' GLU . . . . . 0.519 ' N ' ' CG ' ' A' 2196 ' ' PHE . 1.8 mm-40 -144.58 95.98 5.28 Favored Pre-proline 0 C--N 1.304 -1.37 0 O-C-N 121.526 -0.733 . . . . 0.0 109.597 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2198 ' ' PRO . . . . . 0.674 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 8.1 Cg_endo -66.94 -162.2 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.279 1.986 . . . . 0.0 111.075 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -137.0 -175.08 13.59 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -63.63 -72.31 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 121.991 1.794 . . . . 0.0 110.675 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2201 ' ' MET . . . . . 0.492 ' HA ' ' O ' ' A' 2188 ' ' PHE . 7.3 ptp -141.07 48.62 1.68 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.186 -0.947 . . . . 0.0 110.107 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2202 ' ' MET . . . . . 0.412 ' O ' ' CE1' ' A' 2188 ' ' PHE . 2.1 mmt -120.19 -85.03 0.66 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.081 -1.012 . . . . 0.0 109.845 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2203 ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' 2175 ' ' PRO . 7.3 t -168.66 -168.32 0.88 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.249 -0.907 . . . . 0.0 109.568 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2204 ' ' CYS . . . . . 0.575 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.7 t -71.59 144.81 49.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -0.934 . . . . 0.0 109.484 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A 2205 ' ' GLU . . . . . 0.41 ' HG3' ' O ' ' A' 2197 ' ' GLU . 19.0 pt-20 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.457 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 58.6 m . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -113.37 114.48 26.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.423 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 24.6 t -101.81 145.84 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.506 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2127 ' ' ASP . . . . . . . . . . . . . 15.6 t70 -97.26 109.29 22.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.218 -0.926 . . . . 0.0 109.49 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.76 130.57 47.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.296 -0.878 . . . . 0.0 109.717 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2129 ' ' ASP . . . . . 0.544 ' O ' ' ND2' ' A' 2144 ' ' ASN . 27.5 t0 -67.35 -38.98 85.69 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2130 ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' 2129 ' ' ASP . 1.5 mt-10 81.21 -48.74 0.26 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.668 -0.645 . . . . 0.0 110.427 179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2131 ' ' CYS . . . . . 0.488 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 13.7 p -90.97 -26.58 19.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.882 -1.136 . . . . 0.0 109.715 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2132 ' ' LYS . . . . . 0.529 ' HB2' ' CB ' ' A' 2129 ' ' ASP . 0.0 OUTLIER -65.34 -11.45 42.1 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.839 -1.163 . . . . 0.0 109.137 179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -70.28 148.75 95.82 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.399 -0.813 . . . . 0.0 109.413 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2134 ' ' PRO . . . . . 0.537 ' HA ' ' CD ' ' A' 2138 ' ' LYS . 1.2 Cg_endo -64.67 -7.8 15.69 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.232 1.954 . . . . 0.0 110.726 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.91 16.94 15.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.044 -1.035 . . . . 0.0 109.841 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2136 ' ' VAL . . . . . 0.64 ' CG1' ' CE1' ' A' 2149 ' ' TYR . 22.1 t -143.09 118.84 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.134 -0.979 . . . . 0.0 109.314 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2137 ' ' CYS . . . . . 0.47 ' SG ' HG12 ' A' 2136 ' ' VAL . 1.9 m 41.64 71.05 0.22 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.331 -0.856 . . . . 0.0 109.252 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2138 ' ' LYS . . . . . 0.537 ' CD ' ' HA ' ' A' 2134 ' ' PRO . 0.0 OUTLIER -98.35 129.24 45.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 0.0 109.928 -179.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 2139 ' ' HIS . . . . . 0.48 ' O ' ' HB3' ' A' 2164 ' ' CYS . 0.7 OUTLIER 67.95 52.2 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 0.0 109.499 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -161.52 -160.77 11.11 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2141 ' ' GLN . . . . . 0.436 ' HB3' ' O ' ' A' 2152 ' ' GLU . 1.6 tt0 -119.03 94.49 4.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.321 -1.105 . . . . 0.0 109.405 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2142 ' ' CYS . . . . . 0.514 ' C ' HD12 ' A' 2143 ' ' ILE . 10.9 p -90.47 177.7 6.31 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.294 -0.879 . . . . 0.0 110.011 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2143 ' ' ILE . . . . . 0.514 HD12 ' C ' ' A' 2142 ' ' CYS . 3.6 mp -132.16 117.22 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2144 ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' 2129 ' ' ASP . 5.2 t-20 -75.32 113.61 12.9 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.096 -1.002 . . . . 0.0 111.367 -178.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2145 ' ' THR . . . . . 0.441 ' OG1' ' C ' ' A' 2148 ' ' SER . 16.2 p -99.87 179.53 4.49 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -59.14 -47.94 83.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.311 -0.868 . . . . 0.0 109.849 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -142.58 57.71 0.56 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2148 ' ' SER . . . . . 0.467 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER 174.92 -160.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.302 -1.116 . . . . 0.0 109.287 -179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 2149 ' ' TYR . . . . . 0.64 ' CE1' ' CG1' ' A' 2136 ' ' VAL . 43.2 p90 -174.11 -170.9 0.58 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.35 -0.844 . . . . 0.0 109.336 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2150 ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' 2149 ' ' TYR . 26.8 mtt180 -160.04 107.61 1.66 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.339 -0.851 . . . . 0.0 109.435 179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 36.2 m -64.82 89.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.464 -0.772 . . . . 0.0 109.746 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2152 ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' 2141 ' ' GLN . 2.0 mt-10 -102.16 86.18 2.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.034 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2153 ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -59.24 153.38 47.61 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.297 -0.877 . . . . 0.0 109.973 -179.407 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 2154 ' ' PRO . . . . . 0.439 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.1 Cg_endo -65.16 -167.56 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.624 2.216 . . . . 0.0 111.205 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 17.9 t80 -90.15 104.89 17.42 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 178.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.03 -17.91 5.1 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.676 -2.17 . . . . 0.0 107.676 -178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2157 ' ' TYR . . . . . 0.521 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 12.0 m-85 -107.98 -175.38 2.77 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.673 -0.898 . . . . 0.0 109.574 179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2158 ' ' ILE . . . . . 0.771 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -153.6 -163.2 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.661 -0.65 . . . . 0.0 109.319 179.429 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 2159 ' ' LEU . . . . . 0.434 ' HA ' HD12 ' A' 2159 ' ' LEU . 24.4 tp -135.41 136.36 41.33 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.195 -0.941 . . . . 0.0 110.073 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -113.99 44.14 1.71 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.411 -0.806 . . . . 0.0 109.255 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 100.42 -28.31 16.41 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2162 ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -179.46 -35.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -1.109 . . . . 0.0 109.47 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -81.66 113.62 19.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 0.0 109.254 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2164 ' ' CYS . . . . . 0.541 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -87.37 135.59 33.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.229 -0.919 . . . . 0.0 109.854 -179.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 2165 ' ' VAL . . . . . 0.584 ' O ' HD13 ' A' 2158 ' ' ILE . 0.3 OUTLIER -158.42 -168.37 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.416 -0.802 . . . . 0.0 108.848 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 2166 ' ' ASP . . . . . 0.485 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 0.6 OUTLIER -90.46 140.04 30.1 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.895 -1.128 . . . . 0.0 109.405 179.612 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 2167 ' ' THR . . . . . 0.635 ' HB ' HG21 ' A' 2158 ' ' ILE . 7.6 t -93.13 161.33 14.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.252 -0.905 . . . . 0.0 109.373 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2168 ' ' ASP . . . . . 0.503 ' O ' ' HB2' ' A' 2171 ' ' SER . 59.7 t0 -69.92 95.38 0.92 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.831 -1.168 . . . . 0.0 109.517 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2169 ' ' GLU . . . . . 0.601 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 41.2 mp0 -69.35 -35.85 76.29 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.489 -0.757 . . . . 0.0 109.399 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2170 ' ' CYS . . . . . 0.499 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 0.2 OUTLIER -65.01 -8.7 17.11 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.451 -0.781 . . . . 0.0 109.057 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 2171 ' ' SER . . . . . 0.503 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -72.18 -0.6 12.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.962 -1.087 . . . . 0.0 109.781 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 9.9 t -98.82 -74.04 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.092 -1.005 . . . . 0.0 109.914 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2173 ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -166.61 138.92 5.46 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2174 ' ' ASN . . . . . 0.579 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 18.5 p-10 -38.64 99.31 0.19 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.694 -0.886 . . . . 0.0 110.245 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2175 ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' 2181 ' ' CYS . 1.8 Cg_endo -61.87 -27.94 80.73 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 122.053 1.835 . . . . 0.0 110.182 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2176 ' ' CYS . . . . . 0.55 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -46.14 -50.48 15.47 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 133.14 -16.92 4.62 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2178 ' ' ASN . . . . . 0.433 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.4 OUTLIER -162.86 -40.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -1.111 . . . . 0.0 109.911 -179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 2179 ' ' GLY . . . . . 0.603 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -60.85 -119.95 0.01 OUTLIER Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.3 p -143.11 160.42 40.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.432 -1.04 . . . . 0.0 109.469 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2181 ' ' CYS . . . . . 0.59 ' HB3' ' HD3' ' A' 2175 ' ' PRO . 16.7 p -88.1 166.42 14.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.137 -0.977 . . . . 0.0 110.794 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2182 ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.2 OUTLIER -145.62 156.01 43.39 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 61.3 t30 -100.59 131.33 46.55 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.698 -1.251 . . . . 0.0 109.506 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2184 ' ' VAL . . . . . 0.689 HG12 ' N ' ' A' 2188 ' ' PHE . 0.6 OUTLIER -140.89 -166.8 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.515 -0.741 . . . . 0.0 109.368 -179.566 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 2185 ' ' ILE . . . . . 0.614 ' N ' HG13 ' A' 2184 ' ' VAL . 4.0 mp -107.36 136.41 42.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.029 -1.045 . . . . 0.0 109.909 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 72.92 6.93 68.96 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2187 ' ' GLY . . . . . 0.646 ' C ' HG12 ' A' 2184 ' ' VAL . . . 169.81 -129.76 1.9 Allowed Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2188 ' ' PHE . . . . . 0.689 ' N ' HG12 ' A' 2184 ' ' VAL . 3.2 p90 -164.38 173.16 12.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.233 -1.157 . . . . 0.0 108.997 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2189 ' ' GLU . . . . . 0.617 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 2.6 tt0 -120.54 159.33 25.42 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 22.4 p -149.18 145.34 27.11 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.738 -1.226 . . . . 0.0 109.917 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2191 ' ' THR . . . . . . . . . . . . . 25.2 m -113.9 85.96 2.31 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.299 -0.875 . . . . 0.0 109.564 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2192 ' ' CYS . . . . . 0.617 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.9 OUTLIER -51.01 178.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.314 -0.866 . . . . 0.0 109.273 179.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 2193 ' ' GLU . . . . . 0.49 ' O ' ' C ' ' A' 2194 ' ' GLU . 2.0 tm-20 -52.71 117.79 3.17 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2194 ' ' GLU . . . . . 0.49 ' C ' ' O ' ' A' 2193 ' ' GLU . 5.7 mt-10 -34.15 127.73 0.42 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.494 0.664 . . . . 0.0 110.833 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.59 4.61 8.82 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2196 ' ' PHE . . . . . 0.669 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.1 p90 -114.99 -162.77 0.84 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.193 -1.181 . . . . 0.0 110.1 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2197 ' ' GLU . . . . . 0.542 ' N ' ' CG ' ' A' 2196 ' ' PHE . 25.3 mt-10 -145.42 95.55 5.0 Favored Pre-proline 0 C--N 1.304 -1.386 0 O-C-N 121.46 -0.775 . . . . 0.0 109.481 -179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2198 ' ' PRO . . . . . 0.669 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 8.3 Cg_endo -67.38 -159.48 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.27 1.98 . . . . 0.0 111.098 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -140.62 -170.49 12.1 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -64.47 -81.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 121.919 1.746 . . . . 0.0 110.531 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2201 ' ' MET . . . . . 0.493 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.4 OUTLIER -135.02 56.52 1.84 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.819 -179.475 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 2202 ' ' MET . . . . . 0.405 ' O ' ' HB ' ' A' 2203 ' ' THR . 0.2 OUTLIER -124.53 -78.63 0.6 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.22 -0.925 . . . . 0.0 109.654 -179.892 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A 2203 ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' 2175 ' ' PRO . 6.7 t -178.5 -165.56 0.09 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.382 -0.824 . . . . 0.0 109.196 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2204 ' ' CYS . . . . . 0.564 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.4 t -75.08 144.79 42.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 0.0 109.462 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.563 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.276 0.56 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 2125 ' ' ALA . . . . . 0.414 ' O ' ' HB ' ' A' 2126 ' ' VAL . . . -141.58 26.6 1.93 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.536 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2126 ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' 2125 ' ' ALA . 44.4 t 58.85 100.9 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 0.0 109.551 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2127 ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' 2128 ' ' MET . 25.9 t70 -44.32 147.19 0.58 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.197 -0.94 . . . . 0.0 109.556 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2128 ' ' MET . . . . . 0.422 ' C ' ' O ' ' A' 2127 ' ' ASP . 1.8 ttt -43.13 103.1 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.347 -0.846 . . . . 0.0 109.688 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2129 ' ' ASP . . . . . 0.54 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 17.5 t0 -82.69 89.04 6.7 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2130 ' ' GLU . . . . . 0.606 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 42.4 mp0 -56.11 -24.76 42.58 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.43 -0.794 . . . . 0.0 110.529 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2131 ' ' CYS . . . . . . . . . . . . . 1.8 t -84.49 -26.72 27.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.653 -1.279 . . . . 0.0 109.094 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2132 ' ' LYS . . . . . 0.479 ' HB2' ' HB3' ' A' 2129 ' ' ASP . 0.0 OUTLIER -84.75 13.05 6.19 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.07 -1.019 . . . . 0.0 109.089 179.445 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 2133 ' ' GLU . . . . . 0.548 ' HB2' ' CG2' ' A' 2136 ' ' VAL . 7.7 mt-10 -70.66 165.04 49.81 Favored Pre-proline 0 N--CA 1.486 1.365 0 O-C-N 121.346 -0.847 . . . . 0.0 109.498 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2134 ' ' PRO . . . . . 0.476 ' HD2' ' HB3' ' A' 2133 ' ' GLU . 2.6 Cg_endo -65.85 -27.76 51.3 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.57 2.18 . . . . 0.0 112.342 -178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -138.91 39.36 2.16 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.53 -1.356 . . . . 0.0 111.487 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2136 ' ' VAL . . . . . 0.781 HG12 ' N ' ' A' 2137 ' ' CYS . 46.5 t -102.84 -100.15 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.834 -1.167 . . . . 0.0 109.248 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2137 ' ' CYS . . . . . 0.781 ' N ' HG12 ' A' 2136 ' ' VAL . 16.2 m -89.46 -65.48 1.01 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.767 -1.208 . . . . 0.0 108.696 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2138 ' ' LYS . . . . . 0.42 ' O ' ' O ' ' A' 2137 ' ' CYS . 0.3 OUTLIER 61.17 124.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.373 -0.829 . . . . 0.0 110.383 178.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 2139 ' ' HIS . . . . . 0.484 ' O ' ' HB3' ' A' 2164 ' ' CYS . 0.7 OUTLIER 63.18 40.83 8.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.335 -0.853 . . . . 0.0 110.366 179.074 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -154.79 162.15 30.65 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.04 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -94.44 87.9 5.32 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.493 -1.004 . . . . 0.0 108.727 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2142 ' ' CYS . . . . . 0.825 ' C ' HD12 ' A' 2143 ' ' ILE . 0.8 OUTLIER -88.22 -166.83 1.69 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.3 -0.875 . . . . 0.0 109.769 -179.136 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 2143 ' ' ILE . . . . . 0.825 HD12 ' C ' ' A' 2142 ' ' CYS . 4.1 mp -144.72 103.75 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2144 ' ' ASN . . . . . 0.54 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 5.7 t-20 -57.63 116.02 3.14 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.302 -0.874 . . . . 0.0 110.3 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2145 ' ' THR . . . . . 0.432 ' HG1' ' C ' ' A' 2148 ' ' SER . 1.3 p -104.48 -177.46 3.37 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.381 -0.825 . . . . 0.0 109.196 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.86 -72.96 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.331 -0.856 . . . . 0.0 109.675 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -128.21 38.28 2.11 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2148 ' ' SER . . . . . 0.468 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER -155.0 -160.06 1.02 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.245 -1.15 . . . . 0.0 109.513 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 2149 ' ' TYR . . . . . 0.694 ' CE2' HG13 ' A' 2136 ' ' VAL . 8.5 p90 -163.38 -169.72 2.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.308 -0.87 . . . . 0.0 109.658 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2150 ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' 2142 ' ' CYS . 32.4 mtt180 -157.81 99.51 1.7 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.388 -0.82 . . . . 0.0 109.374 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 30.6 m -70.09 111.97 6.13 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.252 -0.905 . . . . 0.0 109.17 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.03 84.8 2.31 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.239 -0.913 . . . . 0.0 109.416 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2153 ' ' CYS . . . . . 0.518 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -54.88 148.1 29.29 Favored Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.341 -0.849 . . . . 0.0 109.207 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 2154 ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.93 -167.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.405 2.07 . . . . 0.0 111.018 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 6.5 t80 -90.08 104.72 17.27 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.23 -16.14 5.24 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2157 ' ' TYR . . . . . 0.538 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 6.4 m-85 -105.52 -169.24 1.56 Allowed 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.564 -0.963 . . . . 0.0 110.155 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2158 ' ' ILE . . . . . 0.711 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -153.46 -167.35 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.617 -0.677 . . . . 0.0 109.206 179.481 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 2159 ' ' LEU . . . . . . . . . . . . . 37.9 tp -139.52 127.42 22.14 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.372 -0.83 . . . . 0.0 109.463 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -103.93 44.17 1.04 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.366 -0.834 . . . . 0.0 109.605 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2161 ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' 2162 ' ' ASN . . . 93.87 -17.79 57.96 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2162 ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' 2136 ' ' VAL . 4.0 p-10 179.72 -49.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.258 -1.142 . . . . 0.0 109.469 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2163 ' ' GLU . . . . . 0.456 ' N ' ' CG ' ' A' 2162 ' ' ASN . 0.6 OUTLIER -73.45 120.07 18.55 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.56 -0.712 . . . . 0.0 109.255 179.915 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 2164 ' ' CYS . . . . . 0.603 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -97.08 139.4 33.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 109.456 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 2165 ' ' VAL . . . . . 0.679 HG23 HD11 ' A' 2158 ' ' ILE . 1.6 m -158.39 -172.27 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.064 -1.023 . . . . 0.0 109.475 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2166 ' ' ASP . . . . . 0.403 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 7.6 t70 -88.11 152.65 21.86 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.952 -1.092 . . . . 0.0 109.562 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2167 ' ' THR . . . . . 0.583 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 5.5 t -92.19 -168.16 1.93 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 109.13 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2168 ' ' ASP . . . . . 0.432 ' O ' ' HB2' ' A' 2171 ' ' SER . 58.5 t0 -111.36 100.0 8.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.085 -1.009 . . . . 0.0 109.213 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2169 ' ' GLU . . . . . 0.607 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.7 OUTLIER -74.0 -33.28 63.75 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.448 -0.783 . . . . 0.0 109.22 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 2170 ' ' CYS . . . . . 0.464 ' HB2' ' N ' ' A' 2182 ' ' LYS . 1.8 t -69.59 -9.62 54.81 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2171 ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -72.72 -12.86 61.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.293 -0.879 . . . . 0.0 109.549 -179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 21.7 t -84.76 -71.99 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.146 -0.971 . . . . 0.0 109.288 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2173 ' ' GLY . . . . . 0.465 ' O ' ' SG ' ' A' 2181 ' ' CYS . . . -154.09 -127.58 1.16 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2174 ' ' ASN . . . . . 0.572 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 26.5 p-10 -130.28 97.79 21.93 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.075 -1.25 . . . . 0.0 109.213 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2175 ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' 2181 ' ' CYS . 1.6 Cg_endo -66.58 -18.97 54.6 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 121.918 1.745 . . . . 0.0 109.967 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2176 ' ' CYS . . . . . 0.542 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.1 OUTLIER -51.39 -49.12 62.19 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 122.06 0.933 . . . . 0.0 108.926 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 128.64 -21.05 5.41 Favored Glycine 0 N--CA 1.482 1.709 0 N-CA-C 108.326 -1.909 . . . . 0.0 108.326 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -166.52 -34.09 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.498 -1.001 . . . . 0.0 110.045 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2179 ' ' GLY . . . . . 0.613 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -69.26 -130.51 0.05 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.6 p -131.97 157.0 45.2 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.605 -0.938 . . . . 0.0 109.193 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2181 ' ' CYS . . . . . 0.572 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 24.7 p -89.17 167.09 13.39 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 122.336 1.065 . . . . 0.0 110.899 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2182 ' ' LYS . . . . . 0.542 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 3.9 tttp -146.4 160.79 41.6 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2183 ' ' ASN . . . . . 0.416 ' N ' ' CG ' ' A' 2182 ' ' LYS . 56.3 t30 -100.59 126.32 47.05 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.602 -1.311 . . . . 0.0 110.014 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2184 ' ' VAL . . . . . 0.89 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -132.46 -176.32 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.829 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 2185 ' ' ILE . . . . . 0.538 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 4.0 mp -100.29 140.29 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.019 -1.051 . . . . 0.0 110.008 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 70.64 12.19 69.92 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2187 ' ' GLY . . . . . 0.592 ' C ' HG12 ' A' 2184 ' ' VAL . . . 164.39 -117.92 0.78 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2188 ' ' PHE . . . . . 0.89 ' N ' HG12 ' A' 2184 ' ' VAL . 2.2 p90 -170.57 -179.27 2.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -1.19 . . . . 0.0 109.902 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2189 ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.3 OUTLIER -127.63 169.53 13.66 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.187 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 11.7 p -170.56 146.69 2.78 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.498 -1.376 . . . . 0.0 110.229 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2191 ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' 2192 ' ' CYS . 89.2 m -114.84 86.61 2.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.372 -0.83 . . . . 0.0 109.533 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2192 ' ' CYS . . . . . 0.622 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -50.27 -179.3 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.044 -1.035 . . . . 0.0 108.865 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 2193 ' ' GLU . . . . . 0.489 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.5 tt0 -55.15 113.92 1.56 Allowed 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 178.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2194 ' ' GLU . . . . . 0.489 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.2 tt0 -31.1 129.18 0.14 Allowed 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.589 0.709 . . . . 0.0 111.029 -178.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.61 4.27 9.81 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2196 ' ' PHE . . . . . 0.67 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.3 p90 -114.93 -163.63 0.89 Allowed 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.229 -1.159 . . . . 0.0 110.385 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2197 ' ' GLU . . . . . 0.55 ' N ' ' CG ' ' A' 2196 ' ' PHE . 7.1 mt-10 -145.32 95.54 5.04 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 121.615 -0.678 . . . . 0.0 109.596 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2198 ' ' PRO . . . . . 0.67 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.2 Cg_endo -67.63 -162.14 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.349 2.033 . . . . 0.0 111.42 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -138.27 -174.82 13.58 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 108.774 -1.731 . . . . 0.0 108.774 179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.54 -71.76 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.055 1.837 . . . . 0.0 110.726 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2201 ' ' MET . . . . . 0.471 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.1 OUTLIER -144.4 42.35 1.38 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.212 -0.93 . . . . 0.0 109.756 -179.581 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.35 -77.11 0.58 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.217 -0.927 . . . . 0.0 109.532 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A 2203 ' ' THR . . . . . . . . . . . . . 12.2 t -168.32 -168.69 0.96 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.409 -0.807 . . . . 0.0 109.094 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 2204 ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.0 OUTLIER -115.04 149.7 37.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.895 . . . . 0.0 108.989 -179.791 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.077 -0.964 . . . . 0.0 109.564 179.919 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.265 0.555 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -154.79 -52.5 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.312 -0.867 . . . . 0.0 109.433 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 12.5 m -66.15 162.56 2.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.321 -0.862 . . . . 0.0 109.584 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2127 ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' 2128 ' ' MET . 15.5 t70 -60.08 152.17 24.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.622 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2128 ' ' MET . . . . . 0.467 ' O ' ' HG3' ' A' 2130 ' ' GLU . 0.3 OUTLIER -43.88 132.43 5.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.329 -0.857 . . . . 0.0 109.569 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 2129 ' ' ASP . . . . . 0.53 ' O ' ' CB ' ' A' 2130 ' ' GLU . 16.3 t0 -62.17 -41.84 98.7 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.413 -0.804 . . . . 0.0 108.856 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2130 ' ' GLU . . . . . 0.635 ' O ' HG21 ' A' 2136 ' ' VAL . 2.5 mt-10 82.86 -51.15 0.17 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.857 -0.527 . . . . 0.0 110.265 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2131 ' ' CYS . . . . . 0.55 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 12.0 p -89.51 -25.05 21.63 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.094 -1.004 . . . . 0.0 109.614 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2132 ' ' LYS . . . . . 0.485 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -85.2 41.11 0.86 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.177 -0.952 . . . . 0.0 109.539 179.655 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -112.65 155.93 43.18 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.295 -0.878 . . . . 0.0 109.2 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2134 ' ' PRO . . . . . 0.457 ' O ' ' HD2' ' A' 2138 ' ' LYS . 1.5 Cg_endo -64.67 -5.46 10.34 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.361 2.041 . . . . 0.0 111.262 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2135 ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' 2162 ' ' ASN . 2.9 t0 -124.18 -29.5 3.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.802 -1.186 . . . . 0.0 110.216 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2136 ' ' VAL . . . . . 0.635 HG21 ' O ' ' A' 2130 ' ' GLU . 61.7 t -77.82 -106.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.041 -1.037 . . . . 0.0 109.146 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2137 ' ' CYS . . . . . 0.508 ' N ' HG12 ' A' 2136 ' ' VAL . 0.1 OUTLIER -84.2 138.66 32.86 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.771 -1.206 . . . . 0.0 108.813 179.526 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 2138 ' ' LYS . . . . . 0.541 ' O ' ' CB ' ' A' 2139 ' ' HIS . 0.5 OUTLIER -139.6 23.86 2.47 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.1 -1.0 . . . . 0.0 110.017 -179.269 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 2139 ' ' HIS . . . . . 0.541 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.1 OUTLIER 162.27 42.36 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.314 -0.867 . . . . 0.0 110.036 179.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -144.76 170.99 26.15 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.256 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2141 ' ' GLN . . . . . 0.416 ' O ' ' HG3' ' A' 2141 ' ' GLN . 5.7 pt20 -92.09 65.78 4.81 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.441 -1.035 . . . . 0.0 109.166 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2142 ' ' CYS . . . . . 0.466 ' HB3' ' SG ' ' A' 2137 ' ' CYS . 21.5 p -62.44 -174.13 0.06 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.368 -0.833 . . . . 0.0 110.274 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2143 ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' 2143 ' ' ILE . 1.7 mp -148.71 83.09 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2144 ' ' ASN . . . . . 0.525 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 2.9 t30 -59.08 113.28 2.03 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.253 -0.904 . . . . 0.0 109.584 -179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2145 ' ' THR . . . . . . . . . . . . . 27.7 p -97.26 -151.79 0.37 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.371 -0.83 . . . . 0.0 109.415 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.76 -79.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 110.123 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -120.64 22.26 8.27 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2148 ' ' SER . . . . . 0.494 ' N ' ' OE2' ' A' 2130 ' ' GLU . 0.1 OUTLIER -144.85 -161.8 1.37 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.229 -1.16 . . . . 0.0 109.214 179.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 2149 ' ' TYR . . . . . 0.555 ' CE2' ' CG1' ' A' 2136 ' ' VAL . 24.3 p90 179.6 -164.21 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.23 -0.919 . . . . 0.0 109.695 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2150 ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' A' 2149 ' ' TYR . 0.1 OUTLIER -166.58 119.45 1.03 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 109.358 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 13.2 m -89.03 106.67 18.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.283 -0.885 . . . . 0.0 109.81 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -119.49 97.7 5.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.321 -0.862 . . . . 0.0 108.909 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2153 ' ' CYS . . . . . 0.524 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -58.22 152.95 39.09 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 121.21 -0.931 . . . . 0.0 109.817 -179.481 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 2154 ' ' PRO . . . . . 0.487 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 2.0 Cg_endo -66.11 -167.12 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.525 2.15 . . . . 0.0 111.023 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 22.1 t80 -90.59 104.72 17.27 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2156 ' ' GLY . . . . . 0.657 ' O ' HG22 ' A' 2167 ' ' THR . . . 131.05 -16.37 5.27 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.045 -2.022 . . . . 0.0 108.045 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2157 ' ' TYR . . . . . 0.524 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 8.2 m-85 -107.39 -169.69 1.58 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.599 -0.942 . . . . 0.0 110.005 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2158 ' ' ILE . . . . . 1.13 HD11 HG23 ' A' 2165 ' ' VAL . 0.1 OUTLIER -151.24 -163.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.594 -0.691 . . . . 0.0 109.398 179.42 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 2159 ' ' LEU . . . . . 0.49 ' N ' HG12 ' A' 2158 ' ' ILE . 25.0 tp -145.51 113.26 6.38 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.413 -0.804 . . . . 0.0 109.297 179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -95.55 60.66 2.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.323 -0.861 . . . . 0.0 109.715 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2161 ' ' GLY . . . . . 0.458 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 88.59 -19.49 36.37 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2162 ' ' ASN . . . . . 0.469 ' HB3' ' O ' ' A' 2135 ' ' ASP . 0.1 OUTLIER 167.98 -34.08 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.361 -1.082 . . . . 0.0 109.357 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -76.49 111.62 12.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 109.15 179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2164 ' ' CYS . . . . . 0.725 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -87.83 144.74 26.43 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.301 -0.874 . . . . 0.0 109.69 -179.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 2165 ' ' VAL . . . . . 1.13 HG23 HD11 ' A' 2158 ' ' ILE . 1.4 m -161.96 -169.29 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.292 -0.88 . . . . 0.0 109.54 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2166 ' ' ASP . . . . . 0.451 ' OD1' ' HA ' ' A' 2185 ' ' ILE . 34.7 t70 -78.54 164.35 24.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.162 -0.961 . . . . 0.0 110.179 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2167 ' ' THR . . . . . 0.657 HG22 ' O ' ' A' 2156 ' ' GLY . 6.0 t -117.25 -173.57 2.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.643 -0.661 . . . . 0.0 109.295 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2168 ' ' ASP . . . . . . . . . . . . . 42.0 t0 -101.6 102.47 13.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.197 -0.94 . . . . 0.0 108.976 179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2169 ' ' GLU . . . . . 0.566 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.3 OUTLIER -75.54 -23.89 56.67 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.276 -0.89 . . . . 0.0 110.359 -179.122 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 2170 ' ' CYS . . . . . 0.449 ' O ' ' SG ' ' A' 2170 ' ' CYS . 2.8 t -59.49 -12.34 6.1 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.784 -1.197 . . . . 0.0 108.805 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.48 -10.74 12.69 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.258 -0.901 . . . . 0.0 110.091 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2172 ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' 2169 ' ' GLU . 25.3 t -74.9 -68.21 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.232 -0.918 . . . . 0.0 109.422 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2173 ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' 2174 ' ' ASN . . . 162.54 78.28 0.03 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2174 ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' 2173 ' ' GLY . 1.0 OUTLIER 44.22 91.9 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.275 -1.132 . . . . 0.0 109.557 -179.78 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 2175 ' ' PRO . . . . . 0.611 ' CB ' ' CE2' ' A' 2188 ' ' PHE . 1.3 Cg_endo -66.68 -21.12 52.29 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.104 1.869 . . . . 0.0 110.238 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2176 ' ' CYS . . . . . 0.546 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -65.44 -60.0 3.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.14 -0.975 . . . . 0.0 109.521 -179.682 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 141.62 -18.09 2.62 Favored Glycine 0 N--CA 1.484 1.864 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -175.74 -31.1 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.662 -0.905 . . . . 0.0 109.731 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2179 ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -60.68 -114.02 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.1 p -145.65 154.73 42.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.397 -1.061 . . . . 0.0 109.096 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2181 ' ' CYS . . . . . 0.521 ' HB3' ' HD2' ' A' 2175 ' ' PRO . 26.1 p -96.08 160.07 14.64 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.072 -1.018 . . . . 0.0 110.621 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2182 ' ' LYS . . . . . 0.568 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 3.6 tptm -146.06 156.65 43.61 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 178.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2183 ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' 2167 ' ' THR . 59.7 t30 -100.68 140.14 35.38 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.6 -1.313 . . . . 0.0 109.443 -179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2184 ' ' VAL . . . . . 0.666 HG12 ' N ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -146.95 168.21 5.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.456 -0.777 . . . . 0.0 109.124 -179.674 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 2185 ' ' ILE . . . . . 0.521 HG23 ' OH ' ' A' 2157 ' ' TYR . 2.3 mp -80.64 140.32 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.0 110.755 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2186 ' ' GLY . . . . . 0.436 ' O ' ' SD ' ' A' 2201 ' ' MET . . . 69.81 9.26 62.26 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2187 ' ' GLY . . . . . 0.588 ' C ' HG12 ' A' 2184 ' ' VAL . . . 165.51 -136.66 4.29 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2188 ' ' PHE . . . . . 0.666 ' N ' HG12 ' A' 2184 ' ' VAL . 1.2 p90 -153.06 179.26 8.86 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.199 -1.177 . . . . 0.0 109.055 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2189 ' ' GLU . . . . . 0.568 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.2 tp10 -131.49 171.27 13.61 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 7.8 p -170.79 148.8 2.98 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.78 -1.2 . . . . 0.0 109.876 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2191 ' ' THR . . . . . . . . . . . . . 10.1 m -118.39 88.94 3.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.908 . . . . 0.0 109.965 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2192 ' ' CYS . . . . . 0.622 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.7 OUTLIER -51.58 -179.48 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.171 -0.956 . . . . 0.0 109.219 179.586 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 2193 ' ' GLU . . . . . 0.492 ' O ' ' C ' ' A' 2194 ' ' GLU . 4.7 tt0 -57.2 118.17 4.8 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2194 ' ' GLU . . . . . 0.492 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.5 OUTLIER -32.21 128.49 0.22 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.409 0.623 . . . . 0.0 111.006 -178.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.41 4.69 8.94 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2196 ' ' PHE . . . . . 0.672 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.9 OUTLIER -117.37 -165.98 1.14 Allowed 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.259 -1.142 . . . . 0.0 110.313 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 2197 ' ' GLU . . . . . 0.535 ' N ' ' CG ' ' A' 2196 ' ' PHE . 4.9 mm-40 -143.86 95.98 5.63 Favored Pre-proline 0 C--N 1.302 -1.475 0 O-C-N 121.635 -0.666 . . . . 0.0 109.388 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2198 ' ' PRO . . . . . 0.672 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 6.8 Cg_endo -65.95 -167.17 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.187 1.925 . . . . 0.0 111.273 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -134.65 -171.33 12.47 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.759 -1.736 . . . . 0.0 108.759 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.1 -76.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.111 1.874 . . . . 0.0 110.822 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2201 ' ' MET . . . . . 0.547 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -140.26 52.2 1.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.485 -0.759 . . . . 0.0 109.997 -179.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 8.8 mmm -126.37 -73.84 0.61 Allowed 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.002 -1.062 . . . . 0.0 110.062 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2203 ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' 2175 ' ' PRO . 7.0 t -170.78 -169.12 0.74 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.218 -0.926 . . . . 0.0 109.746 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A 2204 ' ' CYS . . . . . 0.571 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.0 OUTLIER -112.46 148.03 35.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.47 -0.769 . . . . 0.0 108.974 -179.777 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.43 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -176.37 -34.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.248 -0.908 . . . . 0.0 109.374 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 2.7 t -109.25 78.94 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.911 . . . . 0.0 109.315 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2127 ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' 2127 ' ' ASP . 9.5 t0 -76.81 -28.16 55.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.364 -0.835 . . . . 0.0 109.661 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 3.2 mtt 66.31 117.83 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 109.629 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2129 ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' A' 2132 ' ' LYS . 5.2 t0 -68.28 -40.3 81.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.43 -0.794 . . . . 0.0 109.229 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2130 ' ' GLU . . . . . 0.585 ' O ' HG21 ' A' 2136 ' ' VAL . 2.1 mt-10 83.03 -61.29 0.13 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.757 -0.589 . . . . 0.0 110.831 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2131 ' ' CYS . . . . . 0.772 ' HA ' HG11 ' A' 2136 ' ' VAL . 29.5 p -85.45 -5.78 59.26 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.961 -1.087 . . . . 0.0 110.047 -179.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2132 ' ' LYS . . . . . 0.541 ' HB3' ' HB3' ' A' 2129 ' ' ASP . 13.7 tttt -94.89 3.18 55.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.139 -0.976 . . . . 0.0 109.34 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2133 ' ' GLU . . . . . 0.494 ' HB2' HG23 ' A' 2136 ' ' VAL . 5.3 mt-10 -69.61 147.24 96.52 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 120.99 -1.069 . . . . 0.0 109.188 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2134 ' ' PRO . . . . . 0.529 ' HA ' ' CG ' ' A' 2138 ' ' LYS . 1.4 Cg_endo -63.9 -6.13 10.44 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.278 1.985 . . . . 0.0 110.935 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -116.16 -3.73 12.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.983 -1.073 . . . . 0.0 110.078 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2136 ' ' VAL . . . . . 0.772 HG11 ' HA ' ' A' 2131 ' ' CYS . 76.9 t -96.86 -101.03 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.037 -1.04 . . . . 0.0 109.788 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2137 ' ' CYS . . . . . 0.65 ' N ' HG12 ' A' 2136 ' ' VAL . 0.5 OUTLIER -73.27 -72.58 0.25 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.868 -1.145 . . . . 0.0 109.523 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 2138 ' ' LYS . . . . . 0.529 ' CG ' ' HA ' ' A' 2134 ' ' PRO . 1.1 mtmt 63.53 100.57 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.296 -0.878 . . . . 0.0 109.805 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2139 ' ' HIS . . . . . 0.509 ' CB ' ' O ' ' A' 2138 ' ' LYS . 7.7 m-70 76.54 26.68 0.85 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.271 -0.893 . . . . 0.0 109.579 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -132.34 166.82 23.23 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2141 ' ' GLN . . . . . 0.521 ' O ' ' CG ' ' A' 2152 ' ' GLU . 0.9 OUTLIER -103.86 71.51 1.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -1.17 . . . . 0.0 109.022 179.803 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 2142 ' ' CYS . . . . . 0.47 ' HB3' ' SG ' ' A' 2137 ' ' CYS . 25.4 p -70.17 -164.33 0.08 Allowed 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.865 0.841 . . . . 0.0 110.449 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2143 ' ' ILE . . . . . 0.454 ' O ' HG22 ' A' 2143 ' ' ILE . 2.5 mp -151.68 84.58 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2144 ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 3.2 t30 -61.74 113.64 2.86 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.54 -0.725 . . . . 0.0 110.362 -178.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2145 ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' 2146 ' ' ASP . 16.5 p -101.1 -157.2 0.59 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.531 -0.731 . . . . 0.0 109.324 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2146 ' ' ASP . . . . . 0.429 ' N ' ' OD1' ' A' 2146 ' ' ASP . 0.6 OUTLIER -48.37 -94.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.294 -0.879 . . . . 0.0 109.625 -179.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -108.04 16.99 35.57 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2148 ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -133.69 -166.37 1.77 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.202 -1.175 . . . . 0.0 109.165 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2149 ' ' TYR . . . . . 0.558 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 40.5 p90 -176.4 -176.86 0.8 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.278 -0.889 . . . . 0.0 109.655 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2150 ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -145.09 134.9 23.58 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -102.25 119.67 39.2 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.086 -1.009 . . . . 0.0 109.937 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2152 ' ' GLU . . . . . 0.521 ' CG ' ' O ' ' A' 2141 ' ' GLN . 0.8 OUTLIER -134.68 178.64 6.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 109.389 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 2153 ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -142.09 158.34 61.84 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.195 -0.941 . . . . 0.0 109.302 -179.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 2154 ' ' PRO . . . . . 0.501 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.8 Cg_endo -62.93 -171.08 0.11 Allowed 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.457 2.104 . . . . 0.0 111.52 -178.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.18 102.47 14.49 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.39 -16.7 5.4 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 107.795 -2.122 . . . . 0.0 107.795 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2157 ' ' TYR . . . . . 0.537 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 5.2 m-85 -105.25 -170.44 1.75 Allowed 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.682 -0.893 . . . . 0.0 109.898 -179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2158 ' ' ILE . . . . . 0.638 HD13 ' N ' ' A' 2158 ' ' ILE . 0.2 OUTLIER -158.91 -161.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.624 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 2159 ' ' LEU . . . . . 0.505 ' N ' HG12 ' A' 2158 ' ' ILE . 26.3 tp -136.55 123.34 21.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.831 . . . . 0.0 109.499 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -96.39 51.78 1.21 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.359 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 90.36 -29.62 6.53 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2162 ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' 2136 ' ' VAL . 2.8 p-10 -171.13 -48.84 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.153 -1.204 . . . . 0.0 109.331 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2163 ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' 2137 ' ' CYS . 53.8 tt0 -72.57 121.78 20.27 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.543 -0.723 . . . . 0.0 109.273 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2164 ' ' CYS . . . . . 0.632 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -90.94 138.88 31.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 109.593 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 2165 ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' 2164 ' ' CYS . 0.7 OUTLIER -159.84 -167.79 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.941 . . . . 0.0 109.297 179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 2166 ' ' ASP . . . . . 0.469 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 8.7 t70 -89.97 155.73 18.91 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.975 -1.078 . . . . 0.0 109.786 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2167 ' ' THR . . . . . 0.607 HG23 ' OE1' ' A' 2169 ' ' GLU . 7.2 t -90.99 -169.49 2.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 109.449 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2168 ' ' ASP . . . . . 0.478 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 64.9 t0 -109.15 102.44 11.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.218 -0.926 . . . . 0.0 109.836 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2169 ' ' GLU . . . . . 0.613 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.5 OUTLIER -74.95 -32.65 61.79 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.361 -0.837 . . . . 0.0 109.066 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 2170 ' ' CYS . . . . . 0.538 ' HB2' ' N ' ' A' 2182 ' ' LYS . 0.6 OUTLIER -64.6 -11.55 36.1 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.776 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.35 5.22 13.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.845 . . . . 0.0 109.383 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 40.5 t -103.61 -65.88 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.355 -0.84 . . . . 0.0 109.402 -179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2173 ' ' GLY . . . . . . . . . . . . . . . -153.53 -135.18 2.1 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2174 ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -122.85 102.69 37.85 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.316 -1.109 . . . . 0.0 109.07 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2175 ' ' PRO . . . . . 0.645 ' CB ' ' CE2' ' A' 2188 ' ' PHE . 3.4 Cg_endo -69.07 -18.58 40.19 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.695 1.597 . . . . 0.0 109.839 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2176 ' ' CYS . . . . . 0.578 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -69.77 -50.36 44.05 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.127 -0.983 . . . . 0.0 109.653 -179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 124.75 -17.94 7.2 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -166.37 -37.88 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.366 -1.079 . . . . 0.0 110.12 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2179 ' ' GLY . . . . . 0.585 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -63.95 -120.55 0.01 OUTLIER Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.4 p -141.55 161.29 38.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.54 -0.976 . . . . 0.0 109.198 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2181 ' ' CYS . . . . . 0.572 ' HB3' ' HD2' ' A' 2175 ' ' PRO . 26.7 p -97.81 160.76 14.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.043 -1.036 . . . . 0.0 110.593 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2182 ' ' LYS . . . . . 0.576 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 2.5 tppt? -145.46 155.67 43.26 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2183 ' ' ASN . . . . . 0.478 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 32.4 t30 -92.71 137.34 32.45 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 120.52 -1.363 . . . . 0.0 110.203 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2184 ' ' VAL . . . . . 0.847 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -140.92 -167.63 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 2185 ' ' ILE . . . . . 0.695 ' N ' HG13 ' A' 2184 ' ' VAL . 1.5 mp -107.17 141.42 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.106 -0.996 . . . . 0.0 110.461 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 64.7 13.48 56.11 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2187 ' ' GLY . . . . . 0.566 ' C ' HG12 ' A' 2184 ' ' VAL . . . 167.24 -118.85 0.81 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.309 -1.517 . . . . 0.0 109.309 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2188 ' ' PHE . . . . . 0.847 ' N ' HG12 ' A' 2184 ' ' VAL . 1.5 p90 -171.84 -179.19 2.38 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.367 -1.078 . . . . 0.0 109.497 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2189 ' ' GLU . . . . . 0.576 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.5 OUTLIER -128.87 169.19 14.9 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.387 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 8.9 p -170.53 147.66 2.96 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.789 -1.194 . . . . 0.0 109.749 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2191 ' ' THR . . . . . . . . . . . . . 25.2 m -118.18 90.97 3.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 0.0 109.644 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2192 ' ' CYS . . . . . 0.631 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.8 OUTLIER -52.99 -179.88 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.031 -1.043 . . . . 0.0 108.783 179.587 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 2193 ' ' GLU . . . . . 0.499 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.6 tt0 -52.45 112.76 0.87 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2194 ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -31.34 125.73 0.21 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.439 0.637 . . . . 0.0 111.136 -178.601 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.53 11.18 6.17 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.721 -1.351 . . . . 0.0 109.721 179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2196 ' ' PHE . . . . . 0.686 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.8 p90 -118.33 -162.34 0.88 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.135 -1.215 . . . . 0.0 110.489 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2197 ' ' GLU . . . . . 0.5 ' N ' ' CG ' ' A' 2196 ' ' PHE . 18.4 mt-10 -142.28 92.54 7.45 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 121.434 -0.792 . . . . 0.0 110.058 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2198 ' ' PRO . . . . . 0.686 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.0 Cg_endo -67.05 -160.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.303 2.002 . . . . 0.0 111.273 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -140.21 -175.74 14.63 Favored Glycine 0 N--CA 1.486 1.991 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2200 ' ' PRO . . . . . 0.455 ' O ' ' OE1' ' A' 2189 ' ' GLU . 2.0 Cg_endo -62.14 -74.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 121.702 1.601 . . . . 0.0 110.61 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2201 ' ' MET . . . . . 0.475 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -143.44 46.47 1.5 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.213 -0.929 . . . . 0.0 109.458 -179.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 2202 ' ' MET . . . . . 0.432 ' O ' ' HB ' ' A' 2203 ' ' THR . 0.1 OUTLIER -116.95 -65.59 1.17 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.303 -0.873 . . . . 0.0 109.779 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 2203 ' ' THR . . . . . 0.432 ' HB ' ' O ' ' A' 2202 ' ' MET . 13.3 t -179.9 -171.45 0.18 Allowed 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A 2204 ' ' CYS . . . . . 0.581 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.0 OUTLIER -112.44 143.51 43.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.086 -1.009 . . . . 0.0 109.269 -179.552 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.495 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2125 ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' 2126 ' ' VAL . . . -125.36 29.48 6.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.895 . . . . 0.0 109.562 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2126 ' ' VAL . . . . . 0.428 ' O ' ' O ' ' A' 2125 ' ' ALA . 45.3 t 57.25 106.49 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.268 -0.895 . . . . 0.0 109.457 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2127 ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' 2128 ' ' MET . 2.8 p30 -83.66 -161.25 0.5 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.324 -0.86 . . . . 0.0 109.272 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2128 ' ' MET . . . . . 0.422 ' C ' ' O ' ' A' 2127 ' ' ASP . 0.0 OUTLIER -45.15 116.96 1.22 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.136 -0.978 . . . . 0.0 109.254 179.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 2129 ' ' ASP . . . . . 0.62 ' O ' ' HB2' ' A' 2130 ' ' GLU . 4.5 t0 -65.62 -27.48 68.42 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.349 -0.844 . . . . 0.0 108.8 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2130 ' ' GLU . . . . . 0.62 ' HB2' ' O ' ' A' 2129 ' ' ASP . 1.8 mp0 75.81 -57.52 0.57 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 120.92 0.391 . . . . 0.0 111.45 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2131 ' ' CYS . . . . . 0.567 ' HB2' ' CB ' ' A' 2137 ' ' CYS . 0.5 OUTLIER -84.43 -19.31 33.67 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.765 -1.209 . . . . 0.0 109.974 -178.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 2132 ' ' LYS . . . . . 0.53 ' HB3' ' HB3' ' A' 2129 ' ' ASP . 4.4 tttt -68.4 -9.92 51.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.13 -0.981 . . . . 0.0 109.838 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2133 ' ' GLU . . . . . 0.929 ' HB2' HG23 ' A' 2136 ' ' VAL . 6.7 mt-10 -69.13 147.62 97.54 Favored Pre-proline 0 C--N 1.302 -1.491 0 O-C-N 121.329 -0.857 . . . . 0.0 109.921 -179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2134 ' ' PRO . . . . . 0.497 ' O ' ' HD2' ' A' 2138 ' ' LYS . 3.8 Cg_endo -69.27 3.25 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.499 2.132 . . . . 0.0 111.17 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2135 ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' 2162 ' ' ASN . 0.6 OUTLIER -127.08 -6.08 6.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.638 -1.289 . . . . 0.0 110.3 -179.551 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 2136 ' ' VAL . . . . . 0.929 HG23 ' HB2' ' A' 2133 ' ' GLU . 2.4 t -102.31 -143.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.866 -1.146 . . . . 0.0 108.117 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2137 ' ' CYS . . . . . 0.567 ' CB ' ' HB2' ' A' 2131 ' ' CYS . 2.6 t -49.97 128.94 19.75 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.548 -1.345 . . . . 0.0 108.336 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2138 ' ' LYS . . . . . 0.516 ' O ' ' CB ' ' A' 2139 ' ' HIS . 2.9 mtpt -135.4 28.8 3.34 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.119 -0.988 . . . . 0.0 110.353 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2139 ' ' HIS . . . . . 0.516 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.1 OUTLIER 162.21 45.43 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.311 -0.868 . . . . 0.0 109.698 179.582 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -153.92 179.76 29.91 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -88.8 82.62 6.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -1.135 . . . . 0.0 109.171 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2142 ' ' CYS . . . . . 0.525 ' C ' HD13 ' A' 2143 ' ' ILE . 21.4 p -78.67 147.63 33.46 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.366 -0.834 . . . . 0.0 110.032 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2143 ' ' ILE . . . . . 0.525 HD13 ' C ' ' A' 2142 ' ' CYS . 5.0 mm -113.37 129.03 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2144 ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' 2129 ' ' ASP . 4.0 t-20 -84.16 103.47 13.4 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 110.545 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2145 ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' 2146 ' ' ASP . 4.1 p -94.45 -167.19 1.61 Allowed 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2146 ' ' ASP . . . . . 0.456 ' O ' ' O ' ' A' 2145 ' ' THR . 0.4 OUTLIER -45.78 -93.85 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.232 -0.917 . . . . 0.0 109.342 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -108.12 -7.6 30.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2148 ' ' SER . . . . . 0.438 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.2 OUTLIER -100.24 -162.61 0.96 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.28 -1.129 . . . . 0.0 109.471 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 2149 ' ' TYR . . . . . 0.598 ' CD2' ' HB3' ' A' 2130 ' ' GLU . 29.6 p90 -164.85 -171.12 2.16 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.193 -0.942 . . . . 0.0 109.577 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2150 ' ' ARG . . . . . 0.531 ' CG ' ' O ' ' A' 2149 ' ' TYR . 18.0 mtt180 -160.55 104.5 1.41 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.465 -0.772 . . . . 0.0 109.412 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 41.9 t -86.68 78.82 9.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.351 -0.843 . . . . 0.0 109.482 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.86 98.12 11.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.227 -0.921 . . . . 0.0 109.209 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2153 ' ' CYS . . . . . 0.546 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -58.08 157.46 16.29 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.335 -0.853 . . . . 0.0 109.748 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 2154 ' ' PRO . . . . . 0.499 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.2 Cg_endo -65.22 -166.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.703 2.269 . . . . 0.0 111.278 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 8.4 t80 -90.43 102.34 15.08 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.82 -15.4 5.42 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 107.742 -2.143 . . . . 0.0 107.742 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2157 ' ' TYR . . . . . 0.546 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 9.0 m-85 -109.3 -171.19 1.79 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.647 -0.913 . . . . 0.0 109.724 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2158 ' ' ILE . . . . . 0.741 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -157.34 -161.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.641 -0.662 . . . . 0.0 109.597 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 2159 ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' 2159 ' ' LEU . 15.5 tp -134.35 120.72 20.23 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.326 -0.859 . . . . 0.0 109.67 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -97.1 57.47 1.47 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.308 -0.87 . . . . 0.0 109.2 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2161 ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 86.94 -14.0 57.96 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2162 ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' 2135 ' ' ASP . 1.6 m-20 165.44 -41.81 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.253 -1.145 . . . . 0.0 109.683 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -73.63 118.38 16.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.372 -0.83 . . . . 0.0 109.223 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2164 ' ' CYS . . . . . 0.776 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -85.24 138.78 32.12 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.26 -0.9 . . . . 0.0 109.642 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 2165 ' ' VAL . . . . . 0.776 HG13 ' O ' ' A' 2164 ' ' CYS . 1.6 m -164.63 -170.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 0.0 109.07 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2166 ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' A' 2184 ' ' VAL . 3.0 t70 -89.74 147.66 23.71 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.991 -1.068 . . . . 0.0 109.465 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2167 ' ' THR . . . . . 0.602 ' HB ' ' CG2' ' A' 2158 ' ' ILE . 6.8 t -89.72 -173.72 4.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.363 -0.836 . . . . 0.0 109.111 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2168 ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' 2171 ' ' SER . 44.5 t0 -98.94 97.02 8.24 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.266 -0.896 . . . . 0.0 108.649 178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2169 ' ' GLU . . . . . 0.577 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.6 OUTLIER -72.58 -31.18 65.03 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.185 -0.947 . . . . 0.0 109.443 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 2170 ' ' CYS . . . . . 0.522 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 3.3 t -70.59 -4.7 24.49 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.301 -0.874 . . . . 0.0 108.894 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2171 ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.1 OUTLIER -65.62 -8.52 20.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.831 -1.168 . . . . 0.0 109.413 179.572 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 24.9 t -83.11 -71.95 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.156 -0.965 . . . . 0.0 109.571 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2173 ' ' GLY . . . . . 0.459 ' O ' ' SG ' ' A' 2181 ' ' CYS . . . -172.72 -70.21 0.05 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2174 ' ' ASN . . . . . 0.549 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 27.5 p-10 -171.47 95.58 0.41 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.221 -1.164 . . . . 0.0 109.021 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2175 ' ' PRO . . . . . 0.611 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.5 Cg_endo -63.98 -19.75 66.96 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 121.915 1.743 . . . . 0.0 110.253 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2176 ' ' CYS . . . . . 0.523 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -56.04 -58.69 6.86 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.052 -1.03 . . . . 0.0 108.239 179.697 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 148.1 -18.21 1.37 Allowed Glycine 0 N--CA 1.483 1.826 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2178 ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.2 OUTLIER -169.48 -32.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -1.131 . . . . 0.0 110.297 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 2179 ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -61.18 -115.6 0.01 OUTLIER Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2180 ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' 2190 ' ' CYS . 1.1 p -151.3 152.51 33.29 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -1.07 . . . . 0.0 109.486 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2181 ' ' CYS . . . . . 0.59 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 20.7 p -87.83 164.29 15.99 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.974 -1.079 . . . . 0.0 110.896 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2182 ' ' LYS . . . . . 0.598 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.0 OUTLIER -145.16 158.97 43.68 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.467 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 2183 ' ' ASN . . . . . 0.471 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 57.2 t30 -99.72 129.9 45.88 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.446 -1.408 . . . . 0.0 109.735 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2184 ' ' VAL . . . . . 0.793 HG12 ' N ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -140.08 -170.3 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.711 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 2185 ' ' ILE . . . . . 0.544 ' N ' HG13 ' A' 2184 ' ' VAL . 4.6 mp -101.6 136.78 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.96 -1.087 . . . . 0.0 110.448 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 76.33 -2.23 57.97 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2187 ' ' GLY . . . . . 0.533 ' C ' ' CD1' ' A' 2188 ' ' PHE . . . 178.27 -113.67 0.42 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2188 ' ' PHE . . . . . 0.793 ' N ' HG12 ' A' 2184 ' ' VAL . 3.0 p90 -176.19 176.42 1.71 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.384 -1.068 . . . . 0.0 108.876 -179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2189 ' ' GLU . . . . . 0.598 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 8.1 tt0 -124.26 133.67 53.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.125 -0.984 . . . . 0.0 108.685 178.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2190 ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' 2180 ' ' THR . 20.7 p -128.16 136.99 51.88 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.906 -1.121 . . . . 0.0 109.869 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2191 ' ' THR . . . . . 0.491 ' O ' ' HA3' ' A' 2179 ' ' GLY . 17.9 m -109.86 87.95 2.63 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.38 -0.825 . . . . 0.0 109.243 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2192 ' ' CYS . . . . . 0.622 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 1.2 m -48.91 -179.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.414 -0.804 . . . . 0.0 109.167 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2193 ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' 2194 ' ' GLU . 20.5 tt0 -56.26 122.35 11.6 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2194 ' ' GLU . . . . . 0.455 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -36.7 130.17 0.76 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.616 -0.678 . . . . 0.0 110.585 -178.886 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.31 0.02 10.44 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.268 -1.533 . . . . 0.0 109.268 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2196 ' ' PHE . . . . . 0.683 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.2 p90 -112.1 -162.47 0.8 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.277 -1.131 . . . . 0.0 110.015 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2197 ' ' GLU . . . . . 0.551 ' N ' ' CG ' ' A' 2196 ' ' PHE . 9.3 mt-10 -145.96 94.33 5.01 Favored Pre-proline 0 C--N 1.303 -1.448 0 O-C-N 121.429 -0.795 . . . . 0.0 109.872 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2198 ' ' PRO . . . . . 0.683 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 7.9 Cg_endo -67.65 -158.78 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.444 2.096 . . . . 0.0 111.355 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -146.44 -167.4 12.78 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.302 -1.919 . . . . 0.0 108.302 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -63.13 -79.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 121.874 1.716 . . . . 0.0 110.634 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 2201 ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' 2188 ' ' PHE . 5.0 ptp -136.93 62.31 1.6 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.209 -0.932 . . . . 0.0 109.823 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -127.69 -86.1 0.58 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.236 -0.915 . . . . 0.0 109.933 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2203 ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' 2175 ' ' PRO . 15.1 t -175.7 -170.42 0.4 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.387 -0.821 . . . . 0.0 108.961 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2204 ' ' CYS . . . . . 0.54 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 0.7 OUTLIER -61.66 135.98 57.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.011 -1.055 . . . . 0.0 108.972 179.768 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A 2205 ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' 2197 ' ' GLU . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.081 -0.962 . . . . 0.0 109.579 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 13.4 t . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -160.64 -86.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.933 . . . . 0.0 109.409 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 1.1 t -77.63 155.65 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.236 -0.915 . . . . 0.0 109.391 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2127 ' ' ASP . . . . . . . . . . . . . 39.8 t0 -87.84 54.55 3.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.199 -0.938 . . . . 0.0 109.516 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2128 ' ' MET . . . . . 0.419 ' O ' ' HG3' ' A' 2130 ' ' GLU . 2.9 mtt -53.54 147.21 11.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 109.559 179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2129 ' ' ASP . . . . . 0.537 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 19.3 t0 -61.64 -44.41 97.02 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2130 ' ' GLU . . . . . 0.737 ' O ' HG21 ' A' 2136 ' ' VAL . 1.3 mt-10 80.3 -43.96 0.25 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.925 -0.484 . . . . 0.0 111.066 178.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2131 ' ' CYS . . . . . 0.512 ' O ' ' HB2' ' A' 2137 ' ' CYS . 10.4 p -91.0 -42.19 10.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.66 -1.275 . . . . 0.0 110.111 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2132 ' ' LYS . . . . . 0.507 ' N ' ' SG ' ' A' 2131 ' ' CYS . 0.0 OUTLIER -67.27 -2.4 5.91 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.993 -1.067 . . . . 0.0 110.52 -179.571 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 2133 ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -68.75 153.56 95.76 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 120.963 -1.086 . . . . 0.0 109.459 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2134 ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -65.52 -3.81 8.43 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.533 2.155 . . . . 0.0 111.101 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2135 ' ' ASP . . . . . 0.848 ' OD1' HG23 ' A' 2136 ' ' VAL . 53.6 p-10 -119.26 3.13 11.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.861 -1.15 . . . . 0.0 110.346 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2136 ' ' VAL . . . . . 0.848 HG23 ' OD1' ' A' 2135 ' ' ASP . 19.1 t -121.82 -119.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.827 -1.171 . . . . 0.0 109.785 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2137 ' ' CYS . . . . . 0.514 ' N ' HG12 ' A' 2136 ' ' VAL . 0.1 OUTLIER -50.78 -56.19 13.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.624 -1.298 . . . . 0.0 109.488 -179.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 2138 ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' 2137 ' ' CYS . 3.8 mttt 72.64 -81.91 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.4 -0.813 . . . . 0.0 109.866 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2139 ' ' HIS . . . . . 0.515 ' O ' ' HB3' ' A' 2164 ' ' CYS . 21.2 m80 -115.27 58.87 0.71 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.052 -1.03 . . . . 0.0 110.186 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -141.7 -166.74 10.97 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -134.04 93.75 3.14 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -1.153 . . . . 0.0 109.037 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2142 ' ' CYS . . . . . 0.878 ' C ' HD12 ' A' 2143 ' ' ILE . 12.8 p -91.52 -152.25 0.29 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.235 -0.916 . . . . 0.0 110.491 -179.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2143 ' ' ILE . . . . . 0.878 HD12 ' C ' ' A' 2142 ' ' CYS . 2.9 mp -148.46 90.06 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2144 ' ' ASN . . . . . 0.537 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 30.2 t-20 -39.33 108.5 0.09 Allowed 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.404 0.621 . . . . 0.0 110.826 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2145 ' ' THR . . . . . 0.416 ' OG1' ' C ' ' A' 2148 ' ' SER . 0.1 OUTLIER -98.67 170.35 8.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.401 -0.812 . . . . 0.0 108.994 179.302 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.92 -84.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.332 -0.855 . . . . 0.0 109.797 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -107.08 50.83 0.77 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2148 ' ' SER . . . . . 0.466 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.1 OUTLIER -178.06 -162.68 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -1.153 . . . . 0.0 109.714 179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 2149 ' ' TYR . . . . . 0.642 ' CE2' HG11 ' A' 2136 ' ' VAL . 42.0 p90 -169.77 -169.49 0.9 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.454 -0.779 . . . . 0.0 109.737 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2150 ' ' ARG . . . . . 0.456 ' C ' ' HB2' ' A' 2142 ' ' CYS . 0.4 OUTLIER -144.18 -160.78 1.17 Allowed 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.61 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 2151 ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' 2150 ' ' ARG . 1.2 m -169.77 69.9 0.06 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.072 -1.017 . . . . 0.0 109.66 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -89.89 137.71 32.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.408 -0.807 . . . . 0.0 109.151 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2153 ' ' CYS . . . . . 0.496 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -112.07 158.54 36.61 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.192 -0.943 . . . . 0.0 109.501 -179.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 2154 ' ' PRO . . . . . 0.485 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 2.7 Cg_endo -61.61 -176.03 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.68 2.253 . . . . 0.0 111.817 -178.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 12.7 t80 -82.29 103.15 11.67 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.54 -19.03 5.11 Favored Glycine 0 N--CA 1.484 1.879 0 N-CA-C 107.119 -2.393 . . . . 0.0 107.119 -177.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2157 ' ' TYR . . . . . 0.525 ' C ' HG23 ' A' 2158 ' ' ILE . 18.2 m-85 -108.2 176.42 5.13 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.824 -0.81 . . . . 0.0 109.601 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2158 ' ' ILE . . . . . 0.737 HD13 ' N ' ' A' 2158 ' ' ILE . 0.1 OUTLIER -158.08 -163.74 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.658 -0.651 . . . . 0.0 109.403 -179.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 2159 ' ' LEU . . . . . 0.449 HD11 ' O ' ' A' 2162 ' ' ASN . 19.4 tp -131.34 122.78 26.97 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.435 -0.79 . . . . 0.0 109.481 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -93.47 43.01 1.11 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.299 -0.875 . . . . 0.0 109.129 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2161 ' ' GLY . . . . . 0.451 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 97.42 -8.94 64.63 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2162 ' ' ASN . . . . . 0.532 ' ND2' ' HA ' ' A' 2136 ' ' VAL . 1.3 m-20 167.93 -43.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -1.167 . . . . 0.0 109.635 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -79.42 118.83 21.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.206 -0.934 . . . . 0.0 109.376 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2164 ' ' CYS . . . . . 0.816 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -88.53 137.77 32.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.261 -0.899 . . . . 0.0 109.418 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 2165 ' ' VAL . . . . . 0.816 HG13 ' O ' ' A' 2164 ' ' CYS . 1.8 m -166.43 -166.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.374 -0.829 . . . . 0.0 108.92 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2166 ' ' ASP . . . . . 0.425 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 0.7 OUTLIER -83.82 139.18 32.84 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.733 -1.23 . . . . 0.0 109.453 179.83 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 2167 ' ' THR . . . . . 0.636 ' HB ' HD12 ' A' 2158 ' ' ILE . 9.9 t -97.44 178.31 5.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.354 -0.841 . . . . 0.0 109.362 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2168 ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' 2171 ' ' SER . 51.3 t0 -88.55 96.04 10.47 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.164 -0.96 . . . . 0.0 109.024 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2169 ' ' GLU . . . . . 0.59 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.4 OUTLIER -66.67 -34.14 77.21 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.296 -0.877 . . . . 0.0 109.228 179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 2170 ' ' CYS . . . . . 0.459 ' O ' ' SG ' ' A' 2170 ' ' CYS . 1.7 t -68.67 -9.08 48.0 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.327 -0.858 . . . . 0.0 108.753 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2171 ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -78.32 5.84 9.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.372 -0.83 . . . . 0.0 110.574 -179.176 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 5.6 t -112.3 -76.93 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.903 -1.123 . . . . 0.0 109.87 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2173 ' ' GLY . . . . . 0.469 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -150.7 137.53 6.15 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2174 ' ' ASN . . . . . 0.629 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 23.2 p-10 -47.03 104.51 0.41 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.312 -1.111 . . . . 0.0 109.969 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2175 ' ' PRO . . . . . 0.583 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 1.7 Cg_endo -70.42 -23.55 27.66 Favored 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 121.879 1.719 . . . . 0.0 109.763 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2176 ' ' CYS . . . . . 0.554 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -47.33 -30.97 3.52 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.395 -0.815 . . . . 0.0 109.492 -179.585 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 114.49 -23.47 12.21 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -169.3 -34.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.606 -0.937 . . . . 0.0 109.791 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2179 ' ' GLY . . . . . 0.614 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -62.47 -127.81 0.01 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.3 p -134.64 156.76 48.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.601 -0.941 . . . . 0.0 109.549 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2181 ' ' CYS . . . . . 0.629 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 14.6 p -94.12 163.06 13.62 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.199 1.0 . . . . 0.0 111.258 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2182 ' ' LYS . . . . . 0.586 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 5.9 tttp -143.06 156.9 44.92 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2183 ' ' ASN . . . . . 0.408 ' N ' ' HG3' ' A' 2182 ' ' LYS . 60.9 t30 -99.31 133.09 44.12 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.3 -1.5 . . . . 0.0 109.967 -179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2184 ' ' VAL . . . . . 0.81 HG12 ' N ' ' A' 2188 ' ' PHE . 0.4 OUTLIER -140.37 -176.77 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 O-C-N 121.635 -0.666 . . . . 0.0 109.227 -179.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 2185 ' ' ILE . . . . . 0.457 ' N ' HG13 ' A' 2184 ' ' VAL . 1.9 mp -95.8 143.51 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.117 -0.989 . . . . 0.0 110.131 -179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 65.07 12.33 54.59 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2187 ' ' GLY . . . . . 0.627 ' C ' HG12 ' A' 2184 ' ' VAL . . . 165.12 -129.25 1.92 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2188 ' ' PHE . . . . . 0.81 ' N ' HG12 ' A' 2184 ' ' VAL . 1.4 p90 -164.11 -179.32 6.1 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.3 -1.118 . . . . 0.0 108.81 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2189 ' ' GLU . . . . . 0.586 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.2 OUTLIER -125.48 174.2 8.38 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.39 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 1.8 p -171.61 147.71 2.36 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.769 -1.207 . . . . 0.0 109.81 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2191 ' ' THR . . . . . 0.474 ' O ' ' O ' ' A' 2192 ' ' CYS . 13.6 m -123.06 89.9 3.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.0 109.898 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2192 ' ' CYS . . . . . 0.614 ' HA ' ' HA3' ' A' 2179 ' ' GLY . 0.8 OUTLIER -48.91 -179.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.341 -0.85 . . . . 0.0 109.32 179.8 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 2193 ' ' GLU . . . . . 0.462 ' O ' ' C ' ' A' 2194 ' ' GLU . 3.3 tt0 -61.12 125.43 23.7 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2194 ' ' GLU . . . . . 0.462 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -34.86 129.76 0.43 Allowed 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.344 0.592 . . . . 0.0 110.842 -179.244 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.21 5.39 8.77 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.396 -1.482 . . . . 0.0 109.396 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2196 ' ' PHE . . . . . 0.672 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.9 OUTLIER -121.5 -163.5 1.05 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.289 -1.124 . . . . 0.0 110.195 -179.724 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 2197 ' ' GLU . . . . . 0.584 ' N ' ' CG ' ' A' 2196 ' ' PHE . 24.4 mt-10 -148.15 98.07 3.8 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 121.619 -0.675 . . . . 0.0 109.428 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2198 ' ' PRO . . . . . 0.672 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.8 Cg_endo -69.01 -166.31 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.339 2.026 . . . . 0.0 111.597 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -135.84 -170.35 12.04 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.781 -1.728 . . . . 0.0 108.781 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.17 -83.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.21 1.94 . . . . 0.0 110.994 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2201 ' ' MET . . . . . 0.64 ' HG2' HG11 ' A' 2184 ' ' VAL . 8.4 mtt -132.77 52.22 2.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.991 -1.068 . . . . 0.0 109.975 -179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2202 ' ' MET . . . . . 0.451 ' O ' ' HB ' ' A' 2203 ' ' THR . 1.0 OUTLIER -122.98 -71.23 0.73 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.21 -0.931 . . . . 0.0 109.791 -179.775 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 2203 ' ' THR . . . . . 0.451 ' HB ' ' O ' ' A' 2202 ' ' MET . 11.7 t 179.33 -167.82 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.458 -0.776 . . . . 0.0 109.048 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A 2204 ' ' CYS . . . . . 0.554 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -111.52 150.17 30.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.095 -1.003 . . . . 0.0 109.215 -179.669 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 117.896 -1.049 . . . . 0.0 109.572 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -176.08 50.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 109.401 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.43 159.88 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.231 -0.918 . . . . 0.0 109.38 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2127 ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' 2128 ' ' MET . 9.6 t70 -85.51 97.51 10.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.281 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2128 ' ' MET . . . . . 0.467 ' O ' ' HG3' ' A' 2130 ' ' GLU . 0.3 OUTLIER -41.37 120.07 1.34 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.458 -0.776 . . . . 0.0 109.587 179.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2129 ' ' ASP . . . . . 0.59 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 1.3 p30 -65.78 -39.08 90.62 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2130 ' ' GLU . . . . . 0.794 ' O ' HG21 ' A' 2136 ' ' VAL . 1.4 mt-10 80.44 -42.86 0.22 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 122.015 -0.428 . . . . 0.0 111.292 177.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2131 ' ' CYS . . . . . 0.599 ' HA ' HG11 ' A' 2136 ' ' VAL . 17.5 p -90.82 27.16 1.86 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 120.922 -1.111 . . . . 0.0 110.204 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2132 ' ' LYS . . . . . 0.525 ' N ' ' OD1' ' A' 2129 ' ' ASP . 0.6 OUTLIER -131.94 -6.25 3.53 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.243 -0.91 . . . . 0.0 109.728 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2133 ' ' GLU . . . . . 0.468 ' HB3' ' HD2' ' A' 2134 ' ' PRO . 5.8 mt-10 -70.03 158.74 86.62 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.141 -0.974 . . . . 0.0 109.323 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2134 ' ' PRO . . . . . 0.507 ' O ' ' HD2' ' A' 2138 ' ' LYS . 2.8 Cg_endo -67.27 -1.53 6.54 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.379 2.053 . . . . 0.0 110.804 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -123.07 4.65 9.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.8 -1.188 . . . . 0.0 110.088 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2136 ' ' VAL . . . . . 0.794 HG21 ' O ' ' A' 2130 ' ' GLU . 55.0 t -107.46 -107.01 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.869 -1.145 . . . . 0.0 110.116 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2137 ' ' CYS . . . . . 0.531 ' N ' HG12 ' A' 2136 ' ' VAL . 1.3 m -56.21 -77.39 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.796 -1.19 . . . . 0.0 109.599 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2138 ' ' LYS . . . . . 0.58 ' O ' ' CG ' ' A' 2139 ' ' HIS . 0.1 OUTLIER 68.7 3.05 3.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.584 -0.698 . . . . 0.0 111.12 179.188 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2139 ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' 2138 ' ' LYS . 0.8 OUTLIER 168.64 40.43 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.701 -1.249 . . . . 0.0 110.835 178.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -158.21 160.65 31.03 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.494 -1.336 . . . . 0.0 110.116 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -89.51 124.22 34.32 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2142 ' ' CYS . . . . . 0.883 ' C ' HD12 ' A' 2143 ' ' ILE . 22.8 p -111.86 -166.85 1.11 Allowed 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.131 -0.98 . . . . 0.0 111.237 -178.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2143 ' ' ILE . . . . . 0.883 HD12 ' C ' ' A' 2142 ' ' CYS . 4.2 mp -150.24 98.1 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2144 ' ' ASN . . . . . 0.59 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 26.6 t-20 -46.86 114.54 0.86 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.452 -0.78 . . . . 0.0 111.254 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2145 ' ' THR . . . . . 0.48 ' OG1' ' HA ' ' A' 2149 ' ' TYR . 0.1 OUTLIER -108.54 175.55 5.43 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.236 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.25 105.64 9.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.349 -0.844 . . . . 0.0 110.055 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 73.01 8.77 74.69 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2148 ' ' SER . . . . . 0.488 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.5 OUTLIER -152.68 -173.6 4.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.977 -1.308 . . . . 0.0 109.951 179.785 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2149 ' ' TYR . . . . . 0.636 ' CD2' ' CB ' ' A' 2130 ' ' GLU . 50.7 p90 -165.66 -168.4 1.31 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.522 -0.736 . . . . 0.0 109.168 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2150 ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' 2142 ' ' CYS . 0.4 OUTLIER -168.93 124.98 0.92 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.324 -0.86 . . . . 0.0 108.914 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 2.1 t -105.49 107.2 18.07 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.149 -0.969 . . . . 0.0 110.278 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -98.77 134.15 42.08 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2153 ' ' CYS . . . . . 0.508 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -97.54 161.07 27.15 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.071 -1.018 . . . . 0.0 109.955 -179.149 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2154 ' ' PRO . . . . . 0.5 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.8 Cg_endo -61.43 -169.93 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 122.812 2.342 . . . . 0.0 111.812 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 3.4 t80 -86.12 99.86 11.79 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.09 -13.17 5.77 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 108.002 -2.039 . . . . 0.0 108.002 -178.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2157 ' ' TYR . . . . . 0.536 ' OH ' ' CG2' ' A' 2185 ' ' ILE . 5.1 m-85 -107.16 -173.5 2.31 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 121.503 -0.998 . . . . 0.0 110.205 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2158 ' ' ILE . . . . . 0.707 HD13 ' N ' ' A' 2158 ' ' ILE . 0.1 OUTLIER -159.36 -166.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.419 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2159 ' ' LEU . . . . . 0.636 HD11 ' O ' ' A' 2162 ' ' ASN . 31.4 tp -133.67 119.64 19.62 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.333 -0.854 . . . . 0.0 109.236 179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -89.89 55.83 3.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.215 -0.928 . . . . 0.0 109.664 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2161 ' ' GLY . . . . . 0.505 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 80.08 -2.31 76.23 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2162 ' ' ASN . . . . . 0.636 ' O ' HD11 ' A' 2159 ' ' LEU . 0.3 OUTLIER 166.51 -58.48 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.1 -1.236 . . . . 0.0 109.69 -179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -69.66 115.5 8.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.873 . . . . 0.0 109.49 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2164 ' ' CYS . . . . . 0.83 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -86.2 140.32 30.26 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.307 -0.871 . . . . 0.0 109.273 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2165 ' ' VAL . . . . . 0.83 HG13 ' O ' ' A' 2164 ' ' CYS . 1.0 OUTLIER -166.35 -166.63 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.483 -179.659 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2166 ' ' ASP . . . . . 0.49 ' OD1' ' CE1' ' A' 2157 ' ' TYR . 0.7 OUTLIER -89.93 142.04 28.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.949 -1.095 . . . . 0.0 109.606 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2167 ' ' THR . . . . . 0.693 HG23 ' OE1' ' A' 2169 ' ' GLU . 12.8 t -81.67 175.75 10.21 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.249 -0.907 . . . . 0.0 108.972 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2168 ' ' ASP . . . . . 0.44 ' O ' ' HB2' ' A' 2171 ' ' SER . 56.6 t0 -95.38 94.59 7.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.102 -0.999 . . . . 0.0 109.248 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2169 ' ' GLU . . . . . 0.693 ' OE1' HG23 ' A' 2167 ' ' THR . 0.8 OUTLIER -69.28 -33.82 73.79 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.407 -0.808 . . . . 0.0 109.363 -179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2170 ' ' CYS . . . . . 0.527 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 2.3 t -69.62 -6.01 28.46 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.373 -0.83 . . . . 0.0 109.044 179.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2171 ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -79.59 7.59 8.03 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.992 -1.067 . . . . 0.0 109.941 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 24.1 t -112.87 -79.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.031 -1.043 . . . . 0.0 110.008 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2173 ' ' GLY . . . . . 0.473 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -152.45 139.74 7.22 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2174 ' ' ASN . . . . . 0.593 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 29.9 p-10 -45.9 104.19 0.39 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.51 -0.994 . . . . 0.0 110.249 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2175 ' ' PRO . . . . . 0.577 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 3.1 Cg_endo -67.29 -18.37 50.23 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 121.977 1.785 . . . . 0.0 110.324 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2176 ' ' CYS . . . . . 0.569 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -61.1 -10.52 6.36 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.111 -0.993 . . . . 0.0 110.185 -179.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 96.35 -31.47 7.4 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.272 -1.442 . . . . 0.0 109.58 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2178 ' ' ASN . . . . . 0.466 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.1 OUTLIER -158.26 -37.13 0.07 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -1.098 . . . . 0.0 109.962 -179.647 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2179 ' ' GLY . . . . . 0.609 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -57.41 -113.25 0.01 OUTLIER Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2180 ' ' THR . . . . . 0.436 HG23 ' O ' ' A' 2179 ' ' GLY . 1.4 p -154.23 168.71 25.65 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.411 -1.052 . . . . 0.0 109.305 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2181 ' ' CYS . . . . . 0.593 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 24.6 p -101.66 163.5 12.23 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.066 0.936 . . . . 0.0 111.414 -179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2182 ' ' LYS . . . . . 0.569 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.2 OUTLIER -144.68 158.34 43.82 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 178.542 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 58.2 t30 -100.35 128.67 46.36 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.555 -1.341 . . . . 0.0 108.957 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2184 ' ' VAL . . . . . 0.864 HG12 ' CA ' ' A' 2188 ' ' PHE . 0.9 OUTLIER -137.24 -166.53 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.632 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2185 ' ' ILE . . . . . 0.638 ' H ' HG22 ' A' 2184 ' ' VAL . 4.7 mp -101.08 140.53 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 110.176 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 71.02 4.16 54.47 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2187 ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 167.23 -116.13 0.66 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2188 ' ' PHE . . . . . 0.864 ' CA ' HG12 ' A' 2184 ' ' VAL . 2.4 p90 -166.85 -177.76 3.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.052 -1.263 . . . . 0.0 110.083 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2189 ' ' GLU . . . . . 0.569 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 7.5 tt0 -129.84 139.45 51.2 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2190 ' ' CYS . . . . . 0.44 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 13.7 p -128.48 144.06 51.08 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.606 -1.309 . . . . 0.0 110.179 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2191 ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' 2192 ' ' CYS . 73.3 m -111.17 84.23 1.9 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.323 -0.86 . . . . 0.0 109.701 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2192 ' ' CYS . . . . . 0.611 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.8 OUTLIER -49.93 179.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 109.047 179.763 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2193 ' ' GLU . . . . . 0.493 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.3 OUTLIER -54.83 115.76 2.36 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2194 ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.3 OUTLIER -30.17 126.8 0.14 Allowed 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.375 0.607 . . . . 0.0 111.072 -179.033 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.37 5.58 8.55 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2196 ' ' PHE . . . . . 0.671 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.8 OUTLIER -117.51 -164.17 0.98 Allowed 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.212 -1.169 . . . . 0.0 110.283 -179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A 2197 ' ' GLU . . . . . 0.557 ' N ' ' CG ' ' A' 2196 ' ' PHE . 2.1 mm-40 -145.48 98.21 4.61 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2198 ' ' PRO . . . . . 0.671 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.1 Cg_endo -68.08 -160.97 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.066 1.844 . . . . 0.0 110.726 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -135.52 -170.33 12.07 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.63 -74.98 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 121.96 1.773 . . . . 0.0 110.711 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2201 ' ' MET . . . . . 0.489 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 4.5 ptt? -146.22 60.51 1.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.15 -0.969 . . . . 0.0 110.118 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2202 ' ' MET . . . . . 0.452 ' O ' ' HB ' ' A' 2203 ' ' THR . 1.9 mmt -129.55 -68.97 0.7 Allowed 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.102 -0.999 . . . . 0.0 109.75 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2203 ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' 2202 ' ' MET . 10.7 t 179.02 -168.74 0.09 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.414 -0.804 . . . . 0.0 109.138 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2204 ' ' CYS . . . . . 0.569 ' HB2' ' O ' ' A' 2176 ' ' CYS . 4.4 t -74.25 143.79 44.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.002 -1.061 . . . . 0.0 109.685 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.352 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 2124 ' ' SER . . . . . 0.634 ' O ' ' HB3' ' A' 2125 ' ' ALA . 18.6 m . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.298 0.57 . . . . 0.0 109.559 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2125 ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' 2124 ' ' SER . . . 71.11 89.35 0.1 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.394 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 49.7 t -97.42 84.87 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.527 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2127 ' ' ASP . . . . . 0.43 ' O ' ' O ' ' A' 2128 ' ' MET . 0.9 OUTLIER -95.67 88.62 5.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.276 -0.89 . . . . 0.0 109.75 -179.864 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2128 ' ' MET . . . . . 0.43 ' O ' ' O ' ' A' 2127 ' ' ASP . 0.1 OUTLIER 62.34 130.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 0.0 109.635 179.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2129 ' ' ASP . . . . . 0.657 ' O ' ' HB2' ' A' 2130 ' ' GLU . 0.7 OUTLIER -68.16 -20.15 64.86 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 0.0 109.444 179.927 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2130 ' ' GLU . . . . . 0.657 ' HB2' ' O ' ' A' 2129 ' ' ASP . 1.9 mt-10 76.57 -69.48 0.16 Allowed 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.032 0.444 . . . . 0.0 110.457 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2131 ' ' CYS . . . . . 0.458 ' O ' ' SG ' ' A' 2131 ' ' CYS . 47.5 t -78.69 8.22 5.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.998 -1.064 . . . . 0.0 110.199 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2132 ' ' LYS . . . . . 0.514 ' HB3' ' HB3' ' A' 2129 ' ' ASP . 0.0 OUTLIER -109.89 40.37 1.93 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.952 -1.093 . . . . 0.0 110.096 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2133 ' ' GLU . . . . . 0.891 ' HB2' HG23 ' A' 2136 ' ' VAL . 2.0 mt-10 -129.69 140.62 39.17 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.09 -1.006 . . . . 0.0 109.509 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2134 ' ' PRO . . . . . 0.521 ' O ' ' CD ' ' A' 2138 ' ' LYS . 3.3 Cg_endo -68.83 -3.96 12.39 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.065 1.843 . . . . 0.0 109.964 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2135 ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' 2162 ' ' ASN . 5.7 p-10 -107.23 0.12 23.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.11 -0.993 . . . . 0.0 110.03 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2136 ' ' VAL . . . . . 0.957 HG12 ' SG ' ' A' 2151 ' ' CYS . 11.1 t -97.63 -121.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.062 -1.024 . . . . 0.0 108.641 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2137 ' ' CYS . . . . . 0.499 ' N ' ' SG ' ' A' 2151 ' ' CYS . 8.7 m -56.61 -68.6 0.2 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.579 -1.326 . . . . 0.0 109.297 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2138 ' ' LYS . . . . . 0.521 ' CD ' ' O ' ' A' 2134 ' ' PRO . 1.9 mtmt 70.32 21.13 5.88 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.04 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2139 ' ' HIS . . . . . 0.478 ' CB ' ' O ' ' A' 2164 ' ' CYS . 0.0 OUTLIER 169.8 -42.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.485 -0.759 . . . . 0.0 109.323 179.591 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -86.31 175.06 47.62 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -93.52 123.54 36.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.148 -1.207 . . . . 0.0 109.539 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2142 ' ' CYS . . . . . 0.774 ' C ' HD12 ' A' 2143 ' ' ILE . 0.1 OUTLIER -112.72 178.82 4.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.558 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2143 ' ' ILE . . . . . 0.774 HD12 ' C ' ' A' 2142 ' ' CYS . 4.6 mp -142.51 129.27 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2144 ' ' ASN . . . . . 0.494 ' HB2' ' O ' ' A' 2129 ' ' ASP . 0.7 OUTLIER -71.88 118.23 14.46 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.097 -1.002 . . . . 0.0 110.037 -179.142 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2145 ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' 2148 ' ' SER . 40.4 p -117.69 -161.04 0.8 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.225 -0.922 . . . . 0.0 108.682 178.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.23 102.86 12.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.082 -1.011 . . . . 0.0 110.279 -179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 59.31 27.84 63.62 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.304 -1.118 . . . . 0.0 110.304 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2148 ' ' SER . . . . . 0.468 ' O ' ' OG1' ' A' 2145 ' ' THR . 0.4 OUTLIER -166.45 179.14 5.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.059 -1.259 . . . . 0.0 109.773 179.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2149 ' ' TYR . . . . . 0.527 ' HB3' ' HB3' ' A' 2130 ' ' GLU . 0.6 OUTLIER -139.85 -169.8 2.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.321 -0.862 . . . . 0.0 109.577 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2150 ' ' ARG . . . . . 0.506 ' O ' ' C ' ' A' 2151 ' ' CYS . 9.1 mmt180 -139.07 27.74 2.35 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.3 -0.875 . . . . 0.0 109.34 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2151 ' ' CYS . . . . . 0.957 ' SG ' HG12 ' A' 2136 ' ' VAL . 0.8 OUTLIER -28.99 109.42 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.875 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -130.34 125.92 35.85 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2153 ' ' CYS . . . . . 0.535 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -84.14 155.93 63.59 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 121.167 -0.958 . . . . 0.0 110.339 -178.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2154 ' ' PRO . . . . . 0.483 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.2 Cg_endo -63.44 -168.9 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.801 2.334 . . . . 0.0 111.794 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -88.01 102.31 14.63 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.54 -15.85 5.45 Favored Glycine 0 N--CA 1.485 1.917 0 N-CA-C 107.75 -2.14 . . . . 0.0 107.75 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2157 ' ' TYR . . . . . 0.535 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 6.5 m-85 -107.13 -174.81 2.62 Favored 'General case' 0 N--CA 1.484 1.244 0 O-C-N 121.655 -0.909 . . . . 0.0 109.828 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2158 ' ' ILE . . . . . 0.849 ' H ' HD13 ' A' 2158 ' ' ILE . 0.2 OUTLIER -146.03 -155.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.447 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2159 ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' 2163 ' ' GLU . 25.9 tp -148.84 127.0 12.07 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.376 -0.828 . . . . 0.0 109.281 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -102.27 62.05 0.86 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.376 -0.828 . . . . 0.0 109.293 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 86.96 -43.96 3.28 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2162 ' ' ASN . . . . . 0.516 ' ND2' ' HA ' ' A' 2136 ' ' VAL . 0.1 OUTLIER -158.33 -45.82 0.06 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.43 -1.041 . . . . 0.0 109.149 179.753 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2163 ' ' GLU . . . . . 0.741 ' O ' HD12 ' A' 2159 ' ' LEU . 65.5 tt0 -62.64 159.85 15.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.344 -0.848 . . . . 0.0 109.229 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2164 ' ' CYS . . . . . 0.512 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -131.64 137.05 48.2 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.13 -0.981 . . . . 0.0 109.638 -179.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2165 ' ' VAL . . . . . 0.607 HG23 HD11 ' A' 2158 ' ' ILE . 1.2 m -156.1 -170.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.307 -0.87 . . . . 0.0 109.282 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2166 ' ' ASP . . . . . 0.458 ' OD2' ' O ' ' A' 2184 ' ' VAL . 39.2 t70 -85.8 166.13 16.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.938 -1.101 . . . . 0.0 109.627 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2167 ' ' THR . . . . . 0.847 HG23 ' OE1' ' A' 2169 ' ' GLU . 11.6 t -106.8 167.86 9.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.891 . . . . 0.0 109.423 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2168 ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' 2171 ' ' SER . 56.4 t0 -92.99 98.75 11.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.115 -0.991 . . . . 0.0 109.348 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2169 ' ' GLU . . . . . 0.847 ' OE1' HG23 ' A' 2167 ' ' THR . 0.8 OUTLIER -73.64 -32.11 63.86 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.426 -0.796 . . . . 0.0 109.415 -179.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2170 ' ' CYS . . . . . 0.526 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.2 t -67.58 -8.1 31.56 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.319 -0.863 . . . . 0.0 108.981 179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2171 ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.3 OUTLIER -69.95 -4.59 21.33 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.168 -0.957 . . . . 0.0 109.537 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 9.3 t -100.55 -74.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.197 -0.939 . . . . 0.0 110.006 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2173 ' ' GLY . . . . . 0.488 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -168.82 141.48 6.78 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2174 ' ' ASN . . . . . 0.621 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 24.6 p-10 -36.61 97.31 0.13 Allowed Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.733 -0.863 . . . . 0.0 110.534 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2175 ' ' PRO . . . . . 0.602 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.8 Cg_endo -66.25 -20.31 55.82 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 121.982 1.788 . . . . 0.0 110.54 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2176 ' ' CYS . . . . . 0.551 ' O ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -51.54 -58.96 4.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.069 -1.019 . . . . 0.0 108.322 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 146.33 -20.82 1.72 Allowed Glycine 0 C--N 1.294 -1.781 0 N-CA-C 109.105 -1.598 . . . . 0.0 109.105 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 4.1 t30 -160.53 -35.44 0.05 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.342 -1.093 . . . . 0.0 110.127 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2179 ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -63.97 -119.13 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.049 -1.22 . . . . 0.0 110.049 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2180 ' ' THR . . . . . 0.498 ' HA ' ' HB3' ' A' 2174 ' ' ASN . 2.9 p -148.11 161.81 40.68 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.439 -1.036 . . . . 0.0 109.595 -179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2181 ' ' CYS . . . . . 0.621 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 27.0 p -93.64 160.8 14.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 110.906 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2182 ' ' LYS . . . . . 0.54 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 10.4 tttt -146.89 157.28 43.6 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2183 ' ' ASN . . . . . 0.474 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 59.0 t30 -93.4 129.09 39.67 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.453 -1.405 . . . . 0.0 110.13 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2184 ' ' VAL . . . . . 0.864 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -132.81 -168.73 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2185 ' ' ILE . . . . . 0.679 ' N ' HG13 ' A' 2184 ' ' VAL . 3.9 mp -105.56 140.53 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.956 -1.09 . . . . 0.0 110.282 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 64.48 14.36 57.17 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.969 -1.252 . . . . 0.0 109.969 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2187 ' ' GLY . . . . . 0.591 ' C ' HG12 ' A' 2184 ' ' VAL . . . 167.94 -117.98 0.76 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2188 ' ' PHE . . . . . 0.864 ' N ' HG12 ' A' 2184 ' ' VAL . 2.0 p90 -172.92 177.1 2.9 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.173 -1.193 . . . . 0.0 109.609 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2189 ' ' GLU . . . . . 0.54 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.5 OUTLIER -123.28 139.57 53.9 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2190 ' ' CYS . . . . . 0.45 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 22.9 p -135.73 137.33 41.58 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.765 -1.209 . . . . 0.0 109.721 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2191 ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' 2192 ' ' CYS . 25.3 m -108.79 83.45 1.76 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.412 -0.805 . . . . 0.0 109.478 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2192 ' ' CYS . . . . . 0.619 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -47.42 -179.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.934 0.873 . . . . 0.0 109.672 -179.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2193 ' ' GLU . . . . . 0.494 ' O ' ' C ' ' A' 2194 ' ' GLU . 11.3 tp10 -55.89 119.44 5.82 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2194 ' ' GLU . . . . . 0.494 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.5 OUTLIER -33.75 130.91 0.27 Allowed 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 121.496 0.665 . . . . 0.0 110.675 -178.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.34 -0.67 10.48 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.089 -1.605 . . . . 0.0 109.089 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2196 ' ' PHE . . . . . 0.661 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.7 OUTLIER -114.37 -166.7 1.13 Allowed 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.264 -1.139 . . . . 0.0 110.109 179.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2197 ' ' GLU . . . . . 0.554 ' N ' ' CG ' ' A' 2196 ' ' PHE . 1.7 mm-40 -145.31 98.02 4.68 Favored Pre-proline 0 C--N 1.299 -1.629 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2198 ' ' PRO . . . . . 0.661 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 7.9 Cg_endo -67.77 -161.05 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.118 1.879 . . . . 0.0 110.876 -179.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -138.1 -170.4 11.86 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.723 -1.751 . . . . 0.0 108.723 179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.75 -71.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.033 1.822 . . . . 0.0 110.547 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2201 ' ' MET . . . . . 0.489 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.1 OUTLIER -139.18 53.53 1.74 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.212 -0.93 . . . . 0.0 110.192 -179.436 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 2.5 mmm -122.3 -93.68 0.51 Allowed 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.048 -1.033 . . . . 0.0 109.995 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 2203 ' ' THR . . . . . 0.487 ' OG1' ' O ' ' A' 2175 ' ' PRO . 6.0 t -169.42 -163.3 0.39 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.23 -0.919 . . . . 0.0 109.176 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2204 ' ' CYS . . . . . 0.551 ' HB2' ' O ' ' A' 2176 ' ' CYS . 1.9 t -67.82 138.35 56.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.09 -1.006 . . . . 0.0 109.306 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2205 ' ' GLU . . . . . 0.431 ' O ' ' HG3' ' A' 2205 ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.515 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.245 0.545 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -134.72 156.66 48.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.241 -0.912 . . . . 0.0 109.49 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2126 ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' 2127 ' ' ASP . 7.3 p -143.31 133.07 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.253 -0.905 . . . . 0.0 109.48 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2127 ' ' ASP . . . . . 0.445 ' O ' ' O ' ' A' 2126 ' ' VAL . 2.7 p30 -52.87 -173.68 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.374 -0.829 . . . . 0.0 109.587 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.54 117.2 3.64 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.232 -0.917 . . . . 0.0 109.855 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2129 ' ' ASP . . . . . 0.526 ' HA ' ' ND2' ' A' 2144 ' ' ASN . 22.9 t0 -86.49 92.48 8.88 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.282 -0.886 . . . . 0.0 108.906 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2130 ' ' GLU . . . . . 0.556 ' O ' HG21 ' A' 2136 ' ' VAL . 30.5 mp0 -63.39 -21.6 66.38 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.407 -0.808 . . . . 0.0 110.398 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2131 ' ' CYS . . . . . 0.516 ' HB3' ' HB2' ' A' 2149 ' ' TYR . 5.8 p -88.07 -40.86 13.47 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 120.758 -1.214 . . . . 0.0 109.699 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2132 ' ' LYS . . . . . 0.502 ' N ' ' SG ' ' A' 2131 ' ' CYS . 0.0 OUTLIER -85.51 43.58 1.04 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.206 -0.934 . . . . 0.0 108.921 179.323 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 2133 ' ' GLU . . . . . 0.514 ' CB ' ' HD2' ' A' 2134 ' ' PRO . 4.8 mt-10 -94.39 171.91 6.26 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.331 -0.855 . . . . 0.0 109.537 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2134 ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' 2133 ' ' GLU . 1.3 Cg_endo -63.81 -17.93 61.89 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.51 2.14 . . . . 0.0 112.029 -179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 4.0 t70 -144.72 32.28 1.16 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.568 -1.332 . . . . 0.0 111.283 -178.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2136 ' ' VAL . . . . . 0.556 HG21 ' O ' ' A' 2130 ' ' GLU . 46.9 t -112.75 -110.8 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.777 -1.202 . . . . 0.0 109.901 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2137 ' ' CYS . . . . . 0.551 ' N ' HG12 ' A' 2136 ' ' VAL . 64.5 m -74.11 -65.07 0.89 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.766 -1.209 . . . . 0.0 109.486 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2138 ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' 2137 ' ' CYS . 21.6 mttt 62.53 124.81 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.255 -0.903 . . . . 0.0 109.806 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2139 ' ' HIS . . . . . 0.467 ' O ' ' HB3' ' A' 2164 ' ' CYS . 2.6 m170 44.26 48.58 7.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.83 179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -140.11 168.8 24.97 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.46 56.0 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.165 -1.197 . . . . 0.0 108.842 179.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2142 ' ' CYS . . . . . 0.452 ' HA ' ' O ' ' A' 2150 ' ' ARG . 26.3 p -65.82 174.76 2.22 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.349 -0.845 . . . . 0.0 110.56 -179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 3.3 mp -135.01 87.56 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2144 ' ' ASN . . . . . 0.526 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 8.4 t-20 -48.28 113.5 0.76 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.642 -0.661 . . . . 0.0 110.864 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2145 ' ' THR . . . . . . . . . . . . . 13.6 p -95.16 -174.65 3.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.405 -0.809 . . . . 0.0 109.021 179.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2146 ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' 2146 ' ' ASP . 2.9 p30 -91.13 41.41 1.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.181 -0.949 . . . . 0.0 109.531 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2147 ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' A' 2148 ' ' SER . . . 145.55 41.01 0.05 OUTLIER Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2148 ' ' SER . . . . . 0.435 ' CB ' ' O ' ' A' 2147 ' ' GLY . 0.3 OUTLIER 168.34 -163.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -1.191 . . . . 0.0 109.362 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 2149 ' ' TYR . . . . . 0.516 ' HB2' ' HB3' ' A' 2131 ' ' CYS . 43.9 p90 -169.03 -173.25 1.74 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 110.132 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2150 ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' 2142 ' ' CYS . 0.0 OUTLIER -159.43 110.31 2.0 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.895 -0.779 . . . . 0.0 108.895 179.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 58.8 m -86.78 61.99 7.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 109.947 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2152 ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' 2153 ' ' CYS . 0.3 OUTLIER -87.27 80.61 8.18 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.114 -0.991 . . . . 0.0 108.837 179.396 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 2153 ' ' CYS . . . . . 0.527 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -43.16 153.12 0.36 Allowed Pre-proline 0 N--CA 1.487 1.423 0 O-C-N 121.355 -0.841 . . . . 0.0 109.993 -179.352 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 2154 ' ' PRO . . . . . 0.407 ' HD2' ' HB2' ' A' 2157 ' ' TYR . 1.7 Cg_endo -65.91 -166.67 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.589 2.192 . . . . 0.0 111.258 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 8.1 t80 -90.39 104.41 16.99 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2156 ' ' GLY . . . . . 0.437 ' O ' HG22 ' A' 2167 ' ' THR . . . 130.69 -16.66 5.33 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 107.897 -2.081 . . . . 0.0 107.897 -178.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2157 ' ' TYR . . . . . 0.642 ' OH ' HG23 ' A' 2185 ' ' ILE . 7.6 m-85 -106.12 -166.79 1.23 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.551 -0.97 . . . . 0.0 109.783 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2158 ' ' ILE . . . . . 0.916 HD11 HG23 ' A' 2165 ' ' VAL . 0.2 OUTLIER -155.27 -163.39 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.534 -0.729 . . . . 0.0 109.468 179.723 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 2159 ' ' LEU . . . . . 0.492 ' N ' HG12 ' A' 2158 ' ' ILE . 30.5 tp -146.86 117.27 7.43 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.408 -0.807 . . . . 0.0 109.685 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -94.95 57.48 2.1 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.577 -0.702 . . . . 0.0 109.461 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2161 ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' A' 2162 ' ' ASN . . . 87.18 -14.98 56.21 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2162 ' ' ASN . . . . . 0.448 ' O ' ' O ' ' A' 2136 ' ' VAL . 0.0 OUTLIER 168.81 -46.03 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.405 -1.056 . . . . 0.0 109.092 179.71 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 2163 ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -63.77 126.02 26.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.181 -0.949 . . . . 0.0 108.685 179.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2164 ' ' CYS . . . . . 0.592 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -104.32 139.78 38.82 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.912 -1.117 . . . . 0.0 109.953 -179.608 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 2165 ' ' VAL . . . . . 0.916 HG23 HD11 ' A' 2158 ' ' ILE . 3.7 m -158.56 -177.8 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.348 -0.845 . . . . 0.0 109.441 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2166 ' ' ASP . . . . . 0.457 ' OD2' ' O ' ' A' 2184 ' ' VAL . 29.1 t70 -74.85 167.27 22.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.642 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2167 ' ' THR . . . . . 0.591 HG23 ' OE1' ' A' 2169 ' ' GLU . 4.9 t -114.26 -177.71 3.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.4 -0.812 . . . . 0.0 109.109 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2168 ' ' ASP . . . . . 0.489 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 51.9 t0 -103.29 100.64 10.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.087 -1.008 . . . . 0.0 109.74 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2169 ' ' GLU . . . . . 0.598 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.7 OUTLIER -77.01 -32.63 57.29 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.385 -0.822 . . . . 0.0 109.143 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 2170 ' ' CYS . . . . . 0.508 ' HB2' ' N ' ' A' 2182 ' ' LYS . 1.7 t -67.23 -10.07 46.85 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.94 -10.62 59.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.34 -0.85 . . . . 0.0 109.72 -179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 21.9 t -86.35 -71.58 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 109.544 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2173 ' ' GLY . . . . . . . . . . . . . . . -149.29 -114.95 0.75 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2174 ' ' ASN . . . . . 0.507 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 16.1 t-20 -146.67 97.3 4.29 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.39 -1.065 . . . . 0.0 109.49 -179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2175 ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' A' 2181 ' ' CYS . 1.3 Cg_endo -68.38 -24.63 36.77 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.93 1.754 . . . . 0.0 110.58 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2176 ' ' CYS . . . . . 0.585 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.1 OUTLIER -48.6 -43.86 36.53 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.122 -0.986 . . . . 0.0 109.391 -179.352 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 120.45 -19.24 9.23 Favored Glycine 0 C--N 1.292 -1.861 0 N-CA-C 108.221 -1.952 . . . . 0.0 108.221 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -171.97 -32.34 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.462 -1.022 . . . . 0.0 110.259 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2179 ' ' GLY . . . . . 0.652 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -69.75 -128.06 0.05 OUTLIER Glycine 0 N--CA 1.491 2.335 0 O-C-N 120.932 -1.105 . . . . 0.0 110.358 -179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 2.0 p -132.58 153.85 50.6 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.549 -0.971 . . . . 0.0 109.631 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2181 ' ' CYS . . . . . 0.555 ' HB3' ' HD2' ' A' 2175 ' ' PRO . 25.0 p -92.48 161.85 14.46 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.125 0.964 . . . . 0.0 110.976 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2182 ' ' LYS . . . . . 0.563 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 44.0 tptt -144.2 166.77 24.1 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2183 ' ' ASN . . . . . 0.499 ' N ' ' HG3' ' A' 2182 ' ' LYS . 62.6 t30 -100.94 138.74 37.59 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.616 -1.302 . . . . 0.0 109.676 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2184 ' ' VAL . . . . . 0.849 HG12 ' N ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -144.42 -168.76 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 O-C-N 121.484 -0.76 . . . . 0.0 109.246 -179.739 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 2185 ' ' ILE . . . . . 0.642 HG23 ' OH ' ' A' 2157 ' ' TYR . 2.7 mp -104.64 137.28 34.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.111 -0.993 . . . . 0.0 110.24 -179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 69.85 10.36 64.38 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2187 ' ' GLY . . . . . 0.57 ' C ' HG12 ' A' 2184 ' ' VAL . . . 168.99 -116.7 0.68 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2188 ' ' PHE . . . . . 0.849 ' N ' HG12 ' A' 2184 ' ' VAL . 1.0 OUTLIER -171.87 -178.51 2.2 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.204 -1.174 . . . . 0.0 109.461 -179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 2189 ' ' GLU . . . . . 0.563 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 2.5 tt0 -128.33 174.13 9.57 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 2.6 p -171.08 149.7 2.93 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.621 -1.232 . . . . 0.0 110.41 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2191 ' ' THR . . . . . 0.415 ' O ' ' O ' ' A' 2192 ' ' CYS . 50.8 m -117.41 83.81 2.05 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.568 -0.708 . . . . 0.0 109.355 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2192 ' ' CYS . . . . . 0.652 ' HA ' ' HA3' ' A' 2179 ' ' GLY . 0.8 OUTLIER -50.54 178.27 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.09 -1.006 . . . . 0.0 109.189 179.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 2193 ' ' GLU . . . . . 0.486 ' O ' ' C ' ' A' 2194 ' ' GLU . 31.8 tt0 -53.97 116.38 2.53 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2194 ' ' GLU . . . . . 0.486 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -32.61 129.37 0.21 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.526 0.679 . . . . 0.0 110.917 -178.674 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.95 4.5 9.42 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2196 ' ' PHE . . . . . 0.681 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.9 OUTLIER -116.65 -164.51 0.98 Allowed 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.197 -1.178 . . . . 0.0 110.169 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 2197 ' ' GLU . . . . . 0.556 ' N ' ' CG ' ' A' 2196 ' ' PHE . 14.0 mt-10 -145.81 96.95 4.63 Favored Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.596 -0.69 . . . . 0.0 109.373 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2198 ' ' PRO . . . . . 0.681 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 10.2 Cg_endo -68.68 -169.78 0.29 Allowed 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.272 1.981 . . . . 0.0 111.084 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -124.89 178.06 16.65 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.93 -72.8 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 121.844 1.696 . . . . 0.0 110.306 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 2201 ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.1 OUTLIER -132.78 33.27 3.74 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.14 -0.975 . . . . 0.0 109.791 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 2202 ' ' MET . . . . . 0.46 ' O ' ' CE2' ' A' 2188 ' ' PHE . 0.2 OUTLIER -105.6 -92.51 0.38 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.165 -0.959 . . . . 0.0 109.706 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 2203 ' ' THR . . . . . 0.472 HG23 ' N ' ' A' 2204 ' ' CYS . 6.0 t -159.68 -162.93 1.08 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.142 -0.974 . . . . 0.0 109.182 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A 2204 ' ' CYS . . . . . 0.585 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -115.71 155.82 27.05 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.126 -0.984 . . . . 0.0 109.145 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.41 179.98 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 2124 ' ' SER . . . . . 0.411 ' O ' ' HB3' ' A' 2125 ' ' ALA . 8.4 t . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2125 ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' 2124 ' ' SER . . . 60.78 -90.71 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.285 -0.884 . . . . 0.0 109.423 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2126 ' ' VAL . . . . . 0.566 ' O ' HG12 ' A' 2126 ' ' VAL . 58.1 t 51.0 76.94 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.331 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2127 ' ' ASP . . . . . . . . . . . . . 27.1 t70 -90.65 120.59 31.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 109.791 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -47.7 127.91 12.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.338 -0.851 . . . . 0.0 109.893 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2129 ' ' ASP . . . . . 0.517 ' O ' ' CB ' ' A' 2130 ' ' GLU . 24.4 t0 -66.56 -44.15 83.08 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2130 ' ' GLU . . . . . 0.569 ' O ' HG21 ' A' 2136 ' ' VAL . 1.9 mt-10 82.73 -50.77 0.18 Allowed 'General case' 0 N--CA 1.493 1.713 0 CA-C-O 121.133 0.492 . . . . 0.0 110.065 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2131 ' ' CYS . . . . . 0.467 ' SG ' ' HB2' ' A' 2137 ' ' CYS . 7.7 t -80.47 -41.91 23.53 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.025 -1.047 . . . . 0.0 109.461 -179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2132 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.28 -26.59 3.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 109.436 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2133 ' ' GLU . . . . . 0.482 ' HB2' HG23 ' A' 2136 ' ' VAL . 1.3 mt-10 -73.28 137.53 78.44 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.162 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2134 ' ' PRO . . . . . 0.544 ' CA ' ' HD3' ' A' 2138 ' ' LYS . 5.5 Cg_endo -69.96 -2.39 10.23 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.177 1.918 . . . . 0.0 110.821 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -99.19 -11.7 21.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.001 -1.062 . . . . 0.0 110.395 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2136 ' ' VAL . . . . . 0.569 HG21 ' O ' ' A' 2130 ' ' GLU . 2.2 t -107.39 -136.7 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.061 -1.024 . . . . 0.0 109.005 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2137 ' ' CYS . . . . . 0.555 ' CB ' ' HB3' ' A' 2142 ' ' CYS . 8.7 m -50.35 104.83 0.08 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.964 -1.085 . . . . 0.0 108.638 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2138 ' ' LYS . . . . . 0.544 ' HD3' ' CA ' ' A' 2134 ' ' PRO . 3.6 mtmt -124.07 140.54 52.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.912 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2139 ' ' HIS . . . . . 0.499 ' HB2' ' O ' ' A' 2164 ' ' CYS . 10.6 m80 56.3 39.16 30.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.986 -1.071 . . . . 0.0 109.548 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -165.07 176.16 40.85 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -90.28 143.81 26.42 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.071 -1.253 . . . . 0.0 108.525 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2142 ' ' CYS . . . . . 0.555 ' HB3' ' CB ' ' A' 2137 ' ' CYS . 0.6 OUTLIER -126.54 153.95 44.5 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.072 -1.017 . . . . 0.0 110.535 -178.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 2143 ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' 2145 ' ' THR . 4.3 mp -116.5 89.76 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2144 ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' 2129 ' ' ASP . 9.4 t-20 -47.21 114.94 0.96 Allowed 'General case' 0 C--N 1.298 -1.668 0 CA-C-O 121.455 0.645 . . . . 0.0 110.66 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2145 ' ' THR . . . . . 0.502 HG23 ' O ' ' A' 2143 ' ' ILE . 23.0 p -107.68 -171.67 1.92 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.472 -0.767 . . . . 0.0 108.933 179.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.4 97.45 10.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.411 -0.806 . . . . 0.0 109.46 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 72.54 33.5 60.93 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2148 ' ' SER . . . . . 0.424 ' HB3' ' OG1' ' A' 2145 ' ' THR . 0.4 OUTLIER -173.11 -160.73 0.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.301 -1.117 . . . . 0.0 109.792 179.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 2149 ' ' TYR . . . . . . . . . . . . . 7.8 p90 -168.43 -170.33 1.23 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.542 -0.724 . . . . 0.0 109.429 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2150 ' ' ARG . . . . . 0.547 ' O ' ' C ' ' A' 2151 ' ' CYS . 0.0 OUTLIER -153.1 33.38 0.47 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.351 -0.843 . . . . 0.0 109.0 -179.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 2151 ' ' CYS . . . . . 0.547 ' C ' ' O ' ' A' 2150 ' ' ARG . 35.9 m -12.83 89.94 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.231 -179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -97.57 169.84 9.44 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2153 ' ' CYS . . . . . 0.517 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -131.77 159.14 73.24 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 120.934 -1.104 . . . . 0.0 109.831 -179.499 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 2154 ' ' PRO . . . . . 0.494 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.5 Cg_endo -62.65 -168.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 122.63 2.22 . . . . 0.0 111.568 -178.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 39.4 t80 -88.17 101.19 13.58 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 129.92 -13.61 5.78 Favored Glycine 0 N--CA 1.485 1.943 0 N-CA-C 107.927 -2.069 . . . . 0.0 107.927 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2157 ' ' TYR . . . . . 0.517 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 5.8 m-85 -108.62 -172.5 2.07 Favored 'General case' 0 N--CA 1.484 1.253 0 O-C-N 121.661 -0.905 . . . . 0.0 109.961 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2158 ' ' ILE . . . . . 0.769 HD12 ' HB ' ' A' 2167 ' ' THR . 0.2 OUTLIER -156.29 -158.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.453 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 2159 ' ' LEU . . . . . 0.506 ' HG ' ' N ' ' A' 2160 ' ' ALA . 13.7 tp -142.19 146.8 35.64 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.169 -0.957 . . . . 0.0 109.768 -179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2160 ' ' ALA . . . . . 0.506 ' N ' ' HG ' ' A' 2159 ' ' LEU . . . -122.02 48.53 1.71 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.237 -0.914 . . . . 0.0 109.443 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 95.55 -35.76 4.15 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2162 ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -168.44 -34.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.088 -1.242 . . . . 0.0 109.911 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2163 ' ' GLU . . . . . 0.479 ' OE1' ' HE2' ' A' 2138 ' ' LYS . 1.2 tp10 -88.59 111.26 21.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 0.0 109.837 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2164 ' ' CYS . . . . . 0.904 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -82.13 147.83 28.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.442 -0.786 . . . . 0.0 109.362 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 2165 ' ' VAL . . . . . 0.904 HG13 ' O ' ' A' 2164 ' ' CYS . 0.3 OUTLIER -170.86 -168.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 2166 ' ' ASP . . . . . . . . . . . . . 1.6 t70 -90.4 143.63 26.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.901 -1.124 . . . . 0.0 109.179 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2167 ' ' THR . . . . . 0.769 ' HB ' HD12 ' A' 2158 ' ' ILE . 9.7 t -95.05 171.65 8.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 0.0 109.402 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2168 ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' 2171 ' ' SER . 62.5 t0 -85.73 96.29 9.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.948 -1.095 . . . . 0.0 109.352 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2169 ' ' GLU . . . . . 0.597 ' OE1' HG23 ' A' 2167 ' ' THR . 0.5 OUTLIER -67.3 -33.93 76.32 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.414 -0.804 . . . . 0.0 109.598 -179.919 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 2170 ' ' CYS . . . . . 0.51 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.6 t -69.24 -7.49 37.21 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.172 -0.955 . . . . 0.0 108.915 179.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2171 ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.2 OUTLIER -77.09 3.13 13.18 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.086 -1.009 . . . . 0.0 109.663 179.847 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 48.5 t -105.6 -70.55 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.101 -1.0 . . . . 0.0 109.826 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2173 ' ' GLY . . . . . 0.477 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -168.97 138.17 4.95 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2174 ' ' ASN . . . . . 0.589 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 18.6 p-10 -39.38 99.31 0.19 Allowed Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.517 -0.99 . . . . 0.0 110.22 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2175 ' ' PRO . . . . . 0.615 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.5 Cg_endo -65.47 -25.17 55.92 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 122.046 1.831 . . . . 0.0 110.487 -179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2176 ' ' CYS . . . . . 0.565 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -47.13 -50.89 19.41 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.069 -1.019 . . . . 0.0 108.588 -179.844 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 138.25 -22.29 3.07 Favored Glycine 0 C--N 1.292 -1.9 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2178 ' ' ASN . . . . . 0.417 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.0 OUTLIER -162.53 -35.97 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.447 -1.031 . . . . 0.0 109.993 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 2179 ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -61.59 -119.21 0.01 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -146.34 160.36 42.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.378 -1.072 . . . . 0.0 109.637 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2181 ' ' CYS . . . . . 0.589 ' HB3' ' HA ' ' A' 2174 ' ' ASN . 22.5 p -92.08 163.95 13.77 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.198 0.999 . . . . 0.0 111.306 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2182 ' ' LYS . . . . . 0.6 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.0 OUTLIER -142.56 155.88 45.05 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 57.7 t30 -100.55 140.56 34.65 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.39 -1.444 . . . . 0.0 109.883 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2184 ' ' VAL . . . . . 0.633 HG12 ' CA ' ' A' 2188 ' ' PHE . 0.8 OUTLIER -154.52 174.48 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A 2185 ' ' ILE . . . . . . . . . . . . . 4.3 mp -91.77 136.73 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.051 -1.031 . . . . 0.0 109.882 -179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 80.39 5.45 89.78 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2187 ' ' GLY . . . . . 0.524 ' C ' HG12 ' A' 2184 ' ' VAL . . . 163.06 -131.32 2.45 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2188 ' ' PHE . . . . . 0.633 ' CA ' HG12 ' A' 2184 ' ' VAL . 5.6 p90 -160.94 173.31 15.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.353 -1.087 . . . . 0.0 109.165 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2189 ' ' GLU . . . . . 0.6 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 1.7 tt0 -121.61 138.98 54.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.3 -0.875 . . . . 0.0 108.826 178.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2190 ' ' CYS . . . . . 0.435 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 15.4 p -130.64 143.53 50.81 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.66 -1.275 . . . . 0.0 109.997 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2191 ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' 2192 ' ' CYS . 61.3 m -117.51 85.31 2.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.348 -0.845 . . . . 0.0 109.505 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2192 ' ' CYS . . . . . 0.602 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 1.1 m -49.09 179.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 109.242 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2193 ' ' GLU . . . . . 0.45 ' O ' ' C ' ' A' 2194 ' ' GLU . 18.5 tt0 -56.98 126.9 29.25 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2194 ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' 2193 ' ' GLU . 1.2 tt0 -38.81 130.16 1.46 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.487 -0.758 . . . . 0.0 110.591 -179.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.24 3.04 9.82 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2196 ' ' PHE . . . . . 0.683 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.2 p90 -116.56 -161.43 0.8 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.144 -1.209 . . . . 0.0 110.16 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2197 ' ' GLU . . . . . 0.561 ' N ' ' CG ' ' A' 2196 ' ' PHE . 34.8 mm-40 -146.09 95.14 4.82 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 121.53 -0.731 . . . . 0.0 109.82 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2198 ' ' PRO . . . . . 0.683 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 6.5 Cg_endo -66.91 -163.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.119 1.88 . . . . 0.0 111.021 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -138.22 -171.65 12.26 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.88 -80.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.004 1.802 . . . . 0.0 110.727 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2201 ' ' MET . . . . . 0.492 ' HA ' ' O ' ' A' 2188 ' ' PHE . 6.6 mtt -132.0 47.17 2.55 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.166 -0.959 . . . . 0.0 110.033 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2202 ' ' MET . . . . . 0.515 ' O ' ' CE2' ' A' 2188 ' ' PHE . 1.9 mmt -117.13 -88.42 0.6 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.238 -0.914 . . . . 0.0 109.849 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2203 ' ' THR . . . . . 0.469 HG23 ' N ' ' A' 2204 ' ' CYS . 5.8 t -169.33 -162.59 0.36 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.278 -0.889 . . . . 0.0 109.49 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2204 ' ' CYS . . . . . 0.569 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 5.2 t -76.28 145.06 39.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.151 -0.968 . . . . 0.0 109.39 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A 2205 ' ' GLU . . . . . 0.426 ' HG3' ' O ' ' A' 2197 ' ' GLU . 8.6 pt-20 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.951 -1.024 . . . . 0.0 109.409 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 2124 ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' 2125 ' ' ALA . 79.6 p . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2125 ' ' ALA . . . . . 0.46 ' O ' ' O ' ' A' 2124 ' ' SER . . . 61.25 131.61 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.341 -0.849 . . . . 0.0 109.6 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 91.9 t -109.43 125.34 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 109.439 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2127 ' ' ASP . . . . . . . . . . . . . 23.5 t0 -55.97 93.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 109.589 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 8.3 mtp -64.42 147.6 52.3 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 109.503 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2129 ' ' ASP . . . . . 0.568 ' O ' ' HB2' ' A' 2130 ' ' GLU . 11.5 t0 -70.31 -42.04 72.49 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.339 -0.851 . . . . 0.0 108.86 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2130 ' ' GLU . . . . . 0.61 ' HB3' ' CD1' ' A' 2149 ' ' TYR . 1.5 mt-10 80.58 -55.47 0.34 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.915 -0.491 . . . . 0.0 111.158 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2131 ' ' CYS . . . . . 0.565 ' HA ' ' CG1' ' A' 2136 ' ' VAL . 8.0 p -91.34 -14.59 30.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.761 -1.212 . . . . 0.0 110.503 -179.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2132 ' ' LYS . . . . . 0.507 ' HB2' ' OD2' ' A' 2129 ' ' ASP . 0.0 OUTLIER -88.93 6.57 38.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.996 -1.065 . . . . 0.0 109.218 179.534 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 2133 ' ' GLU . . . . . 0.49 ' HB3' ' HD2' ' A' 2134 ' ' PRO . 36.3 mt-10 -81.11 159.41 68.16 Favored Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.242 -0.911 . . . . 0.0 109.337 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2134 ' ' PRO . . . . . 0.493 ' O ' ' HD2' ' A' 2138 ' ' LYS . 4.7 Cg_endo -68.54 -1.88 8.24 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.341 2.027 . . . . 0.0 110.451 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2135 ' ' ASP . . . . . 0.506 ' O ' ' ND2' ' A' 2162 ' ' ASN . 0.4 OUTLIER -123.11 14.16 9.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.934 -1.104 . . . . 0.0 109.887 -179.57 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 2136 ' ' VAL . . . . . 0.637 ' CG1' ' CE2' ' A' 2149 ' ' TYR . 43.3 t -146.99 126.01 4.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.04 -1.038 . . . . 0.0 108.867 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2137 ' ' CYS . . . . . 0.542 ' CA ' ' O ' ' A' 2162 ' ' ASN . 0.5 OUTLIER 69.67 -84.78 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.428 -0.795 . . . . 0.0 109.969 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 2138 ' ' LYS . . . . . 0.493 ' HD2' ' O ' ' A' 2134 ' ' PRO . 0.8 OUTLIER 63.62 109.67 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.254 -0.904 . . . . 0.0 109.571 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 2139 ' ' HIS . . . . . 0.501 ' O ' ' HB3' ' A' 2164 ' ' CYS . 11.6 m170 62.03 50.39 4.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.866 . . . . 0.0 109.892 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -148.85 168.39 29.35 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 10.1 tp60 -106.43 78.68 1.3 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -1.137 . . . . 0.0 109.13 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2142 ' ' CYS . . . . . 0.954 ' C ' HD13 ' A' 2143 ' ' ILE . 25.3 p -82.96 -177.65 6.84 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.306 -0.871 . . . . 0.0 110.634 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2143 ' ' ILE . . . . . 0.954 HD13 ' C ' ' A' 2142 ' ' CYS . 3.0 mm -127.63 122.6 59.49 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2144 ' ' ASN . . . . . 0.55 ' ND2' ' O ' ' A' 2129 ' ' ASP . 4.3 t-20 -78.04 113.49 16.02 Favored 'General case' 0 C--N 1.296 -1.731 0 O-C-N 121.34 -0.85 . . . . 0.0 110.912 -178.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2145 ' ' THR . . . . . 0.465 HG23 ' HA ' ' A' 2149 ' ' TYR . 2.7 p -92.68 -162.79 0.97 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 1.3 p30 -86.7 -32.52 20.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.133 -0.98 . . . . 0.0 110.449 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -129.77 -34.39 0.48 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.497 -1.335 . . . . 0.0 110.161 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2148 ' ' SER . . . . . 0.432 ' O ' ' OG1' ' A' 2145 ' ' THR . 0.5 OUTLIER -111.79 -164.44 0.92 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.144 -1.21 . . . . 0.0 110.035 -179.479 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 2149 ' ' TYR . . . . . 0.637 ' CE2' ' CG1' ' A' 2136 ' ' VAL . 13.5 p90 -148.67 -176.55 5.37 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2150 ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' 2149 ' ' TYR . 0.1 OUTLIER -148.32 116.48 6.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.476 179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 6.2 m -87.32 118.62 26.87 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.338 -0.851 . . . . 0.0 109.545 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.01 81.05 1.94 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.309 -0.869 . . . . 0.0 109.139 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2153 ' ' CYS . . . . . 0.501 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -54.25 156.24 5.92 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.276 -0.89 . . . . 0.0 109.257 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 2154 ' ' PRO . . . . . 0.483 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.3 Cg_endo -63.06 -171.76 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.417 2.078 . . . . 0.0 111.306 -179.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -88.0 102.84 15.13 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.37 -14.79 5.59 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 107.885 -2.086 . . . . 0.0 107.885 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2157 ' ' TYR . . . . . 0.547 ' CD2' ' C ' ' A' 2165 ' ' VAL . 5.6 m-85 -106.01 -168.23 1.41 Allowed 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.635 -0.921 . . . . 0.0 109.549 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2158 ' ' ILE . . . . . 0.639 HD11 HG23 ' A' 2165 ' ' VAL . 0.2 OUTLIER -156.93 -164.13 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.859 . . . . 0.0 109.923 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 2159 ' ' LEU . . . . . 0.523 HD12 ' O ' ' A' 2163 ' ' GLU . 39.5 tp -142.38 114.16 8.03 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -90.57 56.87 3.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.286 -0.883 . . . . 0.0 109.589 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 89.11 -29.2 6.12 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2162 ' ' ASN . . . . . 0.542 ' O ' ' CA ' ' A' 2137 ' ' CYS . 1.5 m-20 -171.47 -46.69 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.241 -1.152 . . . . 0.0 109.332 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2163 ' ' GLU . . . . . 0.523 ' O ' HD12 ' A' 2159 ' ' LEU . 14.5 tt0 -66.17 147.78 52.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.118 -0.989 . . . . 0.0 109.248 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2164 ' ' CYS . . . . . 0.693 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -122.82 137.58 54.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.049 -1.032 . . . . 0.0 109.394 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 2165 ' ' VAL . . . . . 0.693 HG13 ' O ' ' A' 2164 ' ' CYS . 0.7 OUTLIER -161.1 -169.81 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.121 -0.987 . . . . 0.0 109.779 -179.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 2166 ' ' ASP . . . . . 0.427 ' OD2' ' O ' ' A' 2184 ' ' VAL . 36.8 t70 -77.02 166.94 22.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.167 -0.958 . . . . 0.0 110.035 -179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2167 ' ' THR . . . . . 0.538 ' HB ' HG23 ' A' 2158 ' ' ILE . 1.2 t -115.99 -170.6 1.82 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.355 -0.84 . . . . 0.0 109.414 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2168 ' ' ASP . . . . . 0.536 ' N ' HG23 ' A' 2167 ' ' THR . 64.6 t0 -109.4 101.26 10.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.945 . . . . 0.0 109.511 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2169 ' ' GLU . . . . . 0.624 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.5 OUTLIER -76.22 -30.93 58.14 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.347 -0.845 . . . . 0.0 109.337 179.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 2170 ' ' CYS . . . . . 0.526 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 0.1 OUTLIER -64.87 -12.32 47.47 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.578 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.76 -22.54 29.6 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 0.0 109.623 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 31.3 t -75.9 -68.56 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.33 -0.856 . . . . 0.0 109.448 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2173 ' ' GLY . . . . . 0.441 ' O ' ' HD3' ' A' 2175 ' ' PRO . . . -159.87 140.37 6.74 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2174 ' ' ASN . . . . . 0.497 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 1.6 t-20 -45.0 104.49 0.39 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.411 -1.052 . . . . 0.0 109.616 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2175 ' ' PRO . . . . . 0.648 ' CB ' ' CE2' ' A' 2188 ' ' PHE . 2.1 Cg_endo -68.92 -19.94 39.59 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.837 1.692 . . . . 0.0 110.03 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2176 ' ' CYS . . . . . 0.601 ' HA ' ' HB3' ' A' 2204 ' ' CYS . 0.0 OUTLIER -71.43 -24.08 61.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.152 -0.967 . . . . 0.0 109.902 -179.516 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 105.84 -25.79 22.99 Favored Glycine 0 N--CA 1.483 1.779 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2178 ' ' ASN . . . . . 0.465 ' O ' ' O ' ' A' 2179 ' ' GLY . 0.1 OUTLIER -170.59 -31.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.295 -1.121 . . . . 0.0 110.611 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 2179 ' ' GLY . . . . . 0.583 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -59.77 -120.68 0.01 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 1.3 p -136.03 151.18 49.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.44 -1.035 . . . . 0.0 109.336 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2181 ' ' CYS . . . . . 0.549 ' HB3' ' HD2' ' A' 2175 ' ' PRO . 26.1 p -99.35 155.63 17.42 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.12 -0.987 . . . . 0.0 110.716 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2182 ' ' LYS . . . . . 0.55 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 8.5 tttp -140.67 159.07 43.01 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2183 ' ' ASN . . . . . 0.432 ' CG ' ' HA ' ' A' 2168 ' ' ASP . 53.5 t30 -100.26 129.64 46.28 Favored 'General case' 0 C--N 1.298 -1.653 0 O-C-N 120.562 -1.336 . . . . 0.0 110.175 -179.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2184 ' ' VAL . . . . . 0.914 HG12 ' N ' ' A' 2188 ' ' PHE . 0.3 OUTLIER -134.41 -179.42 3.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 2185 ' ' ILE . . . . . 0.444 ' N ' HG13 ' A' 2184 ' ' VAL . 4.1 mp -95.01 141.13 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.764 -1.21 . . . . 0.0 110.424 -179.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 67.94 10.92 59.89 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2187 ' ' GLY . . . . . 0.575 ' C ' HG12 ' A' 2184 ' ' VAL . . . 168.14 -118.77 0.8 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2188 ' ' PHE . . . . . 0.914 ' N ' HG12 ' A' 2184 ' ' VAL . 2.6 p90 -175.23 178.58 1.68 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -1.109 . . . . 0.0 109.72 -179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2189 ' ' GLU . . . . . 0.55 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 5.6 tp10 -124.54 168.1 13.56 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 3.1 p -170.51 145.89 2.67 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.547 -1.345 . . . . 0.0 110.453 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2191 ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' 2192 ' ' CYS . 88.6 m -117.88 88.34 2.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.504 -0.748 . . . . 0.0 109.614 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2192 ' ' CYS . . . . . 0.63 ' HB2' ' CZ ' ' A' 2196 ' ' PHE . 0.5 OUTLIER -49.6 -178.57 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.167 -0.958 . . . . 0.0 109.049 179.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 2193 ' ' GLU . . . . . 0.548 ' O ' ' C ' ' A' 2194 ' ' GLU . 7.2 tt0 -55.24 102.27 0.06 Allowed 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2194 ' ' GLU . . . . . 0.548 ' C ' ' O ' ' A' 2193 ' ' GLU . 2.3 mt-10 -20.14 124.89 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.365 0.602 . . . . 0.0 111.716 -178.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 121.71 11.35 6.0 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.624 -1.391 . . . . 0.0 109.624 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2196 ' ' PHE . . . . . 0.686 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.5 p90 -120.06 -161.93 0.9 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.357 -1.084 . . . . 0.0 110.165 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2197 ' ' GLU . . . . . 0.52 ' N ' ' CG ' ' A' 2196 ' ' PHE . 12.9 mt-10 -144.47 94.87 5.54 Favored Pre-proline 0 C--N 1.306 -1.32 0 O-C-N 121.475 -0.766 . . . . 0.0 109.659 -179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2198 ' ' PRO . . . . . 0.686 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 9.2 Cg_endo -69.36 -162.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.353 2.035 . . . . 0.0 111.192 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -133.66 -177.02 14.66 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.247 -1.941 . . . . 0.0 108.247 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -62.36 -65.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.006 1.804 . . . . 0.0 110.618 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2201 ' ' MET . . . . . 0.496 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -147.29 41.11 1.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 109.58 -179.674 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 2202 ' ' MET . . . . . 0.431 ' O ' ' CE2' ' A' 2188 ' ' PHE . 0.0 OUTLIER -112.88 -84.4 0.59 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.208 -0.932 . . . . 0.0 109.613 -179.807 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 2203 ' ' THR . . . . . . . . . . . . . 11.5 t -162.6 -172.62 3.2 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.23 -0.918 . . . . 0.0 109.406 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 2204 ' ' CYS . . . . . 0.601 ' HB3' ' HA ' ' A' 2176 ' ' CYS . 0.0 OUTLIER -110.42 144.94 38.44 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.285 -0.885 . . . . 0.0 108.933 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.548 -179.864 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2125 ' ' ALA . . . . . . . . . . . . . . . -167.58 103.19 0.5 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.244 -0.91 . . . . 0.0 109.316 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2126 ' ' VAL . . . . . 0.489 HG13 ' H ' ' A' 2128 ' ' MET . 10.0 p -139.2 148.92 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 109.489 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2127 ' ' ASP . . . . . 0.438 ' CG ' ' O ' ' A' 2127 ' ' ASP . 24.0 t70 -91.39 30.4 1.3 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.187 -0.946 . . . . 0.0 109.403 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2128 ' ' MET . . . . . 0.489 ' H ' HG13 ' A' 2126 ' ' VAL . 1.8 mtp 59.9 106.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.199 -0.938 . . . . 0.0 109.2 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2129 ' ' ASP . . . . . 0.527 ' O ' ' CB ' ' A' 2130 ' ' GLU . 11.3 t70 -60.65 -46.24 91.08 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2130 ' ' GLU . . . . . 0.638 ' O ' HG21 ' A' 2136 ' ' VAL . 6.4 mt-10 82.56 -43.16 0.13 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.856 -0.528 . . . . 0.0 109.798 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2131 ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -90.11 -23.02 21.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.176 -0.952 . . . . 0.0 109.086 179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2132 ' ' LYS . . . . . 0.432 ' HB2' ' CB ' ' A' 2129 ' ' ASP . 0.3 OUTLIER -87.6 40.25 0.92 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.345 -0.847 . . . . 0.0 109.144 179.561 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 2133 ' ' GLU . . . . . 0.525 ' HB2' HG23 ' A' 2136 ' ' VAL . 80.3 mt-10 -108.09 160.17 27.92 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.33 -0.856 . . . . 0.0 109.66 -179.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2134 ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' 2133 ' ' GLU . 1.2 Cg_endo -66.02 0.51 3.12 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.539 2.159 . . . . 0.0 111.771 -179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2135 ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' A' 2162 ' ' ASN . 67.1 m-20 -130.03 -10.65 4.29 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.478 -1.389 . . . . 0.0 110.564 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2136 ' ' VAL . . . . . 0.638 HG21 ' O ' ' A' 2130 ' ' GLU . 3.4 t -100.13 -131.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.927 -1.108 . . . . 0.0 108.492 179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2137 ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' 2142 ' ' CYS . 5.0 t -58.45 131.46 50.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.521 -1.362 . . . . 0.0 108.65 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2138 ' ' LYS . . . . . 0.515 ' O ' ' CB ' ' A' 2139 ' ' HIS . 32.0 mtpt -139.64 43.03 1.99 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.185 -0.947 . . . . 0.0 110.061 -179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2139 ' ' HIS . . . . . 0.515 ' CB ' ' O ' ' A' 2138 ' ' LYS . 0.0 OUTLIER 163.73 -34.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.052 -1.03 . . . . 0.0 110.099 179.473 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -83.67 173.65 51.21 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -91.91 94.68 9.42 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.265 -1.138 . . . . 0.0 109.163 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2142 ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' 2137 ' ' CYS . 10.4 t -91.0 161.47 15.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.292 -0.88 . . . . 0.0 109.725 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2143 ' ' ILE . . . . . . . . . . . . . 2.6 mp -122.72 98.59 5.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2144 ' ' ASN . . . . . 0.479 ' HB2' ' OD1' ' A' 2129 ' ' ASP . 3.2 t30 -60.02 112.85 2.03 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.273 -0.892 . . . . 0.0 109.712 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2145 ' ' THR . . . . . . . . . . . . . 30.5 p -90.73 -166.28 1.54 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.378 -0.826 . . . . 0.0 109.376 179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 5.6 t0 -62.63 -72.48 0.13 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.326 -0.859 . . . . 0.0 109.817 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . -118.12 37.0 3.41 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2148 ' ' SER . . . . . 0.451 ' O ' ' HB3' ' A' 2149 ' ' TYR . 0.8 OUTLIER -165.13 -160.89 0.51 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -1.157 . . . . 0.0 109.629 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 2149 ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' 2148 ' ' SER . 27.2 p90 170.8 -175.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.49 -0.756 . . . . 0.0 109.217 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2150 ' ' ARG . . . . . 0.433 ' C ' ' SG ' ' A' 2142 ' ' CYS . 11.6 ptt180 -167.93 95.05 0.41 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -0.951 . . . . 0.0 109.831 179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2151 ' ' CYS . . . . . 0.465 ' HA ' ' SG ' ' A' 2142 ' ' CYS . 42.5 t -57.64 102.56 0.1 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.615 -0.678 . . . . 0.0 109.447 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -104.47 108.02 19.24 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.314 -0.866 . . . . 0.0 109.256 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2153 ' ' CYS . . . . . 0.528 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.1 OUTLIER -70.06 158.78 86.55 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.168 -0.957 . . . . 0.0 109.664 -179.657 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 2154 ' ' PRO . . . . . 0.474 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 1.1 Cg_endo -63.85 -168.97 0.1 OUTLIER 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.858 2.372 . . . . 0.0 112.03 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -86.48 101.79 13.5 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 129.95 -15.49 5.63 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 107.821 -2.112 . . . . 0.0 107.821 -178.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2157 ' ' TYR . . . . . 0.593 ' OH ' HG23 ' A' 2185 ' ' ILE . 5.4 m-85 -106.34 -170.79 1.78 Allowed 'General case' 0 C--N 1.306 -1.303 0 O-C-N 121.682 -0.893 . . . . 0.0 110.053 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2158 ' ' ILE . . . . . 0.744 HD13 ' N ' ' A' 2158 ' ' ILE . 0.2 OUTLIER -156.93 -160.97 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.522 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 2159 ' ' LEU . . . . . 0.517 HD12 ' O ' ' A' 2163 ' ' GLU . 33.2 tp -147.55 122.81 10.24 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.187 -0.945 . . . . 0.0 109.942 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2160 ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' 2162 ' ' ASN . . . -90.22 -152.12 0.26 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2161 ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' 2160 ' ' ALA . . . -42.13 -25.95 0.29 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2162 ' ' ASN . . . . . 0.503 ' O ' HD11 ' A' 2159 ' ' LEU . 1.5 t-20 178.75 -29.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.133 -1.216 . . . . 0.0 110.179 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2163 ' ' GLU . . . . . 0.517 ' O ' HD12 ' A' 2159 ' ' LEU . 74.5 tt0 -76.23 152.58 36.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.084 -1.01 . . . . 0.0 109.514 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2164 ' ' CYS . . . . . 0.804 ' O ' HG13 ' A' 2165 ' ' VAL . 0.1 OUTLIER -111.82 145.08 40.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.122 -0.986 . . . . 0.0 109.374 179.839 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 2165 ' ' VAL . . . . . 0.804 HG13 ' O ' ' A' 2164 ' ' CYS . 1.6 m -164.81 -170.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 109.425 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2166 ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' 2157 ' ' TYR . 3.3 t70 -90.41 149.69 22.16 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.002 -1.061 . . . . 0.0 109.706 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2167 ' ' THR . . . . . 0.912 HG23 ' OE1' ' A' 2169 ' ' GLU . 8.7 t -87.84 175.38 7.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 109.511 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2168 ' ' ASP . . . . . 0.469 ' HA ' ' OD1' ' A' 2183 ' ' ASN . 57.9 t0 -95.77 92.67 6.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.296 -0.877 . . . . 0.0 108.752 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2169 ' ' GLU . . . . . 0.912 ' OE1' HG23 ' A' 2167 ' ' THR . 0.7 OUTLIER -65.68 -32.15 73.55 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.331 -0.856 . . . . 0.0 109.883 -179.409 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 2170 ' ' CYS . . . . . 0.559 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 1.3 t -66.34 -12.04 54.44 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.165 -0.959 . . . . 0.0 108.891 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2171 ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.1 OUTLIER -73.68 -2.28 22.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.393 -0.817 . . . . 0.0 109.243 179.447 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 2172 ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' 2169 ' ' GLU . 34.4 t -84.23 -69.71 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.21 -0.931 . . . . 0.0 109.549 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2173 ' ' GLY . . . . . 0.431 ' O ' ' C ' ' A' 2174 ' ' ASN . . . 164.26 76.46 0.03 OUTLIER Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.069 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2174 ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' 2178 ' ' ASN . 3.5 t-20 43.2 83.78 0.2 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.253 -1.145 . . . . 0.0 109.613 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2175 ' ' PRO . . . . . 0.633 ' HG2' ' CD2' ' A' 2188 ' ' PHE . 1.4 Cg_endo -66.76 -20.03 52.7 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.257 1.971 . . . . 0.0 110.537 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2176 ' ' CYS . . . . . 0.532 ' SG ' ' HB3' ' A' 2204 ' ' CYS . 1.4 m -64.79 -55.41 19.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.169 -0.957 . . . . 0.0 109.926 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 160.2 -28.94 0.35 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2178 ' ' ASN . . . . . 0.503 ' N ' ' OD1' ' A' 2174 ' ' ASN . 1.5 t-20 -171.05 -26.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.185 -1.185 . . . . 0.0 110.966 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2179 ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -59.66 -124.09 0.01 OUTLIER Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.787 -1.196 . . . . 0.0 110.309 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2180 ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' 2190 ' ' CYS . 1.1 p -136.64 151.07 48.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.394 -1.062 . . . . 0.0 109.227 -179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2181 ' ' CYS . . . . . 0.568 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 23.0 p -99.54 150.19 22.48 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.089 -1.007 . . . . 0.0 111.468 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2182 ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' 2189 ' ' GLU . 0.5 OUTLIER -132.4 160.79 35.35 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.381 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 2183 ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' A' 2168 ' ' ASP . 57.0 t30 -100.28 123.7 44.83 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.579 -1.326 . . . . 0.0 109.21 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2184 ' ' VAL . . . . . 0.828 HG12 ' N ' ' A' 2188 ' ' PHE . 0.5 OUTLIER -130.89 -174.96 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -179.371 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 2185 ' ' ILE . . . . . 0.593 HG23 ' OH ' ' A' 2157 ' ' TYR . 3.3 mp -94.62 139.26 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.028 -1.045 . . . . 0.0 110.287 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 69.78 10.06 63.59 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2187 ' ' GLY . . . . . 0.532 ' HA3' ' HB2' ' A' 2201 ' ' MET . . . 166.2 -118.11 0.78 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.514 -1.326 . . . . 0.0 110.078 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2188 ' ' PHE . . . . . 0.828 ' N ' HG12 ' A' 2184 ' ' VAL . 1.8 p90 -166.46 -179.45 4.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.264 -1.139 . . . . 0.0 109.889 -179.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2189 ' ' GLU . . . . . 0.591 ' OE1' HG21 ' A' 2184 ' ' VAL . 0.1 OUTLIER -132.09 94.04 3.39 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.406 -0.808 . . . . 0.0 109.286 178.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 2190 ' ' CYS . . . . . 0.527 ' HB3' ' HA ' ' A' 2181 ' ' CYS . 9.1 p -114.26 139.26 49.56 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.92 -1.112 . . . . 0.0 109.802 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2191 ' ' THR . . . . . 0.526 ' O ' ' HA3' ' A' 2179 ' ' GLY . 1.8 m -113.85 106.58 14.62 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2192 ' ' CYS . . . . . 0.669 ' HB2' ' CD2' ' A' 2196 ' ' PHE . 0.5 OUTLIER -53.54 -172.36 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.057 -1.027 . . . . 0.0 110.157 -178.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 2193 ' ' GLU . . . . . 0.435 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.2 tp10 -68.03 136.43 53.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.656 -0.652 . . . . 0.0 110.1 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2194 ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.0 OUTLIER -40.37 131.5 2.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.523 -0.736 . . . . 0.0 110.203 179.933 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 116.75 12.76 8.37 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2196 ' ' PHE . . . . . 0.701 ' CD2' ' HB2' ' A' 2204 ' ' CYS . 8.0 p90 -128.99 -158.71 0.9 Allowed 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.575 -0.956 . . . . 0.0 110.22 -178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2197 ' ' GLU . . . . . 0.555 ' N ' ' CD2' ' A' 2196 ' ' PHE . 25.7 mt-10 -147.16 96.7 4.21 Favored Pre-proline 0 C--N 1.306 -1.319 0 O-C-N 121.565 -0.709 . . . . 0.0 109.496 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2198 ' ' PRO . . . . . 0.633 ' CD ' ' CE2' ' A' 2196 ' ' PHE . 2.2 Cg_endo -62.41 -170.65 0.09 OUTLIER 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.356 2.037 . . . . 0.0 111.148 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -147.58 -168.02 13.74 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.04 -80.22 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.259 1.973 . . . . 0.0 110.929 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2201 ' ' MET . . . . . 0.532 ' HB2' ' HA3' ' A' 2187 ' ' GLY . 0.0 OUTLIER -142.54 42.11 1.6 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.159 -0.963 . . . . 0.0 110.115 -179.237 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A 2202 ' ' MET . . . . . . . . . . . . . 2.0 mmm -114.23 -72.28 0.71 Allowed 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.411 -0.806 . . . . 0.0 109.502 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2203 ' ' THR . . . . . 0.486 ' OG1' ' HA ' ' A' 2176 ' ' CYS . 11.8 t -166.84 -165.91 0.78 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2204 ' ' CYS . . . . . 0.701 ' HB2' ' CD2' ' A' 2196 ' ' PHE . 31.3 p -104.1 114.14 28.17 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.853 -1.155 . . . . 0.0 110.232 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A 2205 ' ' GLU . . . . . 0.423 ' CG ' ' O ' ' A' 2205 ' ' GLU . 9.1 pt-20 . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.513 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A 2124 ' ' SER . . . . . 0.685 ' O ' ' HB2' ' A' 2125 ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2125 ' ' ALA . . . . . 0.685 ' HB2' ' O ' ' A' 2124 ' ' SER . . . 164.84 -87.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 109.475 179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2126 ' ' VAL . . . . . . . . . . . . . 38.7 t -119.39 156.32 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.278 -0.889 . . . . 0.0 109.521 -179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 2127 ' ' ASP . . . . . . . . . . . . . 2.8 p30 -75.39 -161.72 0.16 Allowed 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.268 -0.895 . . . . 0.0 109.713 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 2128 ' ' MET . . . . . . . . . . . . . 9.4 mtt -53.9 141.7 26.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.37 -0.831 . . . . 0.0 109.855 -179.857 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 2129 ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' 2130 ' ' GLU . 16.6 t0 -69.6 -44.98 69.65 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.413 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2130 ' ' GLU . . . . . 0.598 ' HB3' ' CD2' ' A' 2149 ' ' TYR . 2.0 mt-10 82.87 -47.11 0.15 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.845 -0.534 . . . . 0.0 109.942 179.597 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2131 ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' 2137 ' ' CYS . 0.0 OUTLIER -80.9 -46.14 15.67 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.963 -1.086 . . . . 0.0 109.152 179.968 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 2132 ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.88 -16.31 4.47 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.14 -0.975 . . . . 0.0 109.79 179.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2133 ' ' GLU . . . . . 0.437 ' HG3' ' C ' ' A' 2130 ' ' GLU . 7.5 mt-10 -69.95 146.06 94.84 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.264 -0.898 . . . . 0.0 110.204 -179.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2134 ' ' PRO . . . . . 0.528 ' O ' ' CE ' ' A' 2138 ' ' LYS . 6.4 Cg_endo -72.55 2.27 5.37 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.597 2.198 . . . . 0.0 110.309 179.113 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2135 ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' 2162 ' ' ASN . 36.3 t70 -108.43 -14.29 14.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.96 -1.087 . . . . 0.0 109.693 -179.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2136 ' ' VAL . . . . . 0.576 ' CG1' ' CE1' ' A' 2149 ' ' TYR . 2.3 t -112.21 -136.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.093 -1.005 . . . . 0.0 109.074 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2137 ' ' CYS . . . . . 0.497 ' HB3' ' SG ' ' A' 2131 ' ' CYS . 1.9 t -44.54 105.72 0.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.018 -1.051 . . . . 0.0 108.68 179.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2138 ' ' LYS . . . . . 0.528 ' CE ' ' O ' ' A' 2134 ' ' PRO . 3.7 mttm -114.22 18.35 17.09 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.336 -0.852 . . . . 0.0 110.332 -178.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2139 ' ' HIS . . . . . 0.492 ' O ' ' HB3' ' A' 2164 ' ' CYS . 0.9 OUTLIER 171.77 50.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.892 -1.13 . . . . 0.0 110.461 179.773 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 2140 ' ' GLY . . . . . . . . . . . . . . . -169.83 -175.22 38.7 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.647 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -89.78 142.8 27.35 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.348 -1.09 . . . . 0.0 108.611 179.562 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 2142 ' ' CYS . . . . . 0.678 ' C ' HD12 ' A' 2143 ' ' ILE . 0.8 OUTLIER -128.78 175.93 8.22 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.092 -1.005 . . . . 0.0 110.492 -178.972 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 2143 ' ' ILE . . . . . 0.678 HD12 ' C ' ' A' 2142 ' ' CYS . 4.9 mp -139.51 107.92 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2144 ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' 2129 ' ' ASP . 5.2 t-20 -64.18 119.08 9.54 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.346 -0.846 . . . . 0.0 110.886 -178.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2145 ' ' THR . . . . . 0.423 ' OG1' ' C ' ' A' 2148 ' ' SER . 72.4 p -116.07 -179.08 3.56 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2146 ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -101.35 109.75 21.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.957 . . . . 0.0 109.59 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 89.81 13.94 60.21 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.946 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 2148 ' ' SER . . . . . 0.423 ' C ' ' OG1' ' A' 2145 ' ' THR . 0.1 OUTLIER -178.72 -160.62 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.239 -1.153 . . . . 0.0 109.688 -179.866 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 2149 ' ' TYR . . . . . 0.598 ' CD2' ' HB3' ' A' 2130 ' ' GLU . 22.2 p90 -171.31 -174.43 1.45 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.397 -0.814 . . . . 0.0 108.979 179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2150 ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' 2142 ' ' CYS . 0.0 OUTLIER -157.4 112.62 2.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.119 -0.988 . . . . 0.0 109.636 179.604 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 2151 ' ' CYS . . . . . . . . . . . . . 40.1 t -98.5 87.06 3.73 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.582 -0.699 . . . . 0.0 109.505 179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -86.57 105.98 17.23 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.198 -0.938 . . . . 0.0 109.322 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 2153 ' ' CYS . . . . . 0.507 ' SG ' ' HD2' ' A' 2154 ' ' PRO . 0.0 OUTLIER -66.64 159.9 71.17 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 109.649 -179.624 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 2154 ' ' PRO . . . . . 0.507 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 0.9 OUTLIER -64.46 -166.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.61 2.207 . . . . 0.0 111.276 -179.024 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 21.0 t80 -90.21 103.42 16.1 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 130.81 -17.19 5.24 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 107.909 -2.076 . . . . 0.0 107.909 -178.393 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 2157 ' ' TYR . . . . . 0.56 ' OH ' HG23 ' A' 2185 ' ' ILE . 9.7 m-85 -107.81 -172.34 2.05 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.625 -0.927 . . . . 0.0 109.799 179.866 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2158 ' ' ILE . . . . . 0.76 ' H ' HD13 ' A' 2158 ' ' ILE . 0.1 OUTLIER -155.5 -165.43 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.555 -0.716 . . . . 0.0 109.796 179.418 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 2159 ' ' LEU . . . . . 0.52 HD12 ' O ' ' A' 2163 ' ' GLU . 27.9 tp -141.9 121.8 13.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.387 -0.821 . . . . 0.0 109.508 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -94.63 50.94 1.37 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.357 -0.84 . . . . 0.0 109.83 -179.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 2161 ' ' GLY . . . . . . . . . . . . . . . 91.32 -18.43 51.97 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.286 -1.126 . . . . 0.0 110.286 179.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 2162 ' ' ASN . . . . . 0.523 ' OD1' HG13 ' A' 2136 ' ' VAL . 1.6 m-20 -178.03 -47.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.023 -1.281 . . . . 0.0 109.851 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2163 ' ' GLU . . . . . 0.52 ' O ' HD12 ' A' 2159 ' ' LEU . 78.7 tt0 -75.31 146.05 41.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.264 -0.898 . . . . 0.0 109.035 179.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2164 ' ' CYS . . . . . 0.722 ' O ' HG13 ' A' 2165 ' ' VAL . 0.0 OUTLIER -115.35 140.9 48.71 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.031 -1.043 . . . . 0.0 109.395 -179.958 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 2165 ' ' VAL . . . . . 0.722 HG13 ' O ' ' A' 2164 ' ' CYS . 4.7 m -162.42 -170.13 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.29 -0.881 . . . . 0.0 109.767 -179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2166 ' ' ASP . . . . . 0.478 ' OD2' ' HA ' ' A' 2185 ' ' ILE . 1.3 t0 -89.78 144.77 25.69 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 109.415 179.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2167 ' ' THR . . . . . 0.707 HG23 ' OE1' ' A' 2169 ' ' GLU . 8.9 t -85.39 170.74 12.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.306 -0.871 . . . . 0.0 109.682 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2168 ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' 2171 ' ' SER . 66.9 t0 -81.67 94.5 6.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.196 -0.94 . . . . 0.0 108.592 179.115 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2169 ' ' GLU . . . . . 0.707 ' OE1' HG23 ' A' 2167 ' ' THR . 0.4 OUTLIER -65.56 -26.42 67.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 110.532 -179.012 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 2170 ' ' CYS . . . . . 0.43 ' HB2' ' HB2' ' A' 2181 ' ' CYS . 1.3 t -57.92 -12.82 3.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.912 -1.117 . . . . 0.0 108.77 178.461 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2171 ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' 2168 ' ' ASP . 0.1 OUTLIER -59.44 -13.12 7.47 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.195 -0.94 . . . . 0.0 109.881 -179.553 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 2172 ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' 2169 ' ' GLU . 22.1 t -73.14 -67.95 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.312 -0.867 . . . . 0.0 109.242 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2173 ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' 2174 ' ' ASN . . . 154.95 85.55 0.05 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.856 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2174 ' ' ASN . . . . . 0.422 ' O ' ' O ' ' A' 2173 ' ' GLY . 1.1 t-20 47.31 91.55 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.26 -1.141 . . . . 0.0 109.421 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2175 ' ' PRO . . . . . 0.64 ' CB ' ' CD1' ' A' 2188 ' ' PHE . 1.0 OUTLIER -62.95 -21.95 73.5 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.078 1.852 . . . . 0.0 110.222 -179.899 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 2176 ' ' CYS . . . . . 0.528 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.1 OUTLIER -75.97 -64.67 1.04 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.106 -0.996 . . . . 0.0 108.926 179.68 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 147.93 -14.84 1.35 Allowed Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.194 -1.562 . . . . 0.0 109.194 -179.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 2178 ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -166.93 -34.76 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.205 -1.173 . . . . 0.0 110.106 -179.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2179 ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -61.48 -108.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.451 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.18 157.19 42.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.393 -1.063 . . . . 0.0 109.307 -179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2181 ' ' CYS . . . . . 0.548 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 26.7 p -93.65 159.93 15.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.026 -1.046 . . . . 0.0 110.237 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2182 ' ' LYS . . . . . 0.546 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 0.0 OUTLIER -146.5 154.24 41.33 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.365 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 2183 ' ' ASN . . . . . 0.469 ' N ' ' HG3' ' A' 2182 ' ' LYS . 56.0 t30 -98.48 121.46 40.45 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.685 -1.259 . . . . 0.0 109.413 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2184 ' ' VAL . . . . . 0.738 HG13 ' N ' ' A' 2185 ' ' ILE . 0.3 OUTLIER -123.45 -162.78 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.524 -0.735 . . . . 0.0 109.558 -179.28 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 2185 ' ' ILE . . . . . 0.738 ' N ' HG13 ' A' 2184 ' ' VAL . 2.7 mp -108.52 138.36 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.186 -0.946 . . . . 0.0 110.213 -179.248 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 64.83 16.31 61.34 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 179.34 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 2187 ' ' GLY . . . . . 0.526 ' C ' HG12 ' A' 2184 ' ' VAL . . . 167.56 -128.08 1.67 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.396 -1.481 . . . . 0.0 109.396 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2188 ' ' PHE . . . . . 0.659 ' N ' HG12 ' A' 2184 ' ' VAL . 5.7 p90 -162.6 170.4 18.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.218 -1.166 . . . . 0.0 109.374 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2189 ' ' GLU . . . . . 0.546 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 0.6 OUTLIER -120.57 151.28 39.63 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.314 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 2190 ' ' CYS . . . . . . . . . . . . . 17.8 p -149.96 141.03 22.98 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.756 -1.215 . . . . 0.0 109.794 -179.458 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 2191 ' ' THR . . . . . 0.493 ' O ' ' HA3' ' A' 2179 ' ' GLY . 22.2 m -114.92 88.03 2.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.915 . . . . 0.0 109.773 179.949 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2192 ' ' CYS . . . . . 0.628 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.8 OUTLIER -51.5 -178.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.303 -0.873 . . . . 0.0 109.119 179.654 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 2193 ' ' GLU . . . . . 0.464 ' O ' ' C ' ' A' 2194 ' ' GLU . 0.6 OUTLIER -58.15 123.59 16.51 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.374 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 2194 ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.8 OUTLIER -37.76 131.81 0.97 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.436 -0.79 . . . . 0.0 110.506 -178.796 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.03 -0.18 10.73 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.04 -1.624 . . . . 0.0 109.04 -179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 2196 ' ' PHE . . . . . 0.68 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 0.9 OUTLIER -113.69 -164.43 0.93 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.272 -1.134 . . . . 0.0 110.227 -179.904 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 2197 ' ' GLU . . . . . 0.532 ' N ' ' CG ' ' A' 2196 ' ' PHE . 2.5 mm-40 -145.33 96.31 4.9 Favored Pre-proline 0 C--N 1.302 -1.469 0 O-C-N 121.541 -0.724 . . . . 0.0 109.665 -179.478 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2198 ' ' PRO . . . . . 0.68 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 7.8 Cg_endo -67.79 -160.64 0.05 OUTLIER 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.162 1.908 . . . . 0.0 111.138 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -140.29 -177.24 15.75 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 179.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -62.02 -57.44 0.51 Allowed 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.051 1.834 . . . . 0.0 110.399 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 2201 ' ' MET . . . . . 0.496 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.4 OUTLIER -158.41 60.74 0.44 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.615 -179.858 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 2202 ' ' MET . . . . . 0.464 ' O ' ' CE1' ' A' 2188 ' ' PHE . 0.8 OUTLIER -129.21 -77.16 0.55 Allowed 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.192 -0.943 . . . . 0.0 109.542 -179.589 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A 2203 ' ' THR . . . . . . . . . . . . . 12.7 t -177.15 -173.91 0.48 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.398 -0.814 . . . . 0.0 109.485 179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 2204 ' ' CYS . . . . . 0.528 ' HB2' ' CA ' ' A' 2176 ' ' CYS . 7.7 t -71.99 148.82 45.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.459 -0.776 . . . . 0.0 109.467 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A 2205 ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' 2197 ' ' GLU . 14.7 pt-20 . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.539 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A 2124 ' ' SER . . . . . . . . . . . . . 15.7 m . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A 2125 ' ' ALA . . . . . 0.467 ' O ' ' O ' ' A' 2126 ' ' VAL . . . -78.59 145.82 34.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.38 -0.825 . . . . 0.0 109.483 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2126 ' ' VAL . . . . . 0.792 HG23 ' N ' ' A' 2127 ' ' ASP . 0.8 OUTLIER 37.69 -160.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 O-C-N 121.63 -0.669 . . . . 0.0 110.389 179.283 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A 2127 ' ' ASP . . . . . 0.792 ' N ' HG23 ' A' 2126 ' ' VAL . 12.6 t0 -80.91 -47.27 13.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2128 ' ' MET . . . . . 0.504 ' H ' HG23 ' A' 2126 ' ' VAL . 0.0 OUTLIER 73.57 99.77 0.07 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.19 -0.944 . . . . 0.0 109.117 -179.68 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A 2129 ' ' ASP . . . . . 0.555 ' HB3' ' CG ' ' A' 2132 ' ' LYS . 10.7 t70 -56.0 -42.65 76.7 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.398 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2130 ' ' GLU . . . . . 0.738 ' O ' HG21 ' A' 2136 ' ' VAL . 1.7 mt-10 80.43 -41.55 0.2 Allowed 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.021 0.438 . . . . 0.0 110.197 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2131 ' ' CYS . . . . . 0.485 ' SG ' ' HB3' ' A' 2137 ' ' CYS . 0.7 OUTLIER -90.93 -27.18 18.89 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 179.263 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A 2132 ' ' LYS . . . . . 0.555 ' CG ' ' HB3' ' A' 2129 ' ' ASP . 0.0 OUTLIER -56.7 -19.94 19.19 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.304 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A 2133 ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' 2134 ' ' PRO . 0.8 OUTLIER -70.06 137.86 87.25 Favored Pre-proline 0 N--CA 1.487 1.413 0 O-C-N 121.519 -0.738 . . . . 0.0 109.443 -179.819 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A 2134 ' ' PRO . . . . . 0.472 ' O ' ' HD2' ' A' 2138 ' ' LYS . 4.3 Cg_endo -69.38 0.08 5.86 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.346 2.03 . . . . 0.0 111.181 -179.63 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2135 ' ' ASP . . . . . . . . . . . . . 22.7 t70 -124.14 1.07 8.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.766 -1.209 . . . . 0.0 110.344 -179.353 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 2136 ' ' VAL . . . . . 0.738 HG21 ' O ' ' A' 2130 ' ' GLU . 40.5 t -91.73 -95.8 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.895 -1.128 . . . . 0.0 109.537 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2137 ' ' CYS . . . . . 0.737 ' N ' HG12 ' A' 2136 ' ' VAL . 48.3 t -84.3 -73.24 0.43 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.995 -1.065 . . . . 0.0 109.23 179.876 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2138 ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' 2164 ' ' CYS . 0.0 OUTLIER 64.98 127.05 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.266 -0.896 . . . . 0.0 110.34 179.344 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A 2139 ' ' HIS . . . . . 0.512 ' O ' ' HB3' ' A' 2164 ' ' CYS . 9.6 m-70 51.03 26.4 2.74 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.371 -0.831 . . . . 0.0 110.934 178.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2140 ' ' GLY . . . . . 0.434 ' HA3' ' SG ' ' A' 2137 ' ' CYS . . . -128.98 166.89 21.28 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.399 -1.381 . . . . 0.0 110.197 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2141 ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -89.45 47.87 1.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.258 -1.142 . . . . 0.0 109.003 179.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 2142 ' ' CYS . . . . . 0.786 ' O ' HD13 ' A' 2143 ' ' ILE . 1.6 p -49.23 160.58 0.22 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.625 -0.672 . . . . 0.0 110.184 -179.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2143 ' ' ILE . . . . . 0.786 HD13 ' O ' ' A' 2142 ' ' CYS . 38.1 mm -133.35 121.3 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.267 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2144 ' ' ASN . . . . . 0.498 ' ND2' ' HA ' ' A' 2129 ' ' ASP . 13.3 t-20 -64.33 116.51 6.12 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.343 -0.848 . . . . 0.0 110.864 -179.088 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2145 ' ' THR . . . . . 0.522 ' OG1' ' HA ' ' A' 2149 ' ' TYR . 0.0 OUTLIER -108.89 175.4 5.48 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.455 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A 2146 ' ' ASP . . . . . 0.447 ' OD1' ' O ' ' A' 2146 ' ' ASP . 4.2 p30 -70.08 103.06 2.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.26 -0.9 . . . . 0.0 110.042 -179.608 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2147 ' ' GLY . . . . . . . . . . . . . . . 65.79 10.89 52.39 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.078 -1.209 . . . . 0.0 110.078 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 2148 ' ' SER . . . . . 0.459 ' O ' ' OE1' ' A' 2130 ' ' GLU . 0.0 OUTLIER -145.84 -174.7 4.49 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.112 -1.228 . . . . 0.0 109.607 -179.987 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A 2149 ' ' TYR . . . . . 0.649 ' CD1' ' HB3' ' A' 2130 ' ' GLU . 38.7 p90 -161.78 -170.02 2.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.364 -0.835 . . . . 0.0 109.519 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2150 ' ' ARG . . . . . 0.449 ' CZ ' ' CB ' ' A' 2150 ' ' ARG . 0.0 OUTLIER -170.75 104.18 0.25 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.485 -0.759 . . . . 0.0 109.51 179.531 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A 2151 ' ' CYS . . . . . 0.504 ' SG ' HD13 ' A' 2159 ' ' LEU . 36.5 t -72.14 84.09 1.01 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.37 -0.831 . . . . 0.0 109.151 179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2152 ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -93.47 87.48 5.58 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.364 -0.835 . . . . 0.0 109.208 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 2153 ' ' CYS . . . . . 0.54 ' SG ' ' HB3' ' A' 2157 ' ' TYR . 0.0 OUTLIER -49.79 152.87 2.37 Favored Pre-proline 0 C--N 1.302 -1.49 0 O-C-N 121.397 -0.815 . . . . 0.0 109.723 -179.625 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A 2154 ' ' PRO . . . . . 0.456 ' HD2' ' SG ' ' A' 2153 ' ' CYS . 2.8 Cg_endo -65.4 -165.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.585 2.19 . . . . 0.0 111.018 -179.254 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2155 ' ' PHE . . . . . . . . . . . . . 77.7 t80 -91.19 101.94 14.67 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 2156 ' ' GLY . . . . . . . . . . . . . . . 131.14 -11.88 5.56 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 -178.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 2157 ' ' TYR . . . . . 0.54 ' HB3' ' SG ' ' A' 2153 ' ' CYS . 7.5 m-85 -110.16 -166.84 1.12 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.41 -1.053 . . . . 0.0 109.873 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2158 ' ' ILE . . . . . 0.921 HD11 HG23 ' A' 2165 ' ' VAL . 0.1 OUTLIER -156.5 -165.23 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.507 -0.745 . . . . 0.0 109.395 179.243 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A 2159 ' ' LEU . . . . . 0.504 HD13 ' SG ' ' A' 2151 ' ' CYS . 28.5 tp -142.75 117.2 9.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.259 -0.9 . . . . 0.0 109.639 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2160 ' ' ALA . . . . . . . . . . . . . . . -89.89 49.71 1.76 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.387 -0.821 . . . . 0.0 109.417 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 2161 ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' 2162 ' ' ASN . . . 90.62 -17.79 52.94 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2162 ' ' ASN . . . . . 0.489 ' CG ' ' N ' ' A' 2163 ' ' GLU . 3.1 p-10 -178.89 -49.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.105 -1.233 . . . . 0.0 109.793 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2163 ' ' GLU . . . . . 0.489 ' N ' ' CG ' ' A' 2162 ' ' ASN . 5.5 tt0 -70.87 133.41 46.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.505 -0.747 . . . . 0.0 109.236 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2164 ' ' CYS . . . . . 0.512 ' HB3' ' O ' ' A' 2139 ' ' HIS . 0.0 OUTLIER -106.97 137.23 45.42 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.024 -1.047 . . . . 0.0 109.73 -179.628 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A 2165 ' ' VAL . . . . . 0.921 HG23 HD11 ' A' 2158 ' ' ILE . 1.9 m -152.07 -170.49 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.165 -0.959 . . . . 0.0 109.723 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2166 ' ' ASP . . . . . . . . . . . . . 27.0 t70 -76.75 166.94 22.67 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.366 -0.834 . . . . 0.0 110.164 -179.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 2167 ' ' THR . . . . . 0.536 ' CG2' ' OE1' ' A' 2169 ' ' GLU . 1.4 t -116.83 -169.21 1.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.435 -0.791 . . . . 0.0 109.138 179.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2168 ' ' ASP . . . . . 0.522 ' N ' HG23 ' A' 2167 ' ' THR . 56.1 t0 -108.94 101.26 10.37 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.15 -0.969 . . . . 0.0 109.492 179.513 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2169 ' ' GLU . . . . . 0.588 ' HB2' ' HB3' ' A' 2188 ' ' PHE . 0.9 OUTLIER -81.8 -29.75 32.56 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.413 -0.804 . . . . 0.0 109.396 179.916 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A 2170 ' ' CYS . . . . . 0.532 ' HA ' ' HB2' ' A' 2181 ' ' CYS . 2.0 t -71.71 -4.82 29.64 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.456 -0.777 . . . . 0.0 109.07 179.458 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2171 ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.65 -9.3 34.51 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.944 . . . . 0.0 109.516 179.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2172 ' ' VAL . . . . . . . . . . . . . 20.6 t -82.22 -70.33 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.941 . . . . 0.0 109.554 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 2173 ' ' GLY . . . . . 0.419 ' O ' ' SG ' ' A' 2181 ' ' CYS . . . -173.48 -73.84 0.05 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2174 ' ' ASN . . . . . 0.5 ' HA ' ' HB3' ' A' 2181 ' ' CYS . 0.1 OUTLIER -167.09 96.18 0.67 Allowed Pre-proline 0 N--CA 1.488 1.45 0 O-C-N 121.21 -1.17 . . . . 0.0 109.089 -179.465 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A 2175 ' ' PRO . . . . . 0.586 ' CD ' ' HB3' ' A' 2181 ' ' CYS . 2.2 Cg_endo -63.22 -27.94 72.72 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 121.952 1.768 . . . . 0.0 110.615 -179.654 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2176 ' ' CYS . . . . . 0.55 ' CA ' ' HB2' ' A' 2204 ' ' CYS . 0.0 OUTLIER -51.46 -54.96 21.67 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.037 -1.039 . . . . 0.0 108.596 -179.974 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A 2177 ' ' GLY . . . . . . . . . . . . . . . 138.6 -17.43 3.28 Favored Glycine 0 N--CA 1.482 1.756 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 2178 ' ' ASN . . . . . 0.424 ' O ' ' O ' ' A' 2179 ' ' GLY . 1.6 t-20 -164.49 -37.81 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -1.091 . . . . 0.0 109.98 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2179 ' ' GLY . . . . . 0.57 ' HA3' ' HA ' ' A' 2192 ' ' CYS . . . -60.17 -116.07 0.01 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2180 ' ' THR . . . . . . . . . . . . . 3.0 p -149.59 162.7 39.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.402 -1.057 . . . . 0.0 109.423 -179.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 2181 ' ' CYS . . . . . 0.586 ' HB3' ' CD ' ' A' 2175 ' ' PRO . 21.6 p -97.83 156.41 16.6 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.045 -1.034 . . . . 0.0 111.074 -179.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2182 ' ' LYS . . . . . 0.571 ' HB3' ' HB3' ' A' 2189 ' ' GLU . 2.4 tppt? -137.97 159.58 41.63 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 178.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2183 ' ' ASN . . . . . . . . . . . . . 60.1 t30 -100.66 126.64 47.19 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.46 -1.4 . . . . 0.0 109.471 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 2184 ' ' VAL . . . . . 0.927 HG12 ' N ' ' A' 2188 ' ' PHE . 0.7 OUTLIER -137.61 162.38 32.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.521 -0.737 . . . . 0.0 109.242 -179.656 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A 2185 ' ' ILE . . . . . 0.522 ' CG2' ' OH ' ' A' 2157 ' ' TYR . 3.2 mp -76.64 130.51 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 110.258 -179.255 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2186 ' ' GLY . . . . . . . . . . . . . . . 89.86 -8.51 79.69 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 2187 ' ' GLY . . . . . 0.493 ' C ' HG12 ' A' 2184 ' ' VAL . . . 174.2 -109.41 0.3 Allowed Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.588 -1.292 . . . . 0.0 109.925 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2188 ' ' PHE . . . . . 0.927 ' N ' HG12 ' A' 2184 ' ' VAL . 3.4 p90 -171.16 178.58 3.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.276 -1.132 . . . . 0.0 109.488 -179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2189 ' ' GLU . . . . . 0.571 ' HB3' ' HB3' ' A' 2182 ' ' LYS . 3.1 tt0 -128.13 131.98 48.96 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.243 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2190 ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' 2176 ' ' CYS . 18.3 p -124.07 137.5 54.57 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.576 -1.328 . . . . 0.0 110.039 -179.144 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2191 ' ' THR . . . . . 0.453 ' O ' ' O ' ' A' 2192 ' ' CYS . 25.6 m -108.8 85.28 2.07 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.334 -0.854 . . . . 0.0 109.552 179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2192 ' ' CYS . . . . . 0.61 ' HB2' ' CE1' ' A' 2196 ' ' PHE . 0.9 OUTLIER -49.23 179.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.515 -0.741 . . . . 0.0 109.19 179.893 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A 2193 ' ' GLU . . . . . 0.509 ' O ' ' C ' ' A' 2194 ' ' GLU . 1.3 tt0 -55.22 112.87 1.18 Allowed 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.658 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2194 ' ' GLU . . . . . 0.509 ' C ' ' O ' ' A' 2193 ' ' GLU . 0.8 OUTLIER -28.26 127.43 0.08 Allowed 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.446 0.641 . . . . 0.0 111.263 -178.775 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A 2195 ' ' GLY . . . . . . . . . . . . . . . 122.18 6.65 8.16 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 2196 ' ' PHE . . . . . 0.67 ' CZ ' ' CG ' ' A' 2198 ' ' PRO . 1.2 p90 -117.89 -163.26 0.93 Allowed 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.288 -1.125 . . . . 0.0 110.231 -179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2197 ' ' GLU . . . . . 0.549 ' N ' ' CG ' ' A' 2196 ' ' PHE . 11.8 mt-10 -144.57 95.82 5.32 Favored Pre-proline 0 C--N 1.304 -1.41 0 O-C-N 121.507 -0.746 . . . . 0.0 109.527 -179.699 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2198 ' ' PRO . . . . . 0.67 ' CG ' ' CZ ' ' A' 2196 ' ' PHE . 8.3 Cg_endo -67.52 -165.13 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.274 1.983 . . . . 0.0 111.199 -179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2199 ' ' GLY . . . . . . . . . . . . . . . -129.37 -171.59 12.98 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.695 -1.762 . . . . 0.0 108.695 179.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 2200 ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.79 -58.41 0.19 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.154 1.902 . . . . 0.0 111.169 -179.646 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 2201 ' ' MET . . . . . 0.517 ' HA ' ' O ' ' A' 2188 ' ' PHE . 0.0 OUTLIER -157.18 43.1 0.34 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.091 -1.006 . . . . 0.0 110.52 -179.119 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A 2202 ' ' MET . . . . . 0.451 ' O ' ' CE2' ' A' 2188 ' ' PHE . 17.2 mmm -115.82 -82.9 0.62 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.12 -0.987 . . . . 0.0 109.888 179.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2203 ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' 2175 ' ' PRO . 9.7 t -165.11 -169.97 1.8 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.182 -0.949 . . . . 0.0 109.604 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2204 ' ' CYS . . . . . 0.576 ' SG ' ' CD2' ' A' 2196 ' ' PHE . 4.6 t -71.69 146.35 48.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.244 -0.91 . . . . 0.0 109.616 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A 2205 ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.334 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A 2224 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A 2225 ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_